Citrus Sinensis ID: 042913
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | 2.2.26 [Sep-21-2011] | |||||||
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.719 | 0.434 | 0.448 | 5e-55 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.753 | 0.545 | 0.465 | 7e-55 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.694 | 0.373 | 0.473 | 3e-54 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.763 | 0.397 | 0.472 | 4e-54 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.694 | 0.373 | 0.473 | 4e-54 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.608 | 0.391 | 0.485 | 1e-53 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.681 | 0.446 | 0.457 | 6e-51 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.583 | 0.198 | 0.529 | 2e-49 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.785 | 0.430 | 0.429 | 2e-49 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.646 | 0.224 | 0.427 | 5e-47 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 214 bits (546), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 112/250 (44%), Positives = 158/250 (63%), Gaps = 22/250 (8%)
Query: 34 LARSSLTLSFNESLLSGCT--PHSSTTTT------TTTPATSSTSSLHHH---------- 75
+A SS+ NES T P SS T+ T +P+ SS S L +H
Sbjct: 1 MANSSIFYKDNESDYESSTVGPDSSRRTSWLSSSFTASPSCSSISHLSNHGLNSYNQSKP 60
Query: 76 -RKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC-TSANFALKV 133
+ + + W A+ A + L H +L++ LG+G++G V+LC +R +A +A+KV
Sbjct: 61 HKANQVAWEAM-ARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIRGSPETAFYAMKV 119
Query: 134 VDKDLLSAKK-LSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP 192
VDK+ ++ KK L +ME +IL MLDHPF PTLYA E SHY +++YCP GDL+++
Sbjct: 120 VDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVRL 179
Query: 193 KQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252
+QP+ RF++ + RF+AAE LV LEYLH +GI+YRDLKPEN+L+REDGH+MLSDFDL F+
Sbjct: 180 RQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFKC 239
Query: 253 DVVPTLVETN 262
DVVP + N
Sbjct: 240 DVVPQFLSDN 249
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 7e-55, Method: Compositional matrix adjust.
Identities = 120/258 (46%), Positives = 157/258 (60%), Gaps = 19/258 (7%)
Query: 61 TTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCH 120
+T P S SL HR SD ++ I+ L R +L+R +G G++G V+LC
Sbjct: 38 STIPEEESFLSLKPHRSSDFAYAEIRRRKKQG----LTFRDFRLMRRIGAGDIGTVYLCR 93
Query: 121 L----RDCTSANFALKVVDKDLLSAKKLSH-VQMEAEILSMLDHPFLPTLYAHLEVSHYI 175
L + S+ FA+KVVDK+ L+ KK H +ME IL MLDHPFLPTLYA E SH+
Sbjct: 94 LAGDEEESRSSYFAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFS 153
Query: 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235
C +++YC GDLHSL +QP+ RFSL + RF+AAEVLV LEYLH LGIIYRDLKPENIL+
Sbjct: 154 CIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILV 213
Query: 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKR--RQENVMEFVA 293
R DGHIMLSDFDL SD + VE++ S ++ R S +R R + + V
Sbjct: 214 RSDGHIMLSDFDLSLCSDSI-AAVESSSSSPENQQLR-------SPRRFTRLARLFQRVL 265
Query: 294 EPRREQREHPAQYSVEQP 311
++ Q P + V +P
Sbjct: 266 RSKKVQTLEPTRLFVAEP 283
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 106/224 (47%), Positives = 145/224 (64%), Gaps = 4/224 (1%)
Query: 49 SGCTPHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHL 108
S C P +S+ + + +S +S H+ +D W AI+ + +G L L H KL++ L
Sbjct: 144 SRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIR--TRDGILGLSHFKLLKKL 201
Query: 109 GTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
G G++G V+L L + T + FA+KV+DK L S KKL Q E EIL LDHPFLPTLY
Sbjct: 202 GCGDIGSVYLSEL-NGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYT 260
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
H E + C ++++CP GDLH+L +Q F QAV+F+ AE+L+ +EYLH LGIIYRD
Sbjct: 261 HFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRD 320
Query: 228 LKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRR 271
LKPEN+L+REDGHIMLSDFDL + V PTL+ ++ A R+
Sbjct: 321 LKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRK 364
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 119/252 (47%), Positives = 164/252 (65%), Gaps = 10/252 (3%)
Query: 15 SFTST-TTDRTFTSSSARSSLARSSLTLSFNES-LLSGCTPHSSTTTTTTTPATSSTSSL 72
SFT+T ++ S S +A SS FNES S C + + + + +S +S L
Sbjct: 144 SFTNTEVSECASVDKSCESEVANSS---DFNESRKTSICRASTGSDASDESSTSSLSSVL 200
Query: 73 HH-HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFAL 131
+ H+ +D+ W AI+A + +G L +RH +L++ LG G++G V+L L T +FA+
Sbjct: 201 YKPHKANDIRWEAIQAVR--TRDGMLEMRHFRLLKKLGCGDIGSVYLAELSG-TRTSFAM 257
Query: 132 KVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSL 190
KV++K +L + KKL Q E EIL LDHPFLPTLY H E + C ++++CP GDLH+L
Sbjct: 258 KVMNKTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHAL 317
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250
+QP FS AVRF+ AEVL+ LEYLH LGIIYRDLKPEN+L+REDGHIMLSDFDL
Sbjct: 318 RQRQPGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 377
Query: 251 QSDVVPTLVETN 262
+ V PTLV+++
Sbjct: 378 RCSVSPTLVKSS 389
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 106/224 (47%), Positives = 144/224 (64%), Gaps = 4/224 (1%)
Query: 49 SGCTPHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHL 108
S C P +S+ + + +S +S H+ +D W AI+ + +G L L H KL++ L
Sbjct: 144 SRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIR--TRDGILGLSHFKLLKKL 201
Query: 109 GTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
G G++G V+L L T + FA+KV+DK L S KKL Q E EIL LDHPFLPTLY
Sbjct: 202 GCGDIGSVYLSELSG-TKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYT 260
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
H E + C ++++CP GDLH+L +Q F QAV+F+ AE+L+ +EYLH LGIIYRD
Sbjct: 261 HFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRD 320
Query: 228 LKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRR 271
LKPEN+L+REDGHIMLSDFDL + V PTL+ ++ A R+
Sbjct: 321 LKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRK 364
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 101/208 (48%), Positives = 139/208 (66%), Gaps = 15/208 (7%)
Query: 63 TPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLR 122
TPA+S H+ + W AI+ + G++ L H +LVR LG+G+LG V+LC LR
Sbjct: 45 TPASSC--RYKPHKANQAEWEAIRRLR--AGAGRVGLEHFRLVRRLGSGDLGNVYLCRLR 100
Query: 123 DCTSAN----------FALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
+ S++ +A+KVVDKD L+ KKL ++E +IL LDHPFLPTLYA E
Sbjct: 101 EPWSSSSMTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEA 160
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
SHY C ++++CP GDLH +QP RF++ + RF+ AE ++ LEYLH +G++YRDLKPE
Sbjct: 161 SHYACLVMEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPE 220
Query: 232 NILLREDGHIMLSDFDLCFQSDVVPTLV 259
N+L+R DGHIMLSDFDL + DVVP L+
Sbjct: 221 NVLVRGDGHIMLSDFDLSLKCDVVPKLL 248
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 107/234 (45%), Positives = 149/234 (63%), Gaps = 18/234 (7%)
Query: 32 SSLARSSLTLSFNESLLSGCTPHSSTTTTTTTPATSSTSSL-HHHRKSDLHWSAIKAATN 90
SSL+R LSF+ C+P ++ T+ + S L HR D+ W+AI+AA+
Sbjct: 51 SSLSR----LSFD------CSPSAAVAAAATSCSPPRASVLLRPHRSGDVAWAAIRAAST 100
Query: 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAK-KLS 145
+S L R KLVR +G G++G V+LC LR + +A+KVVD+ ++ K KL
Sbjct: 101 -TSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERESPCMYAMKVVDRRAVARKQKLG 159
Query: 146 HVQMEAEILSMLDHPFLPTLYAHLEVS-HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAV 204
E IL LDHPFLPTL+A + + H+ C ++++CP GDLHSL + P+ RF L +
Sbjct: 160 RAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFCPGGDLHSLRHRMPSRRFPLPSA 219
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258
RF+AAEVL+ +EYLH +GI+YRDLKPEN+L+R DGHIML+DFDL QS P+L
Sbjct: 220 RFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIMLTDFDLSLQSTTSPSL 273
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 100/189 (52%), Positives = 123/189 (65%), Gaps = 4/189 (2%)
Query: 75 HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV 134
H D+ W AIK G L LRH L++ LG G++G V+L L T+ FA+KV+
Sbjct: 513 HMSMDVRWEAIKHIK--VQYGSLGLRHFNLLKKLGCGDIGTVYLAELIG-TNCLFAIKVM 569
Query: 135 DKDLLSAKKLS-HVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK 193
D + L+ +K S Q E EIL MLDHPFLPTLYA + C +++YCP GDLH L K
Sbjct: 570 DNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQK 629
Query: 194 QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
Q F A RF+ AE+L+ LEYLH LGIIYRDLKPENIL+REDGHIML+DFDL +
Sbjct: 630 QLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCA 689
Query: 254 VVPTLVETN 262
V PTLV +N
Sbjct: 690 VNPTLVRSN 698
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 110/256 (42%), Positives = 154/256 (60%), Gaps = 7/256 (2%)
Query: 5 TNFPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTTTTTP 64
TN T+ + SFT+T F+ ++ S++ + L N ++ + S + +++
Sbjct: 90 TNTFYTEAKQSFTNTE----FSECASISTIGIGGIDLEKNGVMIYRGSIGSDVSDESSSS 145
Query: 65 ATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC 124
S+ + H +D W AI+ + L + KL++ LG G++G V+L L
Sbjct: 146 GLSNAAYKPHRDNNDKRWVAIQEVRS-RVGSSLEAKDFKLIKKLGGGDIGNVYLAELIG- 203
Query: 125 TSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183
T +FA+KV++K ++A KKL Q E EIL LDHPFLPTLY+H E C ++++CP
Sbjct: 204 TGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCP 263
Query: 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML 243
GDLHSL KQ F QA RF+ AEVL+ +EYLH LGIIYRDLKPEN+L+REDGHIML
Sbjct: 264 GGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIML 323
Query: 244 SDFDLCFQSDVVPTLV 259
SDFDL + V PTLV
Sbjct: 324 SDFDLSLRCAVSPTLV 339
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 95/222 (42%), Positives = 139/222 (62%), Gaps = 17/222 (7%)
Query: 75 HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV 134
H K W AIK +S + L H K ++ LG+G+ G V L L+ T +A+K +
Sbjct: 552 HNKESTSWKAIKKIQ--ASGETVGLHHFKPIKPLGSGDTGSVHLVELK-GTGELYAMKAM 608
Query: 135 DKDLLSAKKLSH-VQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK 193
+K ++ + +H +E EI+S+LDHPFLPTLYA + S ++C + D+CP G+L +LL +
Sbjct: 609 EKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDR 668
Query: 194 QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
QP + + RF+AAEV++GLEYLH LGI+YRDLKPENILL++DGHI+L+DFDL F +
Sbjct: 669 QPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTT 728
Query: 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEP 295
P L+ + +A +RRR + + + FVAEP
Sbjct: 729 CTPQLI---IPAAPSKRRRS----------KSQPLPTFVAEP 757
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | ||||||
| 225470800 | 474 | PREDICTED: protein kinase G11A-like [Vit | 0.873 | 0.584 | 0.690 | 2e-95 | |
| 147866010 | 474 | hypothetical protein VITISV_043376 [Viti | 0.873 | 0.584 | 0.687 | 7e-95 | |
| 15220907 | 476 | protein WAG1 [Arabidopsis thaliana] gi|1 | 0.902 | 0.600 | 0.66 | 2e-94 | |
| 3435279 | 476 | protein kinase homolog [Arabidopsis thal | 0.902 | 0.600 | 0.66 | 2e-94 | |
| 297847772 | 483 | hypothetical protein ARALYDRAFT_892419 [ | 0.902 | 0.592 | 0.666 | 2e-92 | |
| 297834316 | 480 | hypothetical protein ARALYDRAFT_897709 [ | 0.861 | 0.568 | 0.641 | 8e-92 | |
| 15231840 | 480 | protein kinase WAG2 [Arabidopsis thalian | 0.861 | 0.568 | 0.641 | 1e-91 | |
| 449460052 | 471 | PREDICTED: protein kinase PINOID 2-like | 0.867 | 0.583 | 0.667 | 1e-90 | |
| 449502187 | 353 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.870 | 0.781 | 0.663 | 3e-90 | |
| 296082821 | 440 | unnamed protein product [Vitis vinifera] | 0.801 | 0.577 | 0.708 | 9e-89 |
| >gi|225470800|ref|XP_002263341.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (910), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 210/304 (69%), Positives = 236/304 (77%), Gaps = 27/304 (8%)
Query: 1 MDDETNFP-DTDLELSFTSTTT------DRTFTSSSARSSLARSSLTLSFNESLLSGCTP 53
MD+ET FP DTD++ SFTSTT+ DRTF SSSAR+SLARSSLTLSFNES LS
Sbjct: 1 MDEETFFPSDTDIDFSFTSTTSSVTTATDRTFASSSARTSLARSSLTLSFNESRLS---- 56
Query: 54 HSSTTTTTTTPATSSTSSLHH--HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTG 111
T+T ++ ++LHH HRKSD HWSAI AAT LSS+G LHLRHLKL+RHLGTG
Sbjct: 57 -------TSTAGATAAANLHHRPHRKSDPHWSAINAATTLSSDGALHLRHLKLLRHLGTG 109
Query: 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
NLGRVFLC LRDC +ANFALKVVD+D L+ KKLSHVQMEA+ILS LDHPFLPTLYAHLEV
Sbjct: 110 NLGRVFLCRLRDCDAANFALKVVDRDALTNKKLSHVQMEADILSALDHPFLPTLYAHLEV 169
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
SHY C LIDYCP GDLHSLL KQP NR + AVRF+AAEVLV LEYLHA G++YRDLKPE
Sbjct: 170 SHYTCLLIDYCPGGDLHSLLRKQPGNRLPVDAVRFYAAEVLVALEYLHATGVVYRDLKPE 229
Query: 232 NILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEF 291
N+LLREDGHIMLSDFDLCF++DVVP L +R R R FGS + +E V EF
Sbjct: 230 NVLLREDGHIMLSDFDLCFKADVVPIL-------ESRARTRPVHGCFGSREAAEEVVAEF 282
Query: 292 VAEP 295
VAEP
Sbjct: 283 VAEP 286
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866010|emb|CAN80973.1| hypothetical protein VITISV_043376 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 353 bits (905), Expect = 7e-95, Method: Compositional matrix adjust.
Identities = 209/304 (68%), Positives = 235/304 (77%), Gaps = 27/304 (8%)
Query: 1 MDDETNFP-DTDLELSFTSTTT------DRTFTSSSARSSLARSSLTLSFNESLLSGCTP 53
MD+ET FP DTD++ SFTSTT+ DRTF SSSAR+SLARSSLTLSFNES LS
Sbjct: 1 MDEETFFPSDTDIDFSFTSTTSSVTTATDRTFASSSARTSLARSSLTLSFNESRLS---- 56
Query: 54 HSSTTTTTTTPATSSTSSLHH--HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTG 111
T+T ++ ++LHH HRKSD HWSAI AAT LSS+G LHLRHLKL+RHLGTG
Sbjct: 57 -------TSTAGATAAANLHHRPHRKSDPHWSAINAATTLSSDGALHLRHLKLLRHLGTG 109
Query: 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
NLGRVFLC LRDC +ANFALKVVD+D L+ KKLSHVQMEA+ILS LDHPFLPTLYAHLEV
Sbjct: 110 NLGRVFLCRLRDCDAANFALKVVDRDALTNKKLSHVQMEADILSALDHPFLPTLYAHLEV 169
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
SHY C LIDYCP GDLHSLL KQP NR + A RF+AAEVLV LEYLHA G++YRDLKPE
Sbjct: 170 SHYTCLLIDYCPGGDLHSLLRKQPGNRLPVDAARFYAAEVLVALEYLHATGVVYRDLKPE 229
Query: 232 NILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEF 291
N+LLREDGHIMLSDFDLCF++DVVP L +R R R FGS + +E V EF
Sbjct: 230 NVLLREDGHIMLSDFDLCFKADVVPIL-------ESRARTRPVHGCFGSREAAEEVVAEF 282
Query: 292 VAEP 295
VAEP
Sbjct: 283 VAEP 286
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15220907|ref|NP_175774.1| protein WAG1 [Arabidopsis thaliana] gi|12324035|gb|AAG51984.1|AC024260_22 auxin-induced protein kinase, putative; 23581-22151 [Arabidopsis thaliana] gi|134031904|gb|ABO45689.1| At1g53700 [Arabidopsis thaliana] gi|332194862|gb|AEE32983.1| protein WAG1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 352 bits (902), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 198/300 (66%), Positives = 230/300 (76%), Gaps = 14/300 (4%)
Query: 1 MDDETNFPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTT 60
M+D+ + DTDL+LSFTST TDRTFTSSSARSSLARSSLTLSFN+ L +T T
Sbjct: 1 MEDDGYYLDTDLDLSFTSTATDRTFTSSSARSSLARSSLTLSFNDRL---------STAT 51
Query: 61 TTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCH 120
T + TSS ++ HHR+ D HW++I+AAT LSS+G+LHLRH KLVRHLGTGNLGRVFLCH
Sbjct: 52 TPSTTTSSAATTLHHRRYDPHWTSIRAATTLSSDGRLHLRHFKLVRHLGTGNLGRVFLCH 111
Query: 121 LRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
LRDC + FALKV+D+D+L+AKK+SHV+ EAEILS+LDHPFLPTLYA ++ SHY C LI
Sbjct: 112 LRDCPNPTGFALKVIDRDVLTAKKISHVETEAEILSLLDHPFLPTLYARIDASHYTCLLI 171
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCPNGDLHSLL KQPNNR + VRFFAAEVLV LEYLHALGI+YRDLKPENIL+REDG
Sbjct: 172 DYCPNGDLHSLLRKQPNNRLPISPVRFFAAEVLVALEYLHALGIVYRDLKPENILIREDG 231
Query: 240 HIMLSDFDLCFQSDVV----PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEP 295
HIMLSDFDLCF++DVV S + RR C R+E V EF AEP
Sbjct: 232 HIMLSDFDLCFKADVVPTFRSRRFRRTSSSPRKTRRGGGCFSTEVEYEREEIVAEFAAEP 291
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3435279|gb|AAC78477.1| protein kinase homolog [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 351 bits (901), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 198/300 (66%), Positives = 230/300 (76%), Gaps = 14/300 (4%)
Query: 1 MDDETNFPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTT 60
M+D+ + DTDL+LSFTST TDRTFTSSSARSSLARSSLTLSFN+ L +T T
Sbjct: 1 MEDDGYYLDTDLDLSFTSTATDRTFTSSSARSSLARSSLTLSFNDRL---------STAT 51
Query: 61 TTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCH 120
T + TSS ++ HHR+ D HW++I+AAT LSS+G+LHLRH KLVRHLGTGNLGRVFLCH
Sbjct: 52 TPSTTTSSAATTLHHRRYDPHWTSIRAATTLSSDGRLHLRHFKLVRHLGTGNLGRVFLCH 111
Query: 121 LRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
LRDC + FALKV+D+D+L+AKK+SHV+ EAEILS+LDHPFLPTLYA ++ SHY C LI
Sbjct: 112 LRDCPNPTGFALKVIDRDVLTAKKISHVETEAEILSLLDHPFLPTLYARIDASHYTCLLI 171
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCPNGDLHSLL KQPNNR + VRFFAAEVLV LEYLHALGI+YRDLKPENIL+REDG
Sbjct: 172 DYCPNGDLHSLLRKQPNNRLPISPVRFFAAEVLVALEYLHALGIVYRDLKPENILIREDG 231
Query: 240 HIMLSDFDLCFQSDVV----PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEP 295
HIMLSDFDLCF++DVV S + RR C R+E V EF AEP
Sbjct: 232 HIMLSDFDLCFKADVVPTFRSRRFRRTSSSPRKTRRGGGCFSTEVEFEREEIVAEFAAEP 291
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297847772|ref|XP_002891767.1| hypothetical protein ARALYDRAFT_892419 [Arabidopsis lyrata subsp. lyrata] gi|297337609|gb|EFH68026.1| hypothetical protein ARALYDRAFT_892419 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 345 bits (885), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 200/300 (66%), Positives = 234/300 (78%), Gaps = 14/300 (4%)
Query: 1 MDDETNFPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTT 60
M+D+ + DTDL+LSFTSTTTDRTFTSSSAR+SLARSSLTLSFN+ L +T T
Sbjct: 1 MEDDGYYLDTDLDLSFTSTTTDRTFTSSSARTSLARSSLTLSFNDRL---------STAT 51
Query: 61 TTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCH 120
T + TSS ++ HHR+ D HW++I+AAT LSS+G+LHLRH KLV HLGTGNLGRVFLCH
Sbjct: 52 TPSTTTSSAATTLHHRRYDPHWTSIRAATTLSSDGRLHLRHFKLVHHLGTGNLGRVFLCH 111
Query: 121 LRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
LRDC + FALKV+D+D+L+AKKLSHV+ EAEILS+LDHPFLPTLYA ++ SHY C LI
Sbjct: 112 LRDCPNPTGFALKVIDRDVLTAKKLSHVETEAEILSLLDHPFLPTLYARIDASHYTCLLI 171
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCPNGDLHSLL KQPNNR + +VRFFAAEVLV LEYLHALGI+YRDLKPENIL+REDG
Sbjct: 172 DYCPNGDLHSLLRKQPNNRLPISSVRFFAAEVLVALEYLHALGIVYRDLKPENILIREDG 231
Query: 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRK----SCNGFGSAKRRQENVMEFVAEP 295
HIMLSDFDLCF++DVVPT + A+ RR C R+E V EF AEP
Sbjct: 232 HIMLSDFDLCFKADVVPTFRSRRLRRASSSPRRTRRVGGCFSTEVEYEREEIVAEFAAEP 291
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834316|ref|XP_002885040.1| hypothetical protein ARALYDRAFT_897709 [Arabidopsis lyrata subsp. lyrata] gi|297330880|gb|EFH61299.1| hypothetical protein ARALYDRAFT_897709 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 343 bits (879), Expect = 8e-92, Method: Compositional matrix adjust.
Identities = 190/296 (64%), Positives = 225/296 (76%), Gaps = 23/296 (7%)
Query: 7 FPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTTTTTPAT 66
FPDTDL+LSFTSTTTDRTF SSSAR+SL TLSFN+ L +T++ +
Sbjct: 8 FPDTDLDLSFTSTTTDRTFASSSARTSL-----TLSFNDRL----------STSSAVTTS 52
Query: 67 SSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS 126
S++SS +HR+ D HWSAIK+A LSS+G +HLRHLKL+RHLGTGNLGRVFLC+LRD +S
Sbjct: 53 STSSSTVNHRRHDPHWSAIKSAKLLSSDGNIHLRHLKLIRHLGTGNLGRVFLCNLRD-SS 111
Query: 127 ANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185
A FALKV+D++ L+ KKLS V+ EAEILS+LDHPFLPTLYA ++ SHY C LIDY PNG
Sbjct: 112 ARFALKVIDRNCLTTEKKLSQVETEAEILSLLDHPFLPTLYARIDESHYTCLLIDYAPNG 171
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DLHSLL KQP NR +Q VRFFAAEVLV LEYLHA+GI+YRDLKPEN+LLREDGH+MLSD
Sbjct: 172 DLHSLLRKQPGNRLPIQPVRFFAAEVLVALEYLHAMGIVYRDLKPENVLLREDGHVMLSD 231
Query: 246 FDLCFQSDVVPTL----VETNVGSATRRRRRKSCNGFGSAKR--RQENVMEFVAEP 295
FDLCF+SDVVPT S + RRRR C + K+ R+E V EF AEP
Sbjct: 232 FDLCFKSDVVPTFKSRRYRRTSSSPSLRRRRSGCFSVAAEKKYEREEIVSEFAAEP 287
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231840|ref|NP_188054.1| protein kinase WAG2 [Arabidopsis thaliana] gi|9279584|dbj|BAB01042.1| protein kinase [Arabidopsis thaliana] gi|21618089|gb|AAM67139.1| putative protein kinase [Arabidopsis thaliana] gi|116325946|gb|ABJ98574.1| At3g14370 [Arabidopsis thaliana] gi|332641988|gb|AEE75509.1| protein kinase WAG2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 342 bits (877), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 190/296 (64%), Positives = 226/296 (76%), Gaps = 23/296 (7%)
Query: 7 FPDTDLELSFTSTTTDRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTTTTTTPAT 66
FPDTDL+LSFTSTTTDRTF SSSAR+SL TLSFN+ L +T++ +
Sbjct: 8 FPDTDLDLSFTSTTTDRTFASSSARTSL-----TLSFNDRL----------STSSAVTTS 52
Query: 67 SSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS 126
S++SS +HR+ D HWSAIK+A LSS+G +HLRHLKL+RHLGTGNLGRVFLC+LRD +S
Sbjct: 53 STSSSSVNHRRHDPHWSAIKSAKLLSSDGNIHLRHLKLIRHLGTGNLGRVFLCNLRD-SS 111
Query: 127 ANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185
A FALKV+D++ L+ KKLS V+ EAEILS+LDHPFLPTLYA ++ SHY C LIDY PNG
Sbjct: 112 ARFALKVIDRNCLTTEKKLSQVETEAEILSLLDHPFLPTLYARIDESHYTCLLIDYAPNG 171
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DLHSLL KQP NR +Q VRFFAAEVLV LEYLHA+GI+YRDLKPEN+LLREDGH+MLSD
Sbjct: 172 DLHSLLRKQPGNRLPIQPVRFFAAEVLVALEYLHAMGIVYRDLKPENVLLREDGHVMLSD 231
Query: 246 FDLCFQSDVVPTL----VETNVGSATRRRRRKSCNGFGSAKR--RQENVMEFVAEP 295
FDLCF+SDVVPT + S + RRRR C + K+ R+E V EF AEP
Sbjct: 232 FDLCFKSDVVPTFKSRRYRRSSSSPSLRRRRSGCFSVAAEKKYEREEIVSEFAAEP 287
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460052|ref|XP_004147760.1| PREDICTED: protein kinase PINOID 2-like [Cucumis sativus] gi|5360798|dbj|BAA82168.1| CsPK3 [Cucumis sativus] gi|7416109|dbj|BAA93704.1| cucumber protein kinase CsPK3 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 339 bits (869), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 199/298 (66%), Positives = 228/298 (76%), Gaps = 23/298 (7%)
Query: 2 DDETNFP-DTDLELSFTSTTTDRTFTSSS-ARSSLARSSLTLSFNESLLSGCTPHSSTTT 59
DD + FP D+DL+ SFTSTTTDRTFT+SS AR+SLARSSLTLSFNES LS
Sbjct: 3 DDYSIFPPDSDLDFSFTSTTTDRTFTTSSSARTSLARSSLTLSFNESRLS---------- 52
Query: 60 TTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLC 119
A ++ +L + +SD HWSAI+AAT LSS+G LHLRHLKL+RHLGTGNLGRVFLC
Sbjct: 53 -----AAAAALNLRPYHRSDSHWSAIRAATTLSSDGHLHLRHLKLIRHLGTGNLGRVFLC 107
Query: 120 HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
HLRD A+FALKVVDK+ LS KKL VQ EAEIL+ LDHPFLPTLYA L+VSHY C LI
Sbjct: 108 HLRDNDHASFALKVVDKEALSNKKLLQVQTEAEILASLDHPFLPTLYARLDVSHYTCLLI 167
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCP GDLHSLL KQP +RFS+ A RFFAAEVLV LEYLHALGI+YRDLKPEN+LLREDG
Sbjct: 168 DYCPAGDLHSLLRKQPGSRFSVAAARFFAAEVLVALEYLHALGIVYRDLKPENVLLREDG 227
Query: 240 HIMLSDFDLCFQSDVVPTL-VETNVGSATRRRRRKSCNGFGSAKRRQENVM-EFVAEP 295
H+MLSDFDLCF+SDVVPT T G SC G+ ++ +E ++ EFVAEP
Sbjct: 228 HVMLSDFDLCFKSDVVPTFHTWTRPGPQA----TGSCFGWRTSPEFEEEIVGEFVAEP 281
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449502187|ref|XP_004161568.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase PINOID 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 338 bits (866), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 197/297 (66%), Positives = 229/297 (77%), Gaps = 21/297 (7%)
Query: 2 DDETNFP-DTDLELSFTSTTTDRTFTSSS-ARSSLARSSLTLSFNESLLSGCTPHSSTTT 59
DD + FP D+DL+ SFTSTTTDRTFT+SS AR+SLARSSLTLSFNES LS
Sbjct: 3 DDYSIFPPDSDLDFSFTSTTTDRTFTTSSSARTSLARSSLTLSFNESRLS---------- 52
Query: 60 TTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLC 119
A ++ +L + +SD HWSAI+AAT LSS+G LHLRHLKL+RHLGTGNLGRVFLC
Sbjct: 53 -----AAAAALNLRPYHRSDSHWSAIRAATTLSSDGHLHLRHLKLIRHLGTGNLGRVFLC 107
Query: 120 HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
HLRD A+FALKVVDK+ LS KKL VQ EAEIL+ LDHPFLPTLYA L+VSHY C LI
Sbjct: 108 HLRDNDHASFALKVVDKEALSNKKLXQVQTEAEILASLDHPFLPTLYARLDVSHYTCLLI 167
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCP GDLHSLL KQP +RFS+ A RFFAAEVLV LEYLHALGI+YRDLKPEN+LLREDG
Sbjct: 168 DYCPAGDLHSLLRKQPGSRFSVAAARFFAAEVLVALEYLHALGIVYRDLKPENVLLREDG 227
Query: 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM-EFVAEP 295
H+MLSDFDLCF+SDVVPT + + + SC G+ ++ +E ++ EFVAEP
Sbjct: 228 HVMLSDFDLCFKSDVVPTF---HTWTRPGPQATGSCFGWRTSPEFEEEIVGEFVAEP 281
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082821|emb|CBI21826.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 9e-89, Method: Compositional matrix adjust.
Identities = 194/274 (70%), Positives = 219/274 (79%), Gaps = 20/274 (7%)
Query: 1 MDDETNFP-DTDLELSFTSTTT------DRTFTSSSARSSLARSSLTLSFNESLLSGCTP 53
MD+ET FP DTD++ SFTSTT+ DRTF SSSAR+SLARSSLTLSFNES LS
Sbjct: 1 MDEETFFPSDTDIDFSFTSTTSSVTTATDRTFASSSARTSLARSSLTLSFNESRLS---- 56
Query: 54 HSSTTTTTTTPATSSTSSLHH--HRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTG 111
T+T ++ ++LHH HRKSD HWSAI AAT LSS+G LHLRHLKL+RHLGTG
Sbjct: 57 -------TSTAGATAAANLHHRPHRKSDPHWSAINAATTLSSDGALHLRHLKLLRHLGTG 109
Query: 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
NLGRVFLC LRDC +ANFALKVVD+D L+ KKLSHVQMEA+ILS LDHPFLPTLYAHLEV
Sbjct: 110 NLGRVFLCRLRDCDAANFALKVVDRDALTNKKLSHVQMEADILSALDHPFLPTLYAHLEV 169
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
SHY C LIDYCP GDLHSLL KQP NR + AVRF+AAEVLV LEYLHA G++YRDLKPE
Sbjct: 170 SHYTCLLIDYCPGGDLHSLLRKQPGNRLPVDAVRFYAAEVLVALEYLHATGVVYRDLKPE 229
Query: 232 NILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
N+LLREDGHIMLSDFDLCF++D + VG+
Sbjct: 230 NVLLREDGHIMLSDFDLCFKADPTDAFSRSCVGT 263
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | ||||||
| TAIR|locus:2024892 | 476 | WAG1 "WAG 1" [Arabidopsis thal | 0.902 | 0.600 | 0.513 | 4e-74 | |
| TAIR|locus:2091035 | 480 | WAG2 [Arabidopsis thaliana (ta | 0.690 | 0.456 | 0.634 | 5.5e-70 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.596 | 0.27 | 0.492 | 1.5e-47 | |
| TAIR|locus:2062268 | 438 | PID "PINOID" [Arabidopsis thal | 0.621 | 0.449 | 0.504 | 4.2e-47 | |
| TAIR|locus:2043813 | 525 | PID2 "PINOID2" [Arabidopsis th | 0.485 | 0.293 | 0.557 | 7.9e-46 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.621 | 0.389 | 0.472 | 2.1e-45 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.574 | 0.364 | 0.508 | 2.7e-45 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.621 | 0.336 | 0.487 | 3.4e-45 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.624 | 0.397 | 0.472 | 4.4e-45 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.596 | 0.247 | 0.492 | 9.5e-45 |
| TAIR|locus:2024892 WAG1 "WAG 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 4.0e-74, P = 4.0e-74
Identities = 154/300 (51%), Positives = 182/300 (60%)
Query: 1 MDDETNFPDTDLELXXXXXXXXXXXXXXXXXXXXXXXXXXXXXNESLLSGCXXXXXXXXX 60
M+D+ + DTDL+L N+ L
Sbjct: 1 MEDDGYYLDTDLDLSFTSTATDRTFTSSSARSSLARSSLTLSFNDRL---------STAT 51
Query: 61 XXXXXXXXXXXXXXXRKSDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCH 120
R+ D HW++I+AAT LSS+G GTGNLGRVFLCH
Sbjct: 52 TPSTTTSSAATTLHHRRYDPHWTSIRAATTLSSDGRLHLRHFKLVRHLGTGNLGRVFLCH 111
Query: 121 LRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179
LRDC + FALKV+D+D+L+AKK+SHV+ EAEILS+LDHPFLPTLYA ++ SHY C LI
Sbjct: 112 LRDCPNPTGFALKVIDRDVLTAKKISHVETEAEILSLLDHPFLPTLYARIDASHYTCLLI 171
Query: 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
DYCPNGDLHSLL KQPNNR + VRFFAAEVLV LEYLHALGI+YRDLKPENIL+REDG
Sbjct: 172 DYCPNGDLHSLLRKQPNNRLPISPVRFFAAEVLVALEYLHALGIVYRDLKPENILIREDG 231
Query: 240 HIMLSDFDLCFQSDVVPTLVETN---VGSATRRRRRKS-CNGFGSAKRRQENVMEFVAEP 295
HIMLSDFDLCF++DVVPT S+ R+ RR C R+E V EF AEP
Sbjct: 232 HIMLSDFDLCFKADVVPTFRSRRFRRTSSSPRKTRRGGGCFSTEVEYEREEIVAEFAAEP 291
|
|
| TAIR|locus:2091035 WAG2 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
Identities = 144/227 (63%), Positives = 168/227 (74%)
Query: 76 RKSDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVD 135
R+ D HWSAIK+A LSS+G GTGNLGRVFLC+LRD +SA FALKV+D
Sbjct: 62 RRHDPHWSAIKSAKLLSSDGNIHLRHLKLIRHLGTGNLGRVFLCNLRD-SSARFALKVID 120
Query: 136 KDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ 194
++ L+ KKLS V+ EAEILS+LDHPFLPTLYA ++ SHY C LIDY PNGDLHSLL KQ
Sbjct: 121 RNCLTTEKKLSQVETEAEILSLLDHPFLPTLYARIDESHYTCLLIDYAPNGDLHSLLRKQ 180
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254
P NR +Q VRFFAAEVLV LEYLHA+GI+YRDLKPEN+LLREDGH+MLSDFDLCF+SDV
Sbjct: 181 PGNRLPIQPVRFFAAEVLVALEYLHAMGIVYRDLKPENVLLREDGHVMLSDFDLCFKSDV 240
Query: 255 VPTL----VETNVGSATRRRRRKSCNGFGSAKR--RQENVMEFVAEP 295
VPT + S + RRRR C + K+ R+E V EF AEP
Sbjct: 241 VPTFKSRRYRRSSSSPSLRRRRSGCFSVAAEKKYEREEIVSEFAAEP 287
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 1.5e-47, Sum P(2) = 1.5e-47
Identities = 95/193 (49%), Positives = 123/193 (63%)
Query: 78 SDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVDK- 136
+D W AI A + +G G G++G V+L L T FA+KV+DK
Sbjct: 286 NDPRWKAILAIR--ARDGILGMSHFKLLKRLGCGDIGSVYLSELSG-TRCYFAMKVMDKA 342
Query: 137 DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPN 196
L S KKL+ Q E EIL +LDHPFLPTLY H E + C +++YCP GDLH+L +QP
Sbjct: 343 SLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPG 402
Query: 197 NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256
FS A RF+AAEVL+ LEYLH LG++YRDLKPEN+L+R+DGHIMLSDFDL + V P
Sbjct: 403 KHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSP 462
Query: 257 TLVETNVGSATRR 269
TL+ + ++R
Sbjct: 463 TLIRISSDDPSKR 475
|
|
| TAIR|locus:2062268 PID "PINOID" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
Identities = 105/208 (50%), Positives = 136/208 (65%)
Query: 109 GTGNLGRVFLCHL----RDCTSANFALKVVDKDLLSAKKLSH-VQMEAEILSMLDHPFLP 163
G G++G V+LC L + S+ FA+KVVDK+ L+ KK H +ME IL MLDHPFLP
Sbjct: 82 GAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLP 141
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
TLYA E SH+ C +++YC GDLHSL +QP+ RFSL + RF+AAEVLV LEYLH LGI
Sbjct: 142 TLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGI 201
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKR 283
IYRDLKPENIL+R DGHIMLSDFDL SD + VE++ S+ ++ +S F
Sbjct: 202 IYRDLKPENILVRSDGHIMLSDFDLSLCSDSIAA-VESS-SSSPENQQLRSPRRF----T 255
Query: 284 RQENVMEFVAEPRREQREHPAQYSVEQP 311
R + + V ++ Q P + V +P
Sbjct: 256 RLARLFQRVLRSKKVQTLEPTRLFVAEP 283
|
|
| TAIR|locus:2043813 PID2 "PINOID2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 7.9e-46, P = 7.9e-46
Identities = 87/156 (55%), Positives = 119/156 (76%)
Query: 109 GTGNLGRVFLCHLRDCT-SANFALKVVDKDLLSAKK-LSHVQMEAEILSMLDHPFLPTLY 166
G+G++G V+LC +R +A +A+KVVDK+ ++ KK L +ME +IL MLDHPF PTLY
Sbjct: 94 GSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLY 153
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
A E SHY +++YCP GDL+++ +QP+ RF++ + RF+AAE LV LEYLH +GI+YR
Sbjct: 154 AAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYR 213
Query: 227 DLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
DLKPEN+L+REDGH+MLSDFDL F+ DVVP + N
Sbjct: 214 DLKPENVLIREDGHVMLSDFDLSFKCDVVPQFLSDN 249
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 2.1e-45, P = 2.1e-45
Identities = 95/201 (47%), Positives = 128/201 (63%)
Query: 76 RKSDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVD 135
+ +D+ W AI+A + +G G G++G V L L T FA+KV+D
Sbjct: 99 KANDVRWEAIQAVR--TKHGVLGLNHFRLLKRLGCGDIGTVHLAELHG-TRCFFAMKVMD 155
Query: 136 KDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ 194
K L S KKL Q E EIL LDHPFLPTLY+H E + C ++++CP GDLH+L +Q
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254
P RFS QA +F+ AEVL+ +EYLH LGIIYRDLKPEN+L+R+DGH+MLSDFDL + V
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 255 VPTLVETNVGSATRRRRRKSC 275
PT+V + V ++ ++ C
Sbjct: 276 SPTVVRSTVLASEGQKNSGYC 296
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 2.7e-45, P = 2.7e-45
Identities = 94/185 (50%), Positives = 121/185 (65%)
Query: 78 SDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVDKD 137
+DL W AI+ S N G G++G V+L LR+ FA+KV+DK
Sbjct: 91 NDLRWDAIQNV-KCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELREM-GCFFAMKVMDKG 148
Query: 138 LL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPN 196
+L KKL Q E EIL +LDHPFLPTLY+H E + C L+++C GDLH L KQP
Sbjct: 149 MLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGGDLHILRQKQPG 208
Query: 197 NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256
FS A RF+A+EVL+ LEYLH +G++YRDLKPEN+++REDGHIMLSDFDL QS V P
Sbjct: 209 KHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSDFDLSLQSFVSP 268
Query: 257 TLVET 261
TL+++
Sbjct: 269 TLIQS 273
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 3.4e-45, P = 3.4e-45
Identities = 98/201 (48%), Positives = 125/201 (62%)
Query: 76 RKSDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVD 135
+ +DL W AI+A +G G G++G V+L L T FA+KV+D
Sbjct: 167 KANDLRWEAIQAVR--VRDGLLGLSHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMD 223
Query: 136 K-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ 194
K L S KKL Q E EIL LDHPFLPTLY H E + C ++++CP GDLH+L +Q
Sbjct: 224 KTSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQ 283
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254
P FS QAV+F+ AE L+ LEYLH LGI+YRDLKPEN+L+REDGHIMLSDFDL + V
Sbjct: 284 PGKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLV 343
Query: 255 VPTLVETNVGSATRRRRRKSC 275
PTLV++ + R+ C
Sbjct: 344 SPTLVKSAAIESDPLRKNVYC 364
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 4.4e-45, P = 4.4e-45
Identities = 96/203 (47%), Positives = 129/203 (63%)
Query: 76 RKSDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVD 135
+ +D+ W AI+A + +G G G++G V L L T FA+KV+D
Sbjct: 85 KANDVRWEAIQAVR--TKHGGLGLNHFRLLKRLGCGDIGTVHLAELNG-TRCYFAMKVMD 141
Query: 136 KDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ 194
K L S KKL Q E EIL LDHPFLPTLY+H E + C ++++CP GDLH+L +Q
Sbjct: 142 KTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 201
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254
P RF+ QA +F+ AEVL+ +EYLH LGIIYRDLKPEN+L+R+DGH+MLSDFDL + V
Sbjct: 202 PGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 261
Query: 255 VPTLVET-NVGSATRRRRRKSCN 276
++V + NVGS + SC+
Sbjct: 262 SLSIVRSANVGSEGLSKNSVSCS 284
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 9.5e-45, P = 9.5e-45
Identities = 95/193 (49%), Positives = 125/193 (64%)
Query: 78 SDLHWSAIKAATNLSSNGXXXXXXXXXXXXXGTGNLGRVFLCHLRDCTSANFALKVVDK- 136
+D W+AI A + +G G G++G V+L L T +FA+KV+DK
Sbjct: 341 NDPWWNAILAIR--TRDGILGMSHFKLLKRLGCGDIGSVYLAELSG-TRCHFAVKVMDKA 397
Query: 137 DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPN 196
L KKL+ Q E +IL +LDHPFLPTLY H E + C +++YCP GDLH+L +QP
Sbjct: 398 SLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPG 457
Query: 197 NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256
FS A RF+AAEVL+ LEYLH LG++YRDLKPEN+L+R+DGHIMLSDFDL + V P
Sbjct: 458 KHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSP 517
Query: 257 TLVETNVGSATRR 269
TL++T +RR
Sbjct: 518 TLIKTFDSDPSRR 530
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 317 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-89 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-50 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-47 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-36 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-31 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-28 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-27 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-26 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-23 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 2e-89
Identities = 95/176 (53%), Positives = 117/176 (66%), Gaps = 2/176 (1%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLD 158
+H K ++ LG G++GRVFL L+ T FALKV+DK + K+ V E EIL+ LD
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HPFLPTLYA + Y+C ++DYCP G+L LL +QP S + RF+AAEVL+ LEYL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKS 274
H LGI+YRDLKPENILL E GHIMLSDFDL QSDV P V + +RR S
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 58/147 (39%), Positives = 84/147 (57%), Gaps = 4/147 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ LG G+ G+V+L + T A+KV+ K + K + E +IL L HP +
Sbjct: 2 EILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
LY E + +++YC GDL LL + R S RF+ ++L LEYLH+ G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLC 249
I++RDLKPENILL EDGH+ L+DF L
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-48
Identities = 64/143 (44%), Positives = 90/143 (62%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEILSMLDHPFLPTLY 166
LG G+ G+V L +D T +A+KV+ K + +K + H E ILS ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + +++Y P G+L S L RFS + RF+AAE+++ LEYLH+LGIIYR
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
DLKPENILL DGHI L+DF L
Sbjct: 118 DLKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 60/146 (41%), Positives = 91/146 (62%), Gaps = 4/146 (2%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHP 160
+ ++ LGTG+ GRV L + + +ALK++ K ++ K++ HV E IL + HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
FL LY + + +++Y P G+L S L K + RF RF+AA+V++ LEYLH+
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHS 119
Query: 221 LGIIYRDLKPENILLREDGHIMLSDF 246
L I+YRDLKPEN+LL DG+I ++DF
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 4e-43
Identities = 58/147 (39%), Positives = 92/147 (62%), Gaps = 5/147 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLD-HP 160
K + +G G+ V L + T+ +A+K++DK L KK+ +V++E E+L+ L+ HP
Sbjct: 4 KFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ LY + + F+++Y PNG+L + K + + RF+AAE+L+ LEYLH+
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFD 247
GII+RDLKPENILL +D HI ++DF
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFG 147
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 57/164 (34%), Positives = 88/164 (53%), Gaps = 3/164 (1%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
+L+R LG+G+ G V+ + T A+K++ K +KK + E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKG-TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ L E ++ +++YC GDL L + S + A ++L GLEYLH+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
GII+RDLKPENILL E+G + ++DF L + + + T VG+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 59/159 (37%), Positives = 89/159 (55%), Gaps = 4/159 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG G G V+L + T A+K++ K+ S L + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYG 58
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
E +++ +++YC G L LL K+ + S + ++L GLEYLH+ GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 228 LKPENILL-REDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
LKPENILL ++G + L+DF L +L++T VG+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 57/140 (40%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKL-SHVQMEAEILSMLDHPFLPTLY 166
LG G GRV L ++ + FALK V K + H+ E EIL +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ YI L++YC G+L ++L + F RF+ A V++ EYLH GIIYR
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 227 DLKPENILLREDGHIMLSDF 246
DLKPEN+LL +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 58/146 (39%), Positives = 89/146 (60%), Gaps = 4/146 (2%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD-KDLLSAKKLSHVQMEAEILSMLDHP 160
L+ ++ +GTG GRV L R + +ALKV+ +++ K+ HV E +L + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
F+ L+ ++ L++Y P G+L S L + + RFS F+A+E++ LEYLH+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 221 LGIIYRDLKPENILLREDGHIMLSDF 246
I+YRDLKPENILL ++GHI L+DF
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-35
Identities = 53/139 (38%), Positives = 79/139 (56%), Gaps = 4/139 (2%)
Query: 111 GNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPFLPTLYAHL 169
G GRVFL + T +A+KV+ K + K ++ V E +ILS P++ LY
Sbjct: 4 GAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 170 EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLK 229
+ + +++Y P GDL SLL R + AE+++ LEYLH+ GII+RDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 230 PENILLREDGHIMLSDFDL 248
P+NIL+ +GH+ L+DF L
Sbjct: 121 PDNILIDSNGHLKLTDFGL 139
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 59/167 (35%), Positives = 94/167 (56%), Gaps = 10/167 (5%)
Query: 85 IKAATNLS----SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLL 139
+KAA + S+ KL ++ LGTG+ GRV + + T +A+K + K ++L
Sbjct: 1 MKAAYMFTKPDTSSWKLS--DFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREIL 57
Query: 140 SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRF 199
K++ HV E IL L HPF+ + + + + FL+++ G+L + L K RF
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRF 115
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+F+ AE+++ EYLH+ IIYRDLKPEN+LL GH+ ++DF
Sbjct: 116 PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 54/145 (37%), Positives = 93/145 (64%), Gaps = 4/145 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V+L +D T +A+KV+ K D++ +++HV+ E +IL+ D P++ LY
Sbjct: 9 IGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ ++ +++Y P GDL +LL ++ + F + RF+ AE+++ L+ +H LG I+R
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHR 125
Query: 227 DLKPENILLREDGHIMLSDFDLCFQ 251
D+KP+NIL+ DGHI L+DF LC +
Sbjct: 126 DIKPDNILIDADGHIKLADFGLCKK 150
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 55/144 (38%), Positives = 87/144 (60%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSML-DHPFLPTL 165
LG G+ G+V L L+ T +A+KV+ KD+ L + E +L++ HPFL L
Sbjct: 3 LGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
++ + + F+++Y GDL + Q + RF RF+AAE+++GL++LH GIIY
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +N+LL +GHI ++DF +C
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 55/149 (36%), Positives = 90/149 (60%), Gaps = 4/149 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDH 159
H +L+R +G G G+V + RD T FA+K ++K + + +V E IL L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
PFL L+ + + ++D GDL L ++ +FS + V+F+ E+++ LEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH 117
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ GII+RD+KP+NILL E GH+ ++DF++
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNI 146
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 57/151 (37%), Positives = 89/151 (58%), Gaps = 7/151 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLL--SAKKLSHVQMEAEILSMLD 158
+L+R LGTG G+VFL A +A+KV+ K + AK H + E ++L +
Sbjct: 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR 62
Query: 159 H-PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
PFL TL+ + + ++DY G+L + L ++ F+ VR + AE+++ L++
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDH 120
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
LH LGIIYRD+K ENILL +GH++L+DF L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGL 151
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 59/147 (40%), Positives = 91/147 (61%), Gaps = 4/147 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
LG G+ G+VFL A +A+KV+ K L + +ME +IL+ ++HPF+ L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + ++D+ GDL + L K+ F+ + V+F+ AE+ + L++LH+LGIIY
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 226 RDLKPENILLREDGHIMLSDFDLCFQS 252
RDLKPENILL E+GHI L+DF L +S
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKES 148
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 52/143 (36%), Positives = 85/143 (59%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPFLPTLY 166
LG G G+V L + T +A+K++ K+++ AK +++H E+ +L HPFL L
Sbjct: 3 LGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ +CF+++Y G+L L ++ FS RF+ AE++ L YLH+ ++YR
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
DLK EN++L +DGHI ++DF LC
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLC 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-29
Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
LG G+ G V+L +D T A+K V+ S ++L ++ E ILS L HP +
Sbjct: 3 TRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 163 PTLYAHLEVS---HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
Y E + + ++Y G L SLL K + +R + ++L GL YLH
Sbjct: 62 VRYYGS-ERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ GI++RD+K NIL+ DG + L+DF
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 58/149 (38%), Positives = 92/149 (61%), Gaps = 5/149 (3%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSML-DHPFLP 163
+ LG G+ G+VFL L+ T+ FA+K + KD+ L + +E +LS+ +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + + F+++Y GDL + Q ++F L F+AAE++ GL++LH+ GI
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQS 252
+YRDLK +NILL DGHI ++DF +C ++
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKEN 146
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/144 (38%), Positives = 89/144 (61%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSM-LDHPFLPTL 165
LG G+ G+V L L+ T+ FA+K + KD +L + +E +L++ +HPFL L
Sbjct: 3 LGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + ++ F+++Y GDL + Q + RF RF+AAE++ GL++LH GIIY
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +N+LL +DGHI ++DF +C
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 51/150 (34%), Positives = 84/150 (56%), Gaps = 16/150 (10%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEIL---SMLDHPFLP 163
LG G+ G+V L + T +A+K + K D+++ ++ + E I + HPFL
Sbjct: 7 LGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 164 TLYAHLEVSHYICFLIDYCPNGDL----HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L+A + ++CF+++Y GDL H+ + FS F+AA V++GL+YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLH 118
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLC 249
I+YRDLK +N+LL +G + ++DF LC
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLC 148
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 57/144 (39%), Positives = 81/144 (56%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEIL-SMLDHPFLPTL 165
+G G+ G+V L +A+KV+ K +L K+ H+ E +L + HPFL L
Sbjct: 3 IGKGSFGKVLLAK-HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + + F++DY G+L L Q F RF+AAE+ L YLH+L IIY
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLKPENILL GH++L+DF LC
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 59/144 (40%), Positives = 84/144 (58%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEIL-SMLDHPFLPTL 165
+G G+ G+V L R + +A+KV+ K +L K+ +H+ E +L L HPFL L
Sbjct: 3 IGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + + F++DY G+L L Q F RF+AAEV + YLH+L IIY
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLKPENILL GH++L+DF LC
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 55/150 (36%), Positives = 87/150 (58%), Gaps = 4/150 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDH 159
++ +G G G V L D T+A +A+K + K D+L + +HV+ E +IL+ D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
++ LY + + F++DY P GD+ SLL + F RF+ AE+ +E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH 118
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+G I+RD+KP+NIL+ DGHI L+DF LC
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 47/140 (33%), Positives = 80/140 (57%), Gaps = 5/140 (3%)
Query: 111 GNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEIL-SMLDHPFLPTLYAH 168
G G V+L R T FA+KV+ K D+++ ++++V+ E I+ + P++ LY
Sbjct: 7 GAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 169 LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL 228
+ Y+ +++Y GD SL+ + + AEV++G+E LH GII+RD+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 229 KPENILLREDGHIMLSDFDL 248
KPEN+L+ + GH+ L+DF L
Sbjct: 124 KPENLLIDQTGHLKLTDFGL 143
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 71 SLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFA 130
+L H+K D S K+ +R LGTG+ GRV L ++ A
Sbjct: 6 NLQLHKKKD---SDSTKEPK--RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVA 60
Query: 131 LKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
+K +K ++ K++ HV E +IL+ ++HPF LY + Y+ ++++ G+ +
Sbjct: 61 IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
L + N RF F+AA++++ EYL +L I+YRDLKPEN+LL +DG I ++DF
Sbjct: 121 FLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF- 177
Query: 250 FQSDVVPTLVETNVGS 265
+ VV T T G+
Sbjct: 178 --AKVVDTRTYTLCGT 191
|
Length = 340 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 57/186 (30%), Positives = 102/186 (54%), Gaps = 7/186 (3%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ +G G G V L +D T +A+K + K ++L ++++HV+ E +IL+ D+P++
Sbjct: 6 IKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + +Y+ +++Y P GD+ +LL K+ + F+ + RF+ AE ++ ++ +H LG
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGSATRRRRRKSCNGFGSA 281
I+RD+KP+N+LL GHI LSDF LC + + S+
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM-SS 181
Query: 282 KRRQEN 287
KR+ E
Sbjct: 182 KRKAET 187
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-27
Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 2/142 (1%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPFLPTLY 166
LG G G V C ++ T +A K +DK L +K + + E +IL + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
E +C ++ GDL + F F+AA+++ GLE+LH I+YR
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 227 DLKPENILLREDGHIMLSDFDL 248
DLKPEN+LL + G++ +SD L
Sbjct: 120 DLKPENVLLDDHGNVRISDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 4/151 (2%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---EAEILSMLD 158
L L + LG G G V+ L+ ++V K L ++ EA I+ LD
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKG-KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + +++Y P GDL L K SL + FA ++ G+EYL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ I+RDL N L+ E+ + +SDF L
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 43/147 (29%), Positives = 77/147 (52%), Gaps = 5/147 (3%)
Query: 103 KLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
++++ +G G+ G+V+L D + LK +D +S K+ E +IL L+HP
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSD--GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLH 219
+ Y E +C +++Y GDL + KQ F + + + ++ + L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDF 246
+ I++RD+KP+NI L +G + L DF
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDF 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 60/168 (35%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDH 159
+++ +G G G+VFL +D T ALK + K LL ++ HV E +IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQA--VRFFAAEVLVGLEY 217
+L L + Y+ ++Y P GD +LL NN L RF+ AE+ ++
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDA 116
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
LH LG I+RDLKPEN L+ GHI L+DF L S + T + VGS
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGL---SKGIVTYANSVVGS 161
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 51/143 (35%), Positives = 87/143 (60%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPFLPTLY 166
LG G G+V L + T +A+K++ K+++ AK +++H E+ +L HPFL L
Sbjct: 3 LGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ +CF+++Y G+L L ++ F+ + RF+ AE++ LEYLH+ ++YR
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
D+K EN++L +DGHI ++DF LC
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLC 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 53/149 (35%), Positives = 78/149 (52%), Gaps = 6/149 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLL--SAKKLSHVQMEAEILSMLDHPFLP 163
LG G G+VF FA+KV+ K + + K +H + E IL + HPF+
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L + + +++Y G+L L ++ F F+ +E+ + LE+LH GI
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQS 252
IYRDLKPENILL GH+ L+DF LC +S
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKES 150
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 57/152 (37%), Positives = 90/152 (59%), Gaps = 7/152 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLL--SAKKLSHVQMEAEILSML 157
+L++ LGTG G+VFL +A+KV+ K L AK + H + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 158 -DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
PFL TL+ + + ++DY G++ + L ++ N FS VRF++ E+++ LE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALE 119
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+LH LGI+YRD+K ENILL +GH++L+DF L
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGL 151
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-25
Identities = 54/144 (37%), Positives = 89/144 (61%), Gaps = 6/144 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANF-ALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPFLPTL 165
LG G G+V L +R+ S + A+K++ K+++ AK +++H E+ +L HPFL +L
Sbjct: 3 LGKGTFGKVIL--VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ +CF+++Y G+L L ++ FS RF+ AE++ L+YLH+ I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK EN++L +DGHI ++DF LC
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLC 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 55/145 (37%), Positives = 79/145 (54%), Gaps = 7/145 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEIL---SMLDHPFLP 163
+G G G+V+ +D T +A+KV+ K + AKK ++H E IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L + + + DY G+L L Q RFS +F+ AE+++ LE+LH I
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
+YRDLKPENILL GHI L DF L
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGL 142
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 55/144 (38%), Positives = 82/144 (56%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSM-LDHPFLPTL 165
LG G+ G+V L L+ T +A+KV+ KD +L + E IL++ HPFL L
Sbjct: 3 LGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + F+++Y GDL + Q + +F RF+AAEV + L +LH G+IY
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +NILL +GH L+DF +C
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 53/144 (36%), Positives = 86/144 (59%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSML-DHPFLPTL 165
LG G+ G+V L L+ FA+K + KD+ L + +E +L++ ++PFL L
Sbjct: 3 LGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
Y + ++ F++++ GDL + Q RF L F+AAE++ GL++LH+ GIIY
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +N++L DGHI ++DF +C
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 56/146 (38%), Positives = 89/146 (60%), Gaps = 4/146 (2%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVV-DKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ LG G G V L D T A +A+K + KD+L+ +++HV+ E +IL+ D+ ++
Sbjct: 6 IKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + + F++DY P GD+ SLL + F RF+ AE+ + +E +H +G
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
I+RD+KP+NIL+ DGHI L+DF LC
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 2e-24
Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 5/151 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---EAEILSMLD 158
L L + LG G G V+ L+ ++V K L ++ EA I+ LD
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKK-KVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + +++Y GDL S L ++ + SL + FA ++ G+EYL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ I+RDL N L+ E+ + +SDF L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 56/146 (38%), Positives = 87/146 (59%), Gaps = 4/146 (2%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVV-DKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ LG G G V L D T A +A+K + KD+L +++HV+ E +IL+ D+ ++
Sbjct: 6 IKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + + F++DY P GD+ SLL + F RF+ AE+ +E +H +G
Sbjct: 65 RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
I+RD+KP+NIL+ DGHI L+DF LC
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-24
Identities = 57/155 (36%), Positives = 94/155 (60%), Gaps = 11/155 (7%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLL--SAKKLSHVQMEAEIL 154
+ +L++ LGTG G+VFL +R + + +A+KV+ K + AK H + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFL--VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58
Query: 155 SMLDH-PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
+ PFL TL+ + + ++DY G+L + L ++ RF Q V+ ++ E+++
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVL 116
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
LE+LH LGIIYRD+K ENILL +GH++L+DF L
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 151
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-24
Identities = 56/146 (38%), Positives = 84/146 (57%), Gaps = 5/146 (3%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSML-DHPFLP 163
R LG G+ G+V L L++ + +A+KV+ KD +L + E ILS+ +HPFL
Sbjct: 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + + F++++ GDL + Q + RF RF+AAE+ L +LH GI
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
IYRDLK +N+LL +GH L+DF +C
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMC 143
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 4e-24
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+++ +G G G V+ T A+KV+ L S +K + E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKAR-HKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHP 57
Query: 161 FLPTLY-AHLEVSH-YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+ Y ++L+ +I +++C G L LL K N + + + E+L GLEYL
Sbjct: 58 NIVKYYGSYLKKDELWIV--MEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLC 249
H+ GII+RD+K NILL DG + L DF L
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 53/145 (36%), Positives = 89/145 (61%), Gaps = 4/145 (2%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLP 163
V+ +G G G V L +D T +A+K + K ++ +L+HV+ E ++L+ D P++
Sbjct: 6 VKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+LY + + Y+ ++++ P GDL ++L K + FS RF+ AE ++ +E +H LG
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
I+RD+KP+NIL+ GHI LSDF L
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-24
Identities = 47/145 (32%), Positives = 85/145 (58%), Gaps = 4/145 (2%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ + G G V+L ++ T FA+K ++K +L+ ++ V +E +IL+ ++PF+
Sbjct: 6 IKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVV 64
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+++ E ++C +++Y GD +LL + R + AE ++ LEYLH GI
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGI 122
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
++RDLKP+N+L+ GHI L+DF L
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-23
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 5/151 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF---ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
L+L + LG G G V+ L+ A+K + K+ S ++ EA I+ L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + + +Y P GDL L ++ + +L+ + A ++ G+EYL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ ++RDL N L+ E+ + +SDF L
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 59/160 (36%), Positives = 89/160 (55%), Gaps = 9/160 (5%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEIL-SMLDHPFLPTL 165
+G G+ G+V L R +A+KV+ K + L+ K+ H+ E +L + HPFL L
Sbjct: 3 IGKGSFGKVLLAK-RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + + F++D+ G+L L ++ F RF+AAE+ L YLH++ I+Y
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC----FQSDVVPTLVET 261
RDLKPENILL GH++L+DF LC QSD T T
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 52/144 (36%), Positives = 85/144 (59%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPFLPTLY 166
LG G G+V L + T +A+K++ K+++ AK +++H E +L HPFL L
Sbjct: 3 LGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIY 225
+ +CF+++Y G+L L ++ FS RF+ AE++ L+YLH+ ++Y
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK EN++L +DGHI ++DF LC
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 57/144 (39%), Positives = 82/144 (56%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEIL-SMLDHPFLPTL 165
+G G+ G+V L + +A+KV+ K +L K+ H+ E +L + HPFL L
Sbjct: 3 IGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
+ + + + F++DY G+L L Q F RF+AAE+ L YLH+L I+Y
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLKPENILL GHI+L+DF LC
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLC 143
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 50/146 (34%), Positives = 85/146 (58%), Gaps = 5/146 (3%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEILSML-DHPFLP 163
R +G G+ +V L L+ T +A+KV+ K+L++ + + VQ E + +HPFL
Sbjct: 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L++ + + F+I++ GDL + Q + + RF++AE+ + L +LH GI
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLHERGI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
IYRDLK +N+LL +GHI L+D+ +C
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMC 143
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.9 bits (242), Expect = 4e-23
Identities = 57/151 (37%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKL-SHVQMEAEILSMLDHP- 160
+++R LG G+ G V+L R ALKV+ K L S K E +IL+ L+HP
Sbjct: 3 RILRKLGEGSFGEVYLARDRK----LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLH 219
+ LY + + +++Y G L LL K S F A++L LEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 220 ALGIIYRDLKPENILLREDGH-IMLSDFDLC 249
+ GII+RD+KPENILL DG + L DF L
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-23
Identities = 51/145 (35%), Positives = 79/145 (54%), Gaps = 7/145 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL----SMLDHPFLP 163
+G G G V+ C D T +A+K +DK + K+ + + I+ S D PF+
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+ + F++D GDLH L + + FS +RF+AAE+++GLE++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
+YRDLKP NILL E GH+ +SD L
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-23
Identities = 53/143 (37%), Positives = 79/143 (55%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G+ G+V RD T +ALK + K ++S +++H E +L+ ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + ++ + G+L L ++ RF L RF+ AE+L LE LH +IYR
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
DLKPENILL GHI L DF LC
Sbjct: 118 DLKPENILLDYQGHIALCDFGLC 140
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKV--VDKDLLSAKKLSHVQMEAEILSMLD 158
L+ V+ LG G+ G V+ + T +ALK VD D K+L E + L +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
P++ Y I +++Y G L LL K + + A ++L GL+YL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYL 115
Query: 219 HA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN--VGSAT 267
H II+RD+KP N+L+ G + ++DF + + TL + N VG+ T
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGIS--KVLENTLDQCNTFVGTVT 165
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-22
Identities = 52/147 (35%), Positives = 75/147 (51%), Gaps = 2/147 (1%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPFLPT 164
R LG G G V C +R T +A K ++K + +K + + E +IL ++ F+
Sbjct: 6 RVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L E +C ++ GDL + N F + F+AAE+L GLE LH +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQ 251
YRDLKPENILL + GHI +SD L +
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 2/136 (1%)
Query: 130 ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
A+K + + + + L + E ++L L HP + +E S + +++Y NG L
Sbjct: 29 AIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQ 88
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++ + F V + +VL GL YLH G+I+RD+K NIL +DG + L+DF +
Sbjct: 89 II--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146
Query: 250 FQSDVVPTLVETNVGS 265
+ + V + VG+
Sbjct: 147 TKLNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 53/146 (36%), Positives = 85/146 (58%), Gaps = 5/146 (3%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEILSML-DHPFLP 163
R +G G+ +V L L+ T +A+KVV K+L++ + + VQ E + +HPFL
Sbjct: 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L++ + + F+I+Y GDL + Q + + RF++AE+ + L YLH GI
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
IYRDLK +N+LL +GHI L+D+ +C
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMC 143
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 49/144 (34%), Positives = 83/144 (57%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHP-FLPTL 165
LG G+ G+V L R T +A+K++ KD ++ + +E +L++ P FL L
Sbjct: 8 LGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
++ + + F+++Y GDL + Q +F F+AAE+ +GL +LH+ GIIY
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +N++L +GHI ++DF +C
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMC 148
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-22
Identities = 47/153 (30%), Positives = 87/153 (56%), Gaps = 17/153 (11%)
Query: 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEI 153
G+ H +++VR TG++ +A+KV+ K LL+ + +S + E +I
Sbjct: 10 GRGHFGEVQVVREKATGDI---------------YAMKVMKKSVLLAQETVSFFEEERDI 54
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
LS+ + P++P L + + +++Y P GDL SLL + ++F +F+ AE+++
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVL 113
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ +H +G ++RD+KPEN+L+ GHI L+DF
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADF 146
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 2/150 (1%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPF 161
+ R LG G G V C +R T +A K ++K + +K + + E +IL ++ F
Sbjct: 3 RHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ +L E +C ++ GDL + N F + F+AAE+ GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+YRDLKPENILL + GHI +SD L +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 7/145 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML----DHPFLP 163
+G G G V+ C D T +A+K +DK + K+ + + I+ L D PF+
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+ +CF++D GDLH L + + FS + +RF+A E+++GLE++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
+YRDLKP NILL E GH+ +SD L
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 51/146 (34%), Positives = 86/146 (58%), Gaps = 4/146 (2%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFL 162
+V+ + G G+V+L + S +A+KVV K D+++ + VQ E + L++ PF+
Sbjct: 8 IVKPISRGAFGKVYLGR-KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI 66
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
LY L+ ++ + +++Y GD+ SLL F + + +EV + L+YLH G
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYLHRHG 124
Query: 223 IIYRDLKPENILLREDGHIMLSDFDL 248
II+RDLKP+N+L+ +GHI L+DF L
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGL 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 47/143 (32%), Positives = 88/143 (61%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V L +D T +A+K++ K D+L ++++H++ E +IL D ++ ++
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + ++++ P GD+ +LL K+ + S +A +F+ AE ++ ++ +H LG I+R
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
D+KP+N+LL GH+ LSDF LC
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-21
Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 5/146 (3%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLD-HPFLP 163
R +G G+ +V L L+ +A+KVV K+L+ + + VQ E + +PFL
Sbjct: 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L++ + + + +I+Y GDL + Q + + RF+AAE+ + L +LH GI
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117
Query: 224 IYRDLKPENILLREDGHIMLSDFDLC 249
IYRDLK +N+LL DGHI L+D+ +C
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMC 143
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 51/147 (34%), Positives = 84/147 (57%), Gaps = 5/147 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHP-FLPTL 165
LG G+ G+V L R T +A+K++ KD+ + + +E +L++ D P FL L
Sbjct: 8 LGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
++ + + F+++Y GDL + Q +F F+AAE+ VGL +LH GIIY
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 226 RDLKPENILLREDGHIMLSDFDLCFQS 252
RDLK +N++L +GHI ++DF +C +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEH 151
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 45/143 (31%), Positives = 86/143 (60%), Gaps = 4/143 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V L +D T +A+K++ K D+L +++ H++ E +IL D ++ ++
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + ++++ P GD+ +LL K+ + + + +F+ AE ++ ++ +H LG I+R
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 227 DLKPENILLREDGHIMLSDFDLC 249
D+KP+N+LL GH+ LSDF LC
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 50/144 (34%), Positives = 83/144 (57%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHP-FLPTL 165
LG G+ G+V L R T +A+K++ KD+ + + +E +L++ P FL L
Sbjct: 8 LGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
++ + + F+++Y GDL + Q RF F+AAE+ +GL +LH+ GIIY
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 226 RDLKPENILLREDGHIMLSDFDLC 249
RDLK +N++L +GHI ++DF +C
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMC 148
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 98 HLRHLKLVRHLGTGNLGRVFLCH---LRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL 154
RHLK ++ LG G+ G+V LC L D T A+K ++ S + E EIL
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSDFEREIEIL 60
Query: 155 SMLDHPFLPTL----YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
LDH + S +++Y P+G L L + + + + F +++
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSL--RLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQ 117
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ G++YL + I+RDL NIL+ + + +SDF L
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 54/154 (35%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSML 157
RH ++ LG G G V C +R T +A K ++K + +K + + E IL +
Sbjct: 2 FRHYRV---LGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+ F+ +L E +C ++ GDL + N F Q F+AAE+ GLE
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
L I+YRDLKPENILL + GHI +SD L Q
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 51/144 (35%), Positives = 73/144 (50%), Gaps = 2/144 (1%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPFLPT 164
R LG G G V C +R T +A K ++K + +K + + E +IL ++ F+ +
Sbjct: 6 RVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L E +C ++ GDL + F F+AAE+ GLE LH I+
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
YRDLKPENILL + GHI +SD L
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-19
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 108 LGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
LG G G V+ L+ D + A+K + K+ S ++ EA ++ L HP + L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLL-------PKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+ +++Y GDL L P + SL+ + FA ++ G+EYL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ ++RDL N L+ ED + +SDF L
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 4/144 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPFLPTLY 166
LG G G V C +R T +A K ++K L +K M E IL+ + F+ +L
Sbjct: 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 167 AHLEVSHYICFLIDYCPNGDL--HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+ +C ++ GDL H + N F F+ A+++ GLE+LH II
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
YRDLKPEN+LL DG++ +SD L
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ------MEAEILSM--LDH 159
+G G GRV+L L T A+K V+ A + Q + +EI ++ LDH
Sbjct: 9 IGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+ Y+ ++Y P G + S L RF Q VRFF +VL GL YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH 125
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+ GI++RDLK +N+L+ DG +SDF + +SD
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSD 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 48/182 (26%), Positives = 98/182 (53%), Gaps = 5/182 (2%)
Query: 71 SLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFA 130
+L ++ D + K N + ++ ++V+ +G G G V L + T +A
Sbjct: 14 ALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYA 72
Query: 131 LKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
+K++ K +++ + E +I++ + P++ L+ + Y+ +++Y P GDL +
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 132
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
L+ N + RF+ AEV++ L+ +H++G I+RD+KP+N+LL + GH+ L+DF C
Sbjct: 133 LMS---NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 250 FQ 251
+
Sbjct: 190 MK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 1/139 (0%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G+ G VF +R +A+K +D ++ ++ EA +L+ LD ++ Y
Sbjct: 8 IGKGSFGVVFKV-VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
+ +++Y NGDLH LL Q V F ++L+GL +LH+ I++RD
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126
Query: 228 LKPENILLREDGHIMLSDF 246
+K N+ L ++ + D
Sbjct: 127 IKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 11/168 (6%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
+G G G+V+ D T A+K + K + + E ++L +L HP L
Sbjct: 6 NKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 166 YAHLEVSHY--ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
Y +EV H + ++YC G L LL +R + ++L GL YLH+ GI
Sbjct: 65 YG-VEV-HREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 224 IYRDLKPENILLREDGHIMLSDFD----LCFQSDVVPTLVETNVGSAT 267
++RD+KP NI L +G I L DF L + + V++ G+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-18
Identities = 43/151 (28%), Positives = 87/151 (57%), Gaps = 5/151 (3%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFL 162
+V+ +G G G V L + +A+K++ K +++ + E +I++ + P++
Sbjct: 47 VVKVIGRGAFGEVQLVRHKSSQKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ + Y+ +++Y P GDL +L+ N + +F+ AEV++ L+ +H++G
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+I+RD+KP+N+LL + GH+ L+DF C + D
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---EAEILSMLDHPFLPT 164
LG G G V +++ T +A K +DK L KK S +M E EIL ++ PF+
Sbjct: 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L E ++C ++ GDL + ++ V ++A++ G+ +LH++ I+
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQ 251
YRD+KPEN+LL + G+ LSD L +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV-QMEAEI--LSMLDHPFLPT 164
LG+G+ G V+ D FA+K V V Q+E EI LS L HP +
Sbjct: 8 LGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+ ++ P G L LL K F +R + ++L+GLEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
+RD+K NIL+ +G + L+DF +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 44/151 (29%), Positives = 89/151 (58%), Gaps = 3/151 (1%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHP 160
++++ +G G G V + L++ FA+K+++K ++L + + + E ++L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKV-FAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
++ TL+ + + + ++DY GDL +LL K +R RF+ AE+++ ++ +H
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
L ++RD+KP+NIL+ +GHI L+DF C +
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 48/161 (29%), Positives = 93/161 (57%), Gaps = 4/161 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V + +++ T +A+K+++K ++L + + + E ++L D ++ L+
Sbjct: 9 IGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + + ++DY GDL +LL K +R RF+ AE+++ ++ +H LG ++R
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 227 DLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSAT 267
D+KP+N+LL ++GHI L+DF C + T V++NV T
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+++ LG G G+V+ ++ T A K++ + S ++L +E +ILS HP
Sbjct: 6 IWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHP 62
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ LY + + LI++C G L S++ + + +R+ ++L L +LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 221 LGIIYRDLKPENILLREDGHIMLSDF 246
+I+RDLK NILL DG + L+DF
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADF 147
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 31/159 (19%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE-----------I 153
+ +G G G+V+ A +L++ KK+ ++ E E +
Sbjct: 4 IAQIGEGTYGQVYK-----------ARNKKTGELVALKKIR-MENEKEGFPITAIREIKL 51
Query: 154 LSMLDHPFLPTLY----AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
L L HP + L + + S Y+ F +Y + DL LL P +F+ ++ +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVF--EYMDH-DLTGLL-DSPEVKFTESQIKCYMK 107
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL+YLH+ GI++RD+K NIL+ DG + L+DF L
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 44/151 (29%), Positives = 87/151 (57%), Gaps = 3/151 (1%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHP 160
++++ +G G G V + ++ T +A+K+++K ++L + + + E +L D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
++ TL+ + +Y+ ++DY GDL +LL K +R RF+ AE+++ + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
L ++RD+KP+N+LL +GHI L+DF C +
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 42/150 (28%), Positives = 85/150 (56%), Gaps = 5/150 (3%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ +G G G V L + + +A+K++ K +++ + E +I++ + ++
Sbjct: 48 IKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIV 106
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L+ + Y+ +++Y P GDL +L+ N + RF+ AEV++ L+ +H++G
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQSD 253
I+RD+KP+N+LL + GH+ L+DF C + D
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVV--DKDLLSAKKLSHVQMEAEILSMLDHPF 161
++ LG G+ G V+ ++ T A+KVV ++DL K E IL D P+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEEDLQEIIK------EISILKQCDSPY 59
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ Y + + +++YC G + ++ K N + + + + L GLEYLH+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+RD+K NILL E+G L+DF + Q
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G+ G V+ + T+ A+KV+D + + ++ +Q E + LS P+
Sbjct: 9 IGKGSFGEVYKAIDKR-TNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPY------ 60
Query: 168 HLEVSHYI-CFLID--------YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
++ Y FL YC G LL + F EVL+GLEYL
Sbjct: 61 ---ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYL 114
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDF 246
H G I+RD+K NILL E+G + L+DF
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADF 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L+ + LG GN G V R T A+K + ++ A + + E +IL + P+
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPY 60
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-A 220
+ Y + I ++Y G L +L K+ R + + A VL GL YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSAT 267
II+RD+KP NIL+ G I L DF + Q +V +L +T VG+++
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKTFVGTSS 164
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-------LSHVQMEAEILSMLDHP 160
+G+G+ G V+L + + A+K V+ +SA L + E +L L H
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQA--VRFFAAEVLVGLEYL 218
+ + ++ ++Y P G + +LL NN + + VR F ++L GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYL 122
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNG 277
H GII+RD+K NIL+ G I +SDF + + +E N S R S G
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKK-------LEANSLSTKTNGARPSLQG 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV-QMEAEI--LSMLDHPFLPT 164
LG G GRV+LC+ D T A+K V D S + V +E EI L L H +
Sbjct: 10 LGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
Y L + ++Y P G + L + + R + ++L G+EYLH+ I+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 225 YRDLKPENILLREDGHIMLSDF 246
+RD+K NIL G++ L DF
Sbjct: 127 HRDIKGANILRDSAGNVKLGDF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 3/145 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
K+++ LG G+ G V+ R + +ALK VD +S K+ E IL+ ++HP +
Sbjct: 3 KVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNR--FSLQAVRFFAAEVLVGLEYLHA 220
+ + +C +++Y P GDL + K+ R Q + ++L GL+ LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 221 LGIIYRDLKPENILLREDGHIMLSD 245
I++RDLK NILL + + + D
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGD 146
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 3/147 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+L+ +G G V+ + A+K +D + + ++ E + +S +HP
Sbjct: 2 DYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP-KQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+ Y V + ++ Y G L ++ P + EVL GLEYLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDF 246
+ G I+RD+K NILL EDG + ++DF
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADF 146
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 43/144 (29%), Positives = 80/144 (55%), Gaps = 4/144 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ LG G G+V+ ++ T A A KV++ S ++L +E EIL+ +HP++
Sbjct: 15 EIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYI 71
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L + +I++CP G + +++ + + + ++ ++L L+YLH++
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
II+RDLK N+LL DG I L+DF
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADF 154
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 52/148 (35%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM--EAEILSMLDHPFL 162
+ LG G G V C L++ T FALK + D L Q+ E EI P++
Sbjct: 6 LSRLGEGAGGSVTKCRLKN-TGMIFALKTITTD--PNPDL-QKQILRELEINKSCKSPYI 61
Query: 163 PTLYA--HLEVSHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYL 218
Y E S I ++YC G L S+ K + R + + A VL GL YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDF 246
H+ II+RD+KP NILL G + L DF
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDF 149
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 49/146 (33%), Positives = 71/146 (48%), Gaps = 4/146 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG GN G VF L+D T A+K +DL K+ + EA IL DHP + L
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV--AVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
I +++ P GD S L K+ + + Q V+F A + G+ YL + I+RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYLESKNCIHRD 118
Query: 228 LKPENILLREDGHIMLSDFDLCFQSD 253
L N L+ E+ + +SDF + Q D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQED 144
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 1e-14
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 108 LGTGNLGRVFLCHLRDCTSAN-FALKVV----DKDLLSAKKLSHVQMEAEILSMLDHPFL 162
LG G G V+ RD + ALK + +++ + + L E +L L HP +
Sbjct: 7 LGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNI 60
Query: 163 PTLYAHLEVSH-----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
L L+V H Y+ F +YC DL L + S ++ ++L GL Y
Sbjct: 61 VKL---LDVIHTERKLYLVF--EYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
H+ I++RDLKP+NIL+ DG + L+DF L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 2/143 (1%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+R +G G G V LC R +K + + ++ + Q E ++L +L HP +
Sbjct: 5 IRVVGRGAFGIVHLC-RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
Y + + +++Y P G L + K+ N+ + F ++L+ L ++H I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 225 YRDLKPENILLREDGHIM-LSDF 246
+RDLK +NILL + ++ + DF
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 2/99 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E + L HP++ L +++Y P DL +L + V+ +
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMR 106
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+L G+ Y+HA GI++RDLKP N+L+ DG + ++DF L
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGL 145
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 37/142 (26%), Positives = 72/142 (50%), Gaps = 1/142 (0%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
V+ +G G+ G+ L ++ + +K ++ +S K+ + E +LS + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
E + + ++DYC GDL+ + Q F + + ++ + L+++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 225 YRDLKPENILLREDGHIMLSDF 246
+RD+K +NI L +DG I L DF
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDF 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G G V+ R T A+K + L + + E I+ HP + Y
Sbjct: 27 IGEGASGEVYKATDRA-TGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
V + +++Y G L ++ Q R + + + EVL GLEYLH+ +I+RD
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRD 141
Query: 228 LKPENILLREDGHIMLSDFDLCFQ 251
+K +NILL +DG + L+DF Q
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQ 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 9/126 (7%)
Query: 125 TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL---YAHLEVSHYICFLIDY 181
T ALK+++ D +S +Q E +LS L P + Y + +++Y
Sbjct: 25 TGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83
Query: 182 CPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH 240
G + +L+ P ++ +R EVLV L+Y+H +G+I+RD+K NIL+ G+
Sbjct: 84 AEGGSVRTLMKAGPIAEKYISVIIR----EVLVALKYIHKVGVIHRDIKAANILVTNTGN 139
Query: 241 IMLSDF 246
+ L DF
Sbjct: 140 VKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 1/161 (0%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+R LG G G L + R + K V+ LS K+ E ILS+L HP +
Sbjct: 5 IRVLGKGAFGEATL-YRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
Y H + + ++Y G L+ + +Q F + V ++ +++ + Y+H GI+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
+RD+K NI L + G I L DF + ++ ET VG+
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANF-ALKVV---DKDLLSAKKLSHVQMEAEILSMLD 158
+L++ +G+G G V+ RD + A+KV+ D +Q E +L
Sbjct: 6 ELIQRIGSGTYGDVY--KARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECR 58
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + + + +++YC G L + + S + + E L GL YL
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY-QVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDF 246
H G I+RD+K NILL EDG + L+DF
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADF 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFL 162
LV +G G G+V+ + T A+K++D +++ E IL +HP +
Sbjct: 10 LVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNI 65
Query: 163 PTLY-AHLEVSHYIC-----FLIDYCPNG---DLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
T Y A ++ + +++ C G DL L K+ R + + + E L
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLR 124
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
GL YLH +I+RD+K +NILL ++ + L DF + Q D
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 100 RHLKLVRHLGTGNLGRVFLCH---LRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
RHLK ++ LG GN G V LC L+D T A+K + +A+ L + E EIL
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61
Query: 157 LDHPFLPTLYAHLEVSHY--ICF---------LIDYCPNGDLHSLLPKQPNNRFSLQAVR 205
L H + Y +C+ +++Y P G L L K R + +
Sbjct: 62 LQHDN---------IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLL 111
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+A+++ G+EYL + ++RDL NIL+ + + + DF L
Sbjct: 112 LYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-13
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
KL R +G G+ G VF + + T A+K++D + + ++ +Q E +LS D P++
Sbjct: 8 KLER-IGKGSFGEVFK-GIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYV 64
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y + +++Y G LL P + F + + E+L GL+YLH+
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM---LKEILKGLDYLHSEK 121
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
I+RD+K N+LL E G + L+DF + Q T VG+
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-13
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFL-CH--LRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI 153
H R+LK +R LG G+ G+V L C+ D T A+K + ++ + S + E I
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINI 59
Query: 154 LSMLDHPFLPTLYAHLEVS--HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
L L H + + +++Y P G L LPK ++ +L + FA ++
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQI 116
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G+ YLH+ I+RDL N+LL D + + DF L
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 4/144 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ LG G G+V+ ++ T A KV+D S ++L +E +IL+ DHP +
Sbjct: 8 EIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 64
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L + + LI++C G + +++ + + +R + L L YLH
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
II+RDLK NIL DG I L+DF
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADF 147
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 41/163 (25%), Positives = 87/163 (53%), Gaps = 2/163 (1%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
+++ +G G+ G+++L + S + +K +D + K+ + E +L+ + HP +
Sbjct: 4 IIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
T +A + + + +++YC GDL + +Q FS + + ++ +GL+++H I
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 224 IYRDLKPENILLREDGHIM-LSDFDLCFQSDVVPTLVETNVGS 265
++RD+K +NI L ++G + L DF + Q + L T VG+
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKV---VDKDLLSAKKLSHVQMEAEILSML 157
+L++ +G+G G V + T A+K V DL+ AK + E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFDDLIDAK---RILREIKLLRHL 56
Query: 158 DHPFLPTLYAHLEVSHYICF--------LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
H + L L F L++ DLH ++ K P + +++F
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVI-KSPQP-LTDDHIQYFLY 110
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL+YLH+ +I+RDLKP NIL+ + + + DF L
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 108 LGTGNLGRVF-LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
LG GN G V+ HL T A+KV+ D+ + + + E EIL D P++ Y
Sbjct: 9 LGHGNGGTVYKAYHL--LTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 167 AHLEVSHYICFLIDYCPNG--DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
V + I ++ G D++ +P+ R A V+ GL YL +L I+
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRI--------AVAVVKGLTYLWSLKIL 117
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQ--SDVVPTLVETNVGSATRR 269
+RD+KP N+L+ G + L DF + Q + + T V TN A R
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPER 164
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 102 LKLVRHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
LKL + LG G G V L D + A+K + D+ + ++ EA + DH
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 160 PFLPTLYAHLEVSHYICF-------------LIDYCPNGDLHSLL-----PKQPNNRFSL 201
P + L +CF ++ + +GDLHS L P L
Sbjct: 61 PNVMKLIG-------VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPL 112
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
Q + F ++ +G+EYL I+RDL N +LRED + ++DF L
Sbjct: 113 QTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 35/167 (20%)
Query: 105 VRHLGTGNLGRVFLCHLRD-CTSANFALKVVDK---DLLSAKK-------LSHVQMEAEI 153
+ +G+G G+V C D T A+K + + + AK+ L H+ E +
Sbjct: 20 LSPVGSGAYGQV--CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE-NV 76
Query: 154 LSMLDHPFLPTLYAHLE-------VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRF 206
+ +LD F P + LE V+H + DL++++ Q + S ++F
Sbjct: 77 IGLLD-VFTPA--SSLEDFQDVYLVTHLM--------GADLNNIVKCQ---KLSDDHIQF 122
Query: 207 FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
++L GL+Y+H+ GII+RDLKP NI + ED + + DF L +D
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 5/144 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G+ G VF + + T A+K++D + + ++ +Q E +LS D P++ Y
Sbjct: 12 IGKGSFGEVFK-GIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
+ +++Y G LL P + + + E+L GL+YLH+ I+RD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI---LREILKGLDYLHSEKKIHRD 126
Query: 228 LKPENILLREDGHIMLSDFDLCFQ 251
+K N+LL E G + L+DF + Q
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQ 150
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM--EAEILSMLDH 159
L+ + LG GN G V T A KVV + AK Q+ E +I+
Sbjct: 7 LETISDLGAGNGGSVSKV-KHIPTGTVMAKKVV---HIGAKSSVRKQILRELQIMHECRS 62
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P++ + Y + IC +++ G L + K ++ + A V+ GL YL+
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLY 120
Query: 220 -ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSAT 267
I++RD+KP NIL+ G I L DF + +++ ++ +T VG++T
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--SGELINSIADTFVGTST 167
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 24/63 (38%), Positives = 41/63 (65%), Gaps = 4/63 (6%)
Query: 185 GDLHSLL-PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML 243
DLH ++ QP + + +R+F ++L GL+Y+H+ +I+RDLKP N+L+ ED + +
Sbjct: 92 SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148
Query: 244 SDF 246
DF
Sbjct: 149 GDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 35/144 (24%), Positives = 74/144 (51%), Gaps = 4/144 (2%)
Query: 104 LVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
++R +G G+ GR L H + +A+K + + S+ + + EA +L+ + HP +
Sbjct: 4 VLRVVGEGSFGRALLVQH--VNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
E ++ +++YC GDL + Q F + + ++ +G++++H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
+++RD+K +NI L ++G + L DF
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDF 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG GN G V+ L T A+K + +L +K + + ME +IL P++ Y
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 168 --HLEVSHYICFLIDYCPNGDLHSLLP-KQPNNRFSLQAVRFFAAEVLVGLEYL-HALGI 223
+E + Y+C ++Y G L L +R V+ GL++L I
Sbjct: 67 AFFIEGAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
I+RD+KP N+L+ +G + L DF + ++V +L +TN+G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVASLAKTNIG 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 5/147 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
+KLV+ LG G G V++ + + T A+K + +S + EA ++ L H
Sbjct: 8 IKLVKKLGAGQFGEVWMGYYNNSTKV--AVKTLKPGTMSVQAFLE---EANLMKTLQHDK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA + I + +Y G L L + L + F+A++ G+ Y+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ N+L+ E ++DF L
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 17/167 (10%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILS 155
L ++ + LG G G+V+ L A V K L K + EAE++S
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS-LLPKQPNN-----------RFSLQA 203
L HP + L C L +Y +GDLH L+ P++ + SL
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 204 VRFF--AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
F A ++ G+EYL + ++RDL N L+ E + +SDF L
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+ +G G G V+ + T A+K + S E ++L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 165 LYAHLEVSH-----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L L+V Y+ F ++ + DL+ L+ K ++ + ++L GL + H
Sbjct: 63 L---LDVFRHKGDLYLVF--EFM-DTDLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVP 256
+ GI++RDLKPEN+L+ +G + L+DF L F S V P
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL----LSAKKLSHVQMEAEILSMLDH 159
L + LG G+ G V+L + + LKV+ K++ L+ + EA++LS LDH
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEE-RLKVL-KEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEVLVGLEY 217
P + +A C + +YC DL L K S V + ++L+G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 218 LHALGIIYRDLKPENILLRED 238
+H I++RDLK +NI L+ +
Sbjct: 122 MHQRRILHRDLKAKNIFLKNN 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 12/151 (7%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G+ G V R K +D ++ K+ + E IL L HP + Y
Sbjct: 8 IGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 168 HL--EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL---QAVRFFAAEVLVGLEYLHALG 222
+ + + +++YC GDL L+ K R + R ++L+ L H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLALYECHNRS 125
Query: 223 -----IIYRDLKPENILLREDGHIMLSDFDL 248
+++RDLKP NI L + ++ L DF L
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DH 159
K+++ LG G G V+L ++ T A+K + K E+ S+ +H
Sbjct: 2 KVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEH 57
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P + L + + F+ +Y G+L+ L+ + FS +R ++L GL ++H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
G +RDLKPEN+L+ + ++DF L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGL 145
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 105 VRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
++ +G G G V C RD T N A+K + K + E ++L L H +
Sbjct: 15 LQPVGMGAFGLV--CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENII 72
Query: 164 TL----YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+L + LE +++ L+ DLH LL +P Q +++F ++L GL+Y+H
Sbjct: 73 SLSDIFISPLEDIYFVTELL----GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVH 125
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ G+++RDLKP NIL+ E+ + + DF L
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGL 154
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD--KDLLSAKKLSHVQMEAEI 153
+L L ++ + LG G+++ HL + L + KD+ + ++ Q EA +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS-LLPKQPNN------------RFS 200
++ L HP + L + +C L +Y GDLH L+ + P++ + S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 201 LQAVRFF--AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L F A ++ G+EYL + +++DL NIL+ E H+ +SD L
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
KL R +G G+ G V+ + + T A+K++D + + ++ +Q E +LS D P++
Sbjct: 8 KLER-IGKGSFGEVYK-GIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYI 64
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y + +++Y G LL P + + E+L GL+YLH+
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI---LREILKGLDYLHSER 121
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+RD+K N+LL E G + L+DF + Q
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 7/80 (8%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL + L K P + ++ ++L G+++LH+ I++RDLKP+NIL+ DG + ++D
Sbjct: 91 DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIAD 150
Query: 246 FDL----CFQS---DVVPTL 258
F L F+ VV TL
Sbjct: 151 FGLARIYSFEMALTSVVVTL 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 17/166 (10%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFL---CHLRDCTSANF-ALKVVDKDLLSAKKLSHVQMEAE 152
+ + L R LG G G+VFL HL A+K + K+ S + EAE
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAE 60
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL------------PKQPNNRFS 200
+L+ H + Y + +Y +GDL+ L P P +
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L + A ++ G+ YL + ++RDL N L+ D + + DF
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDF 166
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-11
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
+G GN G V+ L+ T A+K L K +Q EAEIL DHP + L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV--AVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKL 57
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
I +++ P G L + L K NR +++ + + + G+EYL + I+
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 226 RDLKPENILLREDGHIMLSDFDLCFQSD 253
RDL N L+ E+ + +SDF + + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEE 144
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 104 LVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
VR +G G+ G V L H D + +K ++ S ++ + EA++LS L HP +
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 163 PTLYAHLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
E + +++ +C GDL+ L +Q V + ++ + L+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCF----QSDVVPTLVET 261
I++RDLK +N+ L I + D + Q D+ TL+ T
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 6/152 (3%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
++ + LKL +G G G V L R A+K + D +A+ EA +++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAF---LAEASVMTT 56
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L HP L L + + + + +Y G L L + +L FA +V G+E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL ++RDL N+L+ ED +SDF L
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV---QMEAEILSM 156
R LK +R LG G+ G+V LC D N +V K L +H+ + E EIL
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRY-DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 62
Query: 157 LDHPFLPTLYAHL---EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
L H + Y + + + I ++++ P+G L LP+ N+ +L+ +A ++
Sbjct: 63 LYHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICK 120
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL + ++RDL N+L+ + + + DF L
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 6/146 (4%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
V +G G G V+ + T ALK + D + S E +L L+HP +
Sbjct: 5 VEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 165 LY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L H E Y+ F ++ + DL + P + L ++ + ++L GL + H+
Sbjct: 64 LLDVIHTENKLYLVF--EFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 223 IIYRDLKPENILLREDGHIMLSDFDL 248
+++RDLKP+N+L+ +G I L+DF L
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
LKLV+ LG G G V++ + T A+K + + +S EA ++ L HP
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKV--AIKSLKQGSMSP---EAFLAEANLMKQLQHPR 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA + I + +Y NG L L + ++ + AA++ G+ ++
Sbjct: 63 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ NIL+ E ++DF L
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGL 148
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLDH 159
+L + LG G GRV+LC+ D T A+K V D S +K+++ ++ E ++L L H
Sbjct: 5 RLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 160 PFLPTLYAHLE--VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+ Y L + + +++ P G + L + + R + ++L G+ Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSY 121
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDF 246
LH+ I++RD+K NIL G++ L DF
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
+ L ++ LG+G G V L R + A+K++ + +S EA+++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRG--KIDVAIKMIREGAMSEDDFIE---EAKVMMK 55
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L HP L LY I + +Y NG L + L ++ + + + ++V +E
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAME 114
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL + G I+RDL N L+ ED + +SDF L
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLDHPFLPT 164
LG G GRV+LC+ D T A K V D S +K++S ++ E ++L L H +
Sbjct: 10 LGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 165 LYAHLE--VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y L + ++Y P G + L + + R + ++L G+ YLH+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
I++RD+K NIL G++ L DF
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLLSAKKLSHVQMEAEILS 155
R + L R LG G G+VFL + + A+K + L+A+K Q EAE+L+
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLT 62
Query: 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSL 201
L H + Y + + +Y +GDL+ L P+Q L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ A+++ G+ YL + ++RDL N L+ + + + DF +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFA-LKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+L++ +G+G G V+ R+ + A +KV+ L + + VQ E ++ H
Sbjct: 11 FELIQRIGSGTYGDVY--KARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ + + +++C G L + S + + + E L GL YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
G ++RD+K NILL ++GH+ L+DF + Q
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
+H L LV+ +G+G G V+L + + A+K + + +S + EA+++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKV--AIKTIREGAMSEEDFIE---EAQVMMK 55
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L HP L LY IC + ++ +G L L Q +FS + + +V G+
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMA 114
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL + +I+RDL N L+ E+ + +SDF +
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGM 146
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 43/144 (29%), Positives = 64/144 (44%), Gaps = 13/144 (9%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVV-----DKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+G G G V C + T A+K D+D+ KK + E ++L L H +
Sbjct: 9 VGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDV---KKTA--LREVKVLRQLRHENI 62
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L + + +Y L LL P AVR + ++L + Y H+
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
II+RD+KPENIL+ E G + L DF
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALK--VVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
+G G+ G VF C R+ T A+K V +D KK++ E +L L HP L L
Sbjct: 9 IGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNL 65
Query: 166 YAHLEV---SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
+EV + + +YC + L+ L K P ++ + L + + H
Sbjct: 66 ---IEVFRRKRKLHLVFEYCDHTVLNEL-EKNPRGVPEHL-IKKIIWQTLQAVNFCHKHN 120
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
I+RD+KPENIL+ + G I L DF
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 5/149 (3%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
++L+R LG G G V+ + T A+K + + K EA+I+ L H
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPV--AVKTLKPGTMDPKDFLA---EAQIMKKLRH 60
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P L LYA + I + + G L L L + AA+V G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
A I+RDL N+L+ E+ ++DF L
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 6e-10
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 2/100 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E ++L L HP + L I + ++ DL ++ K + + ++ +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI-KDKSIVLTPADIKSYML 109
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
L GLEYLH+ I++RDLKP N+L+ DG + L+DF L
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM--EAEILSM 156
++ ++R +G G +G V+L + C S ALK + +DL S L + EA+I +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVC-SRRVALKKIREDL-SENPLLKKRFLREAKIAAD 58
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL---------PKQPNNRFSLQAVRFF 207
L HP + +Y+ + + + Y L SLL K+ + S+ A
Sbjct: 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
++ +EY+H+ G+++RDLKP+NILL G +++ D+
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157
|
Length = 932 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 5/147 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
LKL R LG G G V++ T A+K + +S + EA+I+ L H
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA I + +Y G L L + L + AA++ G+ YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL NIL+ E+ ++DF L
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 4/145 (2%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
L R LG+G G V+ ++ A+K++ D K Q E + L L H L
Sbjct: 10 LERKLGSGYFGEVWEGLWKN--RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+L+A V + + + G L + L + ++ A +V G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
I+RDL NIL+ ED ++DF L
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGL 150
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 6/140 (4%)
Query: 113 LGRVF----LCHLRDCTSAN--FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G+ F + HL N A+K ++ D S + L +Q E L HP +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
V + + G LL A+ F +VL L+Y+H+ G I+R
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 227 DLKPENILLREDGHIMLSDF 246
+K +ILL DG ++LS
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
++ KL + +G G G VF R+ T ALK V D S E +L L H
Sbjct: 1 KYEKLEK-IGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+ LY L + + +YC + DL N + V+ F ++L GL + H
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYF-DSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL---------CFQSDVV 255
+ +++RDLKP+N+L+ ++G + L+DF L C+ ++VV
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 101 HLKLVRHLGTGNLGRVFLCHL---RDCTSANFALKVVD-KDLLSAKKL----------SH 146
HL LG G G V LC + +D + F V + LL A K+ +
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 147 VQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL------HSLLPKQPNNR-- 198
E +ILS L P + L +C + +Y NGDL H L K+ N
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 199 ---------FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
S ++ A ++ G++YL +L ++RDL N L+ E+ I ++DF +
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLDH 159
+L + LG G G V+LC+ D T A+K V D S +K+++ ++ E ++L L H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 160 PFLPTLYAHLE--VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+ Y L + ++Y P G + L + + R + ++L G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSY 121
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDF 246
LH+ I++RD+K NIL G++ L DF
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 3/113 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E +L L H + TL+ + + + +Y + DL L N S+ V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMF 110
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
++L GL Y H I++RDLKP+N+L+ E G + L+DF L ++ VPT +N
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVD-------KDLLSAKKLSHVQMEAE---I 153
++ HLG+G G V+ ++ ALK ++ KD K S + +E I
Sbjct: 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDK-SIGDIVSEVTII 62
Query: 154 LSMLDHPFLPTLYAHLEVSH--YICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
L HP + Y + YI LI+ P G+ + L K+ RF+ + + +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQ 121
Query: 211 VLVGLEYLHALG-IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
+++ L YLH I++RDL P NI+L ED + ++DF L Q
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 102 LKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+LV +G G G+V+ H++ T A+KV+D ++ + +++E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVK--TGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHH 72
Query: 161 F-LPTLY-AHLEVS-----HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
+ T Y A ++ S + ++++C G + L+ N + + E+L
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
GL +LHA +I+RD+K +N+LL E+ + L DF + Q D
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 9/116 (7%)
Query: 152 EILSMLD--HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E++ M D HP + +Y+ V + ++++ G L ++ R + + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCL 122
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ-SDVVP---TLVET 261
VL L +LHA G+I+RD+K ++ILL DG + LSDF C Q S VP +LV T
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ L ++ LGTG G V R + A+K++ + +S + EA+++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMSEDEFIE---EAKVMMKLSH 58
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L LY I + +Y NG L + L ++ RF + +V G+ YL
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ I+RDL N L+ + G + +SDF L
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 20/163 (12%)
Query: 102 LKLVRHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
L R LG G G V L+ D + A+K++ D+ S+ + EA + DH
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 160 PFLPTLYA---------HLEVSHYICFLIDYCPNGDLHSLL-----PKQPNNRFSLQAVR 205
P + L L + I + + +GDLH+ L ++P LQ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVI---LPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLV 116
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
F ++ G+EYL + I+RDL N +L E+ + ++DF L
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV--QMEAEILS 155
LR +++ LG G G V+ T ALK + + + K + E +IL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIK-TGRVVALKKIL--MHNEKDGFPITALREIKILK 62
Query: 156 MLDHP-FLPTL---YAHLEVSHY---ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
L HP +P + + S +++ + DL LL + P+ + + ++ +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQIKCYM 121
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L G+ YLH I++RD+K NIL+ G + ++DF L
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 152 EILSM--LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
EIL M HP + V + +++Y G L ++ + + + AV
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CR 122
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
E L LE+LH+ +I+RD+K +NILL DG + L+DF C Q
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P + L+ ++ + ++ + G L S + K N V+ +AAE++V L+ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC--VKRWAAEMVVALDALH 102
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257
GI+ RDL P NILL + GHI L+ F S+V +
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYF--SRWSEVEDS 138
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 26/63 (41%), Positives = 38/63 (60%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL + L K P + ++ + L GL++LHA I++RDLKPENIL+ G + L+D
Sbjct: 92 DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLAD 151
Query: 246 FDL 248
F L
Sbjct: 152 FGL 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+R LG G+ G VF DC K+V D + + H E +I+ LDH +
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVK 66
Query: 165 LYAHL-------------EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
+Y L +++ DL ++L + P S + R F ++
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFMYQL 123
Query: 212 LVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSDFDL 248
L GL+Y+H+ +++RDLKP N+ + ED + + DF L
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 8e-09
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 99 LRHLKLVRHLGT--GNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLS-HVQMEAEILS 155
L++ ++V+ L G G+V + + T F K++ +A + H M+
Sbjct: 13 LKNCEIVKKLKLIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFNAIEPMVHQLMK----- 66
Query: 156 MLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
D+P LY H + ++DY +GDL LL + + S V+ +++
Sbjct: 67 --DNPNFIKLYYSVTTLKGHVL--IMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVE 120
Query: 214 GLEYLHALGIIYRDLKPENILL-REDGHIMLSDFDLC 249
L LH II+ D+K EN+L R I L D+ LC
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 108 LGTGNLGRVFLCH---LRDCTSANFALKVVDKD--LLSAKKL---------SHVQMEAEI 153
LG G G V LC + +F+L V L++ K L + E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------PKQPNNRF-SLQAV 204
+S L P + L A S +C + +Y NGDL+ L ++ + S +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
F A ++ G++YL +L ++RDL N L+ ++ I ++DF
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADF 174
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVV----DKDLLSAKKLSHVQMEAEILSMLDHP--- 160
+G G G VF + T ALK V +K+ L E +IL +L H
Sbjct: 20 IGQGTFGEVFKARHKK-TKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVV 74
Query: 161 -------FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
T Y + S Y+ F ++C + DL LL N +F+L ++ +L
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVF--EFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLN 130
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
GL Y+H I++RD+K NIL+ +DG + L+DF L
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 2/121 (1%)
Query: 128 NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL 187
A+K + D LS ++ EA I+ LDH L LY + ++H + + + P G L
Sbjct: 25 PVAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSL 82
Query: 188 HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247
L K F + + +A ++ G+ YL + I+RDL NILL D + + DF
Sbjct: 83 LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG 142
Query: 248 L 248
L
Sbjct: 143 L 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 3/113 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E +L L H + TL+ + + + +Y + DL + N S+ V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLY 111
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
++L GL Y H +++RDLKP+N+L+ E G + L+DF L ++ VPT +N
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 36/145 (24%), Positives = 65/145 (44%), Gaps = 6/145 (4%)
Query: 106 RHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
+ LG GN G V A+K + ++ ++A K EA +++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIV 59
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L + + +++ P G L L K+ + ++ A +V +G+ YL +
Sbjct: 60 RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESKHF 116
Query: 224 IYRDLKPENILLREDGHIMLSDFDL 248
++RDL N+LL +SDF +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGM 141
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 24/56 (42%), Positives = 37/56 (66%)
Query: 198 RFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+ S ++F ++L GL+Y+HA GII+RDLKP N+ + ED + + DF L Q+D
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 102 LKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+LV +G G G+V+ H++ T A+KV+D ++ + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHH 62
Query: 161 F-LPTLYAHL------EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
+ T Y + + ++++C G + L+ N + + + E+L
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
GL +LH +I+RD+K +N+LL E+ + L DF + Q D
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 32/73 (43%), Positives = 44/73 (60%), Gaps = 3/73 (4%)
Query: 177 FLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235
FL+ +YC DL SLL P FS V+ ++L GL+YLH II+RDLK N+LL
Sbjct: 84 FLVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141
Query: 236 REDGHIMLSDFDL 248
+ G + ++DF L
Sbjct: 142 TDKGCLKIADFGL 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 28/77 (36%), Positives = 48/77 (62%), Gaps = 3/77 (3%)
Query: 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR 236
+L+ DL++++ Q + S + V+F ++L GL+Y+H+ GII+RDLKP N+ +
Sbjct: 96 YLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152
Query: 237 EDGHIMLSDFDLCFQSD 253
ED + + DF L Q+D
Sbjct: 153 EDCELRILDFGLARQAD 169
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP-FLPT 164
R L G+ G VF + + ++ +VV K A H EA +L L HP L
Sbjct: 175 RALTPGSEGCVF-----ESSHPDYPQRVVVKAGWYASS-VH---EARLLRRLSHPAVLAL 225
Query: 165 LYAHLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L + V C ++ Y DL++ L + L V A ++L ++Y+H GI
Sbjct: 226 LDVRV-VGGLTCLVLPKY--RSDLYTYLGARLRP-LGLAQVTAVARQLLSAIDYIHGEGI 281
Query: 224 IYRDLKPENILLREDGHIMLSDFD-LCF 250
I+RD+K EN+L+ I L DF CF
Sbjct: 282 IHRDIKTENVLVNGPEDICLGDFGAACF 309
|
Length = 461 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 150 EAEILSMLDHPFLPTLY-AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
E +++ L+HP + + A E SH+ F +++ G + LL K F + +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLF-VEWMAGGSVSHLLSKY--GAFKEAVIINYT 109
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIM-LSDF 246
++L GL YLH II+RD+K N+L+ G + ++DF
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 3/119 (2%)
Query: 130 ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
ALKV+ + ++ EA +L L H + L+ + + F+ +Y + DL
Sbjct: 34 ALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQ 91
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + P VR F ++L GL Y+H I++RDLKP+N+L+ G + L+DF L
Sbjct: 92 YMIQHPGGLHPYN-VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 3/113 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E +L L H + TL+ + + + +Y + DL L N ++ V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLF 111
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
++L GL Y H +++RDLKP+N+L+ E G + L+DF L ++ +PT +N
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 17/83 (20%)
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
Y ++ Y+ D C G L +N VR F ++L GL Y H +++
Sbjct: 84 YLDTDLKQYM----DDCGGG-LS------MHN------VRLFLFQLLRGLAYCHQRRVLH 126
Query: 226 RDLKPENILLREDGHIMLSDFDL 248
RDLKP+N+L+ E G + L+DF L
Sbjct: 127 RDLKPQNLLISERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 34/113 (30%), Positives = 60/113 (53%), Gaps = 3/113 (2%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
EA +L L H + L+ + + + +Y + DL + K P + V+ F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLF 110
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
++L GL Y+H I++RDLKP+N+L+ + G + L+DF L ++ VP+ +N
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSN 162
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 22/59 (37%), Positives = 37/59 (62%), Gaps = 4/59 (6%)
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF----DLC 249
P ++ + ++ +VL GL LH +GI++RD+KPEN+L+ DG + + DF D+C
Sbjct: 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360
|
Length = 507 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 108 LGTGNLGRVFLCHLRDCTSA-NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G+ G V C R+ S A+K++D L ++ + E I+ H + +Y
Sbjct: 29 IGEGSTGIV--CIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
V + L+++ G L ++ + R + + + VL L YLH+ G+I+R
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 227 DLKPENILLREDGHIMLSDFDLCFQ-SDVVP 256
D+K ++ILL DG + LSDF C Q S VP
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 100 RHLKLVRHLGTGNLGRVFLCH------LRDCTSANF-------ALKVVDKDLLSAKKLSH 146
+ L+L LG G G V LC + F A+K++ D+ +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 147 VQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ--------PNN- 197
++ E +I+S L +P + L +C + +Y NGDL+ L ++ NN
Sbjct: 65 LK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 198 -RFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
S+ + + A ++ G++YL +L ++RDL N L+ I ++DF +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 24/63 (38%), Positives = 38/63 (60%)
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250
L K + S V++ ++L GL+Y+H+ GII+RDLKP N+ + ED + + DF L
Sbjct: 106 LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
Query: 251 QSD 253
+D
Sbjct: 166 HAD 168
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 30/161 (18%)
Query: 103 KLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---D 158
K++ +G G V + +A+K + K S L V EI ++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY--YAIKCMKKHFKS---LEQVNNLREIQALRRLSP 56
Query: 159 HPFLPTLYAHLEVSH--------YICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFA 208
HP + L +EV + L+D +L+ L+ K+P + V+ +
Sbjct: 57 HPNILRL---IEVLFDRKTGRLALVFELMD----MNLYELIKGRKRP---LPEKRVKSYM 106
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++L L+++H GI +RD+KPENIL+++D + L+DF C
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSC 146
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 11/158 (6%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLS---HVQMEAEILSMLD 158
+ L+R LG G+ G V+ + +V K + + EA ++ +
Sbjct: 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ-PNNRF-------SLQAVRFFAAE 210
+ L + +++ GDL S L + P +LQ AAE
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ G+ YL A ++RDL N ++ ED + + DF +
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 152 EILSMLD--HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E++ M D H + +Y V + ++++ G L ++ + R + + +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCL 125
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ-SDVVP 256
VL L YLH G+I+RD+K ++ILL DG I LSDF C Q S VP
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG G V+ R T ALK + D + ++ E ++ L H + L+
Sbjct: 8 LGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHD 65
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNR-FSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + + + +Y + DL + V+ F ++L G+ + H +++R
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124
Query: 227 DLKPENILLREDGHIMLSDFDLC---------FQSDVV 255
DLKP+N+L+ + G + L+DF L F ++VV
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-08
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L ++ LG+G G V L R A+K +++ +S + EA+++ L HP
Sbjct: 6 LTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPK 60
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LY + + ++ NG L + L +Q + S + +V G+EYL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 222 GIIYRDLKPENILLREDGHIMLSDF 246
I+RDL N L+ G + +SDF
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDF 144
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 108 LGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTL 165
+G GN G+V ++ D + A+K + K+ S E E+L L HP + L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPK--------------QPNNRFSLQAVRFFAAEV 211
E Y+ I+Y P+G+L L K + S Q + FAA+V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL I+RDL NIL+ E+ ++DF L
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 170
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 153 ILSMLD--HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
+LS LD P + + +++ DLH ++ S V+ F +
Sbjct: 61 VLSALDILQPPHIDPFEEI-------YVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQ 111
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+L GL+YLH+ GI++RD+KP N+L+ + + + DF L
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 34/150 (22%), Positives = 71/150 (47%), Gaps = 6/150 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
L+ ++ LG+G G V+ + A+KV+ ++ S K + EA +++ +D
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVD 67
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + +S + + P G L + + + Q + + ++ G+ YL
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDL 248
+++RDL N+L++ H+ ++DF L
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 20/46 (43%), Positives = 30/46 (65%)
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
R+ ++L L+Y+H+ +I+RDLKP NILL D + L+DF L
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 27/170 (15%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV--------QMEA 151
R + L LG G G+VFL +C + L DK L++ K L Q EA
Sbjct: 5 RDIVLKWELGEGAFGKVFLA---ECHNL---LPEQDKMLVAVKALKEASESARQDFQREA 58
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL-------------PKQPNNR 198
E+L++L H + Y + + +Y +GDL+ L +
Sbjct: 59 ELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 199 FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+L + A+++ G+ YL +L ++RDL N L+ + + + DF +
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 36/144 (25%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ L G+ GRVF+ + LK+ K +EA +L ++HP +
Sbjct: 69 TVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSV 119
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
+ L C ++ + + DL++ L K+ + + ++L GL YLHA
Sbjct: 120 IRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
II+RD+K ENI + + + + D
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 45/170 (26%), Positives = 67/170 (39%), Gaps = 29/170 (17%)
Query: 105 VRHLGTGNLGRVF------LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
VR +G G GRVF L T A+K++ K+ SA + Q EA +++ D
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMV--AVKML-KEEASADMQADFQREAALMAEFD 66
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------------PKQPNNR 198
HP + L V +C L +Y GDL+ L
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 199 FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
S A +V G+ YL ++RDL N L+ E+ + ++DF L
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 7/80 (8%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL + L K P + ++ ++L GL++LH+ +++RDLKP+NIL+ G I L+D
Sbjct: 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153
Query: 246 FDLC----FQ---SDVVPTL 258
F L FQ + VV TL
Sbjct: 154 FGLARIYSFQMALTSVVVTL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 36/170 (21%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLS---HVQMEAE 152
+++L ++ + LG G+V+ HL V K L + + EA
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS-LLPKQPNN-----------RFS 200
+ S L HP + L + + + YC + DLH L+ + P++ + +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 201 LQAVRFF--AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L+ F ++ G+E+L + ++++DL N+L+ + ++ +SD L
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G+ G V + ++ S+ + V DL ++ + E I+ H + +Y
Sbjct: 28 IGEGSTGIVCIATVK---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
V + ++++ G L ++ N + AV VL L LHA G+I+RD
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIHRD 141
Query: 228 LKPENILLREDGHIMLSDFDLCFQ 251
+K ++ILL DG + LSDF C Q
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQ 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 15/185 (8%)
Query: 100 RHLKLVRHLGTGNLGRVFLCH--LRDCTSANFALKVVDKDLLSAKKLSHVQM-------- 149
R+++ HLG G G+V + L A +K+++ K V M
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 150 -EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
E +I++ + H + L +I ++D DL ++ R + V+
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV--DRKIRLTESQVKCIL 125
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATR 268
++L GL LH ++RDL P NI + G ++DF L + P +T T
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA-RRYGYPPYSDTLSKDETM 184
Query: 269 RRRRK 273
+RR +
Sbjct: 185 QRREE 189
|
Length = 335 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 6/144 (4%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+R +G G+ G V+ K+ S +K + E + L + HP
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
H +++YC G LL K+P + A+ A L GL YLH+
Sbjct: 90 YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN 145
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
+I+RD+K NILL E G + L+DF
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 25/77 (32%), Positives = 46/77 (59%), Gaps = 3/77 (3%)
Query: 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR 236
+L+ + DL++++ Q + + V+F ++L GL+Y+H+ II+RDLKP N+ +
Sbjct: 98 YLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154
Query: 237 EDGHIMLSDFDLCFQSD 253
ED + + DF L +D
Sbjct: 155 EDCELKILDFGLARHTD 171
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-----------VQMEAEI 153
+R +G G+ G V+ FA V + ++++ KK+S+ + E
Sbjct: 20 LREIGHGSFGAVY-----------FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEV 211
L L HP H +++YC G LL K+P + AV A
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGA--- 124
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L GL YLH+ +I+RD+K NILL E G + L DF
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 61 TTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCH 120
++ ++SS+SS +A+ + + L L+ V +G+G G V+
Sbjct: 50 PSSSSSSSSSS---------------SASGSAPSAAKSLSELERVNRIGSGAGGTVYKVI 94
Query: 121 LRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180
R T +ALKV+ + + + E EIL ++HP + + + + I L++
Sbjct: 95 HRP-TGRLYALKVIYGNHEDTVRRQ-ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH 240
+ G SL + L V A ++L G+ YLH I++RD+KP N+L+ +
Sbjct: 153 FMDGG---SLEGTHIADEQFLADV---ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN 206
Query: 241 IMLSDF 246
+ ++DF
Sbjct: 207 VKIADF 212
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 28/155 (18%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-----------VQMEAEI 153
+R +G G+ G V+ FA V ++++ KK+S+ + E
Sbjct: 20 LREIGHGSFGAVY-----------FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEV 211
L L HP H +++YC G +L K+P + A+
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAI---CHGA 124
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L GL YLH+ I+RD+K NILL E G + L+DF
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
L+++ LKL++ +G G G V L R A+K + D + L+ EA +++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQAFLA----EASVMTQ 55
Query: 157 LDHPFLPTLYAHL-EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
L H L L + E + + +Y G L L + + + F+ +V +
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
EYL A ++RDL N+L+ ED +SDF L
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSML- 157
L L + LG G G+V + N V K L + K LS + E E++ M+
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSLQA 203
H + L + +++Y +G+L L P+ P + +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ FA +V G+E+L + I+RDL N+L+ ED + ++DF L
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL 178
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E +L L+HP + L H E Y+ F ++ + DL + P ++ +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVF--EFL-DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L G+ Y H+ +++RDLKP+N+L+ +G + L+DF L
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 5/144 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+L++ +G+G G V+ R+ + A + K L S +Q E ++ H +
Sbjct: 12 ELIQRVGSGTYGDVY--KARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
+ + ++YC G L + S + + E L GL YLH+ G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 223 IIYRDLKPENILLREDGHIMLSDF 246
++RD+K NILL ++G + L+DF
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADF 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 41/144 (28%), Positives = 61/144 (42%), Gaps = 9/144 (6%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDHPFLPT 164
+G GN G VF LR + A+K + L L AK L EA IL HP +
Sbjct: 3 IGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFL----QEARILKQYSHPNIVR 57
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L I +++ GD + L + R ++ + G+EYL + I
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
+RDL N L+ E + +SDF +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGM 140
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFAL--KVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLP 163
+G G G VF T+ + A +V K + K+ + EIL M L +P +
Sbjct: 27 IGQGASGTVF-------TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
V + +++Y G L ++ + + + AV E L LE+LHA +
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQV 136
Query: 224 IYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+RD+K +N+LL DG + L+DF C Q
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
+ R LG+G G V LC R FA+KVVD + +S + Q AE+ +L+ F
Sbjct: 36 ISRVLGSGATGTV-LCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ--AEVCCLLNCDFFS 92
Query: 164 TLYAHLEVSH----------YICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEV 211
+ H + + I ++DY GDL + + N F +V
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L+ + ++H+ +I+RD+K NILL +G + L DF
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187
|
Length = 496 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLD 158
+K+ + +G G G V C R + V K L + K+ EA I+ D
Sbjct: 6 IKIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + S + + +Y NG L + L K +Q V + G++YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-IASGMKYL 122
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDL 248
+G ++RDL NIL+ + +SDF L
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGL 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 23/172 (13%)
Query: 101 HLKLVRHLGTGNLGRVFLCH---LRDCTSANFAL-KVVDKDLLSAKK----------LSH 146
L V LG G G V LC L+D + FA D +L A K
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 147 VQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK-QPNNRFSLQAVR 205
E +ILS L P + L V +C +++Y NGDL+ L K +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 206 FFAAEVLV--------GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ L+ G+ YL +L ++RDL N L+ ++ I ++DF +
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 31/165 (18%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSAN---FALK----VVDKDLLSAKKLSHVQMEAEI 153
+L++ LG G G V C R+ ++ A+K V K +L+ + L E ++
Sbjct: 1 RYELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKL 54
Query: 154 LSML-DHPFLPTLYAHLEVSHYICF--------LIDYCPNGDLHSLL-PKQPNNRFSLQA 203
L H + LY +++ F L++ DLH ++ QP Q
Sbjct: 55 LRHFRGHKNITCLY-DMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQ- 108
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
F ++L GL+Y+H+ +++RDLKP N+L+ D + + DF L
Sbjct: 109 --SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL 151
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 108 LGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTL 165
+G GN G+V ++ D N A+K++ K+ S E E+L L HP + L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQ--------------PNNRFSLQAVRFFAAEV 211
E Y+ I+Y P G+L L K + + Q + FA++V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL I+RDL N+L+ E+ ++DF L
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGL 165
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 17/150 (11%)
Query: 108 LGTGNLGRVFLCHLRDC-TSANFALK-VVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
LG G G V+ RD T A+K + ++D + L E + S L H +
Sbjct: 16 LGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQY 70
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLL-----PKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ + ++ P G L +LL P + N Q + F+ ++L GL+YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIIFYTKQILEGLKYLHD 126
Query: 221 LGIIYRDLKPENILLRE-DGHIMLSDFDLC 249
I++RD+K +N+L+ G + +SDF
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 24/56 (42%), Positives = 35/56 (62%), Gaps = 1/56 (1%)
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L K PN VR + ++L G+E+ H+ II+RD+KPENIL+ + G + L DF
Sbjct: 90 LEKYPNG-LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
LKL + LG G G V++ T A+K + +S + EA ++ L H
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKV--AVKTMKPGSMSVEAFLA---EANVMKTLQHDK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L L+A + I + ++ G L L ++ L + F+A++ G+ ++
Sbjct: 63 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ NIL+ ++DF L
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGL 148
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
L+L+ L L +G G G V + T A+K + D+ + L E +++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQ---GEYTGQKVAVKNIKCDVTAQAFLE----ETAVMTK 55
Query: 157 LDHPFL-PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
L H L L L YI +++ G+L + L + S+ + F+ +V G+
Sbjct: 56 LHHKNLVRLLGVILHNGLYI--VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
EYL + +++RDL NIL+ EDG +SDF L
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 22/63 (34%), Positives = 39/63 (61%), Gaps = 3/63 (4%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL+ L+ Q S +++F ++L GL+Y+H+ +++RDLKP N+LL + + + D
Sbjct: 93 DLYKLIKTQH---LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICD 149
Query: 246 FDL 248
F L
Sbjct: 150 FGL 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L+L++ LG G G V++ T A+K + +S + EA+I+ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKV--AVKTLKPGTMSPESFLE---EAQIMKKLRHDK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA + I + +Y G L L L + AA+V G+ Y+ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ NIL+ + ++DF L
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGL 148
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 152 EILSMLDHPFLPTLYAHLE---VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
EIL M ++ P + +L+ V + +++Y G L ++ + + + AV
Sbjct: 67 EILVMRENKN-PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---C 122
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
E L LE+LH+ +I+RD+K +NILL DG + L+DF C Q
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 27/100 (27%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DLH ++ + + S ++F ++L GL+Y+H+ +++RDLKP N+LL + + + D
Sbjct: 94 DLHQII--RSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 151
Query: 246 FDLCFQSDVVPTLVETNVGSATRRRRRK----SCNGFGSA 281
F L + + V TR R +C+ + +A
Sbjct: 152 FGLARTTSEKGDFMTEYV--VTRWYRAPELLLNCSEYTTA 189
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 33/149 (22%), Positives = 65/149 (43%), Gaps = 5/149 (3%)
Query: 102 LKLVRHLGTGNLGRVF--LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ L R +G G G V+ + + A+K + + +Q EA I+ DH
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDH 66
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P + L + + + +++ P G+L S L + L ++ ++ ++ L YL
Sbjct: 67 PHIVKLIGVITENP-VWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ ++RD+ N+L+ + L DF L
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGL 153
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 26/113 (23%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSH-------------YICF-LIDYCPNGDLHSLLPKQP 195
E ++L +L HP + +E+ H Y+ F L++ DLH ++ +
Sbjct: 49 EIKLLRLLRHPDI------VEIKHIMLPPSRREFKDIYVVFELME----SDLHQVI--KA 96
Query: 196 NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
N+ + + +FF ++L L+Y+H + +RDLKP+NIL D + + DF L
Sbjct: 97 NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 28/155 (18%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-----------VQMEAEI 153
+ +G G+ G V+ FA ++++ KK+S+ + E +
Sbjct: 26 LHEIGHGSFGAVY-----------FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKF 74
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEV 211
L L HP H +++YC G LL K+P + A+ A
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGA--- 130
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L GL YLH+ +I+RD+K NILL E G + L+DF
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 108 LGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTL 165
+G GN G+V ++ D + A+K + K+ S E E+L L HP + L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQ---------------PNNRFSLQAVRFFAAE 210
E Y+ I+Y P+G+L L K + S Q + F AA+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AAD 120
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
V G++YL I+RDL NIL+ E+ ++DF L
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKD----LLSAKKLSHVQMEAEILSMLDHPFLP 163
LG G G V+ C L + A+K V+ D L + K+ +Q E ++L L H +
Sbjct: 8 LGKGAYGTVY-CGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL---QAVRFFAAEVLVGLEYLHA 220
+ I +++ P G + S+L NRF + ++L G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 221 LGIIYRDLKPENILLREDGHIMLSDF 246
+++RD+K N++L +G I L DF
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L+L LG G G V++ T A+K + +S + EA+++ L H
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTLKPGTMSPEAFLQ---EAQVMKKLRHEK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA + I + +Y G L L + L + AA++ G+ Y+ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
++RDL+ NIL+ E+ ++DF L
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGL 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD--KDLLSAKKLSHVQMEAEILSML-DH 159
+++ +G G G+VF + + A+K++D D+ ++ E IL L DH
Sbjct: 21 EIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIHDIDE-----EIEAEYNILKALSDH 74
Query: 160 PFLPTLYA-----HLEVSHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVL 212
P + Y ++ + +++ C G + L+ + R + + E L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
+GL++LH I+RD+K NILL +G + L DF + Q T+VG+
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 1/40 (2%)
Query: 208 AAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDF 246
A ++ LEYLH+ L +I+RD+KP N+L+ +G + L DF
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF 148
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 43/179 (24%)
Query: 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE-- 152
GK + ++ +G G G+V+ K DKD L V+++ E
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVY--------------KARDKDTGELVALKKVRLDNEKE 47
Query: 153 -----------ILSMLDHPFL------------PTLYAHLEVSHYICFLIDYCPNGDLHS 189
IL L+H + + + + Y+ F +Y + DL
Sbjct: 48 GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVF--EYM-DHDLMG 104
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
LL + FS ++ F ++L GL Y H ++RD+K NILL G I L+DF L
Sbjct: 105 LLESGLVH-FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 18/43 (41%), Positives = 31/43 (72%)
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ ++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 16/147 (10%)
Query: 108 LGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
LG G G V+ + T A+K + +D + ++ EA ++ + HP L L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQL 67
Query: 166 YA--HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVR--FFAAEVLVGLEYLHAL 221
E YI + ++ G+L L + NR + AV + A ++ +EYL
Sbjct: 68 LGVCTREPPFYI--ITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL N L+ E+ + ++DF L
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGL 150
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 42/151 (27%), Positives = 62/151 (41%), Gaps = 25/151 (16%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFL 162
++ L G+ G VF+C KV+ K + K E +IL + H +
Sbjct: 96 ILSSLTPGSEGEVFVCTKHGDEQRK---KVIVKAVTGGKTPGR---EIDILKTISHRAII 149
Query: 163 PTLYAH-------LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
++A+ + + Y C L Y D LP L+ +L L
Sbjct: 150 NLIHAYRWKSTVCMVMPKYKCDLFTYV---DRSGPLP--------LEQAITIQRRLLEAL 198
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDF 246
YLH GII+RD+K ENI L E + +L DF
Sbjct: 199 AYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---EAEILSML- 157
L + LG G G+V + ++ +KV K L S + E +I+S L
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+H + L + I + +YC GDL + L ++ + +L+ + F+ +V G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 218 LHALGIIYRDLKPENILLREDGHIM-LSDFDL 248
L + I+RDL N+LL G I+ + DF L
Sbjct: 157 LASKNCIHRDLAARNVLLTH-GKIVKICDFGL 187
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
+G G G V+ + T A+K ++ K+L + EIL M ++ P +
Sbjct: 27 IGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKEL----IINEILVMRENKN-PNIVN 80
Query: 168 HLE---VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+L+ V + +++Y G L ++ + + + AV E L L++LH+ +I
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQVI 137
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQ 251
+RD+K +NILL DG + L+DF C Q
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQ 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 99 LRHLKLVRHLGTGNLGRVF-LCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSM 156
L + ++ + +G G V+ L D ALK V DL+ AK + E ++L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPV--ALKKVQIFDLMDAKARADCIKEIDLLKQ 58
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAAEVLVG 214
L+HP + YA + + +++ GDL ++ K+ + V + ++
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
LE++H+ +++RD+KP N+ + G + L D L
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 44/155 (28%), Positives = 62/155 (40%), Gaps = 26/155 (16%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLD 158
+ L+R LG G G V+ R L+V K L S + S MEA I+S +
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67
Query: 159 HPFLPTLYAHLEVSHYI--CF-------LIDYCPNGDLHSLLPK---QPNNRFSL--QAV 204
H + I F L++ GDL S L + +P SL + +
Sbjct: 68 HQ---------NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239
F A +V G +YL I+RD+ N LL G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 100 RH-LKLVRHLGTGNLGRVFLCHLRD-CTSAN---FALKVVDKDLLSAKKLSHVQMEAEIL 154
RH + L R LG G G+VFL + C + A+K + +A+K H EAE+L
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELL 61
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ-----------PNNRFSLQA 203
+ L H + Y + + +Y +GDL+ L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ A ++ G+ YL + ++RDL N L+ E+ + + DF +
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 166
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 1/63 (1%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL SL+ F V+ ++L G+ +LH I++RDLK N+LL G + + D
Sbjct: 91 DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICD 149
Query: 246 FDL 248
F L
Sbjct: 150 FGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 103 KLVRHLGTGNLGRVF-LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHP 160
+++ +G G G+V+ + + +D + A A+K++D + ++ E IL L +HP
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLA--AVKILDP---ISDVDEEIEAEYNILQSLPNHP 79
Query: 161 FLPTLYAHL-EVSHYI----CFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLV 213
+ Y + + +++ C G + L+ R + + L+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
GL++LH II+RD+K NILL +G + L DF + Q T+VG+
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDK--DLLSAKKLSHVQM----------EAE 152
+ LG GN G VF KV K L+ A+KL H+++ E +
Sbjct: 10 ISELGAGNGGVVF--------------KVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ 55
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
+L + P++ Y I +++ G L +L K R Q + + V+
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 113
Query: 213 VGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
GL YL I++RD+KP NIL+ G I L DF + Q ++ ++ + VG+
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 29/152 (19%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDK--DLLSAKKLSHVQMEAEI-------LSML- 157
LG GN G V KV+ + L+ A+KL H++++ I L +L
Sbjct: 9 LGAGNGGVVT--------------KVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH 54
Query: 158 --DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
+ P++ Y I +++ G L +L K R + + VL GL
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGL 112
Query: 216 EYLH-ALGIIYRDLKPENILLREDGHIMLSDF 246
YL I++RD+KP NIL+ G I L DF
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 144
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 35/142 (24%), Positives = 65/142 (45%), Gaps = 4/142 (2%)
Query: 108 LGTGNLGRVFLCHLRDCTSAN-FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
LG+GN G V + S A+K++ D + EA ++ LD+P++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
E ++ +++ G L+ L Q N + + + +V +G++YL ++R
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 227 DLKPENILLREDGHIMLSDFDL 248
DL N+LL + +SDF L
Sbjct: 120 DLAARNVLLVTQHYAKISDFGL 141
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 22/172 (12%)
Query: 85 IKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV-------DKD 137
I N S N + KL +G G+ G V+ D TS A+K V +++
Sbjct: 56 IDNDINRSPN-----KSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYKNRE 109
Query: 138 LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNN 197
LL K L+H+ I+ + D+ + + E + ++ ++++ P +H + N
Sbjct: 110 LLIMKNLNHIN----IIFLKDYYYTECFKKN-EKNIFLNVVMEFIPQ-TVHKYMKHYARN 163
Query: 198 RFSLQA--VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIM-LSDF 246
+L V+ ++ ++ L Y+H+ I +RDLKP+N+L+ + H + L DF
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 4/106 (3%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
EA IL ++HP + L + + C ++ DL+ L + ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAK--RNIAICDILAIER 189
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD-LCFQSDV 254
VL ++YLH II+RD+K ENI + G + L DF CF D+
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--------LSAKKLSH---- 146
L H +++ L G G++F+C LR T A + V+ L AK++
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 147 -VQMEAEILSM--LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK---QPNNRFS 200
+Q+E EIL++ L+H + + L ++I + DL+S + +R
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDFDLYSFMYDEAFDWKDRPL 265
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L+ R ++L +EY+H +I+RD+K ENI L DG I+L DF
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDF 311
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 20/38 (52%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 215 LEYL-HALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
L YL L II+RD+KP NILL +G+I L DF + Q
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 102 LKLVRHLGTGNLGRVFLCHL-RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
L L + LG G G V L +D + A+K + + + ++ EA + DHP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 161 ----FLPTLYAHLEVSHYIC--FLIDYCPNGDLHSLL-----PKQPNNRFSLQAVRFFAA 209
+ +E Y ++ + +GDLHS L P + V+F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT- 119
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++ G+EYL + I+RDL N +L E+ ++ ++DF L
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL 158
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 102 LKLVRHLGTGNLGRVF---LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
LK V+ LG+G G V+ + A+K+++ + K EA I++ +D
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMD 67
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP L L + +S I + P+G L + + +N S Q + + ++ G+ YL
Sbjct: 68 HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGS-QLLLNWCVQIAKGMMYL 125
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDL 248
+++RDL N+L++ H+ ++DF L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGL 155
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L+L LG G G V++ T A+K + + + EA+I+ L H
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTTKV--AIKTLKPGTMMPEAFLQ---EAQIMKKLRHDK 62
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L LYA + I + ++ G L L + L + AA++ G+ Y+ +
Sbjct: 63 LVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ NIL+ ++ ++DF L
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGL 148
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHL------RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V + + A+K++ KD + K LS + E E++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVSEMEMMK 72
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--------------KQPNNRFS 200
M+ H + L + L++Y G+L L K P + +
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + A +V G+EYL + I+RDL N+L+ ED + ++DF L
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 108 LGTGNLGRVF--LCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-EAEILSMLDHPFLPT 164
LG+GN G V + +R + A+KV+ + + K + M EAEI+ LD+P++
Sbjct: 3 LGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+ E + + +++ G L+ L + + ++ V +V +G++YL +
Sbjct: 60 MIGVCE-AEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
+RDL N+LL + +SDF L
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGL 141
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 15/57 (26%), Positives = 34/57 (59%), Gaps = 1/57 (1%)
Query: 193 KQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIM-LSDFDL 248
+ P + ++ F ++L G+ + H G+++RDLKP+N+L+ + ++ ++D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 18/39 (46%), Positives = 30/39 (76%)
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 169
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 33/160 (20%), Positives = 60/160 (37%), Gaps = 12/160 (7%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM----EAEILSM 156
+L+ + LG G G VFL + V+ K L K ++Q E ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK-ALQKTKDENLQSEFRRELDMFRK 64
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNR---FSLQAVRFFAA 209
L H + L + +++Y GDL L K + S +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++ +G+++L ++RDL N L+ + +S L
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 18/47 (38%), Positives = 33/47 (70%)
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + + ++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 4/153 (2%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILSML 157
L + K+ + +G G V+ ALK V +++ AK E ++L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNR--FSLQAVRFFAAEVLVGL 215
DHP + A ++ + +++ GDL ++ + + + + ++ L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
E++H+ I++RD+KP N+ + G + L D L
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 18/47 (38%), Positives = 33/47 (70%)
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + + ++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 28/161 (17%)
Query: 102 LKLVRHLGTGNLGRVFLCHL-----RDCTSANFALKV-----VDKDLLSAKKLSHVQMEA 151
+K+ +G G G V L R+ A LK +D LS EA
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS---------EA 56
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS-LQAV---RFF 207
I+ DHP + L + S + + ++ NG L S L +Q + +F+ +Q V R
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGI 115
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
AA G++YL + ++RDL NIL+ + +SDF L
Sbjct: 116 AA----GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 35/159 (22%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 99 LRHLKLVRHLGTGNLGRVF--LCHLRDCTSANFALKVVDK-DLLSAKKLSHVQMEAEILS 155
L + ++ + +G G V+ C L ALK V +++ AK E ++L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKP---VALKKVQIFEMMDAKARQDCVKEIDLLK 57
Query: 156 MLDHP----FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP--KQPNNRFSLQAVRFFAA 209
L+HP +L + E++ +++ GDL ++ K+ + V +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELN----IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++ +E++H+ +++RD+KP N+ + G + L D L
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 102 LKLVRHLGTGNLGRVFLCHL--RDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSM 156
L L + LG G G+V + D N KV K L S K LS + E E++ M
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 79
Query: 157 L-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL-------------PKQ-PNNRFSL 201
+ H + L + +++Y G+L L P Q P + S
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + A +V G+EYL + I+RDL N+L+ ED + ++DF L
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM-LDHP 160
L+ + +G+G G+V+ + T A+K + + + ++ + M+ +++ D P
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCP 74
Query: 161 FLPTLYAHL--EVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
++ Y + + +IC L+ C L LL K+ + ++ L Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTC----LDKLL-KRIQGPIPEDILGKMTVAIVKALHY 129
Query: 218 L---HALGIIYRDLKPENILLREDGHIMLSDF 246
L H G+I+RD+KP NILL G++ L DF
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASGNVKLCDF 159
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 102 LKLVRHLGTGNLGRV---FLCHLRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSML 157
L L + LG G G+V L+ A+K++ ++ S+ +L + E +L +
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQV 60
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ---------------------PN 196
+HP + LY + +++Y G L S L + P+
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 197 NR-FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
R ++ + FA ++ G++YL + +++RDL N+L+ E + +SDF L
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 17/45 (37%), Positives = 31/45 (68%)
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
V+ + ++L G+ + H+ +++RDLKP+N+L+ G I L+DF L
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 15/139 (10%)
Query: 138 LLSAKKLSHVQM----------EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL 187
L+ A+KL H+++ E ++L + P++ Y I +++ G L
Sbjct: 31 LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90
Query: 188 HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDF 246
+L + R + + + VL GL YL I++RD+KP NIL+ G I L DF
Sbjct: 91 DQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDF 148
Query: 247 DLCFQSDVVPTLVETNVGS 265
+ Q ++ ++ + VG+
Sbjct: 149 GVSGQ--LIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 15/147 (10%)
Query: 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML 157
+L + L RH TG L V + L +CT + LK + +++ LSH
Sbjct: 12 NLTSVYLARHTPTGTLVTVRITDLENCTEEH--LKALQNEVV----LSH---------FF 56
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
HP + T + ++ + + G +SLL S + L GL Y
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNY 116
Query: 218 LHALGIIYRDLKPENILLREDGHIMLS 244
LH G I+R++K +IL+ DG + LS
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 20/155 (12%)
Query: 109 GTGNLGRVFLCHLRDCTSAN-FALKVVDKDLLSAKKLSHVQMEA--EI--LSMLDHPFLP 163
G G GRV+ ++ +A+K D +S A EI L L H +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS---QSACREIALLRELKHENVV 65
Query: 164 TLY----AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQA--VRFFAAEVLVGLEY 217
+L H + S Y+ L DY + + + R S+ V+ ++L G+ Y
Sbjct: 66 SLVEVFLEHADKSVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 218 LHALGIIYRDLKPENILL----REDGHIMLSDFDL 248
LH+ +++RDLKP NIL+ E G + + D L
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHL------RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V R + A+K++ KD + K L+ + E E++
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLISEMELMK 72
Query: 156 MLD-HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFS 200
++ H + L + +++Y G+L L K P + S
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + A +V G+EYL + I+RDL N+L+ ED + ++DF L
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 19/64 (29%), Positives = 38/64 (59%), Gaps = 1/64 (1%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL-REDGHIMLS 244
DL + P+ + + ++ + ++L G+ Y H+ +++RDLKP+N+L+ R + L+
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145
Query: 245 DFDL 248
DF L
Sbjct: 146 DFGL 149
|
Length = 294 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 4/154 (2%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEIL 154
+ ++ + + +G G G V L+ + A+K + K S K+ EA I+
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIM 59
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
DHP + L + S + + +Y NG L L ++ + +F++ + + G
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASG 118
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++YL + ++RDL NIL+ + +SDF L
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 14/154 (9%)
Query: 94 NGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE 152
+G+ L ++++ +G G G VFL H R T F K + L ++ S + +E
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 153 ILSMLDHPFLPTLYAHL--EVSHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFA 208
++ L H + + + + L+++C GDL + K + + A+
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 209 AEVLVGLEYLHALG-------IIYRDLKPENILL 235
++L L Y H L +++RDLKP+NI L
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 34/161 (21%), Positives = 68/161 (42%), Gaps = 28/161 (17%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLD 158
K ++ LG+G G V+ L + V K+L S K + EA +++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYK-GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLH---SLLP--------KQPNNRFSLQAVRFF 207
+P ++C L+ C + L+P ++ + Q + +
Sbjct: 68 NP-------------HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++ G+ YL +++RDL N+L++ H+ ++DF L
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 22/155 (14%)
Query: 125 TSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI-DYC 182
T A+K++ D + + + E + + L HP + L E + F + +Y
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 183 PNGDLHSLL------PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR 236
P L +L P R LQ VL L H GI++RDLKP+NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQ--------VLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 237 EDG---HIMLSDFDLCFQSDVVPTLVETNVGSATR 268
+ G H + DF + ++P + + +V + TR
Sbjct: 114 QTGVRPHAKVLDFGI---GTLLPGVRDADVATLTR 145
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 22/168 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHL------RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V + + + A+K++ KD + K LS + E E++
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMK 75
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFS 200
M+ H + L + +++Y G+L L + P+ + +
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + +V G+EYL + I+RDL N+L+ E+ + ++DF L
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 34/172 (19%)
Query: 99 LRHLKLVRHLGTGNLGRV---FLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS 155
LR LKL LG+G G V D A+K + +D + + +
Sbjct: 9 LRKLKL---LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMG 64
Query: 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLH---------SLLPKQPNNRFSLQAVRF 206
LDH YI L+ CP L SLL +R SL R
Sbjct: 65 SLDHA-------------YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 207 --FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF---DLCFQSD 253
+ ++ G+ YL +++R+L NILL+ D + ++DF DL + D
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 21/165 (12%)
Query: 108 LGTGNLGRVFLCHLRDCTS-ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V+ +D ++ALK ++ +S E +L L HP + +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR----EIALLRELKHPNVISL- 63
Query: 167 AHLEVSHY---ICFLIDYCPNGDLHSLLPKQPN--NRFSLQ----AVRFFAAEVLVGLEY 217
+ +SH + L DY + H + + + N+ +Q V+ ++L G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 218 LHALGIIYRDLKPENILLR----EDGHIMLSD--FDLCFQSDVVP 256
LHA +++RDLKP NIL+ E G + ++D F F S + P
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 102 LKLVRHLGTGNLGRVFL-CHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
LK V+ LG+G G V+ + D + A+KV+ ++ S K + EA +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVG 67
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLH---SLLP--------KQPNNRFSLQAVRFF 207
P Y+C L+ C + L+P ++ +R Q + +
Sbjct: 68 SP-------------YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW 114
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254
++ G+ YL + +++RDL N+L++ H+ ++DF L D+
Sbjct: 115 CVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 13/147 (8%)
Query: 122 RDCTSANF--------ALKVVDKDLL--SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
R+ T+A F KVV K ++ ++ ++ + E L+ DH + + +
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQA--VRFFAAEVLVGLEYLHALGIIYRDLK 229
+ +++Y GDL+ + ++ Q V ++++ L+ +H+ +++RDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 230 PENILLREDGHIMLSDFDLCFQ-SDVV 255
NI L G I L DF Q SD V
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSV 223
|
Length = 478 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 108 LGTGNLGRVFLCHLRDCT-SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V+ +D +ALK ++ +S E +L L HP + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL- 63
Query: 167 AHLEVSHY---ICFLIDYCPNGDLH-------SLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+ +SH + L DY + H S K+P + V+ ++L G+
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM-QLPRSMVKSLLYQILDGIH 122
Query: 217 YLHALGIIYRDLKPENILLR----EDGHIMLSD--FDLCFQSDVVP 256
YLHA +++RDLKP NIL+ E G + ++D F F S + P
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 11/145 (7%)
Query: 111 GNLGRVF---LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP-FLPTLY 166
G GR+F L + +K V KD S +++ + E+ +L L H LP L+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLL------PKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+E L Y G+L L S Q + A ++ G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 221 LGIIYRDLKPENILLREDGHIMLSD 245
G+I++D+ N ++ E+ + ++D
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 102 LKLVRHLGTGNLGRVF----LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML 157
+ + R LG G+ G V+ ++D A+K V++ +++ + EA ++
Sbjct: 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMKEF 66
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRF----SLQAVRFFAA 209
+ + L + +++ GDL S L P+ NN SL+ + A
Sbjct: 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
E+ G+ YL+A ++RDL N ++ ED + + DF +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLLSAKKLSHVQMEAEILSML 157
+ L+R LG G+ G V+ + RD A+K V++ +++ + EA ++
Sbjct: 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVMKGF 66
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRFS----LQAVRFFAA 209
+ L + +++ +GDL S L P+ NN LQ + AA
Sbjct: 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
E+ G+ YL+A ++RDL N ++ D + + DF +
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 29/150 (19%), Positives = 56/150 (37%), Gaps = 21/150 (14%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFL 162
++ L G RV+L ++ LK+ A + E IL +L +
Sbjct: 3 IKLLKGGLTNRVYLLGT---KDEDYVLKINPSREKGADRER----EVAILQLLARKGLPV 55
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL- 221
P + A E + L+++ G+ + ++ + Q A LH L
Sbjct: 56 PKVLASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQLAELLAK--------LHQLP 106
Query: 222 --GIIYRDLKPENILLREDGHIMLSDFDLC 249
+ + DL P NIL+ + + + D++
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 106 RHLGTGNLGRVFLCHL-RDCTSANFALKVVDKDL-LSAKKLSHVQM--EAEILSMLDHP- 160
+ +G G G+V L + T A +VV K+L +SA ++ EA+ L H
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPA----QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSN 56
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ---PNNRFSLQAVRFFAAEVLVGLEY 217
L L EV+ Y+ ++++CP GDL L ++ A E+ +GL +
Sbjct: 57 LLQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
LH I+ DL N LL D + + D+ L
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 13/28 (46%), Positives = 22/28 (78%)
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLRE 237
++L L+ LH+ GI++RD+KP+NI+ E
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSE 290
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.003
Identities = 18/44 (40%), Positives = 23/44 (52%), Gaps = 3/44 (6%)
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255
LVG LH+ GII+ DL N++L I L DF L S +
Sbjct: 107 LVGK--LHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDHP-F 161
+ +G G G+V L + T +VV K+L S+K+ + + + +L HP
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVA---RVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRF--FAAEVLVGLEYLH 219
L L +E Y+ + +YC GDL S L ++ +R + Q + A E+ G+ ++H
Sbjct: 58 LQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCF 250
++ DL N L D + + D+ +
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGP 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 6/156 (3%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAE 152
++H H+ + +G G G VF L+ + V K L + K+ EA
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTLKPGYTEKQRQDFLSEAS 58
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
I+ H + L + + +Y NG L L S Q V +
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-IA 117
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL + ++RDL NIL+ + +SDF L
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.64 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.62 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.46 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.41 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.23 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.2 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.73 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.58 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.55 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.2 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.07 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.04 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.83 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.7 | |
| PLN02236 | 344 | choline kinase | 97.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.49 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.41 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.29 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.12 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.95 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.85 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.49 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.94 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.86 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.66 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.62 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=305.32 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=177.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-E
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-Y 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 174 (317)
.+...+++.++.||+|..|+||+|.++. +++.+|+|++... ..+...+++.+|+++++.++|||||.+|+.|..++ .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKP-TGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcC-CCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3566788889999999999999999888 8999999999443 35677789999999999999999999999999999 4
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++++||||++|+|.++++.. +++++.....++.+|++||.|||+ .+||||||||+||||+..|.|||||||.++.+.
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999999999664 789999999999999999999996 999999999999999999999999999998875
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
.. ...+++ ||..||+||+.+.+.- ....|+||+|.+++|++.| .|.
T Consensus 231 nS--~a~tfv----------GT~~YMsPERi~g~~Y-----s~~sDIWSLGLsllE~a~GrfP~ 277 (364)
T KOG0581|consen 231 NS--IANTFV----------GTSAYMSPERISGESY-----SVKSDIWSLGLSLLELAIGRFPY 277 (364)
T ss_pred hh--hccccc----------ccccccChhhhcCCcC-----CcccceecccHHHHHHhhCCCCC
Confidence 54 444444 6678999999987733 3559999999999999999 664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=311.64 Aligned_cols=198 Identities=24% Similarity=0.379 Sum_probs=172.2
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
...+|.+.+.||+|+|++||+|++++ ++..||||.+.+..+..+..+.+..|+.+|+.++|||||.++++++.++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999998 77999999999887778888889999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC------CcEEEeeeccccc
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED------GHIMLSDFDLCFQ 251 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~------~~~kl~DFG~a~~ 251 (317)
|||||.||+|.+|+... +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999999664 689999999999999999999999999999999999999864 4699999999998
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+... .+..+.+|+ .-||+||.. ......-++|+|++|..++++..|-
T Consensus 165 L~~~-~~a~tlcGS----------plYMAPEV~-----~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 165 LQPG-SMAETLCGS----------PLYMAPEVI-----MSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred CCch-hHHHHhhCC----------ccccCHHHH-----HhccccchhhHHHHHHHHHHHHhCC
Confidence 8733 233344433 346666544 3444456799999999999999993
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=302.35 Aligned_cols=202 Identities=32% Similarity=0.539 Sum_probs=179.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
....++|++++.||+|+||+||.++.++ +++.+|+|++++..... ...+....|..||..++||.||+++..|++...
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~d-t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKD-TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcc-cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 4567899999999999999999999886 99999999998875554 577889999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|||+||+.||.|...|.+ .+.|++..++.++..|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+..-.
T Consensus 100 LylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999999955 58899999999999999999999999999999999999999999999999999987655
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
......+.| |+|||+.+++.....-....|-|++|..++||..|+|
T Consensus 178 ~~~~t~tfc---------------GT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 178 DGDATRTFC---------------GTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred CCCcccccc---------------CCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 554444444 4456666666666677899999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.16 Aligned_cols=201 Identities=26% Similarity=0.369 Sum_probs=170.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-----HHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+.|.+.+.||+|+||.|-+|..++ +++.||||++++..... .....+++|+++|++|+|||||+++++|+..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 56789999999999999999998888 99999999998765433 1234568999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC---CcEEEeeeccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED---GHIMLSDFDLC 249 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~---~~~kl~DFG~a 249 (317)
+..||||||++||+|.+.+-. ++.+.+...+.++.|++.||.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999955 5778899999999999999999999999999999999999765 78999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+... ..++..|.||| .+|.+||.....--+ ..+...|+||+|+.++-...|-
T Consensus 327 K~~g-~~sfm~TlCGT----------psYvAPEVl~~kg~~--~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 327 KVSG-EGSFMKTLCGT----------PSYVAPEVLASKGVE--YYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred hccc-cceehhhhcCC----------ccccChhheecCCee--cccchheeeeccceEEEEeccC
Confidence 9876 44555666654 467888776533222 2247889999999999999993
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=308.83 Aligned_cols=215 Identities=33% Similarity=0.471 Sum_probs=187.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSML-DHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 173 (317)
.....+|.+++.||+|+|++|++|+... +++.||||++.+..... ...+-+.+|.++|.+| .||.|++||..|.++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC-CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 5667899999999999999999999988 99999999998775544 5556788899999999 7999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+|+||+++|+|.++|++. +.|++..++.++.||+.||+|||++|||||||||+|||+|.+++++|+|||.|+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999999764 889999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+.............. ....+...|+.+|.++++.........+|+|.++|+++.|..|.|
T Consensus 226 ~~~~~~~~~~~~~~a--~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~P 285 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQA--SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQP 285 (604)
T ss_pred hhhccccCccCcccc--cCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCC
Confidence 765443322211111 111355679999999999999999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.65 Aligned_cols=198 Identities=29% Similarity=0.416 Sum_probs=180.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+|+..+.||+|||+.||++++.. +|+.||+|++.+... .....+++.+||+|.+.|+|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 689999999999999999999866 899999999987543 346778899999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
+|+|..++|..++++ .+.++|.+++.+++||+.||.|||+++|+|||||..|||++++.+|||+|||||.++..+...
T Consensus 97 LELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999975 488999999999999999999999999999999999999999999999999999998877665
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
-.|.| |+|-|+.+++.....-+.-.|+||+||+++-+..|.|
T Consensus 175 k~TlC---------------GTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 175 KKTLC---------------GTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred cceec---------------CCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 55555 5577777777777777889999999999999999977
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=282.39 Aligned_cols=198 Identities=34% Similarity=0.588 Sum_probs=180.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
..+++|++++.||.|+||+|.+++.+. ++..+|+|++.+...-. ++.+...+|..+|+.+.||+++++++.+.+.+++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 778999999999999999999999888 79999999998765443 7778899999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
||||||++||.|..++++ .++|++..++.++.||+.||+|||.++|++|||||+|||+|.+|.+||+|||+|++....
T Consensus 120 ymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999999966 488999999999999999999999999999999999999999999999999999886542
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.-| -.|+|||..+++.......+..|-|++|..++||.+|-|
T Consensus 198 ---T~T---------------lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 198 ---TWT---------------LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred ---EEE---------------ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 222 247789999899999999999999999999999999954
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=285.51 Aligned_cols=200 Identities=20% Similarity=0.258 Sum_probs=167.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+.|+.+.++|+|+||+||+|++++ +|+.||||.+......+...+-..+||++|++|+|+|+|.++++|.....++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~-TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD-TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC-cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 568888999999999999999988 9999999999876666667777899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|||+ -++.+.+.+.+ ..++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..+....
T Consensus 81 E~~d-hTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 81 EYCD-HTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eecc-hHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9994 55555555554 558999999999999999999999999999999999999999999999999999887533322
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
...+ .+.-|.+||-..+.+.. +.-.|+|++||+..|+..|.|+
T Consensus 159 TDYV----------ATRWYRaPELLvGDtqY----G~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 159 TDYV----------ATRWYRAPELLVGDTQY----GKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred hhhh----------hhhhccChhhhcccCcC----CCcccchhhhHHHHHHhcCCcC
Confidence 2222 22234556655444433 4567899999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=289.58 Aligned_cols=206 Identities=21% Similarity=0.286 Sum_probs=179.5
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEE-EEE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA-HLE 170 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~ 170 (317)
++.+...+.+|+|+++||+|.||.||++.... +|..||.|.+..+..+.+..+.+..|+.+|++|+|||||++++ .|.
T Consensus 11 ~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~-~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 11 FSPPQKTLADYQILKKIGRGSFGEVYKVQCLL-DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred CCCCcccHHHHHHHHHHcCCcchheEEeeecc-CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 44466777899999999999999999999887 8999999999988888899999999999999999999999998 455
Q ss_pred ecCE-EEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeccCCCCcEEEccCCcEEE
Q 042913 171 VSHY-ICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHA--LG--IIYRDLKPENILLREDGHIML 243 (317)
Q Consensus 171 ~~~~-~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~--~~--ivHrDikp~Nill~~~~~~kl 243 (317)
.++. +++|||+|.+|+|...++.. ..+.+++..+|+++.|+|.||.+||. .. |+||||||.||+|+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 89999999999999998653 45779999999999999999999998 44 999999999999999999999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+|||+++.+....+...+.+|| .-||+||...++- ..++.|+|++||.+.|+..-
T Consensus 170 GDfGL~r~l~s~~tfA~S~VGT----------PyYMSPE~i~~~~-----Y~~kSDiWslGCllyEMcaL 224 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAHSLVGT----------PYYMSPERIHESG-----YNFKSDIWSLGCLLYEMCAL 224 (375)
T ss_pred ccchhHhHhcchhHHHHhhcCC----------CcccCHHHHhcCC-----CCcchhHHHHHHHHHHHHhc
Confidence 9999999998877776666655 4588888775543 34788999999999998653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=294.62 Aligned_cols=217 Identities=29% Similarity=0.496 Sum_probs=184.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|+++++||+|+||.||+|+-+. +|..+|+|++++...- ..+.+.++.|..+|...++++||++|-.|++..+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~-Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKD-TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEcc-CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 5667899999999999999999999888 9999999999876544 4778899999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+||||||++||++..+|.+ ...+++..++.++.+++.||.-||+.|+|||||||+|+|||..|++||+|||||.-+..
T Consensus 216 LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999999955 58899999999999999999999999999999999999999999999999999954432
Q ss_pred CCCee-------------ecccc--c-----------------ccccccccccCCCCCcccccccccceeccchhhhccC
Q 042913 255 VPTLV-------------ETNVG--S-----------------ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREH 302 (317)
Q Consensus 255 ~~~~~-------------~~~~~--~-----------------~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~ 302 (317)
..... ..... . +.+.++.......|+|.|+.++|...+.....+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 11100 00000 0 0011112224457999999999999999999999999
Q ss_pred CcccccccCCCCC
Q 042913 303 PAQYSVEQPGGVP 315 (317)
Q Consensus 303 ~~~~~~e~~~G~p 315 (317)
+||+++|+.-|-|
T Consensus 374 LG~ImyEmLvGyP 386 (550)
T KOG0605|consen 374 LGCIMYEMLVGYP 386 (550)
T ss_pred HHHHHHHHHhCCC
Confidence 9999999999966
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=280.25 Aligned_cols=239 Identities=49% Similarity=0.809 Sum_probs=198.7
Q ss_pred cCCCCCCcchhhHHHhhccCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHH
Q 042913 73 HHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEA 151 (317)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~ 151 (317)
..+...+..|..+....+ ...+.+..++|++++.||.|.-|+||+|++.. ++..+|+|++.+.... .+...+++.|.
T Consensus 51 kph~~~d~~w~a~~~~~~-~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~rkKl~Ra~tE~ 128 (459)
T KOG0610|consen 51 KPHKGNDVRWEAISSIRN-SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASRKKLKRAQTER 128 (459)
T ss_pred CCCCCCchhhhhhccccc-cCCCccCHHHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhhhHHHHHHHHH
Confidence 344455556777666665 67788999999999999999999999999998 7799999999887655 47778999999
Q ss_pred HHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 042913 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231 (317)
Q Consensus 152 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~ 231 (317)
+||+.++||.+++||..|+.+++.|+|||||+||+|..++++++++.|++..++.++..|+.||+|||-.|||+|||||+
T Consensus 129 eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE 208 (459)
T KOG0610|consen 129 EILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE 208 (459)
T ss_pred HHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeeecccccCCCCCCeeeccc-----------------cc-----cccc-------------------c
Q 042913 232 NILLREDGHIMLSDFDLCFQSDVVPTLVETNV-----------------GS-----ATRR-------------------R 270 (317)
Q Consensus 232 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~-----------------~~-----~~~~-------------------~ 270 (317)
||||.++|++.|+||.|+.+....+++..... -. ...+ .
T Consensus 209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~ 288 (459)
T KOG0610|consen 209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT 288 (459)
T ss_pred eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence 99999999999999999988877666653210 00 0000 0
Q ss_pred cccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 271 RRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 271 ~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....-...|+=||..+++..+..-.-..|-|++|..++|+.=|
T Consensus 289 ~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG 331 (459)
T KOG0610|consen 289 GARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG 331 (459)
T ss_pred CccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC
Confidence 0011112466666666666666666888899999999999877
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=290.94 Aligned_cols=204 Identities=23% Similarity=0.272 Sum_probs=172.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HY 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 174 (317)
.....|+.+++||+|.||.||+|++.. +|+.||+|.++.+...+.......+||.||++|+||||++|.+..... +.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~-tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE-TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc-cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 445789999999999999999999988 999999999998877777788899999999999999999999998765 78
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+||||||| .-+|..++.. +.-.|++.+++.++.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+.+..
T Consensus 193 iYlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999999 5678777753 356799999999999999999999999999999999999999999999999999998877
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
......|+. ..+.=|-+||-.-+... .....|+|+.||++.|+..|-|.
T Consensus 271 ~~~~~~T~r---------VvTLWYRpPELLLG~t~----Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 271 SGSAPYTSR---------VVTLWYRPPELLLGATS----YGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred CCCcccccc---------eEEeeccChHHhcCCcc----cccceeehhhhHHHHHHHcCCCC
Confidence 665433333 33334555555433332 34678999999999999999663
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=284.75 Aligned_cols=210 Identities=26% Similarity=0.297 Sum_probs=178.2
Q ss_pred CCCCcchhhHHHhhccCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHH
Q 042913 76 RKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS 155 (317)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~ 155 (317)
....|++.++..+|++|+...+ ||+|+||.||+|...+ +..||||.+....... ..+|.+|++++.
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~----------ig~Ggfg~VYkG~l~~--~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls 126 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNL----------IGEGGFGTVYKGVLSD--GTVVAVKRLSSNSGQG--EREFLNEVEILS 126 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcc----------eecCCCeEEEEEEECC--CCEEEEEEecCCCCcc--hhHHHHHHHHHh
Confidence 5567899999999999999887 9999999999999886 5899999876543221 455999999999
Q ss_pred hcCCCCcceEEEEEEecC-EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCC
Q 042913 156 MLDHPFLPTLYAHLEVSH-YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG---IIYRDLKPE 231 (317)
Q Consensus 156 ~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivHrDikp~ 231 (317)
+++|||+|+|+|||.+.+ ..+||+||+++|+|.+++.......++|..+.+|+.++++||+|||... ||||||||+
T Consensus 127 ~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 127 RLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred cCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 999999999999999888 5999999999999999997754338899999999999999999999853 999999999
Q ss_pred cEEEccCCcEEEeeecccccCCC-CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 232 NILLREDGHIMLSDFDLCFQSDV-VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 232 Nill~~~~~~kl~DFG~a~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
|||+|+++++||+|||+|+.... .... . +.. .++.||++|||...+.. ..+.|+.+-+.+++|+
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~~~~~-~----~~~-----~gt~gY~~PEy~~~g~l-----t~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEGDTSV-S----TTV-----MGTFGYLAPEYASTGKL-----TEKSDVYSFGVVLLEL 271 (361)
T ss_pred HeeECCCCCEEccCccCcccCCccccce-e----eec-----CCCCccCChhhhccCCc-----CcccccccchHHHHHH
Confidence 99999999999999999965443 1111 1 100 68889999999976333 3678899999999999
Q ss_pred CCCC
Q 042913 311 PGGV 314 (317)
Q Consensus 311 ~~G~ 314 (317)
..|-
T Consensus 272 itgr 275 (361)
T KOG1187|consen 272 ITGR 275 (361)
T ss_pred HhCC
Confidence 9984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.76 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=167.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC--EEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH--YICF 177 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 177 (317)
.+|..++.||+|+||.||++...+ +|..+|||.+.... ....+.+.+|+.+|..++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecC-CCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 457778889999999999999887 68999999997652 222677999999999999999999999744333 7999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~~ 256 (317)
+|||+++|+|.+++.+..+ .+++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||+++......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999987654 8999999999999999999999999999999999999999 7999999999998876411
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... .......++..||+||.... .....+..|+|+++|+.+|+.+|.|
T Consensus 173 ~~~-------~~~~~~~Gtp~~maPEvi~~----g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 173 TKS-------DSELSVQGTPNYMAPEVIRN----GEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred ccc-------cccccccCCccccCchhhcC----CCcCCccchhhhcCCEEEeccCCCC
Confidence 110 11223466778899988865 2122368999999999999999943
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.39 Aligned_cols=205 Identities=27% Similarity=0.413 Sum_probs=172.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc---HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLD-HPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 171 (317)
....+.|.+++.||+|+||+|++|.... +++.||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeecc-CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 3566899999999999999999998887 7899999988765221 234566778999999999 9999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeeecccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDFDLCF 250 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DFG~a~ 250 (317)
...+|+||||+.||+|.+++.+ .+++.+..++.++.||+.|++|||++||+||||||+|||++.+ +++||+|||++.
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999999976 5889999999999999999999999999999999999999999 999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
..+.......+.+ |+..|++||....... -.+..+|+||+|.+++.+.+| +|-
T Consensus 170 ~~~~~~~~l~t~c----------Gsp~Y~aPEvl~~~~~---Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 170 ISPGEDGLLKTFC----------GSPAYAAPEVLSGKGT---YSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred ccCCCCCcccCCC----------CCcccCCHHHhCCCCC---cCCchhhhhhhHHHHHHHHhCCCCC
Confidence 7753333334444 3344666665543322 237899999999999999999 773
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=264.05 Aligned_cols=200 Identities=23% Similarity=0.277 Sum_probs=168.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.+|...+.||+|.||.||+|++.+ +|+.||||.++.............+||+.|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 478888999999999999999988 9999999999877555555567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+ ..+|..++++. ...+....++.++.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+.......
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 999 78999999765 5778999999999999999999999999999999999999999999999999999887766543
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
...+.+ |+++..-.-||+--|- ...|+|+.+|++.|+..|+|.
T Consensus 159 ~~~V~T---RWYRAPELLfGsr~Yg-----------~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 159 THQVVT---RWYRAPELLFGSRQYG-----------TGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred ccceee---eeccChHHhccchhcC-----------CcchhhhHHHHHHHHHccCCC
Confidence 333322 2222222222222222 346899999999999999885
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=290.84 Aligned_cols=197 Identities=25% Similarity=0.376 Sum_probs=172.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|.+.+.||+|+||+||+|+-+. +.+.||+|.+.+....++.++.+.+|++|++.++||||+.++++|+...++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~-t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY-TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc-ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 578899999999999999998776 8999999999988878889999999999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+.| +|..++.. .+.++++.+..++.|++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.........
T Consensus 81 e~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 99955 99999965 5789999999999999999999999999999999999999999999999999998765533221
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ...|+.-||+||. -+....+..+|+|++||+++|++.|.|
T Consensus 158 t----------sikGtPlYmAPEl-----v~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 158 T----------SIKGTPLYMAPEL-----VEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred e----------eccCcccccCHHH-----HcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 1 1244455566654 444555688999999999999999977
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.92 Aligned_cols=215 Identities=27% Similarity=0.399 Sum_probs=176.9
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH------------HHHHHHHHHHHHHhcCC
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK------------KLSHVQMEAEILSMLDH 159 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h 159 (317)
..++...+++|++++.||+|.||+|-+|.+.. +++.||||++.+.....+ ..+++++||.||++|+|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 35567888999999999999999999998887 899999999987533221 24678999999999999
Q ss_pred CCcceEEEEEEe--cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 042913 160 PFLPTLYAHLEV--SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE 237 (317)
Q Consensus 160 ~~iv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~ 237 (317)
||||+|+++..+ .+.+|||+|||..|.+...-... ..+.+.+++.|+++++.||+|||.+|||||||||+|+||+.
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence 999999999875 46799999999988887665332 23899999999999999999999999999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+|++||+|||.+........ .+.-..-..-.|+..|++||-|..+.. +.-..+..|+|++|.+++=|.-| +|
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~-----~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSD-----EGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred CCcEEeeccceeeecccCCc-----cccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999876533211 111111222478899999999988655 55568899999999999887777 55
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.07 Aligned_cols=211 Identities=21% Similarity=0.281 Sum_probs=180.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.++||.|..++||+|+... .+..||||+++.+..... ++.+++|+..|..++||||++++..|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34667899999999999999999999988 789999999988765544 7899999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||.||.+|++.++++..-...+++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||++.-+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999999999887667799999999999999999999999999999999999999999999999998754433
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
...... .+-..-.++.-||+||....+++-| ..++|+|+.|.+.+|++.| +|.
T Consensus 179 ~G~R~~------~rf~tfvgtp~wmAPEvl~q~~~GY---dfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 179 SGDRQV------TRFNTFVGTPCWMAPEVLMQQLHGY---DFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred cCceee------EeeccccCcccccChHHhhhcccCc---cchhhhhhhhHHHHHHhcCCCCc
Confidence 211100 0002336677789998865555544 4889999999999999999 664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=282.18 Aligned_cols=205 Identities=24% Similarity=0.390 Sum_probs=175.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCce-EEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN-FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+...++.+.+.||+|+||+||++.++. .. ||+|++..........+.+.+|+.+|.+++|||||+++|++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g---~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRG---TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCC---ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34555667777779999999999999985 44 999999877666655889999999999999999999999998887
Q ss_pred -EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCCCcEEEccCC-cEEEeeecccc
Q 042913 174 -YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG-IIYRDLKPENILLREDG-HIMLSDFDLCF 250 (317)
Q Consensus 174 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivHrDikp~Nill~~~~-~~kl~DFG~a~ 250 (317)
.+++||||+++|+|.+++.......+++..+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 7999999999999999997744678999999999999999999999999 99999999999999997 99999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... ...+ ...|+..|||||....+ ......++|++|-+..++|+.+| +|
T Consensus 193 ~~~~~~-~~~~---------~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK-TSMT---------SVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc-cccc---------CCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCC
Confidence 654432 1111 13677899999988766 34456889999999999999999 66
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=281.27 Aligned_cols=202 Identities=31% Similarity=0.536 Sum_probs=180.6
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 172 (317)
..+..++|+++++||+|.||+|+++..+. +++.+|||+++++..- .+..+..+.|.+|+.... ||.+++++..|...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 56788999999999999999999999988 8899999999887543 477788999999998876 99999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.++|+||||+.||++..+.+ ...|++..++.++..|+.||.|||++||||||||.+|||+|.+|.+||+|||+|+..
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999999666553 367999999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
-.......|.| |+|+|+.+++.......+..|-|++|..++||..|.|
T Consensus 519 m~~g~~TsTfC---------------GTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~ 566 (694)
T KOG0694|consen 519 MGQGDRTSTFC---------------GTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGES 566 (694)
T ss_pred CCCCCcccccc---------------CChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCC
Confidence 65555555555 5688888888888899999999999999999999943
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=276.45 Aligned_cols=197 Identities=24% Similarity=0.337 Sum_probs=172.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
....|...++||+|+.|.||.|.... +++.||||.+.... ....+-+.+|+.+|+..+|+|||.+++.|...+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIS-TKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeecc-CCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 35789999999999999999998877 78899999998763 3344568999999999999999999999998899999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||++||+|.|++.. ..+++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||||.++.....
T Consensus 348 VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999999965 4489999999999999999999999999999999999999999999999999999887665
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...+ ..|+.-||+||.. ...+.+.+.|+||||.|.|||.+|.|
T Consensus 425 KR~T----------mVGTPYWMAPEVv-----trk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 425 KRST----------MVGTPYWMAPEVV-----TRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred cccc----------ccCCCCccchhhh-----hhcccCccccchhhhhHHHHHhcCCC
Confidence 3333 3455668888754 44566788999999999999999976
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=281.30 Aligned_cols=201 Identities=23% Similarity=0.333 Sum_probs=170.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC-E
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSH-Y 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~ 174 (317)
...++|.++++||.|.||.||+|+... +++.||||.+++.....++.-. .+|+..|++|+ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~-~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE-TGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC-CCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 446799999999999999999998887 8999999999888766555433 56999999999 999999999998887 9
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||| ..+|+++++.+ +..|++..++.|+.||++||+|+|.+|+.||||||+|||+.....+||+|||+||....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 88999999988 78999999999999999999999999999999999999999889999999999998766
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
.+..+ ....+.=|.+||..- ...-.....|+|+.||++.|++.--|+
T Consensus 163 kpPYT-----------eYVSTRWYRAPEvLL----rs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 163 KPPYT-----------EYVSTRWYRAPEVLL----RSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred CCCcc-----------hhhhcccccchHHhh----hccccCCchHHHHHHHHHHHHHHhccc
Confidence 55432 124444566777542 222234567899999999999876554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=275.29 Aligned_cols=208 Identities=27% Similarity=0.432 Sum_probs=165.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.... +++.||||++.+... .......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 479999999999999999998887 789999999876532 335567789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999865 467899999999999999999999999999999999999999999999999999644221100
Q ss_pred e-------eccccc---------------c--------c-------ccccccccCCCCCcccccccccceeccchhhhcc
Q 042913 259 V-------ETNVGS---------------A--------T-------RRRRRKSCNGFGSAKRRQENVMEFVAEPRREQRE 301 (317)
Q Consensus 259 ~-------~~~~~~---------------~--------~-------~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~ 301 (317)
. ...... . . ......++..|++||.. .........|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Diw 232 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-----LQQGYGQECDWW 232 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-----ccCCCCCceeeE
Confidence 0 000000 0 0 00012345556666654 333456789999
Q ss_pred CCcccccccCCCCC
Q 042913 302 HPAQYSVEQPGGVP 315 (317)
Q Consensus 302 ~~~~~~~e~~~G~p 315 (317)
++|++++|+..|.|
T Consensus 233 SlGvil~elltG~~ 246 (377)
T cd05629 233 SLGAIMFECLIGWP 246 (377)
T ss_pred ecchhhhhhhcCCC
Confidence 99999999999943
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=275.02 Aligned_cols=207 Identities=22% Similarity=0.383 Sum_probs=165.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||+||+|.... +++.||+|++.+.... ......+.+|+.++..++|+||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 478999999999999999998877 7899999999765332 34556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999965 367999999999999999999999999999999999999999999999999999765432110
Q ss_pred ee--c------------ccc------cc-----cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VE--T------------NVG------SA-----TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~--~------------~~~------~~-----~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. . ... .. .......++..|++||.. ........+|+|++|++++|+..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-----~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-----MQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-----cCCCCCCchhhhhhHHHHHHHHhC
Confidence 00 0 000 00 000112344556666554 333456789999999999999999
Q ss_pred C
Q 042913 314 V 314 (317)
Q Consensus 314 ~ 314 (317)
.
T Consensus 233 ~ 233 (363)
T cd05628 233 Y 233 (363)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.16 Aligned_cols=194 Identities=26% Similarity=0.337 Sum_probs=168.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-C-----CCcceEEEEEEecC
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-H-----PFLPTLYAHLEVSH 173 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~ 173 (317)
.+|.|.+.||+|.||+|.+|.+.+ +++.||||+++.. .....+...|+.+|..|+ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~-T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHK-TGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecC-CCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 489999999999999999999888 9999999999764 566778899999999997 3 48999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC--CcEEEeeeccccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED--GHIMLSDFDLCFQ 251 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~--~~~kl~DFG~a~~ 251 (317)
++|||+|.+ ..+|+++++.+....++...++.++.||+.||.+||+.+|||+||||+||||... ..|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 8999999999888889999999999999999999999999999999999999753 3799999999865
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
..... |.-.-+-=|+.+|+.-+.......|+||+||++.|+..|.|+
T Consensus 341 ~~q~v------------------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 341 ESQRV------------------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred cCCcc------------------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 43211 111233345556667777788899999999999999999886
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=271.43 Aligned_cols=202 Identities=22% Similarity=0.257 Sum_probs=166.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.....+|++++.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 3445778889999999999999998876 78999999986542 334556789999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+.. ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999999986543 2467788899999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... ....++..|++||+...............|+|++|++++|+..| .|
T Consensus 222 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 222 MDPC----------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred cccc----------cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 2111 11246678899997755444434445689999999999999998 44
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=273.98 Aligned_cols=206 Identities=27% Similarity=0.398 Sum_probs=163.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+|++++.||+|+||.||+|++.. +++.||+|++.+.... ......+.+|+++++.++|+||+++++.+..++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 479999999999999999999887 7899999999764322 23456788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+......
T Consensus 80 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999965 366899999999999999999999999999999999999999999999999998644211100
Q ss_pred e----------ec----ccc-------------------cccccccccccCCCCCcccccccccceeccchhhhccCCcc
Q 042913 259 V----------ET----NVG-------------------SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQ 305 (317)
Q Consensus 259 ~----------~~----~~~-------------------~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~ 305 (317)
. .. ... .........++..|++||... .......+|+|++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGv 232 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQLCDWWSVGV 232 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-----CCCCCcceeeeeccc
Confidence 0 00 000 000000113455566666543 334457899999999
Q ss_pred cccccCCC
Q 042913 306 YSVEQPGG 313 (317)
Q Consensus 306 ~~~e~~~G 313 (317)
+++|+..|
T Consensus 233 ilyell~G 240 (376)
T cd05598 233 ILYEMLVG 240 (376)
T ss_pred eeeehhhC
Confidence 99999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=271.64 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=171.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...+|++.+.||+|.||+|-+|..+. .|+.||||.++++... ++.+-.+++||+||..|+||||+++|++|+..+.+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~-sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHK-SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhcc-CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34689999999999999999998877 8999999999876544 467788999999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||..+|.|+||+.+. +.+++..++.+++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+....
T Consensus 130 ivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999999765 789999999999999999999999999999999999999999999999999986654433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceecc-chhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+..++| |+|-|.++++.++... ....|-|+++..++-+--| +|
T Consensus 208 -fLqTFC---------------GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP 252 (668)
T KOG0611|consen 208 -FLQTFC---------------GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP 252 (668)
T ss_pred -HHHHhc---------------CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc
Confidence 223333 6677777777776543 5566789999888777666 55
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=273.82 Aligned_cols=207 Identities=26% Similarity=0.444 Sum_probs=165.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.+.. +++.||||++..... .......+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 479999999999999999999887 789999999986532 234556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+......
T Consensus 80 ~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999999865 356999999999999999999999999999999999999999999999999999765332110
Q ss_pred eeccc--c---------------------ccc-----ccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 259 VETNV--G---------------------SAT-----RRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 259 ~~~~~--~---------------------~~~-----~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
..... . ... ......++..|++||.. ........+|+|++|++++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-----LQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-----cCCCCCCeeeeecchhHHHHh
Confidence 00000 0 000 00012345556666654 333446789999999999999
Q ss_pred CCCC
Q 042913 311 PGGV 314 (317)
Q Consensus 311 ~~G~ 314 (317)
..|.
T Consensus 233 ~~G~ 236 (364)
T cd05599 233 LVGY 236 (364)
T ss_pred hcCC
Confidence 9993
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=270.23 Aligned_cols=198 Identities=28% Similarity=0.480 Sum_probs=168.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++.+..++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 4567899999999999999999999887 789999999976533 22455678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999999965 36789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ...++..|++||.... .......|+|++|++++|+..|.
T Consensus 171 ~~~-------------~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~ 212 (329)
T PTZ00263 171 RTF-------------TLCGTPEYLAPEVIQS-----KGHGKAVDWWTMGVLLYEFIAGY 212 (329)
T ss_pred Ccc-------------eecCChhhcCHHHHcC-----CCCCCcceeechHHHHHHHHcCC
Confidence 211 1134455777776543 33457899999999999999993
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=268.63 Aligned_cols=205 Identities=24% Similarity=0.388 Sum_probs=169.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.... +++.||+|++.+.. ........+.+|+.++..++|+||+++++++...+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 479999999999999999998877 78999999997642 2234455688899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999653 356899999999999999999999999999999999999999999999999999766443221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....++.+|++||+.............++|+|++|++++|+..| .|
T Consensus 159 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 159 QS---------SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ee---------ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 11 11245667888887654322222345678999999999999999 44
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=263.30 Aligned_cols=205 Identities=20% Similarity=0.179 Sum_probs=166.1
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--c
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--S 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 172 (317)
+.-..++|+.+..|++|.||.||+|+++. +++.||+|.++.+......--.-.+||.+|.+++|||||.+-++... -
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~-t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCC-cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 44556889999999999999999999988 89999999998664333344456889999999999999999988764 3
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+||||||| .-+|..++... .++|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 150 d~iy~VMe~~-EhDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 DKIYIVMEYV-EHDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ceeeeeHHHH-HhhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 5799999999 66888888765 378999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
+....-.. +...+.=|.+||-.-+ -.......|+||.+|++.|+..|-|+
T Consensus 228 gsp~k~~T----------~lVVTLWYRaPELLLG----~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 228 GSPLKPYT----------PLVVTLWYRAPELLLG----AKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred cCCcccCc----------ceEEEeeecCHHHhcC----CcccCcchhhhhHHHHHHHHHhcCCC
Confidence 76532111 1122333444443311 11224678999999999999999887
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=268.50 Aligned_cols=205 Identities=23% Similarity=0.379 Sum_probs=168.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||++.... +++.||+|++.+... .....+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 479999999999999999998887 789999999976432 334456688899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|.........
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999653 356899999999999999999999999999999999999999999999999998765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. .....++..|++||................|+|+++++++|+..| .|
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 159 Q---------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred c---------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 1 011235667888887653222222334678999999999999999 45
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.68 Aligned_cols=194 Identities=28% Similarity=0.436 Sum_probs=166.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.+.. +++.||+|++.+..... .....+.+|+++++.++||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 479999999999999999999887 78999999998754332 4556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~--- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--- 154 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence 999999999999955 367899999999999999999999999999999999999999999999999999765431
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||..... ......|+|++|++++|+..|.
T Consensus 155 ----------~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~ 195 (333)
T cd05600 155 ----------ANSVVGSPDYMAPEVLRGK-----GYDFTVDYWSLGCMLYEFLCGF 195 (333)
T ss_pred ----------cCCcccCccccChhHhcCC-----CCCCccceecchHHHhhhhhCC
Confidence 0112355667777766433 4457799999999999999993
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=266.23 Aligned_cols=205 Identities=23% Similarity=0.400 Sum_probs=170.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|.+.+.||+|+||.||+|.... +++.||+|++..... .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 479999999999999999998887 789999999987543 234556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|..+......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 80 MEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred ECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999999654 356899999999999999999999999999999999999999999999999999876543321
Q ss_pred eecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. .....++..|++||........ .......+|+|++|++++|+..| .|
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P 208 (330)
T cd05601 159 N---------SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208 (330)
T ss_pred e---------eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence 1 1112456678888876532222 23345778999999999999999 44
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.15 Aligned_cols=206 Identities=28% Similarity=0.417 Sum_probs=164.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|++++.||+|+||+||+|.+.. +++.||+|++.+... .......+.+|+++++.++|+||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 68999999999999999999887 889999999976543 3355678899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999999865 3568999999999999999999999999999999999999999999999999986542111000
Q ss_pred --e---------------------cccccc--------------cccccccccCCCCCcccccccccceeccchhhhccC
Q 042913 260 --E---------------------TNVGSA--------------TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREH 302 (317)
Q Consensus 260 --~---------------------~~~~~~--------------~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~ 302 (317)
. ...+.. .......++..|++||... .......+|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DiwS 233 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-----RKGYTQLCDWWS 233 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-----CCCCCCccceee
Confidence 0 000000 0001123455566666543 333457899999
Q ss_pred CcccccccCCCC
Q 042913 303 PAQYSVEQPGGV 314 (317)
Q Consensus 303 ~~~~~~e~~~G~ 314 (317)
+|++++|+..|.
T Consensus 234 lG~il~elltG~ 245 (381)
T cd05626 234 VGVILFEMLVGQ 245 (381)
T ss_pred hhhHHHHHHhCC
Confidence 999999999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=269.11 Aligned_cols=200 Identities=29% Similarity=0.516 Sum_probs=168.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..++|++.+.||+|+||.||+|.+....+..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 456778999999999999999999987763457899999976532 2345567889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+..+
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999965 3678999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... ...++..|++||.... ......+|+|++|++++|+..|.
T Consensus 183 ~~~~-------------~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~G~ 225 (340)
T PTZ00426 183 TRTY-------------TLCGTPEYIAPEILLN-----VGHGKAADWWTLGIFIYEILVGC 225 (340)
T ss_pred CCcc-------------eecCChhhcCHHHHhC-----CCCCccccccchhhHHHHHhcCC
Confidence 3110 1134556777776643 33457899999999999999993
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.30 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=164.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+|++++.||+|+||.||+|.... +++.||+|++.+... .......+.+|+++++.++|+||+++++.+...+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 68999999999999999999877 789999999976532 2355677899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998653 568999999999999999999999999999999999999999999999999986442111000
Q ss_pred --ecc-------------cccc----------------------cccccccccCCCCCcccccccccceeccchhhhccC
Q 042913 260 --ETN-------------VGSA----------------------TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREH 302 (317)
Q Consensus 260 --~~~-------------~~~~----------------------~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~ 302 (317)
... .+.. .......++..|++||.. .......++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~~DiwS 233 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-----LRTGYTQLCDWWS 233 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-----cCCCCCCeeeEEe
Confidence 000 0000 000011244455555544 3344567899999
Q ss_pred CcccccccCCCCC
Q 042913 303 PAQYSVEQPGGVP 315 (317)
Q Consensus 303 ~~~~~~e~~~G~p 315 (317)
+|++++|+..|.|
T Consensus 234 lGvil~elltG~~ 246 (382)
T cd05625 234 VGVILYEMLVGQP 246 (382)
T ss_pred chHHHHHHHhCCC
Confidence 9999999999943
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.87 Aligned_cols=192 Identities=28% Similarity=0.513 Sum_probs=160.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+.||+|+||.||+|.... +++.||+|++.+... .......+.+|+++++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 359999999999998877 789999999986543 234556788899999999999999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~----- 152 (323)
T cd05571 80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM----- 152 (323)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc-----
Confidence 999999865 4678999999999999999999999999999999999999999999999999987532221111
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||... ......++|+|++|++++|+..| .|
T Consensus 153 -----~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P 194 (323)
T cd05571 153 -----KTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred -----cceecCccccChhhhc-----CCCCCccccCcccchhhhhhhcCCCC
Confidence 1123555677777653 23446789999999999999999 44
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=271.57 Aligned_cols=207 Identities=23% Similarity=0.415 Sum_probs=169.3
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
...+..++|++.+.||+|+||.||++.+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++..+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 345566899999999999999999999887 789999999976432 234455678899999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999999854 35899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ......++..|++||.....-. .......+|+|++|++++|+..|.
T Consensus 193 ~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~-~~~~~~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 193 DETGMV---------RCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred ccCCce---------ecccCCCCcccCCHHHHhccCC-CCCCCcccCEEeehHHHHHHHhCC
Confidence 432211 0112245566777776542210 011346799999999999999993
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=267.51 Aligned_cols=207 Identities=23% Similarity=0.387 Sum_probs=165.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.... +++.||+|++..... .......+.+|+.++..++|+||+++++.+...+.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999887 789999999976432 234567788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+|+.+......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999865 367899999999999999999999999999999999999999999999999999765432110
Q ss_pred ee--cccc------------------c-----ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VE--TNVG------------------S-----ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~--~~~~------------------~-----~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. .... . ........++..|++||.. ........+|+|++|++++|+..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-----~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-----MQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-----cCCCCCCcceeccccceeeecccC
Confidence 00 0000 0 0000012344455555554 334455789999999999999999
Q ss_pred C
Q 042913 314 V 314 (317)
Q Consensus 314 ~ 314 (317)
.
T Consensus 233 ~ 233 (360)
T cd05627 233 Y 233 (360)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.66 Aligned_cols=202 Identities=21% Similarity=0.284 Sum_probs=165.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecC----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSH---- 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~---- 173 (317)
...|..+++||+|.||+||+|+... +|+.||+|.++.....+.......+|+.+|+.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec-CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4557778889999999999999888 8999999999876443344556788999999999999 999999998877
Q ss_pred --EEEEEEcccCCCChhcccccCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 174 --YICFLIDYCPNGDLHSLLPKQPN--NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 174 --~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+++||||+ ..+|..++..... ..++...++.++.||+.||.|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 8899999977643 46788899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
+.+...... ......+.-|-+||..-+.. ..+-..|+|+++|++.|+..+.|+
T Consensus 168 ra~~ip~~~----------yt~evvTlWYRaPEvLlGs~----~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFSIPMRT----------YTPEVVTLWYRAPEVLLGST----SYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhcCCccc----------ccccEEEeeccCHHHhcCCC----cCCCCcchHhHHHHHHHHHhCCCC
Confidence 865533322 22223344456666543222 345667899999999999999775
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=269.47 Aligned_cols=209 Identities=22% Similarity=0.391 Sum_probs=171.1
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
.....+..++|++.+.||+|+||.||+|.+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 44566777999999999999999999999887 889999999976432 2344456788999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.+..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999999854 358899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... .....++..|++||....... ......++|+|++|++++|+..|.
T Consensus 191 ~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 191 KMNKEGMVR---------CDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred EcCcCCccc---------ccCcccCccccCHHHHhccCC-CccCCCccceeehhHHHHHHHhCC
Confidence 764322110 111245566777776543211 111356899999999999999993
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=274.34 Aligned_cols=199 Identities=23% Similarity=0.368 Sum_probs=179.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE-EEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY-ICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 177 (317)
.++|.+++++|+|+||.+++++.+. .+..+++|.+.-........+...+|+.++++++|||||.+++.|+.++. +++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999998777 77899999998877777777788999999999999999999999998887 999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||+||+||+|.+.+.+.++..|+++.++.|+.||+.|+.|||++.|+|||||+.|||++.++.|+|+|||+|+.+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999999988778899999999999999999999999999999999999999999999999999999887765
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+..+-+ |+|-|..+++.+.++.....|+|+++|++.|+.+=
T Consensus 162 ~a~tvv---------------GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~l 202 (426)
T KOG0589|consen 162 LASTVV---------------GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTL 202 (426)
T ss_pred hhheec---------------CCCcccCHHHhCCCCCCccCcchhhcchHHHHHhc
Confidence 555544 44666677777888888999999999999998753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=269.44 Aligned_cols=209 Identities=22% Similarity=0.380 Sum_probs=170.7
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
.....+..++|++.+.||+|+||.||+|.... +++.||+|++.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred hccCCCCHHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 44556777899999999999999999998887 7899999999764322 234456788999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.++.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 99999999999999999999854 358899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
........ ......++..|++||....... ......+.|+|++|++++|+..|.
T Consensus 191 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 191 KMDANGMV---------RCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred eccCCCcc---------cCCCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhCC
Confidence 65432211 0011235566777776543211 122457899999999999999993
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.88 Aligned_cols=208 Identities=27% Similarity=0.475 Sum_probs=168.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.+.. +++.||+|++....... .....+.+|+++++.++|+||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 479999999999999999999887 78999999998754333 4556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999999654 67999999999999999999999999999999999999999999999999999776543300
Q ss_pred ee-------------------cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VE-------------------TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~-------------------~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. .............++..|++||... ........|+|++|++++|+..| .|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-----GTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHc-----CCCCCCceeeEecchhhhhhccCCCC
Confidence 00 0000001111223444555555543 33556789999999999999999 44
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=251.24 Aligned_cols=203 Identities=26% Similarity=0.342 Sum_probs=174.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..++|.+++.||+|-||.||+|+.++ ++..||+|++.+..... ....++.+|++|...|+||||+++|++|.+..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekk-s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred cccchhhccccccccCCccccEeEeeecc-CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 35667899999999999999999999888 88999999998765443 45568899999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+||++||..+|+|...+.......+++...+.++.|++.||.|||..+||||||||+|+|++..+.+||+|||++....
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999999987778889999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ....+. .++..|.+||.. +........|+|+++..-.||.-|.|
T Consensus 176 ~--~kR~tl----------cgt~dyl~pEmv-----~~~~hd~~Vd~w~lgvl~yeflvg~p 220 (281)
T KOG0580|consen 176 S--NKRKTL----------CGTLDYLPPEMV-----EGRGHDKFVDLWSLGVLCYEFLVGLP 220 (281)
T ss_pred C--CCceee----------ecccccCCHhhc-----CCCCccchhhHHHHHHHHHHHHhcCC
Confidence 1 112222 344456666544 44455678899999999999999976
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=264.84 Aligned_cols=205 Identities=24% Similarity=0.368 Sum_probs=168.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.... +++.+|+|++.+... .......+.+|+.++..++|+||+++++.+...+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 479999999999999999999877 788999999975432 234445678899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999653 356899999999999999999999999999999999999999999999999999765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. .....++..|++||+..............+|+|++|++++|+..| .|
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 159 Q---------SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred e---------ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 1 111245667888887653222222345678999999999999999 44
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=264.89 Aligned_cols=194 Identities=31% Similarity=0.471 Sum_probs=164.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 478999999999999999999887 7899999999764322 24556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~- 156 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW- 156 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc-
Confidence 999999999999965 36789999999999999999999999999999999999999999999999999976532110
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...++..|++||... ........|+|++|++++|+..|.
T Consensus 157 ------------~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~l~~g~ 195 (291)
T cd05612 157 ------------TLCGTPEYLAPEVIQ-----SKGHNKAVDWWALGILIYEMLVGY 195 (291)
T ss_pred ------------cccCChhhcCHHHHc-----CCCCCchhhHHHHHHHHHHHHhCC
Confidence 113445567777553 334467899999999999999993
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=259.27 Aligned_cols=198 Identities=30% Similarity=0.419 Sum_probs=166.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|++.+.||+|+||.||+|.+.. +++.||+|.+....... .....+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 37889999999999999998877 78999999987654332 33456788999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++.........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV- 158 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee-
Confidence 9999999998876544457899999999999999999999999999999999999999999999999999765322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||..... ....++|+|++|++++|+..| .|
T Consensus 159 ----------~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 159 ----------RGRVGTVGYMAPEVINNE-----KYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred ----------cCCCCCCCccCHhhhcCC-----CCCcccCchhHHHHHHHHHhCCCC
Confidence 122466778888877532 345678999999999999999 44
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.49 Aligned_cols=202 Identities=23% Similarity=0.351 Sum_probs=180.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+.|.|+..||.|+||+||+|..+. ++...|-|++... ..+.++.+.-||+||..++||+||++++.|..++.+|++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc-chhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 568899999999999999998886 7778888988655 6678889999999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|||.||....++-.. +..+.+.++..+++|+|.||.|||+++|||||||..|||++.+|.++|+|||++.+........
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999988877554 5779999999999999999999999999999999999999999999999999987665544444
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.+++ |+.-||+||....+.....+..+.+|+|++|+++||+++|-|
T Consensus 188 DsFI----------GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 188 DSFI----------GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred cccc----------CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 4555 445699999999999999999999999999999999999966
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.10 Aligned_cols=197 Identities=24% Similarity=0.348 Sum_probs=172.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..|...+.||+|.||.||+|.+.. +++.||+|++..+. .+..++.++.|+.+|..++++||.++|+.+..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK-TKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeecc-ccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 457777889999999999999988 89999999998764 3466788999999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|||.||++.++++. +..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++.++.......
T Consensus 91 ey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999954 4556888899999999999999999999999999999999999999999999998876655443
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.+++ |+..||+||.+. ......++|+|+||.+.+|+++|.|
T Consensus 169 ~tfv----------GTPfwMAPEVI~-----~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 169 KTFV----------GTPFWMAPEVIK-----QSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred cccc----------ccccccchhhhc-----cccccchhhhhhhhHHHHHHhcCCC
Confidence 4444 556789988775 3445688999999999999999966
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=257.32 Aligned_cols=202 Identities=20% Similarity=0.259 Sum_probs=168.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-----cC
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-----SH 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 173 (317)
..+|..++.||+|+||.|..+.+.. +|+.||||.+...+...-..++..+|+++|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~-t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKR-TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcC-CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3566668999999999999999888 88999999998777777888999999999999999999999999854 46
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+|+|+| +.+|..+++. ++.+++..+..++.||++||+|+|+.+|+||||||.|+|++.+..+||+|||+|+..+
T Consensus 100 DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 799999999 8899999965 3669999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
.. ....-..+. ..+.=|-+||-+ ....+.....|+||.||++.||..|-|+
T Consensus 177 ~~-~~~~~mTeY-------VaTRWYRAPEll----l~~~~Yt~aiDiWSvGCI~AEmL~gkpl 227 (359)
T KOG0660|consen 177 KF-FEDGFMTEY-------VATRWYRAPELL----LNSSEYTKAIDIWSVGCILAEMLTGKPL 227 (359)
T ss_pred cc-Ccccchhcc-------eeeeeecCHHHH----hccccccchhhhhhhhHHHHHHHcCCCC
Confidence 54 111111111 223335566655 3344556889999999999999999775
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.31 Aligned_cols=192 Identities=28% Similarity=0.530 Sum_probs=160.4
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+.||+|+||.||++.... +++.||+|++.+... .......+.+|+++++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 359999999999998877 789999999986533 234556788999999999999999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~----- 152 (328)
T cd05593 80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM----- 152 (328)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc-----
Confidence 999988854 4678999999999999999999999999999999999999999999999999987543221111
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||.... .....+.|+|+++++++|+..| .|
T Consensus 153 -----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~P 194 (328)
T cd05593 153 -----KTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLP 194 (328)
T ss_pred -----ccccCCcCccChhhhcC-----CCCCccCCccccchHHHHHhhCCCC
Confidence 11235566777776643 2345789999999999999999 44
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.27 Aligned_cols=192 Identities=28% Similarity=0.520 Sum_probs=159.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+.||+|+||.||++.+.. +++.||+|++.+.... ......+.+|+++++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 359999999999998877 7899999999865432 34456778899999999999999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
++|.+++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+..........
T Consensus 80 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~--- 154 (325)
T cd05594 80 GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--- 154 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc---
Confidence 999998854 3678999999999999999999997 7999999999999999999999999999875432221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||.... .....+.|+|++|++++|+..| .|
T Consensus 155 -------~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 155 -------TFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred -------cccCCcccCCHHHHcc-----CCCCCccccccccceeeeeccCCCC
Confidence 1235566788876543 3345789999999999999999 44
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.19 Aligned_cols=199 Identities=27% Similarity=0.421 Sum_probs=172.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehh-hhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.+-|++++.||.|+.|.|-+|++.. +|+.+|||++.+. .........+.+||-||+.+.||||+++|++++++.++|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~-TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE-TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhccc-ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 3678999999999999999999888 9999999999876 4455666788999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
|+||++||.|++++.+ .+++++.++.+++.||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.. ..+..
T Consensus 90 vlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL-e~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL-EVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec-ccCCc
Confidence 9999999999999965 58899999999999999999999999999999999999999999999999999853 33444
Q ss_pred eeecccccccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC-CCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
+..|.| |+|-|..+++-.+. =+++.+|+|+=|.++.=+..| ||-
T Consensus 167 lLeTSC---------------GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF 212 (786)
T KOG0588|consen 167 LLETSC---------------GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF 212 (786)
T ss_pred cccccC---------------CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence 556655 34455444444433 347889999999999999999 874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=265.52 Aligned_cols=208 Identities=19% Similarity=0.265 Sum_probs=175.8
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
....+..++..+...||+|.||+||+|.++. .||||+++.+....+.++.|++|+.++++-+|.||+-+.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4556777888999999999999999999986 799999999888889999999999999999999999999999877
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.. .+|..||+|.+|+.+++.. ..+|.....+.|++||++|+.|||.++|||||||..||++.+++.|||+|||++..-
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 76 9999999999999999765 467999999999999999999999999999999999999999999999999998321
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
. .+.. ........+---||+||.+. .-+..+.....|+.+-|++++|+.+| +|.
T Consensus 539 ~----~w~g----~~q~~qp~gsilwmAPEvIR--mqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 T----RWSG----EQQLEQPHGSLLWMAPEVIR--MQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred e----eecc----ccccCCCccchhhhcHHHHh--hcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 1 1100 01111223444589999876 22244567888999999999999999 885
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=258.02 Aligned_cols=197 Identities=26% Similarity=0.373 Sum_probs=158.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec----
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS---- 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 172 (317)
...-.|.-.+++|.|+||.||+|.... +++.||||.+..+. +.-.+|+++|+.++|||||++.-+|...
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 344578889999999999999999998 68999999986542 2335699999999999999999887532
Q ss_pred -CEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeeecc
Q 042913 173 -HYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDFDL 248 (317)
Q Consensus 173 -~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DFG~ 248 (317)
-+..+||||+ ..+|.++++.. .+..++.-.++-+..||++||.|||..||+||||||.|||+|.+ |.+||||||.
T Consensus 94 ~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 94 EVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred hhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 2456899999 77999888642 35778888999999999999999999999999999999999965 9999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
|+.+........-.| .|.+|..-..+|+-+|- -..|+||.||++.|+..|-|+
T Consensus 173 AK~L~~~epniSYic----SRyYRaPELifga~~Yt-----------~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 173 AKVLVKGEPNISYIC----SRYYRAPELIFGATEYT-----------TSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred ceeeccCCCceeEEE----eccccCHHHHcCccccC-----------ceeEEhhhhHHHHHHhcCCcc
Confidence 999877665433222 23333444444444443 578899999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.72 Aligned_cols=192 Identities=28% Similarity=0.538 Sum_probs=160.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+.||+|+||.||++.... ++..||+|++..... .......+.+|+++++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 359999999999998877 789999999986533 234556778899999999999999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~----- 152 (323)
T cd05595 80 GELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM----- 152 (323)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc-----
Confidence 999988855 3578999999999999999999999999999999999999999999999999987532221110
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||..... ......|+|++|++++|+..| .|
T Consensus 153 -----~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell~g~~P 194 (323)
T cd05595 153 -----KTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred -----ccccCCcCcCCcccccCC-----CCCchhchhhhHHHHHHHHhCCCC
Confidence 112355677888876433 345778999999999999999 55
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=258.26 Aligned_cols=198 Identities=30% Similarity=0.462 Sum_probs=162.3
Q ss_pred CeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLS--AKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
+|++++.||+|+||.||+++... .+++.||+|++.+.... ....+.+..|+++++.++ |+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 58999999999999999997642 36789999999764322 234567888999999995 99999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999855 356899999999999999999999999999999999999999999999999999765332
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... .....++..|++||..... .......|+|++|++++|+..|
T Consensus 159 ~~~~---------~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 159 EKER---------TYSFCGTIEYMAPEIIRGK----GGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred CCCc---------cccccCCccccCHHHhcCC----CCCCCccccccchhhhhhhhcC
Confidence 2110 0112355678888876421 1235678999999999999999
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=252.89 Aligned_cols=205 Identities=30% Similarity=0.547 Sum_probs=182.6
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
...+..++|..+++||+|.||+|.+|+.+. +++.+|+|+++++..- .+....-..|-++|+..+||.+..+.-.|+.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKA-TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecc-cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 345678999999999999999999999887 8999999999887543 36677788899999999999999998889999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+|+||||..||.|.-.+.+ ...|++...+.+...|+.||.|||+++||+||||.+|+|+|++|++||.|||+|+.-
T Consensus 241 drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999999998855 578999999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
-.......++| |+|||..+++.+.....+..|-|-++..++|+.|| +|-
T Consensus 319 I~~g~t~kTFC---------------GTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 319 IKYGDTTKTFC---------------GTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred ccccceecccc---------------CChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 43333333333 77999999999999999999999999999999999 874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=240.77 Aligned_cols=200 Identities=20% Similarity=0.294 Sum_probs=169.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
...++++++..||.|..|+|+++..+. +|..+|||.+.+.. ..+..+++...+.++...+ .|+||+.+|+|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcc-cceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 445788889999999999999999998 89999999998764 4455677777887766654 89999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
++.||.| ...+..++++. .+++++..+-++...++.||.||.+ +||+|||+||+|||+|+.|++||||||++-.+-.
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999 66677777654 5779999999999999999999986 5899999999999999999999999999865433
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. -..+.+||..||+||+..++. ......|+|+||++.+++|+++|
T Consensus 245 Sk-----------AhtrsAGC~~YMaPERidp~~--~~kYDiRaDVWSlGITlveLaTg 290 (391)
T KOG0983|consen 245 SK-----------AHTRSAGCAAYMAPERIDPPD--KPKYDIRADVWSLGITLVELATG 290 (391)
T ss_pred cc-----------ccccccCCccccCccccCCCC--CCccchhhhhhhhccchhhhhcc
Confidence 22 223458999999999998763 22345899999999999999999
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.44 Aligned_cols=196 Identities=26% Similarity=0.457 Sum_probs=162.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEecCEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHP-FLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv 178 (317)
+|++++.||+|+||.||+|.... +++.||+|++.+... .....+.+..|++++..+.|+ +|+++++++...+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 58999999999999999999877 788999999986543 234556788899999999765 688899999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 80 ~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999999855 356899999999999999999999999999999999999999999999999998653221111
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 158 ~----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~ 198 (324)
T cd05587 158 T----------RTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQ 198 (324)
T ss_pred e----------eeecCCccccChhhhcC-----CCCCcccchhhhHHHHHHHHhCC
Confidence 1 11235566777776643 33457889999999999999993
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=256.94 Aligned_cols=189 Identities=29% Similarity=0.467 Sum_probs=158.6
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||+|+||.||+|.+.. +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 6999999999999877 788999999976432 33455678889999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~------- 150 (312)
T cd05585 80 LFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT------- 150 (312)
T ss_pred HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcc-------
Confidence 9999965 4678999999999999999999999999999999999999999999999999987543222111
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....++..|++||.... .....++|+|++|++++|+..|.
T Consensus 151 ---~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 151 ---NTFCGTPEYLAPELLLG-----HGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred ---ccccCCcccCCHHHHcC-----CCCCCccceechhHHHHHHHhCC
Confidence 11235566788876643 33457799999999999999994
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=255.99 Aligned_cols=193 Identities=32% Similarity=0.492 Sum_probs=159.9
Q ss_pred eeecccCCeEEEEEEEc--CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||++... ..+++.||+|++............+.+|+++++.++||||+++++++..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 56999999999998763 2368899999998765444455667889999999999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~--- 156 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--- 156 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee---
Confidence 9999999854 36689999999999999999999999999999999999999999999999999876533221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||.... .....+.|+|++|++++|+..| .|
T Consensus 157 -------~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p 197 (318)
T cd05582 157 -------SFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGSLP 197 (318)
T ss_pred -------cccCChhhcCHHHHcC-----CCCCCccceeccceEeeeeccCCCC
Confidence 1134456777776543 3335789999999999999999 55
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.45 Aligned_cols=195 Identities=28% Similarity=0.482 Sum_probs=159.7
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHH---HhcCCCCcceEEEEEEecCEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEIL---SMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
|++++.||+|+||.||+|.+.. +++.||||++.+... .....+.+.+|++++ +.++||||+++++++...+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 7889999999999999998877 789999999986532 224455677777665 45679999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 v~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 9999999999988753 4689999999999999999999999999999999999999999999999999875432221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....++..|++||.... ......+|+|++|++++|+..| .|
T Consensus 157 ~~----------~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~G~~p 200 (324)
T cd05589 157 RT----------STFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIYEMLVGESP 200 (324)
T ss_pred cc----------cccccCccccCHhHhcC-----CCCCcccchhhHHHHHHHHHhCCCC
Confidence 11 11235566788876643 2345678999999999999999 44
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=260.46 Aligned_cols=198 Identities=28% Similarity=0.405 Sum_probs=171.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
....|.+.+.||+|.||.||+|.... +|+.+|+|++.+..... .....+.+|+.+|+.+. |||||++++.|+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~-tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS-TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC-CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34689999999999999999999888 89999999998765433 34678999999999999 99999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc----CCcEEEeeeccccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE----DGHIMLSDFDLCFQ 251 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~----~~~~kl~DFG~a~~ 251 (317)
++|||++.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+.. ++.+|++|||+|+.
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999765 3999999999999999999999999999999999999963 24799999999988
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... .... ....|+|+|..+++..........|+|+++...+.+.+|.|
T Consensus 189 ~~~-~~~~---------------~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 189 IKP-GERL---------------HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred ccC-CceE---------------eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 766 2222 22346667777777777778889999999999999999965
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=254.52 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=163.3
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.... +++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECC-CCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35789999999999999999998877 78999999986542 12233467789999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999995 5898888543 34578999999999999999999999999999999999999999999999999975432221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. .....++..|++||..... .......|+|++|++++|+..|.|
T Consensus 159 ~----------~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 159 T----------YSNEVVTLWYRPPDVLLGS----TEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred c----------ccCceecccccChHHhcCC----cccCcHHHHHHHHHHHHHHHhCCC
Confidence 1 1112345568888865321 234567999999999999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=256.31 Aligned_cols=197 Identities=26% Similarity=0.461 Sum_probs=162.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 178 (317)
+|.+.+.||+|+||.||+|.+.. +++.||+|++.+.... ......+..|..++..+ +|++|+++++++...+.+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 58899999999999999998876 7899999999875432 23445677788888877 488999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 ~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998855 356899999999999999999999999999999999999999999999999999754322111
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. ....++..|++||.... .......|+|++|++++|+..| .|
T Consensus 158 ~----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 158 T----------KTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred c----------ccCCCChhhcCHHHhcC-----CCCCCccchhchhHHHHHHHhCCCC
Confidence 1 11234556777776543 3345789999999999999999 44
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=255.35 Aligned_cols=198 Identities=22% Similarity=0.269 Sum_probs=161.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||+|.... +++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-CCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4689999999999999999999876 789999999875432 22234567899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+ .++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 82 FEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9999 57888877544 356889999999999999999999999999999999999999999999999998754322211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ....++..|++||..... ......+|+|++|++++|+..|.
T Consensus 160 ~----------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 160 Y----------SNEVVTLWYRPPDVLLGS----TEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred C----------CCCcccCCCCChHHHcCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 0 112345567788765322 12356789999999999999993
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=253.82 Aligned_cols=199 Identities=17% Similarity=0.223 Sum_probs=164.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999877 7899999999765444455667889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++++.+..+... ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+|+.........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99988766655432 3568999999999999999999999999999999999999999999999999998764322110
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....++..|++||+.... ......|+|++|++++|+..|-|
T Consensus 158 ---------~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 158 ---------YTEYVATRWYRSPELLLGA-----PYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred ---------ccccccccccCCcHHHcCC-----CCCCchhHHhHHHHHHHHHhCCC
Confidence 0112355678888876432 34568999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=257.11 Aligned_cols=192 Identities=27% Similarity=0.486 Sum_probs=159.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++++..... .....+..|+.+++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 359999999999999887 78999999998754333 4556788999999988 69999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 ~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~---- 153 (329)
T cd05588 80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---- 153 (329)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc----
Confidence 9999988854 3679999999999999999999999999999999999999999999999999987532211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||..... ....+.|+|++|++++|+..| .|
T Consensus 154 ------~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 154 ------STFCGTPNYIAPEILRGE-----DYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ------ccccCCccccCHHHHcCC-----CCCCccceechHHHHHHHHHCCCC
Confidence 112345667788776432 334678999999999999999 44
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=264.48 Aligned_cols=194 Identities=19% Similarity=0.239 Sum_probs=153.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC------CCcceEEEEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH------PFLPTLYAHLE 170 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~ 170 (317)
+..++|++++.||+|+||+||+|.+.. +++.||||+++.. .........|+++++.++| .+++++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 345789999999999999999998877 7889999999643 1223445667777777654 45888888886
Q ss_pred ec-CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCC---------
Q 042913 171 VS-HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDG--------- 239 (317)
Q Consensus 171 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~--------- 239 (317)
.. +.+|+|||++ +++|.+++.+. ..+++..++.++.||+.||.|||. .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 54 5789999998 88999888553 679999999999999999999998 5999999999999998765
Q ss_pred -------cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 240 -------HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 240 -------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
.+||+|||++....... ....++..|++||.... .......|+|++|++++|+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~~~-------------~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERHSR-------------TAIVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred ccCCCCceEEECCCCccccCcccc-------------ccccCCccccCcHHhhc-----CCCCcHHHHHHHHHHHHHHHh
Confidence 49999999885432211 11245566777776643 334578999999999999999
Q ss_pred CCC
Q 042913 313 GVP 315 (317)
Q Consensus 313 G~p 315 (317)
|.|
T Consensus 341 G~~ 343 (467)
T PTZ00284 341 GKL 343 (467)
T ss_pred CCC
Confidence 944
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=258.55 Aligned_cols=201 Identities=19% Similarity=0.253 Sum_probs=162.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----HYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 175 (317)
+|++.+.||+|+||.||+|.+.. ++..||||.+............+.+|+++++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999999999999877 789999999875443444556788999999999999999999987533 358
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 6789998854 356899999999999999999999999999999999999999999999999999764322
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.... .......++..|++||...... .......|+|++|++++|+..|-|
T Consensus 157 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~---~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 157 TPTA-------IFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred cCcc-------ccccCCCCCCCcCCHHHHhccc---cccCchhHHHHHHHHHHHHHcCCC
Confidence 1110 1112234667788888764321 223467899999999999999943
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=255.47 Aligned_cols=191 Identities=30% Similarity=0.504 Sum_probs=157.3
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++.+... .....+.+..|.++++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 359999999999999876 789999999986543 234456677899998876 79999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--- 154 (321)
T cd05591 80 GGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT--- 154 (321)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc---
Confidence 9999998854 36789999999999999999999999999999999999999999999999999875432221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...++..|++||.... .....++|+|++|++++|+..|.
T Consensus 155 -------~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~ 193 (321)
T cd05591 155 -------TFCGTPDYIAPEILQE-----LEYGPSVDWWALGVLMYEMMAGQ 193 (321)
T ss_pred -------ccccCccccCHHHHcC-----CCCCCccceechhHHHHHHhcCC
Confidence 1234556777776542 33456799999999999999993
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=253.67 Aligned_cols=191 Identities=30% Similarity=0.502 Sum_probs=154.5
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAE-ILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||+||+|.+.. +++.||+|++.+.... ......+..|.. +++.++||||+++++.+...+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 359999999999999877 7899999999765332 233344555555 5678999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~---- 153 (323)
T cd05575 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---- 153 (323)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc----
Confidence 9999999865 4678999999999999999999999999999999999999999999999999987532211110
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....++..|++||.... .....+.|+|++|++++|+..|.
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~ 193 (323)
T cd05575 154 ------STFCGTPEYLAPEVLRK-----QPYDRTVDWWCLGAVLYEMLYGL 193 (323)
T ss_pred ------ccccCChhhcChhhhcC-----CCCCccccccccchhhhhhhcCC
Confidence 11134556777776543 33457799999999999999993
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=250.28 Aligned_cols=196 Identities=30% Similarity=0.418 Sum_probs=164.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|++.+.||+|+||.||++.+.. +++.||+|++....... .....+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 48899999999999999998876 78999999997643332 33455778999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||+++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI- 158 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence 9999999998886554567899999999999999999999999999999999999999999999999998765322210
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....++..|++||.... ......+|+|+++++++|+..|
T Consensus 159 ----------~~~~~~~~y~aPE~~~~-----~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 159 ----------RGRVGTVGYMAPEVVKN-----ERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred ----------ccccCCCCccCcHHhcC-----CCCCccccchhHHHHHHHHHHC
Confidence 11234567788887642 3345678999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=262.45 Aligned_cols=193 Identities=18% Similarity=0.255 Sum_probs=160.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+...+|++++.||+|+||.||+|.+.. +++.||+|.... ..+.+|+++++.++||||+++++++..+...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECC-CCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999887 889999997532 3467899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++|+|++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 159 ~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999999 67888888543 56899999999999999999999999999999999999999999999999999653221
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ......++..|++||.... .....+.|+|++|++++|+..|.
T Consensus 236 ~~~---------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 236 NAN---------KYYGWAGTIATNAPELLAR-----DPYGPAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred ccc---------ccccccCccCCCChhhhcC-----CCCCcHHHHHHHHHHHHHHHHCC
Confidence 110 0111245667777776543 34567899999999999999884
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.31 Aligned_cols=204 Identities=19% Similarity=0.283 Sum_probs=160.9
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+. ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 355678999999999999999999752 2245789999987542 334456789999999999 8999999999886
Q ss_pred ec-CEEEEEEcccCCCChhcccccCC------------------------------------------------------
Q 042913 171 VS-HYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------ 195 (317)
Q Consensus 171 ~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------ 195 (317)
.. +.+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 46899999999999998886421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccccccc
Q 042913 196 ------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRR 269 (317)
Q Consensus 196 ------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~ 269 (317)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...........
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~-------- 233 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-------- 233 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcc--------
Confidence 134778889999999999999999999999999999999999999999999999865433221110
Q ss_pred ccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 270 RRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 270 ~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
....++..|++||..... ....++|+|+++++++|+.. |
T Consensus 234 ~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~el~~~g 273 (338)
T cd05102 234 GSARLPLKWMAPESIFDK-----VYTTQSDVWSFGVLLWEIFSLG 273 (338)
T ss_pred cCCCCCccccCcHHhhcC-----CCCcccCHHHHHHHHHHHHhCC
Confidence 111233568888876433 23577899999999999874 6
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.41 Aligned_cols=192 Identities=29% Similarity=0.460 Sum_probs=158.6
Q ss_pred eeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 106 RHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLS--AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
+.||+|+||.||++.... .+++.||+|++...... ......+.+|+++++.++||||+++++.+..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999999998642 36789999999765322 23445678899999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
+++++|.+++.. .+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (323)
T cd05584 82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--- 156 (323)
T ss_pred CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc---
Confidence 999999999865 466889999999999999999999999999999999999999999999999998754322211
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||..... ....+.|+|++|++++|+..|.
T Consensus 157 -------~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 157 -------THTFCGTIEYMAPEILMRS-----GHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred -------ccccCCCccccChhhccCC-----CCCCcceecccHHHHHHHhcCC
Confidence 1112456678888876432 3357899999999999999993
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=255.64 Aligned_cols=190 Identities=28% Similarity=0.483 Sum_probs=157.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++.+.... ......+.+|+.++..+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 359999999999999887 7899999999875432 34556788899988776 79999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~---- 153 (329)
T cd05618 80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---- 153 (329)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc----
Confidence 9999988854 3679999999999999999999999999999999999999999999999999987532221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....++..|++||.... .......|+|+++++++|+..|
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g 192 (329)
T cd05618 154 ------STFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred ------ccccCCccccCHHHHcC-----CCCCCccceecccHHHHHHhhC
Confidence 11235566777776643 2335679999999999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=253.51 Aligned_cols=192 Identities=31% Similarity=0.515 Sum_probs=154.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAE-ILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++.+.... ......+..|.. +++.++||||+++++.+...+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 359999999999999877 7899999999765332 233344555554 6788999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~---- 153 (321)
T cd05603 80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---- 153 (321)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc----
Confidence 9999988854 4678999999999999999999999999999999999999999999999999987532211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....++..|++||..... ....+.|+|+++++++|+..|.|
T Consensus 154 ------~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~ 194 (321)
T cd05603 154 ------STFCGTPEYLAPEVLRKE-----PYDRTVDWWCLGAVLYEMLYGLP 194 (321)
T ss_pred ------ccccCCcccCCHHHhcCC-----CCCCcCcccccchhhhhhhcCCC
Confidence 112345667888765432 23467999999999999999943
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.43 Aligned_cols=192 Identities=31% Similarity=0.491 Sum_probs=153.9
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHH-HHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEA-EILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++.+..... .....+..|. .+++.++|+||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 359999999999999877 78899999997653222 2233444444 45788999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~---- 153 (325)
T cd05602 80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---- 153 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc----
Confidence 9999999865 4668899999999999999999999999999999999999999999999999997543221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....++..|++||.... .....++|+|+++++++|+..|.|
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 154 ------STFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred ------ccccCCccccCHHHHcC-----CCCCCccccccccHHHHHHhcCCC
Confidence 11234556777776543 334567899999999999999943
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=254.97 Aligned_cols=192 Identities=30% Similarity=0.527 Sum_probs=156.4
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++...... ....+.+..|..++..+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 359999999999999877 7889999999865422 23445566677777654 79999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+..........
T Consensus 80 gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~--- 154 (316)
T cd05592 80 GGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS--- 154 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc---
Confidence 9999999865 35799999999999999999999999999999999999999999999999999975432221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||..... ......|+|++|++++|+..| .|
T Consensus 155 -------~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 155 -------TFCGTPDYIAPEILKGQ-----KYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred -------cccCCccccCHHHHcCC-----CCCCcccchhHHHHHHHHHhCCCC
Confidence 12345667888776432 335678999999999999999 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=252.73 Aligned_cols=191 Identities=28% Similarity=0.490 Sum_probs=154.6
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAE-ILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||+||+|.... +++.||+|++.+.... ......+..|.. +++.++||||+++++.+...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 359999999999998876 7899999999765322 233345555554 5678999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~---- 153 (325)
T cd05604 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---- 153 (325)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc----
Confidence 9999988854 4678999999999999999999999999999999999999999999999999987532211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....++..|++||.... ......+|+|++|++++|+..|.
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~ 193 (325)
T cd05604 154 ------TTFCGTPEYLAPEVIRK-----QPYDNTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred ------ccccCChhhCCHHHHcC-----CCCCCcCccccccceehhhhcCC
Confidence 11234556777776543 23356799999999999999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=258.76 Aligned_cols=199 Identities=21% Similarity=0.264 Sum_probs=161.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
...+...+|++++.||+|+||.||+|.... ..++.|++|.+... ....+|+++++.++|+||+++++++...
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 334556789999999999999999997643 24678999988643 2346799999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|+.+
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999999999 6788888843 467999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... .......++..|++||.... .....+.|+|++|++++|+..| .|
T Consensus 236 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~p 286 (392)
T PHA03207 236 DAHPDT--------PQCYGWSGTLETNSPELLAL-----DPYCAKTDIWSAGLVLFEMSVKNVT 286 (392)
T ss_pred Cccccc--------ccccccccccCccCHhHhcC-----CCCCchhhHHHHHHHHHHHHHCCCC
Confidence 543211 01112245566777776543 3345679999999999999887 44
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=254.45 Aligned_cols=192 Identities=31% Similarity=0.527 Sum_probs=157.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++.+... .....+.+..|..++..+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 359999999999999877 789999999976532 234456677888888876 69999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~---- 153 (320)
T cd05590 80 GGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---- 153 (320)
T ss_pred CchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc----
Confidence 9999998855 3679999999999999999999999999999999999999999999999999987542221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||.... ......+|+|+++++++|+..| .|
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 154 ------STFCGTPDYIAPEILQE-----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ------cccccCccccCHHHHcC-----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 11234556777776543 2345678999999999999999 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.97 Aligned_cols=196 Identities=27% Similarity=0.462 Sum_probs=161.3
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 178 (317)
+|++.+.||+|+||.||+|.... +++.||+|++.+.... ....+.+..|..+++.+. |++|+++++++...+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 47888999999999999998877 7899999999865332 344566788999998886 57788899999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 80 ~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999999855 367999999999999999999999999999999999999999999999999998754322211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||.... .....+.|+|++|++++|+..|.
T Consensus 158 ----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~ 198 (323)
T cd05615 158 ----------TRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAYGVLLYEMLAGQ 198 (323)
T ss_pred ----------ccCccCCccccCHHHHcC-----CCCCCccchhhhHHHHHHHHhCC
Confidence 111234566777776543 33457889999999999999993
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=250.83 Aligned_cols=199 Identities=21% Similarity=0.253 Sum_probs=158.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEE-----e
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLE-----V 171 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~ 171 (317)
++|++.+.||+|+||.||+|.+....++.||+|.+............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999988654578899999876543333334456677777665 6999999999875 3
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...+++||||+ .++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 45689999999 57999998766556789999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..... ......++..|++||.... .....+.|+|++|++++|+..|.|
T Consensus 160 ~~~~~-----------~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 160 YSFQM-----------ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred ccCCc-----------ccccccccccccChHHHhC-----CCCCCccchHHHHHHHHHHHcCCC
Confidence 54321 0111245566888886643 234567899999999999999855
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=255.63 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=179.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
......|.+.+.||.|.|++|.++.+.. ++..||||++.+..........+.+|+++|+.|+|||||+++.+.+....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3456889999999999999999999888 899999999999888888878899999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+.+|.+++++.+ .++..+..++.++.|++.|++|||++.|||||||++||||+.+.++||+|||++..++..
T Consensus 131 ylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999999966 477778999999999999999999999999999999999999999999999999877743
Q ss_pred CCeeecccccccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC-CCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
. +..+++ |+|+|..+++.+.. ......|+|+++..++-+-.| ||.
T Consensus 209 ~-~lqt~c---------------gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 209 L-MLQTFC---------------GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred c-cccccC---------------CCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 3 334444 66778777777765 447788999999999999888 773
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=253.40 Aligned_cols=190 Identities=27% Similarity=0.464 Sum_probs=158.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.... +++.||+|++.+.... ....+.+.+|+.++..+ +|+||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 359999999999999887 7899999999875433 34566788999999888 59999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~--- 154 (327)
T cd05617 80 GGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS--- 154 (327)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee---
Confidence 9999988854 35799999999999999999999999999999999999999999999999999875322211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...++..|++||.... ......+|+|++|++++|+..|
T Consensus 155 -------~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~ell~g 192 (327)
T cd05617 155 -------TFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAG 192 (327)
T ss_pred -------cccCCcccCCHHHHCC-----CCCCchheeehhHHHHHHHHhC
Confidence 1234556777776543 3345689999999999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=252.52 Aligned_cols=196 Identities=22% Similarity=0.281 Sum_probs=166.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++++.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+++++.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 456899999999999999999999887 78999999987642 3445577899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999999653 5689999999999999999999986 6999999999999999999999999998765321
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. ....++..|++||..... ....+.|+|++|++++|+..|
T Consensus 158 ~~------------~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 158 MA------------NSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred cc------------ccCCCCcCcCCHhHhcCC-----CCCchHhHHHHHHHHHHHHhC
Confidence 10 112355678888876432 345689999999999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=267.06 Aligned_cols=197 Identities=24% Similarity=0.325 Sum_probs=166.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC------E
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH------Y 174 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~ 174 (317)
-|..-+.||+|+||.||+++++. +|+.||||.++... .....+.+.+|+++|++++|+|||++++.-+... .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke-tG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE-TGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccc-cccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34556679999999999999888 99999999997754 3455678899999999999999999998865443 4
Q ss_pred EEEEEcccCCCChhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--cCC--cEEEeeeccc
Q 042913 175 ICFLIDYCPNGDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--EDG--HIMLSDFDLC 249 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~~~--~~kl~DFG~a 249 (317)
..+|||||.||+|..++.+- +...+++..++.++.+++.||.|||++||+||||||.||++. .+| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999753 345799999999999999999999999999999999999995 334 5899999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCC-CC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
|.++.+.. ....||+++|..+++-+ -..-..-.|.||+|++++|.++| +|
T Consensus 172 rel~d~s~----------------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELDDNSL----------------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCCe----------------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 99887662 23346778888877666 35557778999999999999999 66
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.35 Aligned_cols=192 Identities=29% Similarity=0.520 Sum_probs=156.6
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++...... ......+..|..++..+ +||||+++++++...+.+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 359999999999999887 7899999999865322 23445667788888754 89999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.........
T Consensus 80 ~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---- 153 (316)
T cd05620 80 GGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---- 153 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce----
Confidence 9999998855 3678999999999999999999999999999999999999999999999999987532211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||.... .....++|+|++|++++|+..| .|
T Consensus 154 ------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 154 ------STFCGTPDYIAPEILQG-----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ------eccCCCcCccCHHHHcC-----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 11234566777776543 3345779999999999999999 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=251.12 Aligned_cols=194 Identities=23% Similarity=0.345 Sum_probs=169.8
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
-|.++++||+|+||.||+|.++. +|..+|||.+..+ ..++++..|+.|+++++.++||++||.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~E-sG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRE-SGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhc-cCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 36778889999999999998887 8999999998654 456788899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
||..|++.++++.+ ++.+.+..+..+++..++||+|||...-||||||..|||++.+|..||+|||+|-++...-.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--- 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--- 184 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH---
Confidence 99999999999765 68899999999999999999999999999999999999999999999999999988754332
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+|-...|+..||+||.++ -+...-.+|+|+++.+.+|++.|-|
T Consensus 185 -------KRNTVIGTPFWMAPEVI~-----EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 185 -------KRNTVIGTPFWMAPEVIE-----EIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred -------hhCccccCcccccHHHHH-----HhccchhhhHhhhcchhhhhhcCCC
Confidence 233345677888888654 3445578899999999999999965
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=251.23 Aligned_cols=191 Identities=29% Similarity=0.446 Sum_probs=155.0
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc---CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML---DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
||+|+||+||+|.+.. +++.||+|++.+.... ......+..|..++..+ +||||+++++.+.....+|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 6999999999998877 7899999999764322 23444556677777665 69999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..........
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~--- 154 (330)
T cd05586 80 GGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN--- 154 (330)
T ss_pred CChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc---
Confidence 9999998854 46799999999999999999999999999999999999999999999999999875432221111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||..... .......|+|++|++++|+..| .|
T Consensus 155 -------~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 155 -------TFCGTTEYLAPEVLLDE----KGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred -------CccCCccccCHHHHcCC----CCCCCccceeccccEEEEeccCCCC
Confidence 12356678888876421 1235678999999999999999 44
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=255.09 Aligned_cols=194 Identities=17% Similarity=0.233 Sum_probs=159.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45899999999999999999998876 789999999976544555667788999999999999999999988644
Q ss_pred -CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 -HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
..+|+||||++ ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 35799999994 56766663 3478899999999999999999999999999999999999999999999999975
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... .....++..|++||.... .....+.|+|++|++++|+..|
T Consensus 173 ~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 173 ACTNFM-----------MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred cccCcc-----------CCCCcccCCCCCchhccC-----CCCCcchhhHHHHHHHHHHHhC
Confidence 432211 111234556777776543 2344678999999999999999
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=263.12 Aligned_cols=202 Identities=16% Similarity=0.180 Sum_probs=165.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
...|.+.+.||+|+||.||+|......+..||+|.+... .......+++|+.+++.++||||+++++++..++.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 455999999999999999999877633788999987544 334456778899999999999999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887542 23568899999999999999999999999999999999999999999999999998764422
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ......++.+|++||+... .....+.|+|++|++++|+..| .|
T Consensus 224 ~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 224 SLD--------VASSFCGTPYYLAPELWER-----KRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred ccc--------cccccCCCccccCHhHhCC-----CCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 110 0111235566778876643 2345778999999999999998 44
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=248.83 Aligned_cols=202 Identities=21% Similarity=0.247 Sum_probs=160.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC---------------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD---------------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 161 (317)
+..++|++.++||+|+||.||+|.+.. ..+..||+|++.... .......+.+|+++++.++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 456789999999999999999997643 123479999987543 3445567899999999999999
Q ss_pred cceEEEEEEecCEEEEEEcccCCCChhcccccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 042913 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQP-----------------NNRFSLQAVRFFAAEVLVGLEYLHALGII 224 (317)
Q Consensus 162 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~qi~~al~~LH~~~iv 224 (317)
|+++++++...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999875421 12467788999999999999999999999
Q ss_pred eccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCc
Q 042913 225 YRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPA 304 (317)
Q Consensus 225 HrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~ 304 (317)
||||||+|||++.++.+||+|||+++.......... .....+...|++||+...+ ....++|+|+++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG 227 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI--------QGRAVLPIRWMAWECILMG-----KFTTASDVWAFG 227 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEe--------cCcCCCCccccCHHHHhcC-----CCCchhhhHHHH
Confidence 999999999999999999999999976543221110 0111234567888865432 345789999999
Q ss_pred ccccccCC
Q 042913 305 QYSVEQPG 312 (317)
Q Consensus 305 ~~~~e~~~ 312 (317)
++++|+..
T Consensus 228 ~~l~el~~ 235 (304)
T cd05096 228 VTLWEILM 235 (304)
T ss_pred HHHHHHHH
Confidence 99999764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=246.18 Aligned_cols=190 Identities=27% Similarity=0.405 Sum_probs=157.2
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||+|+||+||+|.+.. +++.||+|.+....... ...+.+..|+++++.++|+||+++++++.....+|+||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6999999999998877 78999999997653332 344677889999999999999999999999999999999999999
Q ss_pred hhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 187 LHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 187 L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
|.+++.. .....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||+++.+........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~---- 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK---- 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc----
Confidence 9877643 2245689999999999999999999999999999999999999999999999999976543221111
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...++..|++||..... ....+.|+|+++++++|+..|
T Consensus 156 ------~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 156 ------GYAGTPGFMAPELLQGE-----EYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred ------ccCCCcCccCHHHhcCC-----CCCccccHHHHHHHHHHHHhC
Confidence 11345567777776533 345789999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=281.23 Aligned_cols=205 Identities=26% Similarity=0.477 Sum_probs=176.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
.-++...+|.|++.||+|+||.|.+++.+. +++.||+|++.+-... ......|+.|..+|...+.+=|++++-.|.++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345677899999999999999999999888 8999999999874433 45667889999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.++||||||++||+|-.++.+. .++++..++.++..|+.||.-||+.|+|||||||+|||||..|++||+|||.|.+.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999999999775 48999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCeeecccccccccccccccCCCCCccccccccccee-----ccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-----AEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-----~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+.+...... -..|+|.|+++++.+-+ ..++-+|-||+|.+++||..| -|
T Consensus 226 ~~dG~V~s~--------------~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 226 DADGTVRSS--------------VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CCCCcEEec--------------cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 765554322 22455666666655533 346888999999999999999 44
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=243.42 Aligned_cols=202 Identities=21% Similarity=0.289 Sum_probs=168.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHH-HhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL-SMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+...+++-+..||.|.||+|++..++. +|+.+|||.++.... +....++..|.+.. +.-+.||||++||.+..++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~-sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKP-SGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCc-cCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 445666778889999999999998887 899999999987654 44556777788765 445699999999999999999
Q ss_pred EEEEcccCCCChhcccc---cCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 176 CFLIDYCPNGDLHSLLP---KQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
|+.||+| ..+|..+.+ ......+++..+..|....+.||.||.+ ..||||||||+|||++..|.+||||||+|-+
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 777765543 2345678999999999999999999986 5899999999999999999999999999977
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+...- -.....||.-||+||++.++.. ....|.|.||++.+++|.++| .|
T Consensus 218 Lv~Si-----------AkT~daGCrpYmAPERi~p~~~---gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 218 LVDSI-----------AKTVDAGCRPYMAPERIDPSDK---GYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred HHHHH-----------HhhhccCCccccChhccCCccC---CcchhhhhhhhcceEeeeecCCCC
Confidence 64322 2234589999999999986655 456899999999999999999 66
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=249.98 Aligned_cols=192 Identities=29% Similarity=0.518 Sum_probs=158.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||+||+|.+.. +++.||+|++.+.... ......+.+|+++++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 359999999999999877 7889999999875432 34556778899999888 69999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--- 154 (318)
T cd05570 80 GGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS--- 154 (318)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc---
Confidence 9999998855 35799999999999999999999999999999999999999999999999999865322211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||.... ......+|+|++|++++|+..| .|
T Consensus 155 -------~~~g~~~y~aPE~~~~-----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 155 -------TFCGTPDYIAPEILSY-----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred -------ceecCccccCHHHhcC-----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 1134556777776543 3345789999999999999999 44
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=249.04 Aligned_cols=192 Identities=31% Similarity=0.537 Sum_probs=156.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHh-cCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. +++.||+|++...... .........|..++.. ++||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 359999999999999887 7899999999875422 2334556678888876 489999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--- 154 (316)
T cd05619 80 GGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--- 154 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee---
Confidence 9999999865 35689999999999999999999999999999999999999999999999999875322211111
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||.... ......+|+|++|++++|+..| .|
T Consensus 155 -------~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 155 -------TFCGTPDYIAPEILLG-----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred -------eecCCccccCHHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 1235566788876643 2345679999999999999999 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=264.53 Aligned_cols=203 Identities=21% Similarity=0.246 Sum_probs=153.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEe--------------ehh-hhcHHHHHHHHHHHHHHHhcCCC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV--------------DKD-LLSAKKLSHVQMEAEILSMLDHP 160 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~--------------~~~-~~~~~~~~~~~~E~~~l~~l~h~ 160 (317)
....++|++++.||+|+||+||+|..+...+..+++|.+ .+. .........+.+|+.+|+.++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345689999999999999999999876533333333311 111 11223445688999999999999
Q ss_pred CcceEEEEEEecCEEEEEEcccCCCChhcccccCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 042913 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQP---NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE 237 (317)
Q Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~ 237 (317)
||+++++++...+..|+|++++ +++|.+++.... ........++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999999999999999999999 667777664321 122345677889999999999999999999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
++.+||+|||+|+.+...... ......++..|++||... ......+.|+|++|++++|+..|
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ell~~ 364 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILA-----GDGYCEITDIWSCGLILLDMLSH 364 (501)
T ss_pred CCCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhc-----CCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999876543211 011124556677777654 33456789999999999999876
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=250.71 Aligned_cols=198 Identities=24% Similarity=0.305 Sum_probs=166.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+++++.++|+||+++++++..++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 456899999999999999999998876 78899999887542 3445567899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999965 35689999999999999999999985 7999999999999999999999999998765321
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....++..|++||.... .....+.|+|++|++++|+..| .|
T Consensus 158 ~~------------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 158 MA------------NSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred cc------------ccCCCCccccCHHHhcC-----CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 10 01134556788887643 3345779999999999999988 44
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=243.41 Aligned_cols=198 Identities=30% Similarity=0.426 Sum_probs=165.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|++.+.||+|+||+||++.+.. +++.||+|.+....... .....+.+|+++++.++|+||+.+++.+..++..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 47888999999999999998887 78999999987653332 33455788999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI- 158 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc-
Confidence 9999999998886554557999999999999999999999999999999999999999999999999998764322110
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||+... .....+.|+|+++++++|+..| .|
T Consensus 159 ----------~~~~g~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 159 ----------RGRVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred ----------cCCCCCcCccChHHhcC-----CCCCcccchHHHHHHHHHHHhCCCC
Confidence 11245667888887643 2345678999999999999999 44
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=243.11 Aligned_cols=197 Identities=27% Similarity=0.440 Sum_probs=164.7
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|++++.||+|+||.||++.... +++.||+|++..............+|+.+++.++|+||+++++++......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8899999999999999999888 788999999988765555555556799999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
+++++|.+++.. ...+++..++.++.||+.||.+||+.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~--- 154 (260)
T PF00069_consen 80 CPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN--- 154 (260)
T ss_dssp ETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE---
T ss_pred cccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 988899999973 467899999999999999999999999999999999999999999999999999764111111
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.....+...|.+||... .......+.|+|+++++++|+..| .|
T Consensus 155 -------~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 155 -------FNPFVGTPEYMAPEVLQ----QGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp -------BSSSSSSGGGSCHHHHT----TTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred -------ccccccccccccccccc----ccccccccccccccccccccccccccc
Confidence 11112333455555433 256678999999999999999988 44
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=255.66 Aligned_cols=198 Identities=20% Similarity=0.259 Sum_probs=161.3
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----EE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-----YI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 175 (317)
+|++.+.||+|+||.||++.+.. +++.||+|.+...........++.+|+++++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47888999999999999998876 7899999998765434455667889999999999999999999998766 78
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+ .++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~lv~e~~-~~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELM-QSDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeecc-ccCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999999 5788887744 467899999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... ......++..|++||...... ....+.|+|++|++++|+..|-+
T Consensus 157 ~~~---------~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 157 ESK---------HMTQEVVTQYYRAPEILMGSR----HYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred ccc---------cCCCCCcCCCcCCHHHHcCCC----CCCcHHHHHhHHHHHHHHHcCCC
Confidence 211 011123455688888664321 12467899999999999999943
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=243.54 Aligned_cols=191 Identities=27% Similarity=0.437 Sum_probs=158.6
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||+|+||.||++.... +++.||+|.+....... .....+..|+++++.++||||+++++.+..+..+|+||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 6999999999998887 78999999997643332 223445679999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~-------- 151 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI-------- 151 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee--------
Confidence 998886655556899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||+.... ....+.|+|+++++++|+..| .|
T Consensus 152 ---~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~~g~~p 193 (277)
T cd05607 152 ---TQRAGTNGYMAPEILKEE-----PYSYPVDWFAMGCSIYEMVAGRTP 193 (277)
T ss_pred ---eccCCCCCccCHHHHccC-----CCCCchhHHHHHHHHHHHHhCCCC
Confidence 112455678888876433 245788999999999999998 45
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=270.35 Aligned_cols=208 Identities=22% Similarity=0.268 Sum_probs=165.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ....+++.+|+++++.++||||+++++++..++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999877 7899999999754322 34456789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccC---------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 179 IDYCPNGDLHSLLPKQ---------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~---------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
|||++|++|.+++... ....++...++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988532 1233566778899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeec-ccc-------cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVET-NVG-------SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+........... ... .........++..|++||+... .....+.|+|++|++++|+..|
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-----~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-----VPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-----CCCCcHhHHHHHHHHHHHHHHC
Confidence 876322111000 000 0011112346667777776543 3446789999999999999999
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=241.70 Aligned_cols=203 Identities=20% Similarity=0.221 Sum_probs=162.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
+..++|++.+.||+|+||.||+|.+.. ..+..||+|.++... .......+.+|+.+++.++||||+++++++..++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 455789999999999999999997652 245689999987643 33445678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999998654 35689999999999999999999999999999999999999999999999998755322
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC-CC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP-GG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~G-~p 315 (317)
.... . .....+...|++||... ......+.|+|+++++++|+. .| .|
T Consensus 160 ~~~~-~--------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 160 EAIY-T--------TMSGKSPVLWAAPEAIQ-----YHHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred cchh-c--------ccCCCCceeecCHHHHh-----hCCccchhHHHHHHHHHHHHhcCCCCC
Confidence 1110 0 00111223577777653 334567899999999999954 47 44
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=262.59 Aligned_cols=205 Identities=21% Similarity=0.247 Sum_probs=167.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH--- 173 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 173 (317)
...++|++.+.||+|+||.||+|.+.. +++.||||++............+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999998876 7899999999876666677778899999999999999999987764322
Q ss_pred -----EEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 174 -----YICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 174 -----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
.+++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999988643 2356899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
|+++.+....... . .....++..|++||.... .....+.|+|+++++++|+..| .|
T Consensus 188 Gls~~~~~~~~~~---~-----~~~~~Gt~~Y~aPE~~~~-----~~~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 188 GFSKMYAATVSDD---V-----GRTFCGTPYYVAPEIWRR-----KPYSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred ccCeecccccccc---c-----cccccCCcceeCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9998754322110 0 011234556777776543 3456789999999999999998 44
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.59 Aligned_cols=200 Identities=26% Similarity=0.307 Sum_probs=165.3
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+....+++++.||+|.||.||+|.++. ...||+|.++...... +.+.+|+++|++|+|+|||++++++..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~--~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG--STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC--CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 345666778889999999999999999996 5689999998764443 44668999999999999999999999988
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|||||||+.|+|.++|+...+..+.....+.++.|||+|++||+++++|||||-+.||||+++..+||+|||+|+..+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999988667889999999999999999999999999999999999999999999999999999433
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
.+.-. .. .+ ...---|.+||-...+. -..+.|+||-+..+.|+..
T Consensus 355 d~~Y~-~~-~~-------~kfPIkWtAPEa~~~~~-----FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 355 DDEYT-AS-EG-------GKFPIKWTAPEALNYGK-----FSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred CCcee-ec-CC-------CCCCceecCHHHHhhCC-----cccccceeehhhhHHHHhc
Confidence 32211 11 10 01122477887664443 4578999999999999753
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.38 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=178.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..+.|++-++||+|+||.||-|+.+. +|+.+|+|.+.+..... .......+|..||.++..+.||.+--.|+..+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvra-TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRA-TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEec-chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 34566889999999999999999998888 99999999987664443 34456788999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||..|.||+|.-+|....+..|++..++.++.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999999988777789999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... ..+.|+.|||+||....++ .....|-|+++|+++|+.+|
T Consensus 339 ~g~~~-----------~~rvGT~GYMAPEvl~ne~-----Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 339 EGKPI-----------RGRVGTVGYMAPEVLQNEV-----YDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred CCCcc-----------ccccCcccccCHHHHcCCc-----ccCCccHHHHHhHHHHHHcc
Confidence 55432 2348899999999987666 34677889999999999999
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=243.28 Aligned_cols=198 Identities=29% Similarity=0.424 Sum_probs=164.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|++.+.||+|+||.||++.+.. +++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+...+.+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 47888999999999999999887 78999999987643322 33456778999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence 9999999999886554556899999999999999999999999999999999999999999999999998654322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||.... .....+.|+|+++++++|+..| .|
T Consensus 159 ----------~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 159 ----------KGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred ----------cCCCCCccccChHHHcC-----CCCCCccccHHHHHHHHHHHhCCCC
Confidence 11245667888887643 2345678999999999999999 44
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=270.68 Aligned_cols=209 Identities=21% Similarity=0.322 Sum_probs=169.1
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
+..+....++|++++.||+|+||.||+|.+.. ++..||+|++............+..|+.+++.|+|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 45567778999999999999999999999887 78899999998765566667789999999999999999999998854
Q ss_pred --cCEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeccCCCCcEEEcc---
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHAL-------GIIYRDLKPENILLRE--- 237 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~-------~ivHrDikp~Nill~~--- 237 (317)
...+||||||+++++|.++|... ....+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 46799999999999999998642 235699999999999999999999985 4999999999999964
Q ss_pred --------------CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCC
Q 042913 238 --------------DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHP 303 (317)
Q Consensus 238 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~ 303 (317)
.+.+||+|||+++........ ....++..|++||....... .....+|+|++
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~-----------~s~vGTp~YmAPEvL~ge~~---~~s~KSDVWSL 229 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA-----------HSCVGTPYYWSPELLLHETK---SYDDKSDMWAL 229 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccc-----------cccCCCccccCHHHHhccCC---CCCchhHHHHH
Confidence 235999999999765432210 11245566788876543221 23467899999
Q ss_pred cccccccCCC-CC
Q 042913 304 AQYSVEQPGG-VP 315 (317)
Q Consensus 304 ~~~~~e~~~G-~p 315 (317)
+++++|+..| .|
T Consensus 230 G~ILYELLTGk~P 242 (1021)
T PTZ00266 230 GCIIYELCSGKTP 242 (1021)
T ss_pred HHHHHHHHHCCCC
Confidence 9999999999 44
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=226.73 Aligned_cols=205 Identities=19% Similarity=0.267 Sum_probs=172.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 174 (317)
.+..+++..+..||+|++|.|-+.++.. +|...|+|.+..... .+..+++.+|+++..+. .+|++|.+||.+...+.
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~-sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQ-SGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeecc-CCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4555667778889999999999988877 899999999977653 45556778888876554 69999999999999999
Q ss_pred EEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 175 ICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+|+.||.| .-+|..+.++ ..++.+++..+-+|+..++.||.|||++ .|+|||+||+||||+.+|++|+||||++-.
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999 7788766543 2467899999999999999999999985 899999999999999999999999999865
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+...-. ..-..||.-||+||...+++++- ....++|+||++.+++|++.| .|
T Consensus 199 L~dSiA-----------kt~daGCkpYmaPEri~~e~n~~-gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 199 LVDSIA-----------KTMDAGCKPYMAPERINPELNQK-GYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred ehhhhH-----------HHHhcCCCccCChhhcCcccCcc-cceeehhhhhhhhhhhhhhhcccc
Confidence 533221 11237999999999999998885 778999999999999999988 54
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=237.47 Aligned_cols=199 Identities=21% Similarity=0.313 Sum_probs=170.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|.+.+.||+|++|.||+|.+.. +++.|++|.+............+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58889999999999999998877 78999999997665556667789999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++..........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999775557789999999999999999999999999999999999999999999999999987654322111
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...+...|.+||+.... ....+.|+|+++++++|+..| .|
T Consensus 160 ----------~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 160 ----------TIVGTPYYLSPELCEDK-----PYNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred ----------ccccCccccCHHHhcCC-----CCCCccchHHHHHHHHHHHhCCCC
Confidence 11234567888876543 234678999999999999999 55
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=257.84 Aligned_cols=204 Identities=22% Similarity=0.348 Sum_probs=178.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEE-----ec
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLE-----VS 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-----~~ 172 (317)
...|.|.+.||.|.+|+||+++..+ +++..|+|+..... +.-+++..|.++|+.+. |||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee-cCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3578999999999999999999888 88999999987653 23345677888998874 999999999985 45
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+|||||||.+|+.-|+++...+.++.|..+..|++.++.||.|||.+.++|||||-.|||++.++.|||+|||++.++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 78999999999999999998877889999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
+.......+.+|+ ..||+||.+..+=.....-..|+|.|+|+.+.+|+..| .|+
T Consensus 174 dsT~grRnT~iGt----------P~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 174 DSTVGRRNTFIGT----------PYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred ecccccccCcCCC----------cccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence 8766655555544 56999999987766666678999999999999999999 443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.70 Aligned_cols=200 Identities=22% Similarity=0.287 Sum_probs=162.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++++.++|+||+++++++..++..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecC-CCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 34789999999999999999998876 788999999875432 2223456789999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 82 VFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999995 5888887554 34578999999999999999999999999999999999999999999999999975433221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.. ....++..|++||..... .....+.|+|+++++++|+..|.|
T Consensus 160 ~~----------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 160 TY----------SNEVVTLWYRPPDVLLGS----SEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred cc----------ccccccccccCCHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 11 112345567788765422 123567899999999999999944
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=257.62 Aligned_cols=195 Identities=21% Similarity=0.241 Sum_probs=153.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++++.||+|+||.||+|.+.. +++.||||.+.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 34689999999999999999998876 78999999885432 2235699999999999999999876432
Q ss_pred ---CEEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeee
Q 042913 173 ---HYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDF 246 (317)
Q Consensus 173 ---~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DF 246 (317)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 35779999995 677766642 2346789999999999999999999999999999999999999655 7999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|+.+....... ...++..|++||..... .......|+|++|++++|+..|.|
T Consensus 216 Gla~~~~~~~~~~-----------~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 216 GSAKNLLAGQRSV-----------SYICSRFYRAPELMLGA----TNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred ccchhccCCCCcc-----------cCCCCcCccCHHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9998764322110 11344568888865322 123567899999999999999954
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=243.63 Aligned_cols=197 Identities=23% Similarity=0.265 Sum_probs=156.4
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----c
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLEV-----S 172 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~ 172 (317)
+|++.+.||+|+||.||+|.+.. +++.||+|.+............+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999887 789999999875432222223455677766655 79999999998754 3
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..++++|||+. ++|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999995 68988887655566899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...... ....++..|++||.... .....+.|+|++|++++|+..|.|
T Consensus 159 ~~~~~~-----------~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 159 SCQMAL-----------TPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred cCcccC-----------CCccccccccCchHhhC-----CCCCCcchhhhHHHHHHHHHhCCc
Confidence 422110 11134556778876643 234567899999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=251.21 Aligned_cols=195 Identities=16% Similarity=0.225 Sum_probs=160.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec----
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS---- 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 172 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+............+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecC-CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 346899999999999999999998776 789999999976554555667788999999999999999999988543
Q ss_pred --CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 173 --HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 173 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
...|+||||+ .++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 93 EFQDVYLVMELM-DANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ccceeEEEhhhh-cccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 3579999999 456777663 348889999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... .....++..|++||.... .....+.|+|++|++++|+..|
T Consensus 168 ~~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g 214 (355)
T cd07874 168 TAGTSFM-----------MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_pred cCCCccc-----------cCCccccCCccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhC
Confidence 6543211 111244566788876643 2345678999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=255.11 Aligned_cols=192 Identities=21% Similarity=0.203 Sum_probs=159.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
....|.+.+.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|+.++|+||+++++++..++..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECC-CCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999998887 788999996432 235679999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
|||++ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 238 v~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 67888887543 34689999999999999999999999999999999999999999999999999976543221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
. .......++..|++||+.... ....+.|+|+++++++|+..|
T Consensus 316 ~--------~~~~~~~GT~~Y~APE~~~~~-----~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 316 T--------PFHYGIAGTVDTNAPEVLAGD-----PYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred c--------ccccccCCCcCCcCHHHHcCC-----CCCchHHHHHHHHHHHHHHHc
Confidence 1 011122466778888876443 345688999999999998765
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=233.16 Aligned_cols=197 Identities=18% Similarity=0.291 Sum_probs=165.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||++.+.. +++.+|+|.++... .....+.+.+|+.+++.++|+||+++++.+..++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-CCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58899999999999999998877 78999999986543 23455678889999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 157 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA- 157 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc-
Confidence 9999999998876555678999999999999999999999999999999999999999999999999987654322111
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....+...|++||... ........|+|+++++++|+..|.
T Consensus 158 ---------~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 158 ---------CTYVGTPYYVPPEIWE-----NMPYNNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred ---------ccccCCccccCHHHHc-----cCCcCchhhhhhhchhheehhhcc
Confidence 1113444577777653 334567899999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=250.46 Aligned_cols=194 Identities=16% Similarity=0.240 Sum_probs=159.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45899999999999999999998876 789999999976554455567788999999999999999999887533
Q ss_pred -CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 -HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
..+|+||||+ .++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 101 ~~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELM-DANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCC-CCCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 4579999999 567777763 2478899999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... ....++..|++||.... .....+.|+|++|++++|+..|
T Consensus 176 ~~~~~~~-----------~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g 221 (364)
T cd07875 176 AGTSFMM-----------TPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKG 221 (364)
T ss_pred cCCCCcc-----------cCCcccCCcCCHHHHhC-----CCCCchhhHHhHHHHHHHHHhC
Confidence 5332110 11234566788876643 3345689999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=241.11 Aligned_cols=205 Identities=23% Similarity=0.355 Sum_probs=169.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...+.|++++.||.|+||.||+|.+.. ++..+++|.+... .......+.+|+.+++.++|+||+++++.+..++.+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECC-CCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 344679999999999999999998877 7899999998754 4455677889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|..++.+. ...+++..++.++.||+.+|.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999999998877543 3568999999999999999999999999999999999999999999999999986543221
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.. .....+...|++||+...+.........++|+|++|++++|+..|-|
T Consensus 165 ~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 165 QR----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred cc----------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence 11 11123455789999876544333344678999999999999999943
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=243.10 Aligned_cols=210 Identities=46% Similarity=0.738 Sum_probs=170.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||+|.... +++.||+|.+....... .....+.+|+++++.++|+||+++++.+......|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 479999999999999999998877 78999999997754333 4567789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+.+++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999999999997665678999999999999999999999999999999999999999999999999999766443221
Q ss_pred eeccccc-------------------ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGS-------------------ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~-------------------~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....... ........++..|++||+... .....+.|+|++|++++|+..| .|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHhhCCCC
Confidence 1100000 001112234556777776643 3346789999999999999998 44
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=256.22 Aligned_cols=192 Identities=22% Similarity=0.348 Sum_probs=167.7
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
+||+|.||+||.|++.. +...+|||.+... .....+.+..||.+.+.|+|.|||+++|.+..++++-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~-tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-TQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeecccc-ceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 59999999999999988 8889999998654 34555778899999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEEeeecccccCCCCCCeeeccc
Q 042913 187 LHSLLPKQPNNRF--SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 187 L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
|.++++... +++ .+..+-.+..||++||+|||++.|||||||-+|+||+ -.|.+||+|||.++++........|+.
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 999997664 445 7788899999999999999999999999999999997 578999999999999988877777776
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+ .-||+||.+..+.- ..+..+|+||+||+++|+++|-|
T Consensus 738 GT----------LQYMAPEvIDqG~R---GYG~aADIWS~GCT~vEMATGrP 776 (1226)
T KOG4279|consen 738 GT----------LQYMAPEVIDQGPR---GYGKAADIWSFGCTMVEMATGRP 776 (1226)
T ss_pred cc----------hhhhChHhhccCCc---CCCchhhhhhccceeEeeccCCC
Confidence 55 56899887754332 23578999999999999999966
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=239.42 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=168.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|++.+.||+|+||.||++.+.. ++..+++|.+... .......+.+|+++++.++|+||+++++.+...+..|+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 6788899999999999999887 7889999998654 345567788999999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
+++++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--- 159 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--- 159 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc---
Confidence 9999998887543 356899999999999999999999999999999999999999999999999998765322111
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....++..|++||+...+...........|+|+++++++|+..|-|
T Consensus 160 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 160 -------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred -------cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCC
Confidence 11123556799999887555555566788999999999999999843
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=252.42 Aligned_cols=204 Identities=20% Similarity=0.251 Sum_probs=162.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+.. .++..||+|++.... .......+.+|+++++.+ +|+||+++++++.
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456789999999999999999998643 134579999997543 234456788999999999 8999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC-------------------------------------------------------
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------- 195 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 195 (317)
..+.+++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999998874321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecc
Q 042913 196 -------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 196 -------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~-- 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV-- 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee--
Confidence 13478888999999999999999999999999999999999999999999999976543322110
Q ss_pred cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.++ ..+...|++||+... .....++|+|+++++++|+.. |
T Consensus 271 ~~~------~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ellt~G 311 (374)
T cd05106 271 KGN------ARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIFSLG 311 (374)
T ss_pred ccC------CCCccceeCHHHhcC-----CCCCccccHHHHHHHHHHHHhCC
Confidence 000 112345888887643 234578999999999999984 7
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=221.25 Aligned_cols=199 Identities=25% Similarity=0.333 Sum_probs=161.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.|.-.++||+|.||+||+++.++ +++.||+|.++.+...+.......+|+.+|+.++|.|||++++....++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~-t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC-ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999999888 89999999999877666666778999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|| ..+|..++... ++.+..+.++.++.|+++||.++|+++++||||||.|+||+.+|.+||+|||+|+.++....-..
T Consensus 82 ~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred Hh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99 88898888654 57799999999999999999999999999999999999999999999999999998765432222
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVPR 316 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p~ 316 (317)
..+.+ -|++ ..---||+--| .-..|+|+.+|++.|++. |-|+
T Consensus 160 aevvt-lwyr--ppdvlfgakly-----------~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 160 AEVVT-LWYR--PPDVLFGAKLY-----------STSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred ceeee-eecc--Ccceeeeeehh-----------ccchHhhhcchHHHHHhhcCCCC
Confidence 22211 1111 11112233222 356789999999999875 4554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=252.08 Aligned_cols=204 Identities=20% Similarity=0.231 Sum_probs=161.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+. ..++..||+|+++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 345668999999999999999999752 2256789999986543 233446788999999999 8999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC-------------------------------------------------------
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------- 195 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 195 (317)
..+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999998885421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 196 ------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 196 ------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12467888999999999999999999999999999999999999999999999976644322
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
... .+ .......|++||..... ......|+|+++++++|+.. |
T Consensus 270 ~~~--~~------~~~~~~~y~aPE~~~~~-----~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 270 YVV--KG------NARLPVKWMAPESIFNC-----VYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred ccc--cC------CCCCCcceeChhHhcCC-----CCCCCCCHHHHHHHHHHHHhcC
Confidence 110 00 01123457777766432 34577999999999999875 5
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=237.89 Aligned_cols=199 Identities=19% Similarity=0.284 Sum_probs=164.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.+++.++|+||+++++.+..++.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34689999999999999999999876 78899999987542 2334567889999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999999998854 35689999999999999999999999999999999999999999999999999976542211
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......+...|++||...... ........|+|+++++++|+..|
T Consensus 162 ----------~~~~~~~~~~y~~PE~~~~~~--~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 162 ----------KRKSFIGTPYWMAPEVAAVEK--NGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ----------ccCccccCccccCHhHccccc--CCCCcchhhHHHHHHHHHHHHhC
Confidence 111123455688888764321 11234678999999999999888
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=238.90 Aligned_cols=194 Identities=32% Similarity=0.541 Sum_probs=165.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.+.. +++.||+|++...... ......+.+|+++++.++||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 479999999999999999999887 7899999999765332 34567789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-- 155 (290)
T cd05580 80 MEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-- 155 (290)
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence 9999999999999654 678999999999999999999999999999999999999999999999999987654321
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....+...|++||..... ......|+|+++++++|+..|.
T Consensus 156 -----------~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~ 195 (290)
T cd05580 156 -----------YTLCGTPEYLAPEIILSK-----GYGKAVDWWALGILIYEMLAGY 195 (290)
T ss_pred -----------CCCCCCccccChhhhcCC-----CCCccccHHHHHHHHHHHHhCC
Confidence 112344567778766432 3456789999999999999993
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=245.58 Aligned_cols=204 Identities=17% Similarity=0.240 Sum_probs=163.1
Q ss_pred Eeeeeccc--CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 104 LVRHLGTG--NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 104 i~~~lg~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
++++||+| +|++||++.... +++.||+|.+............+++|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45679999 789999998887 899999999977654555667788999999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
+++++|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 99999999996654456899999999999999999999999999999999999999999999999976543221110000
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. .......+...|++||+...+... ...++|+|+++++++|+..|.
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~---~~~~~DiwslG~il~el~~g~ 207 (327)
T cd08227 161 VH---DFPKYSVKVLPWLSPEVLQQNLQG---YDAKSDIYSVGITACELANGH 207 (327)
T ss_pred cc---cccccccceecccChHHhhcccCC---CCchhhHHHHHHHHHHHHHCC
Confidence 00 001112334568888887543222 346789999999999999993
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=235.65 Aligned_cols=199 Identities=24% Similarity=0.328 Sum_probs=165.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+.|++.+.||+|++|.||+|.... +++.|++|.+...... ......+.+|+++++.++||||+++++++..+...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC-CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 468899999999999999998776 7899999998754322 234567889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+|+||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998653 568899999999999999999999999999999999999999999999999997654321
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ......+...|.+||...... ...+.|+|+++++++|+..|
T Consensus 159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 159 SSGT-------GMKSVTGTPYWMSPEVISGEG-----YGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred cccc-------cccCCCcCccccCcceeccCC-----CCchhhhHHHHHHHHHHHhC
Confidence 1100 001123445688888775432 56789999999999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.92 Aligned_cols=194 Identities=21% Similarity=0.274 Sum_probs=160.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+++++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4789999999999999999998877 788999999976544444556778899999999999999999887532
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899888743 56999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ...++..|++||.... ........|+|++|++++|+..|-
T Consensus 169 ~~~~~-------------~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~ 213 (343)
T cd07878 169 DDEMT-------------GYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGK 213 (343)
T ss_pred CCCcC-------------CccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCC
Confidence 43211 1134556778876532 123456899999999999999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=241.11 Aligned_cols=201 Identities=22% Similarity=0.339 Sum_probs=169.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||.|+||.||++.+.. ++..+|+|++... .....+.+.+|+++++.++|+||+++++.+..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 568999999999999999998876 7899999998754 3455577889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 999999999998653 356899999999999999999999999999999999999999999999999998765332211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||....+.........++|+|+++++++|+..|-
T Consensus 160 ---------~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~ 205 (280)
T cd06611 160 ---------RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205 (280)
T ss_pred ---------cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence 1112345568888887655444445567899999999999999994
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=233.92 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=170.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh------hcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL------LSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
+.|.-.+.||.|..+.|-+|..+. ++..+|+|++.... ......+.-..|+.||+++ .||||+++.++++.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~-t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKE-TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcc-cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 445556669999999999998877 88899999886421 1123445667899999998 499999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+++|+|.|+.|.|+|++.. .-.++++..+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+|.++
T Consensus 96 sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999955 477999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.+...+. ...|+.||.+||....+..+ ....+...|+|+.+.+++-+..|-|
T Consensus 174 ~~GekLr-----------elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 174 EPGEKLR-----------ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred CCchhHH-----------HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 7765432 23577899999988766444 3344677889999999999999954
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=235.57 Aligned_cols=200 Identities=22% Similarity=0.307 Sum_probs=165.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|+++++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN--STKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC--CceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 556899999999999999999998664 6789999876532 23467889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999976656678999999999999999999999999999999999999999999999999997654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
... .....+...|++||+.... ......|+|+++++++|+.. | .|
T Consensus 158 ~~~---------~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 158 YTA---------REGAKFPIKWTAPEAINFG-----SFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred eec---------cCCCccceecCCHHHhccC-----CCChhhhhhhhHHHHHHHHccCCCC
Confidence 110 0111234568888876432 23457899999999999996 6 44
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=236.23 Aligned_cols=199 Identities=18% Similarity=0.219 Sum_probs=164.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+...+|.+.+.||+|+||.||+|.+.+ .+..|++|++... ......+.+|+++++.++|+||+++++++..+..++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEec-CCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 456789999999999999999999877 7889999998654 223457888999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999876555668999999999999999999999999999999999999999999999999997654321
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
... ........+|++||+... .......|+|+++++++|+.. |
T Consensus 159 ~~~---------~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 159 YTA---------HAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred eec---------cCCCCCccccCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCC
Confidence 110 001122345778876643 334567899999999999986 6
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=261.83 Aligned_cols=205 Identities=20% Similarity=0.304 Sum_probs=160.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEE-EE----
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAH-LE---- 170 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~---- 170 (317)
+...+++|.+.|.+|||+.||+|.+.. .+..||+|.+-.. ++..++.+.+|+++|+.|. |+|||.+++. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 445678899999999999999999987 5599999998765 6788899999999999998 9999999993 21
Q ss_pred -e-cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCcEEEeee
Q 042913 171 -V-SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 171 -~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~~kl~DF 246 (317)
. .-+++|+||||.||.|-|++..+....|++.++++|+.|+|+|+.+||..+ |||||||-+||||..+|..|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 235789999999999999998766677999999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccc---eeccchhhhccCCccccccc
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME---FVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~---~~~~~~~~~~~~~~~~~~e~ 310 (317)
|.|...-...+ ....+...... -.-|-+|-|+++|+.+ ...=..+.|+|+|||+++-+
T Consensus 191 GSatt~~~~~~-~~~e~~~ve~e-----I~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 191 GSATTKILSPT-SAQEVNYVEEE-----IEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred cccccccCCCc-cHHHHHHHHHH-----HHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 99854332221 01111111122 2234445555544433 33447889999999987654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=234.48 Aligned_cols=198 Identities=23% Similarity=0.275 Sum_probs=163.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|++|.||+|.+.. ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN--TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC--CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456789999999999999999998654 57899999875432 2356788999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999976555678999999999999999999999999999999999999999999999999998765221
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.. ...+ ......|++||+.... ....++|+|+++++++|+.. |
T Consensus 158 ~~--~~~~-------~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 158 YE--AREG-------AKFPIKWTAPEAALYN-----RFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred cc--ccCC-------CcCceeccCccccccC-----CCCchhhHHHHHHHHHHHHhcC
Confidence 10 1111 0112467888866432 34567999999999999987 6
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=234.14 Aligned_cols=198 Identities=22% Similarity=0.293 Sum_probs=160.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+++++.++||||+++++++......++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc--CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34679999999999999999998764 568999988654322 3467889999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999999986542 4589999999999999999999999999999999999999999999999999876532221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
... . .......|++||+.. ......+.|+|+++++++|+.. | .|
T Consensus 156 ~~~--~-------~~~~~~~y~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 156 TSS--S-------GAKFPVKWSPPEVFN-----FSKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred ecc--C-------CCCCchhhCChhhcc-----cCccchhhhhHHHHHHHHHHHcCCCCC
Confidence 100 0 011223577777654 3345678999999999999987 6 44
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-35 Score=238.03 Aligned_cols=200 Identities=23% Similarity=0.315 Sum_probs=166.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..+.|.+.++||+|.|+.||+|.... +|+.+|+|+++...+.....+++.+|+.|.+.|+||||+++.+.+...++.|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~-tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc-chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345678899999999999999997776 8999999999887777778899999999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~a~~~~ 253 (317)
||||++.|++|..-|-.+ ..+++..+-.+++||+++|.|+|.+||||||+||+|+|+-. .--+||+|||+|.++.
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997665443 55789999999999999999999999999999999999953 3369999999999876
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ..|..-|+|.|.++++..-...+.-.|+|+-+.++.=+..| +|
T Consensus 165 -~g~---------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 165 -DGE---------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred -Ccc---------------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCC
Confidence 222 22333344445554555555666778899988888777777 44
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=274.26 Aligned_cols=204 Identities=23% Similarity=0.313 Sum_probs=175.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|+-.-.||.|.||.||-|.+.+ +|+..|+|.+............+.+|..++..++|||+|++||+-.+.+..++.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~-tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCC-ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 56667789999999999998888 89999999998766556677889999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
||++|+|.+++.. +...++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|+++........
T Consensus 1315 yC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999954 45677888888899999999999999999999999999999999999999999988876532221
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.+-..-.|+..||+||.+.+-.- ....+.+|+|++||+.+||+.| -|
T Consensus 1393 ------~el~~~~GT~~YMAPEvit~t~~--kG~~~A~DiWslGCVVlEM~tGkrP 1440 (1509)
T KOG4645|consen 1393 ------GELQSMMGTPMYMAPEVITGTKG--KGHGGAADIWSLGCVVLEMATGKRP 1440 (1509)
T ss_pred ------HHHHhhcCCchhcCchhhccccc--CCCCcchhhhcccceEEEeecCCCc
Confidence 12223478888999998865433 3457899999999999999999 55
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=248.81 Aligned_cols=207 Identities=21% Similarity=0.226 Sum_probs=162.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHL 169 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 169 (317)
..+..++|++++.||+|+||.||+|.+.. ..+..||||++.... .....+.+.+|+++++.+. ||||+++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34567899999999999999999998643 123579999996542 3344567899999999996 99999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCC------------------------------------------------------
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------ 195 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------ 195 (317)
...+.+|+||||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998875421
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 042913 196 ----------------------------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235 (317)
Q Consensus 196 ----------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill 235 (317)
...+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1247788889999999999999999999999999999999
Q ss_pred ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-
Q 042913 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G- 313 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G- 313 (317)
+.++.+||+|||+++.......... .....++..|++||..... ....+.|+|+++++++|+.. |
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVS--------KGSTFLPVKWMAPESIFDN-----LYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccc--------cCCcCCCcceEChhhhcCC-----CCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999976543221100 0011233457777765432 23567899999999999863 4
Q ss_pred CC
Q 042913 314 VP 315 (317)
Q Consensus 314 ~p 315 (317)
.|
T Consensus 338 ~P 339 (400)
T cd05105 338 TP 339 (400)
T ss_pred CC
Confidence 55
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=238.12 Aligned_cols=199 Identities=19% Similarity=0.256 Sum_probs=162.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|++|.||+|.... ++..||+|.+............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999998876 78999999987654333444678889999999999999999999999999999999
Q ss_pred ccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 181 YCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|++ ++|.+++.... +..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++.........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV- 157 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc-
Confidence 995 68888875533 356899999999999999999999999999999999999999999999999999765432111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....+...|++||...... ......|+|++|++++|+..|.|
T Consensus 158 ---------~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 158 ---------YTHEVVTLWYRAPEVLLGSP----RYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred ---------ccCCcccccccChHHhcCCC----CcCcHHHHHHHHHHHHHHHHCCC
Confidence 01113345688888654321 22467899999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=232.97 Aligned_cols=197 Identities=23% Similarity=0.288 Sum_probs=167.4
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++++.||.|+||.||.+.... +++.+++|.+............+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999998877 78999999987665556666788899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~- 158 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA- 158 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc-
Confidence 9999999999976555678999999999999999999999999999999999999999999999999997664433211
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....+...|.+||+... ......+|+|+++++++|+..|
T Consensus 159 ---------~~~~~~~~y~ape~~~~-----~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 159 ---------ETVVGTPYYMSPELCQG-----VKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred ---------cccCCCccccCHhhcCC-----CCCCCcchhHHHHHHHHHHHHC
Confidence 11234455677776542 2344678999999999999888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=231.79 Aligned_cols=197 Identities=20% Similarity=0.254 Sum_probs=164.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-SHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 179 (317)
.|++.+.||+|++|.||++.+.. +++.||+|.+..........+.+.+|+++++.++|+|++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999876 68899999997765555666778999999999999999999988764 45689999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM- 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc-
Confidence 9999999999997655567899999999999999999999999999999999999999999999999998765432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.....+...|++||... ........|+|+++++++|+..|
T Consensus 159 ---------~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 159 ---------ASTLIGTPYYMSPELFS-----NKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred ---------cccccCCcCccChhHhc-----CCCCCchhhhHHHHHHHHHHHcC
Confidence 11123445577777653 33445678999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=241.21 Aligned_cols=200 Identities=18% Similarity=0.222 Sum_probs=159.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+...+|++.+.||+|+||.||+|.+.. ++. .||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 456789999999999999999998764 333 48999986432 344556788999999999999999999998764
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..++++||+++|+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 568999999999999998754 345889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.......... .......|++||+... .....+.|+|+++++++|+.. |
T Consensus 160 ~~~~~~~~~~--------~~~~~~~y~apE~~~~-----~~~~~~~Di~slGv~l~el~t~g 208 (316)
T cd05108 160 GADEKEYHAE--------GGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFG 208 (316)
T ss_pred cCCCcceecc--------CCccceeecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCC
Confidence 5433211110 0112345778877643 234578899999999999764 5
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=236.71 Aligned_cols=204 Identities=20% Similarity=0.262 Sum_probs=163.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC---CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD---CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+...+|++.+.||+|+||.||+|.+.. ..+..|++|.+.... .......+.+|+++++.++|+||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 345789999999999999999998632 245789999987543 3445567889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP---------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999884321 2347888899999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
+.+||+|||+++........... ....+...|++||+... .....+.|+|+++++++|+.. |.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~~g~ 224 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQ--------PKSLLPIRWMPPEAIMY-----GKFSSDSDIWSFGVVLWEIFSFGL 224 (283)
T ss_pred CcEEeccccccccccCCcceecc--------cCCCccceecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999765432211000 01122345888887643 234578999999999999997 74
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=236.39 Aligned_cols=199 Identities=20% Similarity=0.301 Sum_probs=164.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|+++.. .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34688899999999999999998876 7899999998755 23344567889999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999999999855 35789999999999999999999999999999999999999999999999999876532211
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
. .....++..|++||+..... .......+|+|+++++++|+..|
T Consensus 162 ~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 162 K----------RKSFIGTPYWMAPEVAAVER--KGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred c----------cccccCcccccChhhhcccc--CCCCCchhhhHHHHHHHHHHhcC
Confidence 1 11123556788888753211 11234678999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=234.87 Aligned_cols=189 Identities=24% Similarity=0.322 Sum_probs=158.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468899999999999999998876 78999999987643 3344567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~-- 150 (279)
T cd06619 79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-- 150 (279)
T ss_pred ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc--
Confidence 99999988654 2368889999999999999999999999999999999999999999999999976532210
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....++..|++||+... .....+.|+|+++++++|+..|
T Consensus 151 ----------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g 189 (279)
T cd06619 151 ----------KTYVGTNAYMAPERISG-----EQYGIHSDVWSLGISFMELALG 189 (279)
T ss_pred ----------cCCCCChhhcCceeecC-----CCCCCcchHHHHHHHHHHHHhC
Confidence 11134456777776643 3456789999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=238.46 Aligned_cols=202 Identities=25% Similarity=0.347 Sum_probs=160.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
.+..++|++.+.||+|+||.||+|.+.. ++. .+++|.+... ........+.+|++++.++ +|+||+++++++..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 4567899999999999999999998876 454 4566666432 2345556788899999999 899999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
+.+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999986431 2357899999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+.+||+|||+++...... . .........|++||+.... ....+.|+|++|++++|+.. | .|
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~--------~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~p 223 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---K--------KTMGRLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLWEIVSLGGTP 223 (303)
T ss_pred CcEEeCccccCcccchhh---h--------cccCCCcccccCHHHHhcc-----CCcccccchhhhhHHHHHHhcCCCC
Confidence 999999999986322110 0 0011123457888866432 23567999999999999985 5 44
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=245.32 Aligned_cols=202 Identities=21% Similarity=0.276 Sum_probs=165.6
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCC---ceEEEEEeeh-hhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS---ANFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+...+..+.++||+|+||.||+|.+....+ ..||+|..+. .......+.++.+|+++|+.++|||||++||+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455677778999999999999999876323 2389999875 3356788899999999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
....+++|||+|.||+|.++|++.. ..++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999999998763 369999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
....- ....... .---.|.+||..... -.....|+|+.|.+++|...
T Consensus 311 ~~~~~-~~~~~~~---------klPirWLAPEtl~~~-----~~s~kTDV~sfGV~~~Eif~ 357 (474)
T KOG0194|consen 311 AGSQY-VMKKFLK---------KLPIRWLAPETLNTG-----IFSFKTDVWSFGVLLWEIFE 357 (474)
T ss_pred CCcce-eeccccc---------cCcceecChhhhccC-----ccccccchhheeeeEEeeec
Confidence 65410 0000000 112357788776554 34467899999999999887
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=236.57 Aligned_cols=208 Identities=25% Similarity=0.440 Sum_probs=165.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.+.. +++.|++|.+...... ......+.+|+++++.++||||+++++.+..++.+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 478999999999999999998877 7899999998765332 24456788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++........
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999999653 56899999999999999999999999999999999999999999999999998743221111
Q ss_pred ee--cccc---cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VE--TNVG---SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~--~~~~---~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. .... .........++..|++||+... .....+.|+|+++++++|+..| .|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g~~p 215 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVP 215 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 00 0000 0000011234556888887543 2345778999999999999998 44
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=238.51 Aligned_cols=200 Identities=22% Similarity=0.286 Sum_probs=162.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 45789999999999999999998876 788999999865422 2223456789999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 999995 6898888654 35688999999999999999999999999999999999999999999999999875433221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.. ....+...|++||..... .......|+|+++++++|+..|-|
T Consensus 160 ~~----------~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 160 TY----------SNEVVTLWYRPPDILLGS----TDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred cc----------cccceeecccCcHHHhCC----CCCccHHHHHHHHHHHHHHHhCCC
Confidence 10 111334567778765422 234567899999999999999944
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=233.21 Aligned_cols=204 Identities=22% Similarity=0.271 Sum_probs=162.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...+|++.+.||+|+||.||+|.+... .+..+|+|.+.... .......+.+|+.+++.++||||+++++++..++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 346899999999999999999987642 23479999886543 334456889999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999999654 356899999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.....+.. .......|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 160 ~~~~~~~~-------~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g~~p 209 (267)
T cd05066 160 PEAAYTTR-------GGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERP 209 (267)
T ss_pred cceeeecC-------CCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCCCCC
Confidence 32111111 0111234677776643 344578999999999999664 6 44
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.03 Aligned_cols=198 Identities=24% Similarity=0.297 Sum_probs=161.3
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC--CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45689999999999999999998764 556999988754322 3567889999999999999999999998889999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||.||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999999986542 3689999999999999999999999999999999999999999999999999876533221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
. ...+ ..+...|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 156 ~--~~~~-------~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p 201 (256)
T cd05113 156 T--SSVG-------SKFPVRWSPPEVLLY-----SKFSSKSDVWAFGVLMWEVYSLGKMP 201 (256)
T ss_pred e--ecCC-------CccChhhCCHHHHhc-----CcccchhHHHHHHHHHHHHhcCCCCC
Confidence 1 1111 123345778877643 234567999999999999986 6 55
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=235.80 Aligned_cols=200 Identities=21% Similarity=0.298 Sum_probs=164.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe------c
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV------S 172 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~ 172 (317)
+.|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467888899999999999998877 78999999986542 2235678899999998 69999999999864 3
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|++|||+.+++|.+++.......+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999997655567899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... .....++..|++||+...+...........|+|+++++++|+..|
T Consensus 162 ~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 162 DRTVGR----------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred cccccc----------CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 432211 112245667889988754333333445689999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=229.08 Aligned_cols=193 Identities=21% Similarity=0.299 Sum_probs=158.5
Q ss_pred cCCeEEe-eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----c
Q 042913 99 LRHLKLV-RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV----S 172 (317)
Q Consensus 99 ~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~ 172 (317)
.++|.+. ++||-|-.|+|..|..+. +++.+|+|++... .+.++|+++.... .|+|||.++++|+. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~-T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKR-TQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEecc-chhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3556654 578999999999998777 9999999998543 4567889887666 49999999999853 4
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeeccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDLC 249 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~a 249 (317)
..+.+|||.++||.|+..+..+..+.|++.++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 56889999999999999999988888999999999999999999999999999999999999974 557999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+.-... ....+.+.| ..|.+||....+- .+..+|+|+++..++=+.||.|
T Consensus 212 K~t~~~-~~L~TPc~T----------PyYvaPevlg~eK-----ydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFT----------PYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred cccCCC-ccccCCccc----------ccccCHHHhCchh-----cCCCCCccchhHHHHHhhcCCC
Confidence 876542 233444433 3466666554332 4578899999999999999977
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=232.03 Aligned_cols=201 Identities=23% Similarity=0.323 Sum_probs=163.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh---hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 174 (317)
.+|++.+.||+|+||.||++.+.. +++.|++|.+.... ........+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 578999999999999999998876 78999999886432 123456788999999999999999999998865 356
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
++++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 88999999999999998653 5588899999999999999999999999999999999999999999999999876543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... ......++..|++||..... ....+.|+|+++++++|+..| .|
T Consensus 159 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 159 ICLSGT-------GMKSVTGTPYWMSPEVISGE-----GYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred cccccc-------ccccCCCCccccChhhhcCC-----CCCcchhHHHHHHHHHHHhhCCCC
Confidence 211000 01112355678888876432 335789999999999999998 44
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=237.44 Aligned_cols=193 Identities=23% Similarity=0.281 Sum_probs=162.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... ......++.+|+++++.++||||+++++.+..++.+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-CCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 479999999999999999998877 78899999986542 3445567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++........
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 155 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc-
Confidence 999999999999654 668999999999999999999997 5999999999999999999999999999865432110
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....+...|.+||.... .....++|+|+++++++|+..|
T Consensus 156 -----------~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 156 -----------NSFVGTRSYMSPERLQG-----THYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred -----------ccCCCCcCccChhHhcC-----CCCCccchHHHHHHHHHHHHhC
Confidence 01134456777776532 3345679999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=242.56 Aligned_cols=192 Identities=26% Similarity=0.378 Sum_probs=161.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
+.||.|.||+||-|+.++ +|+.||||++.+..+..+....+++|+.||+.++||.||.+-..|+..+.+|+|||-+ +|
T Consensus 570 evLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecc-cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 569999999999999988 9999999999988777777789999999999999999999999999999999999999 77
Q ss_pred ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC---CcEEEeeecccccCCCCCCeeecc
Q 042913 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED---GHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 186 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~---~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
++.+.|-....+++++...+.++.||+.||+|||-++|+|+||||+|||+... -.+||||||+|+.+++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 77776666667899999999999999999999999999999999999999643 379999999999775533
Q ss_pred cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+|+-..|+..|.+|| +..-+...|.-|+|+-+.+++--.-| +|
T Consensus 722 -----FRrsVVGTPAYLaPE-----VLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPE-----VLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred -----hhhhhcCCccccCHH-----HHhhccccccccceeeeEEEEEEeccccc
Confidence 334445555555555 55555556778899988877765555 44
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=232.80 Aligned_cols=200 Identities=18% Similarity=0.219 Sum_probs=164.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||+|.... +++.||+|.+.... ........+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 689999999999999999998877 78999999886532 2345556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||+++++|.+++... ....+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999999887532 23457899999999999999999999999999999999999999999999999987654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... ...+...|++||+... .......|+|+++++++|+..| .|
T Consensus 161 ~~~~----------~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p 205 (267)
T cd08228 161 TAAH----------SLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred HHHh----------cCCCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 1111 1123445777776643 2345678999999999999988 44
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=241.48 Aligned_cols=205 Identities=21% Similarity=0.273 Sum_probs=170.9
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 174 (317)
.++...|+++++||.||.+.||++...+ .+.+|+|.+.....+.+.+.-+.+|+.+|.+|+ |.+||++|+|-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~--~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD--KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC--CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4667899999999999999999997654 678888888777778888999999999999997 8999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|||||+- ..+|..+|+... ...+...++.+..||+.|++++|+.||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99999987 789999997653 33343478889999999999999999999999999999975 8999999999988766
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccc------eeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME------FVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~------~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..+. ..+.-..|+..||+||-....-.. -.--.+..|+||+||++++|.=|
T Consensus 512 DTTs--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 512 DTTS--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred cccc--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 5543 223334677889999986533221 12247899999999999999877
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=245.13 Aligned_cols=189 Identities=21% Similarity=0.296 Sum_probs=156.2
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
....|++++.||+|+||.||+|.... +++.||+|+.... ....|+.+++.++|+||+++++++......++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 34579999999999999999999877 7889999986433 23468999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
|||++ .++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 135 v~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 99999 67888887543 45689999999999999999999999999999999999999999999999999864322111
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
. ....++..|++||..... ....+.|+|++|++++|+..|
T Consensus 213 ~-----------~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvvl~ell~~ 252 (357)
T PHA03209 213 F-----------LGLAGTVETNAPEVLARD-----KYNSKADIWSAGIVLFEMLAY 252 (357)
T ss_pred c-----------ccccccccccCCeecCCC-----CCCchhhHHHHHHHHHHHHHc
Confidence 0 112456678888876432 335678999999999998753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=231.60 Aligned_cols=201 Identities=20% Similarity=0.248 Sum_probs=162.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
..++|++.+.||+|+||.||+|.+... +...||+|.+.... .......+.+|+.+++.++|+||+++++.+...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 346799999999999999999988642 24589999986543 344456788899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999998654 346899999999999999999999999999999999999999999999999999877522
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.....+. .......|++||+.... ....+.|+|+++++++|+.. |
T Consensus 160 ~~~~~~~--------~~~~~~~y~~Pe~~~~~-----~~~~~~Dv~slG~~l~~l~~~g 205 (266)
T cd05033 160 EATYTTK--------GGKIPIRWTAPEAIAYR-----KFTSASDVWSFGIVMWEVMSYG 205 (266)
T ss_pred ccceecc--------CCCCCccccChhhhccC-----CCccccchHHHHHHHHHHHccC
Confidence 2111111 01122457778766533 33567899999999999765 6
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=235.58 Aligned_cols=204 Identities=21% Similarity=0.302 Sum_probs=162.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|..... ....|++|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3456899999999999999999987641 22679999886542 344556789999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPN--------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
+..|++|||+++++|.+++..... ..+++..++.++.||+.||.|||+.+++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999998865311 457889999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
+.++|+|||+++......... ......+...|++||+.... ....+.|+|+++++++|+.. |.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~slG~il~el~~~g~ 224 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYR--------VQSKSLLPVRWMPPEAILYG-----KFTTESDIWSFGVVLWEIFSYGL 224 (283)
T ss_pred CcEEECCCcceeecccccccc--------ccCCCcccccccCHHHhccC-----cCchhhhHHHHHHHHHHHHcCCC
Confidence 999999999997543221110 00111233558888876432 23467899999999999975 73
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=233.59 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=166.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||+|.+.. ++..|++|++............+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999876 68999999998765444556778999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+ +++|.+++... ...+++..++.++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-- 155 (286)
T cd07832 80 YM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-- 155 (286)
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC--
Confidence 99 99999998654 366899999999999999999999999999999999999999999999999998766433210
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
......++..|++||+.... .......|+|++|++++|+..|.|
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~ 199 (286)
T cd07832 156 -------LYSHQVATRWYRAPELLYGA----RKYDPGVDLWAVGCIFAELLNGSP 199 (286)
T ss_pred -------ccccccCcccccCceeeecc----ccCCchhHHHHHHHHHHHHHcCCc
Confidence 01112455568888865321 123568999999999999999954
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=236.74 Aligned_cols=202 Identities=22% Similarity=0.374 Sum_probs=167.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++++.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+++++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 468899999999999999999886 78999999886542 3444577889999999999999999999999999999999
Q ss_pred cccCCCChhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 180 DYCPNGDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 180 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||+++++|..++... ....+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999999888542 12468999999999999999999997 5999999999999999999999999999876532211
Q ss_pred eeecccccccccccccccCCCCCccccccccc-ceeccchhhhccCCcccccccCCC-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVM-EFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~-~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++.+|++||....... .........|+|+++++++|+..| .|
T Consensus 159 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 206 (286)
T cd06622 159 ------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206 (286)
T ss_pred ------------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence 11235567899998754433 233446789999999999999998 55
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=229.08 Aligned_cols=200 Identities=22% Similarity=0.320 Sum_probs=166.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||.|+||.||+|.... +++.+++|++.... ......+.+|+++++.++||||+++++.+...+.+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999998876 67899999997653 33567889999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999988653 256899999999999999999999999999999999999999999999999998765432111
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|++||....... ......+|+|++++.++|+..|.
T Consensus 158 ----------~~~~~~~~~y~~Pe~~~~~~~--~~~~~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 158 ----------RKSFIGTPYWMAPEVAAVERK--GGYDGKCDIWALGITAIELAELQ 201 (262)
T ss_pred ----------cccccCCccccCchhhccccc--CCcCchhhhHHHHHHHHHHHhCC
Confidence 111234556888887653311 23346789999999999999994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=250.23 Aligned_cols=194 Identities=22% Similarity=0.259 Sum_probs=163.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|.-++.||.|+||.||-|.+.. +.+.||||.+.... ...+.-..+..|+..|+.++|||++.+-|+|..+...||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC-ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 46677889999999999999887 78999999986532 23344567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||| -|+-.|++.-. .+++.+-.+..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|-...+..++
T Consensus 106 EYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF- 182 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF- 182 (948)
T ss_pred HHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcc-
Confidence 999 77777777544 467889999999999999999999999999999999999999999999999999777665554
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.|+..||+||.+- .+.-....-+.|+||+|++-||++.-
T Consensus 183 -------------vGTPywMAPEVIL--AMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 183 -------------VGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred -------------cCCccccchhHhe--eccccccCCccceeeccchhhhhhhc
Confidence 4556699999763 12222335678899999999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=234.89 Aligned_cols=203 Identities=19% Similarity=0.232 Sum_probs=163.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+...+|.+.+.||+|+||.||++.... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 456789999999999999999997532 24567899988654 344556789999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcE
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP-----------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHI 241 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~ 241 (317)
+.+++||||+++++|.+++.... ...+++..++.++.||+.||+|||+.|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999886431 2348999999999999999999999999999999999999999999
Q ss_pred EEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 242 MLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 242 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
+|+|||+++........... ....+...|++||+... .....++|+|+++++++|+.. |.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVG--------GHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred EeccCCccccccCCceeecC--------CCCCccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999765432211000 01122345777776532 334568999999999999997 63
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=230.50 Aligned_cols=203 Identities=20% Similarity=0.251 Sum_probs=161.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCC---ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTS---ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..++|++.+.||+|+||.||+|.+.. ++ ..||+|.+.... .......+..|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKL-PGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEec-CCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 34679999999999999999998875 33 369999986542 34556789999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||+++++|.+++... .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999998654 35689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
..... ..... ........|++||+.. ......+.|+|+++++++|+.. |
T Consensus 159 ~~~~~-~~~~~----~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~e~l~~g 208 (269)
T cd05065 159 DTSDP-TYTSS----LGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYG 208 (269)
T ss_pred Ccccc-ccccc----cCCCcceeecCHhHhc-----cCcccchhhhhhhHHHHHHHhcCC
Confidence 22110 00000 0000122467777654 3344568999999999999653 6
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=233.44 Aligned_cols=204 Identities=22% Similarity=0.304 Sum_probs=164.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE-----e
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE-----V 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~ 171 (317)
..++|++.+.||+|+||.||+|.+.. +++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECC-CCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 45789999999999999999998877 78899999876431 2234577899999999 6999999999873 4
Q ss_pred cCEEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
+..+++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4678999999999999988753 22356889999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+........ .....++..|++||+...+..........+|+|+++++++|+..| .|
T Consensus 172 ~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p 228 (286)
T cd06638 172 AQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228 (286)
T ss_pred eecccCCCc----------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCC
Confidence 766432211 111235667889988754433333446789999999999999988 44
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=243.51 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=169.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..+-|.+.+.||+|-|.+|.+|++.- +|+.||||++.+..+..-...++..|++.|+.++|||||++|++...+..+||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 35678899999999999999998776 89999999999887777777789999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEEeeecccccCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl~DFG~a~~~~~~~ 256 (317)
|+|+-++|+|++||-+. ...+.+..+++++.||+.||.|+|+..||||||||+|+++. +-|-|||.|||++.++.+..
T Consensus 95 iLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999776 46699999999999999999999999999999999999886 57899999999998887766
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.+ .+.||. ..|-+||-.-+.- | .-...|+|+++.+++=+-||.|
T Consensus 174 kL-~TsCGS----------LAYSAPEILLGDs--Y--DAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 174 KL-TTSCGS----------LAYSAPEILLGDS--Y--DAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred hh-hcccch----------hhccCchhhhcCc--c--CCcchhhhHHHHHHHHHHhCCC
Confidence 54 333332 3455665432211 1 1245689999999999999944
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=238.81 Aligned_cols=195 Identities=20% Similarity=0.241 Sum_probs=149.9
Q ss_pred eeeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCEEEEEEcc
Q 042913 105 VRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHYICFLIDY 181 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 181 (317)
.++||+|+||.||+|.... .+++.||+|.+..... ...+.+|+++++.++||||+++++++.. +..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 3569999999999998653 2568899999865422 2346789999999999999999998853 5678999999
Q ss_pred cCCCChhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE----ccCCcEEEeeecccc
Q 042913 182 CPNGDLHSLLPKQ-------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----REDGHIMLSDFDLCF 250 (317)
Q Consensus 182 ~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----~~~~~~kl~DFG~a~ 250 (317)
+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 66887776432 12358999999999999999999999999999999999999 456789999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.......... ......++..|++||..... .......|+|++|++++|+..|.|
T Consensus 161 ~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 161 LFNSPLKPLA-------DLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred ccCCCCcccc-------ccCCccccccccCCHHHcCC----CCcCchhhHHHHHHHHHHHHhCCC
Confidence 6543221100 11122445667888765431 224577899999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=232.33 Aligned_cols=201 Identities=20% Similarity=0.306 Sum_probs=160.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHH-HHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI-LSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.+.. +++.||+|.+......... ..+..|+.+ ++.++|+||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 478999999999999999999887 7999999999765433333 344445554 6777899999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|||+ .++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++..+...
T Consensus 79 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999 47887776432 235689999999999999999999997 9999999999999999999999999998765321
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. ......++..|++||....... ......+.|+|++|++++|+..| .|
T Consensus 158 ~-----------~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 158 V-----------AKTIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred c-----------ccccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhCCCC
Confidence 1 0111245667888987754322 12335678999999999999999 45
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=233.13 Aligned_cols=198 Identities=25% Similarity=0.304 Sum_probs=157.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEc---CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 174 (317)
+.|++.+.||+|+||+||++... ..++..||+|++.... .......+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 34499999999999999887532 2257789999987542 23345677889999999999999999998764 346
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
++++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 8999999999999999854 3589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... .....+...|++||.... .....+.|+|+++++++|+..|
T Consensus 160 ~~~~~~~-------~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 160 GHEYYRV-------REDGDSPVFWYAVECLKE-----NKFSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred cchhhcc-------CCCCCCCceeeCHhHhcc-----cCCCcccccHHHHHHHHHHHhC
Confidence 2211000 001122334677776543 2345788999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=232.50 Aligned_cols=200 Identities=25% Similarity=0.326 Sum_probs=159.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEc---CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cC
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SH 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 173 (317)
..+|++.+.||+|+||.||+|... ..+++.||+|.+... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 358999999999999999999753 236789999998654 34555778999999999999999999998643 35
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 689999999999999998653 2458999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ .........|++||+... .....+.|+|+++++++|+..|
T Consensus 160 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 160 QDKEYYKV-------REPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTY 207 (284)
T ss_pred CCCcceee-------cCCCCCceEeeCHHHhcc-----CCcChHHHHHHHHHHHHHHhhc
Confidence 43221100 001112224778876643 2346789999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=233.16 Aligned_cols=202 Identities=18% Similarity=0.192 Sum_probs=160.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|.+.. ..+..||+|.+.... .......+.+|+.+++.++|+||+++++++..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999997642 235689999986432 233445688999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEe
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~ 244 (317)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999986431 1235678889999999999999999999999999999999999999999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|||+++........... ....+...|++||+... .....+.|+|+++++++|+..
T Consensus 162 dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 162 DFGMTRDIYETDYYRKG--------GKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred CCCCccccCCcceeecC--------CCCccCHhhcChhHhhc-----CCcCchhHHHHHHHHHHHHHc
Confidence 99998765432211100 01122345777776543 334678899999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=232.36 Aligned_cols=197 Identities=20% Similarity=0.230 Sum_probs=154.3
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------CE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------HY 174 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 174 (317)
.+.+.||+|+||.||+|.+.. .+. .+|+|.+..........+.+.+|+++++.++|+||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQ-DDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEcc-CCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 467889999999999998876 333 689999876554566678889999999999999999999976432 34
Q ss_pred EEEEEcccCCCChhcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 175 ICFLIDYCPNGDLHSLLPKQ----PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.+++|||+++++|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999998876321 23457899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... .+...+++++|..++.........+.|+|+++++++|+.. |
T Consensus 161 ~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 161 KIYNGDYYR-------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred ccCccccee-------------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 754322110 1111233344444444444455678999999999999987 5
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=237.80 Aligned_cols=198 Identities=23% Similarity=0.303 Sum_probs=162.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||+|.+.. +|+.|++|.+............+.+|+++++.++|+||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999887 78999999997654333444567789999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|++ ++|.+++... ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||+++.........
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~- 156 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY- 156 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc-
Confidence 995 6888877543 3568999999999999999999999999999999999999999999999999997654322110
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....+...|++||..... .......|+|++|++++|+..| .|
T Consensus 157 ---------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~tg~~p 199 (284)
T cd07839 157 ---------SAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRP 199 (284)
T ss_pred ---------CCCccccCCcChHHHhCC----cccCcHHHHHHHHHHHHHHHhcCCC
Confidence 112344568888876432 1224578999999999999976 65
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=232.01 Aligned_cols=203 Identities=19% Similarity=0.230 Sum_probs=162.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|.+.. .++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 556799999999999999999998764 234789999986543 234446788899999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEe
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~ 244 (317)
...++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986431 2346788999999999999999999999999999999999999999999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
|||+++.......... .....++..|++||...... ...+.|+|+++++++|+.. |
T Consensus 162 dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 162 DFGMTRDIYETDYYRK--------GGKGLLPVRWMAPESLKDGV-----FTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred CcccchhhccCccccc--------CCCCCccccccCHHHHhcCC-----CCcccchHHHHHHHHHhhccC
Confidence 9999876543221100 01112334688888764332 3456899999999999986 6
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=233.48 Aligned_cols=201 Identities=22% Similarity=0.252 Sum_probs=166.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEcccCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+.||+|+|+.|--|.... ++..+|||++.+. ......++.+|++++..++ |+||++++++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~-t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ-TGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeec-cchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 459999999999998777 8999999999876 4455678899999999997 99999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEEeeecccccCCCCCCeeec
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
|+|...|.++ .-|++.++.++..+|+.||.|||.+||.||||||+|||..... -||||||.++-.........
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s-- 236 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS-- 236 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC--
Confidence 9999999664 6799999999999999999999999999999999999997654 48999999985543333221
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..+.+.-.-..|...||+||...--+-+-.-...++|.||++.+++=+..|-
T Consensus 237 -pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 237 -PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred -CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 2222344444566678888877655556556689999999999999888883
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=231.84 Aligned_cols=199 Identities=23% Similarity=0.278 Sum_probs=158.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE-----
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY----- 174 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 174 (317)
|++.+.||+|+||.||+|..... .+..||+|.+............+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987542 34789999997665555667789999999999999999999998765443
Q ss_pred -EEEEEcccCCCChhcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 175 -ICFLIDYCPNGDLHSLLPKQ----PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 175 -~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+++|||+++++|..++... ....+++..++.++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999887442 2246899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
+............ .......|++||+... .....+.|+|+++++++|+.. |
T Consensus 161 ~~~~~~~~~~~~~--------~~~~~~~~~~pe~~~~-----~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 161 KKIYSGDYYRQGR--------IAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred eeccccccccccc--------cccCCccccCHhhccc-----CCCCcccchHHHHHHHHHHHhCC
Confidence 7654332211000 1112235677776543 334578999999999999986 5
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=231.40 Aligned_cols=200 Identities=22% Similarity=0.306 Sum_probs=160.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEc---CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 174 (317)
+-|++++.||+|+||.||+|... ..++..||+|.+.... .......+.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45789999999999999999753 2367899999986542 344556789999999999999999999988765 57
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 89999999999999998654 24589999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... .....+...|++||+.... ....+.|+|++|++++|+..|
T Consensus 162 ~~~~~~~-------~~~~~~~~~y~apE~~~~~-----~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 162 DKEYYTV-------KDDLDSPVFWYAPECLIQS-----KFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred Cccceee-------cCCCCCCccccCHHHhccC-----CCCccccchhhhhhhhhhhcC
Confidence 3321110 0011233457888876432 234678999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=232.14 Aligned_cols=200 Identities=20% Similarity=0.270 Sum_probs=160.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|.+.. ++. .||+|++.... .......+.+|+.+++.+.|+||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 556889999999999999999998765 344 48999986543 33445678899999999999999999998875
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...++++||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999999999998654 356899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.......... .......|++||..... ....++|+|+++++++|+.. |
T Consensus 160 ~~~~~~~~~~--------~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~el~t~g 208 (279)
T cd05109 160 DIDETEYHAD--------GGKVPIKWMALESILHR-----RFTHQSDVWSYGVTVWELMTFG 208 (279)
T ss_pred ccccceeecC--------CCccchhhCCHHHhccC-----CCCchhHHHHHHHHHHHHHcCC
Confidence 5433211110 01223457888876432 24567899999999999765 6
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=230.65 Aligned_cols=198 Identities=23% Similarity=0.277 Sum_probs=162.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|.+.+.||+|+||.||+|.+.. +..+++|.+..... ....+.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~--~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG--TTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC--CceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 567899999999999999999998764 57899999875433 2356788999999999999999999999889999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++.......+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999977655678999999999999999999999999999999999999999999999999997654311
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.. ..........|.+||+... .....++|+|+++++++|+.. |
T Consensus 158 ~~---------~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~t~g 201 (261)
T cd05034 158 YT---------AREGAKFPIKWTAPEAANY-----GRFTIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred hh---------hhhccCCCccccCHHHhcc-----CCcCchhHHHHHHHHHHHHHhCC
Confidence 00 0001112235677776543 234467899999999999986 6
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=230.93 Aligned_cols=197 Identities=21% Similarity=0.279 Sum_probs=159.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.++||+|+||.||+|.+.. ...||+|++...... .+.+.+|+++++.++|+||+++++.+. ....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecC--CceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 445789999999999999999998765 356999998754322 246788999999999999999999875 45689
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999976545568999999999999999999999999999999999999999999999999997664332
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.... ....+...|++||+.. ......+.|+|+++++++|+.. |
T Consensus 157 ~~~~---------~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 157 YTAR---------QGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccc---------cCCcccceecCHhHhc-----cCCCCchhhHHHHHHHHHHHHcCC
Confidence 1100 0112233577777553 3334678899999999999987 5
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.30 Aligned_cols=198 Identities=23% Similarity=0.293 Sum_probs=164.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|++++.||.|+||.||+|.+.. +..+++|++... .......+.+|+.+++.++|+||+++++++......++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4578999999999999999998876 789999998765 233456788899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999999998766677899999999999999999999999999999999999999999999999999766432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.. .......|.+||..... .....+|+|+++++++|+.. | .|
T Consensus 161 ~~----------~~~~~~~~~~PE~~~~~-----~~~~~~DiwslG~~l~~l~~~g~~p 204 (261)
T cd05148 161 SS----------DKKIPYKWTAPEAASHG-----TFSTKSDVWSFGILLYEMFTYGQVP 204 (261)
T ss_pred cc----------CCCCceEecCHHHHccC-----CCCchhhHHHHHHHHHHHHcCCCCC
Confidence 00 11223457777765432 23467899999999999986 5 44
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=232.68 Aligned_cols=198 Identities=20% Similarity=0.228 Sum_probs=162.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++|+||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999876 7899999998654323333456788999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++++.|..++.. ...+++..++.++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred eccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99998888877644 3568999999999999999999999999999999999999999999999999998764432110
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....+...|++||+...+ .......|+|+++++++|+..|-
T Consensus 158 ----------~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 158 ----------TDYVATRWYRAPELLVGD----TQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred ----------cCcccccccCCHHHHhCC----CCcCchhhhHHHHHHHHHHHhCC
Confidence 011234567888875432 12346789999999999999993
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=230.64 Aligned_cols=197 Identities=22% Similarity=0.294 Sum_probs=161.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|+++++||+|+||.||+|.... ++.||+|.+...... ...+.+|+.+++.++|+||+++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~--~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG--HTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC--CceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 556789999999999999999998664 788999998754332 356788999999999999999999874 56789
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999876656678999999999999999999999999999999999999999999999999997665322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.... ....+...|.+||+... .......|+|+++++++|+.. |
T Consensus 157 ~~~~---------~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 157 YTAR---------EGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred cccc---------cCCcccccccCHHHhcc-----CCcCcccchHHHHHHHHHHHhCC
Confidence 1100 01122345777776543 334577999999999999987 6
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=231.09 Aligned_cols=195 Identities=24% Similarity=0.297 Sum_probs=158.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|++.+.||+|+||.||++.+.. +..+|+|++...... ...+.+|+++++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG--KIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC--CccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 4578899999999999999998763 678999998654322 24577899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999986543 46899999999999999999999999999999999999999999999999998765322111
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...+ ......|++||+.... ....++|+|+++++++|+.. |
T Consensus 157 --~~~~-------~~~~~~y~~Pe~~~~~-----~~~~~~Di~slG~il~~l~~~g 198 (256)
T cd05059 157 --SSQG-------TKFPVKWAPPEVFDYS-----RFSSKSDVWSFGVLMWEVFSEG 198 (256)
T ss_pred --ccCC-------CCCCccccCHHHhccC-----CCCchhhHHHHHHHHHHHhccC
Confidence 0000 0112357888876532 23467899999999999987 5
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=232.93 Aligned_cols=195 Identities=19% Similarity=0.263 Sum_probs=163.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|++.+.||+|+||.||+|.+.. +++.|++|.+..... .....+.+|+.+++.+.|+||+++++.+..+...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4799999999999999999998766 788999999876532 2346688899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999999999854 45789999999999999999999999999999999999999999999999998765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|++||+... .....+.|+|+++++++|+..|.
T Consensus 173 ----------~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 173 ----------RSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred ----------cCcccCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCC
Confidence 011234456777776643 23356899999999999999993
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=227.85 Aligned_cols=198 Identities=20% Similarity=0.268 Sum_probs=162.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||++.+.. +..+++|.+... ....+.+.+|+++++.++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecC--CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 3567899999999999999999998654 567999988653 2334678889999999999999999999877 778
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+++|||+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999997655567888999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.... .....+...|.+||+.... ....+.|+|+++++++|+.. |
T Consensus 156 ~~~~---------~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~~l~t~g 200 (260)
T cd05073 156 EYTA---------REGAKFPIKWTAPEAINFG-----SFTIKSDVWSFGILLMEIVTYG 200 (260)
T ss_pred Cccc---------ccCCcccccccCHhHhccC-----CcCccccchHHHHHHHHHHhcC
Confidence 2110 0111234557888876432 33557899999999999997 6
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=233.98 Aligned_cols=204 Identities=19% Similarity=0.227 Sum_probs=162.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|.+.+.||+|+||.||+|.+.. ..++.||+|++.... ..+....+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 45778999999999999999998753 245789999987543 2334578899999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcE
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHI 241 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~ 241 (317)
..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999986431 2457888999999999999999999999999999999999999999
Q ss_pred EEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 242 MLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 242 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+|+|||+++.......... .........|++||+.. ......++|+|+++++++|+.. | .|
T Consensus 162 kl~d~g~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~e~~~~g~~p 224 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRV--------GGHTMLPIRWMPPESIM-----YRKFTTESDVWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred EECCcccceecccCcceec--------CCCCcccceecChhhhc-----cCCcchhhhHHHHHHHHHHHHhcCCCC
Confidence 9999999875432211100 00111223466776553 3344567999999999999986 7 44
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=231.61 Aligned_cols=204 Identities=21% Similarity=0.289 Sum_probs=163.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHL 169 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 169 (317)
..+..++|++.+.||+|+||.||++.... .....+|+|.+.... .......+.+|+++++.+ +|+||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35667889999999999999999998764 134689999987543 334456788999999999 799999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQ--------------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill 235 (317)
..++.++++|||+++++|.+++... ....+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998542 24568899999999999999999999999999999999999
Q ss_pred ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
+.++.+||+|||+++............. ......|++||+.... .....+|+|+++++++|+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~--------~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTN--------GRLPVKWMAPEALFDR-----VYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCC--------CCCCccccCHHHhccC-----CcCcccceeehhhHHHHHhc
Confidence 9999999999999987654322111100 1123457888865432 23567899999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=241.45 Aligned_cols=203 Identities=21% Similarity=0.283 Sum_probs=160.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 171 (317)
+..++|++.+.||+|+||.||+|.... .+++.||+|++.... .......+..|+++++++ +|+||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 445689999999999999999996533 245789999986542 334456778899999999 79999999998764
Q ss_pred -cCEEEEEEcccCCCChhcccccCC-------------------------------------------------------
Q 042913 172 -SHYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------- 195 (317)
Q Consensus 172 -~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 195 (317)
+..++++|||+++++|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 467899999999999998875321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccccccccc
Q 042913 196 ----NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRR 271 (317)
Q Consensus 196 ----~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 271 (317)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+......... ..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~--------~~ 234 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK--------GD 234 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhc--------cC
Confidence 125788999999999999999999999999999999999999999999999999876433221110 01
Q ss_pred ccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 272 RKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 272 ~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
..+...|++||+... .....++|+|+++++++|+.. |
T Consensus 235 ~~~~~~y~aPE~~~~-----~~~~~~~Di~SlGv~l~el~t~g 272 (337)
T cd05054 235 ARLPLKWMAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLG 272 (337)
T ss_pred CCCCccccCcHHhcC-----CCCCccccHHHHHHHHHHHHHcC
Confidence 123345888887643 345578999999999999875 7
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=234.50 Aligned_cols=189 Identities=14% Similarity=0.153 Sum_probs=156.5
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEe----cCEEEEEEc
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEV----SHYICFLID 180 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e 180 (317)
..||+|++|.||+|.+. ++.||+|.+....... ...+.+.+|+.+|++++||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEEC---CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 46899999999999874 6899999997653322 335778899999999999999999999876 457899999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 103 y~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~-- 178 (283)
T PHA02988 103 YCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF-- 178 (283)
T ss_pred eCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc--
Confidence 9999999999965 36789999999999999999999984 999999999999999999999999999976533211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...++..|++||...... .....++|+||+|++++|+..| .|
T Consensus 179 -----------~~~~~~~y~aPE~~~~~~---~~~~~k~Di~SlGvil~el~~g~~P 221 (283)
T PHA02988 179 -----------KNVNFMVYFSYKMLNDIF---SEYTIKDDIYSLGVVLWEIFTGKIP 221 (283)
T ss_pred -----------cccCcccccCHHHhhhcc---ccccchhhhhHHHHHHHHHHHCCCC
Confidence 123455788888775422 2345789999999999999999 55
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=227.92 Aligned_cols=196 Identities=19% Similarity=0.281 Sum_probs=164.8
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||+|.... +++.+|+|.+............+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999998877 78999999998765555667889999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeeecccccCCCCCCee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|+++++|.+++.......+++..++.++.|++.+|.|||++|++|+||||+||+++.+ +.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA- 158 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc-
Confidence 9999999999976555668999999999999999999999999999999999999854 46899999999765432210
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....+...|++||... ........|+|+++++++|+..|
T Consensus 159 ----------~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 159 ----------YTVVGTPCYISPELCE-----GKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred ----------cccccCCcccCchhcc-----CCCCCcccchHHHHHHHHHHHhC
Confidence 0113344677777654 23345678999999999999887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=235.53 Aligned_cols=203 Identities=21% Similarity=0.279 Sum_probs=162.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAH 168 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 168 (317)
.+..++|.+.+.||+|+||.||++.+... ....+|+|.+.... .......+.+|+++++.+ +|+||++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45568899999999999999999976431 23579999987542 344556788899999999 79999999999
Q ss_pred EEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 169 LEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
+...+..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||+.|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999986532 235788999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
++.++.+||+|||+++..........+.. ......|++||..... ....++|+|+++++++|+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~--------~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~ 237 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDR-----IYTHQSDVWSFGVLLWEIFT 237 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhcccc--------CCCccceeChHHhccC-----CCCcHHHHHHHHHHHHHHHc
Confidence 99999999999999876543221111111 1122457888866432 23577999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=233.83 Aligned_cols=196 Identities=19% Similarity=0.261 Sum_probs=163.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||++.... +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3899999999999999999998776 789999999875432 2345678899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.|++||||||+|||++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999999854 45789999999999999999999999999999999999999999999999998765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ....+...|.+||+... .......|+|+++++++|+..|.+
T Consensus 172 ~----------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 172 R----------STMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred c----------CcccCCccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0 11134445777776543 233568999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=228.31 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=169.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||.|+||.||+|.... ++..+++|++....... ....+.+|+++++.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999999999998776 78899999987654333 5678899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 180 DYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|++++++|.+++..... ..+++..++.++.||+.||.|||+.|++|+||||+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999965422 56899999999999999999999999999999999999999999999999998766543221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. ........+...|++||+.... .....+.|+|+++++++|+..| .|
T Consensus 159 ~------~~~~~~~~~~~~y~~Pe~~~~~----~~~~~~~Dv~slG~i~~~l~~g~~p 206 (267)
T cd06610 159 T------RKVRKTFVGTPCWMAPEVMEQV----HGYDFKADIWSFGITAIELATGAAP 206 (267)
T ss_pred c------ccccccccCChhhcChHHHccc----cCcCcccchHhHhHHHHHHHhCCCC
Confidence 1 0111222355678888876543 2346778999999999999999 44
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=234.38 Aligned_cols=207 Identities=19% Similarity=0.239 Sum_probs=165.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHL 169 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 169 (317)
..+..++|.+.+.||+|+||.||++.+. ..++..||+|.+.... .....+.+.+|+++++++ +|+||+++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3456678999999999999999999753 2245689999886542 234456789999999999 799999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
...+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997654445899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+.......... . ........|++||+.... ....+.|+|+++++++|+.. | .|
T Consensus 189 ~~~~~~~~~~~--~------~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDSNYVV--K------GNARLPVKWMAPESIFNC-----VYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCCceee--c------CCCCcccccCCHhhhccC-----CCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 76543321110 0 001223457777765432 34568999999999999875 6 44
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=232.37 Aligned_cols=200 Identities=21% Similarity=0.258 Sum_probs=166.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.+.. +++.|++|+++...........+.+|+++++.++|+||+++++++..++.+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999998887 7889999998765444555678899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++++.|..+... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 80 EYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99987666665533 3558999999999999999999999999999999999999999999999999997765433200
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....+...|++||+..... ....+.|+|+++++++|+..|.|
T Consensus 158 ---------~~~~~~~~~~~~PE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 158 ---------LTDYVATRWYRAPELLVGDT----NYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred ---------ccCcccccCCcCCchhcCCC----CcCchhhHHHHHHHHHHHHhCCC
Confidence 01113455688888875431 34578999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=227.39 Aligned_cols=198 Identities=21% Similarity=0.311 Sum_probs=167.1
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||++.... +++.|++|.+............+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999998877 78999999997654455556788999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+.+++|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-- 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--
Confidence 999999999987654556899999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|.+||+.... ....+.|+|++|++++|+..|-
T Consensus 158 --------~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 158 --------ARTCIGTPYYLSPEICENR-----PYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred --------hhhccCCccccCHHHhCCC-----CCCCccchhHHHHHHHHHHcCC
Confidence 0112345567788776432 3346789999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=228.95 Aligned_cols=192 Identities=19% Similarity=0.269 Sum_probs=154.3
Q ss_pred eecccCCeEEEEEEEc-CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 107 HLGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
+||+|+||.||+|.+. ..++..+|+|++..........+.+.+|+.+++.++|+||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999754 225789999998766545566678999999999999999999999876 45678999999999
Q ss_pred ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccc
Q 042913 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265 (317)
Q Consensus 186 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 265 (317)
+|.+++.. ...+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-- 156 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT-- 156 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC--
Confidence 99999854 35689999999999999999999999999999999999999999999999999976644332211100
Q ss_pred ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 266 ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 266 ~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...+...|++||... ......+.|+|++++.++|+.. |
T Consensus 157 -----~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g 195 (257)
T cd05116 157 -----HGKWPVKWYAPECMN-----YYKFSSKSDVWSFGVLMWEAFSYG 195 (257)
T ss_pred -----CCCCCccccCHhHhc-----cCCcCchhHHHHHHHHHHHHHhCC
Confidence 001123566676543 2345678999999999999986 7
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=234.07 Aligned_cols=198 Identities=20% Similarity=0.222 Sum_probs=163.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
+|++.+.||+|+||.||+|.+.. +++.|++|.+...... ......+.+|+++++.++|+||+++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 48889999999999999999876 6899999999765433 2334567789999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 999999996542 3789999999999999999999999999999999999999999999999999987644221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. .........|.+||..... .......|+|++|++++|+..|.|
T Consensus 158 ~----------~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 158 K----------MTHQVVTRWYRAPELLFGA----RHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred c----------ccccccceeeeCHHHHhCC----CCCCcHHHHHHHHHHHHHHHcCCc
Confidence 1 1111234457777765321 123567899999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=232.24 Aligned_cols=198 Identities=22% Similarity=0.259 Sum_probs=159.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.... +++.|++|++..... ......+.+|+++++.++|+||+++++++..++..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 689999999999999999998876 688999999865432 222235678999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+ .++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++........
T Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 83 EYM-HTDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred ecc-cCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 999 57777766443 245788889999999999999999999999999999999999999999999998754322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....++..|++||+.... .....+.|+|++|++++|+..|-+
T Consensus 160 ---------~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 160 ---------YSSEVVTLWYRPPDVLLGA----TDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred ---------CCCccccccccCCceeecC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0111345568888876421 123457899999999999999943
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=231.85 Aligned_cols=204 Identities=20% Similarity=0.250 Sum_probs=162.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|.+.+.||+|+||.||+|.... .++..+++|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 456789999999999999999997542 23556888988654 334446788999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
...++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986431 2347899999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+.++|+|||+++.......... .....+...|++||+... .....+.|+|+++++++|+.+ | .|
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRV--------GGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred CcEEECCCCcccccCCCceeec--------CCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999976543221100 001122345777776543 234467999999999999987 7 44
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=233.00 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=157.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCC--ceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTS--ANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
++|++.+.||+|+||.||+|.... ++ ..+++|.+... ......+.+.+|++++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999998765 33 34788877632 2334456788999999999 6999999999999999999
Q ss_pred EEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEE
Q 042913 177 FLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIM 242 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~k 242 (317)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999985431 13578899999999999999999999999999999999999999999
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
|+|||++....... ... ....+..|++||+.... ....++|+|+++++++|+.. | .|
T Consensus 160 l~dfg~~~~~~~~~---~~~--------~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlG~il~el~t~g~~p 218 (297)
T cd05089 160 IADFGLSRGEEVYV---KKT--------MGRLPVRWMAIESLNYS-----VYTTKSDVWSFGVLLWEIVSLGGTP 218 (297)
T ss_pred ECCcCCCcccccee---ccC--------CCCcCccccCchhhccC-----CCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999986432110 000 01123458888876432 23568999999999999985 6 55
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=231.93 Aligned_cols=200 Identities=20% Similarity=0.256 Sum_probs=165.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||++.... +++.++||.+.... ........+.+|+.+++.++|+||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578899999999999999998876 78999999886532 2334556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999999988632 23568999999999999999999999999999999999999999999999999987654332
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... ...+...|++||+.... ......|+|+++++++|+..| .|
T Consensus 161 ~~~~----------~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 161 TAAH----------SLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred cccc----------cccCCcCccCHHHhcCC-----CccchhhHHHHHHHHHHHHhCCCC
Confidence 2111 11344568888876433 234678999999999999988 55
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=227.41 Aligned_cols=202 Identities=21% Similarity=0.287 Sum_probs=169.6
Q ss_pred cCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--C----Ccce
Q 042913 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--P----FLPT 164 (317)
Q Consensus 91 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~iv~ 164 (317)
.+..+++..++|.++..+|+|.||+|-+|.+++ ++..||||+++.- ....+..+.|+++|+++.+ | -+|+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 455667778999999999999999999999998 5899999998653 4566777889999999942 2 2678
Q ss_pred EEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-------
Q 042913 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE------- 237 (317)
Q Consensus 165 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~------- 237 (317)
+.++|+..++.|+|+|.+ |-++++++.++...+++...++.|+.|++.++++||+.+++|-||||+|||+..
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 889999999999999999 889999999988899999999999999999999999999999999999999831
Q ss_pred -------------CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCc
Q 042913 238 -------------DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPA 304 (317)
Q Consensus 238 -------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~ 304 (317)
+..|+|+|||-|......... ...+..|-+||. .-...+...+|+||+|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~-------------iVsTRHYRAPEV-----iLgLGwS~pCDvWSiG 296 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHST-------------IVSTRHYRAPEV-----ILGLGWSQPCDVWSIG 296 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCcce-------------eeeccccCCchh-----eeccCcCCccCceeee
Confidence 225899999999765544321 244556667664 4556778899999999
Q ss_pred ccccccCCCCC
Q 042913 305 QYSVEQPGGVP 315 (317)
Q Consensus 305 ~~~~e~~~G~p 315 (317)
|+++|++.|.-
T Consensus 297 CIL~ElytG~~ 307 (415)
T KOG0671|consen 297 CILVELYTGET 307 (415)
T ss_pred eEEEEeeccce
Confidence 99999999953
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=244.02 Aligned_cols=209 Identities=20% Similarity=0.230 Sum_probs=162.9
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAH 168 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 168 (317)
...+..++|.+.+.||+|+||.||+|.++. ..++.||+|++.... .....+.+.+|++++..+. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 345667789999999999999999998643 245689999997643 2334457889999999997 9999999999
Q ss_pred EEecCEEEEEEcccCCCChhcccccCCC----------------------------------------------------
Q 042913 169 LEVSHYICFLIDYCPNGDLHSLLPKQPN---------------------------------------------------- 196 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------- 196 (317)
+...+..++||||+++|+|.+++.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999998854311
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 042913 197 --------------------------------------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPEN 232 (317)
Q Consensus 197 --------------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~N 232 (317)
..+++..++.++.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 235677788999999999999999999999999999
Q ss_pred EEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 233 ILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 233 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
||++.++.+||+|||+++.+........ .....++..|++||.... .....+.|+|+++++++|+..
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYIS--------KGSTFLPLKWMAPESIFN-----NLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccccc--------CCCcCCCCceeChHHhcC-----CCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999999976533221100 000122345666665532 334678999999999999875
Q ss_pred -C-CCC
Q 042913 313 -G-VPR 316 (317)
Q Consensus 313 -G-~p~ 316 (317)
| .|.
T Consensus 337 ~g~~P~ 342 (401)
T cd05107 337 LGGTPY 342 (401)
T ss_pred cCCCCC
Confidence 4 553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=231.35 Aligned_cols=200 Identities=18% Similarity=0.196 Sum_probs=154.0
Q ss_pred eecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 107 HLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
+||+|+||.||+|.... .....+++|.+.... .......+.+|+++++.++|+||+++++.+.....+|+||||++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 134578888775432 3444567888999999999999999999999999999999999999
Q ss_pred ChhcccccCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecc
Q 042913 186 DLHSLLPKQPN---NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 186 sL~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
+|.+++..... ...++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~- 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK- 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc-
Confidence 99999865422 23467888999999999999999999999999999999999999999999998654322211110
Q ss_pred cccccccccccccCCCCCccccccccc--ceeccchhhhccCCcccccccCC-C-CC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVM--EFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~--~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
........|++||+...... .......+.|+|+++++++|+.. | .|
T Consensus 160 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 160 -------DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred -------CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 11123345788887643221 12344678999999999999886 4 44
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=228.95 Aligned_cols=198 Identities=19% Similarity=0.222 Sum_probs=164.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
++|++.+.||+|+||.||+|.... +++.||+|.++... ........+.+|+++++.++|+||+++++.+...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 589999999999999999999886 78999999986432 2334467889999999999999999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++++|.+++... ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999999988542 23558999999999999999999999999999999999999999999999999987654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ...+...|.+||+... .......|+|+++++++|+..|
T Consensus 161 ~~~~----------~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~~l~~g 202 (267)
T cd08224 161 TAAH----------SLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred cccc----------eecCCccccCHHHhcc-----CCCCchhcHHHHHHHHHHHHHC
Confidence 1111 1123445777776542 3345678999999999999888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=230.11 Aligned_cols=196 Identities=30% Similarity=0.495 Sum_probs=166.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+|++.+.||.|+||.||+|.+.. ++..|++|++....... ...+.+.+|+++++.++||||+++++.+......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 58999999999999999999876 78999999997654332 55678999999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||++++++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 156 (258)
T cd05578 80 DLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT- 156 (258)
T ss_pred eCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc-
Confidence 999999999999653 57899999999999999999999999999999999999999999999999998765432210
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....+...|.+||...... .....|+|+++++++|+..| .|
T Consensus 157 ----------~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 157 ----------TSTSGTPGYMAPEVLCRQG-----YSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred ----------cccCCChhhcCHHHHcccC-----CCCcccchhhHHHHHHHHhCCCC
Confidence 1123445577777665433 55789999999999999988 44
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=232.16 Aligned_cols=198 Identities=23% Similarity=0.276 Sum_probs=160.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|++|.||+|.... +++.||+|.+...... .....+.+|+++++.++|+||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999998876 7889999998654321 2223466899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99996 58998886543 46899999999999999999999999999999999999999999999999998754321110
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ....+...|.+||..... .....+.|+|++|++++|+..|.
T Consensus 160 ~----------~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 160 Y----------SNEVVTLWYRPPDVLLGS----TEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred c----------cccccccccCCcHHhhcC----cccCcHHHHHHHHHHHHHHHhCC
Confidence 0 001234457777765432 12346789999999999999994
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=230.65 Aligned_cols=200 Identities=19% Similarity=0.239 Sum_probs=163.4
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh----cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL----SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+|+..+.||+|+||.||++.+.. +++.||+|++..... .......+.+|+++++.++|+||+++++++...+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 47788899999999999998866 789999999865321 1234578899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~ 255 (317)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999999653 5789999999999999999999999999999999999998776 6999999999776443
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... ........+...|++||..... ....+.|+|+++++++|+..|.
T Consensus 158 ~~~~------~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~ 205 (268)
T cd06630 158 GTGA------GEFQGQLLGTIAFMAPEVLRGE-----QYGRSCDVWSVGCVIIEMATAK 205 (268)
T ss_pred cccC------CccccccccccceeCHhHhccC-----CCCcccchHHHHHHHHHHHhCC
Confidence 1110 0111122355678888876432 3356789999999999999993
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=227.75 Aligned_cols=191 Identities=20% Similarity=0.278 Sum_probs=155.5
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
.||+|+||.||+|.+.. +++.||+|.+.... ..+....+.+|+++++.++|+||+++++++......|+||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRA-DNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEec-CCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 59999999999999876 78899999886442 34555778999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++........ ...
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~---- 152 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--AST---- 152 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--ccc----
Confidence 99998643 34689999999999999999999999999999999999999999999999999875432110 000
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.........|++||+.... ....+.|+|++|++++|+.. |
T Consensus 153 --~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~e~~~~~ 193 (252)
T cd05084 153 --GGMKQIPVKWTAPEALNYG-----RYSSESDVWSFGILLWEAFSLG 193 (252)
T ss_pred --CCCCCCceeecCchhhcCC-----CCChHHHHHHHHHHHHHHHhCC
Confidence 0011122357778766432 24567999999999999885 5
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=231.05 Aligned_cols=202 Identities=20% Similarity=0.258 Sum_probs=160.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.++||+|+||.||++... ..++..+++|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45678999999999999999999753 224568899987654 345556889999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPN-------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
...+++|||+++++|.+++..... ..+++..++.++.||+.||.|||+.|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999865321 3478899999999999999999999999999999999999999
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.+||+|||+++.......... .....+...|++||+... .....++|+|+++++++|+.. |
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g 221 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRV--------GGRTMLPIRWMPPESILY-----RKFTTESDIWSFGVVLWEIFTYG 221 (280)
T ss_pred CEEECCCCceeEcCCCceeec--------CCCccccccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCC
Confidence 999999999875533211000 001112234666665543 334567899999999999986 6
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=229.18 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=163.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-------AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+|.+.+.||+|+||.||+|.+.. +++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 47788899999999999998776 6889999988653221 234467889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999999653 668999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ ........+...|++||+.... ......|+|+++++++|+..|
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 158 ANSLSTKT----NGARPSLQGSVFWMAPEVVKQT-----SYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred cccccCCc----cccccccCCCcCccChhHhccC-----CCCchhhhHHHHHHHHHHhhC
Confidence 32211000 0111112345567777766432 335678999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=233.90 Aligned_cols=199 Identities=21% Similarity=0.256 Sum_probs=164.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 478999999999999999999876 6899999998665433344567888999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++++.|.++... ...+++..++.++.||+.||.|||+.+++|+||+|+||++++++.++|+|||++..........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred ecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99998888887643 3458999999999999999999999999999999999999999999999999987654322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....+...|++||+...+ .......|+|+++++++|+..|-|
T Consensus 158 ----------~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 158 ----------TDYVATRWYRAPELLVGD----TKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred ----------CcccceeeccCcHHhccc----cccCchHhHHHHHHHHHHHHcCCC
Confidence 111345668888876432 123467899999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=233.66 Aligned_cols=204 Identities=19% Similarity=0.283 Sum_probs=162.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+...+|.+.+.||+|+||.||+|.... ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 35667899999999999999999997531 134579999886542 345557889999999999 7999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++......|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999986531 23578888999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|++.++.+||+|||+|+..........+. ...+...|++||..... ....++|+|+++++++|+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~--------~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTT--------NGRLPVKWMAPEALFDR-----VYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred EEcCCCcEEECCCccceeccccccccccc--------CCCCCceeeCchhhccC-----CCCchhhHHHHHHHHHHHHc
Confidence 99999999999999998764432211111 11223457888866432 23467899999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=229.24 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=163.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcC---CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cC
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRD---CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SH 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 173 (317)
.++|++.+.||+|+||.||++.+.. .++..+|+|++...... .....+.+|+++++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 4678899999999999999998653 25789999999765432 456789999999999999999999999876 56
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 7999999999999999996542 358999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ........|.+||+.... ......|+|++|++++|+..|
T Consensus 161 ~~~~~~~~~-------~~~~~~~~~~~Pe~~~~~-----~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 161 EDKDYYYVK-------EPGESPIFWYAPECLRTS-----KFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred cCCcceecc-------CCCCCcccccCcHHHccC-----CCCcccchHHHhhhhheeecc
Confidence 332211100 011223457788876443 345778999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=231.63 Aligned_cols=202 Identities=19% Similarity=0.218 Sum_probs=159.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|..++ ..+..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999997643 235589999886543 223345678899999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEe
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~ 244 (317)
...|+||||+++|+|.+++.... ...+....+..++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999996421 1234667888999999999999999999999999999999999999999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|||+++.......... .....+...|++||+.... ....+.|+|+++++++|+..
T Consensus 162 Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~~pE~~~~~-----~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 162 DFGMTRDIYETDYYRK--------GGKGLLPVRWMAPESLKDG-----VFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred cCCccccccccccccc--------cCCCcccccccCHHHhccC-----CCChHhHHHHHHHHHHHHHh
Confidence 9999976533221100 0011223457788776432 33568899999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.07 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=162.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL---SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 174 (317)
..|++.+.||+|+||.||+|.+.. ++..|++|.+..... ..+....+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 368889999999999999998876 789999999865422 23455678899999999999999999998865 467
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+++++||+++++|.+++... ..+++...+.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999998653 5689999999999999999999999999999999999999999999999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ......+...|.+||+... ....++.|+|+++++++|+..|
T Consensus 159 ~~~~~~-------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~el~~g 205 (266)
T cd06651 159 ICMSGT-------GIRSVTGTPYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTE 205 (266)
T ss_pred ccccCC-------ccccCCccccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHHC
Confidence 211100 0011235567888887643 2345788999999999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=228.07 Aligned_cols=199 Identities=21% Similarity=0.268 Sum_probs=159.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+++++.++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcC--CceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 345679999999999999999998765 45799998865432 2356788999999999999999998875 45689
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
++|||+.+++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999997654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.... ........|++||+... .....+.|+|+++++++|+.. | +|
T Consensus 157 ~~~~---------~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p 203 (260)
T cd05069 157 YTAR---------QGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred cccc---------CCCccchhhCCHHHhcc-----CCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 1100 01122345777776542 345678999999999999987 6 44
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=229.22 Aligned_cols=201 Identities=22% Similarity=0.331 Sum_probs=165.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSH---- 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~---- 173 (317)
.++|++.+.||+|+||.||+|.+.. +++.+++|++.... .....+.+|+.+++.+ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3789999999999999999999876 68899999987643 2346788999999998 6999999999986544
Q ss_pred --EEEEEEcccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 174 --YICFLIDYCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 174 --~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999886533 467899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... .....++..|++||....+...........|+|++|++++|+..|
T Consensus 161 ~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 161 AQLDSTLGR----------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred eecccchhh----------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 765432211 112245667899987654443333445678999999999999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=228.65 Aligned_cols=205 Identities=21% Similarity=0.257 Sum_probs=161.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
+..++|+..+.||+|+||.||+|...... ...+++|.+.... .....+.+.+|+++++.++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34567889999999999999999886521 2379999986543 33445678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999998653 35689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
......+... ......|++||+.. ......+.|+|+++++++|+.. | .|
T Consensus 160 ~~~~~~~~~~-------~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~il~ell~~g~~p 210 (268)
T cd05063 160 DPEGTYTTSG-------GKIPIRWTAPEAIA-----YRKFTSASDVWSFGIVMWEVMSFGERP 210 (268)
T ss_pred ccccceeccC-------CCcCceecCHHHhh-----cCCcChHhHHHHHHHHHHHHHhCCCCC
Confidence 2221111000 01112466666553 3334578999999999999775 6 55
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=216.68 Aligned_cols=206 Identities=23% Similarity=0.326 Sum_probs=174.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 173 (317)
..+..+.|+++++||.|+||.+|+|.... .|+.||||+-....- ..++..|.++.+.|++ ..|+.+..++.+..
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeecc-CCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 35677899999999999999999998877 899999998765422 2356778999999874 67888888888888
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDLCF 250 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~a~ 250 (317)
+-.+||+++ |-+|.+++.- ....|+..+++.++-|++.-++|+|.+++|||||||+|+|+.- -..+.|+|||+|+
T Consensus 85 ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 999999999 9999998853 3577999999999999999999999999999999999999963 3479999999999
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
++....+. .--.+++...--|+.+|.+.|.+-.+++.||+|++|.+|++++|-.| +|
T Consensus 163 ky~d~~t~--------~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP 220 (341)
T KOG1163|consen 163 KYRDIRTR--------QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP 220 (341)
T ss_pred hhcccccc--------ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence 88765432 11223445555699999999999999999999999999999999999 77
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=227.16 Aligned_cols=199 Identities=24% Similarity=0.331 Sum_probs=162.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh---hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 174 (317)
.+|++.+.||+|+||.||+|.+.. ++..|++|.+.... ........+.+|+++++.++|+||+++++++... +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 478999999999999999998876 78999999885431 1235567889999999999999999999998653 56
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+++++||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999998653 4588999999999999999999999999999999999999999999999999987643
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ......+...|++||+... .....+.|+|+++++++|+..|
T Consensus 159 ~~~~~~-------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 159 ICMSGT-------GIKSVTGTPYWMSPEVISG-----EGYGRKADVWSVACTVVEMLTE 205 (264)
T ss_pred ccccCc-------cccccCCcccccCHhhhcC-----CCCCccccHHHHHHHHHHHHhC
Confidence 211000 0011234566788887653 2335778999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=234.35 Aligned_cols=204 Identities=17% Similarity=0.237 Sum_probs=161.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+...+|++.+.||+|+||.||+|.+.. ..+..||+|++.... .....+.+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345678889999999999999998753 135789999997543 234456788999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQ--------------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
...++++||+.+++|.+++... ....+++..++.++.|++.||.|||+.||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999887421 12357888899999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
+.+||+|||+++........... ....+...|++||+... .....+.|+|+++++++|+.. |.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~g~ 224 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLM--------GNSLLPIRWMSPEAIMY-----GKFSIDSDIWSYGVVLWEVFSYGL 224 (283)
T ss_pred CceEecccccccccccchheeec--------cCccCCccccCHHHHhc-----CCCCcchhHHHHHHHHHHHHcCCC
Confidence 99999999998865432211100 01122345788876643 234567899999999999886 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=230.87 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=165.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE------e
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE------V 171 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~ 171 (317)
.+.|++.+.||+|+||.||+|.+.. +++.+|+|++... ......+..|+.+++.+ +|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 3688999999999999999999877 7899999998654 23345678899999988 6999999999985 3
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...+|++|||+.+++|.+++.......+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46789999999999999999766566788999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... .....+...|++||..............+.|+|+++++++|+..|-
T Consensus 171 ~~~~~~~----------~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRTVGR----------RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhccccC----------CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 5432211 1112355678888876543322334456789999999999999993
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=226.03 Aligned_cols=204 Identities=24% Similarity=0.373 Sum_probs=169.8
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||+|.... +++.|++|.+..........+.+.+|+++++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58999999999999999998876 68999999998765555677889999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 80 YCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999965 35588999999999999999999999999999999999999999999999999877654332211
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. .....+...|++||+..... ........|+|+++++++|+..| .|
T Consensus 158 ~~------~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 158 EE------VQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred cc------ccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCC
Confidence 10 01123445688888876443 12245778999999999999988 44
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.59 Aligned_cols=200 Identities=20% Similarity=0.253 Sum_probs=161.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+...+|++.+.||+|+||.||+|.+.. +++ .+|+|...... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEec-CCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 445789999999999999999998765 333 68999886553 24455778899999999999999999999887
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999998654 345899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... ........|++||+... .....+.|+|+++++++|+.. |
T Consensus 160 ~~~~~~~~~--------~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~~~g 208 (279)
T cd05057 160 DVDEKEYHA--------EGGKVPIKWMALESILH-----RIYTHKSDVWSYGVTVWELMTFG 208 (279)
T ss_pred cCcccceec--------CCCcccccccCHHHhhc-----CCcCchhhHHHHHHHHHHHhcCC
Confidence 533221110 00111235778876542 234578999999999999886 7
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=230.82 Aligned_cols=200 Identities=18% Similarity=0.237 Sum_probs=162.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|++|.||+|.+.. +++.||+|.+............+.+|+++++.++|+||+++++++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 679999999999999999999876 7899999998665433344567888999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCCCCCe
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||+ +++|.+++.......+++..++.++.||+.||+|||+++++|+||||+||+++. ++.+||+|||++.........
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 999 568888876554455788899999999999999999999999999999999985 557999999999765432111
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ....+...|++||+.... .....+.|+|++|++++|+..|-|
T Consensus 160 ~----------~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 160 F----------THEVVTLWYRAPEILLGS----RHYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred c----------ccCceeecccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0 011334568888876432 123467899999999999999944
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=231.83 Aligned_cols=199 Identities=21% Similarity=0.321 Sum_probs=158.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+|++.+.||+|+||.||+|..... ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 478889999999999999986531 23568888886543 2344577889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 177 FLIDYCPNGDLHSLLPKQ----------------------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
+++||+.+++|.+++... ....+++..++.++.|++.||.|||+.+|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999987532 1235788999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
++.++.+||+|||+++.......... ......+..|++||+.... ....+.|+|+++++++|+.. |
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~~y~apE~~~~~-----~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVK--------RSKGRIPVKWMAIESLFDH-----IYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred EcCCCcEEeccccccccccCccchhc--------ccCCCCCccccCHHHHccC-----CcchHhHHHHHHHHHHHHHhcC
Confidence 99999999999999976543322111 0111233468888866432 34578899999999999987 6
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=233.17 Aligned_cols=200 Identities=21% Similarity=0.199 Sum_probs=163.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HYIC 176 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 176 (317)
.++|++.+.||+|+||.||+|.+.. +++.+++|.+............+.+|+.+++.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3578999999999999999999876 788999999976544444445677899999999999999999998877 8999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999995 69988886542 468999999999999999999999999999999999999999999999999997665432
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... ....+...|++||....... .....|+|+++++++|+..|.|
T Consensus 161 ~~~----------~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~ 205 (293)
T cd07843 161 KPY----------TQLVVTLWYRAPELLLGAKE----YSTAIDMWSVGCIFAELLTKKP 205 (293)
T ss_pred ccc----------ccccccccccCchhhcCCcc----ccchhhHHHHHHHHHHHHhCCC
Confidence 111 11123456788887643221 3567999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=235.79 Aligned_cols=204 Identities=21% Similarity=0.286 Sum_probs=161.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+...+|++++.||+|+||.||+|.+.. .....||+|.+.... .......+.+|+++++++ +|+||+++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 35566789999999999999999997642 122468999886542 344567889999999999 7999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++...+.++++|||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999986531 23477888999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|++.++.+||+|||+++............ .......|++||.... .....++|+|+++++++|+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~--------~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTT--------NGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred EEcCCCcEEECCcccceeccccccccccc--------CCCcCceEcCHHHhcc-----CCcCchhhhHHHHHHHHHHHh
Confidence 99999999999999997654322111111 0112235777776543 334567999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=233.51 Aligned_cols=198 Identities=24% Similarity=0.318 Sum_probs=166.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+++++.++|+||+++++.+.....++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 456789999999999999999998876 78899999986542 3445578899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+||||+++++|.+++.. .+.+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999999865 3568999999999999999999997 68999999999999999999999999998654221
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....++..|++||+.... ....++|+|+++++++|+..| .|
T Consensus 158 ~~------------~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p 201 (284)
T cd06620 158 IA------------DTFVGTSTYMSPERIQGG-----KYTVKSDVWSLGISIIELALGKFP 201 (284)
T ss_pred cc------------CccccCcccCCHHHHccC-----CCCccchHHHHHHHHHHHHhCCCC
Confidence 10 122456678888876433 445789999999999999988 44
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=227.78 Aligned_cols=200 Identities=20% Similarity=0.258 Sum_probs=162.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh----cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL----SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+|++.+.||+|+||.||+|... +++.+|+|.+..... .......+.+|+++++.++|+||+++++++...+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 5888999999999999999764 588999998865321 2344567899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999999653 568999999999999999999999999999999999999999999999999987653211
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... . ........+...|.+||+... .......|+|+++++++|+..|
T Consensus 157 ~~~~-~---~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 157 LHGT-H---SNMLKSMHGTPYWMAPEVINE-----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred cccc-c---cccccccCCCccccChhhhcC-----CCCcchhhHHHHHHHHHHHHhC
Confidence 1100 0 001112235566778877643 2335678999999999999999
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=233.19 Aligned_cols=201 Identities=20% Similarity=0.258 Sum_probs=159.3
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCC-------------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcce
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDC-------------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 164 (317)
..++|++.+.||+|+||.||+|..... ....||+|.+.... .......+.+|+++++.++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 457899999999999999999976531 12358999987542 3445567899999999999999999
Q ss_pred EEEEEEecCEEEEEEcccCCCChhcccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQP----------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 165 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
+++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999885421 123678889999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
++.++.+||+|||+++......... .. ....+...|++||+... .....+.|+|+++++++|+..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~--~~------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYR--IQ------GRAVLPIRWMAWESILL-----GKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred EcCCCcEEecccccccccccCccee--cc------CcCcCceeecChhhhcc-----CCcCchhhHHHHHHHHHHHHH
Confidence 9999999999999997653322110 00 11122345777776542 334678999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=228.85 Aligned_cols=200 Identities=20% Similarity=0.200 Sum_probs=155.3
Q ss_pred eecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 107 HLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
.||+|+||.||+|.+.. .++..+++|.+..... ......+.+|+.+++.++||||+++++++.....+++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997653 2456799998865532 233456888999999999999999999999889999999999999
Q ss_pred ChhcccccCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecc
Q 042913 186 DLHSLLPKQP---NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 186 sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
+|.+++.... ....++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~--- 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV--- 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee---
Confidence 9999986432 2345677888899999999999999999999999999999999999999999986433221110
Q ss_pred cccccccccccccCCCCCcccccccccc--eeccchhhhccCCcccccccCC-C-CC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVME--FVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~--~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
......++..|++||........ ......++|+|+++++++|+.. | .|
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 158 -----TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred -----cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 01112334568888877533222 2244678999999999999874 7 45
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=238.48 Aligned_cols=203 Identities=21% Similarity=0.277 Sum_probs=157.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 171 (317)
+..++|++.+.||+|+||.||+|.+. ..+++.||||+++... .......+.+|+.++..+ +|+||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45578999999999999999999753 2357899999997543 234456788999999999 68999999998754
Q ss_pred -cCEEEEEEcccCCCChhcccccCC-------------------------------------------------------
Q 042913 172 -SHYICFLIDYCPNGDLHSLLPKQP------------------------------------------------------- 195 (317)
Q Consensus 172 -~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 195 (317)
+..+++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 456899999999999998875421
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccc
Q 042913 196 ----------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265 (317)
Q Consensus 196 ----------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 265 (317)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........... +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~- 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK--G- 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc--C-
Confidence 123677888899999999999999999999999999999999999999999999765332211110 0
Q ss_pred ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 266 ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 266 ~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...+...|++||.... .....++|+|+++++++|+.. |
T Consensus 240 -----~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g 278 (343)
T cd05103 240 -----DARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLG 278 (343)
T ss_pred -----CCCCCcceECcHHhcC-----CCCCchhhHHHHHHHHHHHHHCC
Confidence 0122345777776533 234567999999999999874 5
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=237.27 Aligned_cols=194 Identities=17% Similarity=0.253 Sum_probs=159.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++.+..........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45889999999999999999999887 789999999876544445556778899999999999999999988543
Q ss_pred -CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 -HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...|+||||+ .++|.+.+... +++..+..++.||+.||.|||..||+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 3579999999 56888887432 88999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... .....++..|++||.... .....+.|+|++|++++|+..|
T Consensus 168 ~~~~~~-----------~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g 213 (353)
T cd07850 168 AGTSFM-----------MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRG 213 (353)
T ss_pred CCCCCC-----------CCCCcccccccCHHHHhC-----CCCCCchhhHhHHHHHHHHHHC
Confidence 543211 011134456777776643 3445778999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=227.11 Aligned_cols=196 Identities=23% Similarity=0.275 Sum_probs=159.1
Q ss_pred eeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|++|.||+|.+....+. .||+|.+...... ...+.+.+|+.+++.++|+||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 3589999999999987653333 6899999776443 566789999999999999999999999988 88999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-- 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM-- 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec--
Confidence 999999997654356899999999999999999999999999999999999999999999999999876542221100
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.....+..+|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 157 -----~~~~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p 200 (257)
T cd05040 157 -----EEHLKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYGEEP 200 (257)
T ss_pred -----ccCCCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 012234567888886643 224567899999999999986 6 44
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=228.16 Aligned_cols=197 Identities=22% Similarity=0.281 Sum_probs=160.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|+||.||+|.... +..+|+|.+...... .+.+.+|+.+++.++|+|++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNG--NTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecC--CceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 456789999999999999999997664 677999998764333 245788999999999999999999875 45689
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999976555678999999999999999999999999999999999999999999999999997654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.... . ...+...|++||+... .......|+|+++++++|+.. |
T Consensus 157 ~~~~--~-------~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~g 200 (260)
T cd05070 157 YTAR--Q-------GAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred cccc--c-------CCCCCccccChHHHhc-----CCCcchhhhHHHHHHHHHHHhcC
Confidence 1100 0 0012235888886542 234568899999999999987 6
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.70 Aligned_cols=201 Identities=23% Similarity=0.311 Sum_probs=162.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCC---------------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDC---------------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 162 (317)
..++|++++.||+|+||.||+|.+... .+..||+|.+.... .......+.+|+++++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 457899999999999999999987642 12458999987553 23456788999999999999999
Q ss_pred ceEEEEEEecCEEEEEEcccCCCChhcccccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQP---------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 163 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
+++++++..+...+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.+|+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999986532 12689999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
+++.++.++|+|||+++.......... .....++..|++||+... .....+.|+|+++++++|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRV--------QGRAPLPIRWMAWESVLL-----GKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred eecCCCceEEccccceeecccCcceee--------cCcCCCCceecCHHHhhc-----CCCCccchhhhhHHHHHHHHh
Confidence 999999999999999876543221100 111123456788887643 234577999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=228.37 Aligned_cols=202 Identities=20% Similarity=0.266 Sum_probs=163.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec-----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 172 (317)
.++|.+.+.||+|+||.||++.... +++.+|+|++.... .....+.+|+.+++.+ +|+|++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4789999999999999999998876 78999999986432 2235567899999988 799999999998643
Q ss_pred CEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
+.+|+||||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999999999987532 24568999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... ....+...|++||....+.........+.|+|+++++++|+..|-
T Consensus 177 ~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~ 230 (291)
T cd06639 177 QLTSTRLRR----------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230 (291)
T ss_pred hcccccccc----------cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC
Confidence 654322110 112345668888876544322233467899999999999999993
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=230.18 Aligned_cols=195 Identities=21% Similarity=0.295 Sum_probs=164.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|++.+.||.|+||.||+|.+.. +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC-CCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4679999999999999999998776 78999999986542 23346788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999999998854 45899999999999999999999999999999999999999999999999998765433211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||..... .....+|+|+++++++|+..|.
T Consensus 172 ----------~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 172 ----------RSTMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred ----------CCCcCCCccccCcchhcCC-----CCCchhhHHHHHHHHHHHHhCC
Confidence 1112355678888876533 2346799999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=231.28 Aligned_cols=197 Identities=20% Similarity=0.275 Sum_probs=163.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.|++++.||.|++|.||+|.+.. ++..||||.+............+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999998876 78999999987654344444678899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+ .++|.+++.......+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||+++.........
T Consensus 80 ~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~- 157 (284)
T cd07860 80 FL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 157 (284)
T ss_pred cc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc-
Confidence 99 5689888876656778999999999999999999999999999999999999999999999999987654322111
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....+...|++||...... ......|+|++|++++|+..|
T Consensus 158 ---------~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 158 ---------THEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred ---------ccccccccccCCeEEecCC----CCCcHHHHHHHHHHHHHHHHC
Confidence 1112345688888664321 124678999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=226.56 Aligned_cols=194 Identities=24% Similarity=0.344 Sum_probs=159.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE-EecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL-EVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 175 (317)
+...+|++.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.+++.++|+|++++++++ ..++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999655 578999998643 2235688899999999999999999975 455678
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+++|||+++++|.+++.......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997655556899999999999999999999999999999999999999999999999998754332
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
... ......|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 156 ~~~-------------~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 156 QDT-------------GKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred CCC-------------CccceeecCHHHHcc-----CCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 110 112346888887643 233567999999999999985 5 44
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=231.20 Aligned_cols=201 Identities=22% Similarity=0.264 Sum_probs=158.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcC---------------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRD---------------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 162 (317)
..++|++.+.||+|+||.||++.+.. .+...+|+|++.... .......+.+|+++++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 34679999999999999999986432 123468999987542 34455678899999999999999
Q ss_pred ceEEEEEEecCEEEEEEcccCCCChhcccccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQP---------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 163 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
+++++++...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999886532 12467788999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|++.++.++|+|||+++.+........ . ........|++||.... .....++|+|+++++++|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~--~------~~~~~~~~~~~pe~~~~-----~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRI--Q------GRAVLPIRWMSWESILL-----GKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceec--c------CcCcCccccCCHHHHhc-----CCccchhhhhHHHHHHHHHHH
Confidence 999999999999999976533221100 0 00112234667765432 234578999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=228.37 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=160.5
Q ss_pred EEeeeecccCCeEEEEEEEc---CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.+.+.||.|.||.||+|.+. ...+..|+||.+... ......+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 57789999999999999988 124578999999543 34455788999999999999999999999999888899999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++|+|.+++.......+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++.........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~- 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY- 159 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999998765677999999999999999999999999999999999999999999999999999876322221
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
...........|.+||...... ...+.|+|+.|.+++|+.. | .|
T Consensus 160 -------~~~~~~~~~~~~~aPE~~~~~~-----~~~ksDVysfG~~l~ei~~~~~~p 205 (259)
T PF07714_consen 160 -------KNDSSQQLPLRYLAPEVLKDGE-----YTKKSDVYSFGMLLYEILTLGKFP 205 (259)
T ss_dssp -------EESTTSESGGGGS-HHHHHHSE-----ESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred -------cccccccccccccccccccccc-----cccccccccccccccccccccccc
Confidence 1111123445677787654443 6789999999999999998 5 44
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=232.15 Aligned_cols=201 Identities=23% Similarity=0.264 Sum_probs=161.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HYI 175 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 175 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++............+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45789999999999999999999876 789999999875433333334566799999999999999999998754 568
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+. ++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999994 6888887643 356899999999999999999999999999999999999999999999999999776432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... .........|++||..... .......|+|+++++++|+..|-|
T Consensus 162 ~~~----------~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 162 AKP----------MTPKVVTLWYRAPELLLGC----TTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred cCC----------CCcccccccccChhhhcCC----CCcCchHHHHHHHHHHHHHHhCCC
Confidence 210 1111234567888865432 223567899999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=232.83 Aligned_cols=195 Identities=20% Similarity=0.240 Sum_probs=149.5
Q ss_pred eeeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--ecCEEEEEEcc
Q 042913 105 VRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE--VSHYICFLIDY 181 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 181 (317)
..+||+|+||.||+|.... .++..||+|.+..... ...+.+|+++++.++||||+++++++. .+..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3579999999999998653 2567899998865421 235678999999999999999999885 45678999999
Q ss_pred cCCCChhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE----ccCCcEEEeeecccc
Q 042913 182 CPNGDLHSLLPKQ-------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----REDGHIMLSDFDLCF 250 (317)
Q Consensus 182 ~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----~~~~~~kl~DFG~a~ 250 (317)
+ +++|.+++... ....+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||+|+
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56777766421 12357899999999999999999999999999999999999 456799999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.......... ......++..|++||..... .......|+|++|++++|+..|-|
T Consensus 161 ~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 161 LFNSPLKPLA-------DLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred ccCCCccccc-------ccCcceecccccCcHHhcCC----CccCcHHHHHhHHHHHHHHHhCCC
Confidence 7643221100 01112345667888765421 223577999999999999999955
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=232.58 Aligned_cols=203 Identities=19% Similarity=0.267 Sum_probs=161.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAH 168 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 168 (317)
.+...+|.+.+.||+|+||.||+|.... .....+|+|.+.... .......+.+|+++++.+ +||||++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3455789999999999999999997532 134579999987542 344556788999999999 59999999999
Q ss_pred EEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 169 LEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
+...+.+|++|||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 999999999999999999999986532 245788999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
++.++.+||+|||+++............. ......|++||..... ....+.|+|+++++++|+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~--------~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSN--------GRLPVKWMAPEALFDR-----VYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred EcCCCcEEEcccccccccccccccccccc--------CCCCccccCHHHHccC-----CcCccchhhHHHHHHHHHHh
Confidence 99999999999999986543221111111 1122358888876432 23567899999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=228.93 Aligned_cols=200 Identities=16% Similarity=0.196 Sum_probs=158.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++++.||+|+||.||+|.+.. ++. .+++|.+... .......++..|+.+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 445789999999999999999998865 344 4777777432 12344567788888999999999999999875 4
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...++++||+++|+|.+++... ...+++..++.++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 5578999999999999999654 356899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
....... ......+...|++||+.... ....++|+|+++++++|+.. |
T Consensus 160 ~~~~~~~--------~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~el~t~g 208 (279)
T cd05111 160 YPDDKKY--------FYSEHKTPIKWMALESILFG-----RYTHQSDVWSYGVTVWEMMSYG 208 (279)
T ss_pred cCCCccc--------ccCCCCCcccccCHHHhccC-----CcCchhhHHHHHHHHHHHHcCC
Confidence 3322110 01112334468888876432 34578999999999999975 6
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=226.31 Aligned_cols=199 Identities=27% Similarity=0.364 Sum_probs=162.5
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh--------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL--------SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+|.+.+.||+|+||.||+|.... +++.+|+|.+..... .....+.+..|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 58889999999999999998776 688999998864211 112345678899999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999999654 67899999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... .......+...|.+||...... .......|+|+++++++|+..|
T Consensus 159 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 159 DDIYDN--------DQNMSMQGSVFWMAPEVIHSYS---QGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred cccccc--------cccccccCCccccCHHHhcccc---CCCCccchhHHHHHHHHHHHhC
Confidence 322111 0111123456788888765332 1245678999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=225.12 Aligned_cols=193 Identities=24% Similarity=0.307 Sum_probs=162.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec---CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34678999999999999999999765 68899999976532 4567889999999999999999999999899999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999999976544578999999999999999999999999999999999999999999999999997663221
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
. .......|.+||+.... ....+.|+|+++++++|+.. |
T Consensus 157 ~-------------~~~~~~~~~ape~~~~~-----~~~~~~Di~slG~il~~l~~~g 196 (256)
T cd05039 157 D-------------SGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred c-------------cCCCcccccCchhhcCC-----cCCcHHHHHHHHHHHHHHHhcC
Confidence 1 01223468888876432 23457899999999999875 6
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=227.92 Aligned_cols=191 Identities=28% Similarity=0.429 Sum_probs=158.4
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||+|+||.||+|.... +++.|++|++....... .....+.+|+++++.++||||+++++.+...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcC-CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6899999999998776 78999999997643322 334566789999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-------- 151 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI-------- 151 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc--------
Confidence 999987654457899999999999999999999999999999999999999999999999998765321110
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....+...|++||+...+. .....|+|+++++++|+..| .|
T Consensus 152 ---~~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p 193 (277)
T cd05577 152 ---KGRAGTPGYMAPEVLQGEV-----YDFSVDWFALGCTLYEMIAGRSP 193 (277)
T ss_pred ---ccccCCCCcCCHHHhcCCC-----CCchhhhHHHHHHHHHHhhCCCC
Confidence 1123445678888765332 45779999999999999998 55
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=227.79 Aligned_cols=195 Identities=25% Similarity=0.404 Sum_probs=165.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||.|+||.||+|.+.. ++..|++|++.... .......+.+|+++++.++|+||+++++++..+..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 468889999999999999999877 78999999987653 2344567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 999999999998642 7899999999999999999999999999999999999999999999999999776543211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||+..... ...+.|+|++|++++|+..|.
T Consensus 155 ---------~~~~~~~~~y~~PE~~~~~~-----~~~~sDv~slG~il~~l~tg~ 195 (274)
T cd06609 155 ---------RNTFVGTPFWMAPEVIKQSG-----YDEKADIWSLGITAIELAKGE 195 (274)
T ss_pred ---------cccccCCccccChhhhccCC-----CCchhhHHHHHHHHHHHHhCC
Confidence 11123455678888765432 557899999999999999993
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=225.12 Aligned_cols=193 Identities=22% Similarity=0.288 Sum_probs=160.2
Q ss_pred eeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.+.. ..+..|++|++....... ..+.+.+|+++++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 359999999999998875 127899999997654333 56788999999999999999999999999999999999999
Q ss_pred CCChhcccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 184 NGDLHSLLPKQP-------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 184 ~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+++|.+++.... ...+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 999999996642 3678999999999999999999999999999999999999999999999999998765433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
.. ...........|++||..... ....+.|+|+++++++|+..
T Consensus 160 ~~--------~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 160 YY--------RKKTGGKLPIRWMAPESLKDG-----IFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred cc--------ccccCCCcCccccCHHHhccC-----CcchhhccHHHHHHHHHHHh
Confidence 21 011122344567888866544 45678999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=222.60 Aligned_cols=191 Identities=25% Similarity=0.318 Sum_probs=155.0
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
.||+|+||.||+|... .+..+|+|++.... .......+.+|+++++.++|+||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLK--DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEec--CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 5899999999999865 47899999987543 33444568899999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++... ...+.+..+..++.|++.+|.|||+.|++|+||||+||+++.++.+||+|||++..........
T Consensus 79 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 79 FLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 99988654 3457899999999999999999999999999999999999999999999999987543221110
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.........|++||+.... ....+.|+|+++++++|+.. | .|
T Consensus 151 --~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~ll~~~~~~g~~p 194 (250)
T cd05085 151 --SGLKQIPIKWTAPEALNYG-----RYSSESDVWSYGILLWETFSLGVCP 194 (250)
T ss_pred --CCCCCCcccccCHHHhccC-----CCCchhHHHHHHHHHHHHhcCCCCC
Confidence 0011223468888876433 24567899999999999886 6 44
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=224.37 Aligned_cols=194 Identities=21% Similarity=0.285 Sum_probs=152.7
Q ss_pred eecccCCeEEEEEEEcCC-CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 107 HLGTGNLGRVFLCHLRDC-TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
.||+|+||.||+|.+... .+..||+|++.... .....+.+.+|+.+++.++|+||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 389999999999977531 35579999986542 3445567899999999999999999999876 45789999999999
Q ss_pred ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccc
Q 042913 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265 (317)
Q Consensus 186 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 265 (317)
+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.............
T Consensus 80 ~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~-- 156 (257)
T cd05115 80 PLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS-- 156 (257)
T ss_pred CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC--
Confidence 999998643 35689999999999999999999999999999999999999999999999999976543332211110
Q ss_pred ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 266 ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 266 ~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.......|++||... ......++|+|+++++++|+.. | .|
T Consensus 157 -----~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p 198 (257)
T cd05115 157 -----AGKWPLKWYAPECIN-----FRKFSSRSDVWSYGITMWEAFSYGQKP 198 (257)
T ss_pred -----CCCCCcccCCHHHHc-----cCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 011234577777653 2234568999999999999874 6 44
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=230.26 Aligned_cols=205 Identities=22% Similarity=0.275 Sum_probs=161.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH---- 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 173 (317)
..++|++.+.||+|+||.||+|.... +++.||+|.+............+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 35689999999999999999998877 7899999998654333333345678999999999999999999876543
Q ss_pred ----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 174 ----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 174 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 89 RYKGSFYLVFEFC-EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCCceEEEEEcCC-CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 469999999 56888877543 346899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
........... .......++..|++||+...... .....|+|++|++++|+..|.|
T Consensus 167 ~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~----~~~~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 167 RAFSLSKNSKP------NRYTNRVVTLWYRPPELLLGERD----YGPPIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred ccccCCcccCC------CCccCcccCccccCcHHhcCCcc----cCchhhhHHHHHHHHHHHhCCC
Confidence 76543221110 00111234567888887643221 2357899999999999988843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=227.06 Aligned_cols=201 Identities=29% Similarity=0.453 Sum_probs=162.5
Q ss_pred CeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLS--AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 175 (317)
.|++.+.||+|+||.||+|.... .+++.||+|++...... ....+.+.+|+.+++.+ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 48899999999999999998742 25789999999764321 23446778899999999 599999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998653 56889999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... .....+...|++||+....... .....|+|+++++++|+..| .|
T Consensus 159 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~---~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 159 EVER---------AYSFCGTIEYMAPDIVRGGDGG---HDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred cccc---------cccccCCcccCChhhccCCCCC---CCccccHHHHHHHHHHHhcCCCC
Confidence 2110 0112345568888877542211 23568999999999999999 45
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=245.90 Aligned_cols=202 Identities=32% Similarity=0.481 Sum_probs=177.0
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.++.+.+++++..||-|+||.|-++..+. ....+|+|++++... .....+++..|.+||..++.|.||++|-.|.+++
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNS-QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecc-cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 35667889999999999999999998876 344699999977543 3466788999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++||+||-|-||.|+.+++++ +.|.+..++.++..+++|++|||.+|||+|||||+|++++.+|.+||.|||+|+++.
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999664 789999999999999999999999999999999999999999999999999999986
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..... -| ..|+|||..+++.--+.-.+..|.|+++..+.|+..|-|
T Consensus 572 ~g~KT-wT---------------FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 572 SGRKT-WT---------------FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred cCCce-ee---------------ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 54421 12 236788888887776777899999999999999999955
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=226.77 Aligned_cols=200 Identities=17% Similarity=0.194 Sum_probs=160.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+|++.+.||+|+||.||+|+.... ..+.|++|.+.... .......+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 447899999999999999999987531 34679999886532 2335677899999999999999999999999989
Q ss_pred EEEEEEcccCCCChhcccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPN-------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999865431 16899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|+++........ ......+...|++||+.... ....+.|+|+++++++|+..
T Consensus 162 ~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 162 SLSKDVYNSEYY---------KLRNALIPLRWLAPEAVQED-----DFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred ccccccCccccc---------ccCCceeEEeecChhhhccC-----CCCchhhHHHHHHHHHHHHh
Confidence 998644321110 01111223347778765432 23467899999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=233.08 Aligned_cols=195 Identities=22% Similarity=0.317 Sum_probs=160.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+.|.....||+|+||.||++.... ++..||||.+... .....+.+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH-TGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC-CCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 344555679999999999998776 7889999998654 3344567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++..........
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999998843 458899999999999999999999999999999999999999999999999987653322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||+... .....+.|+|+++++++|+..| .|
T Consensus 176 ----------~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 176 ----------KSLVGTPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred ----------ceeecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 11234556778876643 3345789999999999999999 44
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=232.65 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=168.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC----CCcceEEEEE-EecCEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH----PFLPTLYAHL-EVSHYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~ 175 (317)
+|++.+.||+|+||.||+|.+.......+|+|+....... ....+..|+.++..+.. .++..+++.+ ..+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~--~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS--KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC--CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999887623467899987654211 11257788999888873 6899999999 578899
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-----CcEEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-----GHIMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-----~~~kl~DFG~a~ 250 (317)
|+||+.+ |.+|.++....+.+.|+..++..++.|++.+|++||+.|++||||||+|+++... ..++|.|||+|+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 9999999877767889999999999999999999999999999999999999854 369999999998
Q ss_pred cCCCCCCeeeccccccccccccc-ccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRK-SCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+.......... .+.++. .....|+.+|++.+++...++.+++|+|++.|+++|+..| +|
T Consensus 176 ~~~~~~~~~~~------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LP 236 (322)
T KOG1164|consen 176 RFKYVGDSGGN------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLP 236 (322)
T ss_pred cccccCCCCcc------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCC
Confidence 43321111000 112222 3455699999999999999999999999999999999999 88
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=228.21 Aligned_cols=208 Identities=16% Similarity=0.220 Sum_probs=146.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCC---CceEEEEEeehhhhcH--H-H------HHHHHHHHHHHHhcCCCCcc
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCT---SANFALKVVDKDLLSA--K-K------LSHVQMEAEILSMLDHPFLP 163 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~--~-~------~~~~~~E~~~l~~l~h~~iv 163 (317)
++..++|++.+.||+|+||.||+|.+.. + +..+++|+........ + . ......+...+..+.|+|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 4556899999999999999999998876 4 5677777653321110 0 0 01122233445567899999
Q ss_pred eEEEEEEecC----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 164 TLYAHLEVSH----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 164 ~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
++++.+.... ..+++++++ ..++.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9998765433 457888887 55777666442 3467888999999999999999999999999999999999999
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.++|+|||+|+.+......... .........++..|++|+. ........++|+||++++++|+..| .|
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~-----~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDA-----HNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred cEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHH-----hCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999876432211100 0000011124444555554 4444567899999999999999999 55
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=222.09 Aligned_cols=197 Identities=23% Similarity=0.377 Sum_probs=166.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||.|+||.||++.+.. ++..|++|++............+.+|+++++.++|+|++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999887 78999999998765555667788999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 181 YCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999987643 467899999999999999999999999999999999999999999999999999765443311
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. ...+...|++||+... .......|+|+++++++|+..|
T Consensus 160 ~~----------~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g 199 (258)
T cd08215 160 AK----------TVVGTPYYLSPELCQN-----KPYNYKSDIWSLGCVLYELCTL 199 (258)
T ss_pred ec----------ceeeeecccChhHhcc-----CCCCccccHHHHHHHHHHHHcC
Confidence 11 1123345677776533 3345779999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=224.03 Aligned_cols=192 Identities=19% Similarity=0.257 Sum_probs=153.7
Q ss_pred eeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
++||+|+||.||+|.+...+ +..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 36999999999999876522 378999998765433 45567889999999999999999999876 456899999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++... ..+++..++.++.|++.||.|||..+++|+||||+|||++.++.+||+|||+++.............
T Consensus 79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999999654 4789999999999999999999999999999999999999999999999999986644332111100
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...+...|++||+.... ....+.|+|+++++++|+.. |
T Consensus 157 -------~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 157 -------AGRWPLKWYAPECINYG-----KFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -------CccccccccCHHHhcCC-----CCCccchHHHHHHHHHHHHcCC
Confidence 11122357888766432 24568999999999999986 6
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=220.75 Aligned_cols=195 Identities=24% Similarity=0.350 Sum_probs=167.4
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|++|.||++.... .++.|++|.+............+.+|+++++.++|+|++++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999998876 68899999998776555667889999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++... ..+++..++.++.|++.+|.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 99999999998654 67899999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.....+...|.+||+..... .....|+|+++++++|+..|
T Consensus 156 --------~~~~~~~~~y~~pe~~~~~~-----~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 156 --------DASVVGTPYWMAPEVIEMSG-----ASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred --------ccccccchhhcCHhhhcCCC-----CCcchhHHHHHHHHHHHHhC
Confidence 11224455677787664322 45778999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=233.39 Aligned_cols=202 Identities=20% Similarity=0.246 Sum_probs=160.0
Q ss_pred eeeccc--CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTG--NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
..||+| +||+||++.+.. +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 999999998876 79999999997655455666789999999999999999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++||+.+............ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 161 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV-V 161 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc-c
Confidence 999999987654556899999999999999999999999999999999999999999999999876433211110000 0
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. ......+...|++||+...+... .....|+|+++++++|+..|-
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~---~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 162 YD--FPQFSTSVLPWLSPELLRQDLYG---YNVKSDIYSVGITACELATGR 207 (328)
T ss_pred cc--ccccccCccCccChhhhcCCCCC---CCchhhHHHHHHHHHHHHhCC
Confidence 00 00111234558889887543222 347899999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=222.96 Aligned_cols=195 Identities=23% Similarity=0.327 Sum_probs=162.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh---hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
+|++.+.||+|+||+||+|.... +++.|++|.+.... ...+..+.+.+|+.+++.++|+||+++++++.....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcC-CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 47788899999999999998876 68899999986543 123456788999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
++||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 99999999999999653 5688999999999999999999999999999999999999999999999999876533220
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.....++..|++||+..... ......|+|+++++++|+..|
T Consensus 158 -----------~~~~~~~~~y~~pe~~~~~~----~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 158 -----------AKSFKGSPYWMAPEVIAQQG----GYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred -----------ccccCCCcceeCHHHhcCCC----CCCchhhhHHHHHHHHHHHhC
Confidence 01123445577777654322 246778999999999999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=225.01 Aligned_cols=185 Identities=21% Similarity=0.208 Sum_probs=150.1
Q ss_pred eeecccCCeEEEEEEEcCCCC----------ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 106 RHLGTGNLGRVFLCHLRDCTS----------ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+.||+|+||.||+|.+.. ++ ..+++|++.... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~-~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRV-QSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEec-cCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 358999999999999876 33 357778765442 115678889999999999999999999887 778
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-------cEEEeeecc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-------HIMLSDFDL 248 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-------~~kl~DFG~ 248 (317)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999997642 2689999999999999999999999999999999999999887 799999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+....... ...+...|++||+..... .......|+|+++++++|+..|
T Consensus 155 a~~~~~~~--------------~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~~~~~l~~~ 202 (259)
T cd05037 155 PITVLSRE--------------ERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSN 202 (259)
T ss_pred cccccccc--------------ccccCCCccChhhhcCCC---CCcchhhHHHHHHHHHHHHHhC
Confidence 97654311 112334578888765432 2345778999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=218.42 Aligned_cols=212 Identities=19% Similarity=0.171 Sum_probs=165.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-----
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE----- 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 170 (317)
.++.++|+|.+.||+|||+-||+++... +++.+|+|.+... ..+..+..++|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s-~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLS-TGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccC-cccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 5777899999999999999999998766 8899999999876 3567788999999999999999999987753
Q ss_pred ecCEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCcEEEeee
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~~kl~DF 246 (317)
.....|++++|+..|+|.+.+... .+..+++.+++.|+.+|++||++||+.. ++||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 345699999999999999998754 3446899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|.+.+..-.-... +..-.-........+--|.+||--....+. .-..+.|+||+||+++++.=|
T Consensus 174 GS~~~a~i~i~~~-~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~--ti~ertDIWSLGCtLYa~mf~ 237 (302)
T KOG2345|consen 174 GSATQAPIQIEGS-RQALRLQEWAEERCTIPYRAPELFNVKSHC--TITERTDIWSLGCTLYAMMFG 237 (302)
T ss_pred cCccccceEeech-HHHHHHHHHHHHhCCCcccCchheecccCc--ccccccchhhhhHHHHHHHHc
Confidence 9987654311100 000000111112223346666654333222 235788999999999987655
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=224.36 Aligned_cols=188 Identities=16% Similarity=0.161 Sum_probs=149.5
Q ss_pred eecccCCeEEEEEEEcCC-----------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 107 HLGTGNLGRVFLCHLRDC-----------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.||+|+||.||+|..... ....|++|++... .......+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 589999999999975421 1235888887654 234445778899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc-------EEEeeecc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH-------IMLSDFDL 248 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~-------~kl~DFG~ 248 (317)
++||||+++++|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++++|||+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999998887543 356899999999999999999999999999999999999987664 89999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC-CC-CC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP-GG-VP 315 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~G-~p 315 (317)
+........ ..+...|++||..... .....++|+|+++++++|+. .| .|
T Consensus 159 ~~~~~~~~~--------------~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 159 PITVLSRQE--------------CVERIPWIAPECVEDS----KNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred CccccCccc--------------ccccccccChhhhcCC----CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 865432211 1234568888876421 22356789999999999986 45 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=227.95 Aligned_cols=199 Identities=17% Similarity=0.235 Sum_probs=158.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCE----
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHY---- 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---- 174 (317)
++|++.+.||+|+||.||+|.+.. +++.||+|.+............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 468999999999999999999877 7899999998765433334467788999999995 6999999999876655
Q ss_pred -EEEEEcccCCCChhcccccCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeeccc
Q 042913 175 -ICFLIDYCPNGDLHSLLPKQP---NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLC 249 (317)
Q Consensus 175 -~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a 249 (317)
.|+||||++ ++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 899999996 58888875432 346899999999999999999999999999999999999998 889999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+.+...... .....+...|.+||+.... .....+.|+|+++++++|+..|-
T Consensus 159 ~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~ 209 (295)
T cd07837 159 RAFSIPVKS----------YTHEIVTLWYRAPEVLLGS----THYSTPVDIWSVGCIFAEMSRKQ 209 (295)
T ss_pred eecCCCccc----------cCCcccccCCCChHHhhCC----CCCCchHHHHHHHHHHHHHHcCC
Confidence 765332110 0111234567888866421 12246789999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=224.71 Aligned_cols=200 Identities=19% Similarity=0.243 Sum_probs=158.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
+...+|.+.+.||+|+||.||+|.+... ....|++|...... .....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 4557899999999999999999987642 23578999886543 24455788999999999999999999998875 45
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 78999999999999999654 24589999999999999999999999999999999999999999999999999976544
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP-GG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~G 313 (317)
......+ .......|++||+.. ........|+|+++++++|+. .|
T Consensus 160 ~~~~~~~---------~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g 205 (270)
T cd05056 160 ESYYKAS---------KGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMLG 205 (270)
T ss_pred ccceecC---------CCCccccccChhhhc-----cCCCCchhhhHHHHHHHHHHHHcC
Confidence 3211110 011223467777553 233457799999999999966 46
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=233.07 Aligned_cols=200 Identities=18% Similarity=0.221 Sum_probs=159.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----C
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----H 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 173 (317)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3689999999999999999998876 78999999986432 234456678899999999999999999886543 3
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..|+|+||+ .++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 589999999 5688877743 568999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....... ......++..|++||.... ........|+|+++++++|+..|-|
T Consensus 158 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 158 PEHDHTG-------FLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred ccccccC-------CcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 3221110 0111234556788876532 2234678999999999999999943
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=226.21 Aligned_cols=186 Identities=19% Similarity=0.180 Sum_probs=147.4
Q ss_pred eecccCCeEEEEEEEcCC-----------------------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcc
Q 042913 107 HLGTGNLGRVFLCHLRDC-----------------------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 163 (317)
.||+|+||.||+|..... ....|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999975321 1235888888654 234446788899999999999999
Q ss_pred eEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----
Q 042913 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---- 239 (317)
Q Consensus 164 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---- 239 (317)
++++++......++||||+++++|..++... ...+++..+..++.||+.||.|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988643 35689999999999999999999999999999999999997644
Q ss_pred ---cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc-CCC
Q 042913 240 ---HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ-PGG 313 (317)
Q Consensus 240 ---~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~G 313 (317)
.++|+|||++........ ..+...|++||+.... .....+.|+|+++++++|+ ..|
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~--------------~~~~~~~~aPe~~~~~----~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREE--------------RVERIPWIAPECVPGG----NSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred ccceeeecCCccccccccccc--------------cccCCcccCchhhcCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 489999999764322111 1233457888866432 3346789999999999997 455
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=222.80 Aligned_cols=197 Identities=19% Similarity=0.283 Sum_probs=164.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--ecCEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE--VSHYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 178 (317)
+|++.+.||.|+||.||++.+.. ++..||+|++..........+.+.+|+++++.++|+||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999998877 7889999999776556666778899999999999999999999775 34668999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLH-----ALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH-----~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998643 2457899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ...++..|++||...... .....|+|+++.+++|+..|
T Consensus 160 ~~~~~~~~~----------~~~~~~~~~~pE~~~~~~-----~~~~~Dv~slG~il~~l~~g 206 (265)
T cd08217 160 LGHDSSFAK----------TYVGTPYYMSPEQLNHMS-----YDEKSDIWSLGCLIYELCAL 206 (265)
T ss_pred ccCCccccc----------ccccCCCccChhhhcCCC-----CCchhHHHHHHHHHHHHHHC
Confidence 654332111 113455678887764332 45678999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=223.15 Aligned_cols=190 Identities=22% Similarity=0.288 Sum_probs=156.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.+++.++|+||+++++++..+ ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 46889999986542 235678899999999999999999998754 4799
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 99999999999999765555689999999999999999999999999999999999999999999999999875432110
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.......|.+||+... .....+.|+|+++++++|+.. |
T Consensus 156 -------------~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~el~~~g 194 (254)
T cd05083 156 -------------NSKLPVKWTAPEALKH-----KKFSSKSDVWSYGVLLWEVFSYG 194 (254)
T ss_pred -------------CCCCCceecCHHHhcc-----CCcCchhhHHHHHHHHHHHHhCC
Confidence 0011245777776542 334578899999999999875 6
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=227.61 Aligned_cols=196 Identities=26% Similarity=0.346 Sum_probs=166.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||++.+.. +++.+++|.+..... ......+.+|+++++.++||||+++++.+...+.+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 467888899999999999999876 789999999876532 355577889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999999996543 678999999999999999999999 99999999999999999999999999998655321110
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...+...|++||+.... ....+.|+|+++++++|+..| .|
T Consensus 158 ------------~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 158 ------------TFVGTSSYMAPERIQGN-----DYSVKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred ------------cccCChhccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhCCCC
Confidence 13455678888876544 445779999999999999998 44
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.03 Aligned_cols=218 Identities=29% Similarity=0.456 Sum_probs=175.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehh-hhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.++...-|..++.||-|+||.|.++.-.+ +...+|+|.+++. .+.......++.|..||..-+.+-||+||-.|.+.+
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvD-T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVD-TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecc-hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 35566789999999999999999998777 7889999999764 445567788999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||+|++||++-.+|-+ .+.|++..++.++..+.+|+++.|..|+|||||||+|||||.+|++||.|||||.-+.
T Consensus 703 nLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred ceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999999855 4889999999999999999999999999999999999999999999999999994332
Q ss_pred C----------CCCeeec-----------ccccccccc-----cc-cccCCCCCcccccccccceeccchhhhccCCccc
Q 042913 254 V----------VPTLVET-----------NVGSATRRR-----RR-KSCNGFGSAKRRQENVMEFVAEPRREQREHPAQY 306 (317)
Q Consensus 254 ~----------~~~~~~~-----------~~~~~~~~~-----~~-~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (317)
= +...... .+-..-+++ ++ ....-.|+|-|+.+++.......-.+|-|+-+.+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1 1110000 111111111 11 1112347777777777777777788999999999
Q ss_pred ccccCCCCC
Q 042913 307 SVEQPGGVP 315 (317)
Q Consensus 307 ~~e~~~G~p 315 (317)
+.|+.-|.|
T Consensus 861 l~em~~g~~ 869 (1034)
T KOG0608|consen 861 LYEMLVGQP 869 (1034)
T ss_pred HHHHhhCCC
Confidence 999999943
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=224.77 Aligned_cols=199 Identities=22% Similarity=0.254 Sum_probs=153.8
Q ss_pred eEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC------
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH------ 173 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 173 (317)
|++.+.||+|+||.||+|.+.. .++..||||++..........+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678889999999999998653 24689999999876656666778899999999999999999999875432
Q ss_pred EEEEEEcccCCCChhcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQ----PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
..+++++|+.+++|.+++... ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999999998876421 1234788999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
+............ .......|++||.. ........+|+|+++++++|+.. |
T Consensus 161 ~~~~~~~~~~~~~--------~~~~~~~~~~pe~~-----~~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 161 KKIYSGDYYRQGC--------ASKLPVKWLALESL-----ADNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred ccccCCcceecCC--------CccCchhhcCHhHH-----hcCccchhhhhHHHHHHHHHHhhCC
Confidence 8654322110000 01112234555543 33334567899999999999887 6
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=228.93 Aligned_cols=202 Identities=20% Similarity=0.259 Sum_probs=158.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|.+.. ++. .+|+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999998765 344 57888886543 233345688899999999999999999988654
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..++++||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 467999999999999998654 345889999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC--CCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG--GVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~--G~p 315 (317)
......... ........|++||+.. ......+.|+|+++++++|+.. +.|
T Consensus 160 ~~~~~~~~~--------~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 160 EGDEKEYNA--------DGGKMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred cCccccccc--------CCCccccccCCHHHhc-----cCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 432221110 0112234577777553 3345678899999999999864 465
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=225.31 Aligned_cols=190 Identities=29% Similarity=0.472 Sum_probs=150.8
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHH---HHHHHhcCCCCcceEEEEEEecCEEEEEEccc
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQME---AEILSMLDHPFLPTLYAHLEVSHYICFLIDYC 182 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 182 (317)
.||+|+||.||+|.... +++.||+|.+.+..... .....+..| +.+++...|++|+.+++.+...+.+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEec-CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 38999999999998876 78999999987643221 111222333 34455567999999999999999999999999
Q ss_pred CCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecc
Q 042913 183 PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 183 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
.+++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----- 152 (278)
T cd05606 80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----- 152 (278)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-----
Confidence 99999998854 36799999999999999999999999999999999999999999999999999875532211
Q ss_pred cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....++..|++||....+ .....+.|+|+++++++|+..| .|
T Consensus 153 -------~~~~~~~~y~aPE~~~~~----~~~~~~~Di~s~G~~l~~l~~g~~p 195 (278)
T cd05606 153 -------HASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRGHSP 195 (278)
T ss_pred -------cCcCCCcCCcCcHHhcCC----CCCCcccchHhHHHHHHHHHhCCCC
Confidence 012355678888876432 2245678999999999999999 44
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=225.89 Aligned_cols=188 Identities=29% Similarity=0.469 Sum_probs=150.2
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHH---hcCCCCcceEEEEEEecCEEEEEEccc
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILS---MLDHPFLPTLYAHLEVSHYICFLIDYC 182 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~e~~ 182 (317)
.||+|+||.||++.+.. +++.+|+|.+.+..... .......+|..+++ ..+|+||+.+++.+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECC-CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 38999999999998876 78999999987653322 22223344444433 447999999999999999999999999
Q ss_pred CCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecc
Q 042913 183 PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 183 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
++++|.+++... +.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++........
T Consensus 80 ~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----- 152 (279)
T cd05633 80 NGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----- 152 (279)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-----
Confidence 999999988653 5699999999999999999999999999999999999999999999999999875532211
Q ss_pred cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....++..|++||.... ......+.|+|+++++++|+..|
T Consensus 153 -------~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g 192 (279)
T cd05633 153 -------HASVGTHGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRG 192 (279)
T ss_pred -------cCcCCCcCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhC
Confidence 11245667888887642 22345778999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=223.03 Aligned_cols=197 Identities=21% Similarity=0.340 Sum_probs=165.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|.+.+.||+|+||.||++.... ++..+|+|.+..........+.+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999887 78899999997754444555678899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCCCCee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~ 259 (317)
|+++++|.+++.+.....+++..++.++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 99999999999765555689999999999999999999999999999999999999875 57999999997664322211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
. ...+...|++||+.... ....+.|+|+++++++|+..|
T Consensus 160 ~----------~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 160 Y----------TCVGTPYYLSPEICQNR-----PYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred c----------ccCCCccccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhC
Confidence 1 12345567888865432 234679999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=224.56 Aligned_cols=194 Identities=23% Similarity=0.336 Sum_probs=162.0
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
-|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+++++.++|+||+++++.+..+..+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC-CCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788899999999999998776 68899999986543 23445678899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 157 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--
Confidence 9999999999853 45899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|++||+... ......+|+|+++++++|+..|.
T Consensus 158 --------~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~ 198 (277)
T cd06641 158 --------RNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred --------hccccCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHHcCC
Confidence 111234556788887643 23456789999999999999993
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=226.53 Aligned_cols=198 Identities=19% Similarity=0.259 Sum_probs=163.3
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|++.+.||.|++|.||+|.+.. ++..||+|++............+.+|+++++.++|+|++++++++...+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6778899999999999999876 789999999976543444446678899999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
+ +++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--- 155 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--- 155 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence 9 578999987654457899999999999999999999999999999999999999999999999999765432111
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....++..|++||+..... ....+.|+|++|++++|+..|-|
T Consensus 156 -------~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 156 -------YTHEVVTLWYRAPEILLGSR----QYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred -------cCccccccCCCCCceeecCc----ccCcHHHHHHHHHHHHHHHhCCC
Confidence 01113356688888764321 22467899999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=223.61 Aligned_cols=205 Identities=18% Similarity=0.187 Sum_probs=164.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCC---CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-c
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDC---TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-S 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 172 (317)
+..++|++.+.||+|+||.||+|.+... .+..|++|.+... ........+.+|+.+++.++|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4568899999999999999999987752 2678999988643 245556788999999999999999999998765 5
Q ss_pred CEEEEEEcccCCCChhcccccCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPN------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
...+++++|+.+++|.+++..... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 778999999999999999865322 45899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
|+++.+......... . ...+...|++||+.... ....++|+|+++++++|+.. | .|
T Consensus 162 g~~~~~~~~~~~~~~---~-----~~~~~~~y~apE~~~~~-----~~~~~~Di~slG~~l~el~~~g~~p 219 (280)
T cd05043 162 ALSRDLFPMDYHCLG---D-----NENRPVKWMALESLVNK-----EYSSASDVWSFGVLLWELMTLGQTP 219 (280)
T ss_pred CCcccccCCceEEeC---C-----CCCcchhccCHHHHhcC-----CCCchhhHHHhHHHHHHHhcCCCCC
Confidence 999876443221110 0 11223458888876433 23577899999999999986 6 44
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=225.03 Aligned_cols=195 Identities=24% Similarity=0.343 Sum_probs=163.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.+.|+||+++++.+..++..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-CCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357788889999999999998876 68899999987543 2345578899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 99999999999854 45889999999999999999999999999999999999999999999999999765432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|.+||+... .....+.|+|+++++++|+..|.
T Consensus 158 ---------~~~~~~~~~y~apE~~~~-----~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06640 158 ---------RNTFVGTPFWMAPEVIQQ-----SAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred ---------cccccCcccccCHhHhcc-----CCCccHHHHHHHHHHHHHHHHCC
Confidence 111234556777877643 33567899999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.15 Aligned_cols=191 Identities=23% Similarity=0.318 Sum_probs=161.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+......-++-||.|+.|.||+|+.+. +.||||.++.- -..+|+-|++|+|+||+.|.|+|...-.
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~n---etVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLHN---ETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeeccC---ceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 34444555567889999999999999885 89999987421 2347888999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|||||||..|.|+.+|+. +..+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+..
T Consensus 187 yCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999965 57889999999999999999999999999999999999999999999999999988766
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..+ -+.++ |+-.||+||.+..+- ...+.|+|+-+.+++|+.+| .|
T Consensus 265 ~ST-kMSFa----------GTVaWMAPEvIrneP-----csEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 265 KST-KMSFA----------GTVAWMAPEVIRNEP-----CSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred hhh-hhhhh----------hhHhhhCHHHhhcCC-----cccccceehhHHHHHHHHhcCCC
Confidence 532 33444 455799999876442 24577899999999999998 55
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=220.82 Aligned_cols=195 Identities=23% Similarity=0.298 Sum_probs=159.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|++.+.||+|+||.||++.+.. +..+|+|.+....... ..+.+|+++++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC--CCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 4688999999999999999998764 6789999987543332 4577899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++... ...+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999999998654 245889999999999999999999999999999999999999999999999998765322110
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
. ........+|++||+...+ .....+|+|+++++++|+.. |
T Consensus 157 --~-------~~~~~~~~~~~aPe~~~~~-----~~~~~~Dv~slG~~l~el~~~g 198 (256)
T cd05112 157 --S-------STGTKFPVKWSSPEVFSFS-----KYSSKSDVWSFGVLMWEVFSEG 198 (256)
T ss_pred --c-------cCCCccchhhcCHhHhccC-----CcChHHHHHHHHHHHHHHHcCC
Confidence 0 0011223468888876543 24467899999999999886 6
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=224.87 Aligned_cols=198 Identities=20% Similarity=0.266 Sum_probs=160.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||.|++|.||+|.+.. ++..||+|++..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-CCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999876 789999999876532 2234566789999999999999999999999999999999
Q ss_pred ccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 181 YCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
|++ ++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 996 58888775432 346899999999999999999999999999999999999999999999999999755332110
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....++..|++||....+ .....+.|+|++|++++|+..|.|
T Consensus 157 ---------~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 157 ---------FSNEVVTLWYRAPDVLLGS----RTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred ---------cccccccccccChHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0111334568888866432 123567899999999999999943
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=229.17 Aligned_cols=203 Identities=18% Similarity=0.197 Sum_probs=158.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCC-CCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDC-TSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HYIC 176 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 176 (317)
+|++.+.||+|+||.||+|..... .++.||+|.+..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 588999999999999999987653 578999999976421 123345678899999999999999999999887 8899
Q ss_pred EEEcccCCCChhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc----CCcEEEeeeccc
Q 042913 177 FLIDYCPNGDLHSLLPKQ---PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE----DGHIMLSDFDLC 249 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~----~~~~kl~DFG~a 249 (317)
+||||++ ++|.+++... ....+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 5676665422 1236899999999999999999999999999999999999999 899999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+......... .......+...|++||..... .......|+|++|++++|+..|.|
T Consensus 160 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 160 RLFNAPLKPL-------ADLDPVVVTIWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred cccCCCcccc-------cccCCccccccccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhcCC
Confidence 8664432210 011112344557888765321 123567899999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=217.54 Aligned_cols=204 Identities=23% Similarity=0.342 Sum_probs=173.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
+..-.|+|+++||+|+||.+++|...- +++.||||.-... ....++..|.+..+.|. .++|..+|-+...+.+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~-nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY-NNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccc-cCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 555689999999999999999998776 7899999987544 23356677888888775 78999999888888889
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-----cEEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-----HIMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-----~~kl~DFG~a~ 250 (317)
.||+|++ |-+|.|++.- .+..|+.++++.++.|++.-++|+|++.+|.|||||+|+||...+ .+.|+|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999999 9999998853 468899999999999999999999999999999999999997543 69999999999
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
++....+. .-..+++.-.--|+.+|++.|.+-+.|++||+|+++++-+.++|..| ||
T Consensus 178 ~YrDp~Tk--------qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 178 EYRDPKTK--------QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred hhcCcccc--------ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 98765542 11223344445689999999999999999999999999999999999 87
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=221.63 Aligned_cols=197 Identities=24% Similarity=0.347 Sum_probs=167.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|++|.||+|.+.. +++.|++|++...... .....+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 468999999999999999999887 7899999998765432 55678899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||+++++|.+++... ..+++..++.++.||+.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999999654 678999999999999999999999 99999999999999999999999999998765432221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. ....+...|++||+.... ..+...|+|+++++++|+..| .|
T Consensus 157 ~----------~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~tg~~p 199 (264)
T cd06623 157 C----------NTFVGTVTYMSPERIQGE-----SYSYAADIWSLGLTLLECALGKFP 199 (264)
T ss_pred c----------cceeecccccCHhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCC
Confidence 1 111344567788776443 456789999999999999998 44
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=224.64 Aligned_cols=205 Identities=21% Similarity=0.237 Sum_probs=160.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++.+.||+|+||.||+|.+... .+..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3456799999999999999999987641 35789999886442 233445688899999999999999999999988
Q ss_pred CEEEEEEcccCCCChhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEEe
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP-----NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIMLS 244 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl~ 244 (317)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999986532 12588999999999999999999999999999999999998654 69999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
|||+++........... ........|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 162 dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 162 DFGMARDIYRASYYRKG--------GRAMLPIKWMPPEAFLD-----GIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred cCccccccCCccceecC--------CCCCccHhhCCHHHHhc-----CCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999876322211000 00011235777777643 234578999999999999775 6 44
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=231.34 Aligned_cols=195 Identities=23% Similarity=0.284 Sum_probs=161.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH---- 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 173 (317)
..++|++++.||+|+||.||++.... ++..||+|++............+.+|+++++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35789999999999999999998876 7899999998654434445567889999999999999999999886543
Q ss_pred --EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 174 --YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 174 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 8899888753 4689999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ...++..|++||..... .......|+|+++++++|+..|-
T Consensus 168 ~~~~~~-------------~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 168 TDSEMT-------------GYVVTRWYRAPEVILNW----MHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred cccCcc-------------ccccCCcccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 533211 11335568888876432 12457799999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=226.41 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=159.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++.+.||+|+||.||+|.+.. .++..||+|++.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 45789999999999999999998642 256889999987543 3344567889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP--------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
..+++|||+++++|.+++.... ...+++..++.++.||+.||.|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986421 12467888999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG- 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~- 312 (317)
+++.++.++|+|||+++........... ........|++||... ......+.|+|+++++++|+..
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKAS--------ENDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred EecCCCceEECccccceecccCcccccc--------CCCccChhhcCHHHHh-----cCCCCchhHHHHHHHHHHHHHhC
Confidence 9999999999999998765332210000 0001122466676543 3334577899999999999875
Q ss_pred C
Q 042913 313 G 313 (317)
Q Consensus 313 G 313 (317)
|
T Consensus 229 ~ 229 (288)
T cd05050 229 G 229 (288)
T ss_pred C
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=221.96 Aligned_cols=197 Identities=24% Similarity=0.297 Sum_probs=160.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCC---CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCT---SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+++.+.||.|+||.||++.+.... +..||+|++.... .......+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 356788999999999999887622 3889999996553 233567889999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.......+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999999997653333899999999999999999999999999999999999999999999999999776543211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.. ....+...|++||+.. ........|+|+++++++|+.. |
T Consensus 160 ~~---------~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 160 KK---------KGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred cc---------ccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCC
Confidence 10 0112345677777653 2334578999999999999976 5
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=232.94 Aligned_cols=202 Identities=19% Similarity=0.260 Sum_probs=161.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----ecCEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE----VSHYI 175 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~ 175 (317)
++|.+.+.||+|+||.||+|.... +++.||+|++............+.+|+.+++.++|+||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999998887 7899999998765433345567788999999999999999998875 34578
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 5789998854 356999999999999999999999999999999999999999999999999998765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..... .......+...|.+||..... .....+.|+|++|++++|+..|-|
T Consensus 161 ~~~~~------~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 161 PTEHK------YFMTEYVATRWYRAPELLLSL----PEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred CcCCC------cccccccccccccChHHhcCC----cccccccchHHHHHHHHHHHcCCC
Confidence 21100 000112345567788865321 224577999999999999998843
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=225.02 Aligned_cols=194 Identities=22% Similarity=0.334 Sum_probs=161.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 177 (317)
.|++.+.||+|+||.||+|.+.. +++.|++|.+.... .......+.+|+.+++.++ |+|++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-CCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 47788899999999999999876 78999999986543 2344567888999999986 9999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. ..+++..++.++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999999854 3689999999999999999999999999999999999999999999999999976644321
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
. .....+...|++||+...+ .....+.|+|+++++++|+..|
T Consensus 157 ~----------~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~ll~g 198 (277)
T cd06917 157 K----------RSTFVGTPYWMAPEVITEG----KYYDTKADIWSLGITIYEMATG 198 (277)
T ss_pred c----------cccccCCcceeCHHHhccC----CccccchhHHHHHHHHHHHHhC
Confidence 1 1112345568888876432 2335678999999999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=223.39 Aligned_cols=191 Identities=25% Similarity=0.346 Sum_probs=151.4
Q ss_pred eecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEEEEcccC
Q 042913 107 HLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
.||+|+||.||+|.+.. ++. .+++|.+... ........+.+|+++++++ +||||+++++++...+..|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcC-CCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999998876 444 4688887632 2334556788999999999 79999999999999999999999999
Q ss_pred CCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 184 NGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 184 ~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
+++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999986432 134789999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+....... ......+..|++||+... .....+.|+|+++++++|+.. | .|
T Consensus 160 ~~~~~~~~-----------~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQEVYVK-----------KTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccchhhh-----------ccCCCCccccCChHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 63221100 000112345888886632 234578999999999999984 5 44
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=218.66 Aligned_cols=197 Identities=26% Similarity=0.363 Sum_probs=167.5
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 178 (317)
+|++.+.||+|++|.||+|.... +++.|++|++..........+.+.+|+++++.++|+||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47889999999999999999886 789999999977654456678899999999999999999999999988 899999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
+||+++++|.+++... ..+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999999664 47899999999999999999999999999999999999999999999999998776554321
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......+...|.+||+.... ......|+|+++++++|+..|
T Consensus 158 --------~~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g 199 (260)
T cd06606 158 --------EGTGSVRGTPYWMAPEVIRGE-----EYGRAADIWSLGCTVIEMATG 199 (260)
T ss_pred --------ccccCCCCCccccCHhhhcCC-----CCCchhhHHHHHHHHHHHHhC
Confidence 011122445566777765433 367889999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=221.97 Aligned_cols=192 Identities=20% Similarity=0.277 Sum_probs=156.4
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
..||+|+||.||+|.+.. ++..|++|.+... .....+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDLS-TQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEecC-CCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 459999999999998876 7889999988654 2344567899999999999999999999999999999999999999
Q ss_pred ChhcccccCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCCCCCeeecc
Q 042913 186 DLHSLLPKQPNNRF--SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVVPTLVETN 262 (317)
Q Consensus 186 sL~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~ 262 (317)
+|.+++.... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.........
T Consensus 91 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~---- 165 (268)
T cd06624 91 SLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---- 165 (268)
T ss_pred CHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc----
Confidence 9999986532 334 78888999999999999999999999999999999986 679999999998755322211
Q ss_pred cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 263 VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 263 ~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||+...+... .....|+|+++.+++|+..|.
T Consensus 166 ------~~~~~~~~~~~aPE~~~~~~~~---~~~~~Dv~slGvvl~~l~~g~ 208 (268)
T cd06624 166 ------TETFTGTLQYMAPEVIDKGPRG---YGAPADIWSLGCTIVEMATGK 208 (268)
T ss_pred ------cccCCCCccccChhhhcccccc---CCchhhhHHHHHHHHHHHhCC
Confidence 1112356678888886543222 235789999999999999884
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=220.91 Aligned_cols=189 Identities=32% Similarity=0.501 Sum_probs=157.8
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||.|+||.||+|.+.. +++.+++|++...... ....+.+.+|+.+++.++|+||+++++.+..+..+++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6899999999999887 7899999999765332 2445678999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++.+. ..+++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 80 L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--------- 148 (262)
T cd05572 80 LWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--------- 148 (262)
T ss_pred HHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---------
Confidence 99999653 5689999999999999999999999999999999999999999999999999976643210
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.....+...|++||+... .......|+|+++++++|+..| .|
T Consensus 149 --~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 149 --TWTFCGTPEYVAPEIILN-----KGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred --cccccCCcCccChhHhcC-----CCCCChhhhhhhHHHHHHHHhCCCC
Confidence 011134456777876532 2235678999999999999998 44
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=222.89 Aligned_cols=198 Identities=16% Similarity=0.185 Sum_probs=150.8
Q ss_pred eecccCCeEEEEEEEcCC-CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 107 HLGTGNLGRVFLCHLRDC-TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
+||+|+||.||++..... ....+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999976431 23456677665432 2345578899999999999999999999999999999999999999
Q ss_pred ChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 186 DLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 186 sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+|.+++.... ...+++..++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~----- 155 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI----- 155 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh-----
Confidence 9999986532 234677788899999999999999999999999999999999999999999998542211110
Q ss_pred ccccccccccccCCCCCccccccccc--ceeccchhhhccCCcccccccCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVM--EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~--~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......+...|++||+...... ........+|+|+++++++|+..|
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 204 (268)
T cd05086 156 ---ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFEN 204 (268)
T ss_pred ---hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhC
Confidence 00011233456888887643211 122446789999999999998743
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=221.09 Aligned_cols=196 Identities=19% Similarity=0.215 Sum_probs=150.5
Q ss_pred eecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-ecCEEEEEEcccC
Q 042913 107 HLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE-VSHYICFLIDYCP 183 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 183 (317)
.||+|+||.||+|.+.. ..+..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 58999999999998653 234579999885432 3345677889999999999999999999765 4566899999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++... .....+..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~-- 157 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH-- 157 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec--
Confidence 99999998654 234677788889999999999999999999999999999999999999999999765432211000
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVP 315 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p 315 (317)
......+...|++||+.. ......++|+|+++++++|+.. |.|
T Consensus 158 ----~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 158 ----NHTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred ----ccccCcCCccccChhHhc-----cCccchHHHHHHHHHHHHHHHcCCCC
Confidence 000112233567777553 3345678999999999999987 444
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=220.91 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=164.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++.+.||+|+||.||+|.... +++.+++|.+..... ...+.+|+++++.++|+||+++++.+......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 678999999999999999999887 688999999865421 578899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 155 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK- 155 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence 999999999998643 356899999999999999999999999999999999999999999999999999876432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|.+||+.... ......|+|++|.+++|+..|.
T Consensus 156 ---------~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~s~G~il~~l~~g~ 196 (256)
T cd06612 156 ---------RNTVIGTPFWMAPEVIQEI-----GYNNKADIWSLGITAIEMAEGK 196 (256)
T ss_pred ---------cccccCCccccCHHHHhcC-----CCCchhhHHHHHHHHHHHHhCC
Confidence 1112244568888876433 3456789999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.25 Aligned_cols=195 Identities=22% Similarity=0.328 Sum_probs=162.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+++++.++|+||+++++.+..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 346677889999999999998876 68899999987543 2345567899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence 99999999998853 56899999999999999999999999999999999999999999999999998765432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|++||+.... ....+.|+|+++++++|+..|.
T Consensus 158 ---------~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06642 158 ---------RNTFVGTPFWMAPEVIKQS-----AYDFKADIWSLGITAIELAKGE 198 (277)
T ss_pred ---------hhcccCcccccCHHHhCcC-----CCchhhhHHHHHHHHHHHHhCC
Confidence 1112345668888876543 3456799999999999999993
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=224.95 Aligned_cols=186 Identities=19% Similarity=0.179 Sum_probs=149.5
Q ss_pred eecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 107 HLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.||+|+||.||+|..... ....+++|.+... .....+.+.+|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 599999999999987541 1234888887543 23445678889999999999999999999999899999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc--------EEEeeecccccC
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH--------IMLSDFDLCFQS 252 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~--------~kl~DFG~a~~~ 252 (317)
|+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 99999999998654 246899999999999999999999999999999999999987664 699999998654
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... ..+...|++||+..... .....+|+|+++++++|+..|
T Consensus 159 ~~~~~--------------~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g 201 (258)
T cd05078 159 LPKEI--------------LLERIPWVPPECIENPQ----NLSLAADKWSFGTTLWEIFSG 201 (258)
T ss_pred CCchh--------------ccccCCccCchhccCCC----CCCchhhHHHHHHHHHHHHcC
Confidence 32211 12334588888764321 124678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=230.82 Aligned_cols=199 Identities=18% Similarity=0.270 Sum_probs=162.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----C
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----H 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 173 (317)
.++|++.+.||+|+||.||+|.+.. +++.||||.+............+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE-TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC-CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3589999999999999999998876 889999999876433344456677899999999999999999987643 3
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..|+|+||+ +++|.+++.. ...+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 589999999 5789888854 3679999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....... ...++..|++||...... ......|+|+++++++|+..|.|
T Consensus 160 ~~~~~~~----------~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 160 EKGDFMT----------EYVVTRWYRAPELLLNCS----EYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred CCccccc----------ccccccCccChHHHhcCC----CCCCcccHHHHHHHHHHHHcCCC
Confidence 3321111 113455688888764321 13467899999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=227.00 Aligned_cols=204 Identities=23% Similarity=0.240 Sum_probs=162.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC--
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-- 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 173 (317)
....++|++.+.||+|+||.||+|.... +++.||+|+++...........+.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3456789999999999999999999876 7889999999765333333456778999999999999999999886544
Q ss_pred --------EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 174 --------YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 174 --------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
.+++|+||+++ +|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999964 777766543 35689999999999999999999999999999999999999999999999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
||++......... ..........|++||...... ......|+|+++++++|+..|.|
T Consensus 160 fg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 160 FGLARLYNSEESR---------PYTNKVITLWYRPPELLLGEE----RYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred ccccccccCCccc---------ccccceeccCccChHHhcCCC----CCCchhHHHHHHHHHHHHHhCCC
Confidence 9999765433210 001112345688888654221 12457899999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=224.96 Aligned_cols=197 Identities=21% Similarity=0.253 Sum_probs=160.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+.|++.+.||+|+||.||+|.... +++.||+|.+.... ........+.+|+++++.++||||+++++++...+..|+|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 569999999999999999998876 78999999986432 2335556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+. ++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~- 170 (307)
T cd06607 94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS- 170 (307)
T ss_pred HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCC-
Confidence 99995 6777766433 35689999999999999999999999999999999999999999999999999865433221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..+...|++||..... .........|+|++|.+++|+..|.|
T Consensus 171 -------------~~~~~~y~aPE~~~~~--~~~~~~~~sDv~s~G~il~el~tg~~ 212 (307)
T cd06607 171 -------------FVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKP 212 (307)
T ss_pred -------------ccCCccccCceeeecc--CCCCCCcccchHHHHHHHHHHHcCCC
Confidence 1344568888865321 11223467899999999999999943
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=225.33 Aligned_cols=195 Identities=21% Similarity=0.281 Sum_probs=162.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||++.... ++..|++|.+... .....+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-TGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-CCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4789999999999999999998766 6789999998644 223346788899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999999854 35789999999999999999999999999999999999999999999999998755432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||+.... ......|+|++++.++|+..|.
T Consensus 172 ----------~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 172 ----------RSTMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred ----------cccccCChhhcCchhhccC-----CCCchhhHHHHHHHHHHHHhCC
Confidence 1112344567888776432 2356799999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=229.77 Aligned_cols=194 Identities=22% Similarity=0.312 Sum_probs=159.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..|.....||+|+||.||++.+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcC-CCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 344556679999999999998876 78899999986542 233456888999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.. ..+++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 99999999988744 45899999999999999999999999999999999999999999999999998755432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+...|++||+... .......|+|+++++++|+..|-
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 174 ---------RKSLVGTPYWMAPEVISR-----TPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred ---------ccceecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 111234556788876643 23457899999999999999993
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=243.34 Aligned_cols=153 Identities=33% Similarity=0.586 Sum_probs=138.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.++|++++.||+|+||.||+|.+.. +++.||||++.... ........+..|+.+++.++|+||+++++++.....+|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 4789999999999999999999886 78999999997543 234555778899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
||||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.++|+||||||+||||+.++.+||+|||+++....
T Consensus 82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 9999999999999965 35689999999999999999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=228.03 Aligned_cols=201 Identities=19% Similarity=0.257 Sum_probs=158.1
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----cC
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV----SH 173 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~ 173 (317)
+|++.+.||+|+||.||++.... . +..||+|.+............+.+|+++++.+ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC-CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 58899999999999999999876 5 78999999875433334456778899999999 49999999987542 24
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|++++|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|+.+.
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 578999999 5789988854 4678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....... .......+...|++||+...+ .....++|+|+++++++|+..|-|
T Consensus 157 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Di~slGv~l~~l~~g~~ 208 (332)
T cd07857 157 ENPGENA------GFMTEYVATRWYRAPEIMLSF----QSYTKAIDVWSVGCILAELLGRKP 208 (332)
T ss_pred ccccccc------ccccCcccCccccCcHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCc
Confidence 4322100 011112345567777765321 234578999999999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=224.20 Aligned_cols=206 Identities=31% Similarity=0.471 Sum_probs=166.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 177 (317)
++|.+.+.||+|+||.||+|.... ++..|++|++..... .......+.+|.++++.++ |+||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 479999999999999999999877 789999999976433 2344567889999999998 9999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 80 VLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999999654 5799999999999999999999999999999999999999999999999999976654332
Q ss_pred eeeccc----------ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNV----------GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~----------~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ..........+...|++||.... .......|+|+++++++|+..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~~l~~g 218 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-----KPAGKSSDLWALGCIIYQMLTG 218 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-----CCCChhhhHHHHHHHHHHHHhC
Confidence 110000 00011112233455666665433 3356789999999999999988
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=230.72 Aligned_cols=191 Identities=20% Similarity=0.278 Sum_probs=156.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-H-----HHHHHHHHHHHHHhcC---CCCcceEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-K-----KLSHVQMEAEILSMLD---HPFLPTLYAHL 169 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~-----~~~~~~~E~~~l~~l~---h~~iv~~~~~~ 169 (317)
..+|..++.+|+|+||+|++|.++. ....|+||.+.+...-. . .+-.+-.||.||..|+ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4579999999999999999999988 57899999997653211 1 1123456999999998 99999999999
Q ss_pred EecCEEEEEEccc-CCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecc
Q 042913 170 EVSHYICFLIDYC-PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 170 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
++++++||+||-. ++.+|+++|.. ...+.+.++..|++||+.|+++||++||||||||-+|++++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999986 45689999965 46799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccc
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSV 308 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (317)
|......+.. .+ .|+-+|.+||...++--.++++ |+|.++..++
T Consensus 717 aa~~ksgpfd--~f----------~gtv~~aapevl~g~~y~gk~q----diwalgilly 760 (772)
T KOG1152|consen 717 AAYTKSGPFD--VF----------VGTVDYAAPEVLGGEKYLGKPQ----DIWALGILLY 760 (772)
T ss_pred hhhhcCCCcc--ee----------eeeccccchhhhCCCccCCCcc----hhhhhhheee
Confidence 8655544422 22 4567899999887776665554 5676665544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=226.49 Aligned_cols=211 Identities=21% Similarity=0.250 Sum_probs=161.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++.+.||+|+||.||+|.+.. +++.+++|++............+.+|+++++.++|+||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIK-TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999877 788999999865533333334567899999999999999999887433
Q ss_pred ---CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 173 ---HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 173 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
..+++|+||+ .++|...+... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 85 ~~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 85 RKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ccCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 3579999999 45677766433 457999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecc-cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 250 FQSDVVPTLVETN-VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+............ ...........+...|++||..... .......|+|+++++++|+..|.|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE----RRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCC----CccCchhHhHHHHHHHHHHHhCCC
Confidence 7665433211110 0011111122334557777765432 223457899999999999999954
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=221.75 Aligned_cols=197 Identities=27% Similarity=0.377 Sum_probs=161.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHYICF 177 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 177 (317)
++|++.+.||.|++|.||+|.+.. +++.+|+|.+.... .......+.+|+++++.++|+||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 468999999999999999999877 78999999987543 23455778999999999999999999998854 447899
Q ss_pred EEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 178 LIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
||||+++++|.+++.. .....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 22456889999999999999999999999999999999999999999999999998654321
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....+...|++||..... ......|+|+++++++|+..| .|
T Consensus 159 ~~------------~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p 202 (287)
T cd06621 159 LA------------GTFTGTSFYMAPERIQGK-----PYSITSDVWSLGLTLLEVAQNRFP 202 (287)
T ss_pred cc------------ccccCCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhCCCC
Confidence 11 011334567888866432 234678999999999999998 44
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=227.94 Aligned_cols=194 Identities=20% Similarity=0.270 Sum_probs=158.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999998776 789999999976543444456788899999999999999999987543
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478899988 8899888753 45899999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ...++..|++||.... ......+.|+|++|++++|+..|-
T Consensus 171 ~~~~~-------------~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 171 DDEMT-------------GYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred ccccc-------------ccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCC
Confidence 32110 1133455788886542 123456789999999999999993
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=253.36 Aligned_cols=209 Identities=21% Similarity=0.287 Sum_probs=163.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
-..+|+.++.||+||||.||+++++- +|+.||||.+.... ......++.+|+.+|.+|+|||||++|..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34678888999999999999999887 89999999998776 667778999999999999999999997433100
Q ss_pred --------------------------------------------------------------------------------
Q 042913 173 -------------------------------------------------------------------------------- 172 (317)
Q Consensus 173 -------------------------------------------------------------------------------- 172 (317)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEcccCCCChhcccccCCCCCC-CHHHHHHHHHHHHHHHHH
Q 042913 173 ----------------------------------HYICFLIDYCPNGDLHSLLPKQPNNRF-SLQAVRFFAAEVLVGLEY 217 (317)
Q Consensus 173 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~i~~qi~~al~~ 217 (317)
..+|+-||||+...|.+++.++ ... .....+++++||++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHH
Confidence 1368899999888888888654 222 467899999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC-------CCCCeeeccccccc-ccccccccCCCCCccccccccc
Q 042913 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD-------VVPTLVETNVGSAT-RRRRRKSCNGFGSAKRRQENVM 289 (317)
Q Consensus 218 LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~~sp~~~~~~~~ 289 (317)
+|++|||||||||.||++++++.|||+|||+|.... ..........|... -.....|+.-|.|||.....-.
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999997632 11111111122222 3345678888999987654332
Q ss_pred ceeccchhhhccCCcccccccCC
Q 042913 290 EFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
....-+.|+.|+|.++.|+..
T Consensus 793 --~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 --NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred --ccccchhhhHHHHHHHHHHhc
Confidence 233467889999999998753
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=221.08 Aligned_cols=197 Identities=22% Similarity=0.282 Sum_probs=161.9
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--CEEEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS--HYICFLI 179 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 179 (317)
|++.+.||+|+||.||+|.+.. +++.+|+|.+............+.+|+++++.++|+|++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 6789999999999999998876 789999999987643344456678899999999999999999999887 8999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++ ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+||++++++.++|+|||++.........
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 80 EYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence 9995 5888888554 257899999999999999999999999999999999999999999999999999766543321
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......+...|++||...... ......|+|+++++++|+..|-
T Consensus 157 --------~~~~~~~~~~y~~PE~~~~~~----~~~~~~Dv~slG~~l~el~t~~ 199 (287)
T cd07840 157 --------DYTNRVITLWYRPPELLLGAT----RYGPEVDMWSVGCILAELFLGK 199 (287)
T ss_pred --------cccccccccccCCceeeEccc----cCChHHHHHHHHHHHHHHHhCC
Confidence 011123445688888654321 2346789999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=220.54 Aligned_cols=196 Identities=21% Similarity=0.266 Sum_probs=157.7
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEecCE----
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLEVSHY---- 174 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~---- 174 (317)
|++.+.||+|+||.||+|.+.. ++..||+|.+............+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999876 789999999975443333345566788777666 59999999999987776
Q ss_pred -EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 175 -ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 175 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++++|||+. ++|.+++.......+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 689888866544568999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..... ....+...|.+||+... .....+.|+|++|++++|+..|-|
T Consensus 159 ~~~~~-----------~~~~~~~~~~~PE~~~~-----~~~~~~~Di~s~G~~l~~l~~~~~ 204 (287)
T cd07838 159 FEMAL-----------TSVVVTLWYRAPEVLLQ-----SSYATPVDMWSVGCIFAELFRRRP 204 (287)
T ss_pred CCccc-----------ccccccccccChHHhcc-----CCCCCcchhhhHHHHHHHHHhCCC
Confidence 33211 01123445677776543 334567899999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=215.47 Aligned_cols=193 Identities=25% Similarity=0.410 Sum_probs=165.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|.+.+.||+|++|.||++.+.. +++.+++|++..... .....+.+|+++++.++|+||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58889999999999999999886 788999999976532 456788999999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.... ..+++..++.++.|++.+|.+||..|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999999986542 5789999999999999999999999999999999999999999999999999876544321
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.....+...|.+||+..... ...+.|+|+++++++|+..|
T Consensus 154 --------~~~~~~~~~~~~PE~~~~~~-----~~~~~Dv~slG~il~~l~~g 193 (253)
T cd05122 154 --------RNTMVGTPYWMAPEVINGKP-----YDYKADIWSLGITAIELAEG 193 (253)
T ss_pred --------ccceecCCcccCHHHHcCCC-----CCccccHHHHHHHHHHHHhC
Confidence 11224556788888775443 45779999999999999988
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=229.42 Aligned_cols=200 Identities=20% Similarity=0.253 Sum_probs=162.4
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----EE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-----YI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 175 (317)
+|++.+.||+|+||.||+|.... +++.|++|.+..........+.+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 58999999999999999999876 6899999999765433455678899999999999999999999987765 78
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|++|||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 6898888553 47999999999999999999999999999999999999999999999999999765443
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.... .......+...|.+||...... ....+.|+|+++++++|+..|-|
T Consensus 157 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~il~~l~~g~~ 205 (330)
T cd07834 157 EDEK-------GFLTEYVVTRWYRAPELLLSSS----RYTKAIDIWSVGCIFAELLTRKP 205 (330)
T ss_pred cccc-------ccccccccccCcCCceeeeccc----CCCcchhHHHHHHHHHHHHcCCC
Confidence 2110 0001112334466776654321 45678999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=225.61 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=158.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 178 (317)
++|...+.||+|+||.||++.+.. +++.||+|.+...... .....+.+|+.++.++. |+||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 466777889999999999999887 7899999998754322 44567888999999996 99999999999999999999
Q ss_pred EcccCCCChhccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 179 IDYCPNGDLHSLL---PKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 179 ~e~~~~gsL~~~l---~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
|||+ +++|.++. .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9998 45655433 223346789999999999999999999974 999999999999999999999999999976532
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... .....++..|++||....+. ......++|+|+++++++|+..| .|
T Consensus 161 ~~~-----------~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 161 SIA-----------KTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred CCc-----------cccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 211 01113455688888765432 12334678999999999999988 55
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=225.84 Aligned_cols=195 Identities=21% Similarity=0.221 Sum_probs=154.8
Q ss_pred CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhccc
Q 042913 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL 191 (317)
Q Consensus 112 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 191 (317)
++|.||.++... +++.||+|++............+.+|+++++.++|+||+++++++...+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445555555555 6899999999876555667788999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccccccccc
Q 042913 192 PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRR 271 (317)
Q Consensus 192 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 271 (317)
.......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||.+.............. .....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~---~~~~~ 167 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH---DFPKS 167 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc---ccccc
Confidence 765556789999999999999999999999999999999999999999999999999876543221100000 00112
Q ss_pred ccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 272 RKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 272 ~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..+...|++||+...+... .....|+|++|++++|+..|
T Consensus 168 ~~~~~~y~aPE~~~~~~~~---~~~~~Diws~G~il~el~~g 206 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQG---YNEKSDIYSVGITACELANG 206 (314)
T ss_pred ccccccccCHHHhcCCCCC---CCcchhHHHHHHHHHHHHhC
Confidence 2344568888877543322 34568999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=217.26 Aligned_cols=203 Identities=29% Similarity=0.488 Sum_probs=180.0
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
....+.+++|.++++||+|+|.+|.++++.+ +.+.+|+|++++..... +.++-.+.|..+.... +||.+|-+..+|.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcc-cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 4556778999999999999999999999888 89999999999887665 4556677788887665 6999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.+..+++|.||++||+|--.+.++ .+++++.++.+...|+.||.|||+.|||+||||.+|+|+|..|++||.|+|+|+
T Consensus 322 tesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999999998888554 779999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..-.......+++ |+|.|+.+++....+.....|-|.++..+.|+..|
T Consensus 400 e~l~~gd~tstfc---------------gtpnyiapeilrgeeygfsvdwwalgvlmfemmag 447 (593)
T KOG0695|consen 400 EGLGPGDTTSTFC---------------GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 447 (593)
T ss_pred cCCCCCccccccc---------------CCCcccchhhhcccccCceehHHHHHHHHHHHHcC
Confidence 7665555555555 55788888888888999999999999999999999
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=223.78 Aligned_cols=196 Identities=20% Similarity=0.247 Sum_probs=160.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..|...+.||+|+||.||++.+.. ++..||+|.+..... ..+....+.+|+++++.++|+|++++++++..+...++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 347888899999999999998876 789999999875422 334556788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+. |+|.+++... ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 104 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (317)
T cd06635 104 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS- 180 (317)
T ss_pred EeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCccc-
Confidence 99995 5777776543 35689999999999999999999999999999999999999999999999999865433211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..++..|++||+..... ........|+|+++++++|+..|-
T Consensus 181 -------------~~~~~~y~aPE~~~~~~--~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 181 -------------FVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred -------------ccCCccccChhhhhcCC--CCCCCccccHHHHHHHHHHHHhCC
Confidence 13455688898864211 112356789999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=225.33 Aligned_cols=196 Identities=24% Similarity=0.297 Sum_probs=160.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-SHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 176 (317)
..++|++++.||.|+||.||+|.... +++.||+|.+.+..........+.+|+++++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC-CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45789999999999999999998877 78999999986544344455678889999999999999999998865 56789
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+++||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+|+|+||||.||+++.++.++|+|||++.......
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 999999 7789888753 457888899999999999999999999999999999999999999999999987543211
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ...+...|++||+... ......+.|+|+++++++|+..|.|
T Consensus 163 ~-------------~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 163 T-------------GYVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred C-------------CCcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 0 0123445777776532 1234578999999999999999943
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=217.17 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=155.4
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
++||+|+||.||+|.+.. ++.|++|.+...... .....+.+|+++++.++|+||+++++++......++||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 359999999999998765 899999998765433 45567899999999999999999999999999999999999999
Q ss_pred ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccc
Q 042913 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265 (317)
Q Consensus 186 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 265 (317)
+|.+++... ...+++..+..++.|++.+|.|||+++++||||||+|||++.++.++|+|||+++...........
T Consensus 78 ~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~---- 152 (251)
T cd05041 78 SLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD---- 152 (251)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc----
Confidence 999998654 346789999999999999999999999999999999999999999999999999765432211110
Q ss_pred ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 266 ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 266 ~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
........|.+||+.... ....+.|+|+++++++|+..
T Consensus 153 ----~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 153 ----GLKQIPIKWTAPEALNYG-----RYTSESDVWSYGILLWETFS 190 (251)
T ss_pred ----ccCcceeccCChHhhccC-----CCCcchhHHHHHHHHHHHHh
Confidence 011223457778766432 24578899999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=230.07 Aligned_cols=197 Identities=21% Similarity=0.265 Sum_probs=164.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~ 173 (317)
-+.....++.+.||+|.||.||+|.+.+ +.||||++. .+..+.+++|.+|... ++|+||++|++.-+...
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~~---~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLDN---RLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhccC---ceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 3456788899999999999999998875 899999994 4556778888888775 57999999998866544
Q ss_pred ----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCcEEEccCCc
Q 042913 174 ----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL---------GIIYRDLKPENILLREDGH 240 (317)
Q Consensus 174 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~ivHrDikp~Nill~~~~~ 240 (317)
.++||++|.+.|+|.+||+. ..++|....+|+..+++||+|||+- .|+|||||..||||.+|+.
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence 79999999999999999976 5689999999999999999999973 4999999999999999999
Q ss_pred EEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccce-eccchhhhccCCcccccccC
Q 042913 241 IMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEF-VAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 241 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~-~~~~~~~~~~~~~~~~~e~~ 311 (317)
+.|+|||+|.++.+......+. ...|+..||+||...+-++-. -..-++.|+.+.+..++|+.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~--------~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTH--------GQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred EEeeccceeEEecCCCCCcchh--------hhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999888655432221 147888999999876554443 34467888999999988864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=222.31 Aligned_cols=191 Identities=15% Similarity=0.036 Sum_probs=141.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh---cHHHHHHHHHHHHHHHhcCCCCcce-EEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL---SAKKLSHVQMEAEILSMLDHPFLPT-LYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~ 171 (317)
....++|.+.+.||+|+||+||+|.+...+++.+|||++..... .......+.+|+++|+.++|+|++. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 44567899999999999999999987754677889998753311 2334567899999999999999985 5432
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCcEEEccCCcEEEeeecccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL-KPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDi-kp~Nill~~~~~~kl~DFG~a~ 250 (317)
+..|+||||++|++|.... . .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-P-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-c-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 4579999999999997321 1 11 1467889999999999999999999 9999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceecc-chhhhcc
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQRE 301 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~ 301 (317)
.+........ ......-....++..|++||+..++-....+. ....|.|
T Consensus 161 ~~~~~~~~~~--~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYR--IAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhh--hhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 8755332111 00001112445677789999988776664433 3555555
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=228.19 Aligned_cols=203 Identities=24% Similarity=0.284 Sum_probs=160.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe--cCE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV--SHY 174 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 174 (317)
..++|.+.+.||+|+||.||+|.+.. +++.+|+|.+............+.+|+.+++.+ +|+||+++++++.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35789999999999999999998876 688999998865433344456677899999999 99999999998864 346
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 899999995 699888854 2678889999999999999999999999999999999999999999999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... +. .......++..|++||..... .....+.|+|++|++++|+..|.
T Consensus 160 ~~~~~----~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 160 LEENP----EN-PVLTDYVATRWYRAPEILLGS----TRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred ccccc----cC-cchhcccccccccCceeeecc----ccccccchHHHHHHHHHHHHhCC
Confidence 32110 00 011112345567888765321 23356789999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=219.12 Aligned_cols=194 Identities=21% Similarity=0.280 Sum_probs=155.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec--CEEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS--HYICFL 178 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 178 (317)
|++.+.||+|+||.||+|.... ++..||+|.+......... ....+|+.+++++. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcC-CCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999998876 7899999998764322222 23456888888885 99999999999887 889999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||++ ++|.+.+... ...+++..++.++.||+.||.|||+.|++||||||+||+++. +.+||+|||+++........
T Consensus 79 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 79 FELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred EecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 99995 6888877543 356899999999999999999999999999999999999999 99999999999765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
. ...++..|++||+...+ .......|+|++|++++|+..|.|
T Consensus 156 ~-----------~~~~~~~y~aPE~~~~~----~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 156 T-----------EYISTRWYRAPECLLTD----GYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred C-----------CCCCCcccCChhHhhcC----CCCCcchhHHHHHHHHHHHHcCCc
Confidence 0 01234568888864321 223567899999999999998843
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=219.44 Aligned_cols=197 Identities=29% Similarity=0.466 Sum_probs=157.6
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||.|+||.||++.+.. +++.+++|++..... .......+.+|+++++.++|+||+++++.+......|+++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999876 789999999976533 23556788999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........... ....
T Consensus 80 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~- 155 (265)
T cd05579 80 LASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-NDDE- 155 (265)
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-cccc-
Confidence 99999664 4789999999999999999999999999999999999999999999999999876443321100 0000
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......+...|.+||..... ......|+|+++++++|+..|.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g~ 198 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQ-----GHSKTVDWWSLGCILYEFLVGI 198 (265)
T ss_pred ccccCcccCccccCHHHhcCC-----CCCcchhhHHHHHHHHHHHhCC
Confidence 011111233456666665432 3567899999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=216.82 Aligned_cols=187 Identities=26% Similarity=0.415 Sum_probs=151.9
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHH-HhcCCCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEIL-SMLDHPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.||+|+||.||+|.... +++.||+|++.+.... ......+..|..++ ...+|+|++++++.+..++.+|+|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 469999999999998876 7889999998754322 22333445555544 44589999999999999999999999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 263 (317)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~------- 151 (260)
T cd05611 81 GGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------- 151 (260)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccc-------
Confidence 99999999653 568999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 264 GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 264 ~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...++..|++||...... .....|+|+++.+++|+..|.
T Consensus 152 -------~~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~il~~l~~g~ 190 (260)
T cd05611 152 -------KFVGTPDYLAPETILGVG-----DDKMSDWWSLGCVIFEFLFGY 190 (260)
T ss_pred -------cCCCCcCccChhhhcCCC-----CcchhhhHHHHHHHHHHHHCC
Confidence 113455688888765432 356789999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=216.87 Aligned_cols=196 Identities=21% Similarity=0.295 Sum_probs=164.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+|++.+.||+|+||.||++.... +++.+++|.+............+.+|+++++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58899999999999999998776 78899999998765555566778889999999999999999999999999999999
Q ss_pred ccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 181 YCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 181 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA- 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc-
Confidence 99999999988652 235689999999999999999999999999999999999999999999999999976544310
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ...+...|.+||+... .......|+|+++++++|+..|.
T Consensus 159 -~----------~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~ 198 (256)
T cd08530 159 -K----------TQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATFA 198 (256)
T ss_pred -c----------cccCCccccCHHHHCC-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 0 1123446777777643 23346789999999999999983
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=241.24 Aligned_cols=202 Identities=21% Similarity=0.292 Sum_probs=164.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.+...+.+..+.||+|.||+||+|+... .....||||.++... ..+...+|++|++++..++|||||+|+|+|..
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4666788999999999999999997653 234689999997653 44577899999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccC--------CCCC----CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQ--------PNNR----FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~--------~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
++.+|||||||..|+|.++|... .+.. ++..+.+.|+.||+.||.||-++.+|||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999998643 1223 78899999999999999999999999999999999999999
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
.|||+|||++|.. +. .++++..-..+..-|+++++-..+..-.-..|+|+-|.+++|..
T Consensus 641 ~VKIsDfGLsRdi-----------Ys--sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 641 VVKISDFGLSRDI-----------YS--SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred EEEecccccchhh-----------hh--hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 9999999999753 11 11222332334444444444445556668899999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=229.20 Aligned_cols=204 Identities=25% Similarity=0.491 Sum_probs=176.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLD-HPFLPTLYAHLEV 171 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 171 (317)
...+...+|..+.+||+|+||+|.++..+. +.+.+|||+++++..-+ +..+--..|.++|.... -|.++++..+|..
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccC-cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 346778899999999999999999997666 88999999998875443 44455667888888775 6788999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
-+.+|+||||+.||+|--.+.. .++|.+..+..++..|+.||-+||++|||+||||.+|||++.+|++||+|||+|+.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999999888844 57899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.-.......+++ |+|.|+.+++..+.+.....|-|+-+..++|+..|.|
T Consensus 500 ni~~~~TTkTFC---------------GTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQp 548 (683)
T KOG0696|consen 500 NIFDGVTTKTFC---------------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 548 (683)
T ss_pred cccCCcceeeec---------------CCCcccccceEEecccccchhHHHHHHHHHHHHcCCC
Confidence 655444444444 5678888888888899999999999999999999966
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=219.68 Aligned_cols=201 Identities=29% Similarity=0.450 Sum_probs=161.5
Q ss_pred CeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLS--AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 175 (317)
+|++.+.||+|+||.||++.... .++..||+|++.+.... ......+.+|+.++..+ +|+||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 48899999999999999997642 25688999998754322 23446788899999999 599999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+.+++|.+++.. ...+++..++.++.|++.+|.|||+.+++|+||||.||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999999854 356899999999999999999999999999999999999999999999999998765433
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... .....+...|++||....... ......|+|+++++++|+..| .|
T Consensus 159 ~~~~---------~~~~~~~~~y~aPE~~~~~~~---~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 159 EEER---------AYSFCGTIEYMAPEVIRGGSG---GHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred cccc---------cccccCCccccCHHHhcCCCC---CCcchhhhHHHHHHHHHHHhCCCC
Confidence 2110 011124456788887644321 134678999999999999998 44
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=221.52 Aligned_cols=193 Identities=21% Similarity=0.297 Sum_probs=159.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.|.....||+|+||.||++.... ++..||+|.+... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKS-SGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcC-CCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 33444679999999999998876 7899999988543 33445678899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+++++|.+++.. ..+++..++.++.|++.+|+|||+.|++|+||||+||++++++.++|+|||++.........
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-- 172 (292)
T cd06657 98 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 172 (292)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--
Confidence 9999999998743 45899999999999999999999999999999999999999999999999998655332111
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++.+|++||+.... ......|+|+++++++|+..|-
T Consensus 173 --------~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 173 --------RKSLVGTPYWMAPELISRL-----PYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred --------ccccccCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhCC
Confidence 1112345678888877432 2346789999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=227.76 Aligned_cols=200 Identities=20% Similarity=0.245 Sum_probs=160.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
++....+.++++||+|.||.|.+|+... +..||+|.++.+. .......|.+|+++|.+|+||||++++++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC--ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4556788999999999999999998775 7899999998764 334457899999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++|+||+++|+|.+++.+.....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+=..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999997764333455667789999999999999999999999999999999999999999999865332
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
...-.. .+-..--.||++|-+-.+ .-.-..|.|.-+.+++|..
T Consensus 691 ~yy~vq--------gr~vlpiRwmawEsillg-----kFttaSDvWafgvTlwE~~ 733 (807)
T KOG1094|consen 691 DYYRVQ--------GRAVLPIRWMAWESILLG-----KFTTASDVWAFGVTLWEVF 733 (807)
T ss_pred Cceeee--------cceeeeeeehhHHHHHhc-----cccchhhhhhhHHHHHHHH
Confidence 211000 001112357888765322 2246778899888888753
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=217.47 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=160.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..|...+.||+|++|.||++.... +++.+++|.+... .....+.+.+|+.+++.++|+||+++++++...+..++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC-CCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 345566789999999999998776 6889999988643 3344466889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999865432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......+...|++||...... ...+.|+|+++++++|+..|-
T Consensus 171 --------~~~~~~~~~~y~aPE~~~~~~-----~~~~~Dv~slGv~l~ell~g~ 212 (285)
T cd06648 171 --------RRKSLVGTPYWMAPEVISRLP-----YGTEVDIWSLGIMVIEMVDGE 212 (285)
T ss_pred --------ccccccCCccccCHHHhcCCC-----CCCcccHHHHHHHHHHHHhCC
Confidence 111123456688888765432 346789999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=223.32 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=162.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEec----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLPTLYAHLEVS---- 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~---- 172 (317)
.++.++.+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.+|.+. |+|+||+.|++.-..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc---CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 478899999999999999999998 589999999643 22457778887765 6999999999875433
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEccCCcEEEe
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL--------GIIYRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~ivHrDikp~Nill~~~~~~kl~ 244 (317)
.++|||.+|.+.|+|+|+|.+ ..++.....+++..++.||+|||.. .|.|||||..||||.++|.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 358999999999999999966 5688999999999999999999963 49999999999999999999999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|+|||...+.......- ..-++.|+-.||+||...+.... ..+.-.++|+|+.+.+++|.++
T Consensus 359 DLGLAv~h~~~t~~idi------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDI------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccC------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999777655332221 22245888899999998766554 3466788999999999999764
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=220.30 Aligned_cols=204 Identities=20% Similarity=0.299 Sum_probs=162.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||||.+..... ......+..|+.++..+. |+||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567899999999999999999999886 689999999976432 233445666777666665 9999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.|++|||+ ++.|.+++... ...+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.+||+|||++..+.
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999998 56777776543 3478999999999999999999997 599999999999999999999999999987653
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... ....++..|++||+...... ........|+|+++++++|+..| .|
T Consensus 167 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 167 DSKAK-----------TRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred CCCcc-----------cCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCC
Confidence 32211 11235567888988754321 12234678999999999999999 44
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=220.23 Aligned_cols=195 Identities=20% Similarity=0.241 Sum_probs=153.8
Q ss_pred eecccCCeEEEEEEEcC-----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 107 HLGTGNLGRVFLCHLRD-----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
.||+|+||.||+|.... ..+..+++|.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998754 123679999886542 234456788899999999999999999999999999999999
Q ss_pred cCCCChhcccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-----cEEEeeeccccc
Q 042913 182 CPNGDLHSLLPKQ-----PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-----HIMLSDFDLCFQ 251 (317)
Q Consensus 182 ~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-----~~kl~DFG~a~~ 251 (317)
+++++|.+++... ....+++..++.++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998643 224478899999999999999999999999999999999999877 899999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
........ ..........|++||+.... ....+.|+|+++++++|+.. | .|
T Consensus 161 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 161 IYKSDYYR--------KEGEGLLPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc--------cCcccCCCccccCHHHHccC-----CcccchhHHHHHHHHHHHHHcCCCC
Confidence 53321110 00111223467888876543 23578999999999999875 6 44
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=219.37 Aligned_cols=207 Identities=18% Similarity=0.214 Sum_probs=157.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCC---ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTS---ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-SH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 173 (317)
.+..|++.+.||+|.||.||+|.-.+..+ +.+|||.++........-....+|+.+++.++|+||+.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 35689999999999999999996554222 268999886542222223456789999999999999999988876 88
Q ss_pred EEEEEEcccCCCChhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC----CcEEEeee
Q 042913 174 YICFLIDYCPNGDLHSLLPKQ---PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED----GHIMLSDF 246 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~----~~~kl~DF 246 (317)
.+||++||. .-+|.++|+-. ..+.++...++.|+.||+.|+.|||++-|+||||||.||||..+ |+|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 55788877532 23568999999999999999999999999999999999999877 89999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
|+|+.+...-.-..+ ..+...+.-|.+||-.-+-.+. ....|+|+.+|+..|+.+--|+
T Consensus 181 GlaR~~~~plkpl~s-------~d~VVVTiWYRAPELLLGa~hY----T~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 181 GLARLFNNPLKPLAS-------LDPVVVTIWYRAPELLLGARHY----TKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred cHHHHhhcccccccc-------CCceEEEEEecChHHhcccccc----cchhhhHHHHHHHHHHHccCcc
Confidence 999887654321111 1112233345666655433322 3678999999999999877664
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=227.07 Aligned_cols=194 Identities=22% Similarity=0.289 Sum_probs=160.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY---- 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 174 (317)
.++|++.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 5689999999999999999999887 78899999987654344455677889999999999999999887765544
Q ss_pred --EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 175 --ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 175 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998854 46899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ...++..|.+||...... .....+|+|++|++++|+..|.
T Consensus 169 ~~~~~-------------~~~~~~~y~aPE~~~~~~----~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 169 DDEMT-------------GYVATRWYRAPEIMLNWM----HYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred ccccc-------------CCcccccccCHHHHhCCC----CCCchHhHHHHHHHHHHHHhCC
Confidence 43210 012334567777653221 3467899999999999999994
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=225.90 Aligned_cols=198 Identities=23% Similarity=0.271 Sum_probs=156.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|++.+.||.|+||.||+|.... +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3789999999999999999998877 78999999986653 24456788899999999999999999776543
Q ss_pred --------CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEE
Q 042913 173 --------HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIML 243 (317)
Q Consensus 173 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl 243 (317)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35799999995 688888743 45899999999999999999999999999999999999984 567999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+|||+++......... .......++..|.+||..... .....++|+|++|++++|+..|-
T Consensus 157 ~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~~g~ 216 (342)
T cd07854 157 GDFGLARIVDPHYSHK-------GYLSEGLVTKWYRSPRLLLSP----NNYTKAIDMWAAGCIFAEMLTGK 216 (342)
T ss_pred CCcccceecCCccccc-------cccccccccccccCHHHHhCc----cccCchhhHHHHHHHHHHHHhCC
Confidence 9999997653321110 011112345568888865321 22456789999999999999883
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=218.37 Aligned_cols=195 Identities=21% Similarity=0.243 Sum_probs=158.1
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|...+.||+|+||.||+|.+.. ++..|++|++..... .......+.+|+++++.++|+|++++++++......|+||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 36677889999999999998876 789999999865432 2344567888999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+ .++|.+++... ...+++..++.++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 101 e~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~--- 175 (313)
T cd06633 101 EYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN--- 175 (313)
T ss_pred ecC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC---
Confidence 999 56777777543 3568999999999999999999999999999999999999999999999999986432211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...+...|++||+..... ......+.|+|+++++++|+..|-
T Consensus 176 -----------~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~slGvil~el~~g~ 217 (313)
T cd06633 176 -----------SFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERK 217 (313)
T ss_pred -----------CccccccccChhhccccC--CCCCCchhhHHHHHHHHHHHHhCC
Confidence 113445688888763211 112346789999999999999883
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=223.61 Aligned_cols=208 Identities=19% Similarity=0.179 Sum_probs=158.8
Q ss_pred CCeE-EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH------------HHHHHHHHHHHHHhcCCCCcceEE
Q 042913 100 RHLK-LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK------------KLSHVQMEAEILSMLDHPFLPTLY 166 (317)
Q Consensus 100 ~~y~-i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~ 166 (317)
++|. +.+.||.|+||.||+|.+.. +++.||+|++........ ....+.+|+++++.++|+||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 4454 56779999999999998876 789999999865432210 012467899999999999999999
Q ss_pred EEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
+++......++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999994 799998854 356899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeeecccc----cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVG----SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+++.............. .........+...|.+||+.... .......|+|+++++++|+..|-|
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA----EKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999766422111000000 00011112234567778766421 123567899999999999999844
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=217.87 Aligned_cols=197 Identities=23% Similarity=0.315 Sum_probs=164.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..+.|++.+.||+|++|.||+|.+.. ++..|++|++..... ....+.+|+++++.++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34568889999999999999998886 688999999976532 45678889999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999997642 3789999999999999999999999999999999999999999999999999865543221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. .....++..|++||+... .....+.|+|++|.+++|+..|.
T Consensus 172 ~----------~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slGvil~~l~~g~ 213 (286)
T cd06614 172 K----------RNSVVGTPYWMAPEVIKR-----KDYGPKVDIWSLGIMCIEMAEGE 213 (286)
T ss_pred h----------hccccCCcccCCHhHhcC-----CCCCCccccHHHHHHHHHHHhCC
Confidence 1 011134456788886542 22356799999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=215.69 Aligned_cols=187 Identities=23% Similarity=0.333 Sum_probs=150.3
Q ss_pred CCeEEeeee--cccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 100 RHLKLVRHL--GTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~l--g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
+.|.+.+.+ |+|+||.||++.... ++..+|+|++........ |+.+...+ +|+||+++++.+...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC-CCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 455666665 999999999998877 789999999875432211 22222222 6999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~ 255 (317)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999999654 4799999999999999999999999999999999999999988 9999999998765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ..++..|++||+.... ......|+|+++++++|+..| .|
T Consensus 164 ~~--------------~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p 205 (267)
T PHA03390 164 SC--------------YDGTLDYFSPEKIKGH-----NYDVSFDWWAVGVLTYELLTGKHP 205 (267)
T ss_pred cc--------------CCCCCcccChhhhcCC-----CCCchhhHHHHHHHHHHHHHCCCC
Confidence 21 1345567888776432 234578999999999999988 44
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=217.94 Aligned_cols=196 Identities=23% Similarity=0.337 Sum_probs=160.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 180 (317)
|++.+.||+|++|.||+|.... +++.|+||.+....... ......+|+..++.++ |+||+++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-CCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999876 68899999986653322 2233456899999999 9999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+ +++|.+++.......+++..++.++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 99 889999887654457899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....++..|++||....+ .......|+|+++.+++|+..|-|
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~----~~~~~~~Di~s~G~~l~el~~g~~ 197 (283)
T cd07830 156 ---------TDYVSTRWYRAPEILLRS----TSYSSPVDIWALGCIMAELYTLRP 197 (283)
T ss_pred ---------CCCCCcccccCceeeecC----cCcCCccchhhHHHHHHHHHhCCC
Confidence 112345568888865432 123467999999999999998843
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=223.45 Aligned_cols=193 Identities=21% Similarity=0.293 Sum_probs=156.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+.+..........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC-CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999998876 789999999876543344445678899999999999999999988644
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+|+||+ ..+|..++ ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYM-QTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEeccc-ccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 3569999999 45777665 245899999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ...++..|++||..... ......+|+|++|++++|+..|-
T Consensus 168 ~~~~~-------------~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 168 DAEMT-------------GYVVTRWYRAPEVILNW----MHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred CCCCC-------------CceeeecccChhhhcCc----cccCchHHHHHHHHHHHHHHhCC
Confidence 32111 11234457888876431 22456799999999999999983
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=214.19 Aligned_cols=198 Identities=19% Similarity=0.283 Sum_probs=160.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh--------hcHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--------LSAKKLSHVQMEAEILSM-LDHPFLPTLYAHLEV 171 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 171 (317)
.|++.+.||+|+||.||+|.+....++.+|+|.+.... .......++.+|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999876567899999885421 123445667788888865 789999999999999
Q ss_pred cCEEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
++..+++|||+++++|.+++.. .....+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 224568999999999999999999996 7899999999999999999999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+........ .....+...|.+||+.... ......|+|+++++++|+..|-
T Consensus 161 ~~~~~~~~~-----------~~~~~~~~~~~~Pe~~~~~-----~~~~~~Dv~slG~ll~~l~~g~ 210 (269)
T cd08528 161 AKQKQPESK-----------LTSVVGTILYSCPEIVKNE-----PYGEKADVWAFGCILYQMCTLQ 210 (269)
T ss_pred eeecccccc-----------cccccCcccCcChhhhcCC-----CCchHHHHHHHHHHHHHHHhCC
Confidence 976543221 1112345668888877532 2357889999999999999883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=218.22 Aligned_cols=196 Identities=21% Similarity=0.228 Sum_probs=158.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+.|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ........+.+|+++++.++|+|++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 457788889999999999999876 68899999986432 2334456788899999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+. ++|.+++... ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX- 170 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCccc-
Confidence 99995 6887776433 35689999999999999999999999999999999999999999999999999876543221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..+...|++||+...... .......|+|+++++++|+..|.
T Consensus 171 -------------~~~~~~y~aPE~~~~~~~--~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 171 -------------FVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred -------------ccCCccccCHHHHhhccc--CCCCcccchHHHHHHHHHHHcCC
Confidence 123446888887532111 11245789999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=215.67 Aligned_cols=196 Identities=19% Similarity=0.248 Sum_probs=163.1
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|++.+.||+|++|.||+|.... +++.+++|.+............+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999998876 789999999876654445567788899999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
++ ++|.+++... ...+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~---- 153 (283)
T cd05118 80 MD-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---- 153 (283)
T ss_pred cC-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc----
Confidence 95 5888887653 35789999999999999999999999999999999999999999999999999876644321
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......++..|.+||..... .....+.|+|+++++++|+..|-
T Consensus 154 ------~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 154 ------PYTHYVVTRWYRAPELLLGD----KGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred ------cccCccCcccccCcHHHhcC----CCCCchhHHHHHHHHHHHHHhCC
Confidence 01112355668888876432 23467799999999999999994
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=209.65 Aligned_cols=188 Identities=36% Similarity=0.576 Sum_probs=157.8
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
||+|+||.||++.... +++.+++|++...... ......+.+|+++++.++|+||+++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6899999999998876 7899999998765432 2456788999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccc
Q 042913 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 187 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 80 L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (250)
T cd05123 80 LFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--------- 148 (250)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---------
Confidence 99999653 4689999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......+...|.+||...... .....|+|+++++++|+..|
T Consensus 149 -~~~~~~~~~~~~~Pe~~~~~~-----~~~~~D~~slG~~~~~l~~g 189 (250)
T cd05123 149 -RTNTFCGTPEYLAPEVLLGKG-----YGKAVDWWSLGVLLYEMLTG 189 (250)
T ss_pred -cccCCcCCccccChHHhCCCC-----CCchhhHHHHHHHHHHHHHC
Confidence 011123455678888764332 45679999999999999988
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=229.26 Aligned_cols=195 Identities=24% Similarity=0.321 Sum_probs=159.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh--hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE--E
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY--I 175 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~ 175 (317)
+..+...+||+|+|-+||+|.+.. +|..||--.++... ..+...+++..|+.+|+.|+|+||+++|+.|.+..+ +
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ceeehhhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 445666779999999999998866 78888765544333 344667899999999999999999999999986554 8
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEc-cCCcEEEeeecccccC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR-EDGHIMLSDFDLCFQS 252 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~-~~~~~kl~DFG~a~~~ 252 (317)
.+|+|++..|+|..|+++. +++....++.|++||++||.|||.+. |||||||.+||+|+ ..|.|||+|+|||...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999999774 77899999999999999999999985 99999999999998 5789999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... ...|+.-||+||.-.+++.+ ..|+.+-|-+++||.+| -|
T Consensus 197 r~s~ak------------svIGTPEFMAPEmYEE~YnE------~VDVYaFGMCmLEMvT~eYP 242 (632)
T KOG0584|consen 197 RKSHAK------------SVIGTPEFMAPEMYEENYNE------LVDVYAFGMCMLEMVTSEYP 242 (632)
T ss_pred hccccc------------eeccCccccChHHHhhhcch------hhhhhhhhHHHHHHHhccCC
Confidence 443321 12566678888866555555 45789999999999987 44
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=237.94 Aligned_cols=202 Identities=22% Similarity=0.290 Sum_probs=164.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.+.....++.+.||+|.||.||.|......+. .||+|.+.+. .+.+....|.+|..+|+.++|||||+++|++..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 35567888999999999999999998875554 4888988664 356777899999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQP-----NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
....++++|||+||+|..+|++.. ...+.....+.++.||++|++||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999997641 345788899999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccc-cccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRR-KSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
|+|+.+-...-.. ...+ ..---||+||...+.+-. -..|+|+-|..++|+..
T Consensus 847 GlArDiy~~~yyr---------~~~~a~lPvkWm~PEsl~d~iFt-----skSDvWsFGVllWEifs 899 (1025)
T KOG1095|consen 847 GLARDIYDKDYYR---------KHGEAMLPVKWMPPESLKDGIFT-----SKSDVWSFGVLLWEIFS 899 (1025)
T ss_pred chhHhhhhchhee---------ccCccccceecCCHHHHhhcccc-----cccchhhhHHHHHHHHh
Confidence 9998432211110 0000 111359999988763332 56789999999999753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=209.55 Aligned_cols=177 Identities=24% Similarity=0.252 Sum_probs=145.0
Q ss_pred cCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhcc
Q 042913 111 GNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSL 190 (317)
Q Consensus 111 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 190 (317)
|.||.||++.+.. +++.||+|.+.... ...+|...+....||||+++++++......|+||||+++++|.++
T Consensus 4 g~~~~v~~~~~~~-~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTR-TQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEcc-CCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999887 88999999997642 223344555556799999999999999999999999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccc
Q 042913 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRR 270 (317)
Q Consensus 191 l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 270 (317)
+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~------------- 140 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD------------- 140 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-------------
Confidence 8653 4589999999999999999999999999999999999999999999999998865433110
Q ss_pred cccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 271 RRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 271 ~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....+..|++||+... .....+.|+|+++++++|+..|.+
T Consensus 141 ~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~ 180 (237)
T cd05576 141 GEAVENMYCAPEVGGI-----SEETEACDWWSLGAILFELLTGKT 180 (237)
T ss_pred cCCcCccccCCcccCC-----CCCCchhhHHHHHHHHHHHHHCcc
Confidence 0123455888886532 234567899999999999999853
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-31 Score=216.01 Aligned_cols=210 Identities=22% Similarity=0.250 Sum_probs=164.9
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE---
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE--- 170 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 170 (317)
+.....+.|.-+.+||+|.||.||+|+..+ +++.||+|++.-+...+..-....+|+++|..|+|+|++.+++.|.
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 334455677888889999999999999888 8888999877544334444556788999999999999999987763
Q ss_pred -----ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 171 -----VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 171 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
....+|+||.+| .-+|..++... ..+++..++..++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|
T Consensus 90 Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred CCcccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence 234589999999 56888888644 57799999999999999999999999999999999999999999999999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVPR 316 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p~ 316 (317)
||+|+.+..... +..+.+.-+..+.-|..||-.-+. .+.....|+|-.+|++.|+-+|-|.
T Consensus 168 FGlar~fs~~~n------~~kprytnrvvTLwYrppEllLG~----r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 168 FGLARAFSTSKN------VVKPRYTNRVVTLWYRPPELLLGD----REYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cccccceecccc------cCCCCcccceeeeecCCHHHhhcc----cccCCcchhHhHHHHHHHHHccCcc
Confidence 999987644332 122233344455556666655333 3345677899999999999998774
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-30 Score=212.24 Aligned_cols=195 Identities=21% Similarity=0.257 Sum_probs=160.7
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----HYI 175 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 175 (317)
+.+--+.||.|+||.||.+.+.. +|+.|++|.+..-...-...+++.+|+++|..++|.|++..++...-. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR-dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR-SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC-CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 33444569999999999998887 899999999977665666778899999999999999999998876533 346
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|++.|++ ..+|..+|-. .+.++...++.++.||++||+|||+.+|+||||||.|+|++.+..+||||||+|+..+..
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8899999 7899998854 477899999999999999999999999999999999999999999999999999987765
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
.....+.. ..++-|.+||-..+..+. .-..|+||-+|+..|+.+
T Consensus 210 ~~~hMTqE---------VVTQYYRAPEiLMGaRhY----s~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 210 DRLNMTHE---------VVTQYYRAPELLMGARRY----TGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred hhhhhHHH---------HHHHHhccHHHhhcchhh----cCccceehhhHHHHHHHh
Confidence 55444432 455667788876655443 345689999999988754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=214.31 Aligned_cols=196 Identities=24% Similarity=0.309 Sum_probs=161.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|++.+.||+|++|.||+|.... +++.|++|++............+..|+.+++.++|+||+++++++......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecC-CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 5677889999999999999877 789999999987643344456778899999999999999999999999999999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeec
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 261 (317)
++ ++|.+++.... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++..........
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~- 156 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT- 156 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC-
Confidence 95 69999996542 4689999999999999999999999999999999999999999999999999976543221100
Q ss_pred ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 262 NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......|++||..... .......|+|+++++++|+..|-
T Consensus 157 ---------~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 157 ---------HEVVTLWYRAPEILLGS----KHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred ---------ccccCcCcCChHHhcCC----cCCCccccHHHHHHHHHHHHhCC
Confidence 11223457888876432 13456789999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=226.02 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=168.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+.....+|.++||.|.||.|++|+++.. ....||||.++... .++....|..|+.||-+++||||++|.|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 56677889999999999999999998762 23579999997654 6777789999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+.+|.|||++|+|+.+|+.+. +.|...++..+++.|+.|++||-+.++|||||-..|||++.+-.+|++|||+++.++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999998875 559999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
.++....+..|. +.--.|-+||-+. +---.-..|+||-+..++|..
T Consensus 783 dd~~~~ytt~GG-------KIPiRWTAPEAIa-----~RKFTsASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 783 DDPEAAYTTLGG-------KIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVM 828 (996)
T ss_pred cCCCccccccCC-------ccceeecChhHhh-----hcccCchhhccccceEEEEec
Confidence 666333322222 1122366776554 222335778999999998853
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=211.66 Aligned_cols=197 Identities=23% Similarity=0.317 Sum_probs=154.8
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehh---hhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD---LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
+|.+.+.||+|+||.||++.+.. .+..+++|+++.. .........+..|+.+++.++||||+++++++......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 58999999999999999998876 4555666665432 2223344567789999999999999999999998899999
Q ss_pred EEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 178 LIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||+++++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||||+||+++. +.++|+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988754 23456899999999999999999999999999999999999975 67999999998765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ...+...|.+||+... .....+.|+|+++.+++|+..|.
T Consensus 159 ~~~~~----------~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 159 CDLAT----------TFTGTPYYMSPEALKH-----QGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred ccccc----------CCCCCcCccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 22111 1123445777776532 23345689999999999998883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=222.04 Aligned_cols=210 Identities=17% Similarity=0.195 Sum_probs=145.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC---------------CCCceEEEEEeehhhhcH--H----------HHHHH
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD---------------CTSANFALKVVDKDLLSA--K----------KLSHV 147 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~~~~--~----------~~~~~ 147 (317)
..+..++|++.++||+|+||.||+|.+.. ..++.||||.+....... + ..+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 35678899999999999999999996521 135689999986532110 0 11223
Q ss_pred HHHHHHHHhcCCCCc-----ceEEEEEEe--------cCEEEEEEcccCCCChhcccccCC-------------------
Q 042913 148 QMEAEILSMLDHPFL-----PTLYAHLEV--------SHYICFLIDYCPNGDLHSLLPKQP------------------- 195 (317)
Q Consensus 148 ~~E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~------------------- 195 (317)
..|+.++.+++|.++ +++++++.. .+..|+||||+++++|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 346677777766544 566776642 356899999999999999885421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccc
Q 042913 196 ---NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRR 272 (317)
Q Consensus 196 ---~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~ 272 (317)
...+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++........ .. ...
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~--------~~g 370 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NP--------LYG 370 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-Cc--------ccc
Confidence 123456788899999999999999999999999999999999999999999999654322110 00 001
Q ss_pred cccCCCCCccccccccc-----------------ceeccchhhhccCCcccccccCCC
Q 042913 273 KSCNGFGSAKRRQENVM-----------------EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 273 ~~~~~~~sp~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..+..|++||....... .....+...|+|+++++++|+..|
T Consensus 371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~ 428 (507)
T PLN03224 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVP 428 (507)
T ss_pred CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhC
Confidence 12345666665432110 001223456999999999999887
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=226.44 Aligned_cols=203 Identities=15% Similarity=0.156 Sum_probs=136.2
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCC----CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEE--
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCT----SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH-- 168 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-- 168 (317)
..+..++|.+.+.||+|+||.||+|.+.. + +..||+|.+......+ ...+| .++...+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhh
Confidence 44567899999999999999999999887 6 7899999875432111 11111 1111122222221111
Q ss_pred ----EEecCEEEEEEcccCCCChhcccccCCC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 042913 169 ----LEVSHYICFLIDYCPNGDLHSLLPKQPN------------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226 (317)
Q Consensus 169 ----~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHr 226 (317)
......+++|+||+.+++|.+++..... .......+..++.||+.||.|||+.+|+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456779999999999999998864321 011234566899999999999999999999
Q ss_pred cCCCCcEEEcc-CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccc---------------
Q 042913 227 DLKPENILLRE-DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME--------------- 290 (317)
Q Consensus 227 Dikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~--------------- 290 (317)
||||+|||++. ++.+||+|||+|+.+........ ....++..|++||........
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~---------~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~ 350 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP---------KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 350 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCC---------cccccCCCccChHHhhccCCCCCCccccccccccch
Confidence 99999999985 57999999999976543221110 111334568888843211110
Q ss_pred --eeccchhhhccCCcccccccCCC
Q 042913 291 --FVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 291 --~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....+.+.|+|+++++++|+..|
T Consensus 351 l~~~~~~~k~DVwSlGviL~el~~~ 375 (566)
T PLN03225 351 LWQLNLPDRFDIYSAGLIFLQMAFP 375 (566)
T ss_pred hccccCCCCcccHHHHHHHHHHHhC
Confidence 01124566999999999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=217.58 Aligned_cols=190 Identities=22% Similarity=0.282 Sum_probs=155.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
....|.+...+|.|+|+.|-.|.... +++.+++|++.+. .....+|+.++... +|+||+++.+.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~-t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP-TDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc-cccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceee
Confidence 45788888899999999999998887 8899999999765 23345677665554 6999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE-ccCCcEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL-REDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill-~~~~~~kl~DFG~a~~~~~~ 255 (317)
+|||++.|+.|.+.+... . .....+..|+.+|+.|+.|||++|||||||||+|||+ +..++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999888887543 2 2336777899999999999999999999999999999 58999999999999886554
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..+. ..+..|.+||.. ...+....+|+||+|..++||.+|.+
T Consensus 470 ---~~tp----------~~t~~y~APEvl-----~~~~yt~acD~WSLGvlLy~ML~G~t 511 (612)
T KOG0603|consen 470 ---CDTP----------ALTLQYVAPEVL-----AIQEYTEACDWWSLGVLLYEMLTGRT 511 (612)
T ss_pred ---hccc----------chhhcccChhhh-----ccCCCCcchhhHHHHHHHHHHHhCCC
Confidence 1111 233455566544 46677899999999999999999954
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=220.31 Aligned_cols=201 Identities=20% Similarity=0.216 Sum_probs=168.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
.++.++.++||+|.||.|++|.|....|+ .||||.++.+.... ....|.+|+.+|.+|+|+|+++|||+..+ ....
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 45667888999999999999999875454 68999998765443 67889999999999999999999999876 7789
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
||||+++.|+|.+.|++.....|.......++.||+.||.||..+++|||||-..|||+-....|||+||||.+-+..+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999988666778999999999999999999999999999999999999999999999999999887766
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
... .....+..-+.|.+||-. ++....-..|.|+-+.+++|+..+
T Consensus 267 d~Y-------vm~p~rkvPfAWCaPEsL-----rh~kFShaSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 267 DMY-------VMAPQRKVPFAWCAPESL-----RHRKFSHASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred cce-------EecCCCcCcccccCHhHh-----ccccccccchhhhhhhhHHhhhcc
Confidence 443 111223444567777643 444455778999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=212.23 Aligned_cols=198 Identities=20% Similarity=0.239 Sum_probs=161.9
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC------CCCcceEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD------HPFLPTLYA 167 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 167 (317)
-+.+...+|.|....|+|-|++|.+|.+.. .+..||||+|+.... ..+.=+.|++||++|+ .-|+++|+-
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 456677899999999999999999999887 677999999987533 2344577999999995 347899999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEee
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSD 245 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~D 245 (317)
.|...+++|||||-+ ..+|.++|++. .+-.+....++.++.|+..||+.|...||+|.||||+|||+++ ...+||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999999 88999999875 2455788899999999999999999999999999999999996 45799999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
||.|.....+. .+.-..+--|+.+++.-+....+-.|+||-+|+++|++.|
T Consensus 581 fGSA~~~~ene-----------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtG 631 (752)
T KOG0670|consen 581 FGSASFASENE-----------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTG 631 (752)
T ss_pred Ccccccccccc-----------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecc
Confidence 99986543322 1111122234455566677778888999999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=193.39 Aligned_cols=196 Identities=31% Similarity=0.415 Sum_probs=162.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
|.+.+.||.|++|.||++.... +++.+++|.+...... ...+.+.+|++.++.++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5678899999999999998886 6889999999765322 2567889999999999999999999999988999999999
Q ss_pred cCCCChhcccccCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 182 CPNGDLHSLLPKQPNNR-FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
+++++|.+++... .. +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 79 CEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred cCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---
Confidence 9988999998664 33 78999999999999999999999999999999999999999999999999877644320
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......+...|++||... .........|+|+++++++|+..|-
T Consensus 154 ------~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Dv~~lG~~~~~l~~g~ 197 (225)
T smart00221 154 ------ALLKTVKGTPFYLAPEVLL----GGKGYGEAVDIWSLGVILYELLWGP 197 (225)
T ss_pred ------ccccceeccCCcCCHhHhc----CCCCCCchhhHHHHHHHHHHHHHCC
Confidence 0111223455688888764 2223334789999999999999883
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=195.61 Aligned_cols=187 Identities=19% Similarity=0.288 Sum_probs=149.2
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec--CE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS--HY 174 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~ 174 (317)
..++|++.+++|+|.|+.||.|.... +++.++||+++ +-..+.+.+|+.||+.|. ||||+++++...+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~-~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT-NNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC-CCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 34789999999999999999998766 68899999985 344578899999999998 99999999998654 55
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSD 253 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~ 253 (317)
..||+||+.+.+...+. ..++...++.++.+++.||.|||+.||+|||+||.|++||. .-.++|+|+|+|..+.
T Consensus 110 paLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 78999999887777665 45788899999999999999999999999999999999995 4579999999997765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
+...... +....-|--||-. -.+....+.-|+||+|||+..+
T Consensus 185 p~~eYnV-----------RVASRyfKGPELL----Vdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 185 PGKEYNV-----------RVASRYFKGPELL----VDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred CCceeee-----------eeehhhcCCchhe----eechhccccHHHHHHHHHHHHH
Confidence 5443211 1111223334433 3344556778899999998765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=190.68 Aligned_cols=143 Identities=17% Similarity=0.204 Sum_probs=109.9
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHH------------------------HHHHHHHHHHHHhcCCC
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK------------------------LSHVQMEAEILSMLDHP 160 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ 160 (317)
.+.||+|+||.||+|... +|+.||+|+++........ .....+|++++..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 356999999999999875 6899999999765321111 12234599999999887
Q ss_pred CcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCcEEEccCC
Q 042913 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL-HALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~ivHrDikp~Nill~~~~ 239 (317)
++.....+... ..+|||||++++++...+.. ...+++..++.++.|++.+|.+| |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 76443332222 23899999988776654322 35689999999999999999999 799999999999999998 57
Q ss_pred cEEEeeecccccCCC
Q 042913 240 HIMLSDFDLCFQSDV 254 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~ 254 (317)
.++|+|||+|...+.
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=222.18 Aligned_cols=199 Identities=22% Similarity=0.318 Sum_probs=170.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+|.++..+|.|.||.||++++.. +++..|+|+++.. ..+.+.-++.|+-+++.++|||||.+++.+.....+|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~-s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc-cCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 4689999999999999999999988 8999999999765 446667789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||.+|+|.++..- .+++++.++..+++..+.+|+|||..|-+|||||-.|||+++.|.+||+|||.+.++...-.
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 999999999999854 58899999999999999999999999999999999999999999999999999987655433
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
++.--.|+.-||+||...-+ .-....-.+|+|..+.+.+|+..-.
T Consensus 168 ---------KrksfiGtpywmapEvaave--rkggynqlcdiwa~gitAiel~eLq 212 (829)
T KOG0576|consen 168 ---------KRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWALGITAIELGELQ 212 (829)
T ss_pred ---------hhhcccCCccccchhHHHHH--hcccccccccccccccchhhhhhcC
Confidence 33344566678999875421 1223345789999999999987653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=217.86 Aligned_cols=187 Identities=22% Similarity=0.258 Sum_probs=152.1
Q ss_pred eeecccCCeE-EEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGR-VFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~-Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
+.+|.|.-|+ ||+|... ++.||||.+-. +....+++|+..|+.-+ |||||++|+.-.+..+.|++.|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE---GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred HHcccCCCCcEEEEEeeC---CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4588999885 8999877 58999998743 44467889999999885 999999999999999999999999
Q ss_pred CCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---C--CcEEEeeecccccCCCCC
Q 042913 184 NGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---D--GHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 184 ~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~--~~~kl~DFG~a~~~~~~~ 256 (317)
..+|.+++... ..........+.++.|++.||+|||+.+||||||||.||||+. + .+++|+|||+|+++....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 89999999763 1111111345778899999999999999999999999999975 3 479999999999998776
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.-... .....|+.||.+||........ ...|+.++||..++-..|
T Consensus 666 sS~~r-------~s~~sGt~GW~APE~L~~~~~~-----~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 666 SSFSR-------LSGGSGTSGWQAPEQLREDRKT-----QAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred chhhc-------ccCCCCcccccCHHHHhccccC-----cccchhhcCceEEEEecC
Confidence 54333 2334789999999987765554 488999999999988777
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=194.57 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=158.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEE-EEecCEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAH-LEVSHYIC 176 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-~~~~~~~~ 176 (317)
.+.|.|.+.||+|.||.+.+|+++. ++..+++|.+++.. ...+.|.+|..---.| .|.||+.-|+. |+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC-CceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3689999999999999999999887 88999999998753 3446677787665445 48999977754 67888999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--cCCcEEEeeecccccCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--EDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~~~~~kl~DFG~a~~~~~ 254 (317)
+++||++.|+|..-+.. ..+-+...+.++.|++.||.|||++++||||||.+||||- +..+|||||||+.++.+.
T Consensus 99 F~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999998854 4578888999999999999999999999999999999995 344899999999876543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.-. +......|-.||.+..-.++.--....-|+|..|..+..-.+| +|
T Consensus 176 tV~-------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P 224 (378)
T KOG1345|consen 176 TVK-------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP 224 (378)
T ss_pred eeh-------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCc
Confidence 221 2344556788887766655544445556799999999999999 55
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-27 Score=205.25 Aligned_cols=215 Identities=22% Similarity=0.237 Sum_probs=162.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-----cHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-----SAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
....++|-++..||+|||+.||+|.+.. ..+.||+|+-..... .+...+...+|.+|.+.|+||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~-EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT-EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccc-hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3445789999999999999999998876 689999998643221 2234566788999999999999999999996
Q ss_pred -ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEc---cCCcEEEe
Q 042913 171 -VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR---EDGHIMLS 244 (317)
Q Consensus 171 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~---~~~~~kl~ 244 (317)
+.+.+|-|+|||+|.+|.-|++. ++.+++..++.|+.||+.||.||.+.. |||-||||.|||+. .-|.+||.
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 55678999999999999999965 477999999999999999999999864 99999999999995 35689999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCCC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPRG 317 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~~ 317 (317)
|||+++..+...... +..........|++-|..||.-..+-..- --.-+.|+|+.+.+++.-.-| -|.|
T Consensus 616 DFGLSKIMdddSy~~---vdGmeLTSQgAGTYWYLPPEcFvVgkePP-KIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNS---VDGMELTSQGAGTYWYLPPECFVVGKEPP-KISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred ecchhhhccCCccCc---ccceeeecccCceeeecCcceeecCCCCC-ccccceeeEeeehhhhhhhccCCCCC
Confidence 999999887655321 11112223345566666666543221000 002456889999888765555 4443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=210.32 Aligned_cols=199 Identities=20% Similarity=0.273 Sum_probs=161.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCC-CC--ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDC-TS--ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
-.+......+.+.||+|-||.||+|.+... .| -.||||..+.+. ..+..+.|..|..+|+.++||||++++|++.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 345556667788999999999999988652 23 358888887654 45557899999999999999999999999875
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...|+|||+++.|.|..|++.+ ...++......++.||+.||.|||+..+|||||-..|||+.....|||+|||+++.
T Consensus 463 -~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred -cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 4689999999999999999765 46689999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
++...-...+ ....---||+||-+ +|-.-.-..|+|.-+.+++|.
T Consensus 541 ~ed~~yYkaS---------~~kLPIKWmaPESI-----NfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 541 LEDDAYYKAS---------RGKLPIKWMAPESI-----NFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred ccccchhhcc---------ccccceeecCcccc-----chhcccchhhHHHHHHHHHHH
Confidence 7665432211 11222348888744 344445788899999888885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=233.49 Aligned_cols=182 Identities=16% Similarity=0.179 Sum_probs=148.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
..+.....||+|+||.||+|.... ++..||+|.+..... ....|++++++++|||||++++++...+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 345667789999999999998876 789999998864321 1234688899999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH---ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
||+++|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+.......
T Consensus 763 Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 763 EYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred eCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 9999999999994 3789999999999999999999 6699999999999999998888776 66653321110
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...++.+|++||+... .....+.|+|+.|++++|+..|
T Consensus 837 --------------~~~~t~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 837 --------------KCFISSAYVAPETRET-----KDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred --------------CccccccccCcccccC-----CCCCcccchhhHHHHHHHHHhC
Confidence 1134567888887643 2345679999999999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=212.48 Aligned_cols=202 Identities=17% Similarity=0.230 Sum_probs=167.4
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
....+...+..+..+||-|.||.||.|.|++ -.-.||||.++.+ ....++|..|..+|+.++|||+|+|+|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeec-cceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4556667788889999999999999999998 6678999998764 34567899999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
-.+|||.|||..|+|.+||++.....++.-.++.++.||..|++||..+++|||||-..|+|+.++..|||+|||+++..
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999998877777888888999999999999999999999999999999999999999999999865
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
..+.- ....|. ..---|-+||-.. |.-...+.|+|.-+..++|+++
T Consensus 416 tgDTY--TAHAGA-------KFPIKWTAPEsLA-----yNtFSiKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 416 TGDTY--TAHAGA-------KFPIKWTAPESLA-----YNTFSIKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred cCCce--ecccCc-------cCcccccCccccc-----ccccccchhhHHHHHHHHHHHh
Confidence 44321 122222 1222366776554 3444567889999888888764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=183.12 Aligned_cols=142 Identities=18% Similarity=0.199 Sum_probs=111.7
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH------------------------HHHHHHHHHHHHHHhcCCC
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA------------------------KKLSHVQMEAEILSMLDHP 160 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~ 160 (317)
.+.||+|+||+||+|.+. +|+.||||+++...... .....+.+|.+.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 467999999999999876 68999999998652110 0122346789999999999
Q ss_pred CcceEEEEEEecCEEEEEEcccCCCChhcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccC
Q 042913 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSL-LPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLRED 238 (317)
Q Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~ 238 (317)
++.....+.... .||||||++|+++... +. ...++...+..++.|++.+|.+||. .||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 875444333322 4899999988755433 32 2457888999999999999999999 9999999999999999 8
Q ss_pred CcEEEeeecccccCCC
Q 042913 239 GHIMLSDFDLCFQSDV 254 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~ 254 (317)
+.++|+|||+|...+.
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=180.88 Aligned_cols=186 Identities=30% Similarity=0.447 Sum_probs=152.8
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCCh
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL 187 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 187 (317)
||+|.+|.||++.... +++.+++|++....... ....+.+|+++++.+.|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998876 68999999997653221 456789999999999999999999999998999999999988999
Q ss_pred hcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCCCCCeeecccccc
Q 042913 188 HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVVPTLVETNVGSA 266 (317)
Q Consensus 188 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 266 (317)
.+++.... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99986532 46899999999999999999999999999999999999998 89999999999876544321
Q ss_pred cccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 267 TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 267 ~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
..........|.+|+..... ...+...|+|+++++++|+
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~----~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGK----GYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred -hhhcccCCCCccChhHhccc----CCCCchhhhHHHHHHHHHH
Confidence 11122455567777766443 3456778899999888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=192.99 Aligned_cols=193 Identities=16% Similarity=0.212 Sum_probs=154.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------ 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 171 (317)
...+|.-++.+|.|.- .|-.+.+.- .++.||+|.+..........++.++|..++..++|+||++++.+|.-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v-~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQV-LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhh-ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3468888899999988 565565554 78999999987665555566788999999999999999999998853
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
....|+|||+| ..+|...+. ..++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+.
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 34589999999 889998885 3477889999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
-+.. +..+.. ..+.-|-+||..-+=. --...|+||.||.+-|+..|
T Consensus 168 e~~~--~~mtpy---------VvtRyyrapevil~~~-----~ke~vdiwSvGci~gEli~~ 213 (369)
T KOG0665|consen 168 EDTD--FMMTPY---------VVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGELILG 213 (369)
T ss_pred cCcc--cccCch---------hheeeccCchheeccC-----CcccchhhhhhhHHHHHhhc
Confidence 6554 222221 3344456666543211 23567899999999999988
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=187.01 Aligned_cols=182 Identities=34% Similarity=0.484 Sum_probs=151.6
Q ss_pred CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhccc
Q 042913 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL 191 (317)
Q Consensus 112 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 191 (317)
+||.||+|.+.. +++.+++|++........ .+.+.+|+++++.++|+||+++++.+......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKK-TGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECC-CCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999876 789999999976532221 578899999999999999999999999999999999999888999998
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccccccccc
Q 042913 192 PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRR 271 (317)
Q Consensus 192 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 271 (317)
... ..+++..++.++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 79 ~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------~~~~ 145 (244)
T smart00220 79 KKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------LLTT 145 (244)
T ss_pred Hhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------cccc
Confidence 654 338999999999999999999999999999999999999999999999999997765432 1112
Q ss_pred ccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 272 RKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 272 ~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..+...|.+||... ........|+|+++++++|+..|
T Consensus 146 ~~~~~~~~~pE~~~-----~~~~~~~~Di~slG~~l~~l~~~ 182 (244)
T smart00220 146 FVGTPEYMAPEVLL-----GKGYGKAVDVWSLGVILYELLTG 182 (244)
T ss_pred ccCCcCCCCHHHHc-----cCCCCchhhHHHHHHHHHHHHhC
Confidence 23455677787664 22234578999999999999988
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=208.95 Aligned_cols=197 Identities=20% Similarity=0.207 Sum_probs=154.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCC---CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDC---TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...+..++||+|+||+||+|.+-.. -+-+||+|++.... ..+...++..|+-+|..++|||++++++++.... +.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3455678999999999999988652 12378999886543 4455678899999999999999999999987665 88
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
||++|+++|.|.++++.. ...+-.+..+.|+.||++||.|||++++|||||-..||||.....+||.|||+|+.+....
T Consensus 774 lvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999999875 4668888999999999999999999999999999999999999999999999999887766
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
....+..|. +.+.++.-+....-.-.-..|+|+-+.+.+|+.+
T Consensus 853 ~ey~~~~gK-------------~pikwmale~i~~~~~thqSDVWsfGVtiWElmT 895 (1177)
T KOG1025|consen 853 KEYSAPGGK-------------VPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT 895 (1177)
T ss_pred ccccccccc-------------cCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence 544333322 2233333222222222345678999888888753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=184.45 Aligned_cols=136 Identities=28% Similarity=0.435 Sum_probs=120.5
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-----C---CCcceEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-----H---PFLPTLYA 167 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~ 167 (317)
.+..++|.+.++||.|-|++||+|.+.. ..+.||+|+++.. +...+....||++|++++ | .+||+|++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 3444999999999999999999998887 7899999999754 355567888999999884 2 46999999
Q ss_pred EEEe----cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEc
Q 042913 168 HLEV----SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLR 236 (317)
Q Consensus 168 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~ 236 (317)
.|.. +.++|||+|++ |.+|..+|.....+.++...++.|++||+.||.|||. .||||-||||+|||+.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9964 56899999999 9999999999889999999999999999999999996 6999999999999994
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=178.27 Aligned_cols=144 Identities=17% Similarity=0.204 Sum_probs=116.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHH------HHHHHHHHHhcCCCCcceEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSH------VQMEAEILSMLDHPFLPTLYAH 168 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~------~~~E~~~l~~l~h~~iv~~~~~ 168 (317)
++..++|++.+.||.|+||.||++.. . +..+|+|+++...... ..... +.+|+..+.++.|++|..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-C--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 35578999999999999999999654 2 5689999997654333 22223 5789999999999999999888
Q ss_pred EEec--------CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc
Q 042913 169 LEVS--------HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH 240 (317)
Q Consensus 169 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~ 240 (317)
+... +..+++|||++|.+|.++.. +++ ..+.+++.+|..||+.|++||||||.||+++.+|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence 6533 35899999999999988741 233 2456999999999999999999999999999988
Q ss_pred EEEeeecccccCC
Q 042913 241 IMLSDFDLCFQSD 253 (317)
Q Consensus 241 ~kl~DFG~a~~~~ 253 (317)
++|+|||......
T Consensus 173 i~liDfg~~~~~~ 185 (232)
T PRK10359 173 LRIIDLSGKRCTA 185 (232)
T ss_pred EEEEECCCccccc
Confidence 9999999987653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=189.74 Aligned_cols=208 Identities=21% Similarity=0.292 Sum_probs=161.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 172 (317)
....+.|+++.+||+|.|+.||++.+... ..+.||+|.+... ....++.+|+++|..+. +.||+++.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34557899999999999999999977653 5789999998654 23356899999999986 89999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEEeeeccccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl~DFG~a~~ 251 (317)
+...+||||+++....+++.. ++...++.+++.++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999998844 67889999999999999999999999999999999998 467899999999973
Q ss_pred CCCCC-------------Ce-e------------e--------cccccccccccccccCCCCCcccccccccceeccchh
Q 042913 252 SDVVP-------------TL-V------------E--------TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRR 297 (317)
Q Consensus 252 ~~~~~-------------~~-~------------~--------~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~ 297 (317)
.+... +. . . .+.+....+..+.|+.||-+||.. .....+.-.
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL----~k~~~Qtta 258 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL----FRCPRQTTA 258 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH----hhccCcCCc
Confidence 22111 00 0 0 011222334445566666555543 234456778
Q ss_pred hhccCCcccccccCCC-CCC
Q 042913 298 EQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 298 ~~~~~~~~~~~e~~~G-~p~ 316 (317)
.|+|+-|.+++=+..+ .|+
T Consensus 259 iDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred cceeeccceeehhhcccccc
Confidence 8999999999888777 554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=173.05 Aligned_cols=137 Identities=21% Similarity=0.245 Sum_probs=105.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-----CCCCcceEEEEEEecC---E-E
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-----DHPFLPTLYAHLEVSH---Y-I 175 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~-~ 175 (317)
.+.||+|+||.||. +.. ++.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. . +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCC-CcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 35699999999995 333 4444 699886542 22346789999999999 5799999999998763 4 3
Q ss_pred EEEEcc--cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeccCCCCcEEEccC----CcEEEeeecc
Q 042913 176 CFLIDY--CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL-EYLHALGIIYRDLKPENILLRED----GHIMLSDFDL 248 (317)
Q Consensus 176 ~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al-~~LH~~~ivHrDikp~Nill~~~----~~~kl~DFG~ 248 (317)
.+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+-
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 478999 557999999955 236655 35678888787 89999999999999999999743 3799999555
Q ss_pred cccC
Q 042913 249 CFQS 252 (317)
Q Consensus 249 a~~~ 252 (317)
+..+
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 5443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=199.52 Aligned_cols=206 Identities=20% Similarity=0.263 Sum_probs=163.5
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLY 166 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 166 (317)
...+..+++++.+.||+|.||+|++|..... ....||||.++..... ...+.+..|+++|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 4456666778888999999999999976531 1457999998766544 67788999999999985 99999999
Q ss_pred EEEEecCEEEEEEcccCCCChhcccccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 042913 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQP------------N--NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPEN 232 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~N 232 (317)
|++...+.+++|+||+..|+|.++++... . ..+.....+.++.||+.|++||++..+|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997653 1 138888999999999999999999999999999999
Q ss_pred EEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 233 ILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 233 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
||+.++..+||+|||+|+............. ..+ --..||+||-... ..|. ...|+||-|..++|+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~------~~~-LP~kWmApEsl~~--~~ft---~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSS------AGT-LPVKWMAPESLFD--RVFT---SKSDVWSFGILLWEIFT 516 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCC------CCc-cceeecCHHHhcc--Cccc---ccchhhHHHHHHHHHhh
Confidence 9999999999999999986544333221100 000 1223999976654 4444 44589999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=173.35 Aligned_cols=147 Identities=18% Similarity=0.154 Sum_probs=114.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----------------------HHHHHHHHHHHHHHhcC
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----------------------KKLSHVQMEAEILSMLD 158 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 158 (317)
-|.+.+.||+|+||.||+|.+...+|+.||+|+++...... .....+.+|+++++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998333378999999997542110 01234678999999997
Q ss_pred CC--CcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCCCcEEE
Q 042913 159 HP--FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG-IIYRDLKPENILL 235 (317)
Q Consensus 159 h~--~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivHrDikp~Nill 235 (317)
+. .++++++. ...++||||+++.+|...... ...+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34555543 235899999988888766522 244566677899999999999999999 9999999999999
Q ss_pred ccCCcEEEeeecccccCCC
Q 042913 236 REDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~ 254 (317)
+ ++.++|+|||.|...+.
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999986544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=160.75 Aligned_cols=164 Identities=20% Similarity=0.236 Sum_probs=117.7
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH--HHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEc
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK--KLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 180 (317)
+...|++|+||+||++.. .+.+++.+.+........ ....+.+|+++|++|. |++|++++++ +..+++||
T Consensus 6 ~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 456799999999997644 367888776654322111 1235789999999996 5889999986 34699999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCcEEEccCCcEEEeeecccccCCCCCCe-
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL-KPENILLREDGHIMLSDFDLCFQSDVVPTL- 258 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDi-kp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 258 (317)
|+.|.+|...+.. . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999888754421 1 1347789999999999999999999 799999999999999999999865543321
Q ss_pred ---eecccccccccccccccCCCCCcccc
Q 042913 259 ---VETNVGSATRRRRRKSCNGFGSAKRR 284 (317)
Q Consensus 259 ---~~~~~~~~~~~~~~~~~~~~~sp~~~ 284 (317)
........... .+..|.++.+|+..
T Consensus 150 r~L~~rDl~~llk~-~~~y~~~~l~~~~~ 177 (218)
T PRK12274 150 RLLAREDLRHLLKH-KRMYCPAALTPVER 177 (218)
T ss_pred HHHHHHHHHHHHHH-HHhcCCCCCCHHHH
Confidence 00011111111 24478888888754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=162.88 Aligned_cols=140 Identities=21% Similarity=0.179 Sum_probs=110.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH--------------------HHHHHHHHHHHHHHhcCCC-
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA--------------------KKLSHVQMEAEILSMLDHP- 160 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~- 160 (317)
|.+.+.||+|+||.||++... +++.||||+++...... ........|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 778889999999999999765 58999999876432110 0112367788899988877
Q ss_pred -CcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 161 -FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 161 -~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
.++.+++. ...++||||++|++|.++... .....++.+++.++.++|+.||+|+||||+||++++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 45555542 445899999999998776521 23567889999999999999999999999999999999
Q ss_pred cEEEeeecccccCCCC
Q 042913 240 HIMLSDFDLCFQSDVV 255 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~ 255 (317)
.++|+|||+|...+..
T Consensus 163 ~~~liDfg~~~~~~~~ 178 (198)
T cd05144 163 KIYIIDWPQMVSTDHP 178 (198)
T ss_pred cEEEEECCccccCCCc
Confidence 9999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=163.24 Aligned_cols=138 Identities=20% Similarity=0.229 Sum_probs=113.6
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS------AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+.||+|++|.||+|.+. +..+++|+....... ......+.+|++++..+.|++|+....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEeeC---CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 56999999999999763 578999986543211 112346788999999999998877776666777889999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
||++|++|.+++... .. ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++....
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999999998542 12 7788999999999999999999999999999999 7899999999987643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=167.09 Aligned_cols=202 Identities=29% Similarity=0.404 Sum_probs=155.7
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH-HHHHHHHHHHHHHhcCCC-CcceEEEEEEecCEEEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHP-FLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 179 (317)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999876 6789999977654443 567889999999999988 7999999998778789999
Q ss_pred cccCCCChhcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCCCC
Q 042913 180 DYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~~~ 257 (317)
+++.+++|.+++..... ..+.......++.|++.++.|+|..+++||||||+||+++..+ .++++|||+++.......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977754321 2689999999999999999999999999999999999999888 799999999985443322
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... .......++..|.+|+...... ........|+|+++.+..++..|
T Consensus 158 ~~~~~----~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 158 TSSIP----ALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred ccccc----ccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhC
Confidence 11000 0112223444555555443211 13556778889888887777776
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=181.79 Aligned_cols=141 Identities=21% Similarity=0.186 Sum_probs=113.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..|...+.||+|+||.||++.+.. ..+++|+...... .....+++.+|+++++.++|++++..+.++....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~---~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG---RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC---ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344567889999999999998764 3444444322111 1123456889999999999999988877777777
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++. ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+..+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 7899999999999998874 356789999999999999999999999999999 67899999999998765
Q ss_pred C
Q 042913 254 V 254 (317)
Q Consensus 254 ~ 254 (317)
.
T Consensus 479 ~ 479 (535)
T PRK09605 479 L 479 (535)
T ss_pred c
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=159.25 Aligned_cols=134 Identities=21% Similarity=0.221 Sum_probs=106.9
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhh------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcc
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
||+|+||.||++.+. +..+++|+...... ......++.+|+++++.+.|+++.....++......++||||
T Consensus 2 ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 2 IAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCceEEEEEeecC---CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 899999999999743 67899998653211 112346678899999999987665444444556667899999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
++|++|.+++... .. .++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||+++....
T Consensus 79 ~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 79 IEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred ECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 9999999887442 11 7789999999999999999999999999999 89999999999876443
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=150.56 Aligned_cols=139 Identities=21% Similarity=0.250 Sum_probs=101.0
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHH----------------------HHHHHHHHHhcCCC--
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH----------------------VQMEAEILSMLDHP-- 160 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~-- 160 (317)
.+.||+|+||.||+|.+. +++.||||++............ ...|.+.+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 456999999999999865 5899999998754322111111 13566666666543
Q ss_pred CcceEEEEEEecCEEEEEEcccCCCChhc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccC
Q 042913 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHS-LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLRED 238 (317)
Q Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~ 238 (317)
.+.+.++. ...++||||++++.+.. .+... .. ...++.++.+++.++.++|. .+|+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 35556553 23589999998855432 12111 01 15678899999999999999 9999999999999999 8
Q ss_pred CcEEEeeecccccCCC
Q 042913 239 GHIMLSDFDLCFQSDV 254 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~ 254 (317)
+.++|+|||.|.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=161.97 Aligned_cols=210 Identities=16% Similarity=0.132 Sum_probs=159.0
Q ss_pred hccCCCCccccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcce
Q 042913 89 TNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164 (317)
Q Consensus 89 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 164 (317)
.....+-.+...++++...+-+|.||.||.|.+++. +.+.|.+|.++.. .++-+...+..|.-++..+.|||+..
T Consensus 273 ~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 273 NRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred hhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 333444556677888889999999999999987752 2345666766433 35566678888999999999999999
Q ss_pred EEEEEE-ecCEEEEEEcccCCCChhccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 042913 165 LYAHLE-VSHYICFLIDYCPNGDLHSLLPK------QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE 237 (317)
Q Consensus 165 ~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~ 237 (317)
+.++.. +....++++.++.-|+|..++.. ...+.+...+...++.|++.|+.|||..||||.||-..|.+|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD 431 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence 999875 45667888999988999999862 22345777888999999999999999999999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
.-++||+|=.+++.+-+..-.. .|.. +. ---.||++|-.+.+ ...-.+|.|+.|..++|+..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhc---LGDn-En----RPvkWMslEal~n~-----~yssasDvWsfGVllWELmt 493 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHC---LGDN-EN----RPVKWMSLEALQNS-----HYSSASDVWSFGVLLWELMT 493 (563)
T ss_pred heeEEeccchhccccCcccccc---cCCC-CC----CcccccCHHHHhhh-----hhcchhhhHHHHHHHHHHHh
Confidence 9999999999998765533211 1110 00 01237888766543 33467899999999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=149.73 Aligned_cols=136 Identities=24% Similarity=0.277 Sum_probs=103.8
Q ss_pred ec-ccCCeEEEEEEEcCCCCceEEEEEeehhhh-----------cHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEec-
Q 042913 108 LG-TGNLGRVFLCHLRDCTSANFALKVVDKDLL-----------SAKKLSHVQMEAEILSMLDHPFL--PTLYAHLEVS- 172 (317)
Q Consensus 108 lg-~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~- 172 (317)
|| .|+.|.||.+... +..++||.+..... ......++.+|++++..|.|++| +..+++....
T Consensus 39 lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 66 7888888887654 57899998854211 11233567889999999998775 6777664432
Q ss_pred CE---EEEEEcccCC-CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecc
Q 042913 173 HY---ICFLIDYCPN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 173 ~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
.. .++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||+.||+||||||.|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 22 3599999987 689888754 3355443 57899999999999999999999999999989999999999
Q ss_pred cccCC
Q 042913 249 CFQSD 253 (317)
Q Consensus 249 a~~~~ 253 (317)
+....
T Consensus 189 ~~~~~ 193 (239)
T PRK01723 189 GELRT 193 (239)
T ss_pred cccCC
Confidence 87644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-20 Score=187.29 Aligned_cols=152 Identities=11% Similarity=0.082 Sum_probs=103.4
Q ss_pred cCC-CCcceEEEEE-------EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 042913 157 LDH-PFLPTLYAHL-------EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL 228 (317)
Q Consensus 157 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDi 228 (317)
+.| .||+.+++.| .....++++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 4677777766 2334577889988 78999999643 456999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeeecccccCCCCCCe--ee---------------------cccccc--cccccccccCCCCCccc
Q 042913 229 KPENILLREDGHIMLSDFDLCFQSDVVPTL--VE---------------------TNVGSA--TRRRRRKSCNGFGSAKR 283 (317)
Q Consensus 229 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~---------------------~~~~~~--~~~~~~~~~~~~~sp~~ 283 (317)
||+||||+..+.+|++|||++......... .. ...+.. .......++..|++||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999976666666666555432211000 00 000000 00111234455777776
Q ss_pred ccccccceeccchhhhccCCcccccccCCCCC
Q 042913 284 RQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.. ........|+|++|++++|+.+|.|
T Consensus 187 ~~-----~~~~~~~sDVwSlGviL~ELl~~~~ 213 (793)
T PLN00181 187 DN-----GSSSNCASDVYRLGVLLFELFCPVS 213 (793)
T ss_pred hc-----cCCCCchhhhhhHHHHHHHHhhCCC
Confidence 53 2334678999999999999999855
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=137.25 Aligned_cols=134 Identities=22% Similarity=0.290 Sum_probs=113.0
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecCEEEEEEcc
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
+++.||+|.++.||++.... ..+++|....... ...+.+|+.+++.+.+ .++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD---EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC---CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45679999999999998753 6899999866532 4568889999999976 5899999988888889999999
Q ss_pred cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL---GIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 182 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++++.+..+ +......++.+++.+|.+||.. +++|+||+|.||++++.+.++|+|||.|+..+
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 988777654 4456677889999999999985 69999999999999998999999999987544
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=171.11 Aligned_cols=147 Identities=25% Similarity=0.396 Sum_probs=115.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~ 172 (317)
.+....|.|.+.||+|+||+||+|...+ ++.||||+-+.....+ +..-.+++.+|+ -+-|..+...+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3445789999999999999999998876 9999999976543322 122233334443 12334444444556
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-------CCcEEEee
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-------DGHIMLSD 245 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-------~~~~kl~D 245 (317)
+.-++|+||.+.|+|.+++. ..+.+++..+..+..|++..+++||..+|||+||||+|+||.. ..-++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 66789999999999999995 5688999999999999999999999999999999999999942 33699999
Q ss_pred eccccc
Q 042913 246 FDLCFQ 251 (317)
Q Consensus 246 FG~a~~ 251 (317)
||.+..
T Consensus 845 fG~siD 850 (974)
T KOG1166|consen 845 FGRSID 850 (974)
T ss_pred ccccee
Confidence 999843
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.5e-19 Score=167.83 Aligned_cols=196 Identities=26% Similarity=0.273 Sum_probs=140.6
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCceEEEEEee----hhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD----KDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.....+|.|++|.|+.+.... ..+.++.|.+. ......+....+..|..+-..+.|+|++..+..+.+....+.+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 456779999999887776554 34445555443 2222223333366777778888999998777666655555556
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||++ +|..++... ..+....+..++.|++.|++|||..||.|||||++|++++.+|.+||+|||.+..+......
T Consensus 400 mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 999988 999999653 57888999999999999999999999999999999999999999999999998654432221
Q ss_pred eecccccccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G 313 (317)
. -.......|+..|..+++.... -.++..|+|+.+..++.+..|
T Consensus 477 ~-----------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 477 N-----------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred h-----------hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 0 0112222344444444444433 337888999999999998887
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=144.42 Aligned_cols=203 Identities=20% Similarity=0.233 Sum_probs=125.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcC----------CCCcceEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLD----------HPFLPTLYAH 168 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~----------h~~iv~~~~~ 168 (317)
..+...+.||.|+++.||.+.+.. +++.+|+|++...... ....+.+++|.-....+. |-.++..++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred eEEEEccccccCCceEEEEEEEcc-CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 467888999999999999999998 8999999998654322 244556666554433321 1122222222
Q ss_pred EE---------ec---C-----EEEEEEcccCCCChhccccc---CCCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 042913 169 LE---------VS---H-----YICFLIDYCPNGDLHSLLPK---QPNN--RFSLQAVRFFAAEVLVGLEYLHALGIIYR 226 (317)
Q Consensus 169 ~~---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivHr 226 (317)
.. .. . +.+++|+-+ .++|.+++.. .... .+.......+..|+++.+++||..|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 21 11 1 246788888 7788777542 1111 12233344556899999999999999999
Q ss_pred cCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCccccccccc---ceeccchhhhccCC
Q 042913 227 DLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM---EFVAEPRREQREHP 303 (317)
Q Consensus 227 Dikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~---~~~~~~~~~~~~~~ 303 (317)
||||+|++++.+|.++|+||+.....+.... . .....+|..||....... ........-|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----------C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee-----------c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 9999999999999999999998765443111 0 123355666665543211 33445667789999
Q ss_pred cccccccCCC-CCCC
Q 042913 304 AQYSVEQPGG-VPRG 317 (317)
Q Consensus 304 ~~~~~e~~~G-~p~~ 317 (317)
|.+++.+-|| +|-|
T Consensus 237 G~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 237 GITLYSLWCGRLPFG 251 (288)
T ss_dssp HHHHHHHHHSS-STC
T ss_pred HHHHHHHHHccCCCC
Confidence 9999999998 7754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=146.25 Aligned_cols=141 Identities=20% Similarity=0.271 Sum_probs=98.3
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----------------------------H----HHH------HH
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----------------------------K----KLS------HV 147 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------------------------~----~~~------~~ 147 (317)
+.||.|++|+||+|..++ |+.||||+.+...... . ... .+
T Consensus 123 ~plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 569999999999999874 8999999986542110 0 000 13
Q ss_pred HHHHHHHHhc----C-CCC--cceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 042913 148 QMEAEILSML----D-HPF--LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV-GLEYLH 219 (317)
Q Consensus 148 ~~E~~~l~~l----~-h~~--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-al~~LH 219 (317)
.+|...+.++ + +++ |++++. ......++||||++|++|.++...... ... ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHH
Confidence 4455555554 2 233 233332 223456999999999999887643211 122 2345555555 478899
Q ss_pred HcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 220 ~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
..|++|+|+||.||+++.++.++|+|||++..++.
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-17 Score=153.45 Aligned_cols=185 Identities=30% Similarity=0.451 Sum_probs=147.9
Q ss_pred ecccCCeEEEEEEEc--CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEcccCC
Q 042913 108 LGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+|+|.||.|+++.-. ...+.-+|+|+..+.............|..++..++ ||.++++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999987432 124678899988766444333336677888999888 99999999999999999999999999
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
|.|...+.+ ...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------ 153 (612)
T KOG0603|consen 82 GDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------ 153 (612)
T ss_pred chhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc------
Confidence 999998855 466888888889999999999999999999999999999999999999999998765332211
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.++.-||+||-. + .-....|-|+.+-.++|+..| +|
T Consensus 154 --------cgt~eymApEI~-----~--gh~~a~D~ws~gvl~felltg~~p 190 (612)
T KOG0603|consen 154 --------CGTYEYRAPEII-----N--GHLSAADWWSFGVLAFELLTGTLP 190 (612)
T ss_pred --------ccchhhhhhHhh-----h--ccCCcccchhhhhhHHHHhhCCCC
Confidence 334456666544 3 223566789999999999999 55
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=150.29 Aligned_cols=147 Identities=16% Similarity=0.232 Sum_probs=96.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH--------------------------------HHHHH-
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA--------------------------------KKLSH- 146 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------------------------------~~~~~- 146 (317)
.+|.. +.||.|++|+||+|..++ +|+.||||+.+...... +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 45666 789999999999999886 69999999997542100 11122
Q ss_pred -----HHHHHHHHHhc----CCCCcceEEEEE-EecCEEEEEEcccCCCChhcccccCCCC----CCCHHHHHHHHHHHH
Q 042913 147 -----VQMEAEILSML----DHPFLPTLYAHL-EVSHYICFLIDYCPNGDLHSLLPKQPNN----RFSLQAVRFFAAEVL 212 (317)
Q Consensus 147 -----~~~E~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i~~qi~ 212 (317)
+.+|...+.++ .+...+.+-.++ +.....+|||||++|+.|.++..-...+ .+.+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 23344333333 233333332222 2245678999999999998753211111 13333333344443
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeecccccCCCC
Q 042913 213 VGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLCFQSDVV 255 (317)
Q Consensus 213 ~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a~~~~~~ 255 (317)
...|++|+|+||.||+++.+| .++++|||++..++..
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 468999999999999999888 9999999999877553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.3e-15 Score=121.86 Aligned_cols=141 Identities=15% Similarity=0.179 Sum_probs=101.8
Q ss_pred eeecccCCeEEEEEEEcCC-----CCceEEEEEeehhhh--------------------cHHHHHH----HHHHHHHHHh
Q 042913 106 RHLGTGNLGRVFLCHLRDC-----TSANFALKVVDKDLL--------------------SAKKLSH----VQMEAEILSM 156 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~--------------------~~~~~~~----~~~E~~~l~~ 156 (317)
..||.|--+.||.|...+. .+..+|||+.+.... ....... .++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4589999999999975531 247899999764210 0001122 2379999998
Q ss_pred cC--CCCcceEEEEEEecCEEEEEEcccCCCChhc-ccccCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCc
Q 042913 157 LD--HPFLPTLYAHLEVSHYICFLIDYCPNGDLHS-LLPKQPNNRFSLQAVRFFAAEVLVGLEYL-HALGIIYRDLKPEN 232 (317)
Q Consensus 157 l~--h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~ivHrDikp~N 232 (317)
+. .-++++++++ ..-+|||||+.+..+.. .+++ ..++......++.+++.+|..| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 86 3577788865 34589999996543321 2221 2345566777889999999999 89999999999999
Q ss_pred EEEccCCcEEEeeecccccCCC
Q 042913 233 ILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 233 ill~~~~~~kl~DFG~a~~~~~ 254 (317)
||++ ++.++|+|||.|...+.
T Consensus 156 IL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEE-CCcEEEEECCCceeCCC
Confidence 9997 57899999999876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-15 Score=119.63 Aligned_cols=130 Identities=19% Similarity=0.235 Sum_probs=97.2
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEEEEEcccC
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
++.|+.|.++.||++... ++.|++|+...... ....+.+|+.+++.+.+.+ +++++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC---CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356899999999998754 57899999765421 1234577889998886544 446665543 23479999999
Q ss_pred CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI-----IYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 184 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i-----vHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
|.++.+.. . ....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.|...+
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 98876531 1 112356789999999999885 9999999999999 6789999999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-15 Score=134.34 Aligned_cols=209 Identities=18% Similarity=0.211 Sum_probs=133.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC------C----------------------------CceEEEEEeehhh---
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC------T----------------------------SANFALKVVDKDL--- 138 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~------~----------------------------~~~vavK~~~~~~--- 138 (317)
.+..++|+|++.||+|.-..||.+..... + .-+.|||.+..-.
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 45668999999999999999999876530 0 0024555442211
Q ss_pred hcHHHHHHHHHHHHH--------------HHh--------cCCCCcceEEEEEEe-------------------------
Q 042913 139 LSAKKLSHVQMEAEI--------------LSM--------LDHPFLPTLYAHLEV------------------------- 171 (317)
Q Consensus 139 ~~~~~~~~~~~E~~~--------------l~~--------l~h~~iv~~~~~~~~------------------------- 171 (317)
.....++...+|..- .+. -+|||||+++++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 111222222222210 011 159999999877632
Q ss_pred --cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--cCC--cEEEee
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--EDG--HIMLSD 245 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~~~--~~kl~D 245 (317)
...+|+||..+ ..+|.+++.. ...+......++.|+++|+.|||++||.|||+|.+||||. +|+ .+.|+|
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 34679999988 7799999854 3456777888999999999999999999999999999995 333 588999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccc-cccceeccchhhhccCCcccccccCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQE-NVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
||+|---+... -......+..-..|..-.|+||-... .-+.-+-.--++|.|.-+...+|...
T Consensus 389 FGCcLAd~~hG----lqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg 452 (598)
T KOG4158|consen 389 FGCCLADDNHG----LQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFG 452 (598)
T ss_pred cceeeeccccc----cccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhc
Confidence 99984322210 01111122223345555788885321 11112222346778988888888754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-16 Score=153.64 Aligned_cols=204 Identities=19% Similarity=0.179 Sum_probs=145.1
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh--hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+|...+.||.+.|=+|.+|++++ |. |+||++.+.. ..-....+...|++ ...+++||++.+.-+.+.+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 67888999999999999998886 44 9999987653 22344444555666 6677899999998887788888999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc--CCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ--SDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~--~~~~~ 256 (317)
-+|. .-+|+|.+..+ .-+..-+.+-|+.||+.||..+|..||+|+|||.+||||+.-+.+.|+||.-=|. +..+.
T Consensus 100 Rqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9999 77999999664 3356677788899999999999999999999999999999999999999975432 11111
Q ss_pred CeeecccccccccccccccCCCCCcccccccc---cceec---cchhhhccCCcccccccCC-CCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENV---MEFVA---EPRREQREHPAQYSVEQPG-GVPR 316 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~---~~~~~---~~~~~~~~~~~~~~~e~~~-G~p~ 316 (317)
...-+.- .-..++..| |.+||+--... ..... -....|+-++||.+.|+.+ |.|+
T Consensus 177 Padf~fF---FDTSrRRtC--YiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 177 PADFTFF---FDTSRRRTC--YIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred cccceEE---EecCCceee--ecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 1110000 011112222 55666543311 11111 2367789999999999754 5764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.9e-15 Score=145.28 Aligned_cols=175 Identities=26% Similarity=0.403 Sum_probs=121.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
-.+|..++.|..|+||.||.++++. +.+.+|+|+ +++.+. +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~-trqrfa~ki-Nkq~li------lRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE-TRQRFAMKI-NKQNLI------LRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc-cccchhhcc-cccchh------hhc---cccccCCccee---------------
Confidence 3678899999999999999998887 788999954 332110 111 23333333333
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|+=..+++.. +.++.. ++.+++|||..||+|||+||+|++|+.-|++|+.|||+.+..-...+.
T Consensus 136 ------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 2323333221 334433 278999999999999999999999999999999999999776443322
Q ss_pred eeccccccc-ccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CCC
Q 042913 259 VETNVGSAT-RRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VPR 316 (317)
Q Consensus 259 ~~~~~~~~~-~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p~ 316 (317)
....|... ....-..-+.+++|+|+.++|.......+-.|-|+++.+++||.-| +|-
T Consensus 200 -nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpf 258 (1205)
T KOG0606|consen 200 -NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 258 (1205)
T ss_pred -hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeec
Confidence 11122222 2222333445899999999988877777778889999999999988 663
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-15 Score=143.66 Aligned_cols=202 Identities=20% Similarity=0.258 Sum_probs=152.3
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.|.+.+.||+|+|+.|-.+.........+|+|.+...............|..+-+.+. |.|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556666999999999988776545667777777655434455566777888888887 999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCCCC
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-ALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~~~ 257 (317)
++..|+++.+.+........+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+...
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~-- 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK-- 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc--
Confidence 9999999999884222225677778889999999999999 99999999999999999999 9999999999766542
Q ss_pred eeecccccccccccccc-cCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKS-CNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~-~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.|.......+.+ ..-|++||..... .-.....|.|+.+..+.=+..|
T Consensus 179 -----~g~~~~~~~~~g~s~~y~a~E~~~~~----~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 179 -----NGAERSLKDRCGSSPPYGAPEHLSGK----AYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred -----CCcceeeecccCCCCCCCCcccccch----hhcCCCcccccccccccccccC
Confidence 111112222233 3445555544332 2335667789999988877777
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-13 Score=107.65 Aligned_cols=135 Identities=21% Similarity=0.179 Sum_probs=98.4
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehh-h----hcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKD-L----LSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~----~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.+++|+-+.+|.+.+. |..+++|.-.++ . ..+ -...+..+|..++..++-..|..-+-+..+.....++||
T Consensus 3 ~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4789999999998665 455777754322 1 111 234567889999998875444433334445666789999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
|++|..|.+++... ...++..+-.-+.-||..||+|+||.++||++..+ ++.++|||++...+.
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~~ 143 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDE 143 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccccc
Confidence 99988898888543 13456667777889999999999999999999764 499999999976544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-14 Score=117.38 Aligned_cols=100 Identities=17% Similarity=0.069 Sum_probs=82.4
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccc
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 264 (317)
|+|.+++... +..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~------- 64 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS------- 64 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccC-------
Confidence 6888888653 456999999999999999999999998 999999999999999 999876543211
Q ss_pred cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 265 SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 265 ~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.++..|++||..... ....++|+|++|++++|+..|
T Consensus 65 --------~g~~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg 100 (176)
T smart00750 65 --------RVDPYFMAPEVIQGQ-----SYTEKADIYSLGITLYEALDY 100 (176)
T ss_pred --------CCcccccChHHhcCC-----CCcchhhHHHHHHHHHHHHhC
Confidence 355678888877543 234679999999999999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.1e-13 Score=106.00 Aligned_cols=146 Identities=20% Similarity=0.162 Sum_probs=105.4
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEee-hhh----hc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVD-KDL----LS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~-~~~----~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.+..|-+|+-+.|+++.+. |+..+||.-. +.. .+ .-...+..+|+++|.++.--.|.--.-++.+...-++
T Consensus 11 ~l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 4566889999999999766 5777777532 221 11 2334677889999998874444333333445555678
Q ss_pred EEcccCC-CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEEeeecccccC
Q 042913 178 LIDYCPN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIMLSDFDLCFQS 252 (317)
Q Consensus 178 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl~DFG~a~~~ 252 (317)
+|||++| .++.+++...............++.+|-..|.-||..+|+|+||..+||++..++ .+.|+|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999965 3788887665444444444578889999999999999999999999999997655 4689999997543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.7e-15 Score=124.87 Aligned_cols=197 Identities=19% Similarity=0.279 Sum_probs=154.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+...++.+..+|.+...|..|+|++.. ..++.|++.........-+.|..|.-.|+.+.||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqg---ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQG---NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccC---cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 444566777789999999999999885 56778988877666667778999999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-Ce-eccCCCCcEEEccCCcEEEe--eecccccC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG-II-YRDLKPENILLREDGHIMLS--DFDLCFQS 252 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-iv-HrDikp~Nill~~~~~~kl~--DFG~a~~~ 252 (317)
++..||+.|+|+.++.+..+...+..++.+++.+|++|+.|||+.. ++ ---|....++||++...+|. |--++.+-
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999998877777788999999999999999999975 33 34588899999998876653 43333221
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..+.....||+||..+.--... .-+.+|+||-...++|+-+- +|
T Consensus 344 -----------------~gr~y~pawmspealqrkped~--n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 344 -----------------VGRAYSPAWMSPEALQRKPEDL--NIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred -----------------cccccCcccCCHHHHhcCchhc--chhhhhHHHHHHHHHHhhccccc
Confidence 1123345688888765322221 24778999999988888655 44
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.7e-13 Score=112.08 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=107.9
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEec---CEEEEEEc
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYAHLEVS---HYICFLID 180 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e 180 (317)
+.|+.|..+.||++...+ |+.+++|+....... .....+.+|.++++.+.+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999997653 678999998654221 134567889999999975 4567788776653 36789999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA---------------------------------------- 220 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---------------------------------------- 220 (317)
|++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988876631 346666777777778888777773
Q ss_pred ----------------cCCeeccCCCCcEEEcc--CCcEEEeeecccccCC
Q 042913 221 ----------------LGIIYRDLKPENILLRE--DGHIMLSDFDLCFQSD 253 (317)
Q Consensus 221 ----------------~~ivHrDikp~Nill~~--~~~~kl~DFG~a~~~~ 253 (317)
..++|+|++|.||+++. ++.+.|+||+.+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 23689999999999998 6678999999986543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.7e-12 Score=108.64 Aligned_cols=136 Identities=17% Similarity=0.056 Sum_probs=97.0
Q ss_pred CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHH----------HHHHHHHHHHhcCC--CCcceEEEEEEe-----cCE
Q 042913 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLS----------HVQMEAEILSMLDH--PFLPTLYAHLEV-----SHY 174 (317)
Q Consensus 112 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~E~~~l~~l~h--~~iv~~~~~~~~-----~~~ 174 (317)
....|+++... |+.|.||......... ..+ .+.+|...+..|.. -.++.++.+++. ...
T Consensus 34 ~~rrvvr~~~~---g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 34 EGRRTLRFELA---GKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred CCceEEEEEEC---CEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 33446666443 5788999764332111 111 36788888888753 334455555543 235
Q ss_pred EEEEEcccCCC-ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-------CCcEEEeee
Q 042913 175 ICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-------DGHIMLSDF 246 (317)
Q Consensus 175 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-------~~~~kl~DF 246 (317)
-++|+|++++. +|.+++........+......++.+++..+.-||+.||+|+|+++.|||++. +..+.|+||
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 78999999775 7888875432344566777889999999999999999999999999999975 468999999
Q ss_pred ccccc
Q 042913 247 DLCFQ 251 (317)
Q Consensus 247 G~a~~ 251 (317)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.7e-12 Score=103.50 Aligned_cols=129 Identities=21% Similarity=0.221 Sum_probs=84.4
Q ss_pred EEEEEEEcCCCCceEEEEEeehhh------------------------hcHHHHHHHHHHHHHHHhcCCC--CcceEEEE
Q 042913 115 RVFLCHLRDCTSANFALKVVDKDL------------------------LSAKKLSHVQMEAEILSMLDHP--FLPTLYAH 168 (317)
Q Consensus 115 ~Vy~~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~ 168 (317)
.||.|...+ +..+|+|+.+... .........++|.+.|..+... ++++++++
T Consensus 1 ~Vy~~~~~~--~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDPD--GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEECT--TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECCC--CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 388887764 7899999876421 0011234568899999999855 57788765
Q ss_pred EEecCEEEEEEcccC--CCChhcccccCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 169 LEVSHYICFLIDYCP--NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY-LHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~-LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
. ..++||||++ |..+..+.... +.......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred e----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 3 2379999997 54554443221 2234456677788885555 579999999999999999876 999999
Q ss_pred ecccccCCC
Q 042913 246 FDLCFQSDV 254 (317)
Q Consensus 246 FG~a~~~~~ 254 (317)
||.|.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.6e-12 Score=118.52 Aligned_cols=163 Identities=12% Similarity=0.149 Sum_probs=124.2
Q ss_pred CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHH
Q 042913 125 TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAV 204 (317)
Q Consensus 125 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 204 (317)
++.+|.|.+..... ........+-++-|+.++||||+++++.++.++.+|+|+|-+ ..|..++++ +....+
T Consensus 36 ~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred cCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 67788888776552 244566778889999999999999999999999999999987 467777754 336667
Q ss_pred HHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCccc
Q 042913 205 RFFAAEVLVGLEYLH-ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKR 283 (317)
Q Consensus 205 ~~i~~qi~~al~~LH-~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~ 283 (317)
...+.||+.||.||| +.+++|++|.-.-|+|+..|..||++|.++........ .........+|-.|.-
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----------~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----------PAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----------ccccchhhhcccChhh
Confidence 777899999999998 57899999999999999999999999999865443221 1111122334555554
Q ss_pred ccccccceeccchhhhccCCcccccccCCC
Q 042913 284 RQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+.++- ...|.|-+++...|+..|
T Consensus 177 ~~~s~-------~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE-------WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc-------cchhhhhHHHHHHHHhCc
Confidence 43332 667889999999888888
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.3e-12 Score=119.11 Aligned_cols=203 Identities=19% Similarity=0.154 Sum_probs=149.5
Q ss_pred cccCCeEEeeeecc--cCCeEEEEEEE--cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 042913 97 LHLRHLKLVRHLGT--GNLGRVFLCHL--RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEV 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~--G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 171 (317)
+....+.+.+.+|. |.+|.||.+.. .. ++..+|+|.-+...........-.+|+...+.++ |+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCccc-CCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 44466778888999 99999999877 55 6788999986554433344344556777777776 9999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCCeeccCCCCcEEEccC-CcEEEeee
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV----GLEYLHALGIIYRDLKPENILLRED-GHIMLSDF 246 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DF 246 (317)
.+..|+-+|++ +.+|..+.... ..-++...++.++.+... ||.++|..+++|-|+||+||++..+ ..++++||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 78888887553 345788899999999999 9999999999999999999999998 89999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+..++....-.....+ ..+ ..+...|...+..+.. ....+|+-+++-+.+|...|
T Consensus 268 ~~v~~i~~~~~~~~~~~-----~~r-----~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~ 323 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKV-----SKR-----PEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILG 323 (524)
T ss_pred ceeEEccCCccccceee-----eec-----CCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhh
Confidence 99988766542211111 111 1333444444444432 23455567777777666665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.5e-11 Score=99.34 Aligned_cols=140 Identities=20% Similarity=0.194 Sum_probs=105.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh------------------c--HHHHHHHHHHHHHHHhcCCC-
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------------------S--AKKLSHVQMEAEILSMLDHP- 160 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~E~~~l~~l~h~- 160 (317)
+.++.+||.|--+.||.|...+ |.++|||.-+.... + .-.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~--g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK--GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECCC--CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3466789999999999998775 89999997543210 0 01233568899999999754
Q ss_pred -CcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 161 -FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 161 -~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
.|++.+++ +.-.+|||+++|..|...-- .......++..|+.-+..+-..||||+|+.+-||+++++|
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 77887764 45689999998877765541 2333445666677777777799999999999999999999
Q ss_pred cEEEeeecccccCCC
Q 042913 240 HIMLSDFDLCFQSDV 254 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~ 254 (317)
.+.++||--+...+.
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999987765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.4e-12 Score=117.22 Aligned_cols=127 Identities=20% Similarity=0.285 Sum_probs=97.1
Q ss_pred CEEEEEEcccCCCChhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.++|+.|++|...+|.+++... .....++...+.++.|+..+++| ++.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999999999999643 34556788899999999999999 9999999999999999999999999999866
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
..... +..-.........++.-||+||.+..+- .....|+.+++.++.|+.
T Consensus 406 ~~~~~----~~~~~~a~~t~~~gt~~YmsPEQi~g~~-----y~~kvdIyaLGlil~EL~ 456 (516)
T KOG1033|consen 406 QDKDE----TVAPAAASHTQQVGTLLYMSPEQIRGQQ-----YSEKVDIYALGLILAELL 456 (516)
T ss_pred cccCC----cccchhhhhhhcccccccCCHHHHhhhh-----hhhhcchhhHHHHHHHHH
Confidence 55544 1112223445567788899998765332 234566777777777653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=114.83 Aligned_cols=153 Identities=20% Similarity=0.204 Sum_probs=125.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
....+|..+..||.|.|+.|+.+..+..++..|++|.+............-..|+-+...+. |.+++.++..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 44578899999999999999998866457889999988766544433334455677776665 88999988888878888
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeeeccccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDFDLCFQ 251 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DFG~a~~ 251 (317)
|+-.|||+++++...+. -...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..
T Consensus 342 ~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 89999999988776652 23557888899999999999999999999999999999999876 7899999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.1e-10 Score=95.32 Aligned_cols=108 Identities=25% Similarity=0.218 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHHhcC--CCCcceEEEEEEec----CEEEEEEcccCCC-ChhcccccCCCCCCCHHHHHHHHHHHHHHHH
Q 042913 144 LSHVQMEAEILSMLD--HPFLPTLYAHLEVS----HYICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216 (317)
Q Consensus 144 ~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 216 (317)
..+..+|...+..|. .-.+++.+++.+.. ...++|+|++++. +|.+++... ...+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHH
Confidence 346778888887775 33456667666542 2458999999874 799998653 22566777889999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCC---cEEEeeecccccCC
Q 042913 217 YLHALGIIYRDLKPENILLREDG---HIMLSDFDLCFQSD 253 (317)
Q Consensus 217 ~LH~~~ivHrDikp~Nill~~~~---~~kl~DFG~a~~~~ 253 (317)
-||+.||+|+|+++.|||++.++ .+.|+||+-++...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999999877 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-11 Score=111.94 Aligned_cols=148 Identities=18% Similarity=0.209 Sum_probs=113.0
Q ss_pred HHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeccCCCCc
Q 042913 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI-IYRDLKPEN 232 (317)
Q Consensus 154 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i-vHrDikp~N 232 (317)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.....+.++|+.||.|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35678999999999999999999999999999999999763 5678888888899999999999998765 999999999
Q ss_pred EEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCccccccccccee--ccchhhhccCCccccccc
Q 042913 233 ILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV--AEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 233 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~--~~~~~~~~~~~~~~~~e~ 310 (317)
.+++....+||.|||+.......... ........-.-|.+||-......... ....+.|+.+.+.++.|+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~--------~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEP--------EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccc--------cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999999997655330000 11111123445778887766533332 345566777776666654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.7e-09 Score=87.94 Aligned_cols=142 Identities=14% Similarity=0.172 Sum_probs=95.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH-HHH------HHHHHHHHHHhcC---CCCcceE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLS------HVQMEAEILSMLD---HPFLPTL 165 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~------~~~~E~~~l~~l~---h~~iv~~ 165 (317)
.+..++|++.+.+.......|.+-... ++.+++|..+......+ ... ...+++..+..++ ......+
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~---~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID---GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC---CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 355678999999988888888776544 68999998865432211 111 1233444444432 2223332
Q ss_pred EEEE-----EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc
Q 042913 166 YAHL-----EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH 240 (317)
Q Consensus 166 ~~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~ 240 (317)
+.+. ......+|+|||++|..|.++.. +++ .+...|..+|.-||+.|++|+|+.|.|++++.+ .
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c
Confidence 3222 22345679999999998887652 222 244567788999999999999999999999854 5
Q ss_pred EEEeeeccccc
Q 042913 241 IMLSDFDLCFQ 251 (317)
Q Consensus 241 ~kl~DFG~a~~ 251 (317)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999988654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3e-09 Score=88.15 Aligned_cols=141 Identities=9% Similarity=0.105 Sum_probs=101.4
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhh----hcHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEe----cCEEEE
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDL----LSAKKLSHVQMEAEILSMLDH--PFLPTLYAHLEV----SHYICF 177 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~----~~~~~l 177 (317)
-|+||-+-|+...... ..+-+|.-.... ..+--...+.+|+..|+.|.. -.++++...... .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~g---~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNG---KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCC---cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 3678999999876554 467778654211 002234568889999888853 235555522111 223689
Q ss_pred EEcccCC-CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc--EEEeeeccccc
Q 042913 178 LIDYCPN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH--IMLSDFDLCFQ 251 (317)
Q Consensus 178 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~--~kl~DFG~a~~ 251 (317)
|+|-+.| .+|.+++....-.+.+......++.+|+..|.-||+.|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998843 58888885543345677778889999999999999999999999999999986677 99999988754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.4e-09 Score=86.76 Aligned_cols=142 Identities=18% Similarity=0.200 Sum_probs=98.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHH----------------------HHHHHHHHHHHhcC--CC
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKL----------------------SHVQMEAEILSMLD--HP 160 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~E~~~l~~l~--h~ 160 (317)
...|..|.-..||+|... .+..+|+|+++.....-... .=...|...|+++. +-
T Consensus 53 ~g~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 53 VGCISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred EeeecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 346778888999999764 48899999987542211110 01245777777764 45
Q ss_pred CcceEEEEEEecCEEEEEEcccCCC-ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccC
Q 042913 161 FLPTLYAHLEVSHYICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLRED 238 (317)
Q Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~ 238 (317)
.+++-+++.. ..|||||+... .-.-.|++ ..+....+..+..++++.+.-|-. .++||+||..=|||+. +
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 5666676543 37999999432 11122222 223333677788899999998877 8999999999999999 8
Q ss_pred CcEEEeeecccccCCCCC
Q 042913 239 GHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~ 256 (317)
+.+.|+|||-|...+.+.
T Consensus 203 ~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 203 GEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred CeEEEEECccccccCCCc
Confidence 899999999997776433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.8e-09 Score=100.26 Aligned_cols=142 Identities=19% Similarity=0.267 Sum_probs=94.8
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH--------------------------------HHHH------HH
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA--------------------------------KKLS------HV 147 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------------------------------~~~~------~~ 147 (317)
+.|+.++-|+||+|.++. |+.||||+.+...... +..+ .+
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 458999999999999996 9999999987641110 0011 12
Q ss_pred HHHHHHHHhcC-----CCCc--ceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 042913 148 QMEAEILSMLD-----HPFL--PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220 (317)
Q Consensus 148 ~~E~~~l~~l~-----h~~i--v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 220 (317)
.+|...+.+++ .++| ++++ ++..+...|+|||++|..+.++..... ..++...+...+.++ -+..+-.
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHh
Confidence 34444444442 3332 3333 334566789999999999988853332 445543333322222 1344455
Q ss_pred cCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 221 ~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.|++|.|..|.||+++.+|.+.+.|||+...+++
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 8999999999999999999999999999877665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-08 Score=84.34 Aligned_cols=139 Identities=9% Similarity=0.136 Sum_probs=87.2
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEecCEEEEEEcccC
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..- .+++.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 24568899886532 223468899999888643 35788888888888899999998
Q ss_pred CCC-hhccccc---------------------CCCCCCCHHHH-HHHHH----------HHHHH-HHHHHH----cCCee
Q 042913 184 NGD-LHSLLPK---------------------QPNNRFSLQAV-RFFAA----------EVLVG-LEYLHA----LGIIY 225 (317)
Q Consensus 184 ~gs-L~~~l~~---------------------~~~~~~~~~~~-~~i~~----------qi~~a-l~~LH~----~~ivH 225 (317)
|.+ +...+.. .+......... ..+.. .+... ..+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 2211110 00001111110 01100 01111 222221 24789
Q ss_pred ccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 226 RDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 226 rDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+.|.||++++++ +.|+||+.|...++
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~Gdp 185 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYGNP 185 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcCCH
Confidence 99999999999888 99999999865443
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.7e-09 Score=93.99 Aligned_cols=141 Identities=15% Similarity=0.148 Sum_probs=108.4
Q ss_pred CeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----ecCEEEEEEcccCC-CCh
Q 042913 113 LGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE----VSHYICFLIDYCPN-GDL 187 (317)
Q Consensus 113 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-gsL 187 (317)
-.+.|+|...- +|..|++|.++... .......-.-+++++++.|.|||++.++|. .+..+++|++|+++ ++|
T Consensus 289 ~~Ttyk~~s~~-DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNV-DGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeecc-CCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45688886665 89999999994431 111122334578899999999999988875 45568999999976 577
Q ss_pred hcccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 188 HSLLPKQ-------------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 188 ~~~l~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++.... .+.+.++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+.+++|..-|+.-.+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 7765332 234568899999999999999999999999999999999999888899987777655444
Q ss_pred CC
Q 042913 255 VP 256 (317)
Q Consensus 255 ~~ 256 (317)
++
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 33
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.4e-08 Score=92.73 Aligned_cols=142 Identities=21% Similarity=0.258 Sum_probs=91.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-----------------------------HHHHH------HHHH
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-----------------------------KKLSH------VQME 150 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-----------------------------~~~~~------~~~E 150 (317)
+.||..+.|+||+|+.+. |+.||||+-+...... +..+. +.+|
T Consensus 167 ~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 569999999999999996 9999999976542110 00111 2223
Q ss_pred HHH----HHhcCCCC------cceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 042913 151 AEI----LSMLDHPF------LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220 (317)
Q Consensus 151 ~~~----l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 220 (317)
.+. .+.+.|-+ |+++|- .......|+|||++|..+.|+-.-. ...++...+...+.++. +.-|-.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHH--HHHHHh
Confidence 332 23334444 455543 2344678999999999887764322 23455554433333321 233345
Q ss_pred cCCeeccCCCCcEEEcc----CCcEEEeeecccccCCC
Q 042913 221 LGIIYRDLKPENILLRE----DGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 221 ~~ivHrDikp~Nill~~----~~~~kl~DFG~a~~~~~ 254 (317)
.|++|+|-.|.||++.. ++.+.+.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 78999999999999983 66899999999876654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.9e-08 Score=77.45 Aligned_cols=131 Identities=27% Similarity=0.319 Sum_probs=97.2
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCEEEEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSHYICFLI 179 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 179 (317)
..++.+.|++|.+|.||+|.+.. ..+|+|+-+.+ .....+..|.++|..++..++ .++|.+.++ ++.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~---~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRG---GEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccC---ceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 34567789999999999998874 68999987654 334668889999999986665 466665443 4569
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC-CCcEEEccCCcEEEeeeccccc
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLK-PENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDik-p~Nill~~~~~~kl~DFG~a~~ 251 (317)
||+.|..|.+..... ...+ +..++..---|-..||-|..|. |..++|..++.+.|+||.-|..
T Consensus 92 e~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 999888887766321 2222 3445566556677899999997 7777777777999999999873
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.2e-07 Score=79.08 Aligned_cols=141 Identities=27% Similarity=0.361 Sum_probs=84.2
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEEEEE---EecCEEEEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLYAHL---EVSHYICFLI 179 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~ 179 (317)
++.|+.|..+.||++...+ +.+++|+.... .....+.+|..+++.+... .+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD---GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT---SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC---cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999997664 58999997543 3446677888888887533 356777644 2344579999
Q ss_pred cccCCCChhcc----------------cc---cC--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 042913 180 DYCPNGDLHSL----------------LP---KQ--PNNRFSLQA---------VRFF------------AAEVLV-GLE 216 (317)
Q Consensus 180 e~~~~gsL~~~----------------l~---~~--~~~~~~~~~---------~~~i------------~~qi~~-al~ 216 (317)
++++|..+... +. .. ....+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 99998888771 10 01 111111110 0000 111222 233
Q ss_pred HHHH-------cCCeeccCCCCcEEEc-cCCcEEEeeecccccC
Q 042913 217 YLHA-------LGIIYRDLKPENILLR-EDGHIMLSDFDLCFQS 252 (317)
Q Consensus 217 ~LH~-------~~ivHrDikp~Nill~-~~~~~kl~DFG~a~~~ 252 (317)
.+++ ..++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3332 3599999999999999 6677789999987543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-07 Score=80.63 Aligned_cols=139 Identities=17% Similarity=0.075 Sum_probs=86.5
Q ss_pred ecccCC-eEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 108 LGTGNL-GRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 108 lg~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
|..|.. ..||++... +..+++|+..... ...+.+|+++++.+. +--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK---NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC---CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 788988543 3678889875432 235667888888875 445678888877767789999999988
Q ss_pred Chhcccc-------------------cCC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHH---
Q 042913 186 DLHSLLP-------------------KQP--NNRFSLQ--AVRFFAA--------------------EVLVGLEYLH--- 219 (317)
Q Consensus 186 sL~~~l~-------------------~~~--~~~~~~~--~~~~i~~--------------------qi~~al~~LH--- 219 (317)
+|..... ..+ ...+... ....... .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764421 000 0011100 0000000 0111122221
Q ss_pred ----HcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 220 ----ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 220 ----~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
...++|+|+.|.|||+++++.+.|+||+.|...+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gdp 196 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVADR 196 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccccccH
Confidence 12489999999999999987789999999876554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-09 Score=106.34 Aligned_cols=213 Identities=18% Similarity=0.229 Sum_probs=148.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..+.+.+.+-+|.++.++.+.-.. ++...+.|+..... ......+....+-.++-..++|-++...-.+......+|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~-sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAG-SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccc-cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345566667888899888876554 55555555543221 1111223333344444444556666555445566778999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
++|+.+++|...++.. ...+.+.++-....+..++++||...++|+|++|.|+|+..+|..++.|||........+..
T Consensus 883 ~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999988654 45666667777788999999999999999999999999999999999999966554433222
Q ss_pred eecc----cccc------------cccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETN----VGSA------------TRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~----~~~~------------~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.... .++. ..+..+......++|.|..++.....+-...+|.|+.+..++|+.+|.|
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2210 0110 1111133556788999999999999999999999999999999999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=88.53 Aligned_cols=152 Identities=18% Similarity=0.302 Sum_probs=94.0
Q ss_pred eeeecccCCeEEEEEEEcCCC-CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCc--ceEEEEEEec---CEEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCT-SANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFL--PTLYAHLEVS---HYICF 177 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~l 177 (317)
++.|+.|.+..+|+....... ...+++|+....... .....+.+|.++++.+. |.+| ++++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 567899999999998765411 146778876543211 12346788999999996 6654 7888877654 46789
Q ss_pred EEcccCCCChhccc-----------------------ccCCC---------CC--CCHHHHHHHHHH-------------
Q 042913 178 LIDYCPNGDLHSLL-----------------------PKQPN---------NR--FSLQAVRFFAAE------------- 210 (317)
Q Consensus 178 v~e~~~~gsL~~~l-----------------------~~~~~---------~~--~~~~~~~~i~~q------------- 210 (317)
||||++|..+.+.. +.... .+ ....++..+..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 99999876543210 00000 00 001122222111
Q ss_pred --HHHHHHHHHH-----------cCCeeccCCCCcEEEccC-C-cEEEeeecccccCCCCCC
Q 042913 211 --VLVGLEYLHA-----------LGIIYRDLKPENILLRED-G-HIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 211 --i~~al~~LH~-----------~~ivHrDikp~Nill~~~-~-~~kl~DFG~a~~~~~~~~ 257 (317)
+...+.+|.. ..+||+|+++.|||++.+ + .+-|+||++|...++...
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl~D 263 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQMCD 263 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChHHH
Confidence 2233556643 249999999999999853 3 367999999987666444
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.4e-07 Score=75.73 Aligned_cols=143 Identities=13% Similarity=0.090 Sum_probs=81.5
Q ss_pred eeecccCCe-EEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEec---CEEEEE
Q 042913 106 RHLGTGNLG-RVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP---FLPTLYAHLEVS---HYICFL 178 (317)
Q Consensus 106 ~~lg~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv 178 (317)
+.|+.|+.. .||+. +..+++|+.+.. .....+.+|.++++.+... -++++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~------~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL------GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc------CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 48875 235778876542 1234688899999888632 455666544332 245889
Q ss_pred EcccCCCChhccccc------------------CCCCCCC---------------HH-HH----HHHH----HHHHHH-H
Q 042913 179 IDYCPNGDLHSLLPK------------------QPNNRFS---------------LQ-AV----RFFA----AEVLVG-L 215 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~------------------~~~~~~~---------------~~-~~----~~i~----~qi~~a-l 215 (317)
|++++|.++.+.... ......+ +. .. ..+. .+.+.. +
T Consensus 73 ~~~i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 152 (235)
T cd05155 73 YRWLEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALW 152 (235)
T ss_pred EEeecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHH
Confidence 999998877543211 0000000 00 00 0000 011111 1
Q ss_pred HHH-H-----HcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 216 EYL-H-----ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 216 ~~L-H-----~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
+.+ + ..+++|+|+.+.|||++.++..-|+||+.|...+....+
T Consensus 153 ~~~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gDp~~Dl 201 (235)
T cd05155 153 EAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGDPACDL 201 (235)
T ss_pred HHHhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcCChHHHH
Confidence 111 1 234899999999999987665679999998766554433
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.1e-06 Score=71.20 Aligned_cols=131 Identities=18% Similarity=0.303 Sum_probs=92.0
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhh--------------hcHHHHHHHHHHHHHHHhcC------CCCcceEE
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--------------LSAKKLSHVQMEAEILSMLD------HPFLPTLY 166 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~~iv~~~ 166 (317)
.||+|+.-.||.- . .+...+||+..... ......++..+|+.-...+. +.+|.+++
T Consensus 8 ~i~~G~~R~cy~H--P--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 8 LIAQGGERDCYQH--P--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred ccccCCCceEEEC--C--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4999999999963 2 34567899987654 11122455566666655554 78899999
Q ss_pred EEEEecCEEEEEEcccCC------CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-
Q 042913 167 AHLEVSHYICFLIDYCPN------GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG- 239 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~- 239 (317)
|+.+++.-..+|+|.+.+ .+|.+++.+ +.++. . +...+-+-..||-+.+|+.+||+|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999989999998642 257777743 33554 2 233344556788899999999999999996422
Q ss_pred ---cEEEee-ecc
Q 042913 240 ---HIMLSD-FDL 248 (317)
Q Consensus 240 ---~~kl~D-FG~ 248 (317)
.+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 578887 554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=70.23 Aligned_cols=127 Identities=24% Similarity=0.346 Sum_probs=88.9
Q ss_pred CCeEEeeeecccCC-eEEEEEEEcCCCCceEEEEEeeh---hh-------hc---------HHHHHHHHHHHHHHHhcC-
Q 042913 100 RHLKLVRHLGTGNL-GRVFLCHLRDCTSANFALKVVDK---DL-------LS---------AKKLSHVQMEAEILSMLD- 158 (317)
Q Consensus 100 ~~y~i~~~lg~G~~-g~Vy~~~~~~~~~~~vavK~~~~---~~-------~~---------~~~~~~~~~E~~~l~~l~- 158 (317)
.+++.++.||.|.- |.||+++.. |+.+|||++.. .. .. ......|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 68899999999999 999999877 57999999322 00 00 022345778888877765
Q ss_pred --CCCc--ceEEEEEEecC------------------EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHH
Q 042913 159 --HPFL--PTLYAHLEVSH------------------YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216 (317)
Q Consensus 159 --h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 216 (317)
+.++ |+++|++.-.. ...+|.||++... .+.. .-+.+|+.-|.
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHH
Confidence 4456 89999873220 1244555543221 1222 23567888899
Q ss_pred HHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 217 ~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999999987 4578999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-07 Score=82.27 Aligned_cols=91 Identities=23% Similarity=0.397 Sum_probs=77.2
Q ss_pred HHhcCCCCcceEEEEEEec-----CEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--Ce
Q 042913 154 LSMLDHPFLPTLYAHLEVS-----HYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALG--II 224 (317)
Q Consensus 154 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~--iv 224 (317)
|-.+-|.|||++..++.+. ....++.||+..|+|..+|++. ....+......+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455699999999887544 3478999999999999999763 3456788889999999999999999975 99
Q ss_pred eccCCCCcEEEccCCcEEEe
Q 042913 225 YRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 225 HrDikp~Nill~~~~~~kl~ 244 (317)
|+++..+-|++..+|-+|+.
T Consensus 201 hgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cCCcchhheeecCCceEEec
Confidence 99999999999998888875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.5e-06 Score=70.31 Aligned_cols=102 Identities=23% Similarity=0.297 Sum_probs=79.6
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEEecCEEEEEEcccCCCChhccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 042913 148 QMEAEILSMLDH-PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK-QPNNRFSLQAVRFFAAEVLVGLEYLHA---LG 222 (317)
Q Consensus 148 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ 222 (317)
.+|.-+++.+++ +++++++|+|-. ++|.||...+++...... ..--..+|..+.+|+.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888899986 699999999843 678899976766432100 011235899999999999999999987 34
Q ss_pred CeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 223 ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
+.-.|++|+|+-++++|++|++|...+...+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 7779999999999999999999999875443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-05 Score=67.49 Aligned_cols=144 Identities=15% Similarity=0.260 Sum_probs=83.1
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCEEEEEEcccC
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEVSHYICFLIDYCP 183 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 183 (317)
++.|..|-...+|++......++.|++|+..... .. .....+|..+++.+.. .-.++++..+. + .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--EL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--cc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 3567778888999986442124688899775431 11 1233468888888853 33456665433 2 47999998
Q ss_pred CCChhcc-c------c----------cC--CC-------CCCC-HHHHHHHHH----------------------HHHHH
Q 042913 184 NGDLHSL-L------P----------KQ--PN-------NRFS-LQAVRFFAA----------------------EVLVG 214 (317)
Q Consensus 184 ~gsL~~~-l------~----------~~--~~-------~~~~-~~~~~~i~~----------------------qi~~a 214 (317)
|.++... + . .. .. .... +..+..+.. .+...
T Consensus 76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 155 (235)
T cd05157 76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE 155 (235)
T ss_pred CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence 8776322 0 0 00 00 0111 112212211 11111
Q ss_pred HHHH----H----HcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCCC
Q 042913 215 LEYL----H----ALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 215 l~~L----H----~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~ 255 (317)
+..| - ...++|+|+.+.|||++. ++.+.|+||..|...+..
T Consensus 156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~~ 205 (235)
T cd05157 156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYRA 205 (235)
T ss_pred HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCchh
Confidence 1222 1 135899999999999997 578999999998765443
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=69.98 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=80.6
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEEEEEcccCCCC
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYICFLIDYCPNGD 186 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~gs 186 (317)
+..|-...+|+... .++.+++|+..... ....-...+|.++++.+.... .++++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 55677888998862 36688889764321 111013467888888886433 345555432 268999998877
Q ss_pred hhcc-----------------cccC--CCCCCCHH-HHHHHHHHH---------HHHHHHHHH--------cCCeeccCC
Q 042913 187 LHSL-----------------LPKQ--PNNRFSLQ-AVRFFAAEV---------LVGLEYLHA--------LGIIYRDLK 229 (317)
Q Consensus 187 L~~~-----------------l~~~--~~~~~~~~-~~~~i~~qi---------~~al~~LH~--------~~ivHrDik 229 (317)
+... ++.. ....+... .+..+..++ ...++.+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 6432 0111 01112211 111221111 111222221 148999999
Q ss_pred CCcEEEccCCcEEEeeecccccCCCCC
Q 042913 230 PENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 230 p~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
|.||+++.++ ++|+||+.|...++.-
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gdp~~ 180 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGDIAL 180 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCCHHH
Confidence 9999999876 7899999987665533
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.6e-06 Score=73.68 Aligned_cols=138 Identities=16% Similarity=0.214 Sum_probs=98.9
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc------------------HHHH--HHHHHHHHHHHhcCC--
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS------------------AKKL--SHVQMEAEILSMLDH-- 159 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------------~~~~--~~~~~E~~~l~~l~h-- 159 (317)
+.++.+||-|.-+.||.+.+.+ |.+.++|+-+....+ ...+ -...+|...|+.|..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~--G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE--GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCC--CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4567889999999999998775 889999974322100 0011 124567888888753
Q ss_pred CCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 160 ~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
--|++.+++ +.-++|||++.|-.|..+-.-. . +..+...++.-|.-|-.+|+||+|..-=||++++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 235566654 4568999999998887765321 2 233455666777888999999999999999999999
Q ss_pred cEEEeeecccccCC
Q 042913 240 HIMLSDFDLCFQSD 253 (317)
Q Consensus 240 ~~kl~DFG~a~~~~ 253 (317)
.++++||--+....
T Consensus 240 ~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTS 253 (465)
T ss_pred CEEEeechHhhccC
Confidence 99999998665443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=9e-05 Score=65.80 Aligned_cols=78 Identities=17% Similarity=0.084 Sum_probs=56.1
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC---CCcceEEEEEEe---cCEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH---PFLPTLYAHLEV---SHYIC 176 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~ 176 (317)
.-.+.||.|..+.||+....+ ..+.+|+.+.. .....+..|.+.|+.|.. ..++++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~---~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ---GNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC---CCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 445679999999999986443 35677875321 112467889999988853 468899987754 36689
Q ss_pred EEEcccCCCCh
Q 042913 177 FLIDYCPNGDL 187 (317)
Q Consensus 177 lv~e~~~~gsL 187 (317)
+|||++++.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999988765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2e-06 Score=81.02 Aligned_cols=183 Identities=16% Similarity=0.154 Sum_probs=123.7
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEEEEEc
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 180 (317)
+.....+++++++++++.+... .+....+++... ....-++++|.+++||| .+..++-++.+.+.+++++
T Consensus 244 s~~fh~fvK~altknpKkRpta--eklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTA--EKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCCh--hhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 4455568899999999876554 233335555332 34556899999999999 7777777788889999999
Q ss_pred ccCCC-ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 181 YCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 181 ~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
++.++ +........ ...+.+-+...+++.-.+++++||+..-+|+| ||+..+ +..++.||+.+..+....
T Consensus 315 i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred hhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---
Confidence 99766 332222111 22344445566677778899999998888999 777765 789999999987775532
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
......++..+++|+....+... ..-+.|+++.-.++++.|+|
T Consensus 386 --------~~~t~~~~~~~~~pev~~~~~~~-----~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 386 --------KPRTAIGTPEPLAPEVIQENTID-----GCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred --------ccccCCCCCCCCCchhhcccccc-----cCCCccCCCcchhhcCCCCC
Confidence 12222455566777766555444 33456777766777777744
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.7e-05 Score=69.40 Aligned_cols=145 Identities=18% Similarity=0.251 Sum_probs=98.0
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh----------------------cH-HHHHH-HHHHHHHHHhcCC
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL----------------------SA-KKLSH-VQMEAEILSMLDH 159 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----------------------~~-~~~~~-~~~E~~~l~~l~h 159 (317)
|-..|..|--..||.|... +|..+|||+++-..+ .+ ...+. ...|++-|++|+.
T Consensus 148 inGCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred cccccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4456778889999998766 488899999754211 11 11111 2457777888765
Q ss_pred CCcceEEEEEEecCEEEEEEcccCCCCh--hcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEc
Q 042913 160 PFLPTLYAHLEVSHYICFLIDYCPNGDL--HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-ALGIIYRDLKPENILLR 236 (317)
Q Consensus 160 ~~iv~~~~~~~~~~~~~lv~e~~~~gsL--~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivHrDikp~Nill~ 236 (317)
..|+.---+.. ..-.|||+|+ |++= .-.|+ ...++...+..+-.|++.-+.-|. .+++||.||.--|+|+.
T Consensus 226 aGIP~PePIlL--k~hVLVM~Fl-Grdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFL-GRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred cCCCCCCceee--ecceEeeeec-cCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 55432211111 2237999999 4332 22232 244677778888888888888775 57999999999999996
Q ss_pred cCCcEEEeeecccccCCCCCC
Q 042913 237 EDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 237 ~~~~~kl~DFG~a~~~~~~~~ 257 (317)
+|.++|+|.+-+...+.+..
T Consensus 300 -dG~lyiIDVSQSVE~DHP~a 319 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHDHPHA 319 (520)
T ss_pred -CCEEEEEEccccccCCChhH
Confidence 58999999999877776554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.6e-05 Score=66.60 Aligned_cols=140 Identities=15% Similarity=0.228 Sum_probs=77.0
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEE------EEEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYA------HLEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~------~~~~~~~~~ 176 (317)
.+.|+.|....+|+..... ..+++|++.. .... .+..|..+++.|.. -.+++++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~---g~~vLK~~~~--~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ---GEYVLTLFER--LTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCC---CcEEEEEecc--CChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4557777778999986543 4788998752 1222 33345555555531 22444442 123356789
Q ss_pred EEEcccCCCChhcc-----------cc---cC-CC--------CCCCH-HHH-H-----------HHHHH-HHHHHHHHH
Q 042913 177 FLIDYCPNGDLHSL-----------LP---KQ-PN--------NRFSL-QAV-R-----------FFAAE-VLVGLEYLH 219 (317)
Q Consensus 177 lv~e~~~~gsL~~~-----------l~---~~-~~--------~~~~~-~~~-~-----------~i~~q-i~~al~~LH 219 (317)
++++|++|..+... +. .. .. ..+.+ ... . ..+.+ +...+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 99999988754221 00 00 00 00111 000 0 01111 111122222
Q ss_pred -------HcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 220 -------ALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 220 -------~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..++||+|+.|.|||++.+...-|+||+.|...
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 237999999999999986655689999998543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00012 Score=64.85 Aligned_cols=140 Identities=18% Similarity=0.185 Sum_probs=84.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEEEE------EEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLYAH------LEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~~~~ 176 (317)
.+.|..|....+|+.... +..+++|+.... . ...+..|+++++.+.+. .+++++.. ...++..+
T Consensus 19 i~~i~~G~~n~~y~v~~~---~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD---SGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC---CCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 556777888899998644 357899987541 1 24466678887777532 34555432 23345678
Q ss_pred EEEcccCCCChhcc----c----------cc----CCC-----CCCCHHHH--H--------HHHHHHHHHHHHHHH---
Q 042913 177 FLIDYCPNGDLHSL----L----------PK----QPN-----NRFSLQAV--R--------FFAAEVLVGLEYLHA--- 220 (317)
Q Consensus 177 lv~e~~~~gsL~~~----l----------~~----~~~-----~~~~~~~~--~--------~i~~qi~~al~~LH~--- 220 (317)
+|++|++|..+... + +. ... ....+... . .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999988776431 0 00 000 00011000 0 011112334444443
Q ss_pred ----cCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 221 ----LGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 221 ----~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.+++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 36999999999999998777899999998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=67.15 Aligned_cols=79 Identities=19% Similarity=0.257 Sum_probs=54.9
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-----cHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-----SAKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 176 (317)
.+.||.|.+..||++...+ .++.++||....... .+-..++...|.+.|+.+. ..++++++.+. ....+
T Consensus 31 ~~elggGn~N~VyrV~~~~-g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE-GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCC-CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCE
Confidence 4679999999999998764 225899998542110 0223456777888888763 35678888763 35578
Q ss_pred EEEcccCCCC
Q 042913 177 FLIDYCPNGD 186 (317)
Q Consensus 177 lv~e~~~~gs 186 (317)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00029 Score=62.91 Aligned_cols=145 Identities=17% Similarity=0.258 Sum_probs=84.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEEEE------EEecC
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLYAH------LEVSH 173 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~ 173 (317)
....+.++.|....+|++... +..+++|+.+... . ...+..|.+++..|... .+++++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~---~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD---VGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC---CCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 344566777877899988643 3468889875421 1 12345567777776422 24455432 12346
Q ss_pred EEEEEEcccCCCChhccc--------------ccC-CC------C--CC-CHHHH--H----------HHHHHHHHHHHH
Q 042913 174 YICFLIDYCPNGDLHSLL--------------PKQ-PN------N--RF-SLQAV--R----------FFAAEVLVGLEY 217 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l--------------~~~-~~------~--~~-~~~~~--~----------~i~~qi~~al~~ 217 (317)
..+++++|++|..+.... +.. .. . .. .+... . .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 679999999886543210 000 00 0 00 00000 0 001123334555
Q ss_pred HHH-------cCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 218 LHA-------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 218 LH~-------~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
+.. .+++|+|+.+.||+++.++.+.|+||+.|....
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~~ 219 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTDA 219 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCcc
Confidence 542 579999999999999988877999999985443
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.7e-05 Score=66.02 Aligned_cols=144 Identities=19% Similarity=0.204 Sum_probs=84.8
Q ss_pred eeecccCCeEEEEEEEcC-----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEEEEE
Q 042913 106 RHLGTGNLGRVFLCHLRD-----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 179 (317)
+.|..|-...+|++.... ..++.+++|+..... .......+|.++++.+.... .++++..+.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 446667777899886542 125789999975432 22235577888888875332 4566665542 3689
Q ss_pred cccCCCChhcc-c----------------ccCCCC-------CCC--HHHHHH--------------------------H
Q 042913 180 DYCPNGDLHSL-L----------------PKQPNN-------RFS--LQAVRF--------------------------F 207 (317)
Q Consensus 180 e~~~~gsL~~~-l----------------~~~~~~-------~~~--~~~~~~--------------------------i 207 (317)
||++|..+... + +..... ..+ +..+.. +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988776431 1 000000 111 001111 1
Q ss_pred HHHHHHHHHHHHH---------cCCeeccCCCCcEEEccC----CcEEEeeecccccCCCCC
Q 042913 208 AAEVLVGLEYLHA---------LGIIYRDLKPENILLRED----GHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 208 ~~qi~~al~~LH~---------~~ivHrDikp~Nill~~~----~~~kl~DFG~a~~~~~~~ 256 (317)
..++...+.+|-. ..++|+|+.+.|||++.+ +.++|+||..|...+..-
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p~~ 218 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYRGF 218 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCcHH
Confidence 1122223334432 248999999999999975 889999999997655533
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00028 Score=61.97 Aligned_cols=36 Identities=28% Similarity=0.357 Sum_probs=29.2
Q ss_pred CCeeccCCCCcEEEccCCc-EEEeeecccccCCCCCC
Q 042913 222 GIIYRDLKPENILLREDGH-IMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 222 ~ivHrDikp~Nill~~~~~-~kl~DFG~a~~~~~~~~ 257 (317)
.++|+|++|.|||++.++. .-|+||+.|...++...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDPa~D 222 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDPARD 222 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCHHHH
Confidence 3899999999999997555 56999999987665443
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00052 Score=61.01 Aligned_cols=153 Identities=13% Similarity=0.171 Sum_probs=87.4
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecC--EEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYAHLEVSH--YICF 177 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~l 177 (317)
..+++.+..|.--.+|..... ++.++++ ...............+|..+++.+.- .-+...++.+..+. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~---~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT---GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC---CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344455533433344544322 6778888 43222233555677888888888753 23445566665544 6799
Q ss_pred EEcccCCCChhcccccCCCC------------------------------CCCHHHHHHHHH--------------HHHH
Q 042913 178 LIDYCPNGDLHSLLPKQPNN------------------------------RFSLQAVRFFAA--------------EVLV 213 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~------------------------------~~~~~~~~~i~~--------------qi~~ 213 (317)
||+|++|..+...+...... .+...++..+.. ....
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999874333222110000 000001111111 1122
Q ss_pred HHHHHHHc--------CCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 214 GLEYLHAL--------GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 214 al~~LH~~--------~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
-..+|+.+ .++|+|+.+.||+++.++-+-|+||+++...++...+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~Dl 235 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLEDL 235 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHHH
Confidence 24455443 3799999999999998888999999999877765544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00053 Score=62.20 Aligned_cols=144 Identities=15% Similarity=0.182 Sum_probs=83.8
Q ss_pred EeeeecccCCeEEEEEEEcCC---CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCEEEEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDC---TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSHYICFLI 179 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 179 (317)
-++.|-.|-.-.+|++..... .++.|++|+.... ....++ ..+|..+++.+...++ +++++.+... .|.
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~--t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG--VELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC--CCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 334555588889999875421 2468899987554 222222 3678888888864433 4666665432 578
Q ss_pred cccCCCChhcc-c----------------ccC--CCC--CCCHHHHHHHHHHH-----------------HHHHHHHH--
Q 042913 180 DYCPNGDLHSL-L----------------PKQ--PNN--RFSLQAVRFFAAEV-----------------LVGLEYLH-- 219 (317)
Q Consensus 180 e~~~~gsL~~~-l----------------~~~--~~~--~~~~~~~~~i~~qi-----------------~~al~~LH-- 219 (317)
+|+++.+|... + +.. +.. ...+..+..++.++ ...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99877666421 0 000 011 11122232332111 11122222
Q ss_pred ------HcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCC
Q 042913 220 ------ALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 220 ------~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~ 254 (317)
...++|+|+++.|||+++ ++.++|+||..|...+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~ 234 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPV 234 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccch
Confidence 125899999999999986 46899999999876554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.002 Score=57.44 Aligned_cols=30 Identities=33% Similarity=0.599 Sum_probs=26.3
Q ss_pred cCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 221 ~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0007 Score=61.07 Aligned_cols=75 Identities=16% Similarity=0.225 Sum_probs=50.0
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhhh-----cHHHHHHHHHHHHHHHhcC--CC-CcceEEEEEEecCEEEEE
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-----SAKKLSHVQMEAEILSMLD--HP-FLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 178 (317)
.||-|....||++.... .++.|+||.-..-.. .+-..++...|.+.|+... -| .++++|.+ +.....+|
T Consensus 2 EigdGnlN~VfrV~~~~-g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCC-CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 58999999999998653 336899997642211 1233456677888887764 24 56666654 34556799
Q ss_pred EcccCC
Q 042913 179 IDYCPN 184 (317)
Q Consensus 179 ~e~~~~ 184 (317)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=59.10 Aligned_cols=150 Identities=13% Similarity=0.183 Sum_probs=84.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~ 176 (317)
....+.. |..|-.-.+|++...... +..|++|+..... . ..-...+|..+++.+...++ +++++++. ++
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3444444 444777789988655311 2478899875432 1 22234668888888865444 46666653 32
Q ss_pred EEEcccCCCChhc--c-----c----------ccC--CCCC-C-CHHHHHHHHHHH----------------------HH
Q 042913 177 FLIDYCPNGDLHS--L-----L----------PKQ--PNNR-F-SLQAVRFFAAEV----------------------LV 213 (317)
Q Consensus 177 lv~e~~~~gsL~~--~-----l----------~~~--~~~~-~-~~~~~~~i~~qi----------------------~~ 213 (317)
+|.+|+++..|.. + + +.. +... . .+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899997766532 1 1 000 0010 1 122222222221 11
Q ss_pred HHHHHHH----cC----CeeccCCCCcEEEcc-CCcEEEeeecccccCCCCCC
Q 042913 214 GLEYLHA----LG----IIYRDLKPENILLRE-DGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 214 al~~LH~----~~----ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~~~~ 257 (317)
-+..+.. .+ ++|+|+.+.|||+++ ++.++|+||..|-..+..-.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~~fD 219 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYRGYD 219 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCccHHH
Confidence 1222221 12 789999999999975 57899999999866554333
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0025 Score=58.59 Aligned_cols=76 Identities=18% Similarity=0.248 Sum_probs=52.3
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh--c---HHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL--S---AKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~ 175 (317)
..+.||-|....||+.... ++.++||.-..... . +-...+...|.+.|+.+. ..++++++.++. +..
T Consensus 36 ~~~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 4677899999999998753 35689998652211 1 113455566777777664 357888998776 345
Q ss_pred EEEEcccCC
Q 042913 176 CFLIDYCPN 184 (317)
Q Consensus 176 ~lv~e~~~~ 184 (317)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999966
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00072 Score=56.82 Aligned_cols=30 Identities=37% Similarity=0.564 Sum_probs=21.3
Q ss_pred CCeeccCCCCcEEE-ccCCcEEEeeeccccc
Q 042913 222 GIIYRDLKPENILL-REDGHIMLSDFDLCFQ 251 (317)
Q Consensus 222 ~ivHrDikp~Nill-~~~~~~kl~DFG~a~~ 251 (317)
-++|+|+.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 7889999999999854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00022 Score=68.19 Aligned_cols=98 Identities=13% Similarity=0.144 Sum_probs=63.7
Q ss_pred HHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccc
Q 042913 208 AAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQE 286 (317)
Q Consensus 208 ~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~ 286 (317)
+.+++.||.|+|. .++||++|.|++|.++..+..||+.|+++....+... ..-..++..-..-...-..|.+|||.-.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhcc
Confidence 3455699999997 5899999999999999999999999999876554332 2222222221222223345777777655
Q ss_pred cccceeccchhhhccCCcccccccC
Q 042913 287 NVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
.+. ....|.-+++..++-.+
T Consensus 184 ~~~-----~~~sd~fSlG~li~~i~ 203 (700)
T KOG2137|consen 184 TTN-----TPASDVFSLGVLIYTIY 203 (700)
T ss_pred ccc-----cccccceeeeeEEEEEe
Confidence 333 34555656665555555
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0048 Score=55.13 Aligned_cols=31 Identities=13% Similarity=0.115 Sum_probs=28.3
Q ss_pred CCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 222 ~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+++|+|+.+.|||++.++.+.|+||..|..-
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 6999999999999999999999999998653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0048 Score=54.39 Aligned_cols=75 Identities=17% Similarity=0.242 Sum_probs=46.9
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCEEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+-.+.|+-|....+|+.. . +++.+.||+-... ....+..|.+-|+.|. .-.+++++++....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~-~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--T-DGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--T-TS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--C-CCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445678889999999876 2 5788999987632 2245667777777773 456889999888777779999
Q ss_pred cccCCC
Q 042913 180 DYCPNG 185 (317)
Q Consensus 180 e~~~~g 185 (317)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.002 Score=57.67 Aligned_cols=73 Identities=19% Similarity=0.231 Sum_probs=55.6
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
+..+.|++|++. |++|.-+- ...++++..++.+.+..+.-+.. ...-|||+.-.||||+ +|+|.|+||-+|
T Consensus 297 e~~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 445678888886 66664432 13567777888877777666654 3688999999999999 899999999999
Q ss_pred cc
Q 042913 250 FQ 251 (317)
Q Consensus 250 ~~ 251 (317)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 83
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0034 Score=57.65 Aligned_cols=81 Identities=10% Similarity=0.217 Sum_probs=48.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCce-----EEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecC
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSAN-----FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSH 173 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~ 173 (317)
..+.+. .|..|-...+|++......+.. |++++... .....-...+|+++++.+...++ +++++.+..
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 344444 5555888999999765422223 33333211 11112234668999999875444 567776642
Q ss_pred EEEEEEcccCCCChh
Q 042913 174 YICFLIDYCPNGDLH 188 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~ 188 (317)
++|.||++|.+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 6999999887764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.014 Score=52.47 Aligned_cols=136 Identities=28% Similarity=0.385 Sum_probs=80.4
Q ss_pred ecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC------cceEEEEE--EecC--EEEE
Q 042913 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF------LPTLYAHL--EVSH--YICF 177 (317)
Q Consensus 108 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~--~~~~--~~~l 177 (317)
|.+ .-..+|+....+ | .+++|+.+.. ... .++..|+..++.|.-.. +..+-|.. .-.+ +.+-
T Consensus 34 l~s-~eN~~f~~~~~~--g-~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTED--G-RYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecC--C-CeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 556789887664 4 4499998775 333 34566777777774211 22221211 1233 7889
Q ss_pred EEcccCCCChhc-cccc------------------C----CC--CCCCHHH-------------HHHHHHHHHHHHHHHH
Q 042913 178 LIDYCPNGDLHS-LLPK------------------Q----PN--NRFSLQA-------------VRFFAAEVLVGLEYLH 219 (317)
Q Consensus 178 v~e~~~~gsL~~-~l~~------------------~----~~--~~~~~~~-------------~~~i~~qi~~al~~LH 219 (317)
+++|++|..+.. .... . ++ ....|.. -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999998888873 2100 0 00 0112210 0112334444555555
Q ss_pred H--------cC--CeeccCCCCcEEEccCCc-EEEeeeccccc
Q 042913 220 A--------LG--IIYRDLKPENILLREDGH-IMLSDFDLCFQ 251 (317)
Q Consensus 220 ~--------~~--ivHrDikp~Nill~~~~~-~kl~DFG~a~~ 251 (317)
+ .+ +||+|+.|.||+++.+.. +.++|||.|..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 4 23 999999999999998774 99999999854
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0034 Score=57.44 Aligned_cols=77 Identities=18% Similarity=0.379 Sum_probs=52.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhh----hcHHHHHHHHHHHHHHHhcC--CC-CcceEEEEEEecCEEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL----LSAKKLSHVQMEAEILSMLD--HP-FLPTLYAHLEVSHYICF 177 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~l 177 (317)
.+.||-|.-.-||++.+.. .++.|+||.-..-. ..+-..++...|.++|+.+. .| +++++|.+ +.....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~-~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence 6778999999999998743 35679999753221 11234567778888888764 34 56677754 3445678
Q ss_pred EEcccCC
Q 042913 178 LIDYCPN 184 (317)
Q Consensus 178 v~e~~~~ 184 (317)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.015 Score=60.20 Aligned_cols=140 Identities=22% Similarity=0.301 Sum_probs=77.7
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCC--cceEEE--------EEEe-c
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPF--LPTLYA--------HLEV-S 172 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~--iv~~~~--------~~~~-~ 172 (317)
+.|+ |..-.+|+.... ++..+++|+.+... . ...+..|..+|..|. .+. +.+++- .... +
T Consensus 31 ~~L~-s~~d~nf~v~~~--~g~~yVLKi~~~~~-~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTD--DGADYILKIVNPSE-P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEeC--CCCeEEEEEcCCcc-c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 4564 456788988655 36789999997542 1 123344555665552 122 333331 1111 2
Q ss_pred C--EEEEEEcccCCCChhccccc---------------------C--C--CCCCCHH-----------------HHHHHH
Q 042913 173 H--YICFLIDYCPNGDLHSLLPK---------------------Q--P--NNRFSLQ-----------------AVRFFA 208 (317)
Q Consensus 173 ~--~~~lv~e~~~~gsL~~~l~~---------------------~--~--~~~~~~~-----------------~~~~i~ 208 (317)
+ +.+.+++|++|..|.+.... . + ...+.|. ..+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56778999998877652110 0 0 0111111 112222
Q ss_pred HHHHHHHH-----HHH--HcCCeeccCCCCcEEEccCC--cEE-EeeecccccC
Q 042913 209 AEVLVGLE-----YLH--ALGIIYRDLKPENILLREDG--HIM-LSDFDLCFQS 252 (317)
Q Consensus 209 ~qi~~al~-----~LH--~~~ivHrDikp~Nill~~~~--~~k-l~DFG~a~~~ 252 (317)
.+++.... .+. ..++||+|+.+.|||++.++ .+. |+|||.+...
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 33333322 121 14799999999999999775 555 9999987543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.046 Score=49.18 Aligned_cols=72 Identities=13% Similarity=-0.012 Sum_probs=42.6
Q ss_pred cCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEE---E--EEEecCEEEEEEcccC
Q 042913 111 GNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLY---A--HLEVSHYICFLIDYCP 183 (317)
Q Consensus 111 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~ 183 (317)
+.-..||+....+ +..+++|+.+..... ...+..|.+.+..|... .++... | ....++..+.|+++++
T Consensus 36 s~eN~vy~v~~~~--~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDED--GRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecCC--CCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 4456799886553 678999988643222 24455677777666321 122211 1 1233567889999997
Q ss_pred CCCh
Q 042913 184 NGDL 187 (317)
Q Consensus 184 ~gsL 187 (317)
|...
T Consensus 111 G~~~ 114 (325)
T PRK11768 111 GRAP 114 (325)
T ss_pred CCCC
Confidence 7653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.022 Score=53.43 Aligned_cols=80 Identities=14% Similarity=0.201 Sum_probs=49.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCC-------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEe
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDC-------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEV 171 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~ 171 (317)
.+. -++.|..|-.-.+|++..... .++.|++|+.-.. .... -....|..+++.+...+| .++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~--te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD--VDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC--ccce-eCHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence 344 556676777888999876531 1467888987543 1222 234567888777764444 35666553
Q ss_pred cCEEEEEEcccCCCCh
Q 042913 172 SHYICFLIDYCPNGDL 187 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL 187 (317)
+ +.|.+|++|.+|
T Consensus 181 g---g~I~efi~g~~l 193 (442)
T PTZ00296 181 G---GRIEEWLYGDPL 193 (442)
T ss_pred C---CEEEEeeCCccC
Confidence 2 457899987744
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.015 Score=53.06 Aligned_cols=132 Identities=19% Similarity=0.254 Sum_probs=85.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcce--------EEEEEEecCEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPT--------LYAHLEVSHYI 175 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~--------~~~~~~~~~~~ 175 (317)
.+.||+|+-+.+|-.-.. +..+-|+.+......+. + .+..|... .||-+-. ++|- .....+
T Consensus 16 gr~LgqGgea~ly~l~e~----~d~VAKIYh~Pppa~~a--q---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV----RDQVAKIYHAPPPAAQA--Q---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh----hchhheeecCCCchHHH--H---HHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 456999999999964222 23455887654221111 1 12223322 3543322 1111 122337
Q ss_pred EEEEcccCCC-Chhccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeee
Q 042913 176 CFLIDYCPNG-DLHSLLPK----QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 176 ~lv~e~~~~g-sL~~~l~~----~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
.++|+.+.+. .+.+++.- +....+.|..+++.++.|+.+...||+.|.+-+|++++|+|+.+++.|.|.|=
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence 7889888765 23344321 22344688999999999999999999999999999999999999999999873
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.02 Score=52.33 Aligned_cols=60 Identities=17% Similarity=0.148 Sum_probs=43.8
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-ALGIIYRDLKPENILLR 236 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivHrDikp~Nill~ 236 (317)
...|+-+|..|.++..+++. ...+++....++.-...||-.|- -.+++|.|+.|.||++-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 34667778888888888854 33456666777766666655443 46899999999999995
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.034 Score=56.88 Aligned_cols=153 Identities=20% Similarity=0.243 Sum_probs=98.6
Q ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE----EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042913 143 KLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC----FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218 (317)
Q Consensus 143 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 218 (317)
.+.....|++.+..+.|+|++.++.+.......- +..+++...++...+.. -..++....+.+..+++.||.|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHH
Confidence 3444556777788889999999998865443322 34567777788877744 46788999999999999999999
Q ss_pred HHcCCeeccCCCC---cEEEccCCcEEEe--eecccccCCCCCCeeecccccccccccccccCCCCCccccccccccee-
Q 042913 219 HALGIIYRDLKPE---NILLREDGHIMLS--DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV- 292 (317)
Q Consensus 219 H~~~ivHrDikp~---Nill~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~- 292 (317)
|+....|.-+... +..++..+.+.+. ||+..+.+........ ..-++.+..++..+..
T Consensus 303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~----------------~~~~~~~~~~e~~~~~~ 366 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS----------------DLLAEIRNADEDLKENT 366 (1351)
T ss_pred HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh----------------hcCcccccccccccccc
Confidence 9997666655555 4444556666666 8888766554332111 1122223333322222
Q ss_pred -ccchhhhccCCcccccccCCC
Q 042913 293 -AEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 293 -~~~~~~~~~~~~~~~~e~~~G 313 (317)
...+..++|.++.-.+-+.+|
T Consensus 367 ~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 367 AKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred chhhhhhHHHHHHHHHhhhhhc
Confidence 234556778777766666655
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.0068 Score=49.66 Aligned_cols=34 Identities=18% Similarity=0.322 Sum_probs=28.6
Q ss_pred CeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 223 ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
.+|+|+.|.||++++++ ++|+||+.|-..++.-.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp~~D 112 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGDIALE 112 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccCCCHHHH
Confidence 68999999999998776 99999999977665433
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.08 Score=44.75 Aligned_cols=76 Identities=20% Similarity=0.325 Sum_probs=50.9
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEecCEEEEEEcc
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLEVSHYICFLIDY 181 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~ 181 (317)
.+.+.-|.--..|...+. ...+-+|+-.. .....+..|+.-|..| +.-.|.+++.+....++.|+||||
T Consensus 21 r~~v~gG~inea~~v~dg---~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 21 REEVSGGDINEAWRLRDG---TDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred ccccCCccccceeEeecC---CcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 334444444455554332 46777887533 3445566677666665 456788999999999999999999
Q ss_pred cCCCChh
Q 042913 182 CPNGDLH 188 (317)
Q Consensus 182 ~~~gsL~ 188 (317)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9877665
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.033 Score=46.76 Aligned_cols=85 Identities=14% Similarity=0.117 Sum_probs=57.2
Q ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH--cC
Q 042913 145 SHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA--LG 222 (317)
Q Consensus 145 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ 222 (317)
..++++.++++++. .|+++.. .....+.+++|+|-. -...... +...=+.+|.-.|+ .+
T Consensus 103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~-----------~~i~~~N----~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYK-----------IKINFSN----FITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccC-----------cccchhH----HHHHhHHHHHHhhccCCC
Confidence 34577888888764 3555552 244557788998821 1111111 11222466778884 46
Q ss_pred CeeccCCCCcEEEccCCcEEEeeecc
Q 042913 223 IIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 223 ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
.+|+|..|+||+-|..|.+||.|=+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999999775
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 317 | ||||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-21 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-21 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-21 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-21 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-21 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-21 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-20 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-20 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-04 |
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-54
Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 4/168 (2%)
Query: 83 SAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSA 141
+++ A K K + LG G+ V L TS +A+K+++K ++
Sbjct: 13 GSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKE 71
Query: 142 KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL 201
K+ +V E +++S LDHPF LY + + F + Y NG+L + K F
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDE 129
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
RF+ AE++ LEYLH GII+RDLKPENILL ED HI ++DF
Sbjct: 130 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-50
Identities = 53/159 (33%), Positives = 92/159 (57%), Gaps = 4/159 (2%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQME 150
S L ++ LGTG+ GRV L ++ + ++A+K++DK ++ K++ H E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 151 AEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
IL ++ PFL L + + + +++Y G++ S L + RFS RF+AA+
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ 149
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+++ EYLH+L +IYRDLKPEN+L+ + G+I ++DF
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-49
Identities = 63/155 (40%), Positives = 95/155 (61%), Gaps = 4/155 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEIL 154
K L+ +++R LGTG+ GRV L R +A+KV+ K+ ++ K++ H E +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
S++ HPF+ ++ + + I ++DY G+L SLL K RF +F+AAEV +
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLA 118
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
LEYLH+ IIYRDLKPENILL ++GHI ++DF
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 50/160 (31%), Positives = 88/160 (55%), Gaps = 4/160 (2%)
Query: 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQM 149
N ++ H +++R +G G+ G+V + D T +A+K ++K + + +V
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E +I+ L+HPFL L+ + + ++D GDL L Q N F + V+ F
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC 122
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
E+++ L+YL II+RD+KP+NILL E GH+ ++DF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-48
Identities = 48/183 (26%), Positives = 96/183 (52%), Gaps = 5/183 (2%)
Query: 68 STSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA 127
+L ++ D S K N + ++ ++V+ +G G G V L + T
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRK 95
Query: 128 NFALKVVDK-DLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186
+A+K++ K +++ + E +I++ + P++ L+ + Y+ +++Y P GD
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L +L+ + RF+ AEV++ L+ +H++G I+RD+KP+N+LL + GH+ L+DF
Sbjct: 156 LVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 247 DLC 249
C
Sbjct: 213 GTC 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-46
Identities = 60/160 (37%), Positives = 95/160 (59%), Gaps = 4/160 (2%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLSAKKLSHVQM 149
+ K +L++ LG G+ G+VFL + A +A+KV+ K L + +M
Sbjct: 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E +IL ++HPF+ L+ + + ++D+ GDL + L K+ F+ + V+F+ A
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLA 133
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
E+ + L++LH+LGIIYRDLKPENILL E+GHI L+DF L
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-46
Identities = 47/183 (25%), Positives = 92/183 (50%), Gaps = 3/183 (1%)
Query: 68 STSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA 127
S L + + +L ++++ +G G V + ++ T
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-TGQ 87
Query: 128 NFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186
+A+K+++K +L ++S + E ++L D ++ L+ + +Y+ +++Y GD
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L +LL K R + RF+ AE+++ ++ +H LG ++RD+KP+NILL GHI L+DF
Sbjct: 148 LLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206
Query: 247 DLC 249
C
Sbjct: 207 GSC 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 4/157 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEIL 154
+ R LG G G VF C ++ T +A K ++K L +K +E +IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL--HSLLPKQPNNRFSLQAVRFFAAEVL 212
+ + F+ +L E +C ++ GD+ H + N F F+ A+++
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
GLE+LH IIYRDLKPEN+LL +DG++ +SD L
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 50/184 (27%), Positives = 98/184 (53%), Gaps = 3/184 (1%)
Query: 67 SSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS 126
+ S L + + K T+ +LH ++++ +G G G V + L++
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN-AD 99
Query: 127 ANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185
FA+K+++K +L + + + E ++L D ++ TL+ + + + ++DY G
Sbjct: 100 KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL +LL K +R + RF+ AE+++ ++ +H L ++RD+KP+NIL+ +GHI L+D
Sbjct: 160 DLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 246 FDLC 249
F C
Sbjct: 219 FGSC 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 2/159 (1%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQME 150
+ + R LG G G V C +R T +A K ++K + +K + E
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 151 AEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
+IL ++ F+ +L E +C ++ GDL + F F+AAE
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ GLE LH I+YRDLKPENILL + GHI +SD L
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 52/155 (33%), Positives = 91/155 (58%), Gaps = 4/155 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEIL 154
K+ + ++ LG G G+V L + T +A+K++ K+++ AK ++H E+ +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
HPFL L + +CF+++Y G+L L ++ F+ + RF+ AE++
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
LEYLH+ ++YRD+K EN++L +DGHI ++DF LC
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-44
Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLSAKK--LSHVQ 148
K+ +L+R LG G G+VF + FA+KV+ K ++ +H +
Sbjct: 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 149 MEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
E IL + HPF+ L + + +++Y G+L L ++ F F+
Sbjct: 70 AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYL 127
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
AE+ + L +LH GIIYRDLKPENI+L GH+ L+DF LC
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 58/160 (36%), Positives = 96/160 (60%), Gaps = 5/160 (3%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQME 150
S KL + L + LG G+ G+VFL + T+ FA+K + KD++ + +E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 151 AEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
+LS+ +HPFL ++ + + F+++Y GDL + Q ++F L F+AA
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
E+++GL++LH+ GI+YRDLK +NILL +DGHI ++DF +C
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 56/164 (34%), Positives = 87/164 (53%), Gaps = 7/164 (4%)
Query: 90 NLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQ 148
N+ N L + + R +G G G V+ C D T +A+K +DK + K+ +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 149 MEAEILSML---DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVR 205
E +LS++ D PF+ + + F++D GDLH L + FS +R
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMR 295
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
F+AAE+++GLE++H ++YRDLKP NILL E GH+ +SD L
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 53 PHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGN 112
H ++ A +S + ++ A K+ + + +L++ LGTG
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 113 LGRVFLCHLRDCTSAN--FALKVVDKDLLSAKK--LSHVQMEAEILSMLDH-PFLPTLYA 167
G+VFL +A+KV+ K + K H + E ++L + PFL TL+
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
+ + ++DY G+L + L ++ RF+ V+ + E+++ LE+LH LGIIYRD
Sbjct: 127 AFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 228 LKPENILLREDGHIMLSDFDLC 249
+K ENILL +GH++L+DF L
Sbjct: 185 IKLENILLDSNGHVVLTDFGLS 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 49/169 (28%), Positives = 90/169 (53%), Gaps = 5/169 (2%)
Query: 83 SAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK 142
+ + N + ++ L + LG G+ G+V L + T +A+K++ KD++
Sbjct: 3 NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQD 61
Query: 143 K-LSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS 200
+ +E +L++ PFL L++ + + F+++Y GDL + + RF
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFK 119
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
F+AAE+ +GL +L + GIIYRDLK +N++L +GHI ++DF +C
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 59/160 (36%), Positives = 87/160 (54%), Gaps = 5/160 (3%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQME 150
SSN ++ +G G+ G+V L + +A+KV+ K + KK H+ E
Sbjct: 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 151 AEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
+L + HPFL L+ + + + F++DY G+L L ++ F RF+AA
Sbjct: 89 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAA 146
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
E+ L YLH+L I+YRDLKPENILL GHI+L+DF LC
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 5/159 (3%)
Query: 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEA 151
+ L L+ L+R +G G+ +V L L+ T +A+KVV K+L++ + + VQ E
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 152 EILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
+ +HPFL L++ + + F+I+Y GDL + +Q + + RF++AE
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAE 118
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ + L YLH GIIYRDLK +N+LL +GHI L+D+ +C
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-43
Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 4/156 (2%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKL-SHVQME 150
S + L ++ R LG G G V+L + + ALKV+ K L + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 151 AEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
EI S L HP + LY + + + +++Y P G ++ L K ++F Q + E
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITE 117
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ L Y H+ +I+RD+KPEN+LL G + ++DF
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-43
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 4/160 (2%)
Query: 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEI 153
K + + R LG G G V+L + ALKV+ K L ++ E EI
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
S L HP + +Y + I ++++ P G+L+ L Q + RF Q F E+
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELAD 125
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
L Y H +I+RD+KPEN+L+ G + ++DF +
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 56/169 (33%), Positives = 96/169 (56%), Gaps = 5/169 (2%)
Query: 83 SAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK 142
A+ + ++ L L+ L+R +G G+ +V L L+ T +A++VV K+L++
Sbjct: 35 EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVNDD 93
Query: 143 K-LSHVQMEAEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS 200
+ + VQ E + +HPFL L++ + + F+I+Y GDL + +Q +
Sbjct: 94 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLP 151
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ RF++AE+ + L YLH GIIYRDLK +N+LL +GHI L+D+ +C
Sbjct: 152 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 57/169 (33%), Positives = 96/169 (56%), Gaps = 5/169 (2%)
Query: 83 SAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK 142
S ++S+ +L + + + +R LG G+ G+V L +++ T +A+KV+ KD++
Sbjct: 6 SKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQD 64
Query: 143 K-LSHVQMEAEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS 200
+ E ILS+ +HPFL L+ + + F++++ GDL + Q + RF
Sbjct: 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFD 122
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
RF+AAE++ L +LH GIIYRDLK +N+LL +GH L+DF +C
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-42
Identities = 62/252 (24%), Positives = 114/252 (45%), Gaps = 21/252 (8%)
Query: 1 MDDETNFPDTDLELSFTSTTT-DRTFTSSSARSSLARSSLTLSFNESLLSGCTPHSSTTT 59
M E P+T + TT +RTF + ++ + + L +
Sbjct: 63 MKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRS 122
Query: 60 TTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLC 119
+ + + + + ++ + + ++ LG G G+V L
Sbjct: 123 GSPSDNSGAEEM---------------EVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167
Query: 120 HLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178
+ T +A+K++ K+++ AK ++H E +L HPFL L + +CF+
Sbjct: 168 KEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226
Query: 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLRE 237
++Y G+L L ++ FS RF+ AE++ L+YLH+ ++YRDLK EN++L +
Sbjct: 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 238 DGHIMLSDFDLC 249
DGHI ++DF LC
Sbjct: 285 DGHIKITDFGLC 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-39
Identities = 51/169 (30%), Positives = 90/169 (53%), Gaps = 5/169 (2%)
Query: 83 SAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK 142
+ I N + ++ L + LG G+ G+V L + T +A+K++ KD++
Sbjct: 324 NTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQD 382
Query: 143 K-LSHVQMEAEILSM-LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS 200
+ +E +L++ PFL L++ + + F+++Y GDL + Q RF
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFK 440
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
F+AAE+ +GL +L + GIIYRDLK +N++L +GHI ++DF +C
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 8/174 (4%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALK 132
HHH S + + + ++ +G G+ G+ L + +K
Sbjct: 4 HHHHSSGV-------DLGTENLYFQSMEKYVRLQKIGEGSFGKAILV-KSTEDGRQYVIK 55
Query: 133 VVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLP 192
++ +S+K+ + E +L+ + HP + E + + ++DYC GDL +
Sbjct: 56 EINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 193 KQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
Q F + + ++ + L+++H I++RD+K +NI L +DG + L DF
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDF 169
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-37
Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 27/177 (15%)
Query: 93 SNGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKK-------- 143
++ +++R L G ++ LC + +ALK +K LL K+
Sbjct: 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 144 -------LSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL------HSL 190
+ E +I++ + + + T + + + +Y N + +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDF 246
L K +Q ++ VL Y+H I +RD+KP NIL+ ++G + LSDF
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF 196
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 20/188 (10%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ + LG G G+V S +A+K + + +KLS + E +L+ L+H ++
Sbjct: 9 EEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYV 64
Query: 163 PTLY-------------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
Y ++ + ++YC NG L+ L+ + N
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFR 123
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGSAT 267
++L L Y+H+ GII+RDLKP NI + E ++ + DF L + +++ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 268 RRRRRKSC 275
+
Sbjct: 184 SDNLTSAI 191
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 12/197 (6%)
Query: 53 PHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGN 112
P + P ++ + + + R R LG G
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLV--------DPRSRRRYVRGRFLGKGG 53
Query: 113 LGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-VQMEAEILSMLDHPFLPTLYAHLEV 171
+ F D T FA K+V K LL + ME I L H + + E
Sbjct: 54 FAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
+ ++ +++ C L L ++ + R++ ++++G +YLH +I+RDLK
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 232 NILLREDGHIMLSDFDL 248
N+ L ED + + DF L
Sbjct: 171 NLFLNEDLEVKIGDFGL 187
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 40/201 (19%), Positives = 65/201 (32%), Gaps = 8/201 (3%)
Query: 54 HSSTTTTTTTPATSSTSSLHHHRKSDLHWSA----IKAATNLSSNGKLHLRHLKLVRHLG 109
HSS T + R+ A + S + + + LG
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLG 66
Query: 110 TGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL-SMLDHPFLPTLYAH 168
G+ G VF ++ +A+K K + E + HP L
Sbjct: 67 HGSYGEVFKVRSKE-DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125
Query: 169 LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL 228
E + + C L + V + + L+ L +LH+ G+++ D+
Sbjct: 126 WEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 229 KPENILLREDGHIMLSDFDLC 249
KP NI L G L DF L
Sbjct: 184 KPANIFLGPRGRCKLGDFGLL 204
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 15/222 (6%)
Query: 49 SGCTPHSSTTTTTTT-PATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRH 107
SG P S T D ++ A +S G+ +++
Sbjct: 8 SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR----IYSILKQ 63
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP--TL 165
+G+G +VF + +A+K V+ + + L + E L+ L L
Sbjct: 64 IGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225
Y + YI +++ C N DL+S L K + + +L + +H GI++
Sbjct: 122 YDYEITDQYI-YMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 226 RDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
DLKP N L+ DG + L DF + Q D + ++ VG+
Sbjct: 179 SDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 5/158 (3%)
Query: 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSH-VQ 148
L++ + K+ LG G+ V+ + T A+K++DK + + VQ
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKAGMVQRVQ 59
Query: 149 MEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
E +I L HP + LY + E S+Y+ +++ C NG+++ L + FS R F
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFM 118
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+++ G+ YLH+ GI++RDL N+LL + +I ++DF
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADF 156
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 10/196 (5%)
Query: 74 HHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKV 133
HH + + + R +++ +G+G +VF + +A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV--LNEKKQIYAIKY 59
Query: 134 VDKDLLSAKKLSHVQMEAEILSMLDHPFLP--TLYAHLEVSHYICFLIDYCPNGDLHSLL 191
V+ + + L + E L+ L LY + YI +++ N DL+S L
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL 118
Query: 192 PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC-- 249
K + + +L + +H GI++ DLKP N L+ DG + L DF +
Sbjct: 119 KK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 175
Query: 250 FQSDVVPTLVETNVGS 265
Q D + ++ VG+
Sbjct: 176 MQPDTTSVVKDSQVGT 191
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 4/152 (2%)
Query: 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-VQMEAEILSM 156
R R LG G + F D T FA K+V K LL + ME I
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L H + + E + ++ +++ C L L + + R++ ++++G +
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQ 129
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YLH +I+RDLK N+ L ED + + DF L
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-33
Identities = 39/167 (23%), Positives = 73/167 (43%), Gaps = 10/167 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ +G+G +VF + +A+K V+ + + L + E L+ L
Sbjct: 12 SILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 163 P--TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
LY + YI +++ N DL+S L + + + +L + +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
GI++ DLKP N L+ DG + L DF + Q D + ++ VG+
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 23/160 (14%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF- 161
K + +G+G G+VF + +K V + A++ E + L+ LDH
Sbjct: 14 KEIELIGSGGFGQVFKA-KHRIDGKTYVIKRVKYNNEKAER------EVKALAKLDHVNI 66
Query: 162 ---------------LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRF 206
+ + + + +++C G L + K+ +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 207 FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
++ G++Y+H+ +I RDLKP NI L + + + DF
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 4/147 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD-KDLLSAKKLSHVQMEAEILSMLDHPF 161
++ + +G G V+ ALK V DL+ AK + E ++L L+HP
Sbjct: 35 RIEKKIGRGQFSEVYRA-ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+ YA + + +++ GDL ++ K+ + V + ++ LE++H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDF 246
+ +++RD+KP N+ + G + L D
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDL 180
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 10/172 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ +GTG+ GR R K +D ++ + + E +L L HP +
Sbjct: 9 EVLYTIGTGSYGRCQKI-RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 163 PTLYAH--LEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQAVRFFAAEVLVGLEYL 218
Y + + +++YC GDL S++ + + V ++ + L+
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 219 H-----ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
H +++RDLKP N+ L ++ L DF L + + +T VG+
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 47/198 (23%), Positives = 77/198 (38%), Gaps = 13/198 (6%)
Query: 70 SSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANF 129
SS HHH S + + + +H ++ LG G V L +
Sbjct: 3 SSHHHHHHSSGRENLYFQGHMVIIDN----KHYLFIQKLGEGGFSYVDLVE-GLHDGHFY 57
Query: 130 ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH----LEVSHYICFLIDYCPNG 185
ALK + + Q EA++ + +HP + L A+ H L+ + G
Sbjct: 58 ALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 186 DLHSLL--PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML 243
L + + K N + + + + GLE +HA G +RDLKP NILL ++G +L
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175
Query: 244 SDFDLCFQSDVVPTLVET 261
D Q+ +
Sbjct: 176 MDLGSMNQACIHVEGSRQ 193
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 32/169 (18%), Positives = 54/169 (31%), Gaps = 20/169 (11%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLLSAKKLSHVQMEA 151
+L + + + LG G +V+ D A F LKV + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLM 118
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK---QPNNRFSLQAVRFFA 208
E L Y+ + + + G L + + P V FA
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLR-----------EDGHIMLSDF 246
+L +E +H II+ D+KP+N +L + L D
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 63/201 (31%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 71 SLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFA 130
HHH S NL G +V LG G+ G V C R T +A
Sbjct: 2 HHHHHHSSGR--------ENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYA 51
Query: 131 LKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSL 190
+KV++K K S + E E+L LDHP + L+ LE S + + G+L
Sbjct: 52 VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE 111
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFD 247
+ K+ RFS +V G+ Y+H I++RDLKPENILL +D I + DF
Sbjct: 112 IIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 248 LC--FQSDVVPTLVETNVGSA 266
L FQ + +G+A
Sbjct: 170 LSTCFQQNTKMK---DRIGTA 187
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 44/177 (24%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKDLLSAKKLSHVQME 150
++ + H+ + +L++ +G GN +V L H+ T A+K++DK L+ L + E
Sbjct: 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTSLQKLFRE 64
Query: 151 AEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
I+ +L+HP + L+ +E + +++Y G++ L + R + R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQ 122
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
++ ++Y H I++RDLK EN+LL D +I ++DF F ++ G+
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGA 176
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
L LG G VF + T FA+KV + + + E E+L L+H +
Sbjct: 12 LLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 163 PTLYAHLEV--SHYICFLIDYCPNGDLHSLL-PKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L+A E + + ++++CP G L+++L +V+ G+ +L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 220 ALGIIYRDLKPENILLR----EDGHIMLSDF 246
GI++R++KP NI+ L+DF
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 10/167 (5%)
Query: 103 KLVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
LV+ LG G G V L + T A+K+VD +++ E I ML+H
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHEN 66
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS-LQAVRFFAAEVLVGLEYLHA 220
+ Y H + ++YC G+L + +P+ A RFF +++ G+ YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFH-QLMAGVVYLHG 123
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
+GI +RD+KPEN+LL E ++ +SDF L F+ + L+ G+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 5/181 (2%)
Query: 72 LHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFAL 131
+HHH S + ++ + LG G V C + T +A
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS-TGQEYAA 59
Query: 132 KVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEVSHYICFLIDYCPNGDLHSL 190
K + K + + E +L + P + L+ E + I +++Y G++ SL
Sbjct: 60 KFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFD 247
+ S V ++L G+ YLH I++ DLKP+NILL G I + DF
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 248 L 248
+
Sbjct: 180 M 180
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 72 LHHHRKSDLHWSAIKAATNLSSNGKLHLRHLK--------LVRHLGTGNLGRVFLCHLRD 123
+HHH + +L + + + K V+ LG+G G V LC +
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDK- 59
Query: 124 CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCP 183
T A+K++ K +S S + E +L +LDHP + LY E +++
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 184 NGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGH 240
G+L + + +F+ +VL G+ YLH I++RDLKPEN+LL +D
Sbjct: 120 GGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177
Query: 241 IMLSDFDLC--FQSDVVPTLVETNVGSA 266
I + DF L F++ +G+A
Sbjct: 178 IKIVDFGLSAVFENQKKMK---ERLGTA 202
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
L LG G VF + T FA+KV + + + E E+L L+H +
Sbjct: 12 LLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 163 PTLYAHLEV--SHYICFLIDYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLH 219
L+A E + + ++++CP G L+++L + N +V+ G+ +L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 220 ALGIIYRDLKPENILLR----EDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
GI++R++KP NI+ L+DF + D + G+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGT 178
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 6/160 (3%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKD-LLSAKKLSHVQM 149
+G++ + H L LG G G+V + H T A+K++++ + S + ++
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 150 EAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAA 209
E + L + HP + LY + +++Y G+L + K + R R
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQ 118
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++L ++Y H +++RDLKPEN+LL + ++DF L
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 10/167 (5%)
Query: 103 KLVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
LV+ LG G G V L + T A+K+VD +++ E I ML+H
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHEN 66
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS-LQAVRFFAAEVLVGLEYLHA 220
+ Y H + ++YC G+L + +P+ A RFF +++ G+ YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFH-QLMAGVVYLHG 123
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
+GI +RD+KPEN+LL E ++ +SDF L F+ + L+ G+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 72 LHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFAL 131
+HHH NL G +V LG G+ G V C R T +A+
Sbjct: 1 MHHHHHHS------SGRENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAV 52
Query: 132 KVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL-HSL 190
KV++K K S + E E+L LDHP + L+ LE S + + G+L +
Sbjct: 53 KVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI 112
Query: 191 LPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFD 247
+ ++ RFS +V G+ Y+H I++RDLKPENILL +D I + DF
Sbjct: 113 IKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 248 L--CFQSDVVPTLVETNVGSA 266
L CFQ + +G+A
Sbjct: 170 LSTCFQQNTKMK---DRIGTA 187
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LG G V C + T FA K+++ LSA+ ++ EA I L HP +
Sbjct: 9 DVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L+ ++ + + D G+L ++ ++ +S ++L + Y H+
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN 124
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDFDL 248
GI++R+LKPEN+LL + + L+DF L
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGL 154
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALK 132
HHH S NL G + R LG+G G V L R + +K
Sbjct: 3 HHHHHSSGR-------ENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEER-SSGLERVIK 53
Query: 133 VVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL-HSLL 191
++KD ++ E E+L LDHP + ++ E H + +++ C G+L ++
Sbjct: 54 TINKDRSQVPM-EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV 112
Query: 192 PKQPNN-RFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFD 247
Q S V +++ L Y H+ ++++DLKPENIL + I + DF
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172
Query: 248 L--CFQSDVVPTLVETNVGSA 266
L F+SD T G+A
Sbjct: 173 LAELFKSDEHST---NAAGTA 190
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 32/157 (20%), Positives = 58/157 (36%), Gaps = 15/157 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ ++ LG G G VF N+A+K + V E + L+ L+HP +
Sbjct: 8 EPIQCLGRGGFGVVFEAK-NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGI 65
Query: 163 PTLYAH------------LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS-LQAVRFFAA 209
+ Y+ + C +L + +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
++ +E+LH+ G+++RDLKP NI D + + DF
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 40/204 (19%), Positives = 72/204 (35%), Gaps = 16/204 (7%)
Query: 49 SGCTPHSSTTTTTTTPATSSTSSLHHHRKSDLHWS-----AIKAATNLSSNGKLHLRHLK 103
SG + + T S+ S R + + + + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLP 163
+G G+ G V + T A+K V ++ + E + L P +
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIV 113
Query: 164 TLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
LY + ++ ++ G L L+ + ++ + L GLEYLH I
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 224 IYRDLKPENILLREDG-HIMLSDF 246
++ D+K +N+LL DG L DF
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDF 195
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEILSMLDHPF 161
K R LG G+ G V LC + T A+KV+ K + K + E ++L LDHP
Sbjct: 29 KGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ LY E Y + + G+L + + RFS +VL G+ Y+H
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN 145
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDFDLC--FQSDVVPTLVETNVGSA 266
I++RDLKPEN+LL +D +I + DF L F++ +G+A
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTA 192
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 28/235 (11%), Positives = 60/235 (25%), Gaps = 34/235 (14%)
Query: 59 TTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFL 118
+ S S W+ + S R L LG +
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNT-GQPFRVESELGERPRTLVRGTVLGQEDPYAYLE 91
Query: 119 CHLRDCTSANFALKVVDKDLL--------------------------SAKKLSHVQMEAE 152
++ T +F + V AK +
Sbjct: 92 ATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150
Query: 153 ILSMLDHPFLPTLYAHLEVSHYIC-FLIDYCPNGDLHSLLPK-----QPNNRFSLQAVRF 206
++ + + + F + +L + + A
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 207 FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261
+V+ L LH G+++ L+P +I+L + G + L+ F+ + +
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLL----------- 139
SS + L L +G G+ G V L + + +A+KV+ K L
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNEN--DNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 140 -------------SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-----SHYICFLIDY 181
+ V E IL LDHP + L EV ++ + +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV---EVLDDPNEDHLYMVFEL 119
Query: 182 CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHI 241
G + + + S RF+ +++ G+EYLH II+RD+KP N+L+ EDGHI
Sbjct: 120 VNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI 176
Query: 242 MLSDFDLCFQSDVVPTLVETNVGS 265
++DF + + L+ VG+
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGT 200
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 7/161 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG G G V+ A+K + ++ + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLS-NQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL--QAVRFFAAEVLVGLEYLHALGIIY 225
+ +I ++ P G L +LL + Q + F+ ++L GL+YLH I++
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 226 RDLKPENILL-REDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
RD+K +N+L+ G + +SDF + + ET G+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LG G V C + T FA K+++ LSA+ ++ EA I L HP +
Sbjct: 32 DVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L+ ++ + + D G+L ++ ++ +S ++L + Y H+
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN 147
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDF 246
GI++R+LKPEN+LL + + L+DF
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADF 175
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 103 KLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKK--LSHVQMEAEILSMLDH 159
+ LG G+ G+V T A+K++ K L ++V+ E ++L L H
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSE--TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 160 PFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL-QAVRFFAAEVLVGLE 216
+ L + E + +++YC G + +L P RF + QA +F +++ GLE
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFC-QLIDGLE 123
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
YLH+ GI+++D+KP N+LL G + +S +
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 88 ATNLSSNGKLHLRHLKLVRHLGTGNLGRVFL-CHLRDCTSANFALKVVDKD-LLSAKKLS 145
A +G++ + H L LG G G+V + H T A+K++++ + S +
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVG 61
Query: 146 HVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFS-LQAV 204
++ E + L + HP + LY + I +++Y G+L + K N R ++
Sbjct: 62 KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESR 119
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETN 262
R F ++L G++Y H +++RDLKPEN+LL + ++DF L + T+
Sbjct: 120 RLFQ-QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTS 175
Query: 263 VGS 265
GS
Sbjct: 176 CGS 178
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 32/193 (16%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLD 158
R LKLV L G+ VFL + +FALKV S +L + + L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 159 HPFLPTLYAHL----------------------------EVSHYICFLIDYCPNGDLHSL 190
++ + L S
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 191 LPKQPNNR--FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L R + A+ A+++ L + G+++ P+N+ + DG +ML D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 249 CFQSDVVPTLVET 261
++
Sbjct: 241 LWKVGTRGPASSV 253
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-26
Identities = 48/176 (27%), Positives = 72/176 (40%), Gaps = 19/176 (10%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
++ LGTG G V +D T A+K ++L S K +E +I+ L+HP +
Sbjct: 17 EMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNV 74
Query: 163 PTLYA------HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSL--QAVRFFAAEVLVG 214
+ L + ++YC GDL L Q N L +R +++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSA 133
Query: 215 LEYLHALGIIYRDLKPENILLREDGH---IMLSDFDLC--FQSDVVPTLVETNVGS 265
L YLH II+RDLKPENI+L+ + D L VG+
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGT 186
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH------VQMEAEILSM 156
+ + LG+G G V L R T A++++ K + V+ E EIL
Sbjct: 138 IMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 157 LDHPFLPTLYAHLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
L+HP + + + Y +++ + G+L + N R + + ++L+ +
Sbjct: 197 LNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 252
Query: 216 EYLHALGIIYRDLKPENILLR---EDGHIMLSDFDL 248
+YLH GII+RDLKPEN+LL ED I ++DF
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH----VQMEAEILSMLD 158
++ LG+G V C + T +A K + K LS+ + ++ E IL +
Sbjct: 8 EMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + TL+ E + +++ G+L L ++ + F ++L G+ YL
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYL 124
Query: 219 HALGIIYRDLKPENILL----REDGHIMLSDFDL 248
H+ I + DLKPENI+L + I L DF +
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
L +G G+ G V + + T A K + K + + E EI+ LDHP +
Sbjct: 12 TLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNI 68
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
LY E + I +++ C G+L ++ K+ F +VL + Y H L
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL 125
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDFDL 248
+ +RDLKPEN L D + L DF L
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 48/219 (21%), Positives = 80/219 (36%), Gaps = 49/219 (22%)
Query: 72 LHHHRKSDLHWSAIKAATNLSSNGKLHLRHL-KLVRHLGTGNLGRVFLCHLRDCTSANFA 130
+HHH H S+ + L L+ L +G G+ G V + T A A
Sbjct: 1 MHHHH----HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQ-TRAIRA 55
Query: 131 LKVVDKDLL---SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDL 187
+K+++K+ + + K + ++ E ++ L HP + LY E YIC +++ C G L
Sbjct: 56 IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL 115
Query: 188 --------------------------------------HSLLPKQPNNRFSLQAVRFFAA 209
+ + + +
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 210 EVLVGLEYLHALGIIYRDLKPENILL--REDGHIMLSDF 246
++ L YLH GI +RD+KPEN L + I L DF
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH------VQMEAEILSM 156
+ + LG+G G V L R T A+K++ K + V+ E EIL
Sbjct: 13 IMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 157 LDHPFLPTLYAHLE-VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
L+HP + + + +YI + G+L + N R + + ++L+ +
Sbjct: 72 LNHPCIIKIKNFFDAEDYYIVL--ELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 127
Query: 216 EYLHALGIIYRDLKPENILLR---EDGHIMLSDFDL 248
+YLH GII+RDLKPEN+LL ED I ++DF
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-----------VQMEA 151
VR LG+G G V LC ++ + A+KV+ K + S + E
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
+L LDHP + L+ E Y + ++ G+L + + ++F ++
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQI 155
Query: 212 LVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFDLC--FQSDVVPTLVETNVGSA 266
L G+ YLH I++RD+KPENILL +I + DF L F D +G+A
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTA 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH----VQMEAEILSMLD 158
+ LG+G V C + T +A K + K A + ++ E IL +
Sbjct: 15 DIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
H + TL+ E + +++ G+L L ++ S + F ++L G+ YL
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYL 131
Query: 219 HALGIIYRDLKPENILLR----EDGHIMLSDFDL 248
H I + DLKPENI+L HI L DF L
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 6/143 (4%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG G G+V C T A K++ + K+ V+ E +++ LDH L LY
Sbjct: 97 LGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKE--EVKNEISVMNQLDHANLIQLYD 153
Query: 168 HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227
E + I +++Y G+L + + + + F ++ G+ ++H + I++ D
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 228 LKPENILL--REDGHIMLSDFDL 248
LKPENIL R+ I + DF L
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGL 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 9/152 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH---VQMEAEILSMLDH 159
+L +G G V C R+ T FA+K+VD ++ ++ EA I ML H
Sbjct: 27 ELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDL-HSLLPK-QPNNRFSLQAVRFFAAEVLVGLEY 217
P + L + + ++ DL ++ + +S + ++L L Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 218 LHALGIIYRDLKPENILLR---EDGHIMLSDF 246
H II+RD+KP +LL + L F
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 36/148 (24%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
++ LG+G G V C + T F K ++ K V+ E I++ L HP L
Sbjct: 54 DILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKL 110
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ E + + ++++ G+L + + + + S V + + GL+++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 223 IIYRDLKPENILL--REDGHIMLSDFDL 248
I++ D+KPENI+ ++ + + DF L
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGL 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 34/158 (21%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-D 158
L++ R L G V+ + +ALK + + +K + E + L
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSG 84
Query: 159 HPFLPTLYAHLEV--------SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
HP + + + L + C + L + S V +
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 211 VLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDF 246
++++H II+RDLK EN+LL G I L DF
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 31/164 (18%), Positives = 64/164 (39%), Gaps = 7/164 (4%)
Query: 87 AATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH 146
A + S + + +G+G G VF C R +A+K K L + +
Sbjct: 1 GAMGMKSR---YTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQN 56
Query: 147 VQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQA 203
E ++L H + ++ ++ +YC G L + + + F
Sbjct: 57 ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247
++ +V GL Y+H++ +++ D+KP NI + + +
Sbjct: 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH----VQMEAEILSMLD 158
+ LG+G V C + T +A K + K A + ++ E IL +
Sbjct: 15 DIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + TL+ E + +++ G+L L ++ S + F ++L G+ YL
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYL 131
Query: 219 HALGIIYRDLKPENILLR----EDGHIMLSDFDL 248
H I + DLKPENI+L HI L DF L
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 6/148 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LGTG G V R T NFA K V S K+ V+ E + +S+L HP L
Sbjct: 160 DIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHPTL 216
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ E + + + ++ G+L + + +N+ S + +V GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 223 IIYRDLKPENILL--REDGHIMLSDFDL 248
++ DLKPENI+ + + L DF L
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGL 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 29/148 (19%), Positives = 57/148 (38%), Gaps = 7/148 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LG G G V C + + K V V+ E IL++ H +
Sbjct: 8 MIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNI 63
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ E + + ++ D+ + + + + + +V L++LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 223 IIYRDLKPENILL--REDGHIMLSDFDL 248
I + D++PENI+ R I + +F
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
R LK +G G+ V+ + T+ A + L+ + + EAE+L L H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 84
Query: 160 P----FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
P F + + ++ I + + +G L + L + ++ +R + ++L GL
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGL 142
Query: 216 EYLHALG--IIYRDLKPENILL-REDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
++LH II+RDLK +NI + G + + D L + + +G+
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGT 193
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 93 SNGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKL-SHVQME 150
+ K H+ + LG G+ G+V L H + T ALK + + LL + V+ E
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYK--TQQKVALKFISRQLLKKSDMHMRVERE 59
Query: 151 AEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
L +L HP + LY + I +I+Y G+L + + R + R F +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQ 116
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++ +EY H I++RDLKPEN+LL ++ ++ ++DF L
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/243 (21%), Positives = 83/243 (34%), Gaps = 16/243 (6%)
Query: 16 FTSTTTDRTFTS--SSARSSLARSSLTLSFNESLLSGCTPHSSTTTTTTTPATSSTSSLH 73
S+ D F AR + + + +
Sbjct: 6 HHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQ 65
Query: 74 HHRKSDLHWSAIKAATNLSSNGKLH--LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFAL 131
+L++ ++ L + +G G V C R T FA+
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAV 124
Query: 132 KVVDKDLLSAKKLSH------VQMEAEILSML-DHPFLPTLYAHLEVSHYICFLIDYCPN 184
K+++ + E IL + HP + TL E S ++ + D
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 185 GDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML 243
G+L L K S + R +L + +LHA I++RDLKPENILL ++ I L
Sbjct: 185 GELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241
Query: 244 SDF 246
SDF
Sbjct: 242 SDF 244
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH----VQMEAEILSMLD 158
LG+G V C + T +A K + K + + ++ E IL +
Sbjct: 14 DTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + TL+ E + +++ G+L L ++ + + F ++L G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYL 130
Query: 219 HALGIIYRDLKPENILLR----EDGHIMLSDFDL 248
H+L I + DLKPENI+L I + DF L
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 40/186 (21%), Positives = 76/186 (40%), Gaps = 17/186 (9%)
Query: 90 NLSSNGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSA------K 142
L++ + + + LG+G G V+ + +K + K+ +
Sbjct: 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKE--KNKEVVVKFIKKEKVLEDCWIEDP 71
Query: 143 KLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID-YCPNGDLHSLLPKQPNNRFSL 201
KL V +E ILS ++H + + E + +++ + DL + + + P R
Sbjct: 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDE 129
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLV 259
+ +++ + YL II+RD+K ENI++ ED I L DF + L
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLF 186
Query: 260 ETNVGS 265
T G+
Sbjct: 187 YTFCGT 192
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+L LG G V C +A +++ LSA+ ++ EA I +L HP +
Sbjct: 14 QLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
L+ + + + D G+L ++ ++ +S ++L + + H +
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM 129
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDF 246
G+++R+LKPEN+LL + + L+DF
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADF 157
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LG+G VFL R T FALK + K ++ E +L + H +
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSS--LENEIAVLKKIKHENI 68
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
TL E + + ++ G+L +L + ++ + +VL ++YLH
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN 125
Query: 222 GIIYRDLKPENILLR---EDGHIMLSDFDL 248
GI++RDLKPEN+L E+ IM++DF L
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL 155
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-24
Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 13/155 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSH-------VQMEAEILS 155
+ LG G V C + T +A+K++D + E +IL
Sbjct: 20 EPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 156 MLD-HPFLPTLYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLV 213
+ HP + L E + + + D G+L L K S + R +L
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLE 135
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ LH L I++RDLKPENILL +D +I L+DF
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 29/164 (17%), Positives = 63/164 (38%), Gaps = 7/164 (4%)
Query: 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQME 150
++ + + + L + L + G ++ + +KV+ S +K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEE 57
Query: 151 AEILSMLDHPFLPTLYA--HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFA 208
L + HP + + + + + + P G L+++L + N FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 209 AEVLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDFDLCF 250
++ G+ +LH L I L ++++ ED +S D+ F
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 42/149 (28%), Positives = 80/149 (53%), Gaps = 4/149 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
++V LG G G+V+ ++ T A A KV++ S ++L +E EIL+ DHP++
Sbjct: 22 EIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L + +I++CP G + +++ + + + ++ ++L L +LH+
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
II+RDLK N+L+ +G I L+DF + +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 7/174 (4%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEA 151
G+L + + LG GN G VF + + A K++ ++ + + E
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI-KPAIRNQIIREL 82
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
++L + P++ Y I +++ G L +L K R Q + + V
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAV 140
Query: 212 LVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
+ GL YL I++RD+KP NIL+ G I L DF + Q ++ ++ + VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFVG 192
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 14/166 (8%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPT 164
+ LG G+ C + ++ FA+K++ K + ++ Q E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKK-SNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVK 70
Query: 165 LYAHLEVSHYICFLIDYCPNGDL-HSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
L+ + +++ G+L + K+ FS + +++ + ++H +G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 224 IYRDLKPENILLR---EDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266
++RDLKPEN+L ++ I + DF ++T +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 6/147 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
+ + + +G+G+ G V+ + A+K+++ + ++L + E +L H
Sbjct: 26 ITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ + + + +C L+ L +F ++ + A + G++YLHA
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL 248
II+RDLK NI L ED + + DF L
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGL 166
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-23
Identities = 39/177 (22%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L LG G G+ R+ +K + + + E +++ L+HP
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEV-MVMKELIR--FDEETQRTFLKEVKVMRCLEHPN 68
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ L + F+ +Y G L ++ K ++++ FA ++ G+ YLH++
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDL-CFQSDVVPTLVETNVGSATRRRRRKSCNG 277
II+RDL N L+RE+ +++++DF L D R++R + G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-23
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 15/168 (8%)
Query: 103 KLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
V+ +G+GN G L T A+K +++ + VQ E L HP
Sbjct: 23 DFVKDIGSGNFGVARLMRDKL--TKELVAVKYIERGAAIDEN---VQREIINHRSLRHPN 77
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ + ++ +++Y G+L+ + RFS RFF ++L G+ Y H++
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 222 GIIYRDLKPENILLRED--GHIMLSDFDLC--FQSDVVPTLVETNVGS 265
I +RDLK EN LL + + DF + ++ VG+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGT 180
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 15/185 (8%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLH-------LRHLKLVRHLGTGNLGRVFLCHLRDCT 125
HHH + I NL G + L + +G G+ G V
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62
Query: 126 SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY-AHLEVSHYICFLIDYCPN 184
A+K++ + A++++ E I+ L HP + A + + + +Y
Sbjct: 63 ---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSR 118
Query: 185 GDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHI 241
G L+ LL K + + A +V G+ YLH I++R+LK N+L+ + +
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 242 MLSDF 246
+ DF
Sbjct: 179 KVCDF 183
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 16/170 (9%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLY 166
LG G RV C TS +A+K+++K + S V E E+L H + L
Sbjct: 21 LGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELI 77
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
E + + G + S + K+ F+ +V L++LH GI +R
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 227 DLKPENILLR---EDGHIMLSDFDL-------CFQSDVVPTLVETNVGSA 266
DLKPENIL + + + DFDL S + + T GSA
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 21/221 (9%)
Query: 55 SSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLG 114
S+ + H +DLH + + + ++ LG+G G
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAP----GKEKEPLESQYQVGPLLGSGGFG 57
Query: 115 RVFLCHLRDCTSANFALKVVDKDLLS----AKKLSHVQMEAEILSMLDHPFLP---TLYA 167
V+ R + A+K V+KD +S + V ME +L + F L
Sbjct: 58 SVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLD 115
Query: 168 HLEVSHYICFLIDYC-PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
E +++ P DL + + + R F +VL + + H G+++R
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHR 173
Query: 227 DLKPENILL-REDGHIMLSDFDLC-FQSDVVPTLVETNVGS 265
D+K ENIL+ G + L DF D T+ G+
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGT 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 34/185 (18%), Positives = 76/185 (41%), Gaps = 12/185 (6%)
Query: 70 SSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTG--NLGRVFL-CHLRDCTS 126
+ HHH +L++ + + +L+ +G G +L V L + T
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGG-------CYELLTVIGKGFEDLMTVNLARYKP--TG 52
Query: 127 ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGD 186
++ ++ + S + ++ +Q E + + +HP + A + + + + G
Sbjct: 53 EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 112
Query: 187 LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L+ + + A+ + VL L+Y+H +G ++R +K +IL+ DG + LS
Sbjct: 113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 247 DLCFQ 251
Sbjct: 173 RSNLS 177
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 10/200 (5%)
Query: 52 TPHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTG 111
HSS T + S + S + SN ++ LG G
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 112 NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171
V+ C + T +ALKV+ K V+ E +L L HP + L E
Sbjct: 65 ATSIVYRCKQKG-TQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPE 231
I +++ G+L + ++ +S + ++L + YLH GI++RDLKPE
Sbjct: 120 PTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 232 NILLR---EDGHIMLSDFDL 248
N+L D + ++DF L
Sbjct: 178 NLLYATPAPDAPLKIADFGL 197
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 52/183 (28%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLR---DCTSANF 129
HHH H + H R+LK +R LG G+ G+V L D T
Sbjct: 4 HHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV 63
Query: 130 ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA----HLEVSHYICFLIDYCPNG 185
A+K + K + S + E +IL L H + S + +++Y P G
Sbjct: 64 AVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL--VMEYVPLG 120
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
L LP+ + L + FA ++ G+ YLHA I+RDL N+LL D + + D
Sbjct: 121 SLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177
Query: 246 FDL 248
F L
Sbjct: 178 FGL 180
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 25/199 (12%), Positives = 58/199 (29%), Gaps = 34/199 (17%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD--------------LLSAKKLS 145
R L LG + ++ T +F + V +L + L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 146 HVQMEAEILS---------MLDHPFLPTLYAHLE-------VSHYICFLIDYCPNGDLHS 189
++ + + ++ P + +S + +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 190 LLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247
+L + A +V+ L LH G+++ L+P +I+L + G + L+ F+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 248 LC-FQSDVVPTLVETNVGS 265
+ +
Sbjct: 257 HLVRDGASAVSPIGRGFAP 275
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-22
Identities = 30/145 (20%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L++ +G G G+V+ A++++D + + +L + E H
Sbjct: 35 LEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ ++ + C L+S++ + + R A E++ G+ YLHA
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 222 GIIYRDLKPENILLREDGHIMLSDF 246
GI+++DLK +N+ ++G ++++DF
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDF 173
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 35/170 (20%), Positives = 72/170 (42%), Gaps = 11/170 (6%)
Query: 83 SAIKAATNLSSNGK---LHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDL 138
S+ K L+ G+ + L+ + +G+G G+V+ + T A+K + +
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSG 62
Query: 139 LSAKKLSHVQMEAEIL-SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNN 197
+ ++ + M+ +++ D P++ + + + ++ L +
Sbjct: 63 -NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG- 119
Query: 198 RFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDF 246
+ + ++ L YL G+I+RD+KP NILL E G I L DF
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ +G G+ G VF T A+K++D + + ++ +Q E +LS D P++
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYV 82
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y + +++Y G LL P + E+L GL+YLH+
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEK 139
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+RD+K N+LL E G + L+DF + Q
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
+ +++ +G G G V R V K + S + +E LS ++
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERKAFIVELRQLSRVN 59
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL-PKQPNNRFSLQAVRFFAAEVLVGLEY 217
HP + LY + +C +++Y G L+++L +P ++ + + G+ Y
Sbjct: 60 HPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 218 LHAL---GIIYRDLKPENILLREDGHIM-LSDF 246
LH++ +I+RDLKP N+LL G ++ + DF
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 38/156 (24%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPF 161
+LV +G G G+V+ T A+KV+D ++ + ++ E +L H
Sbjct: 27 ELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 82
Query: 162 LPTLY------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
+ T Y + + ++++C G + L+ N + + + E+L GL
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
+LH +I+RD+K +N+LL E+ + L DF + Q
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 15/148 (10%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLY 166
LG G G + + + + A+K + + S E ++L D HP + +
Sbjct: 32 LGHGAEGTIVYRGMF--DNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYF 84
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + I+ C L + ++ L+ + + GL +LH+L I++R
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ-QTTSGLAHLHSLNIVHR 142
Query: 227 DLKPENILLREDGH-----IMLSDFDLC 249
DLKP NIL+ M+SDF LC
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLC 170
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-21
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 7/157 (4%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEI 153
R LK +R LG G+ G+V LC D T A+K + K ++ ++ E EI
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEI 76
Query: 154 LSMLDHPFLPTLYA--HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
L L H + + + I ++++ P+G L LPK N + +L+ +A ++
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQI 135
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL + ++RDL N+L+ + + + DF L
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
++ LG G+ G V+ ++ T A+K V + L + E I+ D P +
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHV 86
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y + + +++YC G + ++ + N + + L GLEYLH +
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
I+RD+K NILL +GH L+DF + Q
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 16/178 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+L +G+G V + A+K ++ + + + E + +S HP +
Sbjct: 18 ELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNI 75
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLL------PKQPNNRFSLQAVRFFAAEVLVGLE 216
+ Y V + ++ G + ++ + + + EVL GLE
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKS 274
YLH G I+RD+K NILL EDG + ++DF + G TR + RK+
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL--------ATGGDITRNKVRKT 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF 161
L +G G+ G V L + + A+K++D L ++ + E I+ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ +Y V + L+++ G L ++ R + + + VL L YLHA
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
G+I+RD+K ++ILL DG + LSDF C Q
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 38/185 (20%), Positives = 69/185 (37%), Gaps = 17/185 (9%)
Query: 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHV 147
+ + +L LG G G VF H R A+KV+ ++ +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 148 QMEAEILSMLD----HPFLPTLYAHLEVSHYICFLIDY-CPNGDLHSLLPKQPNNRFSLQ 202
+E +L + HP + L E +++ P DL + +
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEG 139
Query: 203 AVRFFAAEVLVGLEYLHALGIIYRDLKPENILL-REDGHIMLSDFDLCFQSDVVP-TLVE 260
R F +V+ +++ H+ G+++RD+K ENIL+ G L DF ++
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS---GALLHDEPYT 196
Query: 261 TNVGS 265
G+
Sbjct: 197 DFDGT 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 35/169 (20%), Positives = 67/169 (39%), Gaps = 22/169 (13%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLY 166
LG G G+V C R T ALK++ + E + P + +
Sbjct: 37 LGLGVNGKVLECFHRR-TGQKCALKLLYD-----SPK--ARQEVDHHWQASGGPHIVCIL 88
Query: 167 ------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
H + I + G+L S + ++ + F+ + ++ +++LH+
Sbjct: 89 DVYENMHHGKRCLLIIM--ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 221 LGIIYRDLKPENILL---REDGHIMLSDFDLCFQSDVVPTLVETNVGSA 266
I +RD+KPEN+L +D + L+DF F + ++T +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFG--FAKETTQNALQTPCYTP 193
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 6/149 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+G G G V+ T A++ ++ L K + E ++ +P +
Sbjct: 23 TRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNI 79
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
V + +++Y G L ++ + E L LE+LH+
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQ 251
+I+RD+K +NILL DG + L+DF C Q
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 8/156 (5%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI- 153
LK + +G G G V H + A+K + + K+ + M+ ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKP--SGQIMAVKRIRSTV-DEKEQKQLLMDLDVV 74
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG--DLHSLLPKQPNNRFSLQAVRFFAAEV 211
+ D P++ Y L ++ + + ++ + +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 212 LVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDF 246
+ L +L L II+RD+KP NILL G+I L DF
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 14/170 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPF 161
++ +G G+ C + T+ FA+K++DK + E EIL HP
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKRDPTE------EIEILLRYGQHPN 77
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+ TL + Y+ + + G+L + +Q FS + + +EYLHA
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ 135
Query: 222 GIIYRDLKPENILLREDGH----IMLSDFDLCFQSDVVPTLVETNVGSAT 267
G+++RDLKP NIL ++ I + DF Q L+ T +A
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 93 SNGKLHLRHL-KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEA 151
N + L++L + LG G+ G V A+K + D ME
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP--VAVKRMLID-----FCDIALMEI 59
Query: 152 EILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
++L+ D HP + Y ++ ++ C N +L L+ + + +L+ + +
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 211 VLV-----GLEYLHALGIIYRDLKPENILL-------------REDGHIMLSDFDLC 249
L+ G+ +LH+L II+RDLKP+NIL+ E+ I++SDF LC
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 34/158 (21%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 94 NGKLHLRHLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE 152
+ ++ L+ + LG G G V H+ + A+K + + ++++ + M+ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVP--SGQIMAVKRIRATV-NSQEQKRLLMDLD 57
Query: 153 I-LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAA 209
I + +D PF T Y L + ++ + L + + A
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 210 EVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDF 246
++ LE+LH+ L +I+RD+KP N+L+ G + + DF
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
RHLK ++ LG GN G V +C D T A+K + + + L + E EIL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKS 67
Query: 157 LDHPFLPTLYA----HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
L H + + + +++Y P G L L K R + + +++
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKL--IMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQIC 124
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G+EYL I+RDL NIL+ + + + DF L
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 50/195 (25%), Positives = 78/195 (40%), Gaps = 21/195 (10%)
Query: 70 SSLHHHRKSDLHWSAIKAATNLSSNGKLHL---------RHLKLVRHLGTGNLGRVFLC- 119
S HHH D + + G RHLK ++ LG GN G V +C
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61
Query: 120 --HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA----HLEVSH 173
L+D T A+K + + + L + E EIL L H + +
Sbjct: 62 YDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119
Query: 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233
+ +++Y P G L L K R + + +++ G+EYL I+RDL NI
Sbjct: 120 KL--IMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176
Query: 234 LLREDGHIMLSDFDL 248
L+ + + + DF L
Sbjct: 177 LVENENRVKIGDFGL 191
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 32/157 (20%), Positives = 64/157 (40%), Gaps = 16/157 (10%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-----EAEILSM 156
++ + +G G G V L + A+K + + + E I+S
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L+HP + LY + + ++++ P GDL+ L + + ++ +G+E
Sbjct: 80 LNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIE 136
Query: 217 YLHALG--IIYRDLKPENILLREDG-----HIMLSDF 246
Y+ I++RDL+ NI L+ ++DF
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-19
Identities = 39/152 (25%), Positives = 57/152 (37%), Gaps = 8/152 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK-KLSHVQMEAEILSMLDHPF 161
+R +G G+ G V+ S A+K + + K + E L L HP
Sbjct: 57 SDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 162 LPTLYAHLEVSHYICFLIDYCPNG--DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
H +++YC DL + K + L GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 171
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
+ +I+RD+K NILL E G + L DF
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 32/182 (17%), Positives = 58/182 (31%), Gaps = 11/182 (6%)
Query: 76 RKSDLHWSAIK--AATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN----- 128
K D AIK N + +R +K + L + R F L
Sbjct: 27 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86
Query: 129 ---FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNG 185
+ D L S + ++ + Y+ + C
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146
Query: 186 DLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLS 244
+L + ++ ++ +E+LH+ G+++RDLKP NI D + +
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 245 DF 246
DF
Sbjct: 207 DF 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 23/181 (12%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV--DKDLLSAKKLSHVQMEAEILSM 156
L L +G G G+V+ A+K D D ++ + +V+ EA++ +M
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
L HP + L +C ++++ G L+ +L R + +A ++ G+
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMN 119
Query: 217 YLHALG---IIYRDLKPENILLREDGHIM--------LSDFDL-CFQSDVVPTLVETNVG 264
YLH II+RDLK NIL+ + ++DF L T + G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---TTKMSAAG 176
Query: 265 S 265
+
Sbjct: 177 A 177
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 32/153 (20%), Positives = 59/153 (38%), Gaps = 20/153 (13%)
Query: 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL-SMLDHPFLPT 164
+ LG G G+V + T FALK++ + E E+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVR 75
Query: 165 LY------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+ I + G+L S + + + F+ + + ++YL
Sbjct: 76 IVDVYENLYAGRKCLLIVM--ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 219 HALGIIYRDLKPENILLR---EDGHIMLSDFDL 248
H++ I +RD+KPEN+L + + L+DF
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 39/215 (18%), Positives = 74/215 (34%), Gaps = 23/215 (10%)
Query: 49 SGCTPHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRH- 107
+ P + H + + L ++ ++
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 108 ------LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHP 160
LG G G+V + T FALK++ + E E+ P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPK-------ARREVELHWRASQCP 115
Query: 161 FLPTLYAHLE--VSHYICFLI--DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+ + E + C LI + G+L S + + + F+ + + ++
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 217 YLHALGIIYRDLKPENILL---REDGHIMLSDFDL 248
YLH++ I +RD+KPEN+L R + + L+DF
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 41/188 (21%), Positives = 69/188 (36%), Gaps = 31/188 (16%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSML 157
R + L+ +G G G V+ + A+K+ S++ E E+ ML
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGEN---VAVKI-----FSSRDEKSWFRETELYNTVML 59
Query: 158 DHPFLPTLYA---HLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
H + A S +LI Y G L+ L + +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIAS 116
Query: 214 GLEYLHAL--------GIIYRDLKPENILLREDGHIMLSDFDL----CFQSDVVPTLVET 261
GL +LH I +RDLK +NIL++++G ++D L ++ +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 262 NVGSATRR 269
VG T+R
Sbjct: 177 RVG--TKR 182
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLR---DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
RHLK + LG GN G V LC D T A A+K + + Q E +IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKA 80
Query: 157 LDHPFLPTLYA--HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
L F+ + + +++Y P+G L L + R + +++++ G
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKG 139
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+EYL + ++RDL NIL+ + H+ ++DF L
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-18
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSM 156
R + L +G G G V+ R A+K+ S+++ EAEI M
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKWRGEE---VAVKI-----FSSREERSWFREAEIYQTVM 92
Query: 157 LDHPFLPTLYA---HLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
L H + A + +L+ DY +G L L + +++ + A
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTA 149
Query: 213 VGLEYLHA--------LGIIYRDLKPENILLREDGHIMLSDFDL 248
GL +LH I +RDLK +NIL++++G ++D L
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 9/152 (5%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ +G G+ G V+ L D A+K + + ++S E I+ H
Sbjct: 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSH 85
Query: 160 PFLPTLYA---HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
P + +L E S + ++ Y +GDL + + + + +++ + F +V G++
Sbjct: 86 PNVLSLLGICLRSEGSPLV--VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMK 142
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL + ++RDL N +L E + ++DF L
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 16/193 (8%)
Query: 70 SSLHHHRKSD-LHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN 128
SS HHH S L + N + + L L + LG G G V +L+ +
Sbjct: 3 SSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTS 62
Query: 129 F--ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA-------HLEVSHYICFLI 179
A+K + D S +++ EA + HP + L + ++
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV--IL 120
Query: 180 DYCPNGDLHSLL----PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235
+ GDLH+ L + LQ + F ++ +G+EYL ++RDL N +L
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 236 REDGHIMLSDFDL 248
R+D + ++DF L
Sbjct: 181 RDDMTVCVADFGL 193
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
L R LG G G V L+ + A+K++ D++++ + EA + DH
Sbjct: 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 160 PFLPTLYA------HLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRFSLQAVRFFAA 209
P + L ++ + +GDLH+ L + LQ + F
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++ G+EYL + I+RDL N +L ED + ++DF L
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
+ +G G+ G V+ L D A+K + + ++S E I+
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFS 148
Query: 159 HPFLPTLYA---HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
HP + +L E S + ++ Y +GDL + + + + +++ + F +V G+
Sbjct: 149 HPNVLSLLGICLRSEGSPLV--VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGM 205
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L + ++RDL N +L E + ++DF L
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 13/157 (8%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF----ALKVVDKDLLSAKKLSHVQMEAEILSML 157
+ + R LG G+ G V+ + A+K V + S ++ EA ++
Sbjct: 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEF 85
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNN----RFSLQAVRFFAA 209
+ + L + +++ GDL S L P NN SL + A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 210 EVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
E+ G+ YL+A ++RDL N ++ ED + + DF
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 31/148 (20%), Positives = 62/148 (41%), Gaps = 4/148 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+ + LG G G V+ + + A+K + +D + ++ EA ++ + HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEF---LKEAAVMKEIKHP 276
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L L + ++ G+L L + S + + A ++ +EYL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDL 248
I+R+L N L+ E+ + ++DF L
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 25/170 (14%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKV---VDKDLLSAKKLSHVQMEAEILSMLD 158
++ VR +G G GRVF V + K+ SA + Q EA +++ D
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 108
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----------------------PKQPN 196
+P + L V +C L +Y GDL+ L
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 197 NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
S A +V G+ YL ++RDL N L+ E+ + ++DF
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 16/163 (9%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA--KKLSHVQMEAEILSML 157
R + L R LG G G+VFL + + + V K L Q EAE+L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSLQA 203
H + Y + + +Y +GDL+ L P+Q L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ A+++ G+ YL + ++RDL N L+ + + + DF
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 33/150 (22%), Positives = 65/150 (43%), Gaps = 5/150 (3%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
R +G G+ G V+ D A+K + + +++ E ++ L+H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNH 81
Query: 160 PFLPTLYAHLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
P + L + + ++ Y +GDL + + P +++ + F +V G+EYL
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDL 248
++RDL N +L E + ++DF L
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 25/164 (15%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSM 156
+ +++V+ +G G G V++ R A+KV + + E EI +
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKWRGEK---VAVKV-----FFTTEEASWFRETEIYQTVL 87
Query: 157 LDHPFLPTLYA---HLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
+ H + A S +LI DY NG L+ L + +++ A +
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSV 144
Query: 213 VGLEYLHAL--------GIIYRDLKPENILLREDGHIMLSDFDL 248
GL +LH I +RDLK +NIL++++G ++D L
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
L V+ +G+G G V L + + A+K + + +S + EAE++ L H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV--AIKTIREGAMSEEDF---IEEAEVMMKLSH 62
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P L LY IC + ++ +G L L + F+ + + +V G+ YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+I+RDL N L+ E+ I +SDF +
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 19/164 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF----ALKVVDKDLLSAKKLSHVQMEAEILSM 156
++ + LG G+V+ HL A+K + KD + EA + +
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRAR 68
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSLQ 202
L HP + L + + + YC +GDLH L + +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 203 AVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
A++ G+EYL + ++++DL N+L+ + ++ +SD
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 172
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 4/151 (2%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSML 157
+ + + +G+G+ G V LR + A+K + K + ++ EA I+
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQF 107
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
DHP + L + + +Y NG L + L + + +F++ + V G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L LG ++RDL N+L+ + +SDF L
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 15/161 (9%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--LSAKKLSHVQMEAEILSMLD 158
+ L LG G G+VFL + + V K L S Q EAE+L+ML
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 101
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL-------------PKQPNNRFSLQAVR 205
H + + + + +Y +GDL+ L L +
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
A++V G+ YL L ++RDL N L+ + + + DF
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDF 202
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 32/148 (21%), Positives = 62/148 (41%), Gaps = 4/148 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+ + LG G G V+ + + A+K + +D + ++ EA ++ + HP
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSL-TVAVKTLKEDTMEVEEF---LKEAAVMKEIKHP 69
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L L + ++ G+L L + S + + A ++ +EYL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL N L+ E+ + ++DF L
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 4/150 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
++ + + +G G G V L+ + A+K + K + K+ EA I+ D
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFD 104
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + L + S + + +Y NG L S L ++ + +F++ + + G++YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDL 248
+G ++RDL NIL+ + +SDF L
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 12/152 (7%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALK--VVDKDLLSAKKLSHVQMEAEILSML 157
+ LKL++ +G G G V L R A +K + L+ EA +++ L
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA---------EASVMTQL 71
Query: 158 DHPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
H L L +E + + +Y G L L + + + F+ +V +E
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL ++RDL N+L+ ED +SDF L
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 6/179 (3%)
Query: 73 HHHRKSD-LHWSAIKAATNLSSNGKLHLRH--LKLVRHLGTGNLGRVFLCHLRDCTSANF 129
H L + K L H L L +G GN G VF LR +
Sbjct: 84 HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLV 142
Query: 130 ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
A+K ++ L + EA IL HP + L I +++ GD +
Sbjct: 143 AVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 190 LLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L + R ++ + + G+EYL + I+RDL N L+ E + +SDF +
Sbjct: 202 FL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-17
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ L ++ LGTG G V R A+K++ + +S + EA+++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV--AIKMIKEGSMSEDEF---IEEAKVMMNLSH 78
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L LY I + +Y NG L + L ++ +RF Q + +V +EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ ++RDL N L+ + G + +SDF L
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 41/185 (22%), Positives = 75/185 (40%), Gaps = 11/185 (5%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALK 132
HHH + ++ +++S ++ +++ L+R LG G G V+ + + L+
Sbjct: 3 HHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 62
Query: 133 V---VDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHS 189
V ++ S + MEA I+S +H + S L++ GDL S
Sbjct: 63 VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 122
Query: 190 LL----PKQPNNR-FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML- 243
L P+ ++ + A ++ G +YL I+RD+ N LL G +
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 244 --SDF 246
DF
Sbjct: 183 KIGDF 187
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 11/156 (7%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKV---VDKDLLSAKKLSHVQMEAEILSMLD 158
+ L+R LG G G V+ + + L+V ++ S + MEA I+S +
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL-----PKQPNNRFSLQAVRFFAAEVLV 213
H + S L++ GDL S L + ++ + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIML---SDF 246
G +YL I+RD+ N LL G + DF
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 18/157 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF---ALKVVDKDLLSAKKLSHVQMEAEILSML 157
K ++ LG+G G V+ A+K + ++ S K + EA +++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 74
Query: 158 DHPFLPTLYAHLEVSHYIC-----FLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
D+P + L IC LI P G L + ++ + Q + + ++
Sbjct: 75 DNPHVCRLLG-------ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQI 126
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G+ YL +++RDL N+L++ H+ ++DF L
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
LKLV LG G G V++ + T A+K + + +S EA ++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV--AVKSLKQGSMSPDAF---LAEANLMKQLQHQ 68
Query: 161 FLPTLYAHLEVSH---YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
L LYA V+ YI + +Y NG L L + ++ + AA++ G+ +
Sbjct: 69 RLVRLYA--VVTQEPIYI--ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ I+RDL+ NIL+ + ++DF L
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
L+L LG G G V++ T A+K + +S + EA+++ L H
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTLKPGTMSPEAF---LQEAQVMKKLRHE 239
Query: 161 FLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L LYA E YI + +Y G L L + L + AA++ G+ Y+
Sbjct: 240 KLVQLYAVVSEEPIYI--VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ ++RDL+ NIL+ E+ ++DF L
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGL 326
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 5/151 (3%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF---ALKVVDKDLLSAKKLSHVQMEAEILSML 157
+ + +G G G V+ L+ + A+K + K + K+ EA I+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQF 103
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
H + L + + + +Y NG L L ++ + FS+ + + G++Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L + ++RDL NIL+ + +SDF L
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGL 193
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-16
Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 6/149 (4%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ L++ LG+G G V L + A+K++ + +S + EA+ + L H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV--AVKMIKEGSMSEDEF---FQEAQTMMKLSH 62
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P L Y + I + +Y NG L + L + + +V G+ +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ I+RDL N L+ D + +SDF +
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
LKL + LG G G V++ T A+K + +S + EA ++ L H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV--AVKTMKPGSMSVEAF---LAEANVMKTLQHD 243
Query: 161 FLPTLYAH-LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L L+A + YI + ++ G L L ++ L + F+A++ G+ ++
Sbjct: 244 KLVKLHAVVTKEPIYI--ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
I+RDL+ NIL+ ++DF L
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGL 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH- 159
+L R +G+G+ G ++L A+K+ K + +E++I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGG 64
Query: 160 PFLPTLYAHLEVSHYICFLIDYC-PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+PT+ Y +++ P+ L L + +FSL+ V A +++ +EY+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFC-SRKFSLKTVLLLADQMISRIEYI 121
Query: 219 HALGIIYRDLKPENILLREDGH---IMLSDFDLC 249
H+ I+RD+KP+N L+ + + DF L
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-D 158
+K +G GN G+V ++ D + A+K + K+ S E E+L L
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 84
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSLQAV 204
HP + L E Y+ I+Y P+G+L L + S Q +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
FAA+V G++YL I+RDL NIL+ E+ ++DF L
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 32/152 (21%), Positives = 62/152 (40%), Gaps = 8/152 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF---ALKVVDKDLLSAKKLSHVQMEAEILSML 157
L+ ++ LG+G G V + +KV+ +D + V + L
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSL 72
Query: 158 DHPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
DH + L S + + Y P G L + +Q Q + + ++ G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL--VTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL G+++R+L N+LL+ + ++DF +
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 7/152 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSH-VQMEAEILSML 157
L+L+ LG G+ G V + A+K + D+LS + E + L
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 158 DHPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
DH L LY L + + + P G L L ++ F L + +A +V G+
Sbjct: 79 DHRNLIRLYGVVLTPPMKM--VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
YL + I+RDL N+LL + + DF L
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
L+L LG G G V++ T A+K + +S + EA+++ L H
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTLKPGTMSPEAF---LQEAQVMKKLRHE 322
Query: 161 FLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L LYA E YI + +Y G L L + L + AA++ G+ Y+
Sbjct: 323 KLVQLYAVVSEEPIYI--VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ ++RDL+ NIL+ E+ ++DF L
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGL 409
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 27/186 (14%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSML 157
L+L+ G G V+ L + A+K+ + Q E E+ L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNEY---VAVKI-----FPIQDKQSWQNEYEVYSLPGM 75
Query: 158 DHPFLPTLYA---HLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
H + +LI + G L L S + A +
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMAR 132
Query: 214 GLEYLHA----------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263
GL YLH I +RD+K +N+LL+ + ++DF L + + + +T+
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 264 GSATRR 269
TRR
Sbjct: 193 QVGTRR 198
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 12/151 (7%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALK--VVDKDLLSAKKLSHVQMEAEILSMLD 158
LKL++ +G G G V L R A +K + L+ EA +++ L
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA---------EASVMTQLR 244
Query: 159 HPFLPTLYAH-LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
H L L +E + + +Y G L L + + + F+ +V +EY
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L ++RDL N+L+ ED +SDF L
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 7/151 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
++L R +G G G V + A+K K+ S EA + D
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFD 74
Query: 159 HPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
HP + L E +I +++ C G+L S L + L ++ +A ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI--IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAY 131
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L + ++RD+ N+L+ + + L DF L
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF------ALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V + A+K++ KD + K LS + E E++
Sbjct: 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMK 95
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFS 200
M+ H + L + +++Y G+L L + P + +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ + ++ G+EYL + I+RDL N+L+ E+ + ++DF
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 27/172 (15%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF----ALKVVDKDLLSAKKLSHVQMEAEILSM 156
+L L + LG G G+V A+K++ K+ S +L + E +L
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQ 82
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRFSLQAVRF------ 206
++HP + LY + +++Y G L L P S +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 207 ------------FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
FA ++ G++YL + +++RDL NIL+ E + +SDF
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 43/188 (22%), Positives = 68/188 (36%), Gaps = 27/188 (14%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSM 156
L +LKL+ +G G G V+ L + A+KV S + E I + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDERP---VAVKV-----FSFANRQNFINEKNIYRVPL 63
Query: 157 LDHPFLPTLYA----HLEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
++H + L+ +Y PNG L L + + A V
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSV 120
Query: 212 LVGLEYLHA---------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETN 262
GL YLH I +RDL N+L++ DG ++SDF L + +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 263 VGSATRRR 270
+A
Sbjct: 181 EDNAAISE 188
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 19/165 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSML 157
LKL + LG G G+V V K L + + + E +IL +
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 158 D-HPFLPTLYAH-LEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFSL 201
H + L + + ++++C G+L + L + +L
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ + ++ +V G+E+L + I+RDL NILL E + + DF
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 97 LHLRHLKLV-RHLGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEIL 154
L + L L + LG+GN G V + + A+K++ + + EA ++
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 155 SMLDHPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
LD+P++ + S + +++ G L+ L Q N + + +V +
Sbjct: 73 QQLDNPYIVRMIGICEAESWML--VMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 128
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G++YL ++RDL N+LL + +SDF L
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 18/157 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF---ALKVVDKDLLSAKKLSHVQMEAEILSML 157
K ++ LG+G G V+ A+K + ++ S K + EA +++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 74
Query: 158 DHPFLPTLYAHLEVSHYIC-----FLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
D+P + L IC LI P G L + ++ + Q + + ++
Sbjct: 75 DNPHVCRLLG-------ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQI 126
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
G+ YL +++RDL N+L++ H+ ++DF L
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 22/167 (13%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF----ALKVVDKDLLSAKKLSHVQMEAEILSM 156
L + LG G G+V ++ A+K++ K + + E ++LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSY 82
Query: 157 L-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----------------PKQPNNRF 199
L +H + L + + +YC GDL + L +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L+ + F+ +V G+ +L + I+RDL NILL + DF
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E +L L+HP + L H E Y+ F ++ DL + L ++ +
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVF--EFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL + H+ +++RDLKP+N+L+ +G I L+DF L
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-14
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 7/151 (4%)
Query: 101 HLKLVRHLGTGNLGRVF--LCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
+ L R LG G G V+ + N A+K K + EA I+ LD
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLD 71
Query: 159 HPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
HP + L E +I +++ P G+L L ++ N + + ++ ++ + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI--IMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L ++ ++RD+ NIL+ + L DF L
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF------ALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V + A+K++ KD + K LS + E E++
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMK 141
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFS 200
M+ H + L + +++Y G+L L + P + +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ + ++ G+EYL + I+RDL N+L+ E+ + ++DF
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 9/160 (5%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANF------ALKVVDKDLLSAKKLSHVQMEAEI 153
L LG G ++F R+ LKV+DK + + A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASM 65
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
+S L H L Y + ++ G L + L K+ N ++ A ++
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAA 124
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+ +L +I+ ++ +NILL + + SD
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 23/155 (14%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVV----DKDLLSAKKLSHVQMEAEILSMLD 158
++ + G LG ++L R+ LK + D + + E + L+ +
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-----AMAERQFLAEVV 137
Query: 159 HPFLPTLY-------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
HP + ++ H + YI +++Y L + + + E+
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYI--VMEYVGGQSLKRSK----GQKLPVAEAIAYLLEI 191
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
L L YLH++G++Y DLKPENI+L E+ + L D
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 56 STTTTTTTPATSSTSSLHHHRKSDLHW---SAIKAATNLSSNGKLHLRHLKLVRHLGTGN 112
+ + T + + S + + + ++ ATN + +G G
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATN----------NFDHKFLIGHGV 51
Query: 113 LGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH-LEV 171
G+V+ LRD ALK + S++ + + E E LS HP L +L E
Sbjct: 52 FGKVYKGVLRDGAKV--ALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 172 SHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQ-AVRF-FAAEVLVGLEYLHALGIIYRDL 228
+ I LI Y NG+L L S+ R GL YLH II+RD+
Sbjct: 108 NEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165
Query: 229 KPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV 263
K NILL E+ ++DF + S L +T++
Sbjct: 166 KSINILLDENFVPKITDFGI---SKKGTELDQTHL 197
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 7/151 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
++L R +G G G V + A+K K+ S EA + D
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFD 449
Query: 159 HPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
HP + L E +I +++ C G+L S L + L ++ +A ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI--IMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAY 506
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L + ++RD+ N+L+ + + L DF L
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 36/166 (21%), Positives = 69/166 (41%), Gaps = 15/166 (9%)
Query: 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQME 150
+S + H K+ R +G G+ G +F + A+K + ++ E
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRR----SDAPQLRDE 55
Query: 151 AEILSMLDH-PFLPTLYAHLEVSHYICFLIDYC-PNGDLHSLLPKQPNNRFSLQAVRFFA 208
+L +P +Y + + +ID P+ L LL +FS++ V A
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS--LEDLL-DLCGRKFSVKTVAMAA 112
Query: 209 AEVLVGLEYLHALGIIYRDLKPENILLREDGH-----IMLSDFDLC 249
++L ++ +H ++YRD+KP+N L+ I + DF +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPF 161
+LVR LG G VF + +K++ + KK ++ E +IL L P
Sbjct: 39 QLVRKLGRGKYSEVFEAINIT-NNEKVVVKILK--PVKKKK---IKREIKILENLRGGPN 92
Query: 162 LPTLYA--HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+ TL VS + ++ N D L + +RF+ E+L L+Y H
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH 147
Query: 220 ALGIIYRDLKPENILL-REDGHIMLSDFDL 248
++GI++RD+KP N+++ E + L D+ L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 55 SSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLG 114
S + S+ S+ R D AT + + +G G+ G
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 115 RVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--------FLPTLY 166
V+ L D + A+K V +D K E +I+ LDH F +
Sbjct: 69 VVYQAKLCD-SGELVAIKKVLQD--KRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
EV Y+ ++DY P ++ + + + V+ + ++ L Y+H+ GI
Sbjct: 122 KKDEV--YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 225 YRDLKPENILLREDGHIM-LSDF 246
+RD+KP+N+LL D ++ L DF
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDF 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 103 KLVRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQ--MEAEILSML-- 157
++++ +G G+ G+V D + ALK+V +K H Q E IL L
Sbjct: 100 EVLKVIGKGSFGQVVKA--YDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRK 152
Query: 158 -----DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
+ + + ++IC + + +L+ L+ K FSL VR FA +L
Sbjct: 153 QDKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGH--IMLSDFDL-CFQSDVVPTLVET 261
L+ LH II+ DLKPENILL++ G I + DF C++ V T +++
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 19/176 (10%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLS-AKKLSHVQMEAEILSMLDH 159
+L LG G + V L + A+KV+ DL + EA+ + L+H
Sbjct: 15 ELGEILGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 160 PFLPTLY------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
P + +Y YI +++Y L ++ + + A+
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYI--VMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQ 127
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC-FQSDVVPTLVETN--VGSA 266
L + H GII+RD+KP NI++ + + DF + +D ++ +T +G+A
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 34/149 (22%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLSAKK-LSHVQMEAEILSMLDH 159
K+V LG G + V+L T N A+K + ++ L + E S L H
Sbjct: 14 KIVDKLGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 160 PFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+ ++ + +Y+ +++Y L + + + S+ F ++L G+++
Sbjct: 71 QNIVSMIDVDEEDDCYYL--VMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKH 126
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDF 246
H + I++RD+KP+NIL+ + + + DF
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 25/148 (16%), Positives = 46/148 (31%), Gaps = 14/148 (9%)
Query: 104 LVRHLGTGNLGRVFLCH---L-RDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLD 158
L+ G + + L R AL VD L L LS +D
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQV-----ALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
P + + + + ++ G L + P+ A+R + +
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV---GAIRA-MQSLAAAADAA 145
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDF 246
H G+ P + + DG ++L+
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 103 KLVRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKK-LSHVQMEAEILSMLDHP 160
LVR LG G+ V+L +D + + A+K+V K + E ++L ++
Sbjct: 22 ILVRKLGWGHFSTVWLA--KDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVND- 74
Query: 161 FLPTLYAHLEVSHYICFLIDY----CPNGD------------LHSLLPKQPNNRFSLQAV 204
T +++I L+D+ PNG L +L+ K + L V
Sbjct: 75 ADNTKEDS-MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 205 RFFAAEVLVGLEYLHA-LGIIYRDLKPENILLRE------DGHIMLSDF-DLCFQSDVVP 256
+ + ++L+GL+Y+H GII+ D+KPEN+L+ I ++D + C+ +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 257 TLVET 261
++T
Sbjct: 194 NSIQT 198
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 12/149 (8%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLS-AKKLSHVQMEAEILSMLDH 159
+L R +G G +G V+ T ALK++ + L S + +Q EA L
Sbjct: 37 RLRRLVGRGGMGDVYEAE---DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 160 PFLPTLYAHLEV--SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
P + ++ E+ Y+ + DL ++L + + ++ L+
Sbjct: 94 PHVVPIHDFGEIDGQLYV--DMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDF 246
HA G +RD+KPENIL+ D L DF
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E IL L H + LY H + + F ++ DL LL + F
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVF--EHLDQ-DLKKLL-DVCEGGLESVTAKSF 105
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L G+ Y H +++RDLKP+N+L+ +G + ++DF L
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 7/151 (4%)
Query: 101 HLKLVR-HLGTGNLGRVFLCHLRDCT-SANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
+L + LG GN G V R + A+KV+ K + EA+I+ LD
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 68
Query: 159 HPFLPTLYA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+P++ L + + +++ G LH L + V +V +G++Y
Sbjct: 69 NPYIVRLIGVCQAEALML--VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKY 125
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L ++RDL N+LL + +SDF L
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 22/168 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANF------ALKVVDKDLLSAKKLSHVQMEAEILS 155
L L + LG G G+V L A+K++ K + K LS + E E++
Sbjct: 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMK 129
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRFS 200
M+ H + L + +++Y G+L L P + S
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + A +V G+EYL + I+RDL N+L+ ED + ++DF L
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 22/164 (13%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ------MEAEILS 155
L+ + LG G G+V + LKV K L K +H E +I+S
Sbjct: 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMS 104
Query: 156 MLD-HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL------------PKQPNNRFSLQ 202
L H + L + + +YC GDL + L N+ S +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 203 AVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
+ F+++V G+ +L + I+RD+ N+LL + DF
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E +L L HP + +L H E + F ++ DL +L + ++ +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVF--EFMEK-DLKKVL-DENKTGLQDSQIKIY 124
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L G+ + H I++RDLKP+N+L+ DG + L+DF L
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 46/224 (20%), Positives = 76/224 (33%), Gaps = 22/224 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANF-ALKVVDKDLLSAKKLSHVQMEAEILSML---- 157
++R LG G+ V+L D F A+KVV E +L +
Sbjct: 40 HVIRKLGWGHFSTVWLS--WDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSD 94
Query: 158 -DHP---FLPTLYAHLEVS----HYICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFA 208
+ P + L ++S +IC + + G L + K L V+
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 209 AEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSAT 267
+VL GL+YLH II+ D+KPENILL + + + + +T
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 268 RRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311
+ + E + +A+ H Q
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 30/169 (17%), Positives = 55/169 (32%), Gaps = 23/169 (13%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
K+ +G G G ++L + S V K + + E + P
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK--VEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 163 PTLYAHLEVSHY--ICFLIDYCPNG----------------DLHSLLPKQPNNRFSLQAV 204
+ Y + + DL + RFS + V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN-AKRFSRKTV 154
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILL--REDGHIMLSDFDLCFQ 251
+ +L LEY+H ++ D+K N+LL + + L D+ L ++
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E +L L H + L+ H + + F ++C DL N + V+ F
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVF--EFCDQ-DLKKYF-DSCNGDLDPEIVKSF 106
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL + H+ +++RDLKP+N+L+ +G + L++F L
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRFSLQA 203
E ++ L H + LY H E + F ++ N DL + L
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVF--EFMDN-DLKKYMDSRTVGNTPRGLELNL 109
Query: 204 VRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
V++F ++L GL + H I++RDLKP+N+L+ + G + L DF L
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE------------ 152
+ LG G V+ + T ALK +++E E
Sbjct: 7 LDKLGEGTYATVYKGKSKL-TDNLVALK-------------EIRLEHEEGAPCTAIREVS 52
Query: 153 ILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAE 210
+L L H + TL+ H E S + F +Y DL L N ++ V+ F +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVF--EYLDK-DLKQYL-DDCGNIINMHNVKLFLFQ 108
Query: 211 VLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+L GL Y H +++RDLKP+N+L+ E G + L+DF L
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 101 HLKLVRHLGTGNLGRVFLC-HLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ ++ + +G GN G + L +L T+ A+K+ + + +E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLY--TNEYVAIKLEPMK----SRAPQLHLEYRFYKQLGS 63
Query: 160 -PFLPTLYAHLEVSHYICFLIDYC-PN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+P +Y Y +++ P+ DL L + FSL+ V A +++ +E
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR----TFSLKTVLMIAIQLISRME 119
Query: 217 YLHALGIIYRDLKPENILLREDGH-----IMLSDF 246
Y+H+ +IYRD+KPEN L+ G+ I + DF
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 35/171 (20%), Positives = 69/171 (40%), Gaps = 25/171 (14%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKV-VD--KDLLSAKKLSHVQMEAEILSML 157
+L+ + LG+G G+V + +++V V K+ + + + E ++++ L
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 158 -DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL----PKQPNNRFSLQAVRF------ 206
H + L +S I + +YC GDL + L K + + +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 207 -----------FAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDF 246
FA +V G+E+L ++RDL N+L+ + + DF
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 7e-13
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 6/101 (5%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E ++L L HP + L + + + F D+ DL ++ K + + ++ +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVF--DFMET-DLEVII-KDNSLVLTPSHIKAY 117
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
L GLEYLH I++RDLKP N+LL E+G + L+DF L
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 29/169 (17%), Positives = 57/169 (33%), Gaps = 26/169 (15%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML----- 157
L + +G+G G ++L A VV K + ++ + E + +
Sbjct: 40 VLGKKIGSGGFGLIYLAF-PTNKPEKDARHVV-K--VEYQENGPLFSELKFYQRVAKKDC 95
Query: 158 -DHPFLPTLYAHLEVSHYICFLIDYCPNG------------DLHSLLPKQPNNRFSLQAV 204
+L + + + DL + N F V
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS--GQNGTFKKSTV 153
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILL--REDGHIMLSDFDLCFQ 251
+L LEY+H ++ D+K N+LL + + L+D+ L ++
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 31/153 (20%), Positives = 54/153 (35%), Gaps = 18/153 (11%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ--MEAEILSML--- 157
++V +LG G G+V C + ALK++ +E +L +
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEK 76
Query: 158 ----DHPFLPTLYAHLEVSHYICFLID-YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
+ + ++C + N L + + L VR A ++
Sbjct: 77 DKENKFLCV-LMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
L +LH + + DLKPENIL L +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSH-----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAV 204
E ++L L H L L LEV Y+ F ++ + + L + N Q V
Sbjct: 74 EIKLLKQLRHENLVNL---LEVCKKKKRWYLVF--EFVDH-TILDDL-ELFPNGLDYQVV 126
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + +++ G+ + H+ II+RD+KPENIL+ + G + L DF
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 44/180 (24%), Positives = 71/180 (39%), Gaps = 36/180 (20%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ--MEAEILSMLDHP 160
++ +G G+ G+V + R A+K++ KK Q +E +L +++
Sbjct: 57 EIDSLIGKGSFGQVVKAYDRV-EQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNK- 109
Query: 161 FLPTLYAHLEVSHYICFLIDY-------C-------PNGDLHSLLPKQPNNRFSLQAVRF 206
E+ +YI L + C N L+ LL SL R
Sbjct: 110 ------HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRK 161
Query: 207 FAAEVLVGLEYLHA--LGIIYRDLKPENILLREDGH--IMLSDF-DLCFQSDVVPTLVET 261
FA ++ L +L L II+ DLKPENILL I + DF C + +++
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DH 159
+L R +G+G+ G ++L T+ A+K+ + K + E++I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLG-TNIQTNEEVAIKLENVK----TKHPQLLYESKIYRILQGG 62
Query: 160 PFLPTLYAHLEVSHYICFLIDYC-PNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+P + Y ++D P+ L L + + SL+ V A +++ +E++
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 119
Query: 219 HALGIIYRDLKPENILLREDGH---IMLSDFDLC 249
H+ ++RD+KP+N L+ + + DF L
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 22/173 (12%)
Query: 85 IKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKL 144
IK + G+ + +G G+ G VF + S A+K V +D K
Sbjct: 25 IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQA--KLVESDEVAIKKVLQD--KRFKN 80
Query: 145 SHVQMEAEILSMLDHP--------FLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--PKQ 194
E +I+ ++ HP F EV + +Y P ++ +
Sbjct: 81 R----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL--EYVPE-TVYRASRHYAK 133
Query: 195 PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL-REDGHIMLSDF 246
+ ++ + ++L L Y+H++GI +RD+KP+N+LL G + L DF
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 26/180 (14%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ--MEAEILSML--- 157
++V LG G G+V C + A+K+V E ++L L
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTT 71
Query: 158 ----DHPFLPTLYAHLEVSHYICFLID-YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
+ + E +IC + + + + + + F L +R A ++
Sbjct: 72 DPNSTFRCV-QMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV-----GSAT 267
+ +LH+ + + DLKPENIL + + + TL+ ++ GSAT
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK---IKRDERTLINPDIKVVDFGSAT 185
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 12/104 (11%)
Query: 150 EAEILSMLDHPFLPTLYAHLEVSH-----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAV 204
E +L L HP L L LEV ++ F +YC + + L + V
Sbjct: 52 EIRMLKQLKHPNLVNL---LEVFRRKRRLHLVF--EYCDH-TVLHEL-DRYQRGVPEHLV 104
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + L + + H I+RD+KPENIL+ + I L DF
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 33/192 (17%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQ--MEAEILSML--- 157
++R +G G GRV LC D +A+KVV K +EA+IL +
Sbjct: 38 LVIRKMGDGTFGRVLLCQHID-NKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQND 91
Query: 158 ---DHPFLPTLYAHLEVSHYICFLID-YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
++ + + ++C + + P+ L+ ++ + N F ++ ++ + E+L
Sbjct: 92 DINNNNIV-KYHGKFMYYDHMCLIFEPLGPS--LYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRK 273
L YL + + + DLKPENILL + + T+ G + R K
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEK-----------SLITVRRVTDGKKIQIYRTK 197
Query: 274 SCN----GFGSA 281
S FG A
Sbjct: 198 STGIKLIDFGCA 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 40/210 (19%), Positives = 66/210 (31%), Gaps = 34/210 (16%)
Query: 73 HHHRKSDLHWSAIKAATNLSSNGKLHL-----------RHLKLVRHLGTGNLGRVFL--- 118
HHH S + + L R KL N G ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAP 63
Query: 119 ----CHLRDCTSANFALKVVDKD---------LLSAKKLSHVQMEAEILSMLDHPFLPTL 165
F+LK+ KD A K V + L +PT
Sbjct: 64 TSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK-LYSTPLLAIPTC 122
Query: 166 YAH-LEVSHYICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGI 223
+ Y ++ G L S L P + S ++V A +L LE+LH
Sbjct: 123 MGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180
Query: 224 IYRDLKPENILL--REDGHIMLSDFDLCFQ 251
++ ++ ENI + + + L+ + F+
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 23/157 (14%)
Query: 108 LGTGNLGRVFLCHLRDC-TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
+G G G V+ +D ++ALK ++ +S E +L L HP + +L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNVISLQ 84
Query: 167 ----AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV-------LVGL 215
+H + ++ F DY + DL ++ ++ + + V+ V L G+
Sbjct: 85 KVFLSHADRKVWLLF--DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 216 EYLHALGIIYRDLKPENILLRED----GHIMLSDFDL 248
YLHA +++RDLKP NIL+ + G + ++D
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 27/73 (36%), Positives = 42/73 (57%), Gaps = 2/73 (2%)
Query: 177 FLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235
L+ ++ DL + L K P + ++ + L GL++LHA I++RDLKPENIL+
Sbjct: 95 TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 153
Query: 236 REDGHIMLSDFDL 248
G + L+DF L
Sbjct: 154 TSGGTVKLADFGL 166
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYIC-----FLI-DYCPNGDLHSLLPKQPNNRFSL 201
E +IL +L H + L + S Y +L+ D+C + DL LL +F+L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTL 123
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++ +L GL Y+H I++RD+K N+L+ DG + L+DF L
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 25/73 (34%), Positives = 43/73 (58%), Gaps = 2/73 (2%)
Query: 177 FLI-DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235
L+ ++ DL + L K P + ++ ++L GL++LH+ +++RDLKP+NIL+
Sbjct: 95 TLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153
Query: 236 REDGHIMLSDFDL 248
G I L+DF L
Sbjct: 154 TSSGQIKLADFGL 166
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 26/164 (15%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---------EAEI 153
+ R + +G+ G V C D A+K V + + ++ + E +
Sbjct: 25 TVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 154 LSMLDHP--------FLPTLYAHLEVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAV 204
L+ HP F+ + Y+ L+ DL ++ S Q +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMH-KLYLVTELMRT----DLAQVI-HDQRIVISPQHI 136
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++F +L+GL LH G+++RDL P NILL ++ I + DF+L
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 150 EAEILSMLDHPFLPTLY--AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
E +L L H + L H ++ F +Y N DL + K P+ S++ ++ F
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIF--EYAEN-DLKKYMDKNPD--VSMRVIKSF 137
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILL-----REDGHIMLSDFDL 248
+++ G+ + H+ ++RDLKP+N+LL E + + DF L
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 36/144 (25%), Positives = 61/144 (42%), Gaps = 6/144 (4%)
Query: 107 HLGTGNLGRVFLCHLRDCTSA-NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
LG GN G V R + A+KV+ K + EA+I+ LD+P++ L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 166 YA-HLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+ + +++ G LH L + V +V +G++YL +
Sbjct: 402 IGVCQAEALML--VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 225 YRDLKPENILLREDGHIMLSDFDL 248
+R+L N+LL + +SDF L
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGL 482
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 49 SGCTPHSSTTTTTTTPATSSTSSLHHHRKSDLHWSAIKAATNLSSNGKLHLRHLKLVRHL 108
S ++ + T T S S ++ H S A+ + ++ +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 109 GTGNLGRVFLCHLRDCTSANFALKVVDK---DLLSAKKLSHVQMEAEILSMLDHP----- 160
GTG+ G V + + A+K + + DL+ K + E IL+ L+H
Sbjct: 62 GTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCK---RILREIAILNRLNHDHVVKV 117
Query: 161 ---FLPTLYAHL-EVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
+P E+ Y+ + D D L + + ++ +LVG+
Sbjct: 118 LDIVIPKDVEKFDEL--YVVLEIADS----DFKKLF--RTPVYLTELHIKTLLYNLLVGV 169
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+Y+H+ GI++RDLKP N L+ +D + + DF L
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 27/163 (16%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDC-TSANFALKVVD--KDLLSAKKLSHVQMEAEILS 155
+L LG G G V C T A+K ++ L A E +IL
Sbjct: 10 SSDFQLKSLLGEGAYGVV--CSATHKPTGEIVAIKKIEPFDKPLFAL---RTLREIKILK 64
Query: 156 MLDHP--------FLPTLYAHL-EVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVR 205
H P + + EV YI L+ DLH ++ Q S ++
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEV--YIIQELMQT----DLHRVISTQM---LSDDHIQ 115
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+F + L ++ LH +I+RDLKP N+L+ + + + DF L
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 39/161 (24%), Positives = 68/161 (42%), Gaps = 23/161 (14%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK---DLLSAKKLSHVQMEAEILSM 156
+ + +G+G G V T A+K + + ++ AK E +L
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKH 84
Query: 157 LDHP--------FLPTLYAHLEVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
+ H F P Y+ L+ DL++++ Q + V+F
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQK---LTDDHVQFL 137
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL+Y+H+ II+RDLKP N+ + ED + + DF L
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 25/161 (15%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVD--KDLLSAKKLSHVQMEAEILSML 157
+ ++G G G V + A+K + + + E +IL
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQ---RTLREIKILLRF 82
Query: 158 DHP--------FLPTLYAHL-EVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
H + +V YI L++ DL+ LL Q S + +F
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDV--YIVQDLMET----DLYKLLKTQH---LSNDHICYF 133
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL+Y+H+ +++RDLKP N+LL + + DF L
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 174
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 3/63 (4%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DL L+ + ++F ++L GL Y+HA GII+RDLKP N+ + ED + + D
Sbjct: 115 DLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171
Query: 246 FDL 248
F L
Sbjct: 172 FGL 174
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167
LG G G+V+ L D T A+K + ++ + Q E E++SM H L L
Sbjct: 38 LGRGGFGKVYKGRLADGTLV--AVKRLKEERTQGGE-LQFQTEVEMISMAVHRNLLRLRG 94
Query: 168 H-LEVSHYICFLI-DYCPNGDLHSLLPKQPNNRFSLQ-AVRFF----AAEVLVGLEYLH- 219
+ + L+ Y NG + S L ++P ++ L R +A GL YLH
Sbjct: 95 FCMTPTE--RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---GLAYLHD 149
Query: 220 --ALGIIYRDLKPENILLREDGHIMLSDFDL 248
II+RD+K NILL E+ ++ DF L
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 25/163 (15%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK---DLLSAKKLSHVQMEAEILS 155
+ + +G G+ G V+L + ++ T N A+K V++ DL+ K + E IL+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFEDLIDCK---RILREITILN 80
Query: 156 MLDHP--------FLPTLYAHL-EVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVR 205
L +P E+ YI + D DL L + + + ++
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDEL--YIVLEIADS----DLKKLF--KTPIFLTEEHIK 132
Query: 206 FFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+L+G ++H GII+RDLKP N LL +D + + DF L
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 24/161 (14%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDK---DLLSAKKLSHVQMEAEILSM 156
+ H+G+G G V + + A+K + + + AK+ E +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKR---AYRELLLLKH 79
Query: 157 LDHP--------FLPTLYAHLEVSHYICF-LIDYCPNGDLHSLLPKQPNNRFSLQAVRFF 207
+ H F P Y+ + DL ++ FS + +++
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLK---FSEEKIQYL 131
Query: 208 AAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
++L GL+Y+H+ G+++RDLKP N+ + ED + + DF L
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 41/200 (20%), Positives = 63/200 (31%), Gaps = 76/200 (38%)
Query: 85 IKAAT-NLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALK-VVDKDLLSAK 142
+K T N + +G G G V+ K V+ ++ K
Sbjct: 20 LKNVTNNFDERPISVGGNK-----MGEGGFGVVY--------------KGYVNNTTVAVK 60
Query: 143 KLSHV------------QMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYC-------- 182
KL+ + E ++++ H +L V L+ +
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHE-------NL-VE-----LLGFSSDGDDLCL 107
Query: 183 -----PNGDLHSLL---PKQP----NNRFS--LQAVRFFAAEVLVGLEYLHALGIIYRDL 228
PNG L L P + R A G+ +LH I+RD+
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GINFLHENHHIHRDI 159
Query: 229 KPENILLREDGHIMLSDFDL 248
K NILL E +SDF L
Sbjct: 160 KSANILLDEAFTAKISDFGL 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 19/63 (30%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245
DLH+++ ++ +++ ++YLH+ G+++RD+KP NILL + H+ ++D
Sbjct: 96 DLHAVIRANI---LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152
Query: 246 FDL 248
F L
Sbjct: 153 FGL 155
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 28/151 (18%), Positives = 62/151 (41%), Gaps = 15/151 (9%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
R L +++ L N+ + L D F ++ H ++ + + +
Sbjct: 48 NRELDIMKVLDHVNIIK-----LVDY----FYTTGDEEPKPPQPPDDHNKLGGKNNGVNN 98
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQAVRFFAAEVLVGLE 216
H + + +Y P+ LH +L + + + + ++ +
Sbjct: 99 HHKSVIVNPSQNKYLNVIM--EYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155
Query: 217 YLHALGIIYRDLKPENILL-REDGHIMLSDF 246
++H+LGI +RD+KP+N+L+ +D + L DF
Sbjct: 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 26/108 (24%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 150 EAEILSMLDHP--------FLPTLYAHLEVSHYICF-LIDYCPNGDLHSLLPKQPNNRFS 200
E ++ ++H F P Y+ L+D +L ++ +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVI-QME---LD 162
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + + ++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 27/108 (25%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 150 EAEILSMLDHP--------FLPTLYAHLEVSHYICF-LIDYCPNGDLHSLLPKQPNNRFS 200
E ++ ++H F P YI L+D +L ++ +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVI-QME---LD 125
Query: 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248
+ + + ++L G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 173
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 32/170 (18%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDC-TSANFALK-VVDKDLLSAKKLSHVQMEAEILSM 156
++ LG G G V D A+K +V D S K H E +I+
Sbjct: 10 GSRYMDLKPLGCGGNGLV--FSAVDNDCDKRVAIKKIVLTDPQSVK---HALREIKIIRR 64
Query: 157 LDHP--------FLPTLYAHLEVSH--------YICF-LIDYCPNGDLHSLLPKQPNNRF 199
LDH P+ + YI ++ DL ++L + P
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGP---L 117
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL-REDGHIMLSDFDL 248
+ R F ++L GL+Y+H+ +++RDLKP N+ + ED + + DF L
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 32/156 (20%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-------KKLSHVQMEAEILS 155
++ R G G G V L + T + A+K V +D + L+ + I+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP-NIVQ 83
Query: 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--PKQPNNRFSLQAVRFFAAEVLV 213
+ + + ++ Y+ +++Y P+ LH + ++ F +++
Sbjct: 84 LQSYFYTLGERDRRDI--YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 214 GLEYLH--ALGIIYRDLKPENILL-REDGHIMLSDF 246
+ LH ++ + +RD+KP N+L+ DG + L DF
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 31/141 (21%), Positives = 50/141 (35%), Gaps = 11/141 (7%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM---EAEILSMLD 158
LKL + LG G G+V V K L S + E +IL +
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 159 -HPFLPTLY-AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
H + L A + + ++++C G+L + L + R + A G +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKTKGARFRQGKD 140
Query: 217 YLHALGIIYRDLKPENILLRE 237
Y +G I DLK +
Sbjct: 141 Y---VGAIPVDLKRRLDSITS 158
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 26/139 (18%), Positives = 47/139 (33%), Gaps = 10/139 (7%)
Query: 111 GNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170
GNL +L R+ + V ++ + S+ + E
Sbjct: 112 GNL-STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170
Query: 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKP 230
S + + L + + ++ +V G+E+L + I+RDL
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEH---------LICYSFQVAKGMEFLASRKCIHRDLAA 221
Query: 231 ENILLREDGHIMLSDFDLC 249
NILL E + + DF L
Sbjct: 222 RNILLSEKNVVKICDFGLA 240
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-05
Identities = 27/191 (14%), Positives = 49/191 (25%), Gaps = 52/191 (27%)
Query: 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVV------DKDLLSAKKLSHVQMEAEILS 155
L+ +G G G VF A +K++ + K + E I
Sbjct: 22 LQRCEKIGEGVFGEVFQTIADHTPVA---IKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 156 ML---------DHPFLPTLYAHLEV------------------------------SHYIC 176
L L + V +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-ALGIIYRDLKPENILL 235
++++ G L + SL + ++ L +L +RDL N+LL
Sbjct: 139 IVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 236 REDGHIMLSDF 246
++ L
Sbjct: 196 KKTSLKKLHYT 206
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.85 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.6 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 99.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.99 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.61 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.33 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 92.15 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.71 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.94 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 86.27 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 82.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 80.19 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=353.29 Aligned_cols=200 Identities=19% Similarity=0.294 Sum_probs=170.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||+||+|++.. +++.||||++.+........+.+.+|+++|+.|+|||||++++++.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT-TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4799999999999999999999887 899999999988776777788999999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||+||+|.+++.......+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999998766677899999999999999999999999999999999999999999999999999876543222
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..+ ..|+..||+||.... .....++|+||+|++++|+.+|.
T Consensus 182 ~~~----------~~GT~~YmAPE~l~~-----~~y~~~~DiwSlGvilyemltG~ 222 (350)
T 4b9d_A 182 ARA----------CIGTPYYLSPEICEN-----KPYNNKSDIWALGCVLYELCTLK 222 (350)
T ss_dssp HHH----------HHSCCTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccc----------cCCCccccCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCC
Confidence 122 245667888886643 33457899999999999999993
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=349.50 Aligned_cols=195 Identities=21% Similarity=0.279 Sum_probs=168.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
...|+++++||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999887 89999999997653 23345688999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999965 46999999999999999999999999999999999999999999999999999887654433
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..+. .|+..||+||... .......+|+||+|++++|+..|.
T Consensus 227 ~~~~----------~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~ 267 (346)
T 4fih_A 227 RKSL----------VGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGE 267 (346)
T ss_dssp BCCC----------CSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccc----------ccCcCcCCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCC
Confidence 3332 3445567776543 334567899999999999999994
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=357.98 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=169.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+.|+++++||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|..++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 4689999999999999999999887 89999999997653 23345688999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 227 mEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred EeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999999965 46999999999999999999999999999999999999999999999999999987654433
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..+. .|+..||+||.... ......+|+||+|++++|+.+|.|
T Consensus 304 ~~~~----------~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 304 RKSL----------VGTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp BCCC----------EECTTTCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccc----------ccCcCcCCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCCC
Confidence 3332 35566888876543 334678999999999999999943
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=342.11 Aligned_cols=201 Identities=29% Similarity=0.431 Sum_probs=170.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
..++|++++.||+|+||+||+|++.. +++.||||++.+..... ...+.+.+|+++|+.++|||||+++++|++++.+|
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34689999999999999999999887 89999999998764332 45678999999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999999663 679999999999999999999999999999999999999999999999999998875433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... .....|+..||+||.. ........+|+||+|++++|+.+|.
T Consensus 187 ~~~~--------~~~~~GTp~YmAPEvl-----~~~~y~~~~DiWSlGvilyeml~G~ 231 (311)
T 4aw0_A 187 KQAR--------ANSFVGTAQYVSPELL-----TEKSACKSSDLWALGCIIYQLVAGL 231 (311)
T ss_dssp TCCC--------BCCCCSCGGGCCHHHH-----HHSCBCHHHHHHHHHHHHHHHHHSS
T ss_pred Cccc--------ccCcccCcccCCHHHH-----cCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 2111 0111344456666544 4444567899999999999999993
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=324.57 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=156.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++.+..... .....+.+|+++|+.++|||||++++++.+++.+|+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4789999999999999999998877 89999999998654433 445678999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+ +|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 91 vmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 99999 78999999664 6799999999999999999999999999999999999999999999999999986543221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. . ...|+..|++||...... -....+|+||+|++++|+..| .|
T Consensus 168 ~-~----------~~~GT~~Y~APE~~~~~~----y~~~~~DiwSlGvily~lltg~~P 211 (275)
T 3hyh_A 168 L-K----------TSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYVMLCRRLP 211 (275)
T ss_dssp ------------------CTTSCHHHHSSSS----CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred c-C----------CeeECcccCChhhhcCCC----CCCChhhhHHHHHHHHHHHHCCCC
Confidence 1 1 124566777777654321 124678999999999999999 44
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=322.30 Aligned_cols=193 Identities=22% Similarity=0.325 Sum_probs=166.9
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----cCEEEE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV----SHYICF 177 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 177 (317)
|++.++||+|+||+||+|.+.. +++.||+|++..........+.+.+|+++|+.++|||||+++++|.. +..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4888999999999999999887 89999999998776677777889999999999999999999999865 456899
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEc-cCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR-EDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~-~~~~~kl~DFG~a~~~~~ 254 (317)
|||||+||+|.+++.+ ...+++..++.|+.||+.||.|||+++ ||||||||+||||+ .+|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999976 367999999999999999999999998 99999999999998 479999999999975433
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ..+ ..|+..|||||..... ...++|+||+|++++|+.+| .|
T Consensus 185 ~~--~~~----------~~GTp~YmAPE~~~~~------y~~~~DiwSlGvilyelltg~~P 228 (290)
T 3fpq_A 185 SF--AKA----------VIGTPEFMAPEMYEEK------YDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp TS--BEE----------SCSSCCCCCGGGGGTC------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred Cc--cCC----------cccCccccCHHHcCCC------CCcHHHHHHHHHHHHHHHHCCCC
Confidence 21 111 2567789999976432 35689999999999999999 45
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=335.34 Aligned_cols=203 Identities=31% Similarity=0.481 Sum_probs=162.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||+||+|+... .+++.||||++++.........++.+|+++|+.++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3455789999999999999999998742 36789999999765444333456788999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999763 679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.......+. .|+..||+||.. ........+|+||+|++++|+.+| .|
T Consensus 178 ~~~~~~~~~----------~GT~~YmAPE~~-----~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 178 DHEKKAYSF----------CGTVEYMAPEVV-----NRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp ---CCCCSC----------CCCGGGCCHHHH-----HTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcccccc----------ccCcccCCHHHh-----ccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 433222222 344556666654 333445789999999999999999 44
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=331.35 Aligned_cols=198 Identities=18% Similarity=0.232 Sum_probs=162.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..+.|++.++||+|+||+||+|.+.. +|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34679999999999999999999887 899999999986532 2469999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~~~ 256 (317)
|||||+||+|.+++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999764 6799999999999999999999999999999999999999988 69999999998775432
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... .......|+..||+||... ......++|+||+|++++|+..| .|
T Consensus 206 ~~~~~-----~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 206 LGKSL-----LTGDYIPGTETHMAPEVVM-----GKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp -------------CCCCCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccce-----ecCCccccCccccCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 21110 0011123555666666554 33446789999999999999999 44
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=322.92 Aligned_cols=205 Identities=18% Similarity=0.238 Sum_probs=167.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..+++++.++||+|+||+||+|.+.. .||||+++......+..+.+.+|+++|+.++|||||++++++.. +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~----~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG----DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS----EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC----cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46778899999999999999999997653 59999998665567778899999999999999999999998764 56
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++||||||||+||||++++.+||+|||+|+....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 89999999999999999654 35799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... ......|+..|||||.....-. .....++|+||.|++++|+.+| .|
T Consensus 185 ~~~~~--------~~~~~~GT~~ymAPE~l~~~~~--~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 185 WSGSQ--------QVEQPTGSVLWMAPEVIRMQDN--NPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp -----------------CCCCTTSCCHHHHHCCSS--CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCcce--------eecccccCCCccCHHHhhccCC--CCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 22110 1112356678888887643211 1234689999999999999999 55
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=321.70 Aligned_cols=205 Identities=20% Similarity=0.263 Sum_probs=169.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.+..++|.+.++||+|+||+||+|.+.. .++..||||+++.. .....+.+.+|+++|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 5677899999999999999999998753 25788999999754 45566789999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQ-----------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH 240 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~ 240 (317)
++.+|||||||++|+|.+++... ....+++..++.|+.||+.||.|||+++||||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999653 2357999999999999999999999999999999999999999999
Q ss_pred EEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 241 IMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 241 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+||+|||+|+..........+ ....++..||+||..... ....++|+||.|.+++|+.+ | .|
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~--------~~~~gt~~ymAPE~~~~~-----~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVG--------GHTMLPIRWMPPESIMYR-----KFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEET--------TTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEECCcccceecCCCCceeec--------CceecChhhcCHHHHcCC-----CCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999865443322111 112345568888876533 34578999999999999986 7 55
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.37 Aligned_cols=206 Identities=21% Similarity=0.256 Sum_probs=163.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|.+.++||+|+||+||+|.++. .++..||||+++.. .....+.+.+|+++|+.++|||||++++++.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35667899999999999999999998753 25789999999754 4566678999999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP-------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE 237 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~ 237 (317)
+.+.+|||||||++|+|.+++.... ..++++..++.|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999986532 246899999999999999999999999999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
++.+||+|||+|+.......... .....++..||+||.... .....++|+||.+.+++|+.+ | .|
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~--------~~~~~gt~~ymAPE~~~~-----~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRV--------GGRTMLPIRWMPPESILY-----RKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp TTEEEECCCC------------------------CCCCGGGCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCcEEEcccccceeccCCCccee--------cCcccccccccChhhhcC-----CCCCccccccchHHHHHHHHcCCCCC
Confidence 99999999999987644322111 011234556777776543 334578999999999999986 7 55
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=327.60 Aligned_cols=202 Identities=19% Similarity=0.261 Sum_probs=165.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------cC
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------SH 173 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 173 (317)
++|++++.||+|+||+||+|.+.. +|+.||||++++........+.+.+|+++|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC-CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 589999999999999999999887 89999999998766666677888999999999999999999998753 36
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+||||||| +|+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 799999999 5789999955 4789999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
........ ......|+..|++||..... .......|+||+|++++|+..|.|
T Consensus 210 ~~~~~~~~------~~~~~~GT~~Y~APEv~~~~----~~~~~~~DiWSlG~il~ell~G~~ 261 (398)
T 4b99_A 210 TSPAEHQY------FMTEYVATRWYRAPELMLSL----HEYTQAIDLWSVGCIFGEMLARRQ 261 (398)
T ss_dssp ------CC------CCCSSCCCCTTCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cCcccccc------ccccceeChHhcCHHHhcCC----CCCCChhheehhHHHHHHHHHCCC
Confidence 43221111 11112455566666654221 123578899999999999999954
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=317.54 Aligned_cols=207 Identities=18% Similarity=0.252 Sum_probs=154.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH----- 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 173 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++.... .....+.+.+|+++|+.++|||||++++++...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 3579999999999999999999887 89999999997543 3455578899999999999999999999987544
Q ss_pred -------EEEEEEcccCCCChhcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 174 -------YICFLIDYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 174 -------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
++|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999975422 2345677889999999999999999999999999999999999999999
Q ss_pred ecccccCCCCCCeeecc--cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC
Q 042913 246 FDLCFQSDVVPTLVETN--VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG 312 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 312 (317)
||+|+.++......... ...........|+..|||||.... .....++|+||+|++++|+..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-----NSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-----CCCCCHHHHHHHHHHHHHHcc
Confidence 99998876543321111 111111222346666777776543 344678999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.53 Aligned_cols=207 Identities=18% Similarity=0.261 Sum_probs=167.7
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+...++++.++||+|+||+||+|.+.. .+++.||||+++... .....+.+.+|+.++++++|||||+++|++.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 35677889999999999999999998742 256889999997543 3344578999999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR 236 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~ 236 (317)
.++.++||||||++|+|.++|.... ...+++..++.|+.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999985431 24589999999999999999999999999999999999999
Q ss_pred cCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-C
Q 042913 237 EDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-V 314 (317)
Q Consensus 237 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~ 314 (317)
+++.+||+|||+|+......... ......++..||+||..... .....+|+||.|.+++|+.+ | .
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~--------~~~~~~gt~~ymAPE~l~~~-----~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYK--------LLGNSLLPIRWMAPEAIMYG-----KFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBC--------SSSSSCBCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCEEECCcccceeccCCCcee--------EecccccCCcccCHHHHhCC-----CCCccchhhhHHHHHHHHHhCCCC
Confidence 99999999999998654322110 01112445567888766433 34678999999999999986 7 4
Q ss_pred C
Q 042913 315 P 315 (317)
Q Consensus 315 p 315 (317)
|
T Consensus 247 P 247 (308)
T 4gt4_A 247 P 247 (308)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.92 Aligned_cols=202 Identities=28% Similarity=0.443 Sum_probs=166.9
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHL 169 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 169 (317)
...+..++|++++.||+|+||+||+|+... +|+.||||++.+..... ......++++.+++.++|||||+++++|
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 456778999999999999999999999887 89999999998654322 2223334456667778899999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+.+.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999999999763 67999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+.+..... .+ ..|+..|||||.... .......+|+|++|++++|+..|.
T Consensus 340 ~~~~~~~~--~t----------~~GTp~YmAPEvl~~----~~~y~~~vDiWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 340 CDFSKKKP--HA----------SVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGH 388 (689)
T ss_dssp EECSSCCC--CS----------CCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eecCCCCC--CC----------ccCCcCccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 87654321 11 134455666665421 233467899999999999999994
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.43 Aligned_cols=202 Identities=19% Similarity=0.263 Sum_probs=160.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----E
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH----Y 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 174 (317)
.++|.+.++||+|+||+||+|.+. |+.||||++..... .......|+..+..++|||||++++++..++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 367999999999999999999874 68999999975421 1122344666667889999999999997654 6
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEccCCcEEEeee
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL--------GIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
+|||||||++|+|.++++. ..+++..+..++.|++.||.|||++ +||||||||+||||+.++.+||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 8999999999999999975 4589999999999999999999987 8999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|+........... ......++..||+||...+.... ......++|+||.|++++|+.+|.|
T Consensus 153 Gla~~~~~~~~~~~~------~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~ 216 (303)
T 3hmm_A 153 GLAVRHDSATDTIDI------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp TTCEEEETTTTEESC------C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred CCCccccCCCCceee------ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCC
Confidence 999876544332211 11123577789999987654322 2234568999999999999988843
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.80 Aligned_cols=206 Identities=20% Similarity=0.272 Sum_probs=168.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC-CCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 170 (317)
.+..++|++++.||+|+||+||+|.+... .++.||||.+.... .....+.+.+|+++|+.+.| ||||+++++|.
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 56778999999999999999999987641 34679999997653 34556789999999999975 89999999986
Q ss_pred e-cCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 042913 171 V-SHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235 (317)
Q Consensus 171 ~-~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill 235 (317)
. ++.+|+|||||++|+|.++|+... ...+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 5 457899999999999999996532 2458999999999999999999999999999999999999
Q ss_pred ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-
Q 042913 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G- 313 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G- 313 (317)
++++.+||+|||+|+.+........+ ....++..|||||..... .....+|+||.|++++|+.. |
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~--------~~~~gt~~ymAPE~l~~~-----~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRK--------GDARLPLKWMAPETIFDR-----VYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEE--------TTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CCCCCEEECcchhhhhcccCCCceee--------ccccccccccCHHHHhcC-----CCCCcccEeehHHHHHHHHhCCC
Confidence 99999999999999877554432211 112345678888876543 34578999999999999986 7
Q ss_pred CC
Q 042913 314 VP 315 (317)
Q Consensus 314 ~p 315 (317)
.|
T Consensus 286 ~P 287 (353)
T 4ase_A 286 SP 287 (353)
T ss_dssp CS
T ss_pred CC
Confidence 44
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=323.25 Aligned_cols=198 Identities=24% Similarity=0.316 Sum_probs=168.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||+||+|.++. +|+.||+|++... .....+.+.+|+++|+.++|||||+++++|.+.+.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 35799999999999999999999887 8999999999765 34445678999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC--CcEEEeeecccccCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED--GHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~--~~~kl~DFG~a~~~~~~ 255 (317)
|||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 232 v~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999999998643 3579999999999999999999999999999999999999854 89999999999987654
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... .+. .|+..|++||.. .........|+||+|++++|+..|.|
T Consensus 311 ~~~-~~~----------~GT~~y~APEv~-----~~~~y~~~~DiWSlGvilyeml~G~~ 354 (573)
T 3uto_A 311 QSV-KVT----------TGTAEFAAPEVA-----EGKPVGYYTDMWSVGVLSYILLSGLS 354 (573)
T ss_dssp SEE-EEE----------CSSGGGCCHHHH-----TTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred Cce-eee----------EECccccCHHHh-----CCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 322 111 234456666654 33445678999999999999999943
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.50 Aligned_cols=204 Identities=18% Similarity=0.230 Sum_probs=160.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 175 (317)
.++|++.+.||+|+||+||+|.++. .+++.||+|.+.... ...++.+|+++|+.+ +||||++++++|...+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4689999999999999999998752 357899999986542 234578899999998 599999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeeecccccCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDFDLCFQSDV 254 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DFG~a~~~~~ 254 (317)
|+||||+++|+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999983 48999999999999999999999999999999999999876 7999999999987655
Q ss_pred CCCeeecccc------------------cccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC-C
Q 042913 255 VPTLVETNVG------------------SATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG-V 314 (317)
Q Consensus 255 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G-~ 314 (317)
.......... .........|+..|++||.. ... ......|+||+|++++|+..| .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l-----~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL-----TKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHH-----TTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHH-----cCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 4322111110 00111122344555555543 322 346788999999999999999 5
Q ss_pred CC
Q 042913 315 PR 316 (317)
Q Consensus 315 p~ 316 (317)
|.
T Consensus 246 Pf 247 (361)
T 4f9c_A 246 PF 247 (361)
T ss_dssp SS
T ss_pred CC
Confidence 63
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=287.13 Aligned_cols=200 Identities=23% Similarity=0.345 Sum_probs=171.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.....++|++++.||+|+||.||+|.+.. +++.||||++..........+.+.+|+++++.++||||+++++++...+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 34567899999999999999999999877 79999999998876677777889999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999999653 6699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceecc-chhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~G 313 (317)
.... ....++..|++||... .... ....|+|++|++++|+.+|
T Consensus 167 ~~~~-----------~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 167 GGKL-----------DAFCGAPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp SCGG-----------GTTSSSGGGCCHHHHH-----TCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred CCcc-----------ccccCCcceeCccccc-----CCCcCCchhhhhhhHHHHHHHHhC
Confidence 3211 1123445566666543 2222 4689999999999999999
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.86 Aligned_cols=202 Identities=29% Similarity=0.512 Sum_probs=164.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
..+..++|++++.||+|+||+||+|++.. +++.||||++.+... .......+.+|..+++.+ +||||+++++++...
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 35677899999999999999999999887 889999999987533 234556788999999988 699999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999653 67999999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
........+. .++..|++||. ..........|+|+++++++|+..|.
T Consensus 175 ~~~~~~~~~~----------~gt~~y~aPE~-----~~~~~~~~~~DiwslG~il~ell~G~ 221 (353)
T 3txo_A 175 ICNGVTTATF----------CGTPDYIAPEI-----LQEMLYGPAVDWWAMGVLLYEMLCGH 221 (353)
T ss_dssp CC-------------------CCGGGCCHHH-----HHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCcccccc----------CCCcCeEChhh-----cCCCCcCCccCCCcchHHHHHHHhCC
Confidence 4332221111 23344555554 44444567899999999999999993
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.70 Aligned_cols=200 Identities=27% Similarity=0.488 Sum_probs=168.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+..++|++++.||+|+||+||+|.... +++.||+|++.+.... ......+.+|+++++.++||||+++++++...+.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 456899999999999999999999877 8999999999875332 24456788999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999999865 367999999999999999999999999999999999999999999999999999864332
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....+ ..++..|++||... ........|+|++|++++|+..|.
T Consensus 159 ~~~~~~----------~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 159 GATMKT----------FCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp TCCBCC----------CEECGGGCCGGGGS-----SSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCcccc----------cccChhhCChhhhc-----CCCCCchhhcccchhHHHHHhcCC
Confidence 221111 13445566666553 334567899999999999999993
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=296.51 Aligned_cols=208 Identities=24% Similarity=0.360 Sum_probs=170.9
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++++.||+|+||+||+|.+.. +++.||+|++.+..... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4556899999999999999999999887 78999999997643222 223347889999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999653 46799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ....++..|++||................|+|++|++++|+..|.
T Consensus 228 ~~~~~~---------~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 228 DGTVQS---------SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp TSCEEC---------CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccc---------ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 433211 112455567777765421111223457899999999999999993
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=290.52 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=167.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
..+..++|++++.||+|+||+||+|++.. +++.||+|++.+..... ...+.+.+|..+++.+ +||||+++++++...
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 35667899999999999999999999887 88999999998764433 4456688899999887 799999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999999999653 67999999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
........+ ..++..|++||.. .........|+|++|++++|+..|.
T Consensus 204 ~~~~~~~~~----------~~gt~~Y~aPE~l-----~~~~~~~~~DiwslGvllyell~G~ 250 (396)
T 4dc2_A 204 LRPGDTTST----------FCGTPNYIAPEIL-----RGEDYGFSVDWWALGVLMFEMMAGR 250 (396)
T ss_dssp CCTTCCBCC----------CCBCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcccc----------ccCCcccCCchhh-----cCCCCChHHHHHHHHHHHHHHHhCC
Confidence 332221111 1334456666654 3344568899999999999999994
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=287.11 Aligned_cols=205 Identities=25% Similarity=0.427 Sum_probs=172.5
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
..+.+..++|++++.||+|+||.||+|.+.. +++.||+|++.+..... .....+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3456788999999999999999999999887 88999999997654222 445678899999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+.+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 9999999999999999999965 46799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... ....++..|++||..... .........|+|++|++++|+..|
T Consensus 165 ~~~~~~~-----------~~~~gt~~Y~aPE~~~~~--~~~~~~~~~DiwSlG~il~elltG 213 (384)
T 4fr4_A 165 LPRETQI-----------TTMAGTKPYMAPEMFSSR--KGAGYSFAVDWWSLGVTAYELLRG 213 (384)
T ss_dssp CCTTCCB-----------CCCCSCGGGCCGGGTCCC--SSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ccCCCce-----------eccCCCccccCCeeeccC--CCCCCCccceeechHHHHHHHHhC
Confidence 6432211 112345567777765321 122346789999999999999999
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=282.96 Aligned_cols=201 Identities=29% Similarity=0.477 Sum_probs=169.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||.||+|++.. +++.||+|++.+... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 4567899999999999999999999887 789999999987643 345667789999999987 8999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999999999653 569999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... ...++..|++||... ........|+|++|++++|+..|.
T Consensus 162 ~~~~~~~----------~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 162 RPGDTTS----------TFCGTPNYIAPEILR-----GEDYGFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp CTTCCBC----------CCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCccc----------ccCCCccccCccccC-----CCCCChHHhHHHHHHHHHHHHhCC
Confidence 3221111 113444566666543 334567899999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=280.82 Aligned_cols=197 Identities=33% Similarity=0.539 Sum_probs=168.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+..++|++++.||+|+||.||+|.... +++.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 456899999999999999999999877 79999999998754322 3456788999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999999999663 67999999999999999999999999999999999999999999999999999865431
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ....++..|++||... ........|+|++|++++|+..|.
T Consensus 160 ~-------------~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 160 T-------------YTLCGTPDYIAPEVVS-----TKPYNKSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp B-------------CCCCSCTTTCCHHHHT-----TCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred c-------------ccccCCccccCHhHhc-----CCCCCcccchhhhHHHHHHHHhCC
Confidence 1 1123455677776553 334467899999999999999993
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=291.27 Aligned_cols=205 Identities=23% Similarity=0.414 Sum_probs=168.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++++.||+|+||+||+|.+.. +++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4567899999999999999999999887 78999999997643221 223457889999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999999965 4589999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... .....++..|++||........ .......|+|++|++++|+..|.
T Consensus 221 ~~~~~---------~~~~~gt~~Y~APE~l~~~~~~-~~~~~~~DiwSlGvilyell~G~ 270 (410)
T 3v8s_A 221 EGMVR---------CDTAVGTPDYISPEVLKSQGGD-GYYGRECDWWSVGVFLYEMLVGD 270 (410)
T ss_dssp TSEEE---------CCSCCSCGGGCCHHHHHTTTTT-CEEETHHHHHHHHHHHHHHHHSS
T ss_pred CCccc---------ccCCcCCccccCHHHhhccCCC-cCCCCcceEecchHHHHHHHhCC
Confidence 33211 1112345566666655322111 11457899999999999999993
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=282.48 Aligned_cols=201 Identities=29% Similarity=0.519 Sum_probs=166.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||||++++.... ......+..|..+++.+ +||||+++++++...+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 5677899999999999999999999887 8999999999875322 23456678899999876 8999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999999653 569999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... ...++..|++||... ........|+|++|++++|+..|.
T Consensus 170 ~~~~~~~----------~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 215 (345)
T 1xjd_A 170 LGDAKTN----------TFCGTPDYIAPEILL-----GQKYNHSVDWWSFGVLLYEMLIGQ 215 (345)
T ss_dssp CTTCCBC----------CCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCccc----------CCCCCcccCChhhhc-----CCCCCChhhhHHHHHHHHHHhcCC
Confidence 3222111 113344566666543 334568899999999999999994
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=277.00 Aligned_cols=202 Identities=19% Similarity=0.244 Sum_probs=168.0
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+.+..++|++++.||+|+||.||+|.+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 56677899999999999999999999877 78999999986532 23456678999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999999654 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... ......++..|++||.... .....+.|+|+++++++|+..|
T Consensus 163 ~~~~~---------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 163 ETSLT---------QTNHVLGTVQYFSPEQAKG-----EATDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp ---------------------CCSSCCHHHHHT-----CCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccccc---------ccCccccCccccCHhHhcC-----CCCCchHhHHHHHHHHHHHHhC
Confidence 33211 1111235566777776543 3345788999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=284.36 Aligned_cols=203 Identities=25% Similarity=0.454 Sum_probs=166.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSML-DHPFLPTLYAHLEV 171 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 171 (317)
...+..++|++++.||+|+||.||+|.... +++.||||++.+..... ...+.+.+|..++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 345778999999999999999999999876 78999999998754322 3456788899999887 79999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999999999653 5699999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.........+ ..++..|++||.. .........|+|++|++++|+..|.
T Consensus 171 ~~~~~~~~~~----------~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~G~ 218 (353)
T 2i0e_A 171 NIWDGVTTKT----------FCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQ 218 (353)
T ss_dssp CCCTTCCBCC----------CCSCGGGCCHHHH-----TTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred cccCCccccc----------ccCCccccChhhh-----cCCCcCCcccccchHHHHHHHHcCC
Confidence 4332221111 1334455666554 3344568899999999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=276.03 Aligned_cols=195 Identities=19% Similarity=0.247 Sum_probs=165.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 45789999999999999999998776 789999999976532 234568899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999965 3589999999999999999999999999999999999999999999999999987654332
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
... ...++..|++||.. .........|+|++|++++|+..|
T Consensus 172 ~~~----------~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g 212 (297)
T 3fxz_A 172 KRS----------TMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMIEG 212 (297)
T ss_dssp CBC----------CCCSCGGGCCHHHH-----HCSCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccC----------CccCCcCccChhhh-----cCCCCCcHHHHHHHHHHHHHHHhC
Confidence 211 12344456666654 333456789999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=288.76 Aligned_cols=208 Identities=24% Similarity=0.373 Sum_probs=171.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++++.||+|+||+||+|+... +++.||+|++.+.... ......+.+|+.++..++||||+++++++.+.+.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4567899999999999999999999877 8999999999764322 2334568899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 99999999999999999653 24699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccc--cceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENV--MEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~--~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ....++..|++||...... ..........|+|++|++++|+..|.
T Consensus 215 ~~~~~~---------~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 215 DGTVRS---------LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp TSCEEC---------SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred CCcccc---------ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 332111 1124555677777654210 01223467899999999999999993
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=275.11 Aligned_cols=210 Identities=20% Similarity=0.251 Sum_probs=169.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++..++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECC-CCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4567899999999999999999999887 7899999988553 456667899999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999999999764 466999999999999999999999999999999999999999999999999999876544
Q ss_pred CCeeecccc----cccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVG----SATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~----~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... .........++..|++||.. .......+.|+|+++++++|+..|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~~l~el~~g~ 219 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI-----NGRSYDEKVDVFSFGIVLCEIIGRV 219 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccccccccccccccccccccCCCcceeCHHHh-----cCCCCCcHHHHHHHHHHHHHHhcCC
Confidence 332211110 00111122344556666654 3344567899999999999998874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.92 Aligned_cols=194 Identities=18% Similarity=0.244 Sum_probs=155.4
Q ss_pred cccCCeEEe-eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHH-HhcCCCCcceEEEEEEe---
Q 042913 97 LHLRHLKLV-RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL-SMLDHPFLPTLYAHLEV--- 171 (317)
Q Consensus 97 ~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~--- 171 (317)
...++|.+. +.||+|+||+||+|.+.. +++.||||++... ..+.+|++++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECC-CCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345678777 789999999999999877 8999999999643 3466788887 45589999999999875
Q ss_pred -cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeec
Q 042913 172 -SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFD 247 (317)
Q Consensus 172 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG 247 (317)
...+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667999999999999999997765567999999999999999999999999999999999999997 7899999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+|+........ ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 210 ~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~ 260 (400)
T 1nxk_A 210 FAKETTSHNSL-----------TTPCYTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_dssp TCEECC----------------------CTTCCGGGSCC-----CCSSSHHHHHHHHHHHHHHHHSS
T ss_pred cccccCCCCcc-----------ccCCCCCCccCHhhcCC-----CCCCCcccHHHHHHHHHHHHhCC
Confidence 99865432211 11234566888887643 23457899999999999999993
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.75 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=171.5
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.......++|++++.||+|+||.||+|.+.. +++.||+|++.+..... ...+.+.+|+++++.++||||+++++++.+
T Consensus 34 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCCHHHCEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456778999999999999999999999887 79999999997654322 445678899999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence 99999999999999999999653 5699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ....++..|++||... ........|+|++|++++|+..|.
T Consensus 191 ~~~~~-------------~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 235 (350)
T 1rdq_E 191 VKGRT-------------WTLCGTPEALAPEIIL-----SKGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp CSSCB-------------CCCEECGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCc-------------ccccCCccccCHHHhc-----CCCCCCcCCEecccHhHhHHhhCC
Confidence 54321 1113445566666554 334567899999999999999994
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.65 Aligned_cols=205 Identities=19% Similarity=0.268 Sum_probs=167.6
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+..++|++++.||+|+||.||+|.+.. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 35667899999999999999999998742 245679999997653 456677899999999999 8999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++...+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999987542 24588999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG- 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~- 312 (317)
|++.++.+||+|||+|+........... ....++..|++||... ........|+|++|++++|+..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~--------~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKT--------TNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTT--------TTTTSCGGGCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCEEEccccCCcccCcccceecc--------cCCCcccceECHhHhc-----CCCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999999999866543221111 1112233466666553 3345678999999999999987
Q ss_pred C
Q 042913 313 G 313 (317)
Q Consensus 313 G 313 (317)
|
T Consensus 302 g 302 (370)
T 2psq_A 302 G 302 (370)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=280.35 Aligned_cols=199 Identities=22% Similarity=0.312 Sum_probs=170.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+.+++.++||||+++++++...+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345789999999999999999998877 7899999999877666677788999999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC---CcEEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED---GHIMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~---~~~kl~DFG~a~~~~ 253 (317)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 105 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999999855 3678999999999999999999999999999999999999864 459999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 183 ~~~~~-----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 183 DSEAW-----------HGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp TCCSC-----------CCSCSCTTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCccc-----------ccCCCCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHHCC
Confidence 33211 11245566777776543 23457899999999999999994
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=285.26 Aligned_cols=201 Identities=29% Similarity=0.467 Sum_probs=159.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHH-HHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEI-LSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||+||+|++.. +++.||||++.+..... .....+.+|..+ ++.++||||+++++++...+
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 4567899999999999999999999887 78999999998765432 344566777776 57789999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999965 3678999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... ...++..|++||... ........|+|++|++++|+..|.
T Consensus 191 ~~~~~~~----------~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~G~ 236 (373)
T 2r5t_A 191 EHNSTTS----------TFCGTPEYLAPEVLH-----KQPYDRTVDWWCLGAVLYEMLYGL 236 (373)
T ss_dssp CCCCCCC----------SBSCCCCCCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCccc----------cccCCccccCHHHhC-----CCCCCchhhhHHHHHHHHHHHcCC
Confidence 2221111 123445566666543 334567899999999999999994
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=281.65 Aligned_cols=212 Identities=17% Similarity=0.213 Sum_probs=176.2
Q ss_pred ccccCCeEEeeeeccc--CCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTG--NLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
....++|++++.||+| +||.||+|.+.. +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3456899999999999 999999999887 7999999999887666777788999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999999987656779999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......... .......++..|++||....+. .......|+|++|++++|+..|.
T Consensus 180 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il~el~~g~ 234 (389)
T 3gni_B 180 SHGQRQRVVH---DFPKYSVKVLPWLSPEVLQQNL---QGYDAKSDIYSVGITACELANGH 234 (389)
T ss_dssp ETTEECSCBC---CCCTTCTTTGGGSCHHHHSTTS---SCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccc---cccccccccccccCHHHHhccC---CCCCcHhHHHHHHHHHHHHHHCC
Confidence 3221111000 1111224455577777665432 23456899999999999999983
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.51 Aligned_cols=198 Identities=23% Similarity=0.311 Sum_probs=165.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 35789999999999999999999887 89999999997653221 13467889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeeccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLC 249 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a 249 (317)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999999955 46799999999999999999999999999999999999998776 7999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+........ ....++..|++||. ..........|+|++|++++|+..|.
T Consensus 167 ~~~~~~~~~-----------~~~~gt~~y~aPE~-----~~~~~~~~~~DiwslGvil~~ll~g~ 215 (361)
T 2yab_A 167 HEIEDGVEF-----------KNIFGTPEFVAPEI-----VNYEPLGLEADMWSIGVITYILLSGA 215 (361)
T ss_dssp EECCTTCCC-----------CCCCSCGGGCCHHH-----HTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred eEcCCCCcc-----------ccCCCCccEECchH-----HcCCCCCccccHHHHHHHHHHHHhCC
Confidence 876543211 11123444555554 44444567899999999999999994
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=290.11 Aligned_cols=207 Identities=16% Similarity=0.166 Sum_probs=156.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-----cC
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-----SH 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 173 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++..........+++.+|+++|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC---CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4789999999999999999999887 78999999997766566777889999999999999999999999843 35
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 7899999865 4679999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCeeeccc--------------cc---ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNV--------------GS---ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~--------------~~---~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......... .+ ........++..|++||... .........|+|++|++++|+..|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL----LQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHT----TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhh----CCCCCCcHhHHHHHHHHHHHHHHh
Confidence 4322111000 00 00111223455566666431 223356789999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.12 Aligned_cols=200 Identities=20% Similarity=0.258 Sum_probs=168.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45789999999999999999998877 89999999998776666667789999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc---cCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~---~~~~~kl~DFG~a~~~~~ 254 (317)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 88 v~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999998664 6699999999999999999999999999999999999998 467899999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...... ...++..|++||... .......+|+|++|++++|+..|.|
T Consensus 166 ~~~~~~----------~~~gt~~Y~APE~l~-----~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 166 EQQAWF----------GFAGTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp TCCBCC----------CSCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCceee----------cccCCcccCCHHHhc-----CCCCCCccccHHHHHHHHHHHhCCC
Confidence 332211 123445566666543 3345678999999999999999943
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=275.26 Aligned_cols=195 Identities=15% Similarity=0.218 Sum_probs=164.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 5789999999999999999999887 8899999998754 23345688999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc--CCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE--DGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~--~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999999653 346999999999999999999999999999999999999987 7899999999998765433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ...++..|++||.. .........|+|++|++++|+..|.
T Consensus 159 ~~~-----------~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 159 NFR-----------LLFTAPEYYAPEVH-----QHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp EEE-----------EEESCGGGSCHHHH-----TTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccc-----------cccCChhhcCcHHh-----cCCCCCchhhHHHHHHHHHHHHhCC
Confidence 211 11233445566554 3334567899999999999999993
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=270.47 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=162.7
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH------------------------HHHHHHHHH
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA------------------------KKLSHVQME 150 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E 150 (317)
..+..++|++.+.||+|+||.||+|.+.. +++.||||++....... ...+.+.+|
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34667899999999999999999998877 78999999997643211 224568899
Q ss_pred HHHHHhcCCCCcceEEEEEEe--cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 042913 151 AEILSMLDHPFLPTLYAHLEV--SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL 228 (317)
Q Consensus 151 ~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDi 228 (317)
+++++.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999999999999999999986 6789999999999999987643 56999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccc
Q 042913 229 KPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSV 308 (317)
Q Consensus 229 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (317)
||+|||++.++.+||+|||+++.......... ...++..|++||....... .......|+|+++++++
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~----------~~~gt~~y~aPE~~~~~~~--~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLS----------NTVGTPAFMAPESLSETRK--IFSGKALDVWAMGVTLY 231 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEEC----------CCCSCGGGCCGGGCCTTCC--CEESHHHHHHHHHHHHH
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccccc----------CCcCCccccChhhhccCCC--CCCCchhhhHhHHHHHH
Confidence 99999999999999999999987654432211 1235556777776543221 11256789999999999
Q ss_pred ccCCC
Q 042913 309 EQPGG 313 (317)
Q Consensus 309 e~~~G 313 (317)
|+..|
T Consensus 232 ~l~~g 236 (298)
T 2zv2_A 232 CFVFG 236 (298)
T ss_dssp HHHHS
T ss_pred HHHHC
Confidence 99998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=292.85 Aligned_cols=203 Identities=28% Similarity=0.397 Sum_probs=172.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..++|++.+.||+|+||.||+|.+.. +++.||+|++.+..... .....+.+|+++|+.++||||+++++++...+
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 44677899999999999999999999887 89999999997654322 34466889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999976655569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 338 ~~~~~-----------~~~~GT~~Y~APEvl~~-----~~~~~~~DiwSLGvilyeLltG~ 382 (576)
T 2acx_A 338 EGQTI-----------KGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQ 382 (576)
T ss_dssp TTCCE-----------ECCCSCGGGCCHHHHTT-----CEESSHHHHHHHHHHHHHHHHSS
T ss_pred cCccc-----------cccCCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCC
Confidence 43221 11134555666665543 34567899999999999999994
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=269.98 Aligned_cols=200 Identities=21% Similarity=0.280 Sum_probs=165.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+.+++.++||||+++++++..++.+++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999887 789999999987655555667888999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 80 FEFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 99995 5666665443 467999999999999999999999999999999999999999999999999999876533221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ...++..|++||..... .......|+|++|++++|+..| .|
T Consensus 158 ~~----------~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~~~~p 201 (292)
T 3o0g_A 158 YS----------AEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp CC----------SCCSCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred cc----------CCccccCCcChHHHcCC----CCcCchHHHHHHHHHHHHHHHcCCC
Confidence 11 12334556777655321 1246789999999999999965 55
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=276.66 Aligned_cols=199 Identities=24% Similarity=0.355 Sum_probs=166.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++....... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 456899999999999999999999877 78999999997654332 2345788999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 88999988653 67999999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceecc-chhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ....++..|++||... .... ....|+|++|++++|+..| .|
T Consensus 162 ~~~-----------~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~P 207 (336)
T 3h4j_B 162 NFL-----------KTSCGSPNYAAPEVIN-----GKLYAGPEVDVWSCGIVLYVMLVGRLP 207 (336)
T ss_dssp BTT-----------CCCTTSTTTSCGGGSC-----CSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccc-----------ccccCCcCcCCHHHHc-----CCCCCCCccchhHHHHHHHHHHhCCCC
Confidence 211 1123445566666543 2222 5789999999999999998 44
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=275.01 Aligned_cols=199 Identities=23% Similarity=0.314 Sum_probs=162.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35799999999999999999999887 789999999965432 2334668899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999999965 46699999999999999999999999999999999999999999999999999976543221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceecc-chhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~G 313 (317)
. .......++..|++||.. ..... ....|+|++|++++|+..|
T Consensus 161 ~--------~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 161 E--------RLLNKMCGTLPYVAPELL-----KRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp E--------CCBCSCCSCGGGSCHHHH-----HCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred c--------cccCCCccCcCccCcHHh-----ccCCCCCCcccHHHHHHHHHHHHhC
Confidence 1 001112344556666654 32232 5679999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=274.74 Aligned_cols=205 Identities=20% Similarity=0.282 Sum_probs=166.7
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+..++|++.+.||+|+||.||+|.+... .+..||||++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 457789999999999999999999998641 23459999997643 445567889999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999654 357999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........... ...++..|++||.. .........|+|+++++++|+.. |
T Consensus 202 ~~~~~~~~~~~-------~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 202 EDDPDAAYTTT-------GGKIPIRWTAPEAI-----AFRTFSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp C----CCEECC----------CCGGGSCHHHH-----HHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred ccCccceeecc-------CCCCcccccCHhHh-----cCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 55432211111 11223346666654 33445678999999999999987 7
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=289.21 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=172.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..++|++.+.||+|+||+||+|.+.. +++.||+|++.+..... .....+.+|+++++.++||||+++++++....
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 34667899999999999999999999877 89999999998754332 34567889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999886542 45699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... ...++..|++||.... .......|+|++|++++|+..|.
T Consensus 339 ~~~~~~~~~----------~~~GT~~Y~APE~l~~-----~~~~~~~DiwSlGvilyelltG~ 386 (543)
T 3c4z_A 339 LKAGQTKTK----------GYAGTPGFMAPELLLG-----EEYDFSVDYFALGVTLYEMIAAR 386 (543)
T ss_dssp CCTTCCCBC----------CCCSCTTTSCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcccc----------cccCCccccChhhhcC-----CCCChHHhcCcchHHHHHHHhCC
Confidence 654332211 1234556777776543 34567899999999999999993
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=286.19 Aligned_cols=204 Identities=21% Similarity=0.354 Sum_probs=172.4
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
...+.+..++|++++.||+|+||.||+|.+.. +++.||||++....... .....+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34567888999999999999999999999887 79999999997653322 34567899999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
..+.+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 99999999999999999999965 4679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ . ...++..|++||...... ......|+|++|++++|+.+|
T Consensus 165 ~~~~~~~~-~----------~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~elltG 212 (476)
T 2y94_A 165 MMSDGEFL-R----------TSCGSPNYAAPEVISGRL----YAGPEVDIWSSGVILYALLCG 212 (476)
T ss_dssp ECCTTCCB-C----------CCCSCSTTCCHHHHTTCC----BCSHHHHHHHHHHHHHHHHHS
T ss_pred hccccccc-c----------ccCCCcCeEChhhccCCC----CCCCcceehhhHHHHHHHhhC
Confidence 76442211 1 123455677777654321 124689999999999999999
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=277.23 Aligned_cols=202 Identities=21% Similarity=0.284 Sum_probs=166.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA---KKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3455789999999999999999998887 88999999997543211 1356789999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc---EEEeeec
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH---IMLSDFD 247 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~---~kl~DFG 247 (317)
+.+|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999998877543 2345899999999999999999999999999999999999986654 9999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+++.......... ...++..|++||.... .......|+|+++++++|+..|
T Consensus 179 ~a~~~~~~~~~~~----------~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 179 VAIQLGESGLVAG----------GRVGTPHFMAPEVVKR-----EPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp TCEECCTTSCBCC----------CCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS
T ss_pred ceeEecCCCeeec----------CCcCCcCccCHHHHcC-----CCCCchHhhHHHHHHHHHHHHC
Confidence 9987654332111 1234556666665543 3346789999999999999999
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.80 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=159.0
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEc--CCCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLR--DCTSANFALKVVDKDLLS--AKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|... ..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3567789999999999999999999875 236899999999765322 234566788999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
..+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999999653 568999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 170 ~~~~~~~~~----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~ 218 (327)
T 3a62_A 170 ESIHDGTVT----------HTFCGTIEYMAPEILMR-----SGHNRAVDWWSLGALMYDMLTGA 218 (327)
T ss_dssp -------------------CTTSSCCTTSCHHHHTT-----SCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCccc----------cccCCCcCccCHhhCcC-----CCCCCcccchhHHHHHHHHHHCC
Confidence 643322211 11235566777776543 23467899999999999999993
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=271.70 Aligned_cols=202 Identities=17% Similarity=0.256 Sum_probs=163.1
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+..++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+++++.++||||+++++++...+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC---CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34567789999999999999999999764 688999999877666777788999999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+|+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999965421 23899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ .....++..|++||.... .....++|+|+++++++|+..|
T Consensus 188 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg 235 (309)
T 3p86_A 188 LKASTFLS----------SKSAAGTPEWMAPEVLRD-----EPSNEKSDVYSFGVILWELATL 235 (309)
T ss_dssp ------------------------CCTTSCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHC
T ss_pred cccccccc----------cccCCCCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhC
Confidence 54332211 111245556777776543 3346789999999999999988
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.27 Aligned_cols=203 Identities=27% Similarity=0.506 Sum_probs=160.2
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..+..++|++++.||+|+||.||+|.+.. +++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34567899999999999999999999887 899999999986543 2345567888999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+|+..
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999999999653 679999999999999999999998 99999999999999999999999999999864
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
........ ...++..|++||.. .........|+|++|++++|+..| .|
T Consensus 300 ~~~~~~~~----------~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~P 348 (446)
T 4ejn_A 300 IKDGATMK----------TFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLP 348 (446)
T ss_dssp CC-----C----------CSSSCGGGCCHHHH-----HTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcccc----------cccCCccccCHhhc-----CCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 33222111 12345566666654 333456889999999999999998 44
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.06 Aligned_cols=198 Identities=22% Similarity=0.301 Sum_probs=166.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34689999999999999999999887 78999999997653221 13467889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeeccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLC 249 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a 249 (317)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999999954 46799999999999999999999999999999999999999877 8999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+........ ....++..|++||... ........|+|+++++++|+..|.
T Consensus 166 ~~~~~~~~~-----------~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~ 214 (326)
T 2y0a_A 166 HKIDFGNEF-----------KNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGA 214 (326)
T ss_dssp EECCTTSCC-----------CCCCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred eECCCCCcc-----------ccccCCcCcCCceeec-----CCCCCcHHHHHHHHHHHHHHHHCc
Confidence 876543211 1123555677776553 334567899999999999999983
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.29 Aligned_cols=215 Identities=21% Similarity=0.266 Sum_probs=178.1
Q ss_pred CcchhhHHHhhccCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC
Q 042913 79 DLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158 (317)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~ 158 (317)
.++..++..+++...........|...+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCC
Confidence 356777777776655554455568899999999999999999876 78999999997543 233466889999999999
Q ss_pred CCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 159 h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999999854 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+.+||+|||+++......... ....++..|++||.... .......|+|++|++++|+..|.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~----------~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~ 238 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKR----------KSLVGTPYWMAPEVISR-----SLYATEVDIWSLGIMVIEMVDGE 238 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCB----------CCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcEEEeeeeeeeecccCcccc----------ccccCCccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999998765432211 12245566777776643 23456899999999999999983
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=276.12 Aligned_cols=196 Identities=19% Similarity=0.278 Sum_probs=166.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.....+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4789999999999999999999887 78999999997652 33445788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc--CCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE--DGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~--~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999998654 356999999999999999999999999999999999999974 5789999999998765433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ...++..|++||.... ......+|+|++|++++|+..|.
T Consensus 206 ~~~-----------~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 206 IVK-----------VTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp CEE-----------EECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSC
T ss_pred cee-----------eeccCCCccCchhccC-----CCCCCcccEeeHhHHHHHHHhCC
Confidence 211 1134556777776543 33467899999999999999993
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.96 Aligned_cols=210 Identities=17% Similarity=0.231 Sum_probs=161.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH----- 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 173 (317)
.++|++++.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4789999999999999999999886 78999999997543 2344577899999999999999999999985543
Q ss_pred ----------------------------------------------------EEEEEEcccCCCChhcccccCCC-CCCC
Q 042913 174 ----------------------------------------------------YICFLIDYCPNGDLHSLLPKQPN-NRFS 200 (317)
Q Consensus 174 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~ 200 (317)
.+++||||+++++|.+++..... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999976422 2346
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccc--ccccccccccccCCC
Q 042913 201 LQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNV--GSATRRRRRKSCNGF 278 (317)
Q Consensus 201 ~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 278 (317)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+............. ..........++..|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 667899999999999999999999999999999999999999999999987765432111100 000111122344455
Q ss_pred CCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 279 GSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 279 ~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
++||.. .........|+|++|++++|+..|.+
T Consensus 243 ~aPE~~-----~~~~~~~~~Di~slG~il~el~~~~~ 274 (332)
T 3qd2_B 243 MSPEQI-----HGNNYSHKVDIFSLGLILFELLYSFS 274 (332)
T ss_dssp SCHHHH-----HCCCCCTHHHHHHHHHHHHHHHSCCC
T ss_pred cChHHh-----cCCCCcchhhHHHHHHHHHHHHHcCC
Confidence 555544 44455688999999999999998853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.97 Aligned_cols=201 Identities=18% Similarity=0.241 Sum_probs=163.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+...++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+++++.++||||+++++++...+.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 445689999999999999999999885 489999999976644445567788999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999995 5888877654 356999999999999999999999999999999999999999999999999999876533
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... ....++..|++||..... .......|+|++|++++|+..|.
T Consensus 173 ~~~~----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 173 VRSY----------THEVVTLWYRAPDVLMGS----KKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp CC-------------CCCCCCTTCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccc----------cCCcccCCcCCHHHhcCC----CCCCchHHhHHHHHHHHHHHhCC
Confidence 2211 112345667777765321 23357899999999999999984
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.31 Aligned_cols=205 Identities=19% Similarity=0.230 Sum_probs=166.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC--
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-- 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 173 (317)
....++|++.+.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 3456889999999999999999999887 789999999976432 233466789999999999999999999988655
Q ss_pred EEEEEEcccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE----ccCCcEEEeeecc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----REDGHIMLSDFDL 248 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----~~~~~~kl~DFG~ 248 (317)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999997642 2338999999999999999999999999999999999999 7778899999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCccccccccc---ceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM---EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~---~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+........ ....++..|++||....... .........|+|+++++++|+..|
T Consensus 163 a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 163 ARELEDDEQF-----------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp CEECCTTCCB-----------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ceecCCCCce-----------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 9876543321 11235556777775432111 123456789999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=273.34 Aligned_cols=204 Identities=22% Similarity=0.314 Sum_probs=165.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 175 (317)
+..++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+|+++++.+ +|+||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECC-CCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 455789999999999999999999876 789999999875422 23578899999999 899999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc-----EEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH-----IMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~-----~kl~DFG~a~ 250 (317)
++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+|+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999999 99999999764 467999999999999999999999999999999999999998887 9999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.+.......... ........++..|++||.. .......++|+|++|++++|+..| .|
T Consensus 159 ~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~g~~P 216 (330)
T 2izr_A 159 EYIDPETKKHIP---YREHKSLTGTARYMSINTH-----LGKEQSRRDDLEALGHMFMYFLRGSLP 216 (330)
T ss_dssp ESBCTTTCCBCC---CCCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeecCCCCcccc---ccccCCcCCCccccChHHH-----cCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 764433211100 0011122344555555544 444557899999999999999999 44
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.63 Aligned_cols=200 Identities=18% Similarity=0.221 Sum_probs=164.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 173 (317)
+.+..++|+++++||+|+||+||+|.+.. +++.||||++...............|+..+..+ +|+||+++++++...+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 45566889999999999999999999887 789999999876544555555555666655554 8999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999999999 88999888654 3569999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... .....++.+|++||.... ......|+|+++++++|+.+|.
T Consensus 209 ~~~~-----------~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 209 TAGA-----------GEVQEGDPRYMAPELLQG------SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp -----------------CCCCCGGGCCGGGGGT------CCSTHHHHHHHHHHHHHHHHTC
T ss_pred cCCC-----------CcccCCCccccCHhHhcC------CCCchhhHHHHHHHHHHHHhCC
Confidence 3221 111235667888887643 2456899999999999999983
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=261.29 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=168.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999998887 78999999998876677777889999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc---EEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH---IMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~---~kl~DFG~a~~~~~ 254 (317)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 83 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999888653 56899999999999999999999999999999999999986655 99999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ....++..|++||... ........|+|+++++++|+..|
T Consensus 161 ~~~~-----------~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g 203 (284)
T 3kk8_A 161 SEAW-----------HGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVG 203 (284)
T ss_dssp SCBC-----------CCSCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHS
T ss_pred Cccc-----------cCCCCCcCCcCchhhc-----CCCCCcccchHHHHHHHHHHHHC
Confidence 3211 1123445566666543 33456789999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=270.93 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=170.2
Q ss_pred cCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-----CCCcceE
Q 042913 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-----HPFLPTL 165 (317)
Q Consensus 91 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~ 165 (317)
.+..+.+..++|++++.||+|+||.||+|.+.. +++.||||++... ......+..|+++++.+. ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 356777888999999999999999999999877 7899999999643 344566788999999986 9999999
Q ss_pred EEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc--------
Q 042913 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-------- 237 (317)
Q Consensus 166 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-------- 237 (317)
++++...+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 999999998776667999999999999999999999999999999999999975
Q ss_pred -----------------CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhc
Q 042913 238 -----------------DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQR 300 (317)
Q Consensus 238 -----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~ 300 (317)
++.+||+|||+|+....... ...++..|++||... ........|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-------------~~~gt~~y~aPE~~~-----~~~~~~~~Di 242 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-------------SIINTRQYRAPEVIL-----NLGWDVSSDM 242 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-------------SCCSCGGGCCHHHHT-----TCCCCTTHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCCc-------------CccCcccccCcHHHc-----CCCCCCccch
Confidence 78999999999976433211 123445566666554 3345678999
Q ss_pred cCCcccccccCCCC
Q 042913 301 EHPAQYSVEQPGGV 314 (317)
Q Consensus 301 ~~~~~~~~e~~~G~ 314 (317)
|++|++++|+..|-
T Consensus 243 wslG~il~ell~g~ 256 (360)
T 3llt_A 243 WSFGCVLAELYTGS 256 (360)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHCC
Confidence 99999999999993
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=267.70 Aligned_cols=206 Identities=22% Similarity=0.296 Sum_probs=163.2
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEE---cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHL---RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
...+..++|++++.||+|+||.||+|.+ ...+++.||+|++... .....+.+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467789999999999999999999985 2337899999999754 4556678999999999999999999999985
Q ss_pred e--cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecc
Q 042913 171 V--SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 171 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
. ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 45689999999999999999765 34589999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
|+........... .....++..|++||... ......++|+|+++++++|+..|.
T Consensus 161 ~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 161 TKVLPQDKEFFKV-------KEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp CC--------------------CTTCGGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred cccccCCcceeee-------ccCCCCccceeCcHHhc-----CCCCChHHHHHHHHHHHHHHHhcc
Confidence 9876543321110 11112333467776553 334567899999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.36 Aligned_cols=196 Identities=16% Similarity=0.214 Sum_probs=160.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++..........+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 45899999999999999999998887 799999999987766677778899999999999999999999999644
Q ss_pred -CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 -HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
..+|+||||++ +.|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 139 ~~~~~lv~E~~~-~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CCeEEEEEeCCC-CCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 46899999995 55777663 2489999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...... .....++..|++||.... .......|+|++|++++|+..|-|
T Consensus 214 ~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 214 AGTSFM-----------MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp ---CCC-----------C----CCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcc-----------cCCCcccccccCHHHHcC-----CCCCHHHHHHHHHHHHHHHHhCCC
Confidence 543221 112245566777776643 234578999999999999999843
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.61 Aligned_cols=198 Identities=23% Similarity=0.285 Sum_probs=164.5
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||+|.+.. ++.||+|++....... +.+.+|+++++.++||||+++++++...+..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEecC--CCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4667899999999999999999998874 7789999998654333 4588899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999654 356899999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
... ......++..|++||.. ........+|+|+++++++|+.. |
T Consensus 160 ~~~---------~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~ll~~g 204 (269)
T 4hcu_A 160 QYT---------SSTGTKFPVKWASPEVF-----SFSRYSSKSDVWSFGVLMWEVFSEG 204 (269)
T ss_dssp HHH---------STTSTTCCGGGCCHHHH-----HHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccc---------cccCcccccccCCHHHh-----cCCCCCchhhhHHHHHHHHHHhcCC
Confidence 111 00111223346666654 33445678999999999999987 6
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=272.58 Aligned_cols=204 Identities=20% Similarity=0.231 Sum_probs=162.6
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.....++|++.+.||+|+||.||+|.+.. +++.||||++..... .......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 34557899999999999999999999877 789999999976533 3455678899999999999999999999987543
Q ss_pred ----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 174 ----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 174 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 359999999999999999653 57999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+......... .......++..|++||.... .....+.|+|+++++++|+..|
T Consensus 164 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g 215 (311)
T 3ork_A 164 RAIADSGNSV-------TQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTG 215 (311)
T ss_dssp -------------------------CCTTCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccccccc-------ccccccCcCcccCCHHHhcC-----CCCCchHhHHHHHHHHHHHHhC
Confidence 7664432111 11112245666777776543 3345789999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=278.27 Aligned_cols=208 Identities=19% Similarity=0.244 Sum_probs=164.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++..........+++.+|+++|+.++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35799999999999999999999887 889999999987665667778899999999999999999999998766
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 103 DELYIVLEIA-DSDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CCEEEEEECC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEecC-CcCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 5799999999 5799999965 467999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecc-------ccc-----ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETN-------VGS-----ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~-------~~~-----~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......... .+. ........++..|++||... .........|+|++|++++|+..|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL----LQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHT----TCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHh----cCCCCCcccccchHHHHHHHHHhc
Confidence 5433210000 000 00112234455566666431 223356789999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.41 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=167.7
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
....+..++|++++.||+|+||+||+|.+.. +++.||||++.+.... ....+.+..|..++..+ +|++|+++++++.
T Consensus 334 ~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 334 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp ------CTTEEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccccccceEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 3445778999999999999999999999887 8899999999875332 24456788899999887 6999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
..+.+||||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999999999764 579999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..........+ ..++..|++||.. .........|+|++|++++|+..|.
T Consensus 491 ~~~~~~~~~~~----------~~GT~~Y~APE~l-----~~~~~~~~~DvwSlGvilyelltG~ 539 (674)
T 3pfq_A 491 ENIWDGVTTKT----------FCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQ 539 (674)
T ss_dssp ECCCTTCCBCC----------CCSCSSSCCHHHH-----TCCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCccccc----------ccCCCcccCHhhh-----cCCCCCccceEechHHHHHHHHcCC
Confidence 64332221111 2344566666655 3344578899999999999999994
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=270.98 Aligned_cols=195 Identities=23% Similarity=0.315 Sum_probs=152.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
....++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+++++.++||||+++++++...+.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 3445789999999999999999999887 78999999997542 335678899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecccccC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDLCFQS 252 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~a~~~ 252 (317)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999955 466999999999999999999999999999999999999975 889999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... .....++..|++||.... .......|+|++|++++|+..|
T Consensus 202 ~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 202 EHQVL-----------MKTVCGTPGYCAPEILRG-----CAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp ----------------------CGGGSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS
T ss_pred Ccccc-----------cccccCCCCccCHHHhcC-----CCCCcccchHHHHHHHHHHHhC
Confidence 43211 011234556777776543 2346789999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=265.78 Aligned_cols=203 Identities=23% Similarity=0.265 Sum_probs=159.0
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc---HHHHHHHHHHHHHHHhc---CCCCcceEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---AKKLSHVQMEAEILSML---DHPFLPTLYAH 168 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~ 168 (317)
+.+..++|++++.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+.+++.+ +||||++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 34567899999999999999999998776 7899999998743211 11123455666666655 59999999999
Q ss_pred EEecC-----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEE
Q 042913 169 LEVSH-----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIML 243 (317)
Q Consensus 169 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl 243 (317)
+.... .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEECCSSSEEEEEEEEECC-CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred eeccCCCCceeEEEEehhh-hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence 98755 589999999 579999998766566999999999999999999999999999999999999999999999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+|||+|+........ ....++..|++||.... .......|+|+++++++|+..|.|
T Consensus 162 ~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 162 ADFGLARIYSYQMAL-----------TPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp CSCSCTTTSTTCCCS-----------GGGGCCCSSCCHHHHHT-----SCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred eeCccccccCCCccc-----------CCccccccccCchHHcC-----CCCCchHHHHHHHHHHHHHHhCCC
Confidence 999999865432211 12245566777776543 234568999999999999999944
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=271.36 Aligned_cols=194 Identities=22% Similarity=0.333 Sum_probs=157.3
Q ss_pred CeEE--eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 101 HLKL--VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i--~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.|.+ .+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++...+.+++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETT-TCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcC-CCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4554 6789999999999999877 7899999999765 234557789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE--ccCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL--REDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill--~~~~~~kl~DFG~a~~~~~~~ 256 (317)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999988653 3468999999999999999999999999999999999999 566799999999998765432
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. ....++..|++||... ........|+|+++++++|+..|.
T Consensus 244 ~~-----------~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 244 KL-----------KVNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp BC-----------CCCCSSCTTCCHHHHT-----TCBCCHHHHHHHHHHHHHHHHHSS
T ss_pred cc-----------ccccCCCcEeChhhcc-----CCCCCcHHhHHHHHHHHHHHHhCC
Confidence 11 1123556677777553 334567899999999999999993
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=260.03 Aligned_cols=200 Identities=21% Similarity=0.270 Sum_probs=165.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++++.||+|+||.||+|.+.. +..||+|++....... +.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG--QYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC--ceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 4667899999999999999999998774 7789999997654333 4578899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999654 345899999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
..... . ...++..|++||.. .........|+|+++++++|+.. | .|
T Consensus 158 ~~~~~--~-------~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~~g~~p 205 (268)
T 3sxs_A 158 QYVSS--V-------GTKFPVKWSAPEVF-----HYFKYSSKSDVWAFGILMWEVFSLGKMP 205 (268)
T ss_dssp CEEEC--C-------SCCCCGGGCCHHHH-----HHSEEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred hhhcc--c-------CCCcCcccCCHHHH-----hccCCchhhhhHHHHHHHHHHHcCCCCC
Confidence 32111 1 11223346666654 44445678999999999999987 7 44
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=265.08 Aligned_cols=204 Identities=18% Similarity=0.206 Sum_probs=173.4
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
+....+..++|++.+.||+|+||.||+|.+.. ++..||+|++.... ...+.+.+|+++++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45567788999999999999999999999887 78999999997542 344678899999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999999876667799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... ....++..|++||.... ......+|+|+++++++|+.. |
T Consensus 161 ~~~~~~~~~---------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~~g 209 (288)
T 3kfa_A 161 MTGDTYTAH---------AGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYG 209 (288)
T ss_dssp SCSSSSEEE---------TTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCccccc---------cCCccccCcCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 654332211 11123445777776543 334678999999999999998 7
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=272.26 Aligned_cols=198 Identities=21% Similarity=0.270 Sum_probs=158.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...++|++++.||+|+||.||+|.+.. +++.||||++...... .+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 345789999999999999999999887 7899999999764322 245788999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc--EEEeeecccccCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH--IMLSDFDLCFQSDV 254 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~--~kl~DFG~a~~~~~ 254 (317)
+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999998653 56999999999999999999999999999999999999987665 99999999874322
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... .....++..|++||...... .....+|+|++|++++|+..| .|
T Consensus 171 ~~~-----------~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 171 HSQ-----------PKSTVGTPAYIAPEVLLRQE----YDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp ---------------------CTTSCHHHHHCSS----CCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCC-----------CCCCcCCCCcCChhhhcCCC----CCCCeeeeehhHHHHHHHHhCCCC
Confidence 111 11124556677777653221 123558999999999999999 44
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=274.36 Aligned_cols=210 Identities=21% Similarity=0.266 Sum_probs=157.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC--
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSH-- 173 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-- 173 (317)
...++|++++.||+|+||.||+|.+.. +++.||||++............+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT-TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456899999999999999999999887 8999999999766556677788899999999997 999999999997544
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7999999995 789998865 468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecc-----------cccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETN-----------VGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
......... ...........++..|++||.... ........|+|++|++++|+..|-|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----STKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC----CCCCCChhhHHHHHHHHHHHHhCCC
Confidence 422111100 000011112234445555554422 1344678999999999999999954
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.89 Aligned_cols=205 Identities=22% Similarity=0.270 Sum_probs=168.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+..++|++.+.||+|+||.||+|.+.. ..+..||+|++.... .......+.+|+++++.+ +||||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 35677899999999999999999998753 133579999997653 456667899999999999 8999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999997643 24589999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG- 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~- 312 (317)
|++.++.+||+|||+|+........... ....++..|++||... ......+.|+|+++++++|+..
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~--------~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKT--------TNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCC--------TTCCCGGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEcccCcccccccccccccc--------cCCCCCcceeCHHHhc-----CCCCCchhHHHHHHHHHHHHHhC
Confidence 9999999999999999866543221111 1112334566666553 3345678999999999999987
Q ss_pred C
Q 042913 313 G 313 (317)
Q Consensus 313 G 313 (317)
|
T Consensus 290 g 290 (382)
T 3tt0_A 290 G 290 (382)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=261.24 Aligned_cols=199 Identities=19% Similarity=0.287 Sum_probs=166.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+.++..+ +||||+++++++...+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35789999999999999999999886 789999999987654455567788999999999 8999999999999999999
Q ss_pred EEEcccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC----------------
Q 042913 177 FLIDYCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED---------------- 238 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~---------------- 238 (317)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999996532 2568999999999999999999999999999999999999844
Q ss_pred ---CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 239 ---GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 239 ---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
..+||+|||++........ ..++..|++||....+ .......|+|+++++++|+..|.|
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~--------------~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQV--------------EEGDSRFLANEVLQEN----YTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --CCCEEECCCTTCEETTCSCC--------------CCCCGGGCCHHHHTTC----CTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCceEEEEcccccccccCCccc--------------cCCCccccChhHhcCC----CCCCchhhHHHHHHHHHHHhcCCC
Confidence 4799999999987654321 1355567777765432 123468999999999999999965
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=264.96 Aligned_cols=199 Identities=22% Similarity=0.257 Sum_probs=164.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 4789999999999999999999887 789999999977655556677889999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 81 ~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999988854 366999999999999999999999999999999999999999999999999999876543322
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. ...++..|++||..... .......|+|++|++++|+..|.
T Consensus 159 ~~----------~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~ 200 (311)
T 4agu_A 159 YD----------DEVATRWYRSPELLVGD----TQYGPPVDVWAIGCVFAELLSGV 200 (311)
T ss_dssp -----------------GGGCCHHHHHTC----SCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cC----------CCcCCccccChHHHhcC----CCCCcchhhHHHHHHHHHHHhCC
Confidence 11 12344557777765321 23357899999999999999994
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=276.55 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=166.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhh--cHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLL--SAKKLSHVQMEAEILSML-DHPFLPTLYAHL 169 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 169 (317)
..+..++|++++.||+|+||.||+|.... .+++.||||++..... .....+.+.+|+++++.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 34566899999999999999999998842 3689999999865421 112334567799999999 699999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
...+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999653 56999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+........ ......++..|++||...... .....+.|+|+++++++|+..|
T Consensus 207 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 207 KEFVADETE---------RAYDFCGTIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp EECCGGGGG---------GGCGGGSCCTTCCHHHHTTCC------CTHHHHHHHHHHHHHHHHS
T ss_pred eecccCCCC---------cccCcccCcCccChhhhcCCC---CCCCchhhHHHHHHHHHHHHHC
Confidence 865432211 111224566788888765321 2235788999999999999999
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=261.71 Aligned_cols=201 Identities=22% Similarity=0.270 Sum_probs=162.9
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
....+..++|++++.||+|+||.||+|.+.. +..||+|++....... +.+.+|+++++.++|+||+++++++...
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETT--TEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcC--CCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 3446777899999999999999999998774 7789999998654333 4578899999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999653 356999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...... ......++..|++||... ........|+|+++++++|+.. |
T Consensus 171 ~~~~~~---------~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 171 LDDEYT---------SSVGSKFPVRWSPPEVLM-----YSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp CCHHHH---------STTSTTSCGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred cccccc---------cccCCccCcccCCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCC
Confidence 432110 011112233466666543 3345678999999999999986 7
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=268.92 Aligned_cols=203 Identities=18% Similarity=0.182 Sum_probs=165.5
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+..+..++|++++.||+|+||.||+|.+. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC---CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 34567789999999999999999999765 5899999997542 22344566899999999999999999998743
Q ss_pred ----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeccCCCCcEEEccCC
Q 042913 174 ----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL----------GIIYRDLKPENILLREDG 239 (317)
Q Consensus 174 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----------~ivHrDikp~Nill~~~~ 239 (317)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 47999999999999999965 4599999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.+||+|||+|+......... ......++..|++||..............+.|+|+++++++|+..|
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAG--------DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp CEEECCCTTCEEECTTSCCC--------CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEccCCcccccccccCcc--------ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 99999999997765433211 1112245667788877654333233445678999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=264.83 Aligned_cols=206 Identities=19% Similarity=0.282 Sum_probs=169.3
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL 169 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 169 (317)
...+..++|++.+.||+|+||.||+|.+.. .++..||+|++.... .....+.+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 446677899999999999999999998742 245789999997543 456667899999999999999999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPN----------------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRD 227 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrD 227 (317)
...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999976422 3489999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccc
Q 042913 228 LKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYS 307 (317)
Q Consensus 228 ikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (317)
|||+|||++.++.+||+|||+++........... ....++..|++||.. .......+.|+|++++++
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR--------SQGRIPVKWMAIESL-----FDHIYTTQSDVWSFGVLL 242 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECS--------SCCCSCGGGCCHHHH-----HHCEECHHHHHHHHHHHH
T ss_pred cchheEEEcCCCCEEEccccccccccccccceec--------cCCCCcccccChhhh-----cCCCcCchhhHHHHHHHH
Confidence 9999999999999999999999876544322111 111223346666654 334456789999999999
Q ss_pred cccCC-C
Q 042913 308 VEQPG-G 313 (317)
Q Consensus 308 ~e~~~-G 313 (317)
+|+.. |
T Consensus 243 ~el~t~g 249 (314)
T 2ivs_A 243 WEIVTLG 249 (314)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 99997 7
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=265.20 Aligned_cols=198 Identities=20% Similarity=0.267 Sum_probs=162.6
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+++++.++||||+++++++...+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 68999999999999999999884 5899999999765434444467889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 80 EHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp ECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9995 5998888654 3668999999999999999999999999999999999999999999999999997654322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....++..|++||..... .......|+|++|++++|+..|.|
T Consensus 158 ----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~ 199 (288)
T 1ob3_A 158 ----------THEIVTLWYRAPDVLMGS----KKYSTTIDIWSVGCIFAEMVNGTP 199 (288)
T ss_dssp --------------CCCTTCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------ccccccccccCchheeCC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 112345668888765321 124578999999999999999943
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=272.98 Aligned_cols=200 Identities=18% Similarity=0.194 Sum_probs=163.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEE-----EcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC---CCCcceEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCH-----LRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD---HPFLPTLYA 167 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~ 167 (317)
.+..++|++.+.||+|+||.||+|. ... +++.||+|++.... ...+..|+++++.++ |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK-NKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccc-cCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4556889999999999999999995 333 68999999997542 245677888888877 899999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-------
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQ---PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE------- 237 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~------- 237 (317)
++...+..|+||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999999642 3467999999999999999999999999999999999999998
Q ss_pred ----CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 238 ----DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 238 ----~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
++.+||+|||+|+........ .......++.+|++||..... ......|+|++|++++|+..|
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKG--------TIFTAKCETSGFQCVEMLSNK-----PWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTT--------EEECCSSCTTSCCCHHHHTTC-----CBSTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCEEEeeCchhhhhhccCCC--------ceeeeecCCCCCCChHHhcCC-----CCCccccHHHHHHHHHHHHhC
Confidence 899999999999754322111 111223466778888766432 346899999999999999999
Q ss_pred C
Q 042913 314 V 314 (317)
Q Consensus 314 ~ 314 (317)
-
T Consensus 282 ~ 282 (365)
T 3e7e_A 282 T 282 (365)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=268.39 Aligned_cols=204 Identities=20% Similarity=0.250 Sum_probs=165.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++| +||+++++++...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 355678999999999999999999875 48899999998776667777889999999999986 99999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+|||+. +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 83 YIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEECCC-SEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999954 89999999764 6799999999999999999999999999999999999997 6889999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCccccccccc------ceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM------EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~------~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ......++..|++||....... .........|+|++|++++|+..|
T Consensus 159 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 159 PDTTSV--------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp -------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred cccccc--------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 432211 1112246677888887643111 113346789999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=281.63 Aligned_cols=203 Identities=17% Similarity=0.228 Sum_probs=170.4
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
....+...+|++.+.||+|+||.||+|.+.. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3456777899999999999999999999886 788999999976532 346788999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999998765677999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...... .. ....+...|++||... ......+.|+|+++++++|+.. |
T Consensus 369 ~~~~~~--~~-------~~~~~~~~y~aPE~~~-----~~~~~~~sDvwSlG~~l~el~t~g 416 (495)
T 1opk_A 369 TGDTYT--AH-------AGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYG 416 (495)
T ss_dssp TTCCEE--CC-------TTCCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cCCcee--ec-------CCCcCCcceeCHhHHh-----cCCCCcHHhHHhHHHHHHHHHhCC
Confidence 432211 00 0112234577777653 3345678999999999999997 6
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=268.96 Aligned_cols=208 Identities=22% Similarity=0.288 Sum_probs=150.3
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCc---eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA---NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH 168 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 168 (317)
.....+..++|++.+.||+|+||.||+|.+.. ++. .||+|++..........+.+.+|+++++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ-EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcc-cCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34556777899999999999999999998776 333 79999998765455667889999999999999999999999
Q ss_pred EEecCEE------EEEEcccCCCChhcccccCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 169 LEVSHYI------CFLIDYCPNGDLHSLLPKQP----NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 169 ~~~~~~~------~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
+...... ++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9876655 99999999999999985421 2258999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
+.+||+|||+|+........ ...+...+++.|..++.........++|+|++|++++|+.. |
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYY-------------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp SCEEECCCCC------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCEEEeeccccccccccccc-------------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence 99999999999865443211 11222223334444444444445688999999999999888 6
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.45 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=154.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.++|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4789999999999999999998876 78999999997653322 334678999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999999999998654 36789999999999999999999999999999999999999999999999999987653321
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. ....++..|++||.... .......|+|+++++++|+..|.
T Consensus 168 ~~----------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 209 (278)
T 3cok_A 168 KH----------YTLCGTPNYISPEIATR-----SAHGLESDVWSLGCMFYTLLIGR 209 (278)
T ss_dssp ---------------------------------------CTHHHHHHHHHHHHHHSS
T ss_pred cc----------eeccCCCCcCCcchhcC-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 11 11234556777776543 34467899999999999999883
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=262.06 Aligned_cols=207 Identities=22% Similarity=0.294 Sum_probs=165.6
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEE---cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHL---RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL 169 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 169 (317)
....+..++|++++.||+|+||.||+|.+ ...+++.||+|++.... .....+.+.+|+++++.++||||+++++++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 34456678899999999999999999984 23378999999997543 234456789999999999999999999999
Q ss_pred Eec--CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeec
Q 042913 170 EVS--HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247 (317)
Q Consensus 170 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG 247 (317)
... ..+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 876 6789999999999999999554 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+|+........... .....++..|++||.. .........|+|+++++++|+..|
T Consensus 172 ~~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 172 LTKAIETDKEYYTV-------KDDRDSPVFWYAPECL-----MQSKFYIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp TCEECCTTCCEEEC-------CCCTTCCGGGCCHHHH-----HHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ccccccCCCcceec-------cCCCCCCccccCCeee-----cCCCCCcchhHHHHHHHHHHHHHc
Confidence 99877654322111 1112333446666654 333455789999999999999988
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=260.58 Aligned_cols=199 Identities=24% Similarity=0.349 Sum_probs=166.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 4667899999999999999999999887 78899999997654332 335678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999998653 5689999999999999999999999999999999999999999999999999865433
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ....++..|++||.... .......|+|+++++++|+..|.
T Consensus 162 ~~~------------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 204 (279)
T 3fdn_A 162 SRR------------TDLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGK 204 (279)
T ss_dssp ------------------CCCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccc------------cccCCCCCccCHhHhcc-----CCCCccchhHhHHHHHHHHHHCC
Confidence 221 11234556777776533 34457899999999999999983
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=275.53 Aligned_cols=205 Identities=19% Similarity=0.230 Sum_probs=166.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC--
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-- 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 173 (317)
....++|++.+.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|+++++.++||||+++++++...+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3456899999999999999999999887 789999999976432 233466788999999999999999999998655
Q ss_pred EEEEEEcccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE----ccCCcEEEeeecc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----REDGHIMLSDFDL 248 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----~~~~~~kl~DFG~ 248 (317)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997542 2338999999999999999999999999999999999999 7777899999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccc---eeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME---FVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~---~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+........ ....++..|++||........ ........|+|++|++++|+..|
T Consensus 163 a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 163 ARELEDDEQF-----------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp CEECCCGGGS-----------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred ceEccCCCcc-----------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 9876443211 112456667777765432211 13446789999999999999999
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.61 Aligned_cols=197 Identities=22% Similarity=0.294 Sum_probs=165.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45789999999999999999999887 78999999997653221 13467889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeeccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLC 249 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a 249 (317)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999999965 46789999999999999999999999999999999999999887 7999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+........ ....++..|++||.. .........|+|+++++++|+..|
T Consensus 167 ~~~~~~~~~-----------~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g 214 (321)
T 2a2a_A 167 HEIEDGVEF-----------KNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSG 214 (321)
T ss_dssp EECCTTCCC-----------CCCCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eecCccccc-----------cccCCCCCccCcccc-----cCCCCCCccccHHHHHHHHHHHHC
Confidence 876543211 111344456666654 334456789999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=273.57 Aligned_cols=207 Identities=22% Similarity=0.268 Sum_probs=160.2
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+..++|++.+.||+|+||.||+|.+.. ..+..||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 35677899999999999999999998762 256789999997653 455667899999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999754 456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
........+.. ...++..|++||.... .....+.|+|++|++++|+.. | .|
T Consensus 198 ~~~~~~~~~~~-------~~~~~~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 198 EDDPEAAYTTR-------GGKIPIRWTSPEAIAY-----RKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp -----------------------CTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred ccCCccceecc-------CCCcCCCccChhhhcc-----CCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 54332211111 1122345777776543 334578999999999999775 6 44
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.04 Aligned_cols=199 Identities=21% Similarity=0.300 Sum_probs=169.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+.+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45789999999999999999999887 789999999976532 3456678899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 118 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999998653 568999999999999999999999999999999999999999999999999998764332
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. .....++..|++||.... .......|+|+++++++|+..|.
T Consensus 196 ~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 196 ER----------KKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp CC----------BCCCCSCCSSCCHHHHHT-----SCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cc----------ccccCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHHCc
Confidence 21 111245556777776543 33467899999999999999983
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.93 Aligned_cols=197 Identities=27% Similarity=0.381 Sum_probs=166.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++............+.+|+++++.++||||+++++++.....+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999887 78999999997654444456778999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc---cCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~---~~~~~kl~DFG~a~~~~~ 254 (317)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999988653 5799999999999999999999999999999999999995 456899999999986644
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.... ....++..|++||..... .....|+|++|++++|+..|.
T Consensus 177 ~~~~-----------~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~~ll~g~ 219 (486)
T 3mwu_A 177 NTKM-----------KDRIGTAYYIAPEVLRGT------YDEKCDVWSAGVILYILLSGT 219 (486)
T ss_dssp C---------------CCTTGGGGCCGGGGGSC------CCHHHHHHHHHHHHHHHHHSS
T ss_pred CCcc-----------CCCcCCCCCCCHHHhCCC------CCchhhHHHHHHHHHHHHhCC
Confidence 3211 112455667777765432 456899999999999999993
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=268.24 Aligned_cols=205 Identities=21% Similarity=0.272 Sum_probs=168.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.+..++|++++.||+|+||.||+|.+.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 5667899999999999999999998874 245899999997653 44556789999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQP----------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLK 229 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDik 229 (317)
.+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999987642 1568999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccc
Q 042913 230 PENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVE 309 (317)
Q Consensus 230 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e 309 (317)
|+|||++.++.+||+|||+++......... ......++..|++||... ......+.|+|+++++++|
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYK--------ADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCcccc--------ccCCCcccceecChhhhc-----cCCcCcccccHHHHHHHHH
Confidence 999999999999999999997654322110 011123344567776543 3345678999999999999
Q ss_pred cCC-CC
Q 042913 310 QPG-GV 314 (317)
Q Consensus 310 ~~~-G~ 314 (317)
+.. |.
T Consensus 269 l~t~g~ 274 (343)
T 1luf_A 269 IFSYGL 274 (343)
T ss_dssp HHTTTC
T ss_pred HHhcCC
Confidence 997 73
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.59 Aligned_cols=203 Identities=20% Similarity=0.336 Sum_probs=165.0
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
..+.+..++|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECC-CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3567788999999999999999999999876 78999999997653222 345678899999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999999999653 5689999999999999999999999999999999999999999999999999977
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... ....++..|++||...... ......|+|+++++++|+..|
T Consensus 161 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g 207 (276)
T 2h6d_A 161 MSDGEFL-----------RTSCGSPNYAAPEVISGRL----YAGPEVDIWSCGVILYALLCG 207 (276)
T ss_dssp CCC------------------------CCTGGGTTSC----CCHHHHHHHHHHHHHHHHHHS
T ss_pred cCCCcce-----------ecccCCccccCHHHHcCCC----CCCccchHHHHHHHHHHHHhC
Confidence 6432211 1123455677777654321 125789999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=269.14 Aligned_cols=204 Identities=21% Similarity=0.272 Sum_probs=165.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+. ..+++.||||++.... .....+.+.+|+++++.+ +||||+++++++.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456789999999999999999999853 2366899999997643 445567889999999999 7899999999988
Q ss_pred ecC-EEEEEEcccCCCChhcccccCCC-----------------------------------------------------
Q 042913 171 VSH-YICFLIDYCPNGDLHSLLPKQPN----------------------------------------------------- 196 (317)
Q Consensus 171 ~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 196 (317)
..+ .+++||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 754 48999999999999999876432
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeeeccccc
Q 042913 197 -----------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265 (317)
Q Consensus 197 -----------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 265 (317)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~----- 251 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR----- 251 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE-----
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh-----
Confidence 1289999999999999999999999999999999999999999999999999986644332111
Q ss_pred ccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 266 ATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 266 ~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.....++..|++||.... .......|+|+++++++|+.. |
T Consensus 252 ---~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g 292 (359)
T 3vhe_A 252 ---KGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLG 292 (359)
T ss_dssp ---C--CEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ---ccccCCCceeEChhhhcC-----CCCCchhhhhhHHHHHHHHHhcC
Confidence 111234456777776542 334578999999999999997 7
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.18 Aligned_cols=191 Identities=19% Similarity=0.294 Sum_probs=149.5
Q ss_pred CCeEEe---eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEE
Q 042913 100 RHLKLV---RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 100 ~~y~i~---~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 175 (317)
++|.+. +.||+|+||.||+|.+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKK-SNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETT-TCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECC-CCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 456664 779999999999999887 7899999999754 2356778999999997 99999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEEeeecccccC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIMLSDFDLCFQS 252 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl~DFG~a~~~ 252 (317)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999764 6799999999999999999999999999999999999998765 8999999999865
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........+ ..++..|++||... ........|+|++|++++|+..|
T Consensus 160 ~~~~~~~~~----------~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g 205 (325)
T 3kn6_A 160 PPDNQPLKT----------PCFTLHYAAPELLN-----QNGYDESCDLWSLGVILYTMLSG 205 (325)
T ss_dssp CC-------------------------------------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCcccc----------cCCCcCccCHHHhc-----CCCCCCccchHHHHHHHHHHHhC
Confidence 543322111 13355677777653 33456789999999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=266.55 Aligned_cols=203 Identities=21% Similarity=0.248 Sum_probs=166.3
Q ss_pred CCccccCCeEEe-eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 042913 94 NGKLHLRHLKLV-RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEV 171 (317)
Q Consensus 94 ~~~~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 171 (317)
......++|.+. +.||+|+||.||+|.+.. +++.||+|++............+.+|+.+++.+. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 334455778887 899999999999999887 7899999999865444444567889999999995 6999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~ 248 (317)
.+.+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999999997665678999999999999999999999999999999999999987 78999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+........ ....++..|++||.. .......+.|+|+++++++|+..|
T Consensus 181 a~~~~~~~~~-----------~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 181 SRKIGHACEL-----------REIMGTPEYLAPEIL-----NYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp CEEC--------------------CCCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCcccc-----------ccccCCcCccCCeee-----cCCCCCchhhHHHHHHHHHHHHhC
Confidence 9876432211 112344556666654 334456789999999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=262.73 Aligned_cols=200 Identities=21% Similarity=0.213 Sum_probs=159.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 456899999999999999999999876 789999999976543 345567889999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999999653 56999999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
... ......++..|++||.... .......|+|+++++++|+..|
T Consensus 188 ~~~---------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 188 KLT---------QLGNTVGTLYYMAPERFSE-----SHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp ------------------CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHS
T ss_pred ccc---------cccccCCCcCccCHHHHcC-----CCCCchHhHHHHHHHHHHHHHC
Confidence 211 0111234555677765543 3445688999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=258.71 Aligned_cols=200 Identities=21% Similarity=0.295 Sum_probs=169.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 345789999999999999999999887 789999999976543 345667889999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999998653 56899999999999999999999999999999999999999999999999999876432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... .....++..|++||.... .......|+|+++++++|+..|.
T Consensus 169 ~~~----------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 169 GER----------KKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp TCC----------BCCCCSCCSSCCHHHHTT-----SCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccc----------cccccCCCCcCCcchhcc-----CCCCchhhHHHHHHHHHHHHhCC
Confidence 221 111245566777776543 33467899999999999999883
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=268.81 Aligned_cols=193 Identities=23% Similarity=0.283 Sum_probs=159.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++.+... ...+|++++..+ +||||+++++++.+.+.+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 45789999999999999999999887 889999999976532 235688888887 7999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC----CcEEEeeecccccC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED----GHIMLSDFDLCFQS 252 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~----~~~kl~DFG~a~~~ 252 (317)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+|+..
T Consensus 93 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999999653 679999999999999999999999999999999999998543 35999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
........+ ..++..|++||... ........|+|++|++++|+..|.
T Consensus 171 ~~~~~~~~~----------~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~ 217 (342)
T 2qr7_A 171 RAENGLLMT----------PCYTANFVAPEVLE-----RQGYDAACDIWSLGVLLYTMLTGY 217 (342)
T ss_dssp BCTTCCBCC----------SSCCSSCCCHHHHH-----HHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCceec----------cCCCccccCHHHhc-----CCCCCCccCeeeHhHHHHHHhcCC
Confidence 543322221 13345567776543 333457899999999999999993
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.48 Aligned_cols=207 Identities=17% Similarity=0.254 Sum_probs=159.3
Q ss_pred cCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 91 LSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 91 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
.+..+++..++|++.+.||+|+||.||+|.+. ..||+|++..........+.+.+|+++++.++||||++++++.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 35667888999999999999999999999754 3599999987666677778899999999999999999999965
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence 456689999999999999998654 4668999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ .......++..|++||..... .........|+|+++++++|+..|
T Consensus 169 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 169 EKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ--DSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp -----------------------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHS
T ss_pred cccccccc--------ccccccCCCccccCchhhccc--CCCCCCcccchHHHHHHHHHHHHC
Confidence 55432111 111122456677777765311 122345689999999999999988
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.71 Aligned_cols=202 Identities=18% Similarity=0.219 Sum_probs=157.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCce----EEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|.+.. +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 35667899999999999999999998865 4544 5777765432 3345578899999999999999999999998
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
... .++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 755 78899999999999999764 3569999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........... ....++..|++||... ......+.|+|+++++++|+.. |
T Consensus 166 ~~~~~~~~~~~--------~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g 216 (327)
T 3poz_A 166 LLGAEEKEYHA--------EGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFG 216 (327)
T ss_dssp HHTTTCC---------------CCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EccCCcccccc--------cCCCccccccChHHhc-----cCCCCchhhhhhhHHHHHHHHhcC
Confidence 76543322111 1112334567777654 3345678999999999999987 7
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=262.82 Aligned_cols=196 Identities=18% Similarity=0.169 Sum_probs=165.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCC-------ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS-------ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH 168 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 168 (317)
.+..++|++.+.||+|+||.||+|.+.. ++ ..||+|++... .....+.+.+|+++++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRRE-VGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEE-ECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEec-ccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4567899999999999999999998876 44 46999998654 33445678999999999999999999999
Q ss_pred EEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc--------
Q 042913 169 LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH-------- 240 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~-------- 240 (317)
+...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999999999764 344899999999999999999999999999999999999998887
Q ss_pred EEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 241 IMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 241 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+||+|||++........ ..++..|++||.... ........|+|+++++++|+..|
T Consensus 160 ~kl~Dfg~~~~~~~~~~--------------~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g 214 (289)
T 4fvq_A 160 IKLSDPGISITVLPKDI--------------LQERIPWVPPECIEN----PKNLNLATDKWSFGTTLWEICSG 214 (289)
T ss_dssp EEECCCCSCTTTSCHHH--------------HHHTTTTSCHHHHHC----GGGCCHHHHHHHHHHHHHHHHTT
T ss_pred eeeccCcccccccCccc--------------cCCcCcccCHHHhCC----CCCCCchhHHHHHHHHHHHHHcC
Confidence 99999999876533211 123456888886643 12346789999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=273.62 Aligned_cols=203 Identities=21% Similarity=0.268 Sum_probs=168.0
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++++.++||||+++++++...+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 35667899999999999999999999886 78999999987542 44555678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999653 34589999999999999999999999999999999999999999999999999986433
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
... .... ....+...|++||... ........|+|++|++++|+.. |
T Consensus 266 ~~~--~~~~------~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~t~g 312 (377)
T 3cbl_A 266 GVY--AASG------GLRQVPVKWTAPEALN-----YGRYSSESDVWSFGILLWETFSLG 312 (377)
T ss_dssp SEE--ECCS------SCCEEEGGGSCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred Cce--eecC------CCCCCCcCcCCHhHhc-----cCCCCchhhHHHHHHHHHHHHhCC
Confidence 211 1000 0112233577777653 2334678999999999999986 6
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.21 Aligned_cols=203 Identities=19% Similarity=0.251 Sum_probs=155.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+..++|++.+.||+|+||.||+|.+... .+..||+|++.... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 456778999999999999999999988642 34579999986542 4456678899999999999999999999985 5
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 6789999999999999999754 356899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
....... .....++..|++||.. .........|+|+++++++|+.. |.
T Consensus 167 ~~~~~~~---------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 167 EDSTYYK---------ASKGKLPIKWMAPESI-----NFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp ---------------------CCGGGCCHHHH-----HHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred Ccccccc---------cccCCCcccccChhhc-----ccCCCCCccCchHHHHHHHHHHhcCC
Confidence 4332110 0111223346666654 33445678999999999999874 73
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=264.68 Aligned_cols=200 Identities=20% Similarity=0.229 Sum_probs=165.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45899999999999999999999887 78999999997765566666778899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 102 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999998888888644 35699999999999999999999999999999999999999999999999999976544332
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ...++..|++||..... .......|+|+++++++|+..|-
T Consensus 180 ~~~----------~~~~t~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~ 222 (331)
T 4aaa_A 180 VYD----------DEVATRWYRAPELLVGD----VKYGKAVDVWAIGCLVTEMFMGE 222 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTC----TTCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccC----------CCcCCccccCcccccCC----CCcchHHHHHHHHHHHHHHHhCC
Confidence 111 12355668888866432 12357899999999999999994
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=257.64 Aligned_cols=193 Identities=23% Similarity=0.319 Sum_probs=165.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4689999999999999999999887 788999999976532 3346788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~~~~ 255 (317)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999988653 668999999999999999999999999999999999999 78889999999999776543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
... ....++..|++||..... ...+.|+|+++++++|+..|
T Consensus 163 ~~~-----------~~~~~t~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g 203 (277)
T 3f3z_A 163 KMM-----------RTKVGTPYYVSPQVLEGL------YGPECDEWSAGVMMYVLLCG 203 (277)
T ss_dssp SCB-----------CCCCSCTTTCCHHHHTTC------BCTTHHHHHHHHHHHHHHHS
T ss_pred cch-----------hccCCCCCccChHHhccc------CCchhhehhHHHHHHHHHHC
Confidence 211 112456678888866432 45689999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=272.95 Aligned_cols=205 Identities=19% Similarity=0.185 Sum_probs=163.7
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|.+.. .+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 35667899999999999999999998542 257789999996532 3455567889999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP-----NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIM 242 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~k 242 (317)
.....|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999986532 24589999999999999999999999999999999999999555 599
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
|+|||+|+........ .......++..|++||... ......+.|+|++|++++|+.. |
T Consensus 225 L~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~ellt~g 283 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY--------RKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLG 283 (367)
T ss_dssp ECCCHHHHHHHHHSSC--------TTCCGGGSCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ECCCcccccccccccc--------ccCCCcCCcccEECHHHhc-----CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999754321111 0011112334566666543 3345678999999999999986 7
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.03 Aligned_cols=209 Identities=21% Similarity=0.252 Sum_probs=159.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHH-H--------HHHHHHHHHHHHhcCCCCcc
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAK-K--------LSHVQMEAEILSMLDHPFLP 163 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~-~--------~~~~~~E~~~l~~l~h~~iv 163 (317)
+..++|++++.||+|+||.||+|.+... .++.||||++........ . ...+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999988752 258899999876531110 0 11233456667778899999
Q ss_pred eEEEEEEec----CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--c
Q 042913 164 TLYAHLEVS----HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--E 237 (317)
Q Consensus 164 ~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~ 237 (317)
++++++... ...|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 5689999999 99999999764 46799999999999999999999999999999999999999 8
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
++.+||+|||+|+.+......... .........++..|++||... ......++|+|+++++++|+..| .|
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAY---AADPKRCHDGTIEFTSIDAHN-----GVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCS---SCCSSCCCCCCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred CCeEEEEECCcceecccCCccccc---ccCcccccCCCCCccCHHHhC-----CCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 899999999999876543221110 001111223556667776553 33457899999999999999999 44
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=266.88 Aligned_cols=199 Identities=21% Similarity=0.287 Sum_probs=150.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+++++.++||||+++++++..++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSS-SCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4689999999999999999998876 78999999997543 222335678899999999999999999999999999999
Q ss_pred EcccCCCChhcccccC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 179 IDYCPNGDLHSLLPKQ----PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 6999887542 124589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ....++..|++||..... .......|+|++|++++|+..|.
T Consensus 161 ~~~~~----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 161 PVNTF----------SSEVVTLWYRAPDVLMGS----RTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp CCCCC----------CCCCSCCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcccC----------CCCcccccccCchHhhCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 32211 112445667888765321 12457899999999999999994
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=262.65 Aligned_cols=205 Identities=19% Similarity=0.272 Sum_probs=166.3
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+..++|++.+.||+|+||.||+|.+.. .++..||+|++.... .......+.+|+++++.+ +||||+++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 45667899999999999999999998752 256789999997653 445667899999999999 8999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++...+.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997542 23489999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG- 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~- 312 (317)
|++.++.+||+|||+++............ ...++..|++||... ......+.|+|+++++++|+..
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~--------~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTT--------NGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCS--------CCCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCCEEEccccccccccccccccccC--------CCCcccceeChHHhc-----CCCcChHHHHHHHHHHHHHHHhC
Confidence 99999999999999998765433221111 112233466666543 3345688999999999999987
Q ss_pred C
Q 042913 313 G 313 (317)
Q Consensus 313 G 313 (317)
|
T Consensus 256 g 256 (334)
T 2pvf_A 256 G 256 (334)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=270.09 Aligned_cols=195 Identities=22% Similarity=0.262 Sum_probs=159.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|++++.||+|+||.||+|.+.. +++.||||++..........+++.+|+++++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 5789999999999999999999877 899999999977655666778899999999999999999999999765
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 8999999865 46899999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+.... ...++..|++||..... .......|+|++|++++|+..|.|
T Consensus 179 ~~~~~-------------~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~ 224 (367)
T 1cm8_A 179 DSEMT-------------GYVVTRWYRAPEVILNW----MRYTQTVDIWSVGCIMAEMITGKT 224 (367)
T ss_dssp CSSCC-------------SSCSCGGGCCTHHHHTT----TCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccC-------------cCcCCCCcCCHHHHhCC----CCCChhhhHHHHHHHHHHHHhCCC
Confidence 43211 11344557777755321 234678999999999999999943
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=262.13 Aligned_cols=203 Identities=23% Similarity=0.310 Sum_probs=167.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEE---cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHL---RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE-- 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 170 (317)
.+..++|++++.||+|+||.||+|.+ ...+++.||+|++... .....+.+.+|+++++.++|+||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46678999999999999999999985 2337889999999765 4455677899999999999999999999886
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
....+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 557799999999999999999653 2458999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........... .....++..|++||... ........|+|+++++++|+..|
T Consensus 176 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 176 LLPLDKDYYVV-------REPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp ECCTTCSEEEC-------SSCCCSCGGGSCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ecccCCcccee-------eccCCccccccCHHHhc-----cCCCChHHhHHHHHHHHHHHHhC
Confidence 76543322111 11123344466666543 33446789999999999999988
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.33 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=161.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL---SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 4789999999999999999998877 789999999976532 234567899999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 042913 176 CFLIDYCPNGDLHSLLPKQ--------------------------------------PNNRFSLQAVRFFAAEVLVGLEY 217 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~~~~i~~qi~~al~~ 217 (317)
++||||+++++|.+++... ....+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999988521 01224677888999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCC--cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccc
Q 042913 218 LHALGIIYRDLKPENILLREDG--HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEP 295 (317)
Q Consensus 218 LH~~~ivHrDikp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~ 295 (317)
||++||+||||||+|||++.++ .+||+|||+|+.+........ .......++..|++||...... ....
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~ 254 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY------YGMTTKAGTPYFVAPEVLNTTN---ESYG 254 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------CCCGGGCCHHHHTCSS---SCCC
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc------ccccccCCCccccCchhhccCC---CCCC
Confidence 9999999999999999998766 899999999976543221100 1111224555677777653211 2235
Q ss_pred hhhhccCCcccccccCCC
Q 042913 296 RREQREHPAQYSVEQPGG 313 (317)
Q Consensus 296 ~~~~~~~~~~~~~e~~~G 313 (317)
...|+|++|++++|+..|
T Consensus 255 ~~~DiwslG~il~el~~g 272 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMG 272 (345)
T ss_dssp THHHHHHHHHHHHHHHHS
T ss_pred cHHHHHHHHHHHHHHHHC
Confidence 689999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=267.66 Aligned_cols=201 Identities=18% Similarity=0.238 Sum_probs=158.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...++|++++.||+|+||.||+|.+.. +++.||||++............+.+|+++++.++||||+++++++..++.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECC-CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 456789999999999999999998887 7999999999766545555677889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-----cCCcEEEeeeccccc
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-----EDGHIMLSDFDLCFQ 251 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-----~~~~~kl~DFG~a~~ 251 (317)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 110 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999995 6999999664 5699999999999999999999999999999999999994 455699999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
........ ....++..|++||..... .......|+|+++++++|+..|-|
T Consensus 187 ~~~~~~~~----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 187 FGIPIRQF----------THEIITLWYRPPEILLGS----RHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp HC---------------------CCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCccccc----------CCCcCCccccCHHHhcCC----CCCCcHHHHHHHHHHHHHHHHCCC
Confidence 64332211 112345667777765321 124678999999999999998843
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=270.12 Aligned_cols=198 Identities=19% Similarity=0.227 Sum_probs=164.6
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH------HHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA------KKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++....... .....+.+|+++++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34789999999999999999999877 78999999997653221 133457789999999999999999999999
Q ss_pred cCEEEEEEcccCCC-ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 172 SHYICFLIDYCPNG-DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 172 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.+.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 99999999999666 99999965 3679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ ....++..|++||...... ......|+|+++++++|+..|
T Consensus 179 ~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 179 YLERGKLF-----------YTFCGTIEYCAPEVLMGNP----YRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp ECCTTCCB-----------CEECSCGGGCCHHHHTTCC----BCSHHHHHHHHHHHHHHHHHS
T ss_pred ECCCCCce-----------eccCCCccccChhhhcCCC----CCCCcccchhHHHHHHHHHhC
Confidence 76543221 1123455677777654221 125678999999999999988
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=267.80 Aligned_cols=195 Identities=16% Similarity=0.219 Sum_probs=158.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH---- 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 173 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC-CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999998877 7899999999876556667788899999999999999999999997654
Q ss_pred --EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 174 --YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 174 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+|+||||++ ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999995 67888874 3489999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... .....++..|++||.... .......|+|++|++++|+..|-
T Consensus 177 ~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~ 223 (371)
T 2xrw_A 177 AGTSFM-----------MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGG 223 (371)
T ss_dssp ------------------------CTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccc-----------cCCceecCCccCHHHhcC-----CCCCchHhHHHHHHHHHHHHhCC
Confidence 543211 112245566788877643 23457899999999999999993
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=255.66 Aligned_cols=196 Identities=21% Similarity=0.305 Sum_probs=167.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----c
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV----S 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 172 (317)
...+.|++.+.||+|+||.||+|.+.. ++..||+|++..........+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344679999999999999999998887 78999999998776677778889999999999999999999999865 4
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEc-cCCcEEEeeeccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR-EDGHIMLSDFDLC 249 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~-~~~~~kl~DFG~a 249 (317)
..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 5689999999999999999653 66899999999999999999999999 99999999999998 7899999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ ....++..|++||.... ......|+|+++++++|+..|
T Consensus 180 ~~~~~~~~------------~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g 225 (290)
T 1t4h_A 180 TLKRASFA------------KAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp GGCCTTSB------------EESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccc------------ccccCCcCcCCHHHHhc------cCCCcchHHHHHHHHHHHHhC
Confidence 65433221 11245667888886542 245689999999999999988
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=264.71 Aligned_cols=197 Identities=21% Similarity=0.236 Sum_probs=164.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
.+.|++++.||+|+||.||+|.+.. +++.||||++..... .....+.+.+|+++++.++||||+++++++...+..|+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3569999999999999999999876 789999999975432 33556788999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 999995 7888877543 36689999999999999999999999999999999999999999999999999976543221
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..++..|++||..... .......+.|+|++|++++|+..|.
T Consensus 210 --------------~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~ell~g~ 250 (348)
T 1u5q_A 210 --------------FVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERK 250 (348)
T ss_dssp --------------CCSCGGGCCHHHHHTT--SSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------ccCCcceeCHhhhccc--cCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 2355667888765321 1122356789999999999999993
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=257.36 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=168.1
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
...+..++|++.+.||+|+||.||+|.+.. +++.||+|++....... .....+.+|+++++.++||||+++++++...
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 345677899999999999999999999877 78899999997653322 2346788999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999999653 56899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..... ....++..|++||.... .......|+|+++++++|+..|.
T Consensus 165 ~~~~~------------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 209 (284)
T 2vgo_A 165 PSLRR------------RTMCGTLDYLPPEMIEG-----KTHDEKVDLWCAGVLCYEFLVGM 209 (284)
T ss_dssp SSSCB------------CCCCSCGGGCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccc------------ccccCCCCcCCHHHhcc-----CCCCcccchhhHHHHHHHHHHCC
Confidence 33211 11234556677766543 33467899999999999999983
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=260.60 Aligned_cols=204 Identities=19% Similarity=0.252 Sum_probs=168.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEE----cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHL----RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+ ...+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 46678999999999999999999986 33367899999997653 344567889999999999 8999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPN----------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
..+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 99999999999999999999976432 24899999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
++.++.+||+|||+++........... ....++..|++||.... .......|+|+++++++|+.. |
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVK--------GNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEEC--------SSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred EcCCCCEEEccccccccccccccceec--------cCCCCcceeeChHHhcC-----CCCChHHHHHHHHHHHHHHHhCC
Confidence 999999999999999876554322111 11123445777775532 345688999999999999987 6
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=258.66 Aligned_cols=207 Identities=20% Similarity=0.271 Sum_probs=167.1
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
.+.+..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+|+.+++.+ +|+|++++++++...
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 356778899999999999999999999876 78999999986542 224577899999999 799999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc-----EEEeeec
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH-----IMLSDFD 247 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~-----~kl~DFG 247 (317)
...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999999 99999999764 356999999999999999999999999999999999999987775 9999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+|+............ ........++..|++||... ........|+|++|++++|+..| .|
T Consensus 157 ~~~~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p 217 (298)
T 1csn_A 157 MVKFYRDPVTKQHIP---YREKKNLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLP 217 (298)
T ss_dssp TCEESBCTTTCCBCC---CCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccccccccccccc---ccCccCCCCCcccCCchhhc-----CCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 998765433211100 01112234555667776543 33456889999999999999998 44
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=257.03 Aligned_cols=201 Identities=25% Similarity=0.291 Sum_probs=163.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC---CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD---CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-- 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 171 (317)
+..+.|++++.||+|+||.||++.+.. .+++.||||++.... .....+.+.+|+++++.++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 444555999999999999999986532 267899999997653 45566789999999999999999999999987
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...+++||||+++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 46899999999999999999663 489999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......... .....++..|++||.. .........|+|+++++++|+..|
T Consensus 184 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 184 VPEGHEYYRV-------REDGDSPVFWYAPECL-----KEYKFYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp CCTTCSEEEC----------CCCCGGGCCHHHH-----HHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccc-------ccCCCCCceeeChHHh-----cCCCCCcHHHHHHHHHHHHHHHhC
Confidence 6554322111 1111233346666654 333455789999999999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=265.29 Aligned_cols=205 Identities=20% Similarity=0.264 Sum_probs=164.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHL 169 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 169 (317)
..+..++|++.+.||+|+||.||+|.+. ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3567789999999999999999999873 2256789999997543 334557889999999999 899999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPN---------------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDL 228 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDi 228 (317)
...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999976432 23789999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccc
Q 042913 229 KPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSV 308 (317)
Q Consensus 229 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (317)
||+|||++.++.+||+|||+++.......... .....++..|++||.... .......|+|++|++++
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVV--------RGNARLPVKWMAPESLFE-----GIYTIKSDVWSYGILLW 265 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEE--------ETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHH
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcccee--------ccCccCccCccCHHHhcc-----CCCChhHhHHHHHHHHH
Confidence 99999999999999999999986644332111 111123445777775533 33467899999999999
Q ss_pred ccCC-C
Q 042913 309 EQPG-G 313 (317)
Q Consensus 309 e~~~-G 313 (317)
|+.. |
T Consensus 266 el~t~g 271 (344)
T 1rjb_A 266 EIFSLG 271 (344)
T ss_dssp HHTTTS
T ss_pred HHHcCC
Confidence 9997 7
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=277.21 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=163.9
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-----------HHHHHHHHHHHHHHhcCCCCcceEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-----------KKLSHVQMEAEILSMLDHPFLPTLY 166 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~ 166 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 46789999999999999999999887 78999999997653221 2346788999999999999999999
Q ss_pred EEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEE
Q 042913 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIML 243 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl 243 (317)
+++.....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999988653 6699999999999999999999999999999999999998776 6999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+|||+|+........ ....++..|++||.... .....+|+|++|++++|+..|.
T Consensus 191 ~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~ 244 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKL-----------RDRLGTAYYIAPEVLKK------KYNEKCDVWSCGVIMYILLCGY 244 (504)
T ss_dssp CCCTTCEECCTTSCB-----------CCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred EECCCCEEcCCCCcc-----------ccccCCcCCCCHHHhcc------CCCchHHHHHHHHHHHHHHhCC
Confidence 999999876543211 12245667888886542 2456889999999999999993
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=269.60 Aligned_cols=205 Identities=20% Similarity=0.247 Sum_probs=164.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+++.++ |+||+++++++...+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC--CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3445679999999999999999998764 889999999876666677788999999999997 599999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 130 ~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 130 YIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99999995 589999999764 5789999999999999999999999999999999999995 5899999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCccccccccc------ceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM------EFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~------~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ......++..|++||....... .........|+|+++++++|+..|.
T Consensus 206 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 206 PDTTSV--------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp ----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccc--------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 432211 0112245667788876643111 1123567899999999999999983
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=253.51 Aligned_cols=199 Identities=23% Similarity=0.325 Sum_probs=165.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4789999999999999999999876 789999999975432 23456788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999999965 367999999999999999999999999999999999999999999999999999765432211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.......++..|++||...... ......|+|+++++++|+..|
T Consensus 162 --------~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g 204 (276)
T 2yex_A 162 --------RLLNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAG 204 (276)
T ss_dssp --------CCBCCCCSCGGGCCGGGGTCSS----BCHHHHHHHHHHHHHHHHHHS
T ss_pred --------hcccCCccccCccChHHHhcCC----CCCCcchHHHHHHHHHHHHhC
Confidence 0011123455567776653221 125679999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=260.36 Aligned_cols=211 Identities=22% Similarity=0.229 Sum_probs=160.5
Q ss_pred ccCCCCccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 042913 90 NLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYA 167 (317)
Q Consensus 90 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 167 (317)
+......+..++|++.+.||+|+||.||+|.+... ++..||+|++..........+.+.+|+.+++.++||||+++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 34455667789999999999999999999987642 3458999999876656677788999999999999999999999
Q ss_pred EEEecC-----EEEEEEcccCCCChhccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 168 HLEVSH-----YICFLIDYCPNGDLHSLLPK----QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 168 ~~~~~~-----~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
++.... ..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence 987654 35999999999999998843 224669999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
+.+||+|||+++.......... .....++..|++||.. .........|+|++|++++|+.. |
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQ--------GRIAKMPVKWIAIESL-----ADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp SCEEECSCSCC------------------------CCGGGSCHHHH-----HSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcEEEeecCcceecccccccCc--------ccccCCCccccCchhh-----cCCCccchhhhHHHHHHHHHHHhcC
Confidence 9999999999976543221100 0111223345555544 34445678999999999999998 6
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=278.91 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=162.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. ++..||+|++.+..........+.+|+.+++.++||||+++++++.....+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45689999999999999999999887 78999999998765444445778999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~a~~~~~ 254 (317)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999988653 66999999999999999999999999999999999999975 44599999999976643
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... .....++..|++||.... .....+|+|++|++++|+..|.
T Consensus 192 ~~~-----------~~~~~gt~~y~aPE~l~~------~~~~~~DiwslG~il~~ll~g~ 234 (494)
T 3lij_A 192 QKK-----------MKERLGTAYYIAPEVLRK------KYDEKCDVWSIGVILFILLAGY 234 (494)
T ss_dssp TBC-----------BCCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHSS
T ss_pred Ccc-----------ccccCCCcCeeCHHHHcc------cCCCchhHHHHHHHHHHHHhCC
Confidence 221 112246667888887642 2456899999999999999993
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.91 Aligned_cols=208 Identities=23% Similarity=0.233 Sum_probs=160.0
Q ss_pred cCCeEEe-eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 99 LRHLKLV-RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 99 ~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
.++|++. +.||+|+||.||+|.+.. +++.||||++.... ......+.+|++++..+ +||||+++++++...+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS-SCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC-CCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678885 789999999999998776 78999999997652 23346788999999885 7999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc---EEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH---IMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~---~kl~DFG~a~~~~ 253 (317)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999999663 56899999999999999999999999999999999999998775 9999999997654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
........ .........++..|++||................|+|+++++++|+..|.
T Consensus 166 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 166 LNGDCSPI---STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred cCCccccc---cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 32211000 00111122355567777665432111233457899999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=263.87 Aligned_cols=199 Identities=22% Similarity=0.240 Sum_probs=165.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4578999999999999999999865 58999999987652 3345678999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999996543 235899999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ......++..|++||.... .....+.|+|++|++++|+..|
T Consensus 193 ~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 193 DQTH--------LSTVVKGTLGYIDPEYFIK-----GRLTEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp SCCC--------CBCCCEEETTTCCHHHHHH-----CBCCTHHHHHHHHHHHHHHHHC
T ss_pred cccc--------cccccCCCccccCHHHhcC-----CCCCcccchHhHHHHHHHHHhC
Confidence 2110 1112235667888886543 2346789999999999999988
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=257.41 Aligned_cols=197 Identities=22% Similarity=0.339 Sum_probs=163.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 34689999999999999999999887 78999999997653221 13567889999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeeccc
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLC 249 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a 249 (317)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999999965 35689999999999999999999999999999999999998877 8999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ....++..|++||.. .........|+|+++++++|+..|
T Consensus 160 ~~~~~~~~~-----------~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g 207 (283)
T 3bhy_A 160 HKIEAGNEF-----------KNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSG 207 (283)
T ss_dssp EECC-------------------CCCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCcc-----------cccCCCcCccCccee-----cCCCCCcchhhhhHHHHHHHHHHC
Confidence 765432211 111344456666654 333456789999999999999988
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.41 Aligned_cols=205 Identities=23% Similarity=0.277 Sum_probs=164.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------ 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 171 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+++++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45899999999999999999999877 78999999987654444444567889999999999999999999876
Q ss_pred --cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+.+|+||||++ ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 94 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 94 RCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ---CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred cCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 457899999995 5777776543 356999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+.......... .......++..|++||..... .......|+|++|++++|+..|.|
T Consensus 172 ~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 172 RAFSLAKNSQP------NRYTNRVVTLWYRPPELLLGE----RDYGPPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp EECCCCSSSSC------CCCCSSCSCGGGCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccc------cccCCcccccCccCchhhcCC----CCCCcHhHHHHHHHHHHHHHhCCC
Confidence 87653222111 111122445567777754321 223578999999999999999844
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=267.82 Aligned_cols=202 Identities=24% Similarity=0.310 Sum_probs=171.1
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+.+..++|++++.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECC-CCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 4467778999999999999999999999887 78999999997653 455667899999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999663 5689999999999999999999996 999999999999999999999999999865
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... .....++..|++||.... .......|+|+++++++|+..| .|
T Consensus 182 ~~~~~------------~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p 229 (360)
T 3eqc_A 182 LIDSM------------ANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYP 229 (360)
T ss_dssp HHHHC----------------CCCCTTCCHHHHTT-----CCCSHHHHHHHHHHHHHHHHHTSCC
T ss_pred ccccc------------ccCCCCCCCeECHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 42211 011244556777776543 3456789999999999999998 44
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=257.19 Aligned_cols=203 Identities=18% Similarity=0.227 Sum_probs=163.2
Q ss_pred ccccCCeEEee-eecccCCeEEEEEEEc-CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVR-HLGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~-~lg~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++.+ .||+|+||.||+|.+. ..+++.||||++..........+.+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 45668999998 9999999999999653 22578999999976644445567899999999999999999999998 567
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 789999999999999999763 569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... ....++..|++||.. .........|+|+++++++|+.. |
T Consensus 169 ~~~~~~~~~-------~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~~g 217 (291)
T 1xbb_A 169 ADENYYKAQ-------THGKWPVKWYAPECI-----NYYKFSSKSDVWSFGVLMWEAFSYG 217 (291)
T ss_dssp TTCSEEEC-----------CCCGGGCCHHHH-----HHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCccccc-------ccCCCCceeeChHHh-----ccCCCChhhhHHHHHHHHHHHHhcC
Confidence 544322111 011223446666654 33345678999999999999997 7
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=258.09 Aligned_cols=196 Identities=21% Similarity=0.306 Sum_probs=161.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEcc-CCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 4689999999999999999999877 78999999997653 223356788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccCC
Q 042913 179 IDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~~ 253 (317)
|||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999988542 23669999999999999999999999999999999999999 456789999999997654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... .....++..|++||.... ......|+|+++++++|+..|
T Consensus 179 ~~~~-----------~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 179 SDEH-----------STNAAGTALYMAPEVFKR------DVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp -------------------CTTGGGCCHHHHTT------CCCHHHHHHHHHHHHHHHHHS
T ss_pred Cccc-----------CcCcccccCcCChHHhcc------CCCcccCeehHHHHHHHHHhC
Confidence 3221 112245566788886542 235789999999999999988
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=261.58 Aligned_cols=205 Identities=19% Similarity=0.248 Sum_probs=160.7
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCC---CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCT---SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
..+...+|++.+.||+|+||.||+|.+.... +..||+|++.... .......+.+|+++++.++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3577889999999999999999999876522 2359999997643 44555678999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999754 46799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........... ....++..|++||.. .........|+|+++++++|+.. |
T Consensus 197 ~~~~~~~~~~~-------~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~ellt~g 247 (333)
T 1mqb_A 197 LEDDPEATYTT-------SGGKIPIRWTAPEAI-----SYRKFTSASDVWSFGIVMWEVMTYG 247 (333)
T ss_dssp ---------------------CCCGGGSCHHHH-----HSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hcccccccccc-------CCCCccccccCchhc-----ccCCCCchhhhHHHHHHHHHHHcCC
Confidence 65432211110 011223346666654 33345678999999999999886 7
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=255.33 Aligned_cols=200 Identities=22% Similarity=0.292 Sum_probs=164.0
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+..+..++|++++.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+++++.++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcC--CcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 446677899999999999999999998764 778999999765332 356889999999999999999999886 45
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 68999999999999999965433468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
...... .....++..|++||... ........|+|+++++++|+.. |
T Consensus 161 ~~~~~~---------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g 207 (279)
T 1qpc_A 161 DNEYTA---------REGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTHG 207 (279)
T ss_dssp SSCEEC---------CTTCCCCTTTSCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTT
T ss_pred Cccccc---------ccCCCCccCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCC
Confidence 432110 11112344577777653 3344678999999999999997 6
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=268.58 Aligned_cols=198 Identities=23% Similarity=0.262 Sum_probs=165.1
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc------CCCCcceEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML------DHPFLPTLYAH 168 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 168 (317)
......+|++++.||+|+||.||+|.+.. +++.||||++... ......+.+|+++++.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 44566889999999999999999999887 7899999999754 33445677788888877 57799999999
Q ss_pred EEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc--EEEeee
Q 042913 169 LEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH--IMLSDF 246 (317)
Q Consensus 169 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~--~kl~DF 246 (317)
+...+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999999999 579999998776667999999999999999999999999999999999999999887 999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|+....... ...++..|++||.... .......|+|+++++++|+..|.|
T Consensus 247 G~a~~~~~~~~-------------~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 247 GSSCYEHQRVY-------------TYIQSRFYRAPEVILG-----ARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp TTCEETTCCCC-------------SSCSCGGGCCHHHHHT-----BCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccceecCCccc-------------ccCCCCCccChHHHhC-----CCCCchHHHHhHHHHHHHHHhCCC
Confidence 99965432211 1134445777776543 334678999999999999999954
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=264.44 Aligned_cols=202 Identities=24% Similarity=0.313 Sum_probs=169.2
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh------cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------SAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV 171 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 171 (317)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 4689999999999999999999876 789999999875431 123356788999999999 79999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
....|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999999999999653 5699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+...... ....++..|++||........ ........|+|++|++++|+..|.
T Consensus 250 ~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 250 LEPGEKL-----------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CCTTCCB-----------CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred cCCCccc-----------ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 6543211 122456678888876543322 223467899999999999999993
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=253.85 Aligned_cols=198 Identities=23% Similarity=0.283 Sum_probs=164.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||+|.+.. ++.||+|++....... +.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEecC--CCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4567899999999999999999998864 7889999998654333 5688899999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999999765432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
... ......++..|++||.. .......+.|+|+++++++|+.. |
T Consensus 158 ~~~---------~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 158 QYT---------SSTGTKFPVKWASPEVF-----SFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp HHH---------STTSTTCCGGGCCHHHH-----HHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccc---------ccccccccccccChhhh-----cCCCccchhchhhhHHHHHHHhccC
Confidence 110 00111223346666654 33345678999999999999988 6
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=268.91 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=158.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS------AKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+++|+.++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345799999999999999999999887 8899999999765321 122345789999999999999999999975
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC---cEEEeeec
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG---HIMLSDFD 247 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~---~~kl~DFG 247 (317)
.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 4568999999999999999955 46799999999999999999999999999999999999997544 59999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+|+........ ....++..|++||..... .........|+|+++++++|+..|.
T Consensus 288 ~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 288 HSKILGETSLM-----------RTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp TTTSCC----------------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred cceecCCCccc-----------cccCCCCCccCceeeecC--CCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99876432211 112456678888875321 1123356899999999999999993
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=262.18 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=162.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceE--EEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
.+..++|++.+.||+|+||.||+|.+.. ++..+ ++|.+.... .....+.+.+|+++++.+ +||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEcc-CCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 4667899999999999999999999876 56644 999886532 334556789999999999 899999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999996542 2468999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
+.+||+|||+++...... ......++..|++||.. .........|+|++|++++|+.. | .|
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp GCEEECCTTCEESSCEEC-----------CC----CCTTTCCHHHH-----HHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CeEEEcccCcCccccccc-----------cccCCCCCccccChhhh-----ccccCCchhcchHHHHHHHHHHcCCCCC
Confidence 999999999987432211 01111234456777655 33345678999999999999986 7 44
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=256.15 Aligned_cols=196 Identities=20% Similarity=0.296 Sum_probs=164.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV---- 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 171 (317)
....++|++++.||+|+||.||+|.+.. +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred chhccccceeeeeccCCceEEEEEEEcC-CCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 3445789999999999999999999876 78999999997642 346789999999999999999998854
Q ss_pred ------------cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 172 ------------SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 172 ------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence 45689999999999999999765556799999999999999999999999999999999999999999
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.+||+|||+++....... .....++..|++||.... .......|+|+++++++|+..|.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~~ 218 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK-----------RTRSKGTLRYMSPEQISS-----QDYGKEVDLYALGLILAELLHVC 218 (284)
T ss_dssp EEEECCCTTCEESSCCSC-----------CCCCCSCCTTSCHHHHHC-----SCCCTHHHHHHHHHHHHHHHSCC
T ss_pred CEEECcchhheecccccc-----------ccccCCcccccChhhhcc-----CCCcchhhhHHHHHHHHHHHhcC
Confidence 999999999977654321 111245667777776543 33467899999999999999883
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=257.33 Aligned_cols=193 Identities=21% Similarity=0.267 Sum_probs=161.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe--cC
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEV--SH 173 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~ 173 (317)
...++|++++.||+|+||.||+|.+.. +++.||+|++.... .+.+.+|+++++.++ ||||+++++++.. ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECC-CCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 345899999999999999999998877 78999999986432 356889999999997 9999999999987 67
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQS 252 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~ 252 (317)
..++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 89999999999999999843 89999999999999999999999999999999999999776 8999999999866
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... ....++..|++||.... ........|+|++|++++|+..| .|
T Consensus 182 ~~~~~~-----------~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 182 HPGQEY-----------NVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CTTCCC-----------CSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred CCCCcc-----------ccccccccccChhhhcC----CCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 543221 11234455777776532 12345789999999999999988 44
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=255.44 Aligned_cols=198 Identities=20% Similarity=0.251 Sum_probs=162.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH--H---HHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA--K---KLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|++....... . ..+.+.+|+++++.++||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 4667899999999999999999999877 78999999986543221 1 1267899999999999999999999987
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCc-----EEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGH-----IML 243 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~-----~kl 243 (317)
... ++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 665 6999999999998888654 457999999999999999999999999 999999999999988776 999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+|||+|+...... ....++..|++||..... ........|+|+++++++|+..|
T Consensus 171 ~Dfg~~~~~~~~~-------------~~~~g~~~y~aPE~~~~~---~~~~~~~~Di~slG~~l~~l~~g 224 (287)
T 4f0f_A 171 ADFGLSQQSVHSV-------------SGLLGNFQWMAPETIGAE---EESYTEKADTYSFAMILYTILTG 224 (287)
T ss_dssp CCCTTCBCCSSCE-------------ECCCCCCTTSCGGGSSCS---SCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCCCccccccccc-------------cccCCCccccCchhhccC---CCCcCchhhHHHHHHHHHHHHcC
Confidence 9999997543311 112345567777765322 22345789999999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=257.94 Aligned_cols=201 Identities=19% Similarity=0.232 Sum_probs=159.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEe--
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLPTLYAHLEV-- 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~-- 171 (317)
.+..++|++++.||+|+||.||+|.+. ++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQ---GENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEET---TEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEEC---CEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 456789999999999999999999873 689999998654 22445667777776 789999999998654
Q ss_pred --cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCcEEEccCCcE
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH--------ALGIIYRDLKPENILLREDGHI 241 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~ivHrDikp~Nill~~~~~~ 241 (317)
...+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence 3568999999999999999954 56999999999999999999999 9999999999999999999999
Q ss_pred EEeeecccccCCCCCCeeecccccccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC
Q 042913 242 MLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 242 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G 313 (317)
||+|||+|+........... ......++..|++||.......... ......|+|+++++++|+..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDV------GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp EECCCTTCEEEETTTTEEEC------CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeeCCCeeecccccccccc------cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 99999999765443322111 1112245667777776654322111 334689999999999999988
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=275.54 Aligned_cols=202 Identities=20% Similarity=0.289 Sum_probs=165.5
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+++++.++||||+++++++. ..
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT--TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC--ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 345677899999999999999999998874 78899999976532 3467889999999999999999999986 56
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 78999999999999999975433468999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
..... ......++..|++||... ......+.|+|+++++++|+.. | .|
T Consensus 336 ~~~~~---------~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 336 DNEYT---------AREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp CHHHH---------TTCSSSSCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcee---------ccCCCcccccccCHHHhc-----cCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 32110 001112234577777653 2334678999999999999997 7 44
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=271.69 Aligned_cols=197 Identities=23% Similarity=0.324 Sum_probs=163.8
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+++++.++||||+++++++....
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 34577889999999999999999999876 5799999997653 3457889999999999999999999987654
Q ss_pred -EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 174 -YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 174 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 7999999999999999998764455899999999999999999999999999999999999999999999999999854
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
..... ...+...|++||.... .....+.|+|+++++++|+.. | .|
T Consensus 340 ~~~~~-------------~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g~~P 386 (450)
T 1k9a_A 340 SSTQD-------------TGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVP 386 (450)
T ss_dssp C-------------------CCCTTTSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccc-------------CCCCCcceeCHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 32111 0123445778876543 334578999999999999987 7 44
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=261.11 Aligned_cols=204 Identities=21% Similarity=0.282 Sum_probs=162.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEV---- 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---- 171 (317)
...++|++++.||+|+||.||+|.+.. +++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356899999999999999999999876 78999999987542 2235678899999998 79999999999976
Q ss_pred --cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
.+.+|+||||+++++|.+++.......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 568999999999999999997765567999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
......... .....++..|++||................|+|+++++++|+..|.
T Consensus 177 ~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 177 AQLDRTVGR----------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp C-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred eecCcCccc----------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 766432211 1112355668888876543333344567899999999999999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=277.54 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=169.4
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
....++|++.+.||+|+||.||+|.+.. +++.||||++.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456789999999999999999999887 7899999999765332 2445778999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeeccccc
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQ 251 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~ 251 (317)
+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999999865 3679999999999999999999999999999999999999 4678999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... ....++..|++||.... .....+|+|++|++++|+..|.
T Consensus 179 ~~~~~~~-----------~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~ 224 (484)
T 3nyv_A 179 FEASKKM-----------KDKIGTAYYIAPEVLHG------TYDEKCDVWSTGVILYILLSGC 224 (484)
T ss_dssp BCCCCSH-----------HHHTTGGGTCCHHHHHT------CCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc-----------ccCCCCccccCceeecC------CCCCcceeHHHHHHHHHHHHCC
Confidence 6543321 11245667888887643 2356899999999999999994
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=257.01 Aligned_cols=204 Identities=17% Similarity=0.189 Sum_probs=156.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++++.||+|+||.||+|.+.. +++.||+|++..........+.+..+...++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999877 789999999976644444445556666668889999999999999999999
Q ss_pred EEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 176 CFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999995 688777643 1346799999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ....++..|++||....+. .........|+|+++++++|+..|
T Consensus 161 ~~~~~~-----------~~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g 209 (290)
T 3fme_A 161 VDDVAK-----------DIDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAIL 209 (290)
T ss_dssp --------------------CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHT
T ss_pred cccccc-----------cccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHC
Confidence 432211 1124566788888753221 223345789999999999999888
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=266.99 Aligned_cols=195 Identities=18% Similarity=0.243 Sum_probs=150.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS------ 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 172 (317)
.++|++++.||+|+||.||+|.+.. +++.||||++............+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT-TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4799999999999999999998877 899999999977655666678889999999999999999999998653
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 8999999854 56999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.... ....++..|++||..... .......|+|++|++++|+..|.|
T Consensus 183 ~~~~-------------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~ 228 (367)
T 2fst_X 183 ADEM-------------TGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGRT 228 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTC----CSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccC-------------CCcCcCcCccChHHHcCC----cCCCchhhHHHHHHHHHHHHhCCC
Confidence 4221 112455667788765421 234578899999999999999943
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=264.28 Aligned_cols=201 Identities=16% Similarity=0.206 Sum_probs=160.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCce----EEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN----FALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.+..++|++++.||+|+||.||+|.+.. +++. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 4667899999999999999999999876 5555 6777664332 1223345778999999999999999999886
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+...++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 55689999999999999998654 35689999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........ ......++..|++||.... .......|+|+++++++|+.. |
T Consensus 165 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g 214 (325)
T 3kex_A 165 LPPDDKQL--------LYSEAKTPIKWMALESIHF-----GKYTHQSDVWSYGVTVWELMTFG 214 (325)
T ss_dssp SCCCTTCC--------C-----CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCcccccc--------cccCCCCcccccChHHhcc-----CCCChhhHhHHhHHHHHHHHhCC
Confidence 65433211 1111234456777776543 335678999999999999988 7
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=252.02 Aligned_cols=203 Identities=22% Similarity=0.272 Sum_probs=164.2
Q ss_pred ccccCCeEEee-eecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVR-HLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~-~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|.+.+ .||+|+||.||+|.+.. .++..||+|++.... .....+.+.+|+++++.++||||+++++++ ..+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 35567888887 99999999999998642 257789999997652 445667899999999999999999999999 456
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 689999999999999998643 4569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........ .....++..|++||.. .........|+|+++++++|+.. |
T Consensus 162 ~~~~~~~~-------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~ellt~g 210 (287)
T 1u59_A 162 ADDSYYTA-------RSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYGVTMWEALSYG 210 (287)
T ss_dssp TCSCEECC-------CCSSCCCGGGCCHHHH-----HHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cCcceeec-------cccccccccccCHHHh-----ccCCCCchhhHHHHHHHHHHHHcCC
Confidence 43322111 1111233456666654 33445678999999999999997 7
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.99 Aligned_cols=213 Identities=18% Similarity=0.217 Sum_probs=166.1
Q ss_pred HhhccCCCCccc----cCCeEEeeeecccCCeEEEEEEEcCC-------CCceEEEEEeehhhhcHHHHHHHHHHHHHHH
Q 042913 87 AATNLSSNGKLH----LRHLKLVRHLGTGNLGRVFLCHLRDC-------TSANFALKVVDKDLLSAKKLSHVQMEAEILS 155 (317)
Q Consensus 87 ~~~~~~~~~~~~----~~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~ 155 (317)
........+.+. .++|++.+.||+|+||.||+|.+... .++.||+|++... ..+.+|+++++
T Consensus 25 ~~~~~l~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~ 97 (352)
T 2jii_A 25 TSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQ 97 (352)
T ss_dssp HHSCCCCTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHH
T ss_pred hhhhhCCCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHH
Confidence 333444455444 47999999999999999999988752 3789999999764 35778999999
Q ss_pred hcCCCCcce---------------EEEEEEe-cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 042913 156 MLDHPFLPT---------------LYAHLEV-SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219 (317)
Q Consensus 156 ~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 219 (317)
.++||||++ +++++.. ++..|+||||+ +++|.+++.......+++..++.++.||+.||.|||
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999988877 6777765 78899999999 999999997754577999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCC--cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchh
Q 042913 220 ALGIIYRDLKPENILLREDG--HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRR 297 (317)
Q Consensus 220 ~~~ivHrDikp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~ 297 (317)
++||+||||||+|||++.++ .+||+|||+|+.+......... .........++..|++||... ......+
T Consensus 177 ~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~ 248 (352)
T 2jii_A 177 ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHEGDLEFISMDLHK-----GCGPSRR 248 (352)
T ss_dssp HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC---CTTSSCTTCSCTTTCCHHHHT-----TCCCCHH
T ss_pred hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccc---cccccccccCCccccCHHHHc-----cCCCCch
Confidence 99999999999999999988 9999999999876543321111 011112224555666666543 3345689
Q ss_pred hhccCCcccccccCCC-CC
Q 042913 298 EQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 298 ~~~~~~~~~~~e~~~G-~p 315 (317)
.|+|++|++++|+..| .|
T Consensus 249 ~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCT
T ss_pred hhHHHHHHHHHHHHhCCCC
Confidence 9999999999999998 44
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=263.52 Aligned_cols=201 Identities=21% Similarity=0.255 Sum_probs=158.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA---KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45789999999999999999998876 78999999997543222 123467899999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CEEEEECCS-EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred eEEEEEcCC-CCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999995 5888888654 35688999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...... ...++..|++||..... .......|+|++|++++|+..|.|
T Consensus 165 ~~~~~~----------~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 165 PNRAYT----------HQVVTRWYRAPELLFGA----RMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCC----------CSCCCCTTCCHHHHTTC----SCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccCC----------cccccccccCchHhhCC----CCCCchhhhHhHHHHHHHHHHCCC
Confidence 332111 12345667888765322 123578899999999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.14 Aligned_cols=201 Identities=19% Similarity=0.245 Sum_probs=159.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 455789999999999999999999876 78999999997532 2456667889999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999998642 24668999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ....++..|++||..... ......|+|+++++++|+..|
T Consensus 188 ~~~~~~----------~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g 232 (310)
T 2wqm_A 188 SKTTAA----------HSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAAL 232 (310)
T ss_dssp ---------------------CCSSCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCccc----------cccCCCeeEeChHHhCCC-----CCCchhhHHHHHHHHHHHHhC
Confidence 322111 112355667888765432 345789999999999999988
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=255.01 Aligned_cols=196 Identities=22% Similarity=0.325 Sum_probs=165.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+.|++++.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC-CCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999998876 789999999976532 23457789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 99 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999999999999854 56899999999999999999999999999999999999999999999999999765433211
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.....++..|++||.... .....+.|+|+++++++|+..|.
T Consensus 176 ----------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 176 ----------RNTFVGTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp ----------BCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ----------cCccCCCcCccCHHHHhc-----CCCCchhhhHHHHHHHHHHccCC
Confidence 111234455777776543 33456899999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=254.39 Aligned_cols=199 Identities=17% Similarity=0.214 Sum_probs=167.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec--
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-- 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 172 (317)
..+..++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567789999999999999999999875 68899999987766667778899999999999999999999999876
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
+..++||||+++++|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765557999999999999999999999999 9999999999999999999999999875
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...... ..++..|++||...... ........|+|++|++++|+..|
T Consensus 162 ~~~~~~---------------~~~t~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 162 SFQSPG---------------RMYAPAWVAPEALQKKP--EDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp TTSCTT---------------CBSCGGGSCHHHHHSCG--GGSCHHHHHHHHHHHHHHHHHHC
T ss_pred eecccC---------------ccCCccccChhhhccCC--CCCCCchhhHHHHHHHHHHHHhC
Confidence 432211 13345577777654321 12223479999999999999988
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=257.69 Aligned_cols=201 Identities=19% Similarity=0.246 Sum_probs=167.4
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC------CcceE
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP------FLPTL 165 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~ 165 (317)
...+.+..++|++.+.||+|+||.||+|.+...+++.||+|++... ....+.+.+|+++++.++|+ +++++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 3456777899999999999999999999985557899999999653 34456788899999888654 59999
Q ss_pred EEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc--------
Q 042913 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-------- 237 (317)
Q Consensus 166 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-------- 237 (317)
++++...+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 999999998765567899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccc
Q 042913 238 -----------DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQY 306 (317)
Q Consensus 238 -----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (317)
++.+||+|||+|+....... ...++..|++||... ........|+|+++++
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHHS-------------TLVSTRHYRAPEVIL-----ALGWSQPCDVWSIGCI 223 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCCC-------------SSCSCGGGCCHHHHT-----TSCCCTHHHHHHHHHH
T ss_pred CccccccccccCCCceEeeCcccccCccccc-------------cccCCccccChHHhh-----CCCCCcchhhHHHHHH
Confidence 66899999999976433211 123445567776654 3345678999999999
Q ss_pred ccccCCCC
Q 042913 307 SVEQPGGV 314 (317)
Q Consensus 307 ~~e~~~G~ 314 (317)
++|+..|.
T Consensus 224 l~el~~g~ 231 (339)
T 1z57_A 224 LIEYYLGF 231 (339)
T ss_dssp HHHHHHSS
T ss_pred HHHHHhCC
Confidence 99999994
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=264.77 Aligned_cols=197 Identities=21% Similarity=0.270 Sum_probs=156.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|++++.||+|+||.||+|.+.. +++.||+|++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999887 789999999965421 122224557999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||++ ++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.........
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9995 6999888664 4568999999999999999999999999999999999999999999999999997654332211
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
. ...++..|++||..... .......|+|++|++++|+..|.
T Consensus 158 ~----------~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~ 198 (324)
T 3mtl_A 158 D----------NEVVTLWYRPPDILLGS----TDYSTQIDMWGVGCIFYEMATGR 198 (324)
T ss_dssp ---------------CGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred c----------cccCcccccChhhhcCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 1 12345557777754321 23467899999999999999994
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=261.81 Aligned_cols=204 Identities=22% Similarity=0.331 Sum_probs=164.8
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
-..++|++++.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++...+..+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 345789999999999999999999887 7899999998654 3344567889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 93 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999988653 3568999999999999999999999999999999999999999999999999975421111
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......++..|++||....+...........|+|++|++++|+..|.
T Consensus 172 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 172 ----------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp ----------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred ----------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence 011112455668888876433333344567899999999999999883
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=256.68 Aligned_cols=200 Identities=18% Similarity=0.273 Sum_probs=166.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--ecCEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE--VSHYIC 176 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 176 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++..........+.+.+|+++++.++||||+++++++. ....+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4789999999999999999999887 7899999999876666677788999999999999999999999875 467899
Q ss_pred EEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 177 FLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALG-----IIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998653 2345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+......... ....++..|++||.... .....+.|+|+++++++|+..|.
T Consensus 164 ~~~~~~~~~~----------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 164 RILNHDTSFA----------KTFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp HHC---CHHH----------HHHHSCCTTCCHHHHHC-----C-CCHHHHHHHHHHHHHHHHHSS
T ss_pred eeeccccccc----------cccCCCccccChHHhcc-----CCCCchhhHHHHHHHHHHHHHCC
Confidence 8764432111 11235567888876543 23457899999999999999883
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=257.87 Aligned_cols=207 Identities=22% Similarity=0.301 Sum_probs=166.8
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEE---cCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHL---RDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL 169 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 169 (317)
....+..++|++++.||+|+||.||+|.+ ...+++.||+|++... .....+.+.+|+++++.++||||+++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34567778999999999999999999985 2336899999999764 345567889999999999999999999998
Q ss_pred EecC--EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeec
Q 042913 170 EVSH--YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247 (317)
Q Consensus 170 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG 247 (317)
...+ .+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 6543 689999999999999999764 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+++........... .....+...|++||.... .......|+|+++++++|+..|.
T Consensus 191 ~~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 191 LTKVLPQDKEYYKV-------KEPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp TCEECCSSCSEEEC-------SSCCSCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccccccccc-------ccCCCCceeEECchhhcC-----CCCCchhhHHHHHHHHHHHHhcC
Confidence 99877554332111 111123344777776543 33467899999999999999883
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=257.14 Aligned_cols=202 Identities=22% Similarity=0.319 Sum_probs=161.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhcCCCCcceEEEEE--EecCE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS--AKKLSHVQMEAEILSMLDHPFLPTLYAHL--EVSHY 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~ 174 (317)
.++|++.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+++++.++||||+++++++ .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECC-CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5789999999999999999998876 7899999999765322 23457789999999999999999999998 44567
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.|+||||++++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999655 77777666667899999999999999999999999999999999999999999999999999987653
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... ......++..|++||...... .....+.|+|+++++++|+..|
T Consensus 162 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g 209 (305)
T 2wtk_C 162 FAADD--------TCRTSQGSPAFQPPEIANGLD---TFSGFKVDIWSAGVTLYNITTG 209 (305)
T ss_dssp TCSSC--------EECCCCSCGGGCCHHHHTCCS---CEESHHHHHHHHHHHHHHHHHS
T ss_pred ccccc--------ccccCCCCCCCcChhhccCcc---cCCcchhhHHHHHHHHHHHHhC
Confidence 22111 111123455667776553211 1225689999999999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.92 Aligned_cols=202 Identities=17% Similarity=0.192 Sum_probs=158.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE-EecCEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL-EVSHYI 175 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 175 (317)
..+|++.+.||+|+||.||+|.+.... ...+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 467999999999999999999875422 3368899886532 445667899999999999999999999985 456678
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999654 466899999999999999999999999999999999999999999999999999866432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... .......++..|++||. ........+.|+|+++++++|+..|
T Consensus 182 ~~~~~------~~~~~~~~~~~y~aPE~-----~~~~~~~~~~Di~slG~il~~l~~~ 228 (298)
T 3f66_A 182 EYYSV------HNKTGAKLPVKWMALES-----LQTQKFTTKSDVWSFGVLLWELMTR 228 (298)
T ss_dssp GGCBC-----------CCBCGGGSCHHH-----HHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred chhcc------ccccCCCCCccccChHH-----hcCCCCChHHHHHHHHHHHHHHHhC
Confidence 21110 01111122334555554 4444556789999999999999884
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=260.61 Aligned_cols=212 Identities=20% Similarity=0.226 Sum_probs=165.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----e
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE----V 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~ 171 (317)
.+..++|++.+.||+|+||.||+|.... +++.||+|++... .....+.+.+|+++++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 3556799999999999999999999876 7899999998654 4456678899999999999999999999986 3
Q ss_pred cCEEEEEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
....|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 45789999999999999988652 3467999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
............ ...........++..|++||...... ......+.|+|+++++++|+..|
T Consensus 182 ~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 182 NQACIHVEGSRQ-ALTLQDWAAQRCTISYRAPELFSVQS--HCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp EESCEEEESHHH-HHHHHHHHHHHSCGGGCCGGGSSCCS--EEEECTHHHHHHHHHHHHHHHHS
T ss_pred hhcccccccccc-cccccccccccCCcccCCHhHhccCC--CcCCCchhhHHHHHHHHHHHHhC
Confidence 765421110000 00000111223456677887654321 12235689999999999999988
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.85 Aligned_cols=201 Identities=24% Similarity=0.244 Sum_probs=163.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+++++.++||||+++++++...+..+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 34468888899999999999999754 588999999976432 222236889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCC--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 177 FLIDYCPNGDLHSLLPKQP--NNRFSLQAVRFFAAEVLVGLEYLHAL---GIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~---~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999997653 23489999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.......... ...++..|++||... ........|+|++|++++|+..|.
T Consensus 184 ~~~~~~~~~~---------~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 184 MDYKDTHVTT---------AVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp CCSSSSCEEC---------CCCSCGGGCCHHHHH-----HSEECHHHHHHHHHHHHHHHHHCC
T ss_pred cCcccccccc---------cccCCcCccCHHHhc-----cCCCCccccchhHHHHHHHHHhCC
Confidence 6543322111 113455566666543 334567899999999999999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.17 Aligned_cols=208 Identities=18% Similarity=0.192 Sum_probs=162.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS----- 172 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 172 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 45799999999999999999999877 78999999996432 345556788999999999999999999987654
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
...|+||||+ .++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELM-QTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-CccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 6799999999 4799998865 46899999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...........+.........++..|++||.... ........|+|++|++++|+..|.|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHS----CCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccCccccccchhhccccccccCCeeecc----CCCccchhhHHHHHHHHHHHHhCCC
Confidence 6443322211111111122234555666664321 2334678999999999999998843
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=251.71 Aligned_cols=203 Identities=21% Similarity=0.277 Sum_probs=162.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++.+.||+|+||.||+|.+... ++..||+|++.... .....+.+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 45678999999999999999999987642 23469999997653 345567899999999999999999999998754
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 568999999999999999654 3568999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
...... .....++..|++||.. .......+.|+|+++++++|+.. | .|
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~llt~g~~p 214 (281)
T 3cc6_A 165 DEDYYK---------ASVTRLPIKWMSPESI-----NFRRFTTASDVWMFAVCMWEILSFGKQP 214 (281)
T ss_dssp -----------------CCCCCGGGCCHHHH-----HHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cccccc---------cccCCCCcceeCchhh-----ccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence 432111 1111233456677654 33345678999999999999987 7 44
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=260.86 Aligned_cols=205 Identities=19% Similarity=0.250 Sum_probs=166.7
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC----CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+... ....||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 46678999999999999999999988651 12479999997653 345567889999999999 8999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
..+.+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 9999999999999999999986431 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
+.+||+|||+|+.......... .....++..|++||.... .......|+|+++++++|+.. |.
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIV--------KGNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEE--------CSSCEECGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CeEEECccccccccccccceee--------cCCCCCCccccCHHHhcc-----CCCChHHHHHHHHHHHHHHHcCCC
Confidence 9999999999976543322111 111123445777775542 335678999999999999997 73
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=272.13 Aligned_cols=201 Identities=22% Similarity=0.282 Sum_probs=161.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+++++.++||||+++++++.. +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC--CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 45677899999999999999999998875 567999999765433 3568899999999999999999999876 67
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 89999999999999999754445689999999999999999999999999999999999999999999999999986643
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
..... .....+...|++||.... .....+.|+|+++++++|+.. | .|
T Consensus 333 ~~~~~---------~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g~~P 381 (452)
T 1fmk_A 333 NEYTA---------RQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVP 381 (452)
T ss_dssp -------------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred Cceec---------ccCCcccccccCHhHHhc-----CCCCccccHHhHHHHHHHHHhCCCCC
Confidence 22110 011123345777776542 234678999999999999998 6 44
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=261.21 Aligned_cols=202 Identities=18% Similarity=0.219 Sum_probs=155.4
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceE----EEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANF----ALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|.+.. +++.+ ++|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 34667899999999999999999999876 56555 566554322 2334567889999999999999999999998
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
... .++|++|+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred cCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 765 78899999999999999765 3569999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........... ....++..|++||... ......+.|+|+++++++|+.. |
T Consensus 166 ~~~~~~~~~~~--------~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~~g 216 (327)
T 3lzb_A 166 LLGAEEKEYHA--------EGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFG 216 (327)
T ss_dssp ----------------------CCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EccCccccccc--------cCCCccccccCHHHHc-----CCCCChHHHHHHHHHHHHHHHHCC
Confidence 76443221111 0112233466666543 3445678999999999999987 7
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=261.67 Aligned_cols=198 Identities=18% Similarity=0.187 Sum_probs=162.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----HY 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 174 (317)
++|++++.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECC-CCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 689999999999999999998877 78999999997532 445567889999999999999999999998654 46
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~iv~e~~-~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLM-ETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEccc-CcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 89999999 5699998865 4599999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ......++..|++||.... ........|+|+++++++|+..|.
T Consensus 181 ~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 181 DHDHTG-------FLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp GGCBCC-------TTCCCCSCGGGCCHHHHHT----BCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccc-------cccccccccCCCCCHHhcC----CCCCCcchhHHHHHHHHHHHHHCC
Confidence 322110 0111244555666665321 223467899999999999999994
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=261.58 Aligned_cols=206 Identities=17% Similarity=0.167 Sum_probs=166.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL 169 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 169 (317)
...+..++|++.+.||+|+||.||+|.+.. .+++.||+|++.... .......+.+|+++++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345667899999999999999999998762 246789999997543 344556789999999999999999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcE
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQP--------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHI 241 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~ 241 (317)
...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999986521 2457899999999999999999999999999999999999999999
Q ss_pred EEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 242 MLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 242 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
||+|||+++.......... .....++..|++||... ........|+|++|++++|+.. |
T Consensus 178 kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp EECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred EECcCcccccccccccccc--------ccCCCCCCCccChhhhc-----cCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999999976543221111 11112234466666543 3335678999999999999987 5
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=264.21 Aligned_cols=199 Identities=22% Similarity=0.263 Sum_probs=163.9
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--------CCCcce
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--------HPFLPT 164 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~ 164 (317)
..+.+..++|++++.||+|+||.||+|.+.. +++.||||++... ....+.+.+|+++++.++ |+||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3456667899999999999999999998877 7899999999753 344567889999999885 788999
Q ss_pred EEEEEE----ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCC
Q 042913 165 LYAHLE----VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDG 239 (317)
Q Consensus 165 ~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~ 239 (317)
+++++. ....+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 556899999999 77777777665557799999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------------cEEEeeecccccCCCCCCeeecccccccccc
Q 042913 240 -------------------------------------------------HIMLSDFDLCFQSDVVPTLVETNVGSATRRR 270 (317)
Q Consensus 240 -------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 270 (317)
.+||+|||+|+...... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------------~ 251 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------------T 251 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------------C
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------------c
Confidence 79999999997654321 1
Q ss_pred cccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 271 RRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 271 ~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...++..|++||.... ......+|+|+++++++|+..|.
T Consensus 252 ~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~ 290 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIG-----SGYNTPADIWSTACMAFELATGD 290 (397)
T ss_dssp SCCSCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCcccCChhhcC-----CCCCcHHHHHHHHHHHHHHhhCC
Confidence 1134556777776543 33457899999999999999993
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.79 Aligned_cols=197 Identities=19% Similarity=0.318 Sum_probs=164.6
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+.+..++|++.+.||+|+||.||+|.+...+++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 4556777999999999999999999999875468999999986532 345567788999999999999999999999876
Q ss_pred CE-----EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeec
Q 042913 173 HY-----ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFD 247 (317)
Q Consensus 173 ~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG 247 (317)
+. .|+||||+++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 65 7999999999999988743 69999999999999999999999999999999999999875 99999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+++...... ...++.+|++||..... ...+.|+|+++++++|+..|.|
T Consensus 227 ~a~~~~~~~--------------~~~gt~~y~aPE~~~~~------~~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 227 AVSRINSFG--------------YLYGTPGFQAPEIVRTG------PTVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp TCEETTCCS--------------CCCCCTTTSCTTHHHHC------SCHHHHHHHHHHHHHHHHSCCC
T ss_pred cchhcccCC--------------ccCCCccccCHHHHcCC------CCCceehhhhHHHHHHHHhCCC
Confidence 998765431 12466778888876432 2678999999999999998855
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=251.32 Aligned_cols=202 Identities=23% Similarity=0.283 Sum_probs=168.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-------hcHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-------LSAKKLSHVQMEAEILSMLD-HPFLPTLYAHL 169 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 169 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+.+|+++++.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcC-cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45899999999999999999999877 78999999997542 11234567889999999996 99999999999
Q ss_pred EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 170 EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 170 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999999653 56899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCccccccccc-ceeccchhhhccCCcccccccCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM-EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~-~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ....++..|++||....... .........|+|+++++++|+..|
T Consensus 172 ~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 172 CQLDPGEKL-----------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp EECCTTCCB-----------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred hhcCCCccc-----------ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 876543211 11234556777776542211 122346789999999999999988
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=257.07 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=165.5
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++.+.||+|+||.||+|.+. ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 456689999999999999999999863 2367899999997653 345557889999999999 6999999999987
Q ss_pred ecC-EEEEEEcccCCCChhcccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 042913 171 VSH-YICFLIDYCPNGDLHSLLPKQPN--------------NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235 (317)
Q Consensus 171 ~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill 235 (317)
..+ .+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 58999999999999999976432 128899999999999999999999999999999999999
Q ss_pred ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
+.++.+||+|||+++.......... .....++..|++||... ......+.|+|+++++++|+.. |
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~t~g 247 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVR--------KGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLG 247 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEE--------ETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCCEEECCCccccccccCcccee--------ccCCCcceeecCchhhc-----cccccchhHHHHHHHHHHHHHhCC
Confidence 9999999999999987654332111 11123344577777653 2334678999999999999986 7
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=277.00 Aligned_cols=200 Identities=23% Similarity=0.295 Sum_probs=164.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+++|+.++|+||+++++++.. +.+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC--CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4566889999999999999999998875 577999999765432 3568899999999999999999999876 678
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999999997544456899999999999999999999999999999999999999999999999999865432
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
.. .......+...|++||.... .....+.|+|+++++++|+.. | .|
T Consensus 417 ~~---------~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 417 EY---------TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp HH---------HTTCSTTSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred ce---------ecccCCcCcccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 10 00111123345777776542 334578999999999999998 6 44
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=271.72 Aligned_cols=197 Identities=21% Similarity=0.271 Sum_probs=156.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV---- 171 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 171 (317)
.....+|++++.||+|+||.||+|.+.. +++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 3445689999999999999999999887 78999999986542 223469999999999999999998853
Q ss_pred --cCEEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-CcEEEeee
Q 042913 172 --SHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED-GHIMLSDF 246 (317)
Q Consensus 172 --~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~-~~~kl~DF 246 (317)
..++++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+||
T Consensus 123 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 123 KDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp TTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence 234789999995 566665542 234679999999999999999999999999999999999999965 57899999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|+.+...... ....++..|++||..... .......|+|++|++++|+..|.|
T Consensus 202 G~a~~~~~~~~~-----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 202 GSAKQLVRGEPN-----------VSYICSRYYRAPELIFGA----TDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp TTCEECCTTCCC-----------CSCCSCTTSCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhhhcccCCCc-----------eeeeeCCCcCCHHHHcCC----CCCCchhhhHHHHHHHHHHHhCCC
Confidence 999876432211 112345668888866422 134578999999999999999943
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=250.86 Aligned_cols=195 Identities=21% Similarity=0.346 Sum_probs=152.5
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc--HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS--AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+++++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 356689999999999999999999865 689999998764322 234567899999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCCcEEEcc--------CCcEE
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG---IIYRDLKPENILLRE--------DGHIM 242 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivHrDikp~Nill~~--------~~~~k 242 (317)
..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred ceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999999999999853 56999999999999999999999999 899999999999986 67899
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+|||+++........ ...++..|++||.. .........|+|+++++++|+..|
T Consensus 157 l~Dfg~~~~~~~~~~~------------~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKM------------SAAGAYAWMAPEVI-----RASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp ECCCCC-------------------------CCGGGSCHHHH-----HHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred EccCCccccccccccc------------CCCCccceeCHHHh-----ccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999765432211 11344556666654 333456789999999999999988
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.19 Aligned_cols=201 Identities=18% Similarity=0.238 Sum_probs=159.4
Q ss_pred ccCCeEEe-eeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 98 HLRHLKLV-RHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 98 ~~~~y~i~-~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
....+.+. +.||+|+||.||+|.+.. ..++.||||+++.........+.+.+|+++++.++||||+++++++.. +.+
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 34455554 489999999999996642 256889999998765555666789999999999999999999999864 458
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 445 ~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 899999999999999965 367999999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........ ...++..|++||.. .......+.|+|+++++++|+.. |
T Consensus 523 ~~~~~~~~-------~~~~t~~y~APE~~-----~~~~~~~~sDvwSlGv~l~ellt~G 569 (635)
T 4fl3_A 523 ENYYKAQT-------HGKWPVKWYAPECI-----NYYKFSSKSDVWSFGVLMWEAFSYG 569 (635)
T ss_dssp -------------------CGGGSCHHHH-----HHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccc-------CCCCceeeeChhhh-----cCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 32111100 11223346666654 44445678999999999999987 7
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=255.68 Aligned_cols=216 Identities=20% Similarity=0.231 Sum_probs=175.7
Q ss_pred CCcchhhHHHhhccCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh--hcHHHHHHHHHHHHHHH
Q 042913 78 SDLHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--LSAKKLSHVQMEAEILS 155 (317)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~ 155 (317)
..+.+.++..+++++....+ |...+.||+|+||.||+|.+. ++.||+|++.... ......+.+.+|+.+++
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~----~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPI----SVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBT----TTTCCEEEECSSEEEEEEESS---SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CcccHHHHHHHHcccccccc----cccCCccccCCCeEEEEEEEC---CceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 45678888888887776533 555678999999999999753 6899999986532 12345677899999999
Q ss_pred hcCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ-PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 156 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
.++||||+++++++...+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 999999999999999999999999999999999998643 2356899999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
++.++.+||+|||+++......... ......++..|++||..... ...+.|+|++|++++|+..|.
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~------~~~~~Dv~slG~il~~l~~g~ 231 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTV--------MTSRIVGTTAYMAPEALRGE------ITPKSDIYSFGVVLLEIITGL 231 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCE--------ECSSCCSCGGGCCHHHHTTE------ECTHHHHHHHHHHHHHHHHCC
T ss_pred EcCCCcEEEeecccccccccccccc--------cccccCCCcCcCChHHhcCC------CCccchhHHHHHHHHHHHHCC
Confidence 9999999999999998665432211 11122456678888865432 456889999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=254.12 Aligned_cols=195 Identities=24% Similarity=0.322 Sum_probs=162.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 45789999999999999999999876 78999999997642 2334568899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~~~ 254 (317)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999998653 568999999999999999999999999999999999999 7788999999999875432
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. .....++..|++||.... .......|+|++|++++|+..|.
T Consensus 162 ~~------------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 162 GI------------MSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp BT------------THHHHSCCCBCCTTTBSS-----CSCCHHHHHHHHHHHHHHHHHSS
T ss_pred Cc------------cccccCCCCccChHHhcc-----CCCCchhhHHHHHHHHHHHHHCC
Confidence 11 011235566777776543 33467899999999999999983
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=253.02 Aligned_cols=203 Identities=18% Similarity=0.197 Sum_probs=160.3
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE-E
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI-C 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~ 176 (317)
-.|++.+.||+|+||.||+|.+... .+..||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4677889999999999999987541 23379999986532 445667889999999999999999999999766554 9
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999653 4668999999999999999999999999999999999999999999999999997654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... .......++..|++||.. .......+.|+|+++++++|+..| .|
T Consensus 179 ~~~~------~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~~ 227 (298)
T 3pls_A 179 YYSV------QQHRHARLPVKWTALESL-----QTYRFTTKSDVWSFGVLLWELLTRGAP 227 (298)
T ss_dssp GGCS------CCSSCTTCGGGGSCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred cccc------ccCcCCCCCccccChhhh-----ccCCCChhhchhhHHHHHHHHhhCCCC
Confidence 1100 111112233345555544 444456789999999999999884 44
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=258.40 Aligned_cols=199 Identities=21% Similarity=0.234 Sum_probs=161.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEE-----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLE----- 170 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~----- 170 (317)
.++|++.+.||+|+||.||+|.+...+++.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 47899999999999999999998644788999999975433222223455677777665 8999999999987
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
....+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5677999999995 799999987656679999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... .....++..|++||..... ......|+|+++++++|+..|.
T Consensus 169 ~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~ 216 (326)
T 1blx_A 169 IYSFQMA-----------LTSVVVTLWYRAPEVLLQS-----SYATPVDLWSVGCIFAEMFRRK 216 (326)
T ss_dssp CCCGGGG-----------GCCCCCCCTTCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCCCC-----------ccccccccceeCHHHHhcC-----CCCcchhHHHHHHHHHHHHcCC
Confidence 6543211 1122455667777766432 3457899999999999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.48 Aligned_cols=193 Identities=19% Similarity=0.287 Sum_probs=161.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE---
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI--- 175 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--- 175 (317)
.++|++.+.||+|+||.||+|.+.. +++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC-CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4799999999999999999999887 899999999987666667778899999999999999999999999876654
Q ss_pred ---EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 176 ---CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 176 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
|+||||+ .++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 120 ~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFM-QTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECC-CEEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEccc-cccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9999999 478888873 34999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+.... ...++..|++||.... ........|+|+++++++|+..|.
T Consensus 195 ~~~~~-------------~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 195 DAEMT-------------GYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp ------------------CTTCCCTTSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccCcC-------------CcccCccccCHHHhcC----CCCCCcHHhHHHHHHHHHHHHhCC
Confidence 43211 1234556777776532 133467899999999999999993
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=278.69 Aligned_cols=203 Identities=21% Similarity=0.254 Sum_probs=160.5
Q ss_pred ccccCCeEEee-eecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVR-HLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~-~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+...++.+.+ .||+|+||.||+|.+.. ..+..||||+++... .....+.+.+|+++|+.++||||+++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 34556777777 89999999999998763 245679999997642 23445778999999999999999999999876 5
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 689999999999999998654 4569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
........ .....+...|++||.... .....+.|+|++|++++|+.. |
T Consensus 488 ~~~~~~~~-------~~~~~~~~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G 536 (613)
T 2ozo_A 488 ADDSYYTA-------RSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYG 536 (613)
T ss_dssp ---------------------CCTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCceeee-------ccCCCCccceeCHhhhcC-----CCCCcHHHHHHHHHHHHHHHHCC
Confidence 43221111 011122346788876642 344678999999999999986 7
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=261.35 Aligned_cols=208 Identities=19% Similarity=0.225 Sum_probs=158.4
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhhcH---------HHHHHHHHHHHHHHhcCCCCcceE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSA---------KKLSHVQMEAEILSMLDHPFLPTL 165 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~ 165 (317)
+..++|++.+.||+|+||.||+|.+.. .++..||+|++....... .....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445799999999999999999998864 246789999987542111 111235678889999999999999
Q ss_pred EEEEEe----cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC--
Q 042913 166 YAHLEV----SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-- 239 (317)
Q Consensus 166 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-- 239 (317)
++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999987 78899999999 99999999764 4799999999999999999999999999999999999999877
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.+||+|||+|+.+......... .........++..|++||... ......+.|+|+++++++|+..| .|
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQY---QENPRKGHNGTIEFTSLDAHK-----GVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCC---CCCGGGCSCSCTTTCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cEEEEeCCCceecccccccccc---hhccccccCCCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999876543221100 001112234566677777554 33457899999999999999998 44
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.63 Aligned_cols=195 Identities=22% Similarity=0.313 Sum_probs=156.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------ 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 171 (317)
..++|++++.||+|+||.||+|.+.. +++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999877 89999999986542 123469999999999999999999843
Q ss_pred --------------------------------cCEEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHH
Q 042913 172 --------------------------------SHYICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEY 217 (317)
Q Consensus 172 --------------------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~ 217 (317)
..++++||||++ ++|.+.+.. .....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345899999995 687777653 235679999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEc-cCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccch
Q 042913 218 LHALGIIYRDLKPENILLR-EDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPR 296 (317)
Q Consensus 218 LH~~~ivHrDikp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~ 296 (317)
||++||+||||||+|||++ .++.+||+|||+|+......... ...++..|++||..... .....
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~-----------~~~~t~~y~aPE~~~~~----~~~~~ 221 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV-----------AYICSRFYRAPELMLGA----TEYTP 221 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC-----------CCCCCSSCCCHHHHTTC----SSCCT
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc-----------CcccCCCccCHHHhcCC----CCCCc
Confidence 9999999999999999998 68899999999998764433211 11344557777765321 22457
Q ss_pred hhhccCCcccccccCCCCC
Q 042913 297 REQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 297 ~~~~~~~~~~~~e~~~G~p 315 (317)
..|+|++|++++|+..|.|
T Consensus 222 ~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 222 SIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp HHHHHHHHHHHHHHHHSSC
T ss_pred chhhhhHHHHHHHHHhCCC
Confidence 8999999999999999943
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=253.49 Aligned_cols=202 Identities=21% Similarity=0.258 Sum_probs=157.8
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE---- 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 170 (317)
+....++|++++.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETT-TTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 34456899999999999999999999887 7899999998754 4556678899999999999999999999873
Q ss_pred ----------ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCC
Q 042913 171 ----------VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDG 239 (317)
Q Consensus 171 ----------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~ 239 (317)
.....|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 4478999999995 799999854 5689999999999999999999999999999999999997 567
Q ss_pred cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 240 HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 240 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.+||+|||+++.......... ......++..|++||..... .......|+|+++++++|+..|.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKG-------HLSEGLVTKWYRSPRLLLSP----NNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp EEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHCT----TCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eEEEccCccccccCCCccccc-------ccccccccccccCcHHhcCc----ccCCchhhhHhHHHHHHHHHhCC
Confidence 999999999987653221111 11122345667888765321 23457899999999999999983
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=254.41 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=159.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
...++|++.+.||+|+||.||+|.+.. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 456789999999999999999999876 78999999997642 2356788999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999998633 4678999999999999999999999999999999999999999999999999997654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.. .....++..|++||.... .......|+|+++++++|+..|
T Consensus 180 ~~----------~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g 221 (314)
T 3com_A 180 AK----------RNTVIGTPFWMAPEVIQE-----IGYNCVADIWSLGITAIEMAEG 221 (314)
T ss_dssp SC----------BCCCCSCGGGCCHHHHSS-----SCBCTTHHHHHHHHHHHHHHHS
T ss_pred cc----------cCccCCCCCccChhhcCC-----CCCCccccHHHHHHHHHHHHhC
Confidence 11 111234455677766543 3355788999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=258.23 Aligned_cols=208 Identities=19% Similarity=0.263 Sum_probs=148.6
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45677899999999999999999998776 68999999986543 23445678899999999999999999999999999
Q ss_pred EEEEEcccCCCChhccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecc
Q 042913 175 ICFLIDYCPNGDLHSLLPK------QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDL 248 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~ 248 (317)
.++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999863 1245689999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+............ .......++..|++||..... .......|+|+++++++|+..|
T Consensus 168 ~~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 168 SAFLATGGDITRN-----KVRKTFVGTPCWMAPEVMEQV----RGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp HHHCC--------------------CCCTTCCHHHHHHH----HCCCTHHHHHHHHHHHHHHHHS
T ss_pred hheeccCCCccch-----hhhcccCCCccccCHHHhccc----cCCCchhhHHHHHHHHHHHHhC
Confidence 9776543221110 011122455567777755321 2246789999999999999988
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=252.02 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=167.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+++++.++||||+++++++...+.+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 35789999999999999999999876 78999999998765444556788999999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC---CcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED---GHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~---~~~kl~DFG~a~~~~~ 254 (317)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999988653 568999999999999999999999999999999999999754 4799999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ....++..|++||..... ...+.|+|+++++++|+..|
T Consensus 177 ~~~~-----------~~~~~~~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g 218 (287)
T 2wei_A 177 NTKM-----------KDRIGTAYYIAPEVLRGT------YDEKCDVWSAGVILYILLSG 218 (287)
T ss_dssp CSSC-----------SCHHHHHTTCCHHHHTTC------CCTHHHHHHHHHHHHHHHHS
T ss_pred CCcc-----------ccccCcccccChHHhcCC------CCCchhhHhHHHHHHHHHhC
Confidence 3211 112355678888876532 45688999999999999988
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=257.70 Aligned_cols=204 Identities=20% Similarity=0.274 Sum_probs=168.9
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHH---------------HHHHHHHHHHHHHhc
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAK---------------KLSHVQMEAEILSML 157 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l 157 (317)
..+.+..++|++.+.||+|+||.||+|.+ +++.||+|++........ ..+.+.+|+.+++.+
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 44566779999999999999999999988 489999999976533221 126789999999999
Q ss_pred CCCCcceEEEEEEecCEEEEEEcccCCCChhcc------cccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCC
Q 042913 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSL------LPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKP 230 (317)
Q Consensus 158 ~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp 230 (317)
+||||+++++++...+..++||||+++++|.++ +.......+++..++.++.||+.||.|||+ .||+||||||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 999999999999999999999999999999999 655446789999999999999999999999 9999999999
Q ss_pred CcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 231 ENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 231 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
+|||++.++.+||+|||++....... .....++..|++||...... .......|+|+++++++|+
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVDKK------------IKGSRGTYEFMPPEFFSNES---SYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTE------------ECSSCSCGGGCCGGGGSSCC---CEEHHHHHHHHHHHHHHHH
T ss_pred HhEEEcCCCcEEEecccccccccccc------------ccCCCCCcCccCchhhcCCC---CCCcchhhHHHHHHHHHHH
Confidence 99999999999999999997653321 11224555677777654321 1113489999999999999
Q ss_pred CCCC
Q 042913 311 PGGV 314 (317)
Q Consensus 311 ~~G~ 314 (317)
..|.
T Consensus 246 ~~g~ 249 (348)
T 2pml_X 246 FYNV 249 (348)
T ss_dssp HHSS
T ss_pred HhCC
Confidence 9983
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=256.90 Aligned_cols=212 Identities=19% Similarity=0.191 Sum_probs=155.5
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEE----
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLE---- 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---- 170 (317)
.+...+|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3455689999999999999999999877 7899999998654 4455677899999999996 999999999983
Q ss_pred ----ecCEEEEEEcccCCCChhccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEccCCcEEE
Q 042913 171 ----VSHYICFLIDYCPNGDLHSLLPK-QPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLREDGHIML 243 (317)
Q Consensus 171 ----~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~~~~~~kl 243 (317)
....+++||||+ +|+|.+++.. .....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 345689999999 5899888854 22456999999999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCCeeeccc--ccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNV--GSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+|||+++............. ..........++..|++||..... .........|+|+++++++|+..|
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY--SNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CC--TTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc--ccCCCChHHhHHHHHHHHHHHHhC
Confidence 99999987765433211100 000111123355567777765211 222345789999999999999988
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=248.77 Aligned_cols=174 Identities=12% Similarity=0.060 Sum_probs=151.9
Q ss_pred CCCc-cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 93 SNGK-LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 93 ~~~~-~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+. +..++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 3344 667899999999999999999999876 7899999999865433 466678999999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
..+..|+||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|..
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~- 176 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM- 176 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC-
T ss_pred ECCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc-
Confidence 99999999999999999999943 2 355678889999999999999999999999999999999999999855432
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+| ...+.|+|+++++++|+..|
T Consensus 177 -----------------------------~~------------~~~~~Di~slG~il~elltg 198 (286)
T 3uqc_A 177 -----------------------------PD------------ANPQDDIRGIGASLYALLVN 198 (286)
T ss_dssp -----------------------------TT------------CCHHHHHHHHHHHHHHHHHS
T ss_pred -----------------------------CC------------CCchhHHHHHHHHHHHHHHC
Confidence 11 35788999999999999988
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=258.21 Aligned_cols=190 Identities=15% Similarity=0.114 Sum_probs=153.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh------cHHHHHHHHHHHHHHHhcC---------CCC
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------SAKKLSHVQMEAEILSMLD---------HPF 161 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~~ 161 (317)
+..++|++++.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++ |+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 4457899999999999999999987 369999999976532 2233467888999988885 888
Q ss_pred cceEEEEEE------------------------------ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHH
Q 042913 162 LPTLYAHLE------------------------------VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211 (317)
Q Consensus 162 iv~~~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi 211 (317)
|+++++.+. ..+.+|+||||+++|++.+.+.+ ..+++..++.++.||
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQL 170 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHH
Confidence 888888753 26789999999999977776633 568999999999999
Q ss_pred HHHHHHHH-HcCCeeccCCCCcEEEccCC--------------------cEEEeeecccccCCCCCCeeecccccccccc
Q 042913 212 LVGLEYLH-ALGIIYRDLKPENILLREDG--------------------HIMLSDFDLCFQSDVVPTLVETNVGSATRRR 270 (317)
Q Consensus 212 ~~al~~LH-~~~ivHrDikp~Nill~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 270 (317)
+.||.||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------------- 235 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------------- 235 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------------
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------------
Confidence 99999999 99999999999999999887 8999999999865431
Q ss_pred cccccCCCCCcccccccccceeccchhhhccCCccc-ccccCCC
Q 042913 271 RRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQY-SVEQPGG 313 (317)
Q Consensus 271 ~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~-~~e~~~G 313 (317)
...++..|++||...+.. ....|+|++..+ ..++..|
T Consensus 236 ~~~gt~~y~aPE~~~g~~------~~~~Diwsl~~~~~~~~~~g 273 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG------DYQFDIYRLMKKENNNRWGE 273 (336)
T ss_dssp EEECCCCTTCSGGGCCCS------SHHHHHHHHHHHHHTTCTTS
T ss_pred cEEEeecccChhhhcCCC------ccceehhhhhCCCCcccccc
Confidence 124667788888765432 568999998766 5555556
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=271.02 Aligned_cols=200 Identities=14% Similarity=0.082 Sum_probs=155.6
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHH---HHHhcCCCCcceEE-------E
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAE---ILSMLDHPFLPTLY-------A 167 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~ 167 (317)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+.+|++ +++.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECC-CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 5789999999999999999998876 789999999975422 3345577889995 45556799999988 7
Q ss_pred EEEecC-----------------EEEEEEcccCCCChhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 042913 168 HLEVSH-----------------YICFLIDYCPNGDLHSLLPKQP-----NNRFSLQAVRFFAAEVLVGLEYLHALGIIY 225 (317)
Q Consensus 168 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH 225 (317)
++...+ ..|+||||+ +|+|.+++.... ...+++..++.|+.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 766553 289999999 789999997531 112334788889999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCccccccc------ccceeccchhhh
Q 042913 226 RDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQEN------VMEFVAEPRREQ 299 (317)
Q Consensus 226 rDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~------~~~~~~~~~~~~ 299 (317)
|||||+|||++.++.+||+|||+|+..+... ....+ ..|++||..... ...........|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCcc-------------cCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 9999999999999999999999998533211 11234 678888876543 001114468899
Q ss_pred ccCCcccccccCCCC
Q 042913 300 REHPAQYSVEQPGGV 314 (317)
Q Consensus 300 ~~~~~~~~~e~~~G~ 314 (317)
+|++|++++|+..|.
T Consensus 296 vwSlG~il~elltg~ 310 (377)
T 3byv_A 296 AWALGLVIYWIWCAD 310 (377)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHHCC
Confidence 999999999999993
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=257.26 Aligned_cols=199 Identities=23% Similarity=0.320 Sum_probs=159.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS------AKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ......+.+|+++++.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45789999999999999999999887 7899999999754321 1233457899999999999999999999876
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc---EEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH---IMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~---~kl~DFG~ 248 (317)
+. +|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 55 8999999999999999854 467999999999999999999999999999999999999987654 99999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
++....... .....++..|++||..... .........|+|++|++++|+..|
T Consensus 164 ~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g 215 (322)
T 2ycf_A 164 SKILGETSL-----------MRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSG 215 (322)
T ss_dssp CEECCCCHH-----------HHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred ceecccccc-----------cccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhC
Confidence 987643211 1112456678888865211 112235789999999999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=256.96 Aligned_cols=207 Identities=19% Similarity=0.206 Sum_probs=161.1
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEc----CCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|.+. ..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3567789999999999999999999843 2267899999996442 4455567889999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPN-----NRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIM 242 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~k 242 (317)
.....|+||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999976432 45899999999999999999999999999999999999984 44699
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
|+|||+++......... ......++..|++||.... .......|+|++|++++|+.. | .|
T Consensus 184 l~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYR--------KGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp ECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ECccccccccccccccc--------cCCCcCCCcceeCHhHhcC-----CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999997543322110 0111123445677775532 334678999999999999986 7 44
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=266.73 Aligned_cols=204 Identities=20% Similarity=0.317 Sum_probs=162.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 175 (317)
...++|++++.||+|+||.||+|.+.. +++.||||++...... ..+.+|+++++.++| ++|+.+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 346899999999999999999999876 7899999998754322 347789999999986 5666777777888999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQS 252 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~ 252 (317)
++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.+
T Consensus 79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999999 99999999754 4579999999999999999999999999999999999999 68899999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.......... ........++..|++||. ........+.|+|+++++++|+..| .|
T Consensus 157 ~~~~~~~~~~---~~~~~~~~gt~~Y~aPE~-----~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 157 RDTSTHQHIP---YRENKNLTGTARYASVNT-----HLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp BCTTTCCBCC---CCCCCCCCSCTTTCCHHH-----HTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCccccccc---cccccccCCCccccCHHH-----hcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 5433211100 001112234445555554 4445567899999999999999998 44
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=251.35 Aligned_cols=204 Identities=22% Similarity=0.268 Sum_probs=156.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
.+..++|++.+.||+|+||.||+|.+...++. .||+|++...... ....+.+.+|+++++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 45668999999999999999999987543333 6899998765332 25567889999999999999999999999876
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 88999999999999998654 356899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... .....++..|++||... ........|+|+++++++|+.. |
T Consensus 172 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g 221 (291)
T 1u46_A 172 PQNDDHYVM-------QEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYG 221 (291)
T ss_dssp CC-CCEEEC------------CCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred cccccchhh-------hccCCCCceeeCchhhc-----CCCCCchhhHHHHHHHHHHHHhCC
Confidence 543322111 11123344577777653 2334678999999999999997 7
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=249.88 Aligned_cols=206 Identities=22% Similarity=0.294 Sum_probs=159.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------- 171 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 171 (317)
.++|++++.||+|+||.||+|.+.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcC-CCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4689999999999999999999876 7899999999653 4556788999999999999999999998754
Q ss_pred ------cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 172 ------SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 172 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 46789999999999999999754 35678899999999999999999999999999999999999999999999
Q ss_pred ecccccCCCCCCeeec----ccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 246 FDLCFQSDVVPTLVET----NVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
||+++........... ..+.........++..|++||..... .......|+|++|++++|+..+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT----GHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSC----SCCCTHHHHHHHHHHHHHHHSC
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC----CCCcchhhHHHHHHHHHHHHhc
Confidence 9999876533211100 00111112233455667777765421 1345789999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.14 Aligned_cols=198 Identities=18% Similarity=0.192 Sum_probs=145.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhc--CCCCcceEE-------EE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML--DHPFLPTLY-------AH 168 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~ 168 (317)
..+|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+.+|+.+++.+ +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3569999999999999999999887 789999999987644 335566778886555555 699988765 45
Q ss_pred EEec-----------------CEEEEEEcccCCCChhcccccCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCCee
Q 042913 169 LEVS-----------------HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAV------RFFAAEVLVGLEYLHALGIIY 225 (317)
Q Consensus 169 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~al~~LH~~~ivH 225 (317)
+... ..+|+||||++ ++|.+++... ...+.+..+ +.++.||+.||.|||++||+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 4433 34899999997 8999999753 123444445 677799999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcc
Q 042913 226 RDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQ 305 (317)
Q Consensus 226 rDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~ 305 (317)
|||||+|||++.++.+||+|||+|+..+.... ...++..|++||...... .......|+|++|+
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~~~---~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNAST---ATFTHALNAWQLGL 281 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTCSE---EECCHHHHHHHHHH
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccCCC---CCcCccccHHHHHH
Confidence 99999999999999999999999986542110 112335677777663211 34468899999999
Q ss_pred cccccCCC-CC
Q 042913 306 YSVEQPGG-VP 315 (317)
Q Consensus 306 ~~~e~~~G-~p 315 (317)
+++|+..| .|
T Consensus 282 il~elltg~~P 292 (371)
T 3q60_A 282 SIYRVWCLFLP 292 (371)
T ss_dssp HHHHHHHSSCS
T ss_pred HHHHHHhCCCC
Confidence 99999998 44
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=255.43 Aligned_cols=200 Identities=20% Similarity=0.230 Sum_probs=155.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEec--
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLPTLYAHLEVS-- 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~-- 172 (317)
...++|++++.||+|+||.||+|.+. ++.||||++.... .....+|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34579999999999999999999875 6899999986542 1334445566554 4899999999999877
Q ss_pred --CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEccCCcEE
Q 042913 173 --HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL--------GIIYRDLKPENILLREDGHIM 242 (317)
Q Consensus 173 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~ivHrDikp~Nill~~~~~~k 242 (317)
..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 789999999999999999965 4699999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCccccccccccee-ccchhhhccCCcccccccCCC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFV-AEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+|||+|+........... ......++..|++||.......... ....+.|+|++|++++|+..|
T Consensus 183 l~Dfg~a~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDI------PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp ECCCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeCCCceeeccccccccC------CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999776543322111 0112245666777776654322211 112348999999999999988
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.55 Aligned_cols=203 Identities=18% Similarity=0.196 Sum_probs=152.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCC--CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-ecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCT--SANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE-VSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~ 176 (317)
..|++.+.||+|+||.||+|.+.... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 46889999999999999999876423 2468999886532 3355678999999999999999999999865 456789
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999654 4568899999999999999999999999999999999999999999999999998654322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p 315 (317)
.... .......++..|++||... ......+.|+|+++++++|+.. |.|
T Consensus 247 ~~~~------~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlG~il~ellt~~~~ 295 (373)
T 3c1x_A 247 FDSV------HNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAP 295 (373)
T ss_dssp -----------------CCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccc------cccCCCCCcccccChHHhc-----CCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence 1100 0011112334466666543 3345678999999999999988 543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=257.17 Aligned_cols=193 Identities=19% Similarity=0.268 Sum_probs=161.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY---- 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 174 (317)
.++|.+.+.||+|+||.||+|.+.. +++.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4789999999999999999999877 79999999998765566667889999999999999999999999976643
Q ss_pred --EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 175 --ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 175 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 599999995 78888873 34899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+... ....++..|++||..... .......|+|++|++++|+..|.
T Consensus 177 ~~~~-------------~~~~~t~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 177 DAEM-------------TGYVVTRWYRAPEVILSW----MHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp --------------------CCSBCCSCHHHHSCC----SCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCCc-------------cccccCcCcCCHHHHhCc----CCCCchhhHHHHHHHHHHHHhCC
Confidence 4321 112345667888765431 23457899999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.23 Aligned_cols=200 Identities=19% Similarity=0.235 Sum_probs=164.5
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC------cceEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF------LPTLY 166 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~ 166 (317)
..+.+..++|++++.||+|+||.||+|.+....+..||+|++... ....+.+.+|+++++.++|++ ++.++
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 456677899999999999999999999987734479999999753 344567788999999887655 89999
Q ss_pred EEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE-----------
Q 042913 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----------- 235 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----------- 235 (317)
+++...+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 7888888776655679999999999999999999999999999999999999
Q ss_pred --------ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccc
Q 042913 236 --------REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYS 307 (317)
Q Consensus 236 --------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (317)
+.++.+||+|||+|+....... ...++..|++||... ........|+|++++++
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHT-------------TIVATRHYRPPEVIL-----ELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCCC-------------SSCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHH
T ss_pred cccccccccCCCcEEEeecCcccccccccc-------------CCcCCCcccCCeeee-----cCCCCCccchHHHHHHH
Confidence 5678999999999976433211 123445566666553 33446789999999999
Q ss_pred cccCCCC
Q 042913 308 VEQPGGV 314 (317)
Q Consensus 308 ~e~~~G~ 314 (317)
+|+..|.
T Consensus 230 ~el~~g~ 236 (355)
T 2eu9_A 230 FEYYRGF 236 (355)
T ss_dssp HHHHHSS
T ss_pred HHHHhCC
Confidence 9999994
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=252.61 Aligned_cols=204 Identities=19% Similarity=0.251 Sum_probs=151.9
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++++.||+|+||.||+|.+.. +++.||||++..........+.+..+..+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETT-TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEec-CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4556899999999999999999999887 789999999987654444445556666678889999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||+. ||+|+||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999999 66665555432 46789999999999999999999995 999999999999999999999999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ....++..|++||................|+|+++++++|+..|
T Consensus 178 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 178 DKAK-----------DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp --------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred Cccc-----------cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 2211 12246677888888754333334456789999999999999988
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.76 Aligned_cols=201 Identities=19% Similarity=0.291 Sum_probs=155.0
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEE-EEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH-LEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~ 176 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+|+++++.++|++++..+.. +......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34789999999999999999999876 78999999875442 22457889999999998776655554 46788899
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~~ 253 (317)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999999 99999998743 3569999999999999999999999999999999999999 788999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ........++..|++||.. .......+.|+|+++++++|+..|
T Consensus 160 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g 211 (296)
T 4hgt_A 160 DARTHQHIP---YRENKNLTGTARYASINTH-----LGIEQSRRDDLESLGYVLMYFNLG 211 (296)
T ss_dssp CTTTCCBCC---CCCSCCCCSCGGGCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CcccCccCC---CCcccccCCCccccchHHh-----cCCCCCchhHHHHHHHHHHHHhcC
Confidence 433211100 0011122344455555544 444457889999999999999988
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.93 Aligned_cols=207 Identities=21% Similarity=0.238 Sum_probs=155.6
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHH--HHhcCCCCcceEEEEEEe
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEI--LSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~ 171 (317)
...+..++|++++.||+|+||.||+|... ++.||||++.... ...+..|.++ +..++|+||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEET---TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEEC---CeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 34577899999999999999999999763 6899999997542 1233334444 455899999999986542
Q ss_pred -----cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCcEEEcc
Q 042913 172 -----SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL---------GIIYRDLKPENILLRE 237 (317)
Q Consensus 172 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~ivHrDikp~Nill~~ 237 (317)
...+++||||+++|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 33679999999999999999653 458899999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccce--eccchhhhccCCcccccccCCC
Q 042913 238 DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEF--VAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~--~~~~~~~~~~~~~~~~~e~~~G 313 (317)
++.+||+|||+|+............. ........++..|++||......... .....+.|+|++|++++|+..|
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEE--DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCcEEEeeccceeecccccccCcccc--ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 99999999999987654332111000 01111234566677777665432221 3345688999999999999988
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=251.60 Aligned_cols=206 Identities=20% Similarity=0.242 Sum_probs=164.5
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEe
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYAHLEV 171 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~ 171 (317)
...+..++|++++.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++ |+||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34566688999999999999999999875 4889999999876656677788999999999997 5999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
.+.+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 100 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 9999999995 489999999764 5789999999999999999999999999999999999996 48999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCccccccccc------ceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM------EFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~------~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ ......++..|++||....... .........|+|+++++++|+..|
T Consensus 176 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 176 MQPDTTSV--------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp ----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred ccCccccc--------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 65432211 1112245667888887643211 112446789999999999999988
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=249.34 Aligned_cols=201 Identities=18% Similarity=0.246 Sum_probs=161.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
....+|.....||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLS-NQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETT-TCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECC-CCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 444555556689999999999999877 7899999999765 2344567889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccccCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~~~~~ 254 (317)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999997642 235678999999999999999999999999999999999987 89999999999987644
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... ....++..|++||...... .....+.|+|+++++++|+..|
T Consensus 176 ~~~~~----------~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g 221 (295)
T 2clq_A 176 INPCT----------ETFTGTLQYMAPEIIDKGP---RGYGKAADIWSLGCTIIEMATG 221 (295)
T ss_dssp ---------------CCCCCCGGGCCHHHHHHGG---GGCSHHHHHHHHHHHHHHHHHT
T ss_pred CCCcc----------cccCCCccccChhhhcCCC---CCCCcHHHHHHHHHHHHHHHHC
Confidence 22111 1123455677777654321 1245789999999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=246.38 Aligned_cols=171 Identities=20% Similarity=0.296 Sum_probs=148.8
Q ss_pred ccCCeEEe-eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHH-HhcCCCCcceEEEEEEe----
Q 042913 98 HLRHLKLV-RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEIL-SMLDHPFLPTLYAHLEV---- 171 (317)
Q Consensus 98 ~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~---- 171 (317)
..++|.+. +.||+|+||.||+|.+.. +++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC-CCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34667777 789999999999999877 7899999999653 3466788887 66689999999999887
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~ 248 (317)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999998766667999999999999999999999999999999999999997 78999999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|..... .......|+|++|++++|+..|
T Consensus 167 a~~~~~-------------------------------------~~~~~~~DiwslG~il~el~tg 194 (299)
T 3m2w_A 167 AKETTG-------------------------------------EKYDKSCDMWSLGVIMYILLCG 194 (299)
T ss_dssp CEECTT-------------------------------------CGGGGHHHHHHHHHHHHHHHHS
T ss_pred cccccc-------------------------------------ccCCchhhHHHHHHHHHHHHHC
Confidence 865431 1124678999999999999988
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=250.69 Aligned_cols=194 Identities=22% Similarity=0.306 Sum_probs=155.1
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-C
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-H 173 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 173 (317)
..+..++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+++++.++||||+++++++... +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc---CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 3567789999999999999999999765 6899999997542 346788999999999999999999987544 5
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999976433347899999999999999999999999999999999999999999999999987544
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.... ...++..|++||.... .......|+|+++++++|+.. |
T Consensus 169 ~~~~-------------~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 169 STQD-------------TGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp --------------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccc-------------CCCccccccCHHHhCC-----CCCCchhcHHHHHHHHHHHHhCC
Confidence 3211 1123445777776532 334678999999999999987 7
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=245.02 Aligned_cols=201 Identities=19% Similarity=0.284 Sum_probs=159.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEE-EEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAH-LEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~ 176 (317)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+|+.+++.++|++++..+.. +...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999876 789999999865432 2357889999999998876655544 46778899
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE---ccCCcEEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill---~~~~~~kl~DFG~a~~~~ 253 (317)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999999 99999999643 3569999999999999999999999999999999999999 488999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
......... ........++..|++||... ........|+|++|++++|+..|
T Consensus 160 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g 211 (296)
T 3uzp_A 160 DARTHQHIP---YRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLG 211 (296)
T ss_dssp CTTTCCBCC---CCCSCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccccccccc---cccccccccccccCChhhhc-----CCCCCcchhhHHHHHHHHHHHhC
Confidence 443211100 01112234555666666654 33456789999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.51 Aligned_cols=197 Identities=22% Similarity=0.263 Sum_probs=163.1
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-----------CCCc
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-----------HPFL 162 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i 162 (317)
...+..++|++.+.||+|+||.||+|.+.. +++.||||++... ......+.+|+++++.+. |+||
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 345667899999999999999999999876 7899999999754 234466788999988876 8999
Q ss_pred ceEEEEEEecC----EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEcc
Q 042913 163 PTLYAHLEVSH----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLRE 237 (317)
Q Consensus 163 v~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~ 237 (317)
+++++++...+ .+++|||++ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999987654 789999999 99999999876667799999999999999999999998 9999999999999953
Q ss_pred ------CCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccC
Q 042913 238 ------DGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQP 311 (317)
Q Consensus 238 ------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 311 (317)
.+.+||+|||+|+....... ...++..|++||.... .......|+|+++++++|+.
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEHYT-------------NSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELI 229 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBCCC-------------SCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCcCcceEEEcccccccccCCCCC-------------CCCCCccccCcHHHhC-----CCCCchHhHHHHHHHHHHHH
Confidence 34899999999976643211 1134556777776543 33467899999999999999
Q ss_pred CC
Q 042913 312 GG 313 (317)
Q Consensus 312 ~G 313 (317)
.|
T Consensus 230 ~g 231 (373)
T 1q8y_A 230 TG 231 (373)
T ss_dssp HS
T ss_pred hC
Confidence 99
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.80 Aligned_cols=203 Identities=19% Similarity=0.238 Sum_probs=149.2
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAE-ILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.+..++|++++.||+|+||.||+|.+.. +++.||||++..... ......+..|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcC-CCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4667899999999999999999999876 789999999976532 333345555555 6777899999999999999999
Q ss_pred EEEEEcccCCCChhccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 175 ICFLIDYCPNGDLHSLLPK---QPNNRFSLQAVRFFAAEVLVGLEYLHAL-GIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
.++||||++ ++|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 999999995 588777652 2246789999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... .....++..|++||...... .........|+|++|++++|+..|
T Consensus 175 ~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g 225 (327)
T 3aln_A 175 QLVDSIA-----------KTRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATG 225 (327)
T ss_dssp C------------------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred ecccccc-----------cccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHC
Confidence 6543221 11124566788888763221 122345789999999999999988
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=254.51 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=164.7
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CC-----CcceEE
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HP-----FLPTLY 166 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~ 166 (317)
..+....++|++.+.||+|+||.||+|.+.. +++.||||++... ......+.+|+.+++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 4456667899999999999999999999877 7899999999753 344566788888888875 44 499999
Q ss_pred EEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCcEEEc--cCCcEE
Q 042913 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH--ALGIIYRDLKPENILLR--EDGHIM 242 (317)
Q Consensus 167 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivHrDikp~Nill~--~~~~~k 242 (317)
+++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 9999999999999999 569999998765567999999999999999999999 57999999999999995 477899
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|||+|+....... ...++..|++||.... .......|+|++|++++|+..|.|
T Consensus 202 L~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 202 IVDFGSSCQLGQRIY-------------QYIQSRFYRSPEVLLG-----MPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp ECCCTTCEETTCCCC-------------SSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCceecccccc-------------cccCCccccChHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999987643211 1234445777776543 334678999999999999999943
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.35 Aligned_cols=191 Identities=20% Similarity=0.317 Sum_probs=153.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
.+..++|++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|+++++.++||||+++++++.+ ..
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET---TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 356789999999999999999999875 588999998643 234678899999999999999999998763 47
Q ss_pred EEEEcccCCCChhcccccCCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCeeccCCCCcEEEccCCc-EEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPN-NRFSLQAVRFFAAEVLVGLEYLHA---LGIIYRDLKPENILLREDGH-IMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~---~~ivHrDikp~Nill~~~~~-~kl~DFG~a~ 250 (317)
++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999975422 247889999999999999999999 89999999999999998886 7999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
....... ...++..|++||.... .....+.|+|+++++++|+..|
T Consensus 155 ~~~~~~~-------------~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g 199 (307)
T 2eva_A 155 DIQTHMT-------------NNKGSAAWMAPEVFEG-----SNYSEKCDVFSWGIILWEVITR 199 (307)
T ss_dssp -----------------------CCTTSSCHHHHTC-----CCCCTHHHHHHHHHHHHHHHHT
T ss_pred ccccccc-------------cCCCCCceEChhhhCC-----CCCCcHHHHHHHHHHHHHHHHC
Confidence 5532211 1235566777776543 3346789999999999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=251.87 Aligned_cols=199 Identities=21% Similarity=0.281 Sum_probs=161.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEecC--
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM--LDHPFLPTLYAHLEVSH-- 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~-- 173 (317)
..++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4578999999999999999999874 689999999654 23456788999888 78999999999998775
Q ss_pred --EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCcEEEccCCcEEE
Q 042913 174 --YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH--------ALGIIYRDLKPENILLREDGHIML 243 (317)
Q Consensus 174 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~ivHrDikp~Nill~~~~~~kl 243 (317)
..|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 89999999999999999965 45899999999999999999999 899999999999999999999999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccce-eccchhhhccCCcccccccCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEF-VAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~-~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+|||+++........... ......++..|++||......... .....+.|+|++|++++|+..|
T Consensus 189 ~Dfg~~~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDI------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CCCTTCEEEETTTTEEEE------CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCceecccccccccc------ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999766543322111 112234566788888765432221 1223678999999999999988
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=250.17 Aligned_cols=194 Identities=18% Similarity=0.219 Sum_probs=145.0
Q ss_pred cccCCeEEee-eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----
Q 042913 97 LHLRHLKLVR-HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV---- 171 (317)
Q Consensus 97 ~~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 171 (317)
...++|++.+ .||+|+||.||+|.+.. +++.||||++.... .. .......++.++||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC-CCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3457899965 69999999999999887 78999999996541 11 1222334667789999999999876
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~ 248 (317)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 556899999999999999998766667999999999999999999999999999999999999976 45699999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
++....... ....++..|++||.. .........|+|+++++++|+..|.
T Consensus 178 ~~~~~~~~~------------~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~ 226 (336)
T 3fhr_A 178 AKETTQNAL------------QTPCYTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGF 226 (336)
T ss_dssp CEEC---------------------------------------CHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ceecccccc------------ccCCCCcCccChhhh-----CCCCCCchhhHHHHHHHHHHHHHCC
Confidence 976542211 112345567777765 3334467899999999999999983
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=254.38 Aligned_cols=199 Identities=20% Similarity=0.257 Sum_probs=155.3
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh---------hcHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---------LSAKKLSHVQMEAEILSMLDHPFLPTLYA 167 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 167 (317)
...++|++.+.||+|+||.||+|.+.. ++.||||++.... ......+.+.+|+++++.++||||+++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT--SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC--CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 345789999999999999999998764 8999999986432 22344578999999999999999999999
Q ss_pred EEEe-----cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEE
Q 042913 168 HLEV-----SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIM 242 (317)
Q Consensus 168 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~k 242 (317)
++.. ...+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 9843 347899999995 7888887643 45799999999999999999999999999999999999999999999
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
|+|||+|+........ ....++..|++||.... ........|+|+++++++|+..|-
T Consensus 175 l~Dfg~~~~~~~~~~~-----------~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 175 ICDFNLAREDTADANK-----------THYVTHRWYRAPELVMQ----FKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp ECCTTC--------------------------CGGGCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEecCccccccccccc-----------ceecccceecCcHHhcC----CCCCCcHhHHHhHHHHHHHHHhCC
Confidence 9999999754332211 11234455777775532 123467899999999999999883
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=252.76 Aligned_cols=199 Identities=19% Similarity=0.255 Sum_probs=155.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhc----CCCCcceEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSML----DHPFLPTLYA 167 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~~iv~~~~ 167 (317)
....++|++.+.||+|+||.||+|.+.. +++.||+|++....... .....+.+|+.+++.+ +|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4556889999999999999999998776 78999999997653322 2234466799999998 8999999999
Q ss_pred EEEecCEEEEEEcc-cCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEEee
Q 042913 168 HLEVSHYICFLIDY-CPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSD 245 (317)
Q Consensus 168 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl~D 245 (317)
++...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 99999999999999 7899999999663 5699999999999999999999999999999999999999 889999999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
||+++....... ....++..|++||..... .......|+|+++++++|+..|
T Consensus 184 fg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g 235 (312)
T 2iwi_A 184 FGSGALLHDEPY------------TDFDGTRVYSPPEWISRH----QYHALPATVWSLGILLYDMVCG 235 (312)
T ss_dssp CSSCEECCSSCB------------CCCCSCTTTSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHS
T ss_pred cchhhhcccCcc------------cccCCcccccCceeeecC----CCCCccchHHHHHHHHHHHHHC
Confidence 999987654221 112356668888865422 1224578999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=269.92 Aligned_cols=203 Identities=19% Similarity=0.249 Sum_probs=162.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+..++|++.+.||+|+||.||+|.+... .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 345678999999999999999999988642 34679999986542 4455678899999999999999999999985 4
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 5689999999999999999754 346899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
........ ....++..|++||... ........|+|++|++++|+.. |.
T Consensus 542 ~~~~~~~~---------~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ellt~g~ 590 (656)
T 2j0j_A 542 EDSTYYKA---------SKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGV 590 (656)
T ss_dssp CC-------------------CCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCcceec---------cCCCCCcceeCHHHhc-----CCCCCchhhHHHHHHHHHHHHHcCC
Confidence 44322111 1112234567777553 3345678999999999999875 73
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=259.23 Aligned_cols=201 Identities=20% Similarity=0.240 Sum_probs=146.3
Q ss_pred cCCeEE-eeeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCE
Q 042913 99 LRHLKL-VRHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHY 174 (317)
Q Consensus 99 ~~~y~i-~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 174 (317)
.+.|.+ .++||+|+||.||+|.+.. .+++.||||++...... ..+.+|+.+|+.++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 355776 4579999999999998763 25789999999754322 357789999999999999999999954 778
Q ss_pred EEEEEcccCCCChhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE----ccCCcEEE
Q 042913 175 ICFLIDYCPNGDLHSLLPKQ-------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL----REDGHIML 243 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill----~~~~~~kl 243 (317)
+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99999999 56888777521 12358999999999999999999999999999999999999 67789999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+|||+|+......... .......++..|++||..... .......|+|++|++++|+..|.|
T Consensus 174 ~Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~ 234 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPL-------ADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEP 234 (405)
T ss_dssp CCTTCCC-----------------------CCCTTCCHHHHTTC----CSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCceecCCCCccc-------ccCCCceecCcccCchhhcCC----CcccchhhhHHHHHHHHHHHhCCC
Confidence 9999998764322110 111122455667777765321 224678999999999999999943
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=257.36 Aligned_cols=199 Identities=21% Similarity=0.305 Sum_probs=153.4
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
..+.....+|++.+.||+|+||.||+|.+.. +..+|+|.+.... ....+|+++++.++||||+++++++...
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~--~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVE--SDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETT--TEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECC--CCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 3455667899999999999999999999876 4458888875432 1224699999999999999999998544
Q ss_pred C------EEEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEE
Q 042913 173 H------YICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIML 243 (317)
Q Consensus 173 ~------~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl 243 (317)
+ .+++||||+++ ++.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence 3 38899999965 44433321 1246799999999999999999999999999999999999999 7999999
Q ss_pred eeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 244 SDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 244 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+|||+|+......... ...++..|++||.... ........|+|++|++++|+..|.|
T Consensus 184 ~DFG~a~~~~~~~~~~-----------~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 184 IDFGSAKILIAGEPNV-----------SYICSRYYRAPELIFG----ATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp CCCTTCEECCTTCCCC-----------SSCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCcccccCCCCCc-----------ccccCcCccCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999998764332211 1133445677765432 1234678999999999999999943
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.32 Aligned_cols=201 Identities=19% Similarity=0.207 Sum_probs=163.4
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcC--CCCcceEEE
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLD--HPFLPTLYA 167 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~~~~ 167 (317)
.+....++|++.+.||+|+||.||+|.+.. +++.||||++....... .....+.+|+.+++.++ |+||+++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344567899999999999999999998877 78999999997653221 12245677999999996 599999999
Q ss_pred EEEecCEEEEEEcccCC-CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCcEEEee
Q 042913 168 HLEVSHYICFLIDYCPN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR-EDGHIMLSD 245 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~-~~~~~kl~D 245 (317)
++...+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999999976 899999865 36789999999999999999999999999999999999999 789999999
Q ss_pred ecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 246 FDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 246 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
||+++....... ....++..|++||..... .......|+|+++++++|+..|
T Consensus 194 fg~~~~~~~~~~------------~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g 245 (320)
T 3a99_A 194 FGSGALLKDTVY------------TDFDGTRVYSPPEWIRYH----RYHGRSAAVWSLGILLYDMVCG 245 (320)
T ss_dssp CTTCEECCSSCB------------CCCCSCGGGSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHS
T ss_pred Cccccccccccc------------cCCCCCccCCChHHhccC----CCCCccchHHhHHHHHHHHHHC
Confidence 999987653211 112345567777755321 1225778999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-34 Score=255.47 Aligned_cols=211 Identities=17% Similarity=0.261 Sum_probs=164.3
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+..++|++.+.||+|+||.||+|.+.. .+|+|++..........+.+.+|+.+++.++|+||+++++++...+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345677899999999999999999998764 5999999765433344456778999999999999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999999654 34689999999999999999999999999999999999998 6899999999987654
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccc----eeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME----FVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~----~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....... ........++..|++||.......+ ........|+|++|++++|+..| .|
T Consensus 181 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 181 VLQAGRR-----EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccc-----ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 3221110 0111223466678888876543221 12346789999999999999988 44
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=250.73 Aligned_cols=198 Identities=19% Similarity=0.224 Sum_probs=146.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE--
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY-- 174 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 174 (317)
...++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.++++.++.++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT-TCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 456899999999999999999999877 78999999986542 222345677888899999999999999865433
Q ss_pred -----EEEEEcccCCCChhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCcEEEcc-CCcEEEe
Q 042913 175 -----ICFLIDYCPNGDLHSLLPK--QPNNRFSLQAVRFFAAEVLVGLEYLH--ALGIIYRDLKPENILLRE-DGHIMLS 244 (317)
Q Consensus 175 -----~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivHrDikp~Nill~~-~~~~kl~ 244 (317)
+++||||+++ +|.+.+.. .....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8999999954 55544332 23467899999999999999999999 999999999999999996 8999999
Q ss_pred eecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 245 DFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 245 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
|||+|+........ ....++..|++||..... .......|+|++|++++|+..|.
T Consensus 175 Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 175 DFGSAKKLSPSEPN-----------VAYICSRYYRAPELIFGN----QHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp CCTTCBCCCTTSCC-----------CSTTSCGGGCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSS
T ss_pred eCCCceecCCCCCc-----------ccccCCcceeCHHHHcCC----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999876543221 111344557777765321 22467899999999999999993
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=263.70 Aligned_cols=185 Identities=15% Similarity=0.065 Sum_probs=128.2
Q ss_pred eecccCCeEEEEEEEcCCCCceEEEEEeehhh--------hcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEEE
Q 042913 107 HLGTGNLGRVFLCHLRDCTSANFALKVVDKDL--------LSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 107 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 177 (317)
..+.|++|.+..++..- .|+.|++|++.+.. ..+...+++.+|+++|+++ .|+||+++++++++++.+||
T Consensus 241 ~~~~~~~~~h~~~rr~~-fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF-FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEEE-ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCccccccccccc-ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45667777666554333 57899999997642 1234556799999999999 59999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||++|++|.++|.+ .+++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999965 3667664 4789999999999999999999999999999999999999999987765443
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
...+. .++.+|++||...+. .....|+|++++...+++.|
T Consensus 395 ~~~t~----------vGTp~YmAPE~l~g~------~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 395 WPTNL----------VQSFFVFVNELFAEN------KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CSHHH----------HHHHHHHHHHHC-----------------------CCCCTT
T ss_pred cccCc----------eechhhccHHHhCCC------CCCcccccccccchhhhccc
Confidence 32222 345567777766543 23457889999988888776
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=267.79 Aligned_cols=200 Identities=23% Similarity=0.272 Sum_probs=162.4
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------ 171 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 171 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 34789999999999999999998776 78999999987642 45666789999999999999999999998755
Q ss_pred cCEEEEEEcccCCCChhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCc---EEEeeec
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQP-NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGH---IMLSDFD 247 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~---~kl~DFG 247 (317)
.+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999997642 236899999999999999999999999999999999999997664 9999999
Q ss_pred ccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 248 LCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 248 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
+++........ ....++..|++||... ........|+|++|++++|+..| .|
T Consensus 170 ~a~~~~~~~~~-----------~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 170 YAKELDQGELC-----------TEFVGTLQYLAPELLE-----QKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCCBTTSCCCC-----------CCCCSCCTTCSSCSSC-----CSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccccccc-----------ccccCCcccCChHHhc-----cCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 99876443211 1123455667776553 34456789999999999999999 44
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=253.11 Aligned_cols=204 Identities=23% Similarity=0.261 Sum_probs=151.3
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 176 (317)
..+.|.+.+.||+|+||+||.+... +++.||||++.... .+.+.+|+.+++.+ +||||+++++++...+.+|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEES--SSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 3456777899999999999876444 58999999987542 24567899999876 8999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC-------------
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNR-----FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED------------- 238 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~------------- 238 (317)
+||||+ +|+|.+++....... ..+..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 999999 579999997542211 1233457799999999999999999999999999999754
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCccccccccc--ceeccchhhhccCCcccccccCC-C-C
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVM--EFVAEPRREQREHPAQYSVEQPG-G-V 314 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~--~~~~~~~~~~~~~~~~~~~e~~~-G-~ 314 (317)
+.+||+|||+|+..........+ ......++.+|++||....... .........|+|++|++++|+.. | .
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRT------NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp CEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred eEEEEcccccceecCCCCcccee------eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999877654321111 1112356778888887754221 12345688999999999999987 6 4
Q ss_pred C
Q 042913 315 P 315 (317)
Q Consensus 315 p 315 (317)
|
T Consensus 239 P 239 (434)
T 2rio_A 239 P 239 (434)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=251.27 Aligned_cols=199 Identities=20% Similarity=0.234 Sum_probs=150.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 175 (317)
+...+|.+.+.||+|+||+||..... +++.||||++..... ..+.+|+++|+.+ +||||+++++++......
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 34457999999999999997654333 589999999865432 2356799999999 799999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-----CCcEEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-----DGHIMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-----~~~~kl~DFG~a~ 250 (317)
|+||||+ +++|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||+|+
T Consensus 94 ~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999999 579999987643 34555567789999999999999999999999999999953 2368899999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.......... ......++.+|++||...... ........|+|++|++++|+.. |
T Consensus 172 ~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~--~~~~t~~~DiwSlG~il~ellt~g 226 (432)
T 3p23_A 172 KLAVGRHSFS-------RRSGVPGTEGWIAPEMLSEDC--KENPTYTVDIFSAGCVFYYVISEG 226 (432)
T ss_dssp CC-------------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTS
T ss_pred eccCCCccee-------eccccCCCcCccChhhhhccc--ccCCCcHHHHHHHHHHHHHHHcCC
Confidence 7654321111 111234667788888764321 1223468999999999999998 6
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=245.66 Aligned_cols=202 Identities=15% Similarity=0.107 Sum_probs=149.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhh-hcHHHHHHHHHHHHHHHhcCC-CCc-------------
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL-LSAKKLSHVQMEAEILSMLDH-PFL------------- 162 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~~i------------- 162 (317)
..+.|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+.+|+.+++.++| .|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecC-CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34568999999999999999999887 78999999987332 222446778899999999876 211
Q ss_pred --------ceEEEEEEe-----cCEEEEEEcccCCCChhcccc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 042913 163 --------PTLYAHLEV-----SHYICFLIDYCPNGDLHSLLP-----KQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224 (317)
Q Consensus 163 --------v~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~qi~~al~~LH~~~iv 224 (317)
..++.++.. ...++++|+++ +++|.+++. ......+++..++.++.||+.||.|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 111111111 22467888877 899999884 22345578889999999999999999999999
Q ss_pred eccCCCCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccc-----cceeccchhhh
Q 042913 225 YRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENV-----MEFVAEPRREQ 299 (317)
Q Consensus 225 HrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~-----~~~~~~~~~~~ 299 (317)
||||||+||||+.++.+||+|||+|+..... .....+ ..|++||...... ........+.|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-------------cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 9999999999999999999999998764432 111234 6788888764221 13334567899
Q ss_pred ccCCcccccccCCC-CC
Q 042913 300 REHPAQYSVEQPGG-VP 315 (317)
Q Consensus 300 ~~~~~~~~~e~~~G-~p 315 (317)
+|+++++++|+.+| .|
T Consensus 300 vwSlGvil~elltg~~P 316 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLP 316 (413)
T ss_dssp HHHHHHHHHHHHHSSCC
T ss_pred HHHHHHHHHHHHHCCCC
Confidence 99999999999998 54
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=202.75 Aligned_cols=136 Identities=16% Similarity=0.150 Sum_probs=108.8
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----------------HHHHHHHHHHHHHHhcCCCCcce
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----------------KKLSHVQMEAEILSMLDHPFLPT 164 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~iv~ 164 (317)
.|.+.+.||+|+||.||+|.+ . +++.||+|+++...... .....+.+|+.+++.++| ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~-~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-E-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-T-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred EEEecCEeccCCCceEEEEEe-C-CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 455669999999999999998 4 78999999996432111 235678899999999984 44
Q ss_pred EEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEe
Q 042913 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLS 244 (317)
Q Consensus 165 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~ 244 (317)
+++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||+.||+||||||+|||++ ++.+||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 4444433 45699999999999999 522 12456899999999999999999999999999999 9999999
Q ss_pred eecccccC
Q 042913 245 DFDLCFQS 252 (317)
Q Consensus 245 DFG~a~~~ 252 (317)
|||+|+..
T Consensus 235 DFG~a~~~ 242 (282)
T 1zar_A 235 DFPQSVEV 242 (282)
T ss_dssp CCTTCEET
T ss_pred ECCCCeEC
Confidence 99999743
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=216.62 Aligned_cols=136 Identities=16% Similarity=0.128 Sum_probs=107.1
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL------SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
..+.||+|+||.||+|... ++.+++|....... .....+++.+|+++++.++||||+++..++...+..|+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3567999999999999433 67889998644321 12234668999999999999999955444456667799
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
||||+++++|.+++.. ++.++.||+.||.|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999954 5688999999999999999999999999999998 999999999988754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=185.04 Aligned_cols=142 Identities=15% Similarity=0.137 Sum_probs=109.5
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCce--EEEEEeehhhhc----------------------HHHHHHHHHHHHHHHh
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLS----------------------AKKLSHVQMEAEILSM 156 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~E~~~l~~ 156 (317)
-|.+.+.||+|+||.||+|.+.. +|+. ||||+++..... ......+.+|+.+|+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 37899999999999999998844 5788 999997543111 1122367889999999
Q ss_pred cCCCC--cceEEEEEEecCEEEEEEcccCC-C----ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccC
Q 042913 157 LDHPF--LPTLYAHLEVSHYICFLIDYCPN-G----DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH-ALGIIYRDL 228 (317)
Q Consensus 157 l~h~~--iv~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivHrDi 228 (317)
+.|++ ++.+++. +..++||||+.+ | .|.++... .++..+..++.||+.+|.||| +.||+||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 98875 4555543 245899999932 3 56655422 234567889999999999999 999999999
Q ss_pred CCCcEEEccCCcEEEeeecccccCCC
Q 042913 229 KPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 229 kp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
||+|||++. .++|+|||+|...+.
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETTS
T ss_pred CHHHEEEcC--cEEEEECcccccCCC
Confidence 999999988 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-21 Score=172.84 Aligned_cols=139 Identities=15% Similarity=0.156 Sum_probs=104.2
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc---------------H-H--H--HHHHHHHHHHHHhcCCCC
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS---------------A-K--K--LSHVQMEAEILSMLDHPF 161 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---------------~-~--~--~~~~~~E~~~l~~l~h~~ 161 (317)
|.+++.||+|+||.||+|.+. +|+.||||+++..... . . . .-...+|...|.++.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 899999999999999999875 4899999987532110 0 0 0 111345777888886554
Q ss_pred c--ceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 042913 162 L--PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG 239 (317)
Q Consensus 162 i--v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~ 239 (317)
+ ...++. .. .+|||||++|++|.++... .....++.||+.+|.+||+.|||||||||.|||++++|
T Consensus 175 v~vp~p~~~--~~--~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQ--SR--HTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CSCCCEEEE--ET--TEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCCeeeec--cC--ceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 4 344433 22 3799999999888776532 12456789999999999999999999999999998876
Q ss_pred ----------cEEEeeecccccCCC
Q 042913 240 ----------HIMLSDFDLCFQSDV 254 (317)
Q Consensus 240 ----------~~kl~DFG~a~~~~~ 254 (317)
.+.|+||+-+...+.
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CcccccccccceEEEEeCCcccCCC
Confidence 389999998866544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-15 Score=128.58 Aligned_cols=143 Identities=14% Similarity=0.118 Sum_probs=113.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 177 (317)
...|++...++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..++++++++...+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS---SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC---CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 356889999999999999998633 57899999875321 11235788999999985 6778899999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA------------------------------------- 220 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------------------------- 220 (317)
||||++|.+|.+.+.. ......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876421 11234678899999999998
Q ss_pred ----------------------cCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 221 ----------------------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 221 ----------------------~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++|+|++|.|||++.++.+.|+||+.|...+
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 448999999999999876566799999886543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-13 Score=118.52 Aligned_cols=137 Identities=16% Similarity=0.056 Sum_probs=100.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEecCEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF--LPTLYAHLEVSHYICF 177 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~l 177 (317)
..|.+....+.|..+.||++... +|..+++|+.... ....+.+|+.+++.+.+.+ +++++++....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT--TSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEecC--CCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 34555544446667999998643 4678999997643 1245678999998886444 6679998888888999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG----------------------------------- 222 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----------------------------------- 222 (317)
||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 311 11 1245677777888888643
Q ss_pred -----------------------CeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 223 -----------------------IIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 223 -----------------------ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
++|+|++|.|||++.++.+.|+|||.|...+
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999876667799999986544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.44 E-value=6.6e-13 Score=119.76 Aligned_cols=143 Identities=13% Similarity=0.187 Sum_probs=107.9
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEee--hhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEec---CEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVD--KDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYAHLEVS---HYIC 176 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~ 176 (317)
.++.|+.|.++.||++... +..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS---SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC---CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4677899999999998654 4678899876 3321 122356788999999997 45688999988766 4589
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA------------------------------------ 220 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------------------------ 220 (317)
+||||++|..+.+.. -..++......++.+++..|..||.
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999988875532 1336788888999999999999997
Q ss_pred ----------------------cCCeeccCCCCcEEEccCCc--EEEeeecccccCCC
Q 042913 221 ----------------------LGIIYRDLKPENILLREDGH--IMLSDFDLCFQSDV 254 (317)
Q Consensus 221 ----------------------~~ivHrDikp~Nill~~~~~--~kl~DFG~a~~~~~ 254 (317)
..++|+|++|.|||++.++. +.|+||+.|...+.
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p 251 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP 251 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence 35899999999999997653 69999999876543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=4.3e-10 Score=98.88 Aligned_cols=135 Identities=20% Similarity=0.157 Sum_probs=100.4
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CC--CcceEEEEEEecC---EEEEEE
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HP--FLPTLYAHLEVSH---YICFLI 179 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~--~iv~~~~~~~~~~---~~~lv~ 179 (317)
+.++.|....||++ +..+++|+.... .....+.+|.++|+.+. +. .+++++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v------~~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEI------NRDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEES------TTSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEE------CCEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 45899999999986 256899986532 34567889999998884 33 2556665544333 348899
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA--------------------------------------- 220 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------- 220 (317)
++++|.+|.+... ..++......++.|++..|..||.
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999988875432 236777778888888888888886
Q ss_pred -------------------cCCeeccCCCCcEEEcc--CCcEEEeeecccccCCC
Q 042913 221 -------------------LGIIYRDLKPENILLRE--DGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 221 -------------------~~ivHrDikp~Nill~~--~~~~kl~DFG~a~~~~~ 254 (317)
..++|+|++|.||+++. .+.+.|+||+.+...+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~ 226 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP 226 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence 13699999999999998 45688999999876554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=6.8e-09 Score=91.35 Aligned_cols=139 Identities=17% Similarity=0.095 Sum_probs=97.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC---CcceEEEEEE-ecCEEEEEEc
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP---FLPTLYAHLE-VSHYICFLID 180 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e 180 (317)
++.++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .|++++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788888899987 46788998532 23456789999999999742 3667777764 4556789999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL--------------------------------------- 221 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------------------------------------- 221 (317)
|++|..|.+..- ..++......++.++...|..||..
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988876321 1234445555555555555555532
Q ss_pred ---------------------CCeeccCCCCcEEEcc---CCc-EEEeeecccccCCCCCC
Q 042913 222 ---------------------GIIYRDLKPENILLRE---DGH-IMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 222 ---------------------~ivHrDikp~Nill~~---~~~-~kl~DFG~a~~~~~~~~ 257 (317)
.++|+|++|.|||++. ++. +.|+||+.+...++...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~D 230 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYD 230 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGGG
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHHH
Confidence 3599999999999987 455 58999999876655443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=5.8e-09 Score=89.83 Aligned_cols=135 Identities=18% Similarity=0.147 Sum_probs=96.4
Q ss_pred ecccCCe-EEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEEEcccCCC
Q 042913 108 LGTGNLG-RVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 108 lg~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g 185 (317)
+..|..+ .||+..... .+..+++|+.... ....+.+|..+|+.+. +--|.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~-~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP-NAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCT-TCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecC-CCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445555 689876554 5678999987543 3456788999998885 344778999999999999999999988
Q ss_pred ChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------------
Q 042913 186 DLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL-------------------------------------------- 221 (317)
Q Consensus 186 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-------------------------------------------- 221 (317)
++.+..... ......+..++...|..||..
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 877654321 112233445555555555531
Q ss_pred --------------CCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 222 --------------GIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 222 --------------~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++|+|+.+.|||++.++.+-|+||+.|...+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp 226 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADR 226 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEET
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCH
Confidence 168999999999999877778999999876544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.62 E-value=1e-06 Score=78.11 Aligned_cols=141 Identities=14% Similarity=0.134 Sum_probs=79.8
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEE------EEEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYA------HLEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~------~~~~~~~~~ 176 (317)
++.|+.|..+.||++.... ..+++|+.... . ..+..|..+++.|. .-.+++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~---~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS---GAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEETT---EEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeCC---CCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 3456667789999987543 45899998752 2 22334555555442 113333332 123467789
Q ss_pred EEEcccCCCChhc-----------c---cc----cC--CCC------CCCHHH---------------------------
Q 042913 177 FLIDYCPNGDLHS-----------L---LP----KQ--PNN------RFSLQA--------------------------- 203 (317)
Q Consensus 177 lv~e~~~~gsL~~-----------~---l~----~~--~~~------~~~~~~--------------------------- 203 (317)
+||+|++|..+.. . ++ .. +.. ...+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 9999998865430 0 00 00 000 011111
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------cCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 204 ----VRFFAAEVLVGLEYLHA-------------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 204 ----~~~i~~qi~~al~~LH~-------------~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+..+..++..++.+|++ ..++|+|+++.|||++.++.+.|+||+.|.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~~ 255 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDLP 255 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEECCT
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccCCh
Confidence 01111223445666652 5799999999999998888999999999865443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=2.6e-07 Score=82.78 Aligned_cols=87 Identities=13% Similarity=0.101 Sum_probs=57.7
Q ss_pred EEeeee-cccCCeEEEEEEEc---CC--CCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcC-C--CCcceEEEEEEec
Q 042913 103 KLVRHL-GTGNLGRVFLCHLR---DC--TSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLD-H--PFLPTLYAHLEVS 172 (317)
Q Consensus 103 ~i~~~l-g~G~~g~Vy~~~~~---~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~ 172 (317)
...+.| +.|....+|+.... .. .++.+++|+...... .......+.+|..+++.+. + ..+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445678 88889999988654 00 146789998754320 0000134677888888775 2 3577888877654
Q ss_pred ---CEEEEEEcccCCCChhc
Q 042913 173 ---HYICFLIDYCPNGDLHS 189 (317)
Q Consensus 173 ---~~~~lv~e~~~~gsL~~ 189 (317)
+..|+||||++|..+.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35689999998877765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2e-07 Score=84.87 Aligned_cols=79 Identities=13% Similarity=0.188 Sum_probs=50.4
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh--cH---HHHHHHHHHHHHHHhcCC---CCcceEEEEEEecCEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL--SA---KKLSHVQMEAEILSMLDH---PFLPTLYAHLEVSHYI 175 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~ 175 (317)
-.+.||.|.++.||++.... .++.+++|....... .. ....++..|.++++.+.. ..+++++.+ +....
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEEECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 45679999999999997554 467899998653211 01 122456778888887742 345567754 33446
Q ss_pred EEEEcccCCC
Q 042913 176 CFLIDYCPNG 185 (317)
Q Consensus 176 ~lv~e~~~~g 185 (317)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.22 E-value=3.9e-05 Score=67.38 Aligned_cols=77 Identities=17% Similarity=0.218 Sum_probs=60.4
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCEEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD---HPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 179 (317)
.-.+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|. ...+++++.+....+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999999864 2578889987643 2456788888888874 356889999888888999999
Q ss_pred cccCCCCh
Q 042913 180 DYCPNGDL 187 (317)
Q Consensus 180 e~~~~gsL 187 (317)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99988765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.14 E-value=9.8e-06 Score=71.27 Aligned_cols=145 Identities=19% Similarity=0.213 Sum_probs=81.6
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCC--CcceEEEE------EEec
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP--FLPTLYAH------LEVS 172 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~ 172 (317)
...-++.|+.|....+|++...+ ..+++|+..... ....+..|..+++.|... .+++++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~---g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK---DPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS---CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeCC---ccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 34456778888889999987653 378899886521 123455677777766421 13333321 1234
Q ss_pred CEEEEEEcccCCCChhcc--------------cc----cCCCC---CCC---HHHHHH------------HHHHHHHHHH
Q 042913 173 HYICFLIDYCPNGDLHSL--------------LP----KQPNN---RFS---LQAVRF------------FAAEVLVGLE 216 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~--------------l~----~~~~~---~~~---~~~~~~------------i~~qi~~al~ 216 (317)
+..+++|+|++|..+... ++ ..... ... +..... +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 678999999988654321 00 00000 011 111000 0011344455
Q ss_pred HHHH-------cCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 217 YLHA-------LGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 217 ~LH~-------~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
++.. .+++|+|+.+.|||++.++.+.|+||+.|...
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 5553 36999999999999987766689999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.11 E-value=6.6e-06 Score=75.39 Aligned_cols=33 Identities=21% Similarity=0.383 Sum_probs=28.5
Q ss_pred HcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 220 ~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
...++|+|++|.|||++.++ ++|+||+.|...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45699999999999998776 9999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.4e-05 Score=68.19 Aligned_cols=137 Identities=15% Similarity=0.090 Sum_probs=76.6
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCEEEEEEccc-
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSHYICFLIDYC- 182 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~- 182 (317)
++.|+.|....+|++ +.+++|+..... .. .....+|..+++.+....+ ++++... ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~--~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGT--EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCc--cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 677888999999998 458899876431 11 1123457777777652222 5676543 32347899999
Q ss_pred CCCChhcc--------c----------ccCCC---CCCC-HHHHHHHHH--------------HHHHHHHHHH----H--
Q 042913 183 PNGDLHSL--------L----------PKQPN---NRFS-LQAVRFFAA--------------EVLVGLEYLH----A-- 220 (317)
Q Consensus 183 ~~gsL~~~--------l----------~~~~~---~~~~-~~~~~~i~~--------------qi~~al~~LH----~-- 220 (317)
+|.+|... + +.... ..+. ...+..+.. .+...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66555320 0 00000 0011 111111111 1111122221 1
Q ss_pred --cCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 221 --LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 221 --~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
..++|+|+.+.||+ ..++.+.|+||..|...+.
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~ 205 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMNDP 205 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEECT
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCCCH
Confidence 13899999999999 5667889999999876544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=1.6e-05 Score=68.89 Aligned_cols=80 Identities=15% Similarity=0.146 Sum_probs=56.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC---CCcceEEEEEEecCEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH---PFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~ 176 (317)
.+..-++.+|.|..+.||+....+ |+.|++|+...... .....+..|...|+.|.. --+++++.+. . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D--G~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD--GTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT--SCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEECC--CCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 455677889999999999998774 88999998754321 112346789999988852 2456777643 2 37
Q ss_pred EEEcccCCCCh
Q 042913 177 FLIDYCPNGDL 187 (317)
Q Consensus 177 lv~e~~~~gsL 187 (317)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999976643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.5e-05 Score=70.61 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=74.5
Q ss_pred eeecccCCeE-EEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecCEEEEEEccc
Q 042913 106 RHLGTGNLGR-VFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYAHLEVSHYICFLIDYC 182 (317)
Q Consensus 106 ~~lg~G~~g~-Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~ 182 (317)
+.|+.|.... +|+.... +++.+++|...... ...+..|+.+++.+. .-.+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~--~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP--TGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECT--TCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEcC--CCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3465554444 6676532 25678888764421 023445677776664 234667777644444 6899999
Q ss_pred CCCChhcccccC---------------------C---CCCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 042913 183 PNGDLHSLLPKQ---------------------P---NNRFSLQAVR-------FFA-------------AEVLVGLEYL 218 (317)
Q Consensus 183 ~~gsL~~~l~~~---------------------~---~~~~~~~~~~-------~i~-------------~qi~~al~~L 218 (317)
.+..+.+.+... . -..+...... .+. ..+...+..|
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 666654332110 0 0112221110 000 0111222333
Q ss_pred H------HcCCeeccCCCCcEEEccC----CcEEEeeecccccCCCCC
Q 042913 219 H------ALGIIYRDLKPENILLRED----GHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 219 H------~~~ivHrDikp~Nill~~~----~~~kl~DFG~a~~~~~~~ 256 (317)
- ...++|+|+.+.|||++.+ +.+.|+||+.|...+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~~ 222 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRAY 222 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTTH
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCHH
Confidence 1 2369999999999999874 689999999987655443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.95 E-value=3.9e-05 Score=70.49 Aligned_cols=76 Identities=25% Similarity=0.387 Sum_probs=50.2
Q ss_pred EeeeecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYIC 176 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 176 (317)
-++.|+.|....||++..... .++.+++|+..... . ...+.+|..+++.|...+ .+++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 356688888899999976521 24789999884321 1 123446888888875333 4677776542 3
Q ss_pred EEEcccCCCCh
Q 042913 177 FLIDYCPNGDL 187 (317)
Q Consensus 177 lv~e~~~~gsL 187 (317)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00011 Score=64.73 Aligned_cols=142 Identities=17% Similarity=0.145 Sum_probs=80.0
Q ss_pred eeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC--CCcceEEEE-----EEecCEEEEE
Q 042913 106 RHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH--PFLPTLYAH-----LEVSHYICFL 178 (317)
Q Consensus 106 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~-----~~~~~~~~lv 178 (317)
..|+ |....||++... .|+.+++|+........ ..+..|..+++.+.. -.+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE--DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT--TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC--CCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 888899987544 36689999986432222 345567777776642 123444332 2235677899
Q ss_pred EcccCCCChhcc----c--------------ccCC---CCCCCHHHH----------------------HHHHHHHHHHH
Q 042913 179 IDYCPNGDLHSL----L--------------PKQP---NNRFSLQAV----------------------RFFAAEVLVGL 215 (317)
Q Consensus 179 ~e~~~~gsL~~~----l--------------~~~~---~~~~~~~~~----------------------~~i~~qi~~al 215 (317)
|+|++|..+... + .... ...+..... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 999987554310 0 0000 011111110 01111222222
Q ss_pred HHH----HHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 216 EYL----HALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 216 ~~L----H~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
.-+ ....++|+|+++.|||++ + .+.|+||+.|......
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~~ 227 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPAV 227 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECTT
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcHH
Confidence 221 123488999999999998 4 8999999988665443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=7.5e-05 Score=67.31 Aligned_cols=146 Identities=20% Similarity=0.320 Sum_probs=85.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcC------CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS 172 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 172 (317)
+.+.+ +.|..|-...+|++.... ..++.+++|+..... .....+.+|.++++.|. +.-.+++++.+.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 44443 456668888999987642 124789999863321 12345568888888875 3334677776653
Q ss_pred CEEEEEEcccCCCChhcc-cc----------------cC--C-CCCC--CHHHHHHHHHHHHH-----------------
Q 042913 173 HYICFLIDYCPNGDLHSL-LP----------------KQ--P-NNRF--SLQAVRFFAAEVLV----------------- 213 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~-l~----------------~~--~-~~~~--~~~~~~~i~~qi~~----------------- 213 (317)
.+||||++|.+|..- +. .. + .+.. -+..+.++..++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 289999988665421 10 00 0 1111 23455555544322
Q ss_pred --HHHHHHH--------cCCeeccCCCCcEEEccC----CcEEEeeecccccCC
Q 042913 214 --GLEYLHA--------LGIIYRDLKPENILLRED----GHIMLSDFDLCFQSD 253 (317)
Q Consensus 214 --al~~LH~--------~~ivHrDikp~Nill~~~----~~~kl~DFG~a~~~~ 253 (317)
.+..|.+ ..++|+|+.+.|||++.+ +.+.|+||..|...+
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~ 256 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY 256 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC
Confidence 2333332 248999999999999876 789999999986543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.0002 Score=63.57 Aligned_cols=33 Identities=18% Similarity=0.289 Sum_probs=29.1
Q ss_pred CCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 222 ~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++|+|+.+.||+++.++.+.|+||+.+...+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 599999999999999888999999998866554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00025 Score=65.59 Aligned_cols=77 Identities=9% Similarity=0.146 Sum_probs=49.3
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCEEEEEEccc
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL-PTLYAHLEVSHYICFLIDYC 182 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 182 (317)
-++.|+.|-...+|++.... .+..+++|+..... .. .-...+|..+++.|...++ +++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-KQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-TTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECC-CCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 34578888889999997653 34788999874321 11 1112578999998874444 67887763 2 3599999
Q ss_pred CCCChh
Q 042913 183 PNGDLH 188 (317)
Q Consensus 183 ~~gsL~ 188 (317)
+|.+|.
T Consensus 184 ~G~~l~ 189 (458)
T 2qg7_A 184 DGYALS 189 (458)
T ss_dssp CSEECC
T ss_pred CCccCC
Confidence 876553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00024 Score=63.63 Aligned_cols=76 Identities=14% Similarity=0.212 Sum_probs=45.2
Q ss_pred eeeecccCCeEEEEEEEcCC-------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDC-------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 176 (317)
++.|+.|....+|++..... .++.+++|+...... .......|.++++.+...+ ++++++.+ .+ +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 45677888889999876430 126889998754311 1112356888888775333 55777654 22 6
Q ss_pred EEEcccCCCCh
Q 042913 177 FLIDYCPNGDL 187 (317)
Q Consensus 177 lv~e~~~~gsL 187 (317)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0025 Score=58.21 Aligned_cols=77 Identities=13% Similarity=0.289 Sum_probs=49.0
Q ss_pred EeeeecccCCeEEEEEEEcCCC------CceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEE
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCT------SANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 176 (317)
-++.|..|-...+|++...... ++.+++|+..... ...-...+|..+++.+. +.-.+++++.+. + +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 3455667888899999765311 5789999875431 11122356888887775 333567776432 2 7
Q ss_pred EEEcccCCCCh
Q 042913 177 FLIDYCPNGDL 187 (317)
Q Consensus 177 lv~e~~~~gsL 187 (317)
+|+||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999988664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.033 Score=50.32 Aligned_cols=31 Identities=32% Similarity=0.411 Sum_probs=25.9
Q ss_pred CeeccCCCCcEEE------ccCCcEEEeeecccccCC
Q 042913 223 IIYRDLKPENILL------REDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 223 ivHrDikp~Nill------~~~~~~kl~DFG~a~~~~ 253 (317)
++|+|+.+.|||+ ++++.++|+||.+|....
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~ 282 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY 282 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence 6799999999999 346789999999986543
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=92.15 E-value=1.1 Score=39.12 Aligned_cols=77 Identities=14% Similarity=0.174 Sum_probs=44.3
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCcEEEccCC-cEEEeeec
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG-----IIYRDLKPENILLREDG-HIMLSDFD 247 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivHrDikp~Nill~~~~-~~kl~DFG 247 (317)
..+++|+|.+|..|.+.-.......+.......+. -+-++..+..++ +-+.--.+.|||++.++ .+.++|-+
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~IDhn 233 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDSK 233 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSCC
T ss_pred cceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEcCC
Confidence 56799999987777665422111123333322211 123445555432 12223689999998654 59999999
Q ss_pred ccccC
Q 042913 248 LCFQS 252 (317)
Q Consensus 248 ~a~~~ 252 (317)
+|..-
T Consensus 234 ~af~~ 238 (342)
T 1cja_A 234 IIPLD 238 (342)
T ss_dssp CCCCC
T ss_pred ccccC
Confidence 98543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.71 E-value=0.59 Score=38.08 Aligned_cols=87 Identities=13% Similarity=0.057 Sum_probs=62.6
Q ss_pred CCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 042913 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE 237 (317)
Q Consensus 158 ~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~ 237 (317)
.||+++.. .+-+..+.+.+.++.-+.+-=+..+ ..++....++++.+|+....++ ..-+|--|.|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence 58888877 4556667777776655433222224 3367888889998888777443 34577789999999999
Q ss_pred CCcEEEeeecccccC
Q 042913 238 DGHIMLSDFDLCFQS 252 (317)
Q Consensus 238 ~~~~kl~DFG~a~~~ 252 (317)
++.+++.-.|+-...
T Consensus 115 ~~~p~i~~RGik~~l 129 (215)
T 4ann_A 115 DGLPIAKTRGLQNVV 129 (215)
T ss_dssp TSCEEESCCEETTTB
T ss_pred CCCEEEEEccCccCC
Confidence 999999999985444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.81 E-value=0.016 Score=53.57 Aligned_cols=64 Identities=13% Similarity=0.066 Sum_probs=17.3
Q ss_pred EEeeeecccCCeEEEEEEEcCCCCceEEE------EEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTSANFAL------KVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
.+.+.|| ||.||++.+.. ...+||+ |.........+....+.+|..+++.++|+|+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccc-cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3445566 99999998875 3457888 766554445555667888999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.94 E-value=1.1 Score=36.59 Aligned_cols=86 Identities=8% Similarity=-0.041 Sum_probs=60.3
Q ss_pred CCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCCeeccCCCCcEEEc
Q 042913 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE-YLHALGIIYRDLKPENILLR 236 (317)
Q Consensus 158 ~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~-~LH~~~ivHrDikp~Nill~ 236 (317)
.||++ -..+-..++.+.+.++.-+++.=+..+ ..++....++++.+|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57888 333446677777777665343323333 23678888888888776555 33 4567888999999999
Q ss_pred cCCcEEEeeecccccC
Q 042913 237 EDGHIMLSDFDLCFQS 252 (317)
Q Consensus 237 ~~~~~kl~DFG~a~~~ 252 (317)
.++.++|.-.|+-...
T Consensus 119 ~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 119 RALEPFFLHVGVKESL 134 (219)
T ss_dssp TTCCEEESCCEETTTB
T ss_pred CCCcEEEEEcCCcccC
Confidence 9999999999985444
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=86.27 E-value=4.1 Score=39.24 Aligned_cols=26 Identities=27% Similarity=0.496 Sum_probs=23.7
Q ss_pred ccCCCCcEEEccCCcEEEeeeccccc
Q 042913 226 RDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 226 rDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+|=.++||||+.+|.+.-+|||++..
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f~ 576 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYILG 576 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCTT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhhc
Confidence 68889999999999999999999853
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=82.89 E-value=8.5 Score=36.44 Aligned_cols=26 Identities=27% Similarity=0.484 Sum_probs=23.3
Q ss_pred ccCCCCcEEEccCCcEEEeeeccccc
Q 042913 226 RDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 226 rDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
+|=.++||||+.+|++.=+|||++..
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f~ 502 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYILG 502 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCTT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhhc
Confidence 57789999999999999999999853
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=80.19 E-value=1.9 Score=35.27 Aligned_cols=60 Identities=15% Similarity=0.050 Sum_probs=45.7
Q ss_pred CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEee
Q 042913 185 GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 185 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
-+|.++|... +.+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 3688888765 6889999999999999999887622 1212333457899999999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 317 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-41 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-16 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-41
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 4/164 (2%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+++ LG G G+V+ ++ TS A KV+D S ++L +E +IL+ DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ L + + LI++C G + +++ + + ++ + L L YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
II+RDLK NIL DG I L+DF + ++ ++ +G
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-38
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 8/167 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+ + + +G+G+ G V+ + A+K+++ + ++L + E +L H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
+ + + + + +C L+ L +F + + A + G++YLHA
Sbjct: 65 NILLFMGY-STAPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
II+RDLK NI L ED + + DF L E GS
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-37
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 7/170 (4%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
L + + LG GN G VF + + A K++ ++ + + E ++L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI-KPAIRNQIIRELQVLHE 60
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+ P++ Y I +++ G L +L K R Q + + V+ GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 217 YLH-ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
YL I++RD+KP NIL+ G I L DF + ++ ++ + VG+
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGT 166
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (338), Expect = 2e-37
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 6/157 (3%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
L H + LGTG G V R T NFA K V S K+ V+ E + +S+L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLR 81
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP L L+ E + + + ++ G+L + + +N+ S + +V GL ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 219 HALGIIYRDLKPENILL--REDGHIMLSDFDLCFQSD 253
H ++ DLKPENI+ + + L DF L D
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-37
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 4/159 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEIL 154
+ L ++ R LG G G V+L + + ALKV+ K L A ++ E EI
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
S L HP + LY + + + +++Y P G ++ L K ++F Q + E+
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 118
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
L Y H+ +I+RD+KPEN+LL G + ++DF +
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-37
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 6/165 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
LV+ LG G G V L R T A+K+VD + +++ E I ML+H +
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENV 65
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
Y H + ++YC G+L + +P+ + F +++ G+ YLH +G
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLC--FQSDVVPTLVETNVGS 265
I +RD+KPEN+LL E ++ +SDF L F+ + L+ G+
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-36
Identities = 57/148 (38%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSMLDHPF 161
K + LG G+ V L TS +A+K+++K ++ K+ +V E +++S LDHPF
Sbjct: 11 KFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
LY + + F + Y NG+L + K F RF+ AE++ LEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK 127
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLC 249
GII+RDLKPENILL ED HI ++DF
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTA 155
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (323), Expect = 3e-35
Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 6/151 (3%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
+ ++ LG+G G V C + T F K ++ K V+ E I++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 86
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L L+ E + + ++++ G+L + + + + S V + + GL+++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE 145
Query: 221 LGIIYRDLKPENILLR--EDGHIMLSDFDLC 249
I++ D+KPENI+ + + + DF L
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 4e-35
Identities = 40/160 (25%), Positives = 59/160 (36%), Gaps = 4/160 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPF 161
+R +G G+ G V+ S A+K + S +K + E L L HP
Sbjct: 18 SDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
H +++YC L + + L GL YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 222 GIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261
+I+RD+K NILL E G + L DF + V T
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-34
Identities = 35/156 (22%), Positives = 67/156 (42%), Gaps = 10/156 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+++ +GTG+ GR + K +D ++ + + E +L L HP +
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 163 PTLYAHL--EVSHYICFLIDYCPNGDLHSLLPKQPNNR--FSLQAVRFFAAEVLVGLEYL 218
Y + + + +++YC GDL S++ K R + V ++ + L+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 219 HALG-----IIYRDLKPENILLREDGHIMLSDFDLC 249
H +++RDLKP N+ L ++ L DF L
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-34
Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 16/185 (8%)
Query: 88 ATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHV 147
A +S++G R LK +G G+ V+ + T+ A + L+ +
Sbjct: 1 AVGMSNDG----RFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRF 55
Query: 148 QMEAEILSMLDHPFLPTLYAHLEVS----HYICFLIDYCPNGDLHSLLPKQPNNRFSLQA 203
+ EAE+L L HP + Y E + I + + +G L + L + ++
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKV 113
Query: 204 VRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR-EDGHIMLSDFDLCFQSDVVPTLVE 260
+R + ++L GL++LH II+RDLK +NI + G + + D L + +
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAK 171
Query: 261 TNVGS 265
+G+
Sbjct: 172 AVIGT 176
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-34
Identities = 53/158 (33%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEA 151
S L ++ LGTG+ GRV L ++ + ++A+K++DK ++ K++ H E
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 152 EILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEV 211
IL ++ PFL L + + + +++Y G++ S L + RFS RF+AA++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQI 150
Query: 212 LVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++ EYLH+L +IYRDLKPEN+L+ + G+I ++DF
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-34
Identities = 58/165 (35%), Positives = 98/165 (59%), Gaps = 5/165 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKD-LLSAKKLSHVQMEAEILSM-LDHP 160
L + LG G+ G+VFL + T+ FA+K + KD +L + +E +LS+ +HP
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
FL ++ + + F+++Y GDL + Q ++F L F+AAE+++GL++LH+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
GI+YRDLK +NILL +DGHI ++DF +C ++ + T G+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 166
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 6e-34
Identities = 37/163 (22%), Positives = 66/163 (40%), Gaps = 6/163 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+G G G V+ T A++ ++ K + E ++ +P +
Sbjct: 23 TRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNI 79
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
V + +++Y G L ++ + + E L LE+LH+
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
+I+RD+K +NILL DG + L+DF C Q + T VG+
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (308), Expect = 9e-34
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM-------EAEILS 155
+ LG G V C + T +A+K++D + VQ E +IL
Sbjct: 6 EPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 156 ML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
+ HP + L E + + + D G+L L + S + R +L
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEV 122
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+ LH L I++RDLKPENILL +D +I L+DF Q D
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 1e-33
Identities = 60/152 (39%), Positives = 94/152 (61%), Gaps = 4/152 (2%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSML 157
L+ +++R LGTG+ GRV L R +A+KV+ K+++ K++ H E +LS++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 158 DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
HPF+ ++ + + I ++DY G+L SL + + RF +F+AAEV + LEY
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
LH+ IIYRDLKPENILL ++GHI ++DF
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-33
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 6/149 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
LKLV LG G G V++ + T A+K + + +S EA ++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAF---LAEANLMKQLQHQ 68
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L LYA + I + +Y NG L L + ++ + AA++ G+ ++
Sbjct: 69 RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC 249
I+RDL+ NIL+ + ++DF L
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-33
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
+ L ++ LGTG G V R + A+K++ + +S + EA+++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEF---IEEAKVMMNLSH 58
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
L LY I + +Y NG L + L + +RF Q + +V +EYL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ ++RDL N L+ + G + +SDF L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
L+++ LKL++ +G G G V L R A+K + D EA +++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIKND----ATAQAFLAEASVMTQ 56
Query: 157 LDHPFLPTLY-AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
L H L L +E + + +Y G L L + + + F+ +V +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDF 246
EYL ++RDL N+L+ ED +SDF
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 3e-33
Identities = 32/150 (21%), Positives = 61/150 (40%), Gaps = 4/150 (2%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
+ + + LG G G V+ + S A+K + +D ++ EA ++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED---TMEVEEFLKEAAVMKE 69
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+ HP L L + ++ G+L L + S + + A ++ +E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 217 YLHALGIIYRDLKPENILLREDGHIMLSDF 246
YL I+RDL N L+ E+ + ++DF
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADF 159
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-33
Identities = 54/171 (31%), Positives = 96/171 (56%), Gaps = 4/171 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK-LSHVQMEAEIL 154
K+ + ++ LG G G+V L + T +A+K++ K+++ AK ++H E+ +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 155 SMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
HPFL L + +CF+++Y G+L L + F+ + RF+ AE++
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSA 117
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
LEYLH+ ++YRD+K EN++L +DGHI ++DF LC + ++T G+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (308), Expect = 5e-33
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM----EAE 152
L + + R +G G G V+ C D T +A+K +DK + K+ + +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
++S D PF+ + + F++D GDLH L + + FS +RF+AAE++
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII 117
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+GLE++H ++YRDLKP NILL E GH+ +SD L
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 1e-32
Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 5/167 (2%)
Query: 85 IKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANF--ALKVVDKDLLSAK 142
A + ++ + +K+ + +G G G V HL+ A+K + + K
Sbjct: 12 PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEK 69
Query: 143 KLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQ 202
+ EA I+ DHP + L + S + + ++ NG L S +Q + +F++
Sbjct: 70 QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVI 128
Query: 203 AVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
+ + G++YL + ++RDL NIL+ + +SDF L
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-32
Identities = 32/160 (20%), Positives = 65/160 (40%), Gaps = 4/160 (2%)
Query: 106 RHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPT 164
+ LG+GN G V + + A+K++ + + EA ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
+ E + +++ G L+ L + N + + +V +G++YL +
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
+RDL N+LL + +SDF L +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 8e-32
Identities = 60/175 (34%), Positives = 97/175 (55%), Gaps = 8/175 (4%)
Query: 89 TNLSSNG-KLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLS--AKK 143
NL+ + K+ + + +L++ LGTG G+VFL T +A+KV+ K + AK
Sbjct: 12 ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 144 LSHVQMEAEILSMLDH-PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQ 202
H + E ++L + PFL TL+ + + ++DY G+L + L RF+
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEH 129
Query: 203 AVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257
V+ + E+++ LE+LH LGIIYRD+K ENILL +GH++L+DF L + T
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-31
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 6/149 (4%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
L V+ +G+G G V L + + A+K + + +S + EAE++ L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHP 60
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L LY IC + ++ +G L + F+ + + +V G+ YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLC 249
+I+RDL N L+ E+ I +SDF +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMT 148
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-31
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 4/145 (2%)
Query: 108 LGTGNLGRVFLCHLRDC-TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLY 166
LG GN G V R + A+KV+ + + EA+I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 167 AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYR 226
+ + + +++ G LH L + V +V +G++YL ++R
Sbjct: 76 GVCQ-AEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 227 DLKPENILLREDGHIMLSDFDLCFQ 251
DL N+LL + +SDF L
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKA 158
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-31
Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 7/153 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ LG G G V C + + K V V+ E IL++ H +
Sbjct: 8 MIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNI 63
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ E + + ++ D+ + + + + + +V L++LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 223 IIYRDLKPENILL--REDGHIMLSDFDLCFQSD 253
I + D++PENI+ R I + +F Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-30
Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 8/166 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
LGTG V L + T A+K + K L K+ ++ E +L + HP +
Sbjct: 12 DFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNI 69
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L E ++ ++ G+L + + ++ + +VL ++YLH LG
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 223 IIYRDLKPENILLR---EDGHIMLSDFDLCFQSDVVPTLVETNVGS 265
I++RDLKPEN+L ED IM+SDF L D +++ T G+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-30
Identities = 33/158 (20%), Positives = 67/158 (42%), Gaps = 16/158 (10%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILS-MLDHPFL 162
+ LG G G+V + T FALK++ + + E E+ P +
Sbjct: 16 TSQVLGLGINGKVLQIFNKR-TQEKFALKML-------QDCPKARREVELHWRASQCPHI 67
Query: 163 PTLYAHLEVSH----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+ E + + +++ G+L S + + + F+ + + ++YL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 219 HALGIIYRDLKPENILL---REDGHIMLSDFDLCFQSD 253
H++ I +RD+KPEN+L R + + L+DF ++
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-30
Identities = 36/174 (20%), Positives = 71/174 (40%), Gaps = 25/174 (14%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSML 157
+L+ + LG+G G+V + +++V K L + + + E ++++ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 158 -DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL---------------------PKQP 195
H + L +S I + +YC GDL + L ++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 196 NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
N + + + FA +V G+E+L ++RDL N+L+ + + DF L
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-29
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 5/156 (3%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN--FALKVVDKDLLS-AKKLSHVQMEAEI 153
+ + L+L+ LG G+ G V + A+K + D+LS + + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 154 LSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLV 213
+ LDH L LY + + + + + P G L L K F L + +A +V
Sbjct: 65 MHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAE 122
Query: 214 GLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
G+ YL + I+RDL N+LL + + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-29
Identities = 37/190 (19%), Positives = 67/190 (35%), Gaps = 22/190 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
L + LG G G+V + A+K++ + + E ++LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSY 82
Query: 157 L-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNN----------------RF 199
L +H + L + + +YC GDL + L ++ ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259
L+ + F+ +V G+ +L + I+RDL NILL + DF L V
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 260 ETNVGSATRR 269
+
Sbjct: 203 VKGNARLPVK 212
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-29
Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 6/168 (3%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP 160
L+L LG G G V++ T A+K + +S + EA+++ L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPE---AFLQEAQVMKKLRHE 72
Query: 161 FLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA 220
L LYA + I + +Y G L L + L + AA++ G+ Y+
Sbjct: 73 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATR 268
+ ++RDL+ NIL+ E+ ++DF L + +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 1e-29
Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 8/154 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPF 161
+L LG G + V L + A+KV+ DL + EA+ + L+HP
Sbjct: 10 ELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 162 LPTLYAHLE----VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
+ +Y E +++Y L ++ + + A+ L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
H GII+RD+KP NI++ + + DF +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 3/165 (1%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKV-VDKDLLSAKKLSHVQMEAEILSMLDH 159
++L R +G G G V + A+ + K+ S EA + DH
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P + L + + + +++ C G+L S L + L ++ +A ++ L YL
Sbjct: 68 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 125
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
+ ++RD+ N+L+ + + L DF L + +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-28
Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 6/165 (3%)
Query: 108 LGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK---LSHVQMEAEILSMLDHPFLPT 164
LG G V+ ++ T+ A+K + S K E ++L L HP +
Sbjct: 6 LGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 165 LYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L I + D+ + K + + ++ + L GLEYLH I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 225 YRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRR 269
+RDLKP N+LL E+G + L+DF L V + R
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 167
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 3e-28
Identities = 41/177 (23%), Positives = 69/177 (38%), Gaps = 27/177 (15%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
+++ VR +G G GRVF A+K++ ++ SA + Q EA +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE 72
Query: 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNR------------------ 198
D+P + L V +C L +Y GDL+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 199 ----FSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251
S A +V G+ YL ++RDL N L+ E+ + ++DF L
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (269), Expect = 5e-28
Identities = 33/151 (21%), Positives = 58/151 (38%), Gaps = 4/151 (2%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ +G G G V+ FALK + + S E IL L H +
Sbjct: 5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
LY + + + ++ L + F ++L G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+++RDLKP+N+L+ +G + ++DF L
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 6e-28
Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 17/174 (9%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLR-DCTSANFALKVVDKDLLSAKKLSHVQMEAEIL 154
L +K +G GN G+V ++ D + A+K + + S E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVL 64
Query: 155 SML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPK--------------QPNNRF 199
L HP + L E Y+ I+Y P+G+L L K +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
S Q + FAA+V G++YL I+RDL NIL+ E+ ++DF L +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-27
Identities = 35/155 (22%), Positives = 63/155 (40%), Gaps = 9/155 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ ++G G G V + A+K + E +IL H +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENI 68
Query: 163 PTLYAHLEVSHYI----CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
+ + +L+ + DL+ LL Q S + +F ++L GL+Y+
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYI 125
Query: 219 HALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
H+ +++RDLKP N+LL + + DF L +D
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (268), Expect = 1e-27
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DH 159
+LVR LG G VF + +K++ K ++ E +IL L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP-----VKKKKIKREIKILENLRGG 89
Query: 160 PFLPTLYAHLE--VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
P + TL ++ VS + ++ N D L + +RF+ E+L L+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144
Query: 218 LHALGIIYRDLKPENILL-REDGHIMLSDFDLC 249
H++GI++RD+KP N+++ E + L D+ L
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-27
Identities = 33/170 (19%), Positives = 69/170 (40%), Gaps = 6/170 (3%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDL---LSAKKLSHVQMEAEILSMLDH 159
K ++ LG+G G V+ + V K+L S K + EA +++ +D+
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
P + L + ++ + + P G L + + + Q + + ++ G+ YL
Sbjct: 71 PHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 220 ALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRR 269
+++RDL N+L++ H+ ++DF L G +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-27
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 7/154 (4%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DH 159
+ V +G G G+VF ALK V E +L L +H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 160 PFLPTLYAHLEVSHY----ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
P + L+ VS L+ + DL + L K P + ++ ++L GL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
++LH+ +++RDLKP+NIL+ G I L+DF L
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 4e-27
Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 2/162 (1%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ V +G G G V+ + T ALK + D + S E +L L+HP +
Sbjct: 5 QKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L + + + + ++ + DL + L ++ + ++L GL + H+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
+++RDLKP+N+L+ +G I L+DF L V V
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 5e-27
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 3/151 (1%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ + +G G G VF R+ T ALK V D S E +L L H +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG 222
L+ L + + ++C N + V+ F ++L GL + H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 223 IIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+++RDLKP+N+L+ +G + L++F L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-27
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 11/155 (7%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ + +G G G VF R T ALK V + E +IL +L H +
Sbjct: 13 EKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 163 PTLY--------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVG 214
L + I + D+C + L +F+L ++ +L G
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 215 LEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
L Y+H I++RD+K N+L+ DG + L+DF L
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-27
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 22/190 (11%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRD------CTSANFALKVVDKDLLSAKKLSHVQMEAEIL 154
L L + LG G G+V L A+K++ D + K LS + E E++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMM 72
Query: 155 SML-DHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------------PKQPNNRF 199
M+ H + L + +++Y G+L L P +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 200 SLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259
S + + A +V G+EYL + I+RDL N+L+ ED + ++DF L +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 260 ETNVGSATRR 269
+T G +
Sbjct: 193 KTTNGRLPVK 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-26
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK----LSHVQMEAEILSMLD 158
LG+G V C + T +A K + K + + ++ E IL +
Sbjct: 13 DTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 159 HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYL 218
HP + TL+ E + +++ G+L L + + + F ++L G+ YL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYL 129
Query: 219 HALGIIYRDLKPENILLREDG----HIMLSDFDLCFQSD 253
H+L I + DLKPENI+L + I + DF L + D
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-26
Identities = 38/188 (20%), Positives = 75/188 (39%), Gaps = 19/188 (10%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDC----TSANFALKVVDKDLLSAKKLSHVQMEAEILSM 156
LKL + LG G G+V T A+K++ + ++ + + ++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 157 LDHPFLPTL-YAHLEVSHYICFLIDYCPNGDLHSLLPKQPN--------------NRFSL 201
H + L A + + ++++C G+L + L + N + +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 202 QAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVET 261
+ + ++ +V G+E+L + I+RDL NILL E + + DF L P V
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 262 NVGSATRR 269
+
Sbjct: 194 GDARLPLK 201
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 21/166 (12%)
Query: 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH 159
R + L +G G G V+ R A+K+ ++ + E ML H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEE---VAVKIFSSR---EERSWFREAEIYQTVMLRH 56
Query: 160 PFLPTLYAHLEVSH----YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
+ A + + + DY +G L L + +++ + A GL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 113
Query: 216 EYLHA--------LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+LH I +RDLK +NIL++++G ++D L + D
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 13/185 (7%)
Query: 97 LHLRHLKLVRHLGTGNLGRVFLCHLR----DCTSANFALKVVDKDLLSAKKLSHVQMEAE 152
+ + + R LG G+ G V+ + D A+K V++ S ++ EA
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEAS 75
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLL--------PKQPNNRFSLQAV 204
++ + + L + +++ GDL S L SL +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 205 RFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
A E+ G+ YL+A ++RDL N ++ ED + + DF + + G
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 265 SATRR 269
R
Sbjct: 196 LLPVR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-26
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ +G G+ G V+ L D + A+K V +D + E +I+ LDH +
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75
Query: 163 PTLYAHLEVSH------YICFLIDYCPNGDLHSLL-PKQPNNRFSLQAVRFFAAEVLVGL 215
L S Y+ ++DY P + + V+ + ++ L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 216 EYLHALGIIYRDLKPENILLREDGHIM-LSDFDLCFQ 251
Y+H+ GI +RD+KP+N+LL D ++ L DF Q
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-26
Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 3/153 (1%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ ++ +G+G G V T A A+K + + S E +L + H +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 163 PTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHA 220
L + D+ + + + ++F ++L GL Y+HA
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 221 LGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
GII+RDLKP N+ + ED + + DF L Q+D
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (250), Expect = 2e-25
Identities = 35/170 (20%), Positives = 69/170 (40%), Gaps = 11/170 (6%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHP-F 161
+L R +G+G+ G ++L A+K+ K + +E++I M+
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVG 64
Query: 162 LPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL 221
+PT+ Y +++ L + +FSL+ V A +++ +EY+H+
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 222 GIIYRDLKPENILLREDGH---IMLSDFDLCFQSDVVPTLVETNVGSATR 268
I+RD+KP+N L+ + + DF L + T
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-25
Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 5/172 (2%)
Query: 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSAN---FALKVVDKDLLSAKKLSHVQMEAE 152
++H + + +G G G V+ L+ + A+K + + K+ EA
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAG 61
Query: 153 ILSMLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
I+ H + L + + + +Y NG L ++ + FS+ + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIA 120
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVETNVG 264
G++YL + ++RDL NIL+ + +SDF L + P T G
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 1e-24
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 9/158 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKK----LSHVQMEAEILSMLD 158
++ LG+G G V+ + A+K V+KD +S + V ME +L +
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 159 --HPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLE 216
+ L E +++ + + R F +VL +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVR 124
Query: 217 YLHALGIIYRDLKPENILLRED-GHIMLSDFDLCFQSD 253
+ H G+++RD+K ENIL+ + G + L DF
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 1e-24
Identities = 32/157 (20%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD 158
L+ + ++ +G+G G V + N A+K + + + E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 159 HPFLPTLY------AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVL 212
H + +L LE + +++ + + + R + + ++L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-----MSYLLYQML 129
Query: 213 VGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLC 249
G+++LH+ GII+RDLKP NI+++ D + + DF L
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 98.3 bits (244), Expect = 2e-24
Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 13/159 (8%)
Query: 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH- 159
H K+ R +G G+ G +F + A+K + ++ E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGC 60
Query: 160 PFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLH 219
+P +Y + + +ID L +FS++ V A ++L ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 220 ALGIIYRDLKPENILLRE-----DGHIMLSDFDLCFQSD 253
++YRD+KP+N L+ I + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-24
Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
+ + +G+G G V T A+K + + S E +L + H +
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 163 PTLYAHLEVSHYIC-----FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEY 217
L + + +L+ + DL++++ Q + + V+F ++L GL+Y
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKY 136
Query: 218 LHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257
+H+ II+RDLKP N+ + ED + + DF L +D T
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 33/145 (22%), Positives = 65/145 (44%), Gaps = 5/145 (3%)
Query: 108 LGTGNLGRVFLCHLRD--CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTL 165
+G G+ G V+ L D + A+K +++ ++S E I+ HP + +L
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 166 Y-AHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGII 224
L ++ Y +GDL + + + +N + F +V G+++L + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFV 152
Query: 225 YRDLKPENILLREDGHIMLSDFDLC 249
+RDL N +L E + ++DF L
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.4 bits (189), Expect = 1e-16
Identities = 34/153 (22%), Positives = 64/153 (41%), Gaps = 19/153 (12%)
Query: 103 KLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL 162
LVR LG G+ V+L + + A+K+V D + + + E ++L ++
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKVYTEAA---EDEIKLLQRVNDADN 71
Query: 163 PTLYA--HLEVSHYICFLIDYCPNGDLHSLLP------------KQPNNRFSLQAVRFFA 208
+ + + PNG ++ K + L V+ +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 209 AEVLVGLEYLH-ALGIIYRDLKPENILLREDGH 240
++L+GL+Y+H GII+ D+KPEN+L+
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 5e-16
Identities = 26/158 (16%), Positives = 51/158 (32%), Gaps = 16/158 (10%)
Query: 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQM--------EAEILS 155
+ + +G G VF C +K S KK+ + A +
Sbjct: 4 IGKLMGEGKESAVFNC--YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 156 MLDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGL 215
+ L L + + + N L L+ + R ++ +L +
Sbjct: 62 RNEFRALQKLQ-----GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 216 EYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253
+ GI++ DL N+L+ + I + DF +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.47 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 85.58 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=318.19 Aligned_cols=198 Identities=23% Similarity=0.313 Sum_probs=164.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++..... .+..+.+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999887 899999999976532 23446789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 82 mEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999965 467999999999999999999999999999999999999999999999999999876433211
Q ss_pred eecccccccccccccccCCCCCcccccccccceecc-chhhhccCCcccccccCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAE-PRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~G 313 (317)
. ......|+..|++||... .... ....|+||+|++++|+..|
T Consensus 160 ~--------~~~~~~GT~~Y~APE~~~-----~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 160 R--------LLNKMCGTLPYVAPELLK-----RREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp C--------CBCCCCSCGGGSCTHHHH-----CSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred c--------cccceeeCcCccCHhHhc-----CCCCCCCceeeeHhHHHHHHHHhC
Confidence 0 011124555666666543 3332 5678999999999999999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=317.06 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=170.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+..++|++++.||+|+||+||+|.+.. +++.||+|++.+..... ...+.+.+|+++++.++||||+++++++.+++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 346789999999999999999999887 89999999997654333 3456788999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999999653 67999999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ...|+..|++||.... .....++|+||+|++++|+..| .|
T Consensus 160 ~~~------------~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 160 RRT------------TLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp CCE------------ETTEEGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred ccc------------ccCCCCcccCHHHHcC-----CCCCchhhhhhHhHHHHHHhcCCCC
Confidence 211 1235556777776543 3345789999999999999999 44
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=320.04 Aligned_cols=195 Identities=19% Similarity=0.257 Sum_probs=167.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+++++.++|||||++++++..++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3589999999999999999999877 899999999976532 2346789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 96 mEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999998865 46999999999999999999999999999999999999999999999999999877554332
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
... ..++..|++||.... .....++|+|++|++++|+..|.
T Consensus 173 ~~~----------~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~ 213 (293)
T d1yhwa1 173 RST----------MVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGE 213 (293)
T ss_dssp BCC----------CCSCGGGCCHHHHSS-----SCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccc----------cccCCCccChhhhcC-----CCCCchhceehHhHHHHHHhhCC
Confidence 222 234556777776543 33457899999999999999993
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=323.30 Aligned_cols=202 Identities=23% Similarity=0.332 Sum_probs=171.9
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
+.|++++.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999887 8999999999765 3344567889999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++|+|.+++.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~- 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 166 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH-
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc-
Confidence 999999999987543 356999999999999999999999999999999999999999999999999999764322111
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.....++..|++||..............++|+||+|++++|+..| .|
T Consensus 167 ---------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 167 ---------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp ---------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred ---------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 112356677999998765544444446789999999999999999 44
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=322.18 Aligned_cols=201 Identities=27% Similarity=0.485 Sum_probs=171.9
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
+.+++|++++.||+|+||+||+|++.. +++.||||++.+.... ....+.+.+|+++|+.++||||+++++++.+.+.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 457899999999999999999999887 8999999999876433 24567789999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999999966 467999999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
.....+. .|+..|++||.. ........+|+||+|++++|+..|-|
T Consensus 159 ~~~~~~~----------~GT~~Y~aPE~~-----~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 159 GATMKTF----------CGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp TCCBCCC----------EECGGGCCGGGG-----SSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred Ccccccc----------eeCHHHhhhhhc-----cCCCCChhhcccchhhHHHHHHHCCC
Confidence 3322222 344456666654 34445678999999999999999943
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=317.34 Aligned_cols=203 Identities=30% Similarity=0.431 Sum_probs=168.6
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 175 (317)
...++|++++.||+|+||+||+|.+.. +++.||||++.+.... ....+.+.+|+++++.++||||+++++++.+++.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 445789999999999999999999887 7999999999865432 24557789999999999999999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999999998653 67999999999999999999999999999999999999999999999999999876543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... .....|+..|++||... ......++|+||+|++++|+..| .|
T Consensus 162 ~~~~~--------~~~~~GT~~Y~APE~~~-----~~~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 162 SKQAR--------ANSFVGTAQYVSPELLT-----EKSACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp ----------------CCCCGGGCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred Ccccc--------cccccCCccccCceeec-----cCCCCcccceehhhHHHHHHhhCCCC
Confidence 22111 01123455667776553 33446789999999999999999 44
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=314.52 Aligned_cols=200 Identities=18% Similarity=0.267 Sum_probs=160.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--cCEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV--SHYIC 176 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 176 (317)
.++|++++.||+|+||+||+|.+.. +|+.||+|++......+...+.+.+|+++++.++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999999887 89999999998876677777889999999999999999999999864 46689
Q ss_pred EEEcccCCCChhcccccC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCcEEEccCCcEEEeeeccc
Q 042913 177 FLIDYCPNGDLHSLLPKQ--PNNRFSLQAVRFFAAEVLVGLEYLHALG-----IIYRDLKPENILLREDGHIMLSDFDLC 249 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivHrDikp~Nill~~~~~~kl~DFG~a 249 (317)
+||||+++|+|.+++.+. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999998642 2467999999999999999999999976 999999999999999999999999999
Q ss_pred ccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 250 FQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
+.+........+ ..++..|++||.... ......+|+||+|++++|+..|.
T Consensus 162 ~~~~~~~~~~~~----------~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 162 RILNHDTSFAKA----------FVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp HHC---------------------CCCSCCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCCcccc----------CCCCcccCCHHHHcC-----CCCChHHHHHhhCHHHHHHhhCC
Confidence 887544332222 234567888876543 23357889999999999999993
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-44 Score=314.88 Aligned_cols=206 Identities=17% Similarity=0.211 Sum_probs=175.5
Q ss_pred CCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 92 SSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 92 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
+....+..++|++.+.||+|+||+||+|.+.. +++.||||+++.+.. ..+++.+|+++|+.++|||||++++++.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 34456778899999999999999999999887 789999999976533 24568899999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
++.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999776677899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.........+. ..++..|++||....+ ......|+||+|++++|+..| .|
T Consensus 165 ~~~~~~~~~~~---------~~g~~~y~aPE~~~~~-----~~~~k~DiwS~Gv~l~ell~~~~p 215 (287)
T d1opja_ 165 MTGDTYTAHAG---------AKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYGMS 215 (287)
T ss_dssp CCSSSSEEETT---------EEECGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCceeecc---------ccccccccChHHHcCC-----CCCchhhhhhHHHHHHHHHhCCCC
Confidence 65543322211 1345568888876543 335789999999999999874 54
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-43 Score=318.27 Aligned_cols=197 Identities=24% Similarity=0.325 Sum_probs=168.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+++|++++.||+|+||.||+|.+.. +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5789999999999999999999887 8999999999765 334457789999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--cCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--EDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~~~~~kl~DFG~a~~~~~~~ 256 (317)
||||+||+|.+++... .+.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999998544 35699999999999999999999999999999999999996 46789999999998776543
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. .+ ..++..|++||... ......++|+|++|++++|+..| .|
T Consensus 181 ~~-~~----------~~gT~~Y~aPEv~~-----~~~~~~~~DiwSlGvilyell~G~~P 224 (350)
T d1koaa2 181 SV-KV----------TTGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLSP 224 (350)
T ss_dssp CE-EE----------ECSCTTTCCHHHHH-----TCCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cc-ce----------ecCcccccCHHHHc-----CCCCChhHhhhhhhHHHHHHHhCCCC
Confidence 22 11 23455677777653 33345789999999999999999 44
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=322.57 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=169.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
+..++|++++.||+|+||+||+|.+.. +++.||+|+++... .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456799999999999999999999887 89999999997653 3344567899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCcEEEeeecccccCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~ 255 (317)
+||||+++|+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999999999653 679999999999999999999997 59999999999999999999999999999865321
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ....|+..|++||.... .......|+||+|++++|+..| .|
T Consensus 159 ~~------------~~~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvil~ell~G~~P 202 (322)
T d1s9ja_ 159 MA------------NSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYP 202 (322)
T ss_dssp TC---------------CCSSCCCCHHHHHC-----SCCCTTHHHHHHHHHHHHHHHSSCC
T ss_pred cc------------ccccCCccccCchHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 11 11245666777776643 3456789999999999999999 55
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-43 Score=317.34 Aligned_cols=196 Identities=19% Similarity=0.289 Sum_probs=167.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999887 89999999997653 33446788999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc--cCCcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR--EDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~--~~~~~kl~DFG~a~~~~~~~ 256 (317)
||||+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+......
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999999887543 45699999999999999999999999999999999999998 57899999999998876543
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. .+ ..++..|++||.... .....++|+|++|++++|+..|.
T Consensus 184 ~~-~~----------~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 184 IV-KV----------TTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp CE-EE----------ECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSC
T ss_pred ce-ee----------ccCcccccCHHHHcC-----CCCCCccchHHHHHHHHHHHhCC
Confidence 21 11 134456777776643 33467899999999999999994
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-43 Score=314.02 Aligned_cols=197 Identities=34% Similarity=0.562 Sum_probs=170.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
.+++|++++.||+|+||+||+|++.. +|+.||||++++..... ...+.+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 35789999999999999999999887 89999999998764332 45678899999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 81 ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999999999866 4678999999999999999999999999999999999999999999999999998764322
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
. ...|+..|++||..... ....++|+||+|++++|+..| .|
T Consensus 159 ~-------------~~~Gt~~Y~APE~l~~~-----~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 159 Y-------------TLCGTPDYIAPEVVSTK-----PYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp C-------------CCCSCTTTCCHHHHTTC-----CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred c-------------cccCcccccCHHHHcCC-----CCCchhhccccchhHHHHHhCCCC
Confidence 1 12566778888866433 335689999999999999999 44
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=304.73 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=165.9
Q ss_pred CeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----cCEEE
Q 042913 101 HLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV----SHYIC 176 (317)
Q Consensus 101 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 176 (317)
.|++.++||+|+||+||+|.+.. +++.||+|++..........+.+.+|+++|+.++|||||++++++.. +..+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45888899999999999999887 78999999998776677777889999999999999999999999865 45689
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEc-cCCcEEEeeecccccCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALG--IIYRDLKPENILLR-EDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivHrDikp~Nill~-~~~~~kl~DFG~a~~~~ 253 (317)
+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999999653 67999999999999999999999998 99999999999996 57899999999997543
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... . ...|+..|++||..... ....+|+||+|++++|+..| .|
T Consensus 167 ~~~~--~----------~~~GT~~Y~aPE~~~~~------~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 167 ASFA--K----------AVIGTPEFMAPEMYEEK------YDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp TTSB--E----------ESCSSCCCCCGGGGGTC------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCcc--C----------CcccCccccCHHHhCCC------CCCcCchhhHHHHHHHHHHCCCC
Confidence 3221 1 12456678888876432 35679999999999999999 55
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=313.10 Aligned_cols=196 Identities=19% Similarity=0.204 Sum_probs=166.7
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
..|++++.||+|+||+||+|.+.. +++.||||++...... ....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 359999999999999999999887 7999999999765433 35567899999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||||.+|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS- 170 (309)
T ss_dssp EECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC-
T ss_pred EEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCc-
Confidence 999999999877654 36799999999999999999999999999999999999999999999999999986543221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
..|+..|++||.....-. .....++|+||+|++++|+..|.
T Consensus 171 -------------~~GT~~Y~APE~~~~~~~--~~y~~~~DiwSlGvilyel~~g~ 211 (309)
T d1u5ra_ 171 -------------FVGTPYWMAPEVILAMDE--GQYDGKVDVWSLGITCIELAERK 211 (309)
T ss_dssp -------------CCSCGGGCCHHHHTTTTS--CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------cccCccccCHHHHhccCC--CCcCchhhhhhHHHHHHHHHHCC
Confidence 246667888887643211 11235789999999999999993
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-43 Score=312.08 Aligned_cols=222 Identities=19% Similarity=0.250 Sum_probs=166.3
Q ss_pred cchhhHHHhhccCCCCccccCCeEEeeeecccCCeEEEEEEEcCCCCc---eEEEEEeehhhhcHHHHHHHHHHHHHHHh
Q 042913 80 LHWSAIKAATNLSSNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA---NFALKVVDKDLLSAKKLSHVQMEAEILSM 156 (317)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~ 156 (317)
+++.++..++..|.. .+..++|++.+.||+|+||+||+|.+.. +++ .||||.+.... .....+.+.+|+++|+.
T Consensus 7 ~t~~d~~~a~~~f~~-~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKL-PGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp GGSSSHHHHHHHHSC-BCCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHhhhch-hhChhhcEEeeEEeeCCCeEEEEEEEeC-CCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHh
Confidence 455566677766653 5677899999999999999999998875 333 58888876543 44556789999999999
Q ss_pred cCCCCcceEEEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc
Q 042913 157 LDHPFLPTLYAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR 236 (317)
Q Consensus 157 l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~ 236 (317)
++|||||++++++..++.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC
Confidence 99999999999999999999999999999999988654 45699999999999999999999999999999999999999
Q ss_pred cCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-C
Q 042913 237 EDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-V 314 (317)
Q Consensus 237 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~ 314 (317)
.++.+||+|||+|+........... . ......++..|++||.. .........|+||+|++++|+.+ | .
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~-~----~~~~~~~t~~y~aPE~~-----~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTY-T----SALGGKIPIRWTAPEAI-----QYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp TTCCEEECCC----------------------------CGGGSCHHHH-----HSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCcEEECCcccceEccCCCCccee-e----ecccccCCccccCHHHH-----hcCCCCcccccccchHHHHHHHhCCCC
Confidence 9999999999999876543321110 0 00111233445666544 33445677899999999999985 7 4
Q ss_pred C
Q 042913 315 P 315 (317)
Q Consensus 315 p 315 (317)
|
T Consensus 233 P 233 (299)
T d1jpaa_ 233 P 233 (299)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-43 Score=316.15 Aligned_cols=201 Identities=27% Similarity=0.466 Sum_probs=171.8
Q ss_pred CCCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 042913 93 SNGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEV 171 (317)
Q Consensus 93 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 171 (317)
.......++|++++.||+|+||.||+|.++. +|+.||||++.+..... ...+.+.+|+++|+.++|||||++++++..
T Consensus 34 ~~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCCccCeEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 3344556899999999999999999999887 89999999997654332 455778999999999999999999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 99999999999999999999654 5799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
...... ...|+..|++||.... .....++|+|++|++++|+..|.
T Consensus 191 ~~~~~~-------------~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyemltG~ 235 (350)
T d1rdqe_ 191 VKGRTW-------------TLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp CSSCBC-------------CCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-------------cccCccccCCHHHHcC-----CCCCccccccchhHHHHHHHhCC
Confidence 653221 1234556777776543 33457899999999999999993
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=312.50 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=154.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+.|++++.||+|+||+||+|.+.. +++.||||++.+.... .....+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999887 8899999999765433 2335688999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc---cCCcEEEeeecccccCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~---~~~~~kl~DFG~a~~~~~~ 255 (317)
|||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+..+..
T Consensus 86 mE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999965 46799999999999999999999999999999999999995 5789999999999865433
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ....|+..|++||..... .....+|+||+|++++|+..| .|
T Consensus 164 ~~~-----------~~~~GT~~y~APE~~~~~-----~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 164 SVL-----------STACGTPGYVAPEVLAQK-----PYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp --------------------CTTSCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred Cee-----------eeeeeCccccCcHHHcCC-----CCCcHHHhhhhhHHHHHHHhCCCC
Confidence 211 112456678888876543 335789999999999999999 44
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=307.25 Aligned_cols=205 Identities=18% Similarity=0.234 Sum_probs=164.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.+.||+|+||.||+|+++ ..||||+++.........+.+.+|+++|++++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 3567789999999999999999999754 36999999876556667788999999999999999999999875 456
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 89999999999999999654 35699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..... ......++..|++||.....-. .....++|+||.|++++|+..| .|
T Consensus 157 ~~~~~--------~~~~~~gt~~y~APE~l~~~~~--~~~~~~sDiwS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 157 WSGSH--------QFEQLSGSILWMAPEVIRMQDK--NPYSFQSDVYAFGIVLYELMTGQLP 208 (276)
T ss_dssp -----------------CCCCGGGCCHHHHTTCSS--CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCcc--------cccccccCcccCCHHHHhcccC--CCCCchhhhhhhHHHHHHHHHCCCC
Confidence 22111 1112245566788876542211 1235678999999999999999 55
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=305.49 Aligned_cols=196 Identities=22% Similarity=0.308 Sum_probs=166.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
.++|++++.||+|+||+||+|.+.. +|+.||||++.+..... ...+.+.+|+++|+.++|||||++++++.+.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4679999999999999999999887 89999999997643222 235678999999999999999999999999999
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC----cEEEeeecccc
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG----HIMLSDFDLCF 250 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~----~~kl~DFG~a~ 250 (317)
+|+|||||++|+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999999664 6799999999999999999999999999999999999998776 59999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ ....++..|++||... ........|+||+|++++|+..|
T Consensus 166 ~~~~~~~~-----------~~~~~t~~y~APE~~~-----~~~~~~~~DiwSlGvilyell~g 212 (293)
T d1jksa_ 166 KIDFGNEF-----------KNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSG 212 (293)
T ss_dssp ECTTSCBC-----------SCCCCCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHS
T ss_pred hcCCCccc-----------cccCCCCcccCHHHHc-----CCCCCCcccchhhhHHHHHHHcC
Confidence 76543321 1113344566676654 33446789999999999999999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=308.22 Aligned_cols=195 Identities=16% Similarity=0.223 Sum_probs=163.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.++|++++.||+|+||+||+|.+.. +++.||||+++... .....+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999887 89999999997653 2234578999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC--CcEEEeeecccccCCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED--GHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~--~~~kl~DFG~a~~~~~~~ 256 (317)
||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999999654 3469999999999999999999999999999999999999854 489999999998765433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. .+ .+++|+|..++..........+|+|++|++++|+..|-
T Consensus 159 ~~-~~---------------~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~ 200 (321)
T d1tkia_ 159 NF-RL---------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp EE-EE---------------EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred cc-cc---------------cccccccccchhccCCCCCchhhcccHHHHHHHHHhCC
Confidence 21 11 12344444444444445567899999999999999993
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-42 Score=301.54 Aligned_cols=203 Identities=24% Similarity=0.289 Sum_probs=172.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-------HHHHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-------AKKLSHVQMEAEILSMLD-HPFLPTLYAHLE 170 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 170 (317)
.++|++.+.||+|+||+||+|++.. +++.||||++.+.... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4689999999999999999999877 7999999999764321 234457889999999997 999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
+++.+||||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999999763 679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccc-cceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENV-MEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~-~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
..+..... ....++..|++||+..... ........+.|+|++|++++|+..| .|
T Consensus 159 ~~~~~~~~-----------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P 214 (277)
T d1phka_ 159 QLDPGEKL-----------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214 (277)
T ss_dssp ECCTTCCB-----------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EccCCCce-----------eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC
Confidence 76543211 1235667788888876432 2233346789999999999999999 44
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-42 Score=313.33 Aligned_cols=197 Identities=28% Similarity=0.458 Sum_probs=164.1
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
..++|++++.||+|+||.||+|++.. +|+.||||++.+..... .......+|+.+++.++|||||++++++...+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 46799999999999999999999887 89999999997654322 22223344566777788999999999999999
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999999663 678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
.... ....|+..|++||....+ ......+|+||+|++++|+..|
T Consensus 159 ~~~~------------~~~~GT~~y~APE~~~~~----~~~~~~~DiwSlGvilyemltG 202 (364)
T d1omwa3 159 KKKP------------HASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRG 202 (364)
T ss_dssp SSCC------------CSCCSCGGGCCHHHHSTT----CCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCcc------------cccccccccchhHHhhcC----CCCCcccchhHHHHHHHHHHhC
Confidence 4321 112456677777765322 2335688999999999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=301.40 Aligned_cols=202 Identities=20% Similarity=0.252 Sum_probs=167.3
Q ss_pred CCccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 94 NGKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 94 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+..+..++|++++.||+|+||.||+|.++. +..||||+++..... .+.+.+|++++++++|||||++++++.. +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECC--CCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 345677899999999999999999998764 788999999765433 3568999999999999999999998754 5
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999998866545569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....... ....++..|++||....+ .....+|+||+|++++|+.+| .|
T Consensus 161 ~~~~~~~---------~~~~gt~~y~APE~~~~~-----~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 161 DNEYTAR---------EGAKFPIKWTAPEAINYG-----TFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp SSCEECC---------TTCCCCTTTSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCccccc---------cccCCcccccChHHHhCC-----CCCchhhhhhhHHHHHHHHhCCCC
Confidence 4332211 112455678888876432 345789999999999999974 44
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=303.88 Aligned_cols=198 Identities=29% Similarity=0.526 Sum_probs=166.5
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-HHHHHHHHHHHHHHH-hcCCCCcceEEEEEEecCEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-AKKLSHVQMEAEILS-MLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 177 (317)
++|++++.||+|+||+||+|.+.. +++.||||++++.... ....+.+.+|..++. .++||||+++++++.+++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 689999999999999999999887 8999999999865432 234456677777665 6899999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999965 46799999999999999999999999999999999999999999999999999987654332
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ...|+..|++||.... .....++|+||+|++++|+..| .|
T Consensus 159 ~~~----------~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 159 KTN----------TFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp CBC----------CCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccc----------ccCCCCCcCCHHHHcC-----CCCCchhhhhhhhHHHHHHHhCCCC
Confidence 211 1234556667766543 3455789999999999999999 54
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=304.19 Aligned_cols=200 Identities=20% Similarity=0.254 Sum_probs=163.1
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLI 179 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 179 (317)
++|+++++||+|+||+||+|.+.. +++.||||+++.....+...+.+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 689999999999999999999887 8899999999776544555678899999999999999999999999999999999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+ ++.+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........
T Consensus 81 e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~- 158 (298)
T d1gz8a_ 81 EFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 158 (298)
T ss_dssp ECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred eec-CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence 999 556666665555678999999999999999999999999999999999999999999999999999765443221
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.....++..|++||..... .......|+||+|++++|+..| .|
T Consensus 159 ---------~~~~~gt~~y~apE~~~~~----~~~~~~~DiwSlGvily~m~~G~~P 202 (298)
T d1gz8a_ 159 ---------YTHEVVTLWYRAPEILLGC----KYYSTAVDIWSLGCIFAEMVTRRAL 202 (298)
T ss_dssp ---------TTCCBCCCTTCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------ceeecccceeeehhhhccc----cCCCccccccccchhhhHHhhCCCC
Confidence 1122455566666654322 1236789999999999999999 44
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=297.82 Aligned_cols=199 Identities=23% Similarity=0.264 Sum_probs=159.1
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 176 (317)
++.++|++++.||+|+||.||+|.+.. ++.||||+++...... +++.+|+++++.++||||+++++++..++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETT--TEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECC--CCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 345789999999999999999998874 6789999997654332 56889999999999999999999999999999
Q ss_pred EEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCC
Q 042913 177 FLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVP 256 (317)
Q Consensus 177 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~ 256 (317)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999999998654 4668999999999999999999999999999999999999999999999999998764433
Q ss_pred CeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCC
Q 042913 257 TLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVP 315 (317)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p 315 (317)
.... ....++..|++||....+ ......|+||+|.+++|+.+ |.|
T Consensus 156 ~~~~---------~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 156 YTSS---------TGTKFPVKWASPEVFSFS-----RYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp ------------------CTTSCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ceee---------cceecCcccCChHHhcCC-----CCCchhhhcchHHHHHHHHHCCCC
Confidence 2111 112456678888876543 23567899999999999886 444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=303.95 Aligned_cols=193 Identities=18% Similarity=0.232 Sum_probs=160.5
Q ss_pred ccCCeEEee-eecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEe----
Q 042913 98 HLRHLKLVR-HLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSM-LDHPFLPTLYAHLEV---- 171 (317)
Q Consensus 98 ~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~---- 171 (317)
..++|++++ .||+|+||+||+|.+.. +++.||||+++.. ..+.+|++++.+ ++|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC-CCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 457899875 59999999999999887 7999999999754 356779988654 589999999999875
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc---CCcEEEeeecc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE---DGHIMLSDFDL 248 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~---~~~~kl~DFG~ 248 (317)
+..+|+|||||+||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467999999999999999998765678999999999999999999999999999999999999985 56799999999
Q ss_pred cccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 249 CFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 249 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
|+........ ....++..|++||... .......+|+|++|++++|+..|-
T Consensus 161 a~~~~~~~~~-----------~~~~gt~~y~aPE~~~-----~~~y~~~~DiwSlGvily~lltg~ 210 (335)
T d2ozaa1 161 AKETTSHNSL-----------TTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGY 210 (335)
T ss_dssp CEECCCCCCC-----------CCCSCCCSSCCCCCCC-----GGGGSHHHHHHHHHHHHHHHTTSS
T ss_pred eeeccCCCcc-----------ccccCCcccCCcHHHc-----CCCCCHHHHHHhhchhHHHHhhCC
Confidence 9876543321 1124556677777654 334457899999999999999994
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=295.80 Aligned_cols=200 Identities=19% Similarity=0.242 Sum_probs=157.8
Q ss_pred CeEEe-eeecccCCeEEEEEEEcC-CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 101 HLKLV-RHLGTGNLGRVFLCHLRD-CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 101 ~y~i~-~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
.+.+. ++||+|+||+||+|.+.. .+++.||||+++.........+.+.+|+++|++++|||||++++++..+ ..++|
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 34443 479999999999998753 2467899999976654555667899999999999999999999998654 57899
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+........
T Consensus 86 mE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999999999653 67999999999999999999999999999999999999999999999999999877654433
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
..... ...++..|+|||.. .......++|+||+|.+++|+.+ | .|
T Consensus 164 ~~~~~-------~~~gt~~y~APE~l-----~~~~~~~~sDiwS~Gv~l~ellt~g~~P 210 (277)
T d1xbba_ 164 YKAQT-------HGKWPVKWYAPECI-----NYYKFSSKSDVWSFGVLMWEAFSYGQKP 210 (277)
T ss_dssp EEC-----------CCCGGGCCHHHH-----HHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccc-------ccCCCceecCchhh-----cCCCCCchhhhccchhhhhHHhhCCCCC
Confidence 22111 11334456666644 33445678999999999999765 7 55
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=294.32 Aligned_cols=204 Identities=22% Similarity=0.279 Sum_probs=163.8
Q ss_pred cccCCeEEeee-ecccCCeEEEEEEEcCC-CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 97 LHLRHLKLVRH-LGTGNLGRVFLCHLRDC-TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 97 ~~~~~y~i~~~-lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
+..++|.+.+. ||+|+||.||+|.++.. ++..||||+++... .....+.+.+|+++|+.++|||||++++++.. +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 44567888884 99999999999987642 34579999997653 45566789999999999999999999999875 45
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 89999999999999987543 45799999999999999999999999999999999999999999999999999988765
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
........ ....++..|++||... ......++|+||+|++++|+.+ | .|
T Consensus 162 ~~~~~~~~-------~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gv~l~E~lt~G~~P 212 (285)
T d1u59a_ 162 DDSYYTAR-------SAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKP 212 (285)
T ss_dssp CSCEECCC-------CSSCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccccc-------cccccCccccChHHHh-----CCCCCccchhhcchHHHHHHHhCCCCC
Confidence 44322111 1113445567776553 3345678999999999999765 7 44
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=296.40 Aligned_cols=199 Identities=21% Similarity=0.257 Sum_probs=160.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHY 174 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 174 (317)
..+..++|++.+.||+|+||+||+|.++. +..||||++...... .+.+.+|+.++++++|||||++++++. ++.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~--~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 85 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECC--CCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEe-cCC
Confidence 35667899999999999999999998875 567999999765433 356889999999999999999999985 456
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 79999999999999998765556799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
..... .....++..|++||+... .......|+||.+++++|+..|
T Consensus 166 ~~~~~---------~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 166 NEYTA---------RQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp -------------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcee---------eccccccccccChHHHhC-----CCCCcHHhhhcchHHHHHHHhC
Confidence 22211 111234556777776543 3345688999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-41 Score=294.15 Aligned_cols=202 Identities=20% Similarity=0.234 Sum_probs=163.5
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL-SAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH--- 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 173 (317)
..++|++.+.||+|+||.||+|.+.. +++.||||++.+... .......+.+|+++++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 35789999999999999999999887 799999999976543 3456678999999999999999999999987653
Q ss_pred -EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 174 -YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 174 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.+|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 489999999999999988653 67999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... .......|+..|++||.... .....++|+||+|++++|+..|.
T Consensus 162 ~~~~~~~-------~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~ 211 (277)
T d1o6ya_ 162 ADSGNSV-------TQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTGE 211 (277)
T ss_dssp C-----------------------TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc-------cccccccCcccccCHHHHcC-----CCCCcceecccchHHHHHHHhCC
Confidence 4332211 11222345667777776543 23457899999999999999993
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=293.07 Aligned_cols=206 Identities=19% Similarity=0.230 Sum_probs=161.1
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCC---ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTS---ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
.+...+|++.+.||+|+||.||+|.++...+ ..||||++.... .......+.+|+++++.++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4556789999999999999999998875222 479999997543 445556789999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
+.+++||||+.+++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999999887654 467999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p 315 (317)
........+.. ...++..|++||.... .....+.|+||+|++++|+.. |.|
T Consensus 161 ~~~~~~~~~~~-------~~~gt~~Y~APE~l~~-----~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 161 EDDPEATYTTS-------GGKIPIRWTAPEAISY-----RKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp --------------------CCCGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCccceEec-------cCCCCccccCHHHHcc-----CCCCCcccccccHHHHHHHHhCCCC
Confidence 55432221111 1134556777776543 344578999999999999876 454
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=300.05 Aligned_cols=205 Identities=20% Similarity=0.280 Sum_probs=162.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCC----CceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCT----SANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++++.||+|+||+||+|.+.... ...||+|.+.... .......+.+|+.++..+ +|||||++++++.
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 456689999999999999999999887522 2368999886543 334456788999999998 8999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP---------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLK 229 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDik 229 (317)
..+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 9999999999999999999996542 1358899999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccc
Q 042913 230 PENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVE 309 (317)
Q Consensus 230 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e 309 (317)
|+|||++.++.+||+|||+|+.......... .....++..|++||....+ .....+|+||+|++++|
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwS~Gvil~e 258 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVV--------RGNARLPVKWMAPESLFEG-----IYTIKSDVWSYGILLWE 258 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEE--------ETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHH
T ss_pred hhccccccCCeEEEeeccccccccCCCceee--------eccccCCCccCChHHHcCC-----CCCcceeccchhHHHHH
Confidence 9999999999999999999986554332211 1112345567888765432 34578899999999999
Q ss_pred cCC-CC
Q 042913 310 QPG-GV 314 (317)
Q Consensus 310 ~~~-G~ 314 (317)
+.. |.
T Consensus 259 mlt~g~ 264 (325)
T d1rjba_ 259 IFSLGV 264 (325)
T ss_dssp HTTTSC
T ss_pred HHhCCC
Confidence 985 73
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=298.74 Aligned_cols=195 Identities=21% Similarity=0.216 Sum_probs=157.7
Q ss_pred EeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEEEc
Q 042913 104 LVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA---KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFLID 180 (317)
Q Consensus 104 i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 180 (317)
.++.||+|+||+||+|.+.. +|+.||||+++...... ...+.+.+|+++|+.++|||||++++++..++.+|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 46789999999999999877 89999999997653222 223568899999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCeee
Q 042913 181 YCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLVE 260 (317)
Q Consensus 181 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 260 (317)
|+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 81 ~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9988877777643 46789999999999999999999999999999999999999999999999999987655432222
Q ss_pred cccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 261 TNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+ ..++..|++||..... .......|+||+|++++|+..|.|
T Consensus 159 ~----------~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 159 H----------QVVTRWYRAPELLFGA----RMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp C----------SCCCCTTCCHHHHTTC----SCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred c----------eecChhhccHHHHccC----CCCChhhhhhhcchHHHHHHhCcC
Confidence 2 2345567777765321 223578899999999999999954
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=288.00 Aligned_cols=198 Identities=23% Similarity=0.272 Sum_probs=164.8
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEE
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICF 177 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 177 (317)
+.++|+++++||+|+||+||+|+++ +++.||||++++..... +.+.+|+++++.++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4578999999999999999999986 47899999998754433 468899999999999999999999999999999
Q ss_pred EEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCC
Q 042913 178 LIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPT 257 (317)
Q Consensus 178 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~ 257 (317)
||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 v~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999987554 45689999999999999999999999999999999999999999999999999976544322
Q ss_pred eeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C-CC
Q 042913 258 LVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G-VP 315 (317)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G-~p 315 (317)
... ....++..|++||.... .......|+|++|.+++|+.. | .|
T Consensus 156 ~~~---------~~~~~t~~y~aPE~~~~-----~~~~~ksDiwS~G~~l~el~t~g~~P 201 (258)
T d1k2pa_ 156 TSS---------VGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMP 201 (258)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred eee---------cccCCCCCcCCcHHhcC-----CCCCcceeecccchhhHhHHhcCCCC
Confidence 111 11234445666665543 344578999999999999975 6 55
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=290.08 Aligned_cols=203 Identities=19% Similarity=0.265 Sum_probs=154.3
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCC--CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDC--TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
.+..++|++++.||+|+||.||+|.+... .+..||||.+.... .....+.+.+|+++++.++||||+++++++. ++
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45678999999999999999999988652 23568888885432 4555678999999999999999999999986 56
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+...
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 789999999999999987654 4678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~p 315 (317)
.......+. ..++..|++||. .........+|+||+|++++|+.. |.|
T Consensus 160 ~~~~~~~~~---------~~gt~~y~apE~-----l~~~~~~~~~DiwSlGvil~e~lt~g~~ 208 (273)
T d1mp8a_ 160 DSTYYKASK---------GKLPIKWMAPES-----INFRRFTSASDVWMFGVCMWEILMHGVK 208 (273)
T ss_dssp --------------------CCGGGCCHHH-----HHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCcceeccc---------eecCcccchhhH-----hccCCCCCccccccchHHHHHHHhcCCC
Confidence 433221111 123334555554 444455678999999999999765 743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.8e-41 Score=292.33 Aligned_cols=198 Identities=18% Similarity=0.214 Sum_probs=162.5
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+++|+++++||+|+||+||+|++. +++.||||++..........+.+.+|+.+|+.++||||+++++++...+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999886 589999999977654455567889999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
||++.++.+..+... .+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|.........
T Consensus 79 ~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999977666666643 477999999999999999999999999999999999999999999999999999876443221
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.. ...++..|++||.... ........|+|++|++++|+..|-
T Consensus 157 ~~----------~~~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 157 YT----------HEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp ---------------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cc----------eecccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCC
Confidence 11 1123345666665432 223367899999999999999993
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=290.93 Aligned_cols=198 Identities=20% Similarity=0.228 Sum_probs=161.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcH----HHHHHHHHHHHHHHhcC--CCCcceEEEEEEec
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSA----KKLSHVQMEAEILSMLD--HPFLPTLYAHLEVS 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 172 (317)
.++|++.+.||+|+||.||+|.+.. +++.||||++.+..... ....++.+|+.+|+.++ ||||+++++++...
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4689999999999999999999887 79999999997653221 12234678999999997 89999999999999
Q ss_pred CEEEEEEcccCC-CChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-CCcEEEeeecccc
Q 042913 173 HYICFLIDYCPN-GDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-DGHIMLSDFDLCF 250 (317)
Q Consensus 173 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-~~~~kl~DFG~a~ 250 (317)
+..|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 999999999976 577788755 367999999999999999999999999999999999999985 4799999999997
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
....... ....|+..|++||....+- .....+|+||+|++++|+..| .|
T Consensus 160 ~~~~~~~------------~~~~GT~~y~aPE~~~~~~----~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 160 LLKDTVY------------TDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp ECCSSCB------------CCCCSCGGGSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccc------------cccccCCCcCCHHHHcCCC----CCCcccccccceeeehhHhhCCCC
Confidence 6543211 1124566677777654321 125678999999999999999 44
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=284.64 Aligned_cols=200 Identities=20% Similarity=0.249 Sum_probs=167.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCEEEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 178 (317)
+++|+++++||+|+||+||+|++.. +++.||||+++..........++.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3689999999999999999999887 889999999987655556678899999999999999999999999999999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCe
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTL 258 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 258 (317)
++++.++.|..++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 80 ~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999988888888754 477899999999999999999999999999999999999999999999999999876543322
Q ss_pred eecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 259 VETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
... ..+...|.+||.... ....+...|+||+|++++|+..| .|
T Consensus 158 ~~~----------~~~~~~~~~pe~~~~----~~~~~~~~DiwSlG~il~ell~g~~p 201 (292)
T d1unla_ 158 YSA----------EVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp CCS----------CCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred cee----------eccccchhhhhHhcc----CCCCCchhhccccchHHHHHhhCCCC
Confidence 111 122223444443322 11235788999999999999988 55
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=284.42 Aligned_cols=203 Identities=22% Similarity=0.266 Sum_probs=155.7
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCC--ceEEEEEeehhhhcH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTS--ANFALKVVDKDLLSA-KKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
+..++|++++.||+|+||.||+|.+...++ ..||||++.+..... +..+.+.+|+++|+.++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 456789999999999999999998765343 368999987654333 556789999999999999999999999975 4
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 678999999999999887654 3569999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
......... ....++..|++||... ........|+||.|.+++|+.+ |
T Consensus 163 ~~~~~~~~~-------~~~~~~~~~~aPE~~~-----~~~~~~~~Di~S~Gvil~emlt~G 211 (273)
T d1u46a_ 163 QNDDHYVMQ-------EHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYG 211 (273)
T ss_dssp C-CCEEEC------------CCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCcceec-------CccccCcccCCHHHHh-----CCCCCcchhhhhhHHHHHHHHhCC
Confidence 544322111 1113344567777654 3345678899999999999986 7
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=288.60 Aligned_cols=199 Identities=18% Similarity=0.221 Sum_probs=157.7
Q ss_pred ccCCeEEeeeecccCCeEEEEEEEcCCCCc----eEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 042913 98 HLRHLKLVRHLGTGNLGRVFLCHLRDCTSA----NFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH 173 (317)
Q Consensus 98 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 173 (317)
...+|++++.||+|+||+||+|.+.. +++ .||+|.++... ..+..+.+.+|+++++.++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 44689999999999999999998876 444 57888775432 334557789999999999999999999999865
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..++++||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 567788889899999888654 4679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
.......+. ...++..|++||....+ ......|+||+|++++|+.+ |
T Consensus 163 ~~~~~~~~~--------~~~gt~~y~APE~l~~~-----~~~~~sDvwS~Gvil~el~t~g 210 (317)
T d1xkka_ 163 AEEKEYHAE--------GGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFG 210 (317)
T ss_dssp TTCC----------------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccccccccc--------ccccCccccChHHHhcC-----CCChhhhhhhHHHHHHHHHHCC
Confidence 443321111 11345677888766433 34578999999999999986 5
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=287.54 Aligned_cols=200 Identities=21% Similarity=0.220 Sum_probs=157.4
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSML---DHPFLPTLYAHLEV---- 171 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~---- 171 (317)
.++|++++.||+|+||+||+|.+....++.||||+++...........+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999998764577899999976543333334456677776665 79999999999853
Q ss_pred -cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 172 -SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 172 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
...++++|||+.++.+.... ......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35789999999776654433 3345779999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
....... .....++..|++||.... .......|+||+|++++|+..|.|
T Consensus 165 ~~~~~~~-----------~~~~~gT~~Y~APE~~~~-----~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 165 IYSFQMA-----------LTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp CCCGGGG-----------GCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhccccc-----------CCCcccChhhcCcchhcC-----CCCChhehhhchHHHHHHHHHCCC
Confidence 6433221 112245566777775543 344578999999999999999943
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=287.13 Aligned_cols=204 Identities=21% Similarity=0.227 Sum_probs=159.1
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-------
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------- 171 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 171 (317)
.++|+++++||+|+||+||+|.+.. +|+.||||++............+.+|+++|+.++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5899999999999999999999887 89999999997665555556778899999999999999999998754
Q ss_pred -cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccc
Q 042913 172 -SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCF 250 (317)
Q Consensus 172 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~ 250 (317)
++.+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 356899999997776665553 35679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
............. ....++..|++||.... ........|+||+|++++|+..|.|
T Consensus 166 ~~~~~~~~~~~~~------~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 166 AFSLAKNSQPNRY------TNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp ECCC-----CCCC------CSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccccccccc------cceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCC
Confidence 7654332211111 11234455666665422 1234578999999999999999944
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=291.23 Aligned_cols=195 Identities=22% Similarity=0.275 Sum_probs=159.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH----- 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 173 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++++........+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5799999999999999999999887 8999999999877667777788999999999999999999999997554
Q ss_pred -EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 174 -YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 174 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
.+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788887754 56999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
+...+ ...++..|++||.... ........|+|++|++++|+..|-|
T Consensus 172 ~~~~~-------------~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~ 217 (346)
T d1cm8a_ 172 DSEMT-------------GYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKT 217 (346)
T ss_dssp CSSCC-------------SSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCccc-------------cccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcC
Confidence 54221 1234445666665432 1234678999999999999999943
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-39 Score=285.12 Aligned_cols=205 Identities=20% Similarity=0.254 Sum_probs=166.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS 172 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 172 (317)
+..++|++++.||+|+||+||+|+++. .+++.||||+++... ..+..+++.+|+++|+.++||||+++++++...
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 345789999999999999999998753 246789999997643 445567899999999999999999999999999
Q ss_pred CEEEEEEcccCCCChhcccccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQP----------------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKP 230 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp 230 (317)
+..+++|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999985421 23478999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCccccccc
Q 042913 231 ENILLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQ 310 (317)
Q Consensus 231 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 310 (317)
+|||++.++.+||+|||+|+........... ....++..|++||... ........|+||.|++++|+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~-----~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKAD--------GNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHH
T ss_pred cceEECCCCcEEEccchhheeccCCcccccc--------CCCCcCcCcCCHHHHc-----cCCCChhhhhccchhhHHHH
Confidence 9999999999999999999866443321110 1123444567777654 33345789999999999999
Q ss_pred CCC-CC
Q 042913 311 PGG-VP 315 (317)
Q Consensus 311 ~~G-~p 315 (317)
..| .|
T Consensus 236 l~~~~~ 241 (301)
T d1lufa_ 236 FSYGLQ 241 (301)
T ss_dssp HTTTCC
T ss_pred HccCCC
Confidence 777 44
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=283.82 Aligned_cols=204 Identities=20% Similarity=0.249 Sum_probs=153.8
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++++.||+|+||.||+|.+.. .+++.||||+++... .....+.+.+|..++.++ +|+||+.+++++.
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3566899999999999999999998754 234689999987543 344456677788877776 6899999999876
Q ss_pred e-cCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 042913 171 V-SHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILL 235 (317)
Q Consensus 171 ~-~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill 235 (317)
. +..+++|||||++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 456899999999999999986532 2458899999999999999999999999999999999999
Q ss_pred ccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 236 REDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 236 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+.++.+||+|||+|+.......... .....++..|++||.... ......+|+||+|++++|+.+|
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~--------~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVR--------KGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCC--------TTSCCCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcEEEccCcchhhccccccccc--------cCceeeCccccchhHhhc-----CCCCcccceeehHHHHHHHHhC
Confidence 9999999999999987654433211 111234556777765543 3446789999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=285.28 Aligned_cols=206 Identities=20% Similarity=0.237 Sum_probs=170.0
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLE 170 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 170 (317)
.+..++|++++.||+|+||.||+|++.. .+++.||||+++... .......+.+|+.+++.+ +|||||++++++.
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3566899999999999999999998742 356789999997654 345556789999999999 6999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQP----------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENIL 234 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nil 234 (317)
..+.+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999986532 235889999999999999999999999999999999999
Q ss_pred EccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-C
Q 042913 235 LREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-G 313 (317)
Q Consensus 235 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G 313 (317)
++.++.+||+|||+++......... ..+..+|+|+|..+++........+.|+||+|++++|+.+ |
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYV-------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSE-------------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccCcccccccchheeccCCCcce-------------EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 9999999999999998765443321 1112234555555555555566789999999999999976 6
Q ss_pred CC
Q 042913 314 VP 315 (317)
Q Consensus 314 ~p 315 (317)
.|
T Consensus 245 ~p 246 (311)
T d1t46a_ 245 SS 246 (311)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-39 Score=281.62 Aligned_cols=204 Identities=20% Similarity=0.263 Sum_probs=164.2
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCEE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEVSHYI 175 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 175 (317)
+..++|++++.||+|+||+||+|.+.. +++.||||++..... ...+++|+++++.+.| +|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 446799999999999999999999887 799999999865421 2346778999999975 8999999999999999
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc-----CCcEEEeeecccc
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRE-----DGHIMLSDFDLCF 250 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~-----~~~~kl~DFG~a~ 250 (317)
++||||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 89999988654 457999999999999999999999999999999999999974 5789999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.+........... .......|+..|+|||.. .......++|+||++++++|+..| .|
T Consensus 155 ~~~~~~~~~~~~~---~~~~~~~GT~~y~aPE~~-----~~~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 155 FYRDPVTKQHIPY---REKKNLSGTARYMSINTH-----LGREQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp ESBCTTTCCBCCC---CCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EcccCccccceee---cccCceEEchhhcCHHHh-----cCCCCChHHHHHHhhHHHHHHHhCCCc
Confidence 7654332211100 111122455556666654 445567899999999999999998 44
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=287.70 Aligned_cols=198 Identities=17% Similarity=0.183 Sum_probs=156.2
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----E
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH-----Y 174 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 174 (317)
.+|++++.||+|+||+||+|.+.. +++.||||++.+.. .....+.+.+|+++|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 579999999999999999999877 89999999997543 4455678899999999999999999999986543 3
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|++++ +.+++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~l~~~-~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTH-LMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEE-CCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEe-ecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 555555 559999999965 4699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
....... .....++..|++||... ........+|+|++|++++|+..|-
T Consensus 162 ~~~~~~~-------~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 162 DHDHTGF-------LTEYVATRWYRAPEIML----NSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp GGCBCCT-------TCCCCSCGGGCCGGGTT----TBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred CCcccee-------eccccccceechHHHhh----cCCCCCchhhhhccCceehHHhhCC
Confidence 3321110 11123444455555432 2234467899999999999999993
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-39 Score=284.66 Aligned_cols=191 Identities=21% Similarity=0.265 Sum_probs=156.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe--cCEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEV--SHYI 175 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~ 175 (317)
.++|+++++||+|+||+||+|++.. +++.||||+++... .+++.+|+++|+.+. ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 4689999999999999999999877 89999999986542 356788999999996 9999999999974 4569
Q ss_pred EEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccccCCC
Q 042913 176 CFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCFQSDV 254 (317)
Q Consensus 176 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~~~~~ 254 (317)
++||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999998775 4589999999999999999999999999999999999998655 699999999987654
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.... ....++..|++||..... ...+..+|+|+++++++|+..| .|
T Consensus 183 ~~~~-----------~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 183 GQEY-----------NVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp TCCC-----------CSCCSCGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred CCcc-----------cccccCccccCcccccCC----CCCCcccchhhhhhhhHHhccCCCC
Confidence 3321 111234455666643221 2246789999999999999988 44
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=288.15 Aligned_cols=203 Identities=29% Similarity=0.450 Sum_probs=166.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcC--CCCceEEEEEeehhhh--cHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEe
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRD--CTSANFALKVVDKDLL--SAKKLSHVQMEAEILSMLDH-PFLPTLYAHLEV 171 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 171 (317)
+.+++|++++.||+|+||+||+|.... .+|+.||||++++... .....+.+.+|++++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 456889999999999999999998732 3688999999865432 12334567889999999976 899999999999
Q ss_pred cCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 172 SHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 172 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...++++|||+.+|+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999654 6688999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 252 SDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
........ .....++..|++||....+... ...+.|+||+|++++|+..|
T Consensus 179 ~~~~~~~~---------~~~~~g~~~~~~pe~~~~~~~~---~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 179 FVADETER---------AYDFCGTIEYMAPDIVRGGDSG---HDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp CCGGGGGG---------GCGGGSCCTTCCHHHHTTCC------CTHHHHHHHHHHHHHHHHS
T ss_pred hccccccc---------ccccccccccchhHHhhcCCcC---CCchhhhHHHHHHHHHHHhC
Confidence 65433211 1112455567777766433222 24678999999999999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=279.98 Aligned_cols=206 Identities=21% Similarity=0.274 Sum_probs=162.5
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYA 167 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 167 (317)
..+..++|++++.||+|+||.||+|+.... .+..||||+++.+. .......+.+|...+.++ +|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 346779999999999999999999987542 22479999997654 445567788898888888 7999999999
Q ss_pred EEEecCEEEEEEcccCCCChhcccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 042913 168 HLEVSHYICFLIDYCPNGDLHSLLPKQP--------------NNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENI 233 (317)
Q Consensus 168 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Ni 233 (317)
++.+++.+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999999999999996542 34689999999999999999999999999999999999
Q ss_pred EEccCCcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-
Q 042913 234 LLREDGHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG- 312 (317)
Q Consensus 234 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~- 312 (317)
|++.++.+||+|||+++......... ......++..|++||.... .....+.|+|++|++++|+.+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~-----~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTC--------CCTTSCCGGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecCCCCeEeccchhhcccccccccc--------ccccCCCChhhhhhhHhcC-----CCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999998664433211 1112234445666665543 344678899999999999985
Q ss_pred CC
Q 042913 313 GV 314 (317)
Q Consensus 313 G~ 314 (317)
|-
T Consensus 234 g~ 235 (299)
T d1fgka_ 234 GG 235 (299)
T ss_dssp SC
T ss_pred CC
Confidence 53
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-39 Score=282.72 Aligned_cols=200 Identities=24% Similarity=0.308 Sum_probs=161.9
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCc--eEEEEEeehhhhcHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSA--NFALKVVDKDLLSAKKLSHVQMEAEILSML-DHPFLPTLYAHLEVS 172 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 172 (317)
.++.++|++.++||+|+||.||+|.++. ++. .||||.+.... ..+..+.+.+|+++|+.+ +|||||++++++..+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 3567899999999999999999999877 555 46777765432 334556799999999998 799999999999999
Q ss_pred CEEEEEEcccCCCChhcccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQ--------------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLRED 238 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~ 238 (317)
+.+|+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999998653 24678999999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 239 GHIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 239 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
+.+||+|||+|+........ ....++..|++||.... ......+|+||.|.+++|+..|
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~-----------~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK-----------TMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp GCEEECCTTCEESSCEECCC---------------CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTT
T ss_pred CceEEccccccccccccccc-----------cceecCCcccchHHhcc-----CCCCccceeehhHHHHHHHHhc
Confidence 99999999999765432211 11234556777776643 3446789999999999998775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=280.10 Aligned_cols=194 Identities=22% Similarity=0.311 Sum_probs=156.6
Q ss_pred ccccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCE
Q 042913 96 KLHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-SHY 174 (317)
Q Consensus 96 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 174 (317)
.+..++|++++.||+|+||.||+|.++ |..||||+++.+. ..+.+++|++++++++||||+++++++.+ .+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 467789999999999999999999875 5789999997542 33568899999999999999999998854 566
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999999999999765445689999999999999999999999999999999999999999999999999986543
Q ss_pred CCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCC-CC
Q 042913 255 VPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPG-GV 314 (317)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-G~ 314 (317)
.... ..++..|++||+.... ......|+||.|++++|+.+ |-
T Consensus 156 ~~~~-------------~~~~~~y~aPE~l~~~-----~~t~~sDIwSfG~il~el~t~~~ 198 (262)
T d1byga_ 156 TQDT-------------GKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGR 198 (262)
T ss_dssp -------------------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcc-------------ccccccCCChHHHhCC-----CCChHHHHHhHHHHHHHHHHCCC
Confidence 2211 1234568888876432 34578999999999999986 63
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=288.78 Aligned_cols=195 Identities=21% Similarity=0.254 Sum_probs=154.8
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------c
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------S 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 172 (317)
.-+|+.+++||+|+||+||+|++.. +++.||||++.... ....+|+++|+.++|+||++++++|.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 4479999999999999999999887 89999999997642 123469999999999999999999853 3
Q ss_pred CEEEEEEcccCCCChhcccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC-cEEEeeecccc
Q 042913 173 HYICFLIDYCPNGDLHSLLP-KQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDG-HIMLSDFDLCF 250 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~-~~kl~DFG~a~ 250 (317)
.++|+||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 45899999996553333321 12356799999999999999999999999999999999999999775 89999999998
Q ss_pred cCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 251 QSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
........ ....++..|++||.... ........|+|++|++++|+..|.|
T Consensus 172 ~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 172 QLVRGEPN-----------VSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp ECCTTSCC-----------CSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred hccCCccc-----------ccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCC
Confidence 76543211 11245556777765432 2334678999999999999999954
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=280.16 Aligned_cols=202 Identities=19% Similarity=0.264 Sum_probs=159.3
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----E
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVSH----Y 174 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 174 (317)
.++|.+.+.||+|+||.||+|++. |+.||||++..... .....+.|+..+..++||||+++++++...+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET---TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 468999999999999999999864 68999999965421 1122234555556789999999999987654 6
Q ss_pred EEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeccCCCCcEEEccCCcEEEeee
Q 042913 175 ICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA--------LGIIYRDLKPENILLREDGHIMLSDF 246 (317)
Q Consensus 175 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------~~ivHrDikp~Nill~~~~~~kl~DF 246 (317)
+|+||||+++|+|.+++++ ..+++..++.++.|++.||.|||. +||+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 8999999999999999976 358999999999999999999996 58999999999999999999999999
Q ss_pred cccccCCCCCCeeecccccccccccccccCCCCCcccccccccc-eeccchhhhccCCcccccccCCCCC
Q 042913 247 DLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVME-FVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 247 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~-~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
|+|+........... ......++..|++||+..+.... .......+|+|+.|++++|+.+|.|
T Consensus 153 Gl~~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~ 216 (303)
T d1vjya_ 153 GLAVRHDSATDTIDI------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp TTCEEEETTTTEECC----------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred CccccccCCCcceec------cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence 999876544332211 11234677889999987654332 2234567899999999999998843
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=276.72 Aligned_cols=200 Identities=18% Similarity=0.190 Sum_probs=159.1
Q ss_pred EEeeeecccCCeEEEEEEEcCCCC--ceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCEEEEEE
Q 042913 103 KLVRHLGTGNLGRVFLCHLRDCTS--ANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV-SHYICFLI 179 (317)
Q Consensus 103 ~i~~~lg~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 179 (317)
.+.++||+|+||+||+|.+....+ ..||||+++.. ......+++.+|+++|++++||||+++++++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 346789999999999999865322 36899998643 255667889999999999999999999999765 56899999
Q ss_pred cccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCCCCCCee
Q 042913 180 DYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSDVVPTLV 259 (317)
Q Consensus 180 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 259 (317)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.........
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999988654 4567888999999999999999999999999999999999999999999999998765543221
Q ss_pred ecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 260 ETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
.. ......++..|++||... ........|+||.|.+++|+.+| .|
T Consensus 188 ~~------~~~~~~gt~~y~aPE~~~-----~~~~~~ksDI~SfGivl~El~t~~~p 233 (311)
T d1r0pa_ 188 VH------NKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAP 233 (311)
T ss_dssp TT------CTTCSSCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ce------ecccccccccccChHHHh-----cCCCCChhHhhhhHHHHHHHHHCCCC
Confidence 11 111123445566666543 33456788999999999999874 54
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=280.66 Aligned_cols=205 Identities=18% Similarity=0.184 Sum_probs=166.9
Q ss_pred CccccCCeEEeeeecccCCeEEEEEEEcC----CCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 042913 95 GKLHLRHLKLVRHLGTGNLGRVFLCHLRD----CTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLE 170 (317)
Q Consensus 95 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 170 (317)
..+..++|++++.||+|+||.||+|.++. .++..||||+++... .......+.+|++++++++||||+++++++.
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45777999999999999999999998752 235789999997653 4455677899999999999999999999999
Q ss_pred ecCEEEEEEcccCCCChhcccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEE
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPKQ--------PNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIM 242 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~k 242 (317)
.++..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 999999999999999999987542 123468899999999999999999999999999999999999999999
Q ss_pred EeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC
Q 042913 243 LSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG 313 (317)
Q Consensus 243 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G 313 (317)
|+|||+|+......... ..+..+++|+|..++.........+.|+|+.|++++|+..|
T Consensus 174 l~DFGla~~~~~~~~~~-------------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYR-------------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp ECCTTCCCGGGGGGCEE-------------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred EeecccceeccCCccee-------------eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhC
Confidence 99999998664433221 12223344555554444444455788999999999999866
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-38 Score=275.45 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=156.8
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPF-LPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 178 (317)
++|++++.||+|+||.||+|.+.. +++.||||++..... ..++.+|+++++.++|+| |+.+.+++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999877 789999999876432 235778999999998665 55666777888999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc---cCCcEEEeeecccccCCCC
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLR---EDGHIMLSDFDLCFQSDVV 255 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~---~~~~~kl~DFG~a~~~~~~ 255 (317)
|||+ +++|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 77777766543 46799999999999999999999999999999999999986 3557999999999877543
Q ss_pred CCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCC-CC
Q 042913 256 PTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGG-VP 315 (317)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G-~p 315 (317)
...... .........|+|+|+++++........++|+||+|++++|+..| .|
T Consensus 160 ~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P 212 (299)
T d1ckia_ 160 RTHQHI--------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212 (299)
T ss_dssp TTCCBC--------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccce--------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCc
Confidence 322111 01111222344444444445555567899999999999999999 44
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=283.63 Aligned_cols=195 Identities=16% Similarity=0.209 Sum_probs=155.0
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe------c
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEV------S 172 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 172 (317)
.++|+++++||+|+||+||+|.+.. +|+.||||++...........++.+|+.+++.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999887 89999999998877677777889999999999999999999999853 4
Q ss_pred CEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccC
Q 042913 173 HYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQS 252 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~ 252 (317)
..+|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 7899999999554 444442 45899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 253 DVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
...... ....++..|++||... ........|+|++|++++|+..|-|
T Consensus 170 ~~~~~~-----------~~~~~t~~y~aPE~l~-----~~~~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 170 GTSFMM-----------TPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp ----------------------CCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccc-----------ccccccccccChhhhc-----CCCCCCCcccccccchHHHHhhCCC
Confidence 432211 1113445566666654 3345678999999999999999943
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=283.67 Aligned_cols=196 Identities=19% Similarity=0.258 Sum_probs=158.9
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----C
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHLEVS-----H 173 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 173 (317)
.++|++++.||+|+||+||+|.+.. +++.||||++.+........+++.+|+++|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999887 899999999987766667777899999999999999999999998532 3
Q ss_pred EEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 174 YICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 174 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
..+++++++.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 34556667779999999854 569999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCCC
Q 042913 254 VVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGVP 315 (317)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~p 315 (317)
... ....++..|++||.... ........|+|++|++++|+..|.|
T Consensus 173 ~~~-------------~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 173 DEM-------------TGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp GGG-------------SSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccc-------------ccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCC
Confidence 221 11234455677765422 2234678999999999999999943
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.6e-32 Score=243.93 Aligned_cols=196 Identities=22% Similarity=0.262 Sum_probs=150.0
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-----------CCCcceE
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-----------HPFLPTL 165 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~ 165 (317)
+..++|+++++||+|+||+||+|++.. +|+.||||+++++. ...+.+.+|+++++.++ |+||+++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 344679999999999999999999887 89999999997653 33356778888888774 5789999
Q ss_pred EEEEEe--cCEEEEEEcccCCCC-hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCC--
Q 042913 166 YAHLEV--SHYICFLIDYCPNGD-LHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHA-LGIIYRDLKPENILLREDG-- 239 (317)
Q Consensus 166 ~~~~~~--~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivHrDikp~Nill~~~~-- 239 (317)
++++.. ....+++++++..+. ............+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 988753 456667776664443 3333334456778999999999999999999998 8999999999999998665
Q ss_pred ----cEEEeeecccccCCCCCCeeecccccccccccccccCCCCCcccccccccceeccchhhhccCCcccccccCCCC
Q 042913 240 ----HIMLSDFDLCFQSDVVPTLVETNVGSATRRRRRKSCNGFGSAKRRQENVMEFVAEPRREQREHPAQYSVEQPGGV 314 (317)
Q Consensus 240 ----~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~G~ 314 (317)
.++|+|||.|........ ...++..|++||.. ........+|+|+++++++|+..|-
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~~-------------~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHYT-------------NSIQTREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCCC-------------SCCSCGGGCCHHHH-----HTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccceeeEeecccccccccccc-------------cccccccccChhhc-----cccCCCccccccchHHHHHHHHHCC
Confidence 399999999876533221 12344455666544 3344567899999999999999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=9e-27 Score=190.53 Aligned_cols=137 Identities=19% Similarity=0.229 Sum_probs=107.6
Q ss_pred eEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhh----------------cHHHHHHHHHHHHHHHhcCCCCcceE
Q 042913 102 LKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLL----------------SAKKLSHVQMEAEILSMLDHPFLPTL 165 (317)
Q Consensus 102 y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 165 (317)
+.+.++||+|+||.||+|.+. +|+.||||+++.... .........+|...+..+.|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 467899999999999999876 489999998753211 11122345678889999999999998
Q ss_pred EEEEEecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCcEEEee
Q 042913 166 YAHLEVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHALGIIYRDLKPENILLREDGHIMLSD 245 (317)
Q Consensus 166 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivHrDikp~Nill~~~~~~kl~D 245 (317)
+++.. .+++|||+++..+.++ +...+..++.||+.+|.|||++||+||||||+|||++++ .++|+|
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred EEecC----CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 87532 2799999977665443 233456789999999999999999999999999999864 589999
Q ss_pred ecccccCCC
Q 042913 246 FDLCFQSDV 254 (317)
Q Consensus 246 FG~a~~~~~ 254 (317)
||+|+....
T Consensus 146 FG~a~~~~~ 154 (191)
T d1zara2 146 FPQSVEVGE 154 (191)
T ss_dssp CTTCEETTS
T ss_pred CCCcccCCC
Confidence 999977543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.93 E-value=2.6e-09 Score=89.54 Aligned_cols=142 Identities=13% Similarity=0.113 Sum_probs=95.4
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCEEEEE
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVSHYICFL 178 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 178 (317)
..|++.+..+-++...||+... .++.+++|+..... ......+.+|..+++.+. +--+++++.+...++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 5677777655555578998753 35678889876542 122234677888888775 44478889888888999999
Q ss_pred EcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 042913 179 IDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL------------------------------------- 221 (317)
Q Consensus 179 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~------------------------------------- 221 (317)
|++++|.++.+..... .. ...++.++...|..||+.
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999888876554221 11 112233334444444421
Q ss_pred ----------------------CCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 222 ----------------------GIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 222 ----------------------~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.++|+|+.|.|||+++++.+-|+||+.|...+
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~ 215 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC
Confidence 26899999999999976667799999986543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.53 E-value=1.7e-07 Score=77.65 Aligned_cols=139 Identities=17% Similarity=0.030 Sum_probs=84.8
Q ss_pred ecccCC-eEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecCEEEEEEcccCC
Q 042913 108 LGTGNL-GRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD--HPFLPTLYAHLEVSHYICFLIDYCPN 184 (317)
Q Consensus 108 lg~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~ 184 (317)
+..|.. ..||+.... .+..+++|...... ...+..|..+++.+. .-.+++++.+...++..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC--CCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 444543 678998755 36778999875442 134667788777764 33467888888888899999999988
Q ss_pred CChhccccc-----------------C--CCCCC--CHHHHHH-----H---------------HHHHHHHHHHHHHc--
Q 042913 185 GDLHSLLPK-----------------Q--PNNRF--SLQAVRF-----F---------------AAEVLVGLEYLHAL-- 221 (317)
Q Consensus 185 gsL~~~l~~-----------------~--~~~~~--~~~~~~~-----i---------------~~qi~~al~~LH~~-- 221 (317)
.++.+.... . ....+ ....... + .......+..+...
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 170 (255)
T ss_dssp EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence 776543210 0 00000 0000000 0 00011122333321
Q ss_pred -----CCeeccCCCCcEEEccCCcEEEeeecccccCC
Q 042913 222 -----GIIYRDLKPENILLREDGHIMLSDFDLCFQSD 253 (317)
Q Consensus 222 -----~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~ 253 (317)
.++|+|+.|.|||++.+..+.|+||+.+...+
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g~ 207 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 207 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred ccCCceEEeCCCCCcceEEeCCceEEEEEchhcccCC
Confidence 27999999999999987667899999986543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=2.7e-07 Score=81.82 Aligned_cols=79 Identities=14% Similarity=0.210 Sum_probs=50.0
Q ss_pred eeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhc-----HHHHHHHHHHHHHHHhcC-C--CCcceEEEEEEecCEEE
Q 042913 105 VRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLS-----AKKLSHVQMEAEILSMLD-H--PFLPTLYAHLEVSHYIC 176 (317)
Q Consensus 105 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~ 176 (317)
.+.||.|....||++.... .++.++||........ +....+...|.++|+.+. + ..+++++.+. ....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCE
Confidence 4568999999999997765 5778999975432110 112344567888887663 2 3567777653 34457
Q ss_pred EEEcccCCCC
Q 042913 177 FLIDYCPNGD 186 (317)
Q Consensus 177 lv~e~~~~gs 186 (317)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.76 E-value=7.5e-05 Score=65.60 Aligned_cols=80 Identities=26% Similarity=0.438 Sum_probs=52.0
Q ss_pred CCeEEeeeecccCCeEEEEEEEcCC------CCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec
Q 042913 100 RHLKLVRHLGTGNLGRVFLCHLRDC------TSANFALKVVDKDLLSAKKLSHVQMEAEILSMLD-HPFLPTLYAHLEVS 172 (317)
Q Consensus 100 ~~y~i~~~lg~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 172 (317)
+.++| +.|+-|-.=.+|++..... ..+.|++++.-.. .. .....+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 44555 5677788889999987541 2356777776422 11 123457888888875 4334688887653
Q ss_pred CEEEEEEcccCCCChh
Q 042913 173 HYICFLIDYCPNGDLH 188 (317)
Q Consensus 173 ~~~~lv~e~~~~gsL~ 188 (317)
++|+||++|..|.
T Consensus 117 ---g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPLS 129 (395)
T ss_dssp ---EEEECCCCEEECC
T ss_pred ---ceEEEEeccccCC
Confidence 6899999875543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.71 E-value=6.1e-05 Score=64.35 Aligned_cols=135 Identities=16% Similarity=0.114 Sum_probs=76.0
Q ss_pred CeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc--ceEE-----EEEEecCEEEEEEcccCCC
Q 042913 113 LGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL--PTLY-----AHLEVSHYICFLIDYCPNG 185 (317)
Q Consensus 113 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~g 185 (317)
--.||++...+ |..|++|+.+....+. +++..|...+..|....| +..+ ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~~d--g~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDED--RRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTT--CCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCC--CCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35899997764 8899999987654333 345667777777642221 1111 1234567889999999765
Q ss_pred Chhccc------------------ccC--C-CCC-------------------CCHHHHHHHHHHHHHHHHHHHH-----
Q 042913 186 DLHSLL------------------PKQ--P-NNR-------------------FSLQAVRFFAAEVLVGLEYLHA----- 220 (317)
Q Consensus 186 sL~~~l------------------~~~--~-~~~-------------------~~~~~~~~i~~qi~~al~~LH~----- 220 (317)
.+...- ... . ... ++......+...+-..+..+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 432110 000 0 001 1111111122222222333322
Q ss_pred --cCCeeccCCCCcEEEccCCcEEEeeecccccCCC
Q 042913 221 --LGIIYRDLKPENILLREDGHIMLSDFDLCFQSDV 254 (317)
Q Consensus 221 --~~ivHrDikp~Nill~~~~~~kl~DFG~a~~~~~ 254 (317)
.++||+|+.+.|||++. + ..++||+.|.....
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~~ 223 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARNGPA 223 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCEECT
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhcccCcH
Confidence 35899999999999974 3 56899999875443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.47 E-value=8.3e-05 Score=63.04 Aligned_cols=146 Identities=20% Similarity=0.163 Sum_probs=76.7
Q ss_pred cCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCc--ceEE------EEEE
Q 042913 99 LRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFL--PTLY------AHLE 170 (317)
Q Consensus 99 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~------~~~~ 170 (317)
++...-.+.|..|---+.|+..... ..+++|+..... ..+.+..|++++..|...++ +..+ .+..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~~---g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTTK---DPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEESS---CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEECC---CcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 3445556667778778899987654 468999986431 22345556777766642211 1111 0122
Q ss_pred ecCEEEEEEcccCCCChhccccc------------------C---CCCCCCHH------------------HHHHHHHHH
Q 042913 171 VSHYICFLIDYCPNGDLHSLLPK------------------Q---PNNRFSLQ------------------AVRFFAAEV 211 (317)
Q Consensus 171 ~~~~~~lv~e~~~~gsL~~~l~~------------------~---~~~~~~~~------------------~~~~i~~qi 211 (317)
..+..+.++.++.+......... . ........ .....+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 34566677777765443221100 0 00000000 011112222
Q ss_pred HHHHHHHHH----cCCeeccCCCCcEEEccCCcEEEeeeccccc
Q 042913 212 LVGLEYLHA----LGIIYRDLKPENILLREDGHIMLSDFDLCFQ 251 (317)
Q Consensus 212 ~~al~~LH~----~~ivHrDikp~Nill~~~~~~kl~DFG~a~~ 251 (317)
...+...+. .|+||+|+.++||+++.+...-|+||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 222222221 3799999999999999887789999999853
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=85.58 E-value=2.7 Score=34.14 Aligned_cols=142 Identities=14% Similarity=0.152 Sum_probs=76.5
Q ss_pred cccCCeEEeeeecccCCeEEEEEEEcCCCCceEEEEEeehhhhcHHHHHHHHHHHHHHHhcCCCCcceEEEEE-------
Q 042913 97 LHLRHLKLVRHLGTGNLGRVFLCHLRDCTSANFALKVVDKDLLSAKKLSHVQMEAEILSMLDHPFLPTLYAHL------- 169 (317)
Q Consensus 97 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------- 169 (317)
...++++-++.=-.|+-|..|. ... +..++||.-.. ...+.+-.|+...-.++-|...-+ ..+
T Consensus 66 ~~l~~~K~i~~s~~Gs~Gv~FV-~~e---~gaiVlK~s~t-----ta~E~y~~eLAr~LGvpvPqmRvI-~~~~~E~~~~ 135 (342)
T d1cjaa_ 66 KNLQQFKGIERSEKGTEGLFFV-ETE---SGVFIVKRSTN-----IESETFCSLLCMRLGLHAPKVRVV-SSNSEEGTNM 135 (342)
T ss_dssp TCGGGEEEEEECCSTTSCEEEE-EES---SCEEEEECCTT-----HHHHHHHHHHHHHHTCCCCCEEEE-ESSSHHHHHH
T ss_pred hhHHhhhceEEeecCCceEEEE-EcC---CceEEEecCCc-----hHHHHHHHHHHHHhCCCCCceEEe-cCCCHHHHHH
Confidence 4556677776665677666664 322 45778887431 222334444444444556655332 211
Q ss_pred ----------------EecCEEEEEEcccCCCChhcccccCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecc-CC
Q 042913 170 ----------------EVSHYICFLIDYCPNGDLHSLLPKQPNNRFSLQAVRFFAAEVLVGLEYLHAL---GIIYRD-LK 229 (317)
Q Consensus 170 ----------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivHrD-ik 229 (317)
....-.+++|||.+|..|.+.-.......+....+..+.+ |+--=.+++.. .+++|+ =.
T Consensus 136 ~~~~l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGk-IiaFDifInN~DR~PL~Wrn~GN 214 (342)
T d1cjaa_ 136 LECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS-LMALDVIVNNSDRLPIAWTNEGN 214 (342)
T ss_dssp HHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH-HHHHHHHHTCCSSSCSSSCSCCC
T ss_pred HHHHhcCCChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhh-HHHHHHHHcCCccccccccCCCC
Confidence 0123468999999888877665332112233333322211 22112244542 355552 28
Q ss_pred CCcEEEccCC-cEEEeeeccc
Q 042913 230 PENILLREDG-HIMLSDFDLC 249 (317)
Q Consensus 230 p~Nill~~~~-~~kl~DFG~a 249 (317)
+.||+++.++ .+..+|=|+.
T Consensus 215 ~~Niml~~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 215 LDNIMLSERGATVVPIDSKII 235 (342)
T ss_dssp GGGEEEESBTTCEEECSCCCC
T ss_pred ccceEEecCCcEEEEecCCcc
Confidence 9999998777 7888885554
|